Interaction	O
of	O
sickle	cell_type
erythrocytes	cell_type
with	O
endothelial	cell_type
cells	cell_type
in	O
the	O
presence	O
of	O
endothelial	O
cell	O
conditioned	O
medium	O
induces	O
oxidant	O
stress	O
leading	O
to	O
transendothelial	O
migration	O
of	O
monocytes	cell_type
.	O
The	O
abnormal	O
adherence	O
of	O
sickle	cell_type
red	cell_type
blood	cell_type
cells	cell_type
(	O
SS	cell_type
RBC	cell_type
)	O
to	O
endothelial	cell_type
cells	cell_type
has	O
been	O
thought	O
to	O
contribute	O
to	O
vascular	O
occlusion	O
,	O
a	O
major	O
cause	O
of	O
morbidity	O
in	O
sickle	O
cell	O
disease	O
(	O
SCD	O
).	O
We	O
determined	O
whether	O
the	O
interaction	O
of	O
SS	cell_type
RBC	cell_type
with	O
cultured	O
endothelial	cell_type
cells	cell_type
induced	O
cellular	O
oxidant	O
stress	O
that	O
would	O
culminate	O
in	O
expression	O
of	O
cell	protein
adhesion	protein
molecules	protein
(	O
CAMs	protein
)	O
involved	O
in	O
the	O
adhesion	O
and	O
diapedesis	O
of	O
monocytes	cell_type
and	O
the	O
adherence	O
of	O
SS	cell_type
reticulocytes	cell_type
.	O
We	O
showed	O
that	O
the	O
interaction	O
of	O
SS	cell_type
RBC	cell_type
at	O
2%	O
concentration	O
in	O
the	O
presence	O
of	O
multimers	O
of	O
von	protein
Willebrand	protein
factor	protein
(	O
vWf	protein
),	O
derived	O
from	O
endothelial	O
cell-derived	O
conditioned	O
medium	O
(	O
E-CM	O
)	O
with	O
cultured	cell_line
human	cell_line
umbilical	cell_line
vein	cell_line
endothelial	cell_line
cells	cell_line
(	O
HUVEC	cell_line
),	O
resulted	O
in	O
a	O
fivefold	O
increased	O
formation	O
of	O
thiobarbituric	O
acid-reactive	O
substances	O
(	O
TBARS	O
)	O
and	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kB	protein
,	O
both	O
indicators	O
of	O
cellular	O
oxidant	O
stress	O
.	O
Normal	cell_type
RBC	cell_type
show	O
none	O
of	O
these	O
phenomena.	O
The	O
oxidant	O
stress-induced	O
signaling	O
resulted	O
in	O
an	O
increased	O
surface	O
expression	O
of	O
a	O
subset	O
of	O
CAMs	protein
,	O
ICAM-1	protein
,	O
E-selectin	protein
,	O
and	O
VCAM-1	protein
in	O
HUVEC	cell_line
.	O
The	O
addition	O
of	O
oxygen	protein
radical	protein
scavenger	protein
enzymes	protein
(	O
catalase	protein
,	O
superoxide	protein
dismutase	protein
)	O
and	O
antioxidant	O
(	O
probucol	O
)	O
inhibited	O
these	O
events.	O
Additionally,	O
preincubation	O
of	O
HUVEC	cell_line
with	O
a	O
synthetic	O
peptide	O
Arg-Gly-Asp	O
(	O
RGD	O
)	O
that	O
prevents	O
vWf	protein
-mediated	O
adhesion	O
of	O
SS	cell_type
RBC	cell_type
reduced	O
the	O
surface	O
expression	O
of	O
VCAM-1	protein
and	O
NF-kB	protein
activation	O
.	O
Furthermore,	O
SS	cell_type
RBC	cell_type
-induced	O
oxidant	O
stress	O
resulted	O
in	O
a	O
twofold	O
increase	O
in	O
the	O
transendothelial	O
migration	O
of	O
both	O
monocyte-like	cell_line
HL-60	cell_line
cells	cell_line
and	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
,	O
and	O
approximately	O
a	O
sixfold	O
increase	O
in	O
platelet-endothelial	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
PECAM-1	protein
)	O
phosphorylation	O
,	O
each	O
of	O
which	O
was	O
blocked	O
by	O
protein	protein
kinase	protein
C	protein
inhibitor	O
and	O
antioxidants	O
.	O
These	O
results	O
suggest	O
that	O
the	O
adherence/contact	O
of	O
SS	cell_type
RBC	cell_type
to	O
endothelial	cell_type
cells	cell_type
in	O
large	O
vessel	O
can	O
generate	O
enhanced	O
oxidant	O
stress	O
leading	O
to	O
increased	O
adhesion	O
and	O
diapedesis	O
of	O
monocytes	cell_type
,	O
as	O
well	O
as	O
heightened	O
adherence	O
of	O
SS	cell_type
reticulocytes	cell_type
,	O
indicating	O
that	O
injury/activation	O
of	O
endothelium	O
can	O
contribute	O
to	O
vaso-occlusion	O
in	O
SCD	O
.	O

Signal	O
transduction	O
abnormalities	O
in	O
T	cell_type
lymphocytes	cell_type
from	O
patients	O
with	O
advanced	O
renal	O
carcinoma	O
:	O
clinical	O
relevance	O
and	O
effects	O
of	O
cytokine	protein
therapy	O
.	O
Studies	O
have	O
demonstrated	O
abnormalities	O
of	O
the	O
CD3/T-cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
)	O
and	O
pathways	O
of	O
signal	O
transduction	O
in	O
T	cell_type
lymphocytes	cell_type
from	O
animals	O
and	O
patients	O
with	O
advanced	O
malignancy	O
.	O
Diminished	O
expression	O
of	O
TCRzeta	protein
and	O
p56(lck)	protein
that	O
are	O
associated	O
with	O
the	O
TCR	protein
and	O
reduced	O
nuclear	O
localization	O
of	O
RelA	protein
containing	protein
nuclear	protein
factor	protein
kappaB	protein
(	protein
NFkappaB	protein
)	protein
complexes	protein
have	O
been	O
noted.	O
These	O
defects	O
have	O
been	O
described	O
in	O
T	cell_type
cells	cell_type
from	O
patients	O
with	O
malignant	O
melanoma	O
,	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
),	O
ovarian	O
cancer	O
,	O
and	O
colorectal	O
cancer	O
.	O
Preliminary	O
observations	O
also	O
indicate	O
possible	O
correlation	O
with	O
clinical	O
variables	O
such	O
as	O
stage	O
in	O
selected	O
instances.	O
To	O
further	O
characterize	O
altered	O
expression	O
of	O
TCRzeta	protein
,	O
p56(lck)	protein
,	O
and	O
impaired	O
activation	O
of	O
NFkappaB	protein
,	O
T	cell_type
lymphocytes	cell_type
were	O
obtained	O
from	O
65	O
patients	O
with	O
RCC	O
,	O
the	O
majority	O
of	O
whom	O
were	O
receiving	O
combination	O
cytokine	protein
therapy	O
[	O
interleukin	protein
(IL)-2	protein
,	O
IFN	protein
alpha	protein
-containing	O
regimens	O
]	O
and	O
37	O
control	O
individuals.	O
In	O
29	O
of	O
these	O
patients	O
,	O
levels	O
of	O
TCRzeta	protein
and	O
p56(lck)	protein
were	O
determined	O
by	O
Western	O
blots	O
of	O
T-cell	O
lysates	O
and	O
semiquantitated	O
using	O
densitometry	O
.	O
Relative	O
levels	O
were	O
then	O
correlated	O
with	O
a	O
series	O
of	O
clinical	O
variables	O
including	O
response	O
to	O
therapy	O
,	O
performance	O
status	O
,	O
survival,	O
disease	O
sites	O
,	O
age,	O
and	O
others.	O
In	O
another	O
group	O
of	O
28	O
patients	O
(three	O
individuals	O
from	O
the	O
first	O
group),	O
the	O
frequency	O
of	O
abnormal	O
NFkappaB	protein
activation	O
was	O
studied	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
after	O
activation	O
of	O
T	cell_type
cells	cell_type
with	O
phorbol	O
myristate	O
acetate/ionomycin	O
or	O
anti-CD3	protein
monoclonal	protein
antibody	protein
.	O
Changes	O
in	O
these	O
signaling	O
molecules	O
during	O
cytokine	protein
treatment	O
were	O
also	O
investigated.	O
TCRzeta	protein
and	O
p56(lck)	protein
were	O
detected	O
in	O
the	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
in	O
27	O
of	O
29	O
patients	O
,	O
and	O
overall,	O
reduced	O
levels	O
were	O
noted	O
visually	O
in	O
12	O
of	O
29	O
(41%)	O
and	O
13	O
of	O
29	O
(45%)	O
individuals,	O
respectively.	O
When	O
levels	O
were	O
semiquantitated	O
using	O
densitometry	O
,	O
significant	O
decreases	O
of	O
TCRzeta	protein
(P	O
=	O
0.029)	O
and	O
p56(lck)	protein
(P	O
=	O
0.029)	O
but	O
not	O
CD3epsilon	protein
(P	O
=	O
0.131),	O
compared	O
with	O
control	O
levels,	O
were	O
found.	O
In	O
patients	O
treated	O
with	O
IL-2/	O
IFN	protein
alpha	protein
-based	O
therapy	O
,	O
relative	O
levels	O
of	O
TCRzeta	protein
increased	O
significantly	O
(P	O
=	O
0.002)	O
on	O
day	O
15	O
of	O
cycle	O
one	O
compared	O
with	O
the	O
baseline.	O
Correlations	O
of	O
TCRzeta	protein
or	O
p56(lck)	protein
levels	O
with	O
response	O
or	O
disease	O
variables,	O
except	O
for	O
lower	O
TCRzeta	protein
levels	O
(P	O
&lt;	O
0.001)	O
in	O
the	O
presence	O
of	O
bone	O
metastases	O
,	O
were	O
not	O
found.	O
Abnormal	O
NFkappaB	protein
activation	O
after	O
stimulation	O
with	O
phorbol	O
myristate	O
acetate/ionomycin	O
and/or	O
anti-CD3	protein
monoclonal	protein
antibody	protein
was	O
found	O
in	O
59%	O
of	O
patients	O
(17	O
of	O
28)	O
and	O
was	O
not	O
accounted	O
for	O
by	O
the	O
advanced	O
age	O
of	O
the	O
study	O
cohort.	O
Activation	O
of	O
NFkappaB	protein
in	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
was	O
inducible	O
during	O
cytokine	protein
therapy	O
in	O
four	O
of	O
six	O
individuals	O
who	O
displayed	O
impaired	O
NFkappaB	protein
activity	O
prior	O
to	O
therapy.	O
Moreover,	O
impaired	O
activation	O
of	O
NFkappaB	protein
does	O
not	O
appear	O
linked	O
to	O
a	O
reduction	O
of	O
TCRzeta	protein
expression	O
,	O
because	O
in	O
five	O
patients	O
,	O
normal	O
TCRzeta	protein
levels	O
were	O
present	O
although	O
kappaB	protein
binding	O
was	O
not	O
inducible.	O
In	O
the	O
majority	O
of	O
patients	O
with	O
advanced	O
RCC	O
,	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
express	O
TCRzeta	protein
and	O
p56(lck)	protein
,	O
and	O
in	O
a	O
subset,	O
reduced	O
levels	O
of	O
these	O
TCRzeta	protein
associated	protein
molecules	protein
are	O
seen	O
that	O
may	O
increase	O
during	O
cytokine	protein
-based	O
therapy	O
.	O
Abnormal	O
activation	O
of	O
NFkappaB	protein
is	O
also	O
present	O
in	O
&gt;50%	O
of	O
patients	O
and	O
may	O
also	O
revert	O
to	O
normal	O
during	O
IL-2/	O
IFN	protein
alpha	protein
-based	O
treatment	O
.	O
This	O
alteration	O
in	O
NFkappaB	protein
activation	O
occurred	O
in	O
the	O
presence	O
of	O
normal	O
expression	O
of	O
TCRzeta	DNA
-associated	DNA
signaling	DNA
elements	DNA
.	O
The	O
clinical	O
significance	O
of	O
these	O
findings	O
remains	O
unclear.	O

Identification	O
of	O
transcription	protein
factors	protein
expressed	O
during	O
ATRA-induced	O
neutrophil	O
differentiation	O
of	O
HL60	cell_line
cells	cell_line
.	O
A	O
recent	O
clinical	O
therapeutic	O
initiative	O
has	O
been	O
the	O
use	O
of	O
chemical	O
agents	O
which	O
induce	O
the	O
leukaemic	cell_type
cells	cell_type
to	O
overcome	O
their	O
block	O
in	O
differentiation.	O
In	O
order	O
to	O
understand	O
this	O
block	O
the	O
cascade	O
of	O
molecular	O
events	O
needs	O
to	O
be	O
characterized.	O
Haemopoietic	O
differentiation	O
is	O
ultimately	O
controlled	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
which	O
is	O
mediated	O
by	O
an	O
array	O
of	O
transcription	protein
factors	protein
.	O
Many	O
transcription	protein
factors	protein
contain	O
similar	O
structural	protein
protein	protein
sequences	protein
,	O
and	O
we	O
have	O
used	O
an	O
RT-PCR	O
-based	O
approach	O
to	O
isolate	O
sequences,	O
from	O
transcription	protein
factor	protein
gene	O
families	O
which	O
share	O
similar	O
domains.	O
Degenerate	O
primers	O
corresponding	O
to	O
the	O
TFIIIA	DNA
zinc-finger	DNA
consensus	DNA
amino	DNA
acid	DNA
sequences	DNA
and	O
to	O
the	O
POU-homeodomain	protein
and	O
POU-specific	protein
domain	protein
were	O
used	O
to	O
amplify	O
genes	O
on	O
the	O
basis	O
that	O
they	O
contained	O
similarities	O
in	O
structural	O
motifs	O
shared	O
within	O
these	O
families	O
of	O
transcription	protein
factors	protein
.	O
A	O
serum-independent	cell_line
HL60	cell_line
cell	cell_line
line	cell_line
was	O
induced	O
towards	O
the	O
neutrophil	O
lineage	O
by	O
treatment	O
with	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
for	O
24	O
h.	O
CD38+	cell_type
cells	cell_type
committed	O
towards	O
this	O
lineage	O
were	O
enriched	O
and	O
a	O
population	O
of	O
these	O
cells	O
treated	O
with	O
dihydroxyvitamin	O
D3	O
to	O
induce	O
neutrophil	O
maturation.	O
RNA	O
extracted	O
from	O
uninduced,	O
ATRA	cell_line
-induced	cell_line
CD38+	cell_line
cells	cell_line
,	O
and	O
vitamin	cell_line
D3	cell_line
treated	cell_line
maturing	cell_line
cell	cell_line
cultures	cell_line
were	O
amplified	O
using	O
the	O
degenerate	O
primers	O
.	O
PCR	DNA
fragments	DNA
were	O
cloned,	O
sequenced,	O
clustered	O
into	O
homologous	O
groups,	O
and	O
the	O
group	O
sequences	O
searched	O
on	O
the	O
GenBank	O
database	O
.	O
The	O
Oct	O
1	O
transcription	protein
factor	protein
,	O
and	O
a	O
very	O
close	O
homologue,	O
KIAA0144	DNA
,	O
was	O
identified	O
using	O
the	O
POU	O
family	O
primers	O
.	O
The	O
zinc-finger	O
primers	O
identified	O
three	O
zinc-finger	O
genes	O
.	O
The	O
pattern	O
of	O
gene	O
expression	O
was	O
suggested	O
from	O
the	O
number	O
of	O
clones	O
in	O
each	O
group	O
at	O
neutrophil	O
commitment	O
and	O
maturation.	O
The	O
differential	O
expression	O
of	O
the	O
genes	O
in	O
the	O
zinc	O
finger	O
and	O
POU	O
families	O
will	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
the	O
cascade	O
of	O
gene	O
expression	O
which	O
occurs	O
following	O
ATRA	O
-induced	O
differentiation	O
.	O

GATA-3	protein
-dependent	O
enhancer	O
activity	O
in	O
IL-4	DNA
gene	DNA
regulation	O
.	O
Previously,	O
we	O
analyzed	O
the	O
proximal	DNA
IL-4	DNA
promoter	DNA
in	O
directing	O
Th2-specific	O
activity	O
.	O
An	O
800-base	DNA
pair	DNA
proximal	DNA
promoter	DNA
conferred	O
some	O
Th2-selective	O
expression	O
in	O
transgenic	O
mice	O
.	O
However,	O
this	O
region	O
directed	O
extremely	O
low	O
reporter	O
mRNA	O
levels	O
relative	O
to	O
endogenous	O
IL-4	RNA
mRNA	RNA
,	O
suggesting	O
that	O
full	O
gene	O
activity	O
requires	O
additional	O
enhancer	DNA
elements	DNA
.	O
Here,	O
we	O
analyzed	O
large	O
genomic	DNA
IL-4	DNA
regions	DNA
for	O
enhancer	O
activity	O
and	O
interaction	O
with	O
transcription	protein
factors	protein
.	O
The	O
proximal	O
IL-4	DNA
promoter	DNA
is	O
only	O
moderately	O
augmented	O
by	O
GATA-3	protein
,	O
but	O
certain	O
genomic	DNA
regions	DNA
significantly	O
enhanced	O
GATA-3	DNA
promoter	DNA
transactivation	O
.	O
Some	O
enhancing	O
regions	O
contained	O
consensus,	O
GATA	DNA
sites	DNA
that	O
bound	O
Th2-specific	protein
complexes	protein
.	O
However,	O
retroviral	O
transduction	O
of	O
GATA-3	protein
into	O
developing	cell_type
T	cell_type
cells	cell_type
induced	O
IL-5	protein
to	O
full	O
Th2	protein
levels	O
,	O
but	O
only	O
partially	O
restored	O
IL-4	protein
production	O
.	O
Thus,	O
we	O
propose	O
that	O
GATA-3	protein
is	O
permissive,	O
but	O
not	O
sufficient,	O
for	O
full	O
IL-4	protein
enhancement	O
and	O
may	O
act	O
through	O
GATA	DNA
elements	DNA
surrounding	O
the	O
IL-13	DNA
/	DNA
IL-4	DNA
gene	DNA
locus	DNA
.	O

Position	O
effect	O
of	O
translocations	O
involving	O
the	O
inactive	DNA
X	DNA
chromosome	DNA
:	O
physical	O
linkage	O
to	O
XIC/XIST	DNA
does	O
not	O
lead	O
to	O
long-range	O
de	O
novo	O
inactivation	O
in	O
human	cell_type
differentiated	cell_type
cells	cell_type
.	O
Given	O
the	O
reported	O
long-range	O
cis-inactivating	O
effect	O
of	O
the	O
XIST	DNA
gene	DNA
in	O
early	O
embryonic	O
development	O
and	O
the	O
lack	O
of	O
requirement	O
of	O
X-chromosome-specific	DNA
elements	DNA
for	O
propagating	O
the	O
inactive	O
state,	O
there	O
exists	O
the	O
possibility	O
of	O
cis	O
inactivation	O
of	O
autosomal	O
material	O
after	O
de	O
novo	O
translocation	O
to	O
an	O
inactive	DNA
X	DNA
chromosome	DNA
(	O
Xi	DNA
)	O
in	O
differentiated	cell_type
cells	cell_type
.	O
We	O
have	O
analyzed	O
de	O
novo	O
radiation-induced	O
translocations	O
between	O
the	O
Xi	DNA
and	O
autosomes	DNA
to	O
study	O
the	O
maintenance	O
and	O
spreading	O
of	O
X-chromosome	DNA
inactivation	O
(	O
X	O
inactivation	O
)	O
in	O
relation	O
to	O
the	O
position	O
of	O
the	O
X-inactivation	O
center	O
(XIC)/XIST	DNA
in	O
differentiated	cell_type
cells	cell_type
.	O
Autosome/	O
Xi	DNA
translocations	O
were	O
detected	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
).	O
The	O
activation	O
status	O
of	O
the	O
chromosomes	DNA
involved	O
in	O
the	O
translocation	O
was	O
determined	O
by	O
simultaneous	O
immunocytogenetic	O
studies	O
using	O
antibodies	protein
against	O
either	O
BrdU	protein
incorporated	O
at	O
late	O
S	O
phase	O
or	O
acetylated	protein
histone	protein
H4	protein
.	O
The	O
position	O
of	O
XIC/XIST	DNA
in	O
the	O
reciprocal	O
products	O
of	O
the	O
translocation	O
was	O
determined	O
by	O
XIST-specific	O
FISH	O
and	O
computer	O
enhancement	O
.	O
In	O
other	O
experiments,	O
the	O
Xq13	DNA
region	DNA
carrying	O
XIC/XIST	DNA
was	O
localized	O
by	O
computer	O
enhancement	O
of	O
the	O
DAPI	O
banding	O
pattern	O
.	O
Our	O
study	O
in	O
differentiated	cell_type
cells	cell_type
provides	O
a	O
visual	O
demonstration	O
that	O
physical	O
separation	O
from	O
XIC/XIST	DNA
does	O
not	O
result	O
in	O
reactivation	O
of	O
inactive	DNA
X-chromosome	DNA
material	O
and	O
that	O
X	O
inactivation	O
is	O
not	O
spread	O
to	O
the	O
translocated	DNA
autosomes	DNA
irrespective	O
of	O
the	O
position	O
of	O
XIC/XIST	DNA
.	O
This	O
observation	O
suggests	O
that	O
physical	O
linkage	O
to	O
XIC/XIST	DNA
does	O
not	O
lead	O
to	O
de	O
novo	O
inactivation	O
of	O
autosomal	O
material	O
.	O

Interleukin	O
-4	O
and	O
-13	O
induce	O
upregulation	O
of	O
the	O
murine	O
macrophage	O
12/15-lipoxygenase	protein
activity	protein
:	O
evidence	O
for	O
the	O
involvement	O
of	O
transcription	protein
factor	protein
STAT6	protein
.	O
When	O
human	O
monocytes	cell_type
or	O
alveolar	cell_type
macrophages	cell_type
are	O
cultured	O
in	O
the	O
presence	O
of	O
interleukin	protein
(IL)-4	protein
or	O
IL-13	protein
,	O
the	O
expression	O
of	O
the	O
reticulocyte-type	protein
15-lipoxygenase	protein
is	O
induced.	O
In	O
mice	O
a	O
15-lipoxygenase	protein
is	O
not	O
expressed,	O
but	O
a	O
leukocyte-type	protein
12-lipoxygenase	protein
is	O
present	O
in	O
peritoneal	cell_type
macrophages	cell_type
.	O
To	O
investigate	O
whether	O
both	O
lipoxygenase	protein
isoforms	protein
exhibit	O
a	O
similar	O
regulatory	O
response	O
toward	O
cytokine	protein
stimulation	O
,	O
we	O
studied	O
the	O
regulation	O
of	O
the	O
leukocyte-type	protein
12-lipoxygenase	protein
of	O
murine	cell_type
peritoneal	cell_type
macrophages	cell_type
by	O
interleukins	protein
and	O
found	O
that	O
the	O
activity	O
of	O
this	O
enzyme	protein
is	O
upregulated	O
in	O
a	O
dose-dependent	O
manner	O
when	O
the	O
cells	O
were	O
cultured	O
in	O
the	O
presence	O
of	O
the	O
IL-4	protein
or	O
IL-13	protein
but	O
not	O
by	O
IL-10	protein
.	O
When	O
peripheral	O
murine	O
monocytes	cell_type
that	O
do	O
not	O
express	O
the	O
lipoxygenase	protein
were	O
treated	O
with	O
IL-4	protein
expression	O
of	O
12/15-lipoxygenase	RNA
mRNA	RNA
was	O
induced,	O
suggesting	O
pretranslational	O
control	O
mechanisms	O
.	O
In	O
contrast,	O
no	O
upregulation	O
of	O
the	O
lipoxygenase	protein
activity	O
was	O
observed	O
when	O
the	O
macrophages	cell_type
were	O
prepared	O
from	O
homozygous	O
STAT6	protein
-deficient	O
mice	O
.	O
Peritoneal	cell_type
macrophages	cell_type
of	O
transgenic	O
mice	O
that	O
systemically	O
overexpress	O
IL-4	protein
exhibited	O
a	O
threefold	O
to	O
fourfold	O
higher	O
12-lipoxygenase	protein
activity	O
than	O
cells	O
prepared	O
from	O
control	O
animals.	O
A	O
similar	O
upregulation	O
of	O
12-lipoxygenase	protein
activity	O
was	O
detected	O
in	O
heart,	O
spleen,	O
and	O
lung	O
of	O
the	O
transgenic	O
animals.	O
Moreover,	O
a	O
strong	O
induction	O
of	O
the	O
enzyme	O
was	O
observed	O
in	O
red	cell_type
cells	cell_type
during	O
experimental	O
anemia	O
in	O
mice	O
.	O
The	O
data	O
presented	O
here	O
indicate	O
that	O
(1)	O
the	O
12-lipoxygenase	protein
activity	O
of	O
murine	O
macrophages	O
is	O
upregulated	O
in	O
vitro	O
and	O
in	O
vivo	O
by	O
IL-4	protein
and/or	O
IL-13	protein
,	O
(2)	O
this	O
upregulation	O
requires	O
expression	O
of	O
the	O
transcription	protein
factor	protein
STAT6	protein
,	O
and	O
(3)	O
the	O
constitutive	O
expression	O
of	O
the	O
enzyme	O
appears	O
to	O
be	O
STAT6	protein
independent	O
.	O
The	O
cytokine	protein
-dependent	O
upregulation	O
of	O
the	O
murine	protein
macrophage	protein
12-lipoxygenase	protein
and	O
its	O
induction	O
during	O
experimental	O
anemia	O
suggests	O
its	O
close	O
relatedness	O
with	O
the	O
human	protein
reticulocyte-type	protein
15-lipoxygenase	protein
despite	O
their	O
differences	O
in	O
the	O
positional	O
specificity	O
of	O
arachidonic	O
acid	O
oxygenation	O
.	O

Interferon-gamma-induced	protein
factor	protein
binding	O
to	O
the	O
interleukin-4	DNA
-responsive	DNA
element	DNA
of	O
CD23b	DNA
promoter	DNA
in	O
human	cell_type
tonsillar	cell_type
mononuclear	cell_type
cells	cell_type
:	O
role	O
in	O
transient	O
up-regulation	O
of	O
the	O
interleukin-4	RNA
-induced	RNA
CD23b	RNA
mRNA	RNA
.	O
Stimulation	O
of	O
human	cell_type
tonsillar	cell_type
mononuclear	cell_type
cells	cell_type
with	O
interleukin-4	protein
(	O
IL-4	protein
)	O
and	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
rapidly	O
induced	O
the	O
activation	O
of	O
distinct	O
nuclear	protein
factors	protein
with	O
different	O
mobilities,	O
both	O
of	O
which	O
bind	O
the	O
IL-4	DNA
response	DNA
element	DNA
(	O
IL-4RE	DNA
)	O
of	O
CD23b	DNA
promoter	DNA
as	O
examined	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
).	O
Co-treatment	O
of	O
IL-4	protein
and	O
IFN-gamma	protein
induced,	O
in	O
addition	O
to	O
the	O
two	O
distinct	O
complexes,	O
a	O
new	O
complex	O
with	O
an	O
intermediate	O
mobility	O
.	O
The	O
IL-4	protein
-induced	protein
complex	protein
reacted	O
with	O
anti-	protein
STAT	protein
(signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription)	protein
6	protein
,	O
resulting	O
in	O
a	O
supershift	O
whereas	O
the	O
formation	O
of	O
the	O
IFN-gamma	protein
-induced	protein
complex	protein
was	O
inhibited	O
by	O
anti-	protein
STAT	protein
1	protein
.	O
The	O
intermediate	O
complex	O
appeared	O
to	O
react	O
with	O
both	O
anti-	protein
STAT	protein
6	protein
and	O
anti-	protein
STAT	protein
1	protein
.	O
Although	O
IFN-gamma	protein
alone	O
did	O
not	O
induce	O
CD23	RNA
mRNA	RNA
transcription	O
,	O
Northern	O
blot	O
analysis	O
revealed	O
a	O
transient	O
up-regulation	O
of	O
the	O
IL-4	RNA
-induced	RNA
CD23	RNA
mRNA	RNA
by	O
IFN-gamma	protein
within	O
2	O
h	O
of	O
IFN-gamma	protein
treatment	O
in	O
these	O
tonsillar	cell_type
cells	cell_type
.	O
The	O
results	O
suggest	O
that	O
the	O
IL-4RE	DNA
of	O
the	O
IL-4	DNA
-inducible	DNA
gene	DNA
can	O
accommodate	O
both	O
IL-4-	O
and	O
IFN-gamma-	O
activated	O
factors	O
,	O
such	O
as	O
STAT	protein
6	protein
and	O
STAT	protein
1	protein
,	O
either	O
in	O
homodimeric	O
or	O
heterodimeric	O
forms	O
and	O
the	O
binding	O
of	O
these	O
different	O
proteins	O
to	O
the	O
respective	O
promoter	O
may	O
play	O
a	O
potential	O
regulatory	O
role	O
in	O
the	O
IL-4	protein
-inducible	O
gene	O
expression	O
.	O

A	O
p56lck	protein
-independent	O
pathway	O
of	O
CD2	protein
signaling	O
involves	O
Jun	protein
kinase	protein
.	O
The	O
p56	protein
Src	protein
family	protein
non-receptor	protein
tyrosine	protein
kinase	protein
has	O
been	O
shown	O
to	O
be	O
critical	O
for	O
T	O
lymphocyte	O
differentiation	O
and	O
activation	O
.	O
Hence	O
in	O
the	O
absence	O
of	O
p56	protein
,	O
T	protein
cell	protein
receptor	protein
triggered	O
activation	O
does	O
not	O
occur.	O
We	O
now	O
provide	O
evidence	O
for	O
a	O
CD2	protein
-based	O
signaling	O
pathway	O
which,	O
in	O
contrast	O
to	O
that	O
of	O
the	O
T	protein
cell	protein
receptor	protein
,	O
is	O
independent	O
of	O
p56	protein
.	O
CD2	protein
-mediated	O
interleukin-2	protein
production	O
occurs	O
via	O
activation	O
of	O
Jun	protein
kinase	protein
in	O
cell	O
lines	O
lacking	O
p56	protein
.	O
Jun	protein
kinase	protein
then	O
facilitates	O
the	O
binding	O
of	O
c-Jun/c-Fos	protein
heterodimers	protein
to	O
the	O
AP-1	DNA
consensus	DNA
site	DNA
and	O
the	O
subsequent	O
transcriptional	O
activity	O
of	O
the	O
interleukin-2	DNA
promoter	DNA
.	O
These	O
data	O
elucidate	O
differences	O
between	O
TCR	protein
and	O
CD2	protein
signaling	O
pathways	O
in	O
the	O
same	O
T	cell_type
cells	cell_type
.	O

Activation	O
of	O
E2F	protein
-mediated	O
transcription	O
by	O
human	protein
T-cell	protein
leukemia	protein
virus	protein
type	protein
I	protein
Tax	protein
protein	protein
in	O
a	O
p16(INK4A)-negative	cell_line
T-cell	cell_line
line	cell_line
.	O
The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
causative	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O
Although	O
the	O
exact	O
mechanism	O
by	O
which	O
HTLV-I	O
contributes	O
to	O
leukemogenesis	O
is	O
still	O
unclear,	O
the	O
Tax	protein
protein	protein
is	O
thought	O
to	O
play	O
a	O
major	O
role	O
in	O
this	O
process.	O
This	O
40-kDa	O
polypeptide	O
is	O
able	O
to	O
interact	O
with	O
the	O
tumor	protein
suppressor	protein
p16(INK4A)	protein
.	O
Consequently,	O
Tax	protein
can	O
activate	O
the	O
signaling	O
pathway	O
that	O
lead	O
to	O
the	O
release	O
of	O
E2F	protein
that	O
in	O
turn	O
induces	O
expression	O
of	O
factors	O
required	O
for	O
cell	O
cycle	O
progression	O
.	O
In	O
this	O
paper,	O
we	O
demonstrate	O
that	O
Tax	protein
can	O
also	O
activate	O
E2F	protein
-mediated	O
transcription	O
independently	O
of	O
p16(INK4A)	protein
.	O
Indeed,	O
when	O
Tax	protein
is	O
coexpressed	O
with	O
the	O
E2F-1	protein
transcription	protein
factor	protein
in	O
CEM	cell_line
T-cells	cell_line
,	O
which	O
lack	O
expression	O
of	O
p16(INK4A)	protein
,	O
it	O
strongly	O
potentiates	O
the	O
E2F	protein
-dependent	O
activation	O
of	O
a	O
reporter	O
construct	O
driven	O
by	O
a	O
promoter	O
containing	O
E2F	DNA
binding	DNA
sites	DNA
.	O
This	O
stimulation	O
is	O
abrogated	O
by	O
mutations	O
affecting	O
the	O
E2F	DNA
-binding	DNA
sites	DNA
.	O
In	O
addition,	O
Tax	protein
also	O
stimulates	O
the	O
transcription	O
of	O
the	O
E2F-1	DNA
gene	DNA
itself.	O
Using	O
Tax	protein
mutants	O
that	O
fail	O
to	O
activate	O
either	O
ATF	protein
-or	O
NF-kappaB-dependent	DNA
promoters	DNA
and	O
different	O
5'	DNA
truncation	DNA
mutants	DNA
of	O
the	O
E2F-1	DNA
promoter	DNA
,	O
we	O
show	O
that	O
the	O
Tax	protein
-dependent	O
transcriptional	O
control	O
of	O
the	O
E2F1	DNA
gene	DNA
involves,	O
at	O
least	O
in	O
part,	O
the	O
ATF	DNA
binding	DNA
site	DNA
located	O
in	O
the	O
E2F-1	DNA
promoter	DNA
.	O

Inducible	O
nitric	O
oxide	O
:	O
an	O
autoregulatory	O
feedback	O
inhibitor	O
of	O
vascular	O
inflammation	O
.	O
Inducible	O
nitric	O
oxide	O
(	O
iNO	O
)	O
is	O
produced	O
at	O
sites	O
of	O
vascular	O
inflammation	O
by	O
resident	O
and	O
nonresident	O
vascular	cell_type
wall	cell_type
cells	cell_type
,	O
but	O
its	O
role	O
in	O
the	O
inflammatory	O
process	O
is	O
not	O
known.	O
In	O
this	O
study,	O
we	O
show	O
that	O
a	O
novel	O
function	O
of	O
iNO	O
is	O
to	O
terminate	O
inflammatory	O
processes	O
.	O
We	O
find	O
that	O
iNO	O
produced	O
by	O
murine	cell_line
macrophage-like	cell_line
cells	cell_line
,	O
RAW264.7	cell_line
,	O
can	O
inhibit	O
cytokine	protein
-induced	O
endothelial	O
cell	O
activation	O
in	O
a	O
separated	O
and	O
mixed	O
endothelial-RAW264.7	cell_line
coculture	cell_line
system	cell_line
.	O
Both	O
iNO	O
production	O
and	O
endothelial	O
VCAM-1	protein
expression	O
were	O
induced	O
simultaneously	O
with	O
bacterial	O
LPS	O
and	O
murine-specific	protein
IFN-gamma	protein
.	O
Inhibition	O
of	O
iNO	protein
synthase	protein
(	O
iNOS	protein
)	O
activity	O
with	O
N	O
omega-monomethyl-L-arginine	O
in	O
endothelial-RAW264.7	cell_line
cocultures	cell_line
,	O
stimulated	O
with	O
murine-specific	protein
IFN-gamma	protein
and	O
LPS	O
,	O
decreased	O
iNO	O
production	O
by	O
86%,	O
augmented	O
VCAM-1	protein
and	O
iNOS	protein
expression	O
in	O
endothelial	O
and	O
RAW264.7	cell_line
cells	cell_line
,	O
respectively,	O
and	O
increased	O
monocyte	O
adhesion	O
to	O
the	O
endothelial	O
cell	O
surface	O
.	O
Transient	O
transfection	O
studies	O
using	O
various	O
VCAM-1	DNA
promoter	DNA
constructs	O
demonstrated	O
that	O
inhibitory	O
effects	O
of	O
iNO	O
on	O
VCAM-1	protein
gene	O
transcription	O
were	O
mediated,	O
in	O
part,	O
by	O
inhibitory	O
effects	O
of	O
iNO	O
on	O
kappa	DNA
B	DNA
cis-acting	DNA
elements	DNA
.	O
Immunofluorescence	O
studies	O
using	O
an	O
Ab	O
to	O
the	O
RelA	protein
(	protein
p65	protein
)	protein
subunit	protein
of	O
nuclear	O
factor-kappa	protein
B	protein
revealed	O
that	O
iNO	O
inhibited	O
the	O
activation	O
of	O
nuclear	protein
factor-kappa	protein
B	protein
.	O
These	O
studies	O
indicate	O
that	O
iNO	O
attenuates	O
iNOS	protein
expression	O
in	O
macrophages	cell_type
and	O
inhibits	O
monocyte	O
adhesion	O
to	O
endothelial	cell_type
cells	cell_type
,	O
and	O
suggest	O
that	O
endogenously	O
derived	O
iNO	O
may	O
be	O
an	O
important	O
autoregulatory	O
inhibitor	O
of	O
vascular	O
inflammation	O

Detection	O
of	O
oestrogen	protein
receptor	protein
variants	protein
in	O
endometrium	O
,	O
myometrium	O
,	O
leiomyoma	O
and	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
:	O
comparison	O
to	O
variants	O
present	O
in	O
breast	O
cancer	O
.	O
Oestradiol	O
has	O
mitogenic	O
and	O
regulatory	O
effects	O
on	O
various	O
organs	O
and	O
cells,	O
mediated	O
mainly	O
by	O
its	O
nuclear	protein
receptor	protein
(	O
ER	protein
).	O
The	O
presence	O
of	O
aberrant	O
ER	protein
forms	O
in	O
Oestrogen-dependent	O
tumours	O
has	O
been	O
discussed	O
in	O
correlation	O
with	O
tumour	O
progression	O
.	O
ER	protein
variants,	O
generated	O
by	O
alternative	O
splicing,	O
have	O
been	O
detected	O
in	O
human	O
breast	O
cancer	O
,	O
but	O
also	O
in	O
normal	O
mammary	O
glands	O
,	O
therefore	O
their	O
role	O
in	O
tumorigenesis	O
has	O
been	O
questioned.	O
We	O
have	O
investigated,	O
by	O
the	O
use	O
of	O
the	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
amplification	O
technique	O
,	O
the	O
possible	O
existence	O
of	O
ER	protein
variants	O
in	O
other	O
normal	O
oestrogen	O
target	O
organs	O
and	O
cells,	O
such	O
as	O
uterus	O
(	O
myometrium	O
and	O
endometrium	O
),	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
in	O
a	O
benign	O
uterus	O
tumour	O
(	O
leiomyoma	O
).	O
We	O
have	O
detected	O
variant	O
ER	protein
in	O
these	O
samples	O
and	O
have	O
compared	O
the	O
variant	O
profile	O
to	O
that	O
observed	O
in	O
breast	O
cancer	O
.	O
All	O
tissues	O
and	O
cells	O
studied	O
expressed	O
both	O
wild-type	protein
ER	protein
and	O
variant	protein
species	protein
.	O
Variant	O
forms	O
encompassed	O
ER	protein
with	O
deletions	O
of	O
exons	O
2	O
,	O
5	O
and	O
7	O
.	O
Variants	O
with	O
exon	DNA
5	DNA
deleted	O
were	O
detected	O
only	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
in	O
breast	O
cancer	O
.	O
Variants	O
with	O
exons	O
2	O
and	O
7	O
deleted	O
were	O
present	O
in	O
all	O
specimens	O
tested.	O
These	O
results	O
corroborate	O
previous	O
findings	O
that	O
the	O
presence	O
of	O
ER	protein
variants	O
is	O
not	O
a	O
characteristic	O
of	O
breast	O
cancer	O
.	O
The	O
physiological	O
significance	O
and	O
possible	O
clinical	O
relevance	O
of	O
the	O
variant	O
ER	protein
forms	O
remain	O
to	O
be	O
elucidated.	O

p21ras	protein
initiates	O
Rac-1	protein
but	O
not	O
phosphatidyl	protein
inositol	protein
3	protein
kinase	protein
/PKB	protein
,	O
mediated	O
signaling	O
pathways	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
p21ras	protein
is	O
activated	O
by	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
(	O
TCR	protein
)	O
and	O
then	O
co-ordinates	O
important	O
signaling	O
pathways	O
for	O
T	protein
lymphocyte	protein
activation	O
.	O
Effector	O
pathways	O
for	O
this	O
guanine	protein
nucleotide	protein
binding	protein
protein	protein
in	O
T	cell_type
cells	cell_type
are	O
mediated	O
by	O
the	O
serine/threonine	protein
kinase	protein
Raf-1	protein
and	O
the	O
Ras-related	protein
GTPase	protein
Rac-1	protein
.	O
In	O
fibroblasts	cell_type
,	O
an	O
important	O
effector	O
for	O
the	O
Ras	DNA
oncogene	DNA
is	O
Phosphatidylinositol	protein
3-kinase	protein
(	O
PtdIns	protein
3-kinase	protein
).	O
Activation	O
of	O
this	O
lipid	protein
kinase	protein
is	O
able	O
to	O
induce	O
critical	O
Rac-1	protein
signaling	O
pathways	O
and	O
can	O
couple	O
p21ras	protein
to	O
cell	O
survival	O
mechanisms	O
via	O
the	O
serine	protein
/threonine	protein
kinase	protein
Akt/PKB	protein
.	O
The	O
role	O
of	O
PtdIns	protein
3-kinase	protein
in	O
Ras	protein
signaling	O
in	O
T	cell_type
cells	cell_type
has	O
not	O
been	O
explored.	O
In	O
the	O
present	O
study,	O
we	O
examined	O
the	O
ability	O
of	O
PtdIns	protein
3-kinase	protein
to	O
initiate	O
the	O
Rac-1	protein
signaling	O
pathways	O
important	O
for	O
T	O
cell	O
activation	O
.	O
We	O
also	O
examined	O
the	O
possibility	O
that	O
Akt/PKB	protein
is	O
regulated	O
by	O
Ras	O
signaling	O
pathways	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
The	O
results	O
show	O
that	O
Ras	protein
can	O
initiate	O
a	O
Rac-1	protein
mediated	O
pathway	O
that	O
regulates	O
the	O
transcriptional	O
function	O
of	O
AP-1	protein
complexes	protein
.	O
PtdIns	protein
3-kinase	protein
signals	O
cannot	O
mimic	O
p21ras	protein
and	O
induce	O
the	O
Rac	protein
mediated	O
responses	O
of	O
AP-1	protein
transcriptional	O
activation	O
.	O
Moreover,	O
neither	O
TCR	protein
or	O
Ras	protein
activation	O
of	O
AP-1	protein
is	O
dependent	O
on	O
PtdIns	protein
3-kinase	protein
.	O
PKB	protein
is	O
activated	O
in	O
response	O
to	O
triggering	O
of	O
the	O
T	protein
cell	protein
antigen	protein
receptor	protein
;	O
PtdIns	protein
3-kinase	protein
activity	O
is	O
both	O
required	O
and	O
sufficient	O
for	O
this	O
TCR	protein
response	O
.	O
In	O
contrast,	O
p21ras	protein
signals	O
are	O
unable	O
to	O
induce	O
Akt/PKB	protein
activity	O
in	O
T	cell_type
cell	cell_type
nor	O
is	O
Ras	protein
function	O
required	O
for	O
Akt/PKB	protein
activation	O
in	O
response	O
to	O
the	O
TCR	protein
.	O
The	O
present	O
data	O
thus	O
highlight	O
that	O
PtdIns	protein
3-kinase	protein
and	O
Akt/PKB	protein
are	O
not	O
universal	O
Ras	protein
effector	protein
molecules	protein
.	O
Ras	protein
can	O
initiate	O
Rac-1	protein
regulated	O
signaling	O
pathways	O
in	O
the	O
context	O
of	O
T	protein
cell	protein
antigen	protein
receptor	protein
function	O
independently	O
of	O
PtdIns	protein
3-kinase	protein
activity	O
.	O

Interleukin	protein
1beta	protein
mediates	O
the	O
modulatory	O
effects	O
of	O
monocytes	cell_type
on	O
LNCaP	cell_type
human	cell_type
prostate	cell_type
cancer	cell_type
cells	cell_type
.	O
Proliferative	O
and	O
secretory	O
responses	O
in	O
androgen-sensitive	cell_type
prostate	cell_type
cancer	cell_type
LNCaP	cell_type
cells	cell_type
are	O
regulated	O
by	O
steroid	O
and	O
peptide	O
hormones	O
and	O
by	O
differentiation-promoting	O
substances	O
.	O
In	O
the	O
present	O
study,	O
we	O
evaluated	O
whether	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
that	O
exhibit	O
anti-tumour	O
activity	O
in	O
haematopoietic	O
and	O
solid	O
tumours	O
influence	O
growth	O
and	O
secretion	O
in	O
the	O
LNCaP	cell_line
cell	cell_line
line	cell_line
.	O
For	O
this	O
purpose,	O
LNCaP	cell_line
cells	cell_line
were	O
incubated	O
with	O
monocyte-conditioned	O
medium	O
(	O
MCM	O
),	O
and	O
proliferation	O
as	O
well	O
as	O
expression	O
of	O
androgen	protein
receptor	protein
(	O
AR	protein
)	O
and	O
secretion	O
of	O
prostate-specific	protein
antigen	protein
(	O
PSA	protein
)	O
were	O
assessed.	O
Conditioned	O
medium	O
from	O
monocytes	cell_type
reduced	O
proliferation	O
in	O
a	O
dose-dependent	O
manner.	O
Incubation	O
with	O
40%	O
MCM	O
caused	O
a	O
50%	O
reduction	O
in	O
cell	O
proliferation	O
.	O
AR	protein
protein	protein
decreased	O
by	O
70%	O
and	O
PSA	protein
levels	O
in	O
supernatants	O
from	O
LNCaP	cell_line
cells	cell_line
were	O
reduced	O
by	O
approximately	O
80%	O
following	O
treatment	O
with	O
MCM	O
.	O
We	O
focused	O
on	O
the	O
contribution	O
of	O
two	O
major	O
products	O
of	O
activated	O
monocytes	cell_type
,	O
prostaglandin	O
E2	O
and	O
interleukin	protein
1beta	protein
(	O
IL-1beta	protein
),	O
to	O
the	O
MCM	O
modulatory	O
action.	O
LNCaP	cell_line
cells	cell_line
treated	O
with	O
prostaglandin	O
E2	O
showed	O
neither	O
a	O
reduction	O
in	O
proliferation	O
nor	O
a	O
down-regulation	O
of	O
AR	protein
and	O
PSA	protein
levels	O
.	O
The	O
effects	O
of	O
MCM	O
on	O
cellular	O
proliferation	O
,	O
AR	protein
protein	protein
and	O
PSA	protein
secretion	O
were	O
abolished	O
by	O
pretreatment	O
of	O
MCM	O
with	O
a	O
neutralizing	O
anti-	protein
IL-1beta	protein
antibody	protein
.	O
In	O
addition,	O
recombinant	O
IL-1beta	protein
was	O
able	O
to	O
replace	O
MCM	O
for	O
the	O
inhibition	O
of	O
proliferation	O
and	O
down-regulation	O
of	O
AR	protein
and	O
PSA	protein
proteins.	O
LNCaP	cell_line
cells	cell_line
were	O
shown	O
to	O
express	O
the	O
IL-1beta	protein
receptor	O
type	O
1,	O
which	O
transduces	O
IL-1beta	protein
signal	O
.	O
Our	O
findings	O
reveal	O
that	O
monocyte-derived	protein
IL-1beta	protein
inhibits	O
the	O
proliferation	O
of	O
androgen-responsive	cell_type
prostate	cell_type
tumour	cell_type
cells	cell_type
and	O
reduces	O
AR	protein
and	O
PSA	protein
levels	O
.	O

Differential	O
responsiveness	O
of	O
the	O
IL-5	O
and	O
IL-4	O
genes	O
to	O
transcription	protein
factor	protein
GATA-3	protein
.	O
The	O
cytokines	protein
IL-4	protein
and	O
IL-5	protein
are	O
often	O
coordinately	O
produced	O
by	O
Th2	cell_line
cells	cell_line
as	O
in	O
asthma	O
.	O
However,	O
it	O
is	O
unclear	O
whether	O
similar	O
molecular	O
mechanisms	O
underlie	O
transcription	O
of	O
the	O
two	O
genes	DNA
.	O
We	O
have	O
previously	O
shown	O
that	O
the	O
transcription	protein
factor	protein
GATA-3	protein
is	O
expressed	O
in	O
Th2	O
but	O
not	O
Th1	O
cells	O
and	O
is	O
crucial	O
for	O
activation	O
of	O
the	O
IL-5	DNA
promoter	DNA
by	O
different	O
stimuli.	O
In	O
a	O
different	O
study,	O
GATA-3	protein
was	O
shown	O
to	O
be	O
sufficient	O
for	O
the	O
expression	O
of	O
IL-4	protein
and	O
other	O
Th2	DNA
cytokine	DNA
genes	DNA
.	O
Here,	O
we	O
show	O
that	O
ectopic	O
expression	O
of	O
GATA-3	protein
is	O
sufficient	O
to	O
drive	O
IL-5	protein
but	O
not	O
IL-4	protein
gene	O
expression	O
.	O
Also,	O
in	O
Th2	cell_line
cells	cell_line
,	O
antisense	O
GATA-3	protein
RNA	O
inhibits	O
IL-5	protein
but	O
not	O
IL-4	protein
promoter	O
activation	O
.	O
The	O
induction	O
of	O
IL-5	DNA
gene	DNA
expression	O
by	O
GATA-3	protein
involves	O
high	O
affinity	O
binding	O
of	O
GATA-3	protein
to	O
an	O
inverted	O
GATA	DNA
repeat	DNA
in	O
the	O
IL-5	DNA
promoter	DNA
.	O

The	O
interleukin	DNA
2	DNA
receptor	DNA
alpha	DNA
chain	DNA
/CD25	DNA
promoter	DNA
is	O
a	O
target	O
for	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
.	O
The	O
expression	O
of	O
the	O
murine	protein
interleukin	protein
(IL)-2	protein
receptor	protein
alpha	protein
chain	protein
/CD25	protein
is	O
strongly	O
induced	O
at	O
the	O
transcriptional	O
level	O
after	O
T	O
cell	O
activation	O
.	O
We	O
show	O
here	O
that	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cell	protein
(NF-AT)	protein
factors	protein
are	O
involved	O
in	O
the	O
control	O
of	O
CD25	DNA
promoter	DNA
induction	O
in	O
T	cell_type
cells	cell_type
.	O
NF-ATp	protein
and	O
NF-ATc	protein
bind	O
to	O
two	O
sites	O
around	O
positions	O
-585	O
and	O
-650	O
located	O
upstream	O
of	O
the	O
proximal	DNA
CD25	DNA
promoter	DNA
.	O
Immediately	O
3'	O
from	O
these	O
NF-AT	DNA
motifs	DNA
,	O
nonconsensus	DNA
sites	DNA
are	O
located	O
for	O
the	O
binding	O
of	O
AP-1	protein
-like	protein
factors	protein
.	O
Mutations	O
of	O
sites	O
that	O
suppress	O
NF-AT	protein
binding	O
impair	O
the	O
induction	O
and	O
strong	O
NF-ATp	protein
-mediated	O
transactivation	O
of	O
the	O
CD25	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O
In	O
T	cell_type
lymphocytes	cell_type
from	O
NF-ATp	protein
-deficient	O
mice	O
,	O
the	O
expression	O
of	O
CD25	protein
is	O
severely	O
impaired,	O
leading	O
to	O
a	O
delayed	O
IL-2	protein
receptor	protein
expression	O
after	O
T	O
cell	O
receptor	O
(	O
TCR	protein
)/	O
CD3	protein
stimulation	O
.	O
Our	O
data	O
indicate	O
an	O
important	O
role	O
for	O
NF-AT	protein
in	O
the	O
faithful	O
expression	O
of	O
high	protein
affinity	protein
IL-2	protein
receptors	protein
and	O
a	O
close	O
link	O
between	O
the	O
TCR	protein
-mediated	O
induction	O
of	O
IL-2	protein
and	O
IL-2	DNA
receptor	DNA
alpha	DNA
chain	DNA
promoters	DNA
,	O
both	O
of	O
which	O
are	O
regulated	O
by	O
NF-AT	protein
factors	protein
.	O

A	O
novel	O
mutation	O
in	O
the	O
coding	O
sequence	O
of	O
the	O
FY*B	DNA
allele	DNA
of	O
the	O
Duffy	DNA
chemokine	DNA
receptor	DNA
gene	DNA
is	O
associated	O
with	O
an	O
altered	O
erythrocyte	O
phenotype	O
.	O
The	O
Duffy	O
blood	O
group	O
system	O
is	O
of	O
clinical	O
and	O
biological	O
significance	O
.	O
Antibodies	protein
to	O
Duffy	protein
antigens	protein
are	O
responsible	O
for	O
some	O
cases	O
of	O
transfusion	O
incompatibility	O
and	O
newborn	O
hemolytic	O
disease	O
.	O
The	O
Duffy	protein
protein	protein
is	O
a	O
receptor	O
for	O
the	O
Plasmodium	protein
vivax	protein
erythrocyte-binding	protein
protein	protein
and	O
is	O
also	O
a	O
receptor	O
for	O
various	O
chemokines	protein
(thus	O
renamed	O
Duffy	protein
Antigen	protein
Receptor	protein
for	protein
Chemokines	protein
[	O
DARC	protein
]).	O
The	O
two	O
Duffy	protein
polymorphic	protein
antigens	protein
,	O
Fya	protein
and	O
Fyb	protein
(coded	O
by	O
the	O
FY*A	O
and	O
FY*B	O
alleles	O
),	O
are	O
present	O
on	O
erythrocyte	protein
membranes	protein
.	O
The	O
Fy(a-b-)	O
phenotype	O
is	O
the	O
predominant	O
one	O
in	O
populations	O
of	O
black	O
people	O
and	O
also	O
occurs	O
in	O
other	O
populations,	O
including	O
some	O
non-Ashkenazi	O
Jewish	O
groups	O
.	O
The	O
Fy(a-b-)	O
phenotype	O
has	O
been	O
associated	O
with	O
a	O
mutation	O
in	O
the	O
FY*B	DNA
promoter	DNA
at	O
the	O
GATA	DNA
box	DNA
that	O
abolishes	O
the	O
expression	O
of	O
erythrocyte	protein
Duffy	protein
protein	protein
.	O
We	O
describe	O
here	O
a	O
novel	O
mutation	O
,	O
present	O
in	O
the	O
FY*B	DNA
coding	DNA
sequence	DNA
(	O
271C	O
--&gt;	O
T	O
),	O
that	O
is	O
associated	O
with	O
some	O
Fy(b-)	O
phenotypes	O
among	O
non-Ashkenazi	O
Jews	O
and	O
among	O
Brazilian	O
blacks	O
.	O
The	O
mutation	O
is	O
present	O
in	O
Fy(b-)	O
individuals	O
,	O
who	O
have	O
wild-type	DNA
FY*B	DNA
GATA	DNA
and	O
carry	O
the	O
previously	O
described	O
304G	O
--&gt;	O
A	O
substitution	O
.	O
The	O
271C	O
--&gt;	O
T	O
and	O
304G	O
--&gt;	O
A	O
can	O
be	O
identified	O
by	O
restriction	DNA
enzyme-generated	DNA
restriction	DNA
fragment	DNA
length	DNA
polymorphisms	DNA
.	O
The	O
271C	O
--&gt;	O
T	O
substitution	O
represents	O
a	O
considerable	O
change	O
in	O
chemical	O
nature	O
(	O
Arg91	O
--&gt;	O
Cys	O
),	O
one	O
which	O
may	O
affect	O
the	O
antigenic	O
determinants	O
of	O
DARC	protein
,	O
and	O
thus	O
be	O
of	O
clinical	O
significance.	O
The	O
mutation	O
may	O
have	O
implications	O
for	O
some	O
physiological	O
roles	O
of	O
DARC	protein
and	O
be	O
of	O
interest	O
in	O
malaria	O
research	O
and	O
in	O
studies	O
of	O
population	O
genetics	O
.	O

Establishment	O
and	O
characterization	O
of	O
EBV-positive	O
and	O
EBV-negative	O
primary	O
effusion	O
lymphoma	O
cell	O
lines	O
harbouring	O
human	O
herpesvirus	O
type-8	O
.	O
In	O
this	O
study	O
we	O
report	O
on	O
the	O
establishment	O
and	O
characterization	O
of	O
two	O
novel	O
lymphoma	cell_line
cell	cell_line
lines	cell_line
(	O
CRO-AP/3	cell_line
and	O
CRO-AP/5	cell_line
)	O
which	O
carry	O
infection	O
by	O
human	O
herpesvirus	O
type-8	O
(	O
HHV-8	O
)	O
and	O
have	O
derived	O
from	O
AIDS-related	O
primary	O
effusion	O
lymphoma	O
(	O
PEL	cell_line
).	O
These	O
two	O
cell	cell_line
lines	cell_line
are	O
representative	O
of	O
different	O
virologic	O
subtypes	O
of	O
PEL	cell_line
,	O
i.e.	O
HHV-8	cell_line
+/EBV-	cell_line
PEL	cell_line
in	O
the	O
case	O
of	O
CRO-AP/3	cell_line
and	cell_line
HHV-8	cell_line
+/EBV+	cell_line
PEL	cell_line
in	O
the	O
case	O
of	O
CRO-AP/5	cell_line
.	O
Consistent	O
with	O
the	O
diagnosis	O
of	O
PEL	cell_line
,	O
both	O
CRO-AP/3	cell_line
and	O
CRO-AP/5	cell_line
expressed	O
indeterminate	O
(i.e.	O
non-B,	O
non-T)	O
phenotypes	O
although	O
immunogenotypic	O
studies	O
documented	O
their	O
B-cell	cell_type
origin	cell_type
.	O
Both	O
cell	cell_line
lines	cell_line
are	O
devoid	O
of	O
genetic	O
lesions	O
of	O
c-MYC	protein
,	O
BCL-2	protein
and	O
p53	protein
as	O
well	O
as	O
gross	O
rearrangements	O
of	O
BCL-6	protein
.	O
Detailed	O
histogenetic	O
characterization	O
of	O
these	O
novel	O
PEL	cell_line
cell	cell_line
lines	cell_line
suggests	O
that	O
PEL	cell_line
may	O
derive	O
from	O
a	O
post-germinal	cell_line
centre	cell_line
B	cell_line
cell	cell_line
which	O
has	O
undergone	O
pre-terminal	O
differentiation	O
.	O
The	O
CRO-AP/3	cell_line
and	O
CRO-AP/5	cell_line
cell	cell_line
lines	cell_line
may	O
provide	O
a	O
valuable	O
model	O
for	O
clarifying	O
the	O
pathogenesis	O
of	O
PEL	cell_line
.	O
In	O
particular,	O
these	O
cell	cell_line
lines	cell_line
may	O
help	O
understand	O
the	O
relative	O
contribution	O
of	O
HHV-8	O
and	O
EBV	O
to	O
PEL	O
growth	O
and	O
development	O
and	O
may	O
facilitate	O
the	O
identification	O
of	O
recurrent	O
cytogenetic	O
abnormalities	O
highlighting	O
putative	O
novel	O
cancer	O
related	O
loci	O
relevant	O
to	O
PEL	cell_line
.	O

Two-site	O
interaction	O
of	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
with	O
activated	O
calcineurin	protein
.	O
Transcription	protein
factors	protein
belonging	O
to	O
the	O
nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(NFAT)	protein
family	protein
regulate	O
the	O
expression	O
of	O
cytokine	DNA
genes	DNA
and	O
other	O
inducible	O
genes	O
during	O
the	O
immune	O
response	O
.	O
The	O
functions	O
of	O
NFAT	protein
proteins	protein
are	O
directly	O
controlled	O
by	O
the	O
calcium-	O
and	O
calmodulin-	O
dependent	O
phosphatase	O
calcineurin	protein
.	O
Here	O
we	O
show	O
that	O
the	O
binding	O
of	O
calcineurin	protein
to	O
NFAT	protein
is	O
substantially	O
increased	O
when	O
calcineurin	protein
is	O
activated	O
with	O
calmodulin	protein
and	O
calcium	O
.	O
FK506.FKBP12	O
drug-immunophilin	O
complexes	O
inhibited	O
the	O
interaction	O
of	O
NFAT	protein
with	O
activated	O
calcineurin	protein
much	O
more	O
effectively	O
than	O
they	O
inhibited	O
the	O
interaction	O
with	O
inactive	O
calcineurin	protein
,	O
suggesting	O
that	O
part	O
of	O
the	O
interaction	O
with	O
activated	O
calcineurin	protein
involved	O
the	O
enzyme	DNA
active	DNA
site	DNA
.	O
We	O
have	O
previously	O
shown	O
that	O
NFAT	protein
is	O
targeted	O
to	O
inactive	O
calcineurin	protein
at	O
a	O
region	O
distinct	O
from	O
the	O
calcineurin	DNA
active	DNA
site	DNA
(Aramburu,	O
J.,	O
Garcia-Cozar,	O
F.	O
J.,	O
Raghavan,	O
A.,	O
Okamura,	O
H.,	O
Rao,	O
A.,	O
and	O
Hogan,	O
P.	O
G.	O
(1998)	O
Mol.	O
Cell	O
1,	O
627-637);	O
this	O
region	O
is	O
also	O
involved	O
in	O
NFAT	protein
binding	O
to	O
activated	O
calcineurin	protein
,	O
since	O
binding	O
is	O
inhibited	O
by	O
an	O
NFAT	O
peptide	O
spanning	O
the	O
calcineurin	protein
docking	O
site	O
on	O
NFAT	protein
.	O
The	O
interacting	O
surfaces	O
are	O
located	O
on	O
the	O
catalytic	protein
domain	protein
of	O
the	O
calcineurin	protein
A	protein
chain	protein
and	O
on	O
an	O
86-amino	protein
acid	protein
fragment	protein
of	O
the	O
NFAT	protein
regulatory	protein
domain	protein
.	O
NFAT	protein
binding	O
to	O
the	O
calcineurin	protein
catalytic	protein
domain	protein
was	O
inhibited	O
by	O
the	O
calcineurin	protein
autoinhibitory	protein
domain	protein
and	O
the	O
RII	O
substrate	O
peptide	O
,	O
which	O
bind	O
in	O
the	O
calcineurin	protein
active	protein
site	protein
,	O
as	O
well	O
as	O
by	O
the	O
NFAT	protein
docking	O
site	O
peptide	O
,	O
which	O
binds	O
to	O
a	O
region	O
of	O
calcineurin	protein
distinct	O
from	O
the	O
active	protein
site	protein
.	O
We	O
propose	O
that,	O
in	O
resting	cell_type
cells	cell_type
,	O
NFAT	protein
is	O
targeted	O
to	O
a	O
region	O
of	O
the	O
calcineurin	protein
catalytic	protein
domain	protein
that	O
does	O
not	O
overlap	O
the	O
calcineurin	protein
active	protein
site	protein
.	O
Upon	O
cell	O
activation,	O
displacement	O
of	O
the	O
autoinhibitory	protein
domain	protein
by	O
calmodulin	protein
binding	O
allows	O
NFAT	protein
to	O
bind	O
additionally	O
to	O
the	O
calcineurin	protein
active	protein
site	protein
,	O
thus	O
positioning	O
NFAT	protein
for	O
immediate	O
dephosphorylation	O
at	O
functional	O
phosphoserine	O
residues	O
.	O

Nuclear	protein
factor-kappaB	protein
induction	O
in	O
CD45RO+	O
and	O
CD45RA+	O
T	O
cell	O
subsets	O
during	O
aging.	O
An	O
increase	O
in	O
the	O
ratio	O
of	O
memory	O
to	O
naive	O
T	O
cells	O
has	O
been	O
postulated	O
to	O
underlie	O
immune	O
hyporesponsiveness	O
accompanying	O
aging.	O
Our	O
analyses	O
of	O
the	O
induction	O
of	O
nuclear	protein
factor-kappaB	protein
(	O
NFkappaB	protein
)	O
in	O
activated	O
memory	O
(CD45RO+)	O
and	O
naive	O
(CD45RA+)	O
T	O
cell	O
subsets	O
from	O
young	O
and	O
elderly	O
donors	O
has	O
demonstrated	O
that,	O
regardless	O
of	O
donor	O
age,	O
memory	cell_type
T	cell_type
cells	cell_type
are	O
not	O
significantly	O
altered	O
in	O
their	O
responsiveness	O
to	O
TNF-alpha	protein
-mediated	O
induction	O
of	O
NFkappaB	protein
.	O
Although	O
treatment	O
with	O
TNF-alpha	protein
induced	O
nuclear	O
localization	O
of	O
NFkappaB	protein
in	O
both	O
memory	O
and	O
naive	O
T	O
cell	O
subsets	O
,	O
irrespective	O
of	O
the	O
age	O
of	O
the	O
donor,	O
the	O
levels	O
of	O
induced	O
NFkappaB	protein
were	O
significantly	O
lower	O
in	O
both	O
subsets	O
of	O
T	cell_type
cells	cell_type
obtained	O
from	O
the	O
elderly,	O
when	O
compared	O
to	O
those	O
in	O
young.	O
Examination	O
of	O
IkappaB	protein
alpha	protein
regulation	O
revealed	O
that	O
TNF-alpha	protein
-mediated	O
degradation	O
of	O
IkappaB	protein
alpha	protein
in	O
both	O
memory	O
and	O
naive	O
T	O
cells	O
from	O
the	O
elderly	O
was	O
severely	O
impaired,	O
thus	O
contributing	O
to	O
the	O
lowered	O
induction	O
of	O
the	O
observed	O
NFkappaB	protein
.	O
In	O
addition,	O
this	O
age-related	O
decrease	O
in	O
induction	O
of	O
nuclear	protein
NFkappaB	protein
correlated	O
with	O
decrease	O
in	O
intracellular	O
IL-2	protein
receptor	O
expression	O
and	O
anti-CD3	protein
-induced	O
proliferation	O
of	O
both	O
memory	O
and	O
naive	O
T	O
cells	O
subsets	O
.	O
Taken	O
together,	O
our	O
results	O
suggest	O
that	O
the	O
age-related	O
hyporesponsiveness	O
cannot	O
be	O
attributed	O
to	O
a	O
skewing	O
of	O
the	O
T	O
cell	O
population	O
towards	O
a	O
memory	O
phenotype	O
in	O
the	O
elderly.	O

Cyclosporin	O
A	O
-resistant	O
transactivation	O
of	O
the	O
IL-2	DNA
promoter	DNA
requires	O
activity	O
of	O
okadaic	protein
acid-sensitive	protein
serine	protein
/threonine	protein
phosphatases	protein
.	O
Expression	O
of	O
the	O
IL-2	DNA
gene	DNA
requires	O
activation	O
of	O
T	cell_type
cells	cell_type
through	O
stimulation	O
of	O
the	O
TCR	protein
and	O
costimulation	O
through	O
accessory	protein
receptors	protein
.	O
We	O
have	O
found	O
recently	O
that	O
okadaic	protein
acid-sensitive	protein
Ser	protein
/Thr	protein
phosphatases	protein
are	O
involved	O
in	O
a	O
cyclosporin	O
A	O
-insensitive	O
pathway	O
that	O
selectively	O
transmits	O
costimulatory	O
signals.	O
In	O
this	O
study,	O
we	O
analyzed	O
whether	O
activities	O
of	O
these	O
phosphatases	O
are	O
necessary	O
for	O
the	O
expression	O
of	O
the	O
IL-2	DNA
gene	DNA
.	O
In	O
both	O
activated	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
and	O
activated	cell_line
tumorigenic	cell_line
T	cell_line
cell	cell_line
lines	cell_line
,	O
IL-2	protein
gene	O
expression	O
was	O
blocked	O
at	O
the	O
transcriptional	O
level	O
by	O
okadaic	O
acid	O
.	O
The	O
transcription	protein
factors	protein
active	O
at	O
the	O
IL-2	DNA
promoter	DNA
were	O
differentially	O
influenced:	O
upon	O
down-modulation	O
of	O
okadaic	protein
acid	protein
-sensitive	protein
phosphatases	protein
,	O
transactivation	O
by	O
octamer,	O
NF-kappa	protein
B	protein
,	O
and	O
NF	protein
of	protein
activated	protein
T	protein
cells	protein
proteins	protein
was	O
abrogated,	O
while	O
transactivation	O
by	O
AP-1	protein
proteins	protein
was	protein
even	protein
enhanced.	protein

YM268	O
increases	O
the	O
glucose	O
uptake	O
,	O
cell	O
differentiation,	O
and	O
mRNA	O
expression	O
of	O
glucose	protein
transporter	protein
in	O
3T3-L1	cell_type
adipocytes	cell_type
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effects	O
of	O
bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane	O
(	O
YM-268	O
),	O
a	O
thiazolidinedione	O
derivative	O
,	O
on	O
glucose	O
uptake	O
,	O
adipocyte	cell_type
differentiation	O
through	O
peroxisome	protein
proliferator-activated	protein
receptor	protein
gamma	protein
(	O
PPARgamma	protein
),	O
and	O
phosphatidylinositol	protein
3-kinase	protein
(	O
PI	protein
3-kinase	protein
)	O
activity	O
in	O
cultured	cell_line
cells	cell_line
.	O
YM268	O
and	O
pioglitazone	O
dose-dependently	O
increased	O
the	O
2-deoxyglucose	O
uptake	O
in	O
3T3-L1	cell_line
cells	cell_line
.	O
YM268	O
facilitated	O
the	O
insulin-stimulated	O
triglyceride	O
accumulation	O
in	O
3T3-L1	cell_type
adipocytes	cell_type
and	O
increased	O
the	O
mRNA	O
expression	O
of	O
fatty	protein
acid-binding	protein
protein	protein
.	O
YM268	O
,	O
with	O
and	O
without	O
insulin	O
,	O
increased	O
the	O
mRNA	O
expression	O
of	O
glucose	protein
transporter	protein
isoforms	O
such	O
as	O
GLUT1	protein
and	O
GLUT4	protein
,	O
indicating	O
enhancement	O
of	O
adipocyte	cell_type
differentiation	O
.	O
Additionally,	O
YM268	O
and	O
pioglitazone	O
showed	O
activity	O
of	O
the	O
PPARgamma	protein
ligand	protein
,	O
a	O
member	O
of	O
the	O
nuclear	protein
receptor	protein
superfamily	protein
responsible	O
for	O
adipogenesis	O
.	O
To	O
examine	O
the	O
possible	O
involvement	O
of	O
the	O
increased	O
activity	O
of	O
PI	protein
3-kinase	protein
in	O
YM268	O
-stimulated	O
glucose	O
uptake	O
,	O
the	O
enzyme	O
activity	O
was	O
estimated	O
by	O
measuring	O
the	O
phosphatidylinositol-3,4,5-trisphosphate	O
(	O
PI-3,4,5-P3	O
)	O
concentration	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Insulin	O
dose-dependently	O
increased	O
the	O
PI-3,4,5-P3	O
production	O
but	O
YM268	O
had	O
no	O
significant	O
effect	O
on	O
the	O
insulin	O
-dependent	O
and	O
-independent	O
PI	O
3-kinase	O
activation	O
.	O
These	O
results	O
indicate	O
that	O
the	O
mechanism	O
by	O
which	O
YM268	O
increased	O
glucose	O
uptake	O
,	O
may	O
be	O
accounted	O
for	O
in	O
part	O
by	O
the	O
enhancement	O
of	O
GLUT1	protein
and	O
GLUT4	protein
expression	O
through	O
PPARgamma	protein
activation	O
.	O

The	O
nuclear	protein
receptor	protein
PPARgamma	protein
-	O
bigger	O
than	O
fat	O
.	O
Work	O
reported	O
over	O
the	O
past	O
year	O
has	O
provided	O
insights	O
into	O
the	O
mechanisms	O
whereby	O
ligand	O
activation	O
of	O
the	O
nuclear	protein
receptor	protein
peroxisome	protein
proliferator-activated	protein
receptor	protein
gamma	protein
(	O
PPARgamma	protein
)	O
regulates	O
systemic	O
glucose	O
and	O
lipid	O
homeostasis	O
.	O
PPARgamma	protein
has	O
also	O
been	O
implicated	O
recently	O
in	O
the	O
biology	O
of	O
monocytes	O
and	O
in	O
cell-cycle	O
regulation	O
and	O
cancer	O
.	O
Polyunsaturated	O
fatty	O
acids	O
and	O
eicosanoids	O
bind	O
and	O
activate	O
PPARgamma	protein
,	O
suggesting	O
that	O
these	O
lipids	O
may	O
serve	O
as	O
hormonal	O
regulators	O
of	O
a	O
variety	O
of	O
biological	O
processes	O
.	O

The	O
role	O
of	O
caspases	O
in	O
T	O
cell	O
development	O
and	O
the	O
control	O
of	O
immune	O
responses	O
.	O
Apoptosis	O
is	O
responsible	O
for	O
the	O
removal	O
of	O
potentially	O
autoreactive	O
or	O
useless	O
T	O
cells	O
during	O
thymic	O
selection	O
and	O
activated	cell_type
T	cell_type
cells	cell_type
in	O
the	O
periphery.	O
Specific	O
families	O
of	O
receptors	protein
,	O
kinases	protein
,	O
transcription	protein
factors	protein
,	O
and	O
cysteine	protein
proteases	protein
,	O
termed	protein
caspases	protein
,	O
are	O
involved	O
in	O
the	O
apoptotic	O
cascade	O
leading	O
to	O
proteolysis	O
of	O
specific	O
substrates	O
and	O
to	O
morphological	O
changes	O
associated	O
with	O
programmed	O
cell	O
death	O
.	O
Although	O
common	O
members	O
of	O
the	O
apoptotic	O
cascade	O
are	O
shared	O
between	O
different	O
cell	O
types,	O
it	O
appears	O
that	O
cell-specific	protein
factors	protein
can	O
influence	O
the	O
response	O
to	O
a	O
given	O
apoptotic	O
stimuli	O
.	O
Characterization	O
and	O
understanding	O
of	O
the	O
basic	O
mechanisms	O
involved	O
in	O
the	O
different	O
pathways	O
protecting	O
or	O
leading	O
to	O
cell	O
death	O
may	O
provide	O
novel	O
ways	O
to	O
control	O
inappropriate	O
apoptosis	O
involved	O
in	O
several	O
diseases.	O

Cross-priming	O
of	O
CTL	O
responses	O
in	O
vivo	O
does	O
not	O
require	O
antigenic	O
peptides	O
in	O
the	O
endoplasmic	O
reticulum	O
of	O
immunizing	cell_type
cells	cell_type
.	O
It	O
has	O
been	O
proposed	O
that	O
the	O
cross-priming	O
of	O
CTL	O
responses	O
in	O
vivo	O
involves	O
the	O
transfer	O
to	O
host	O
APCs	cell_type
of	O
heat	protein
shock	protein
protein	protein
glycoprotein	protein
96	protein
-chaperoned	O
antigenic	O
peptides	O
released	O
from	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
of	O
dying	O
or	O
infected	O
cells	O
.	O
We	O
have	O
tested	O
this	O
possibility	O
directly	O
using	O
TAP-deficient	cell_line
cell	cell_line
lines	cell_line
lacking	O
antigenic	O
ER	O
peptides	O
derived	O
from	O
two	O
model	O
Ags	protein
,	O
the	O
human	O
adenovirus	O
type	O
5	O
early	O
regions	O
E1A	O
and	O
E1B	O
.	O
Although	O
both	O
proteins	O
were	O
well	O
expressed,	O
the	O
cells	O
were	O
not	O
recognized	O
by	O
E1A-	O
or	O
E1B-	O
specific	O
CTLs	O
unless	O
the	O
relevant	O
epitope	O
was	O
either	O
provided	O
exogenously	O
as	O
a	O
synthetic	O
peptide	O
or	O
targeted	O
to	O
the	O
ER	O
in	O
a	O
TAP-independent	O
fashion	O
.	O
Despite	O
the	O
absence	O
of	O
these	O
ER	O
peptides,	O
the	O
TAP1-/-	cell_type
cells	cell_type
were	O
able	O
to	O
efficiently	O
cross-prime	O
E1A-	O
and	O
E1B-	O
specific	O
CTLs	O
following	O
immunization	O
of	O
syngeneic	O
mice	O
.	O
These	O
results	O
indicate	O
that,	O
although	O
purified	O
peptide/glycoprotein	protein
96	protein
complexes	protein
are	O
potent	O
immunogens,	O
the	O
mechanism	O
of	O
CTL	O
cross-priming	O
in	O
vivo	O
does	O
not	O
depend	O
upon	O
antigenic	O
peptides	O
in	O
the	O
ER	O
of	O
immunizing	cell_type
cells	cell_type
.	O

A	O
critical	O
role	O
of	O
the	O
p75	protein
tumor	protein
necrosis	protein
factor	protein
receptor	protein
(	O
p75TNF-R	protein
)	O
in	O
organ	O
inflammation	O
independent	O
of	O
TNF	protein
,	O
lymphotoxin	protein
alpha	protein
,	O
or	O
the	O
p55TNF-R.	protein
Despite	O
overwhelming	O
evidence	O
that	O
enhanced	O
production	O
of	O
the	O
p75	protein
tumor	protein
necrosis	protein
factor	protein
receptor	protein
(	O
p75TNF-R	protein
)	O
accompanies	O
development	O
of	O
specific	O
human	O
inflammatory	O
pathologies	O
such	O
as	O
multi-organ	O
failure	O
during	O
sepsis	O
,	O
inflammatory	O
liver	O
disease	O
,	O
pancreatitis	O
,	O
respiratory	O
distress	O
syndrome	O
,	O
or	O
AIDS	O
,	O
the	O
function	O
of	O
this	O
receptor	O
remains	O
poorly	O
defined	O
in	O
vivo.	O
We	O
show	O
here	O
that	O
at	O
levels	O
relevant	O
to	O
human	O
disease	O
,	O
production	O
of	O
the	O
human	protein
p75TNF-R	protein
in	O
transgenic	O
mice	O
results	O
in	O
a	O
severe	O
inflammatory	O
syndrome	O
involving	O
mainly	O
the	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
and	O
lung	O
,	O
and	O
characterized	O
by	O
constitutively	O
increased	O
NF-kappaB	protein
activity	O
in	O
the	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cell	cell_type
compartment	O
.	O
This	O
process	O
is	O
shown	O
to	O
evolve	O
independently	O
of	O
the	O
presence	O
of	O
TNF	protein
,	O
lymphotoxin	protein
alpha	protein
,	O
or	O
the	O
p55TNF-R	protein
,	O
although	O
coexpression	O
of	O
a	O
human	DNA
TNF	DNA
transgene	DNA
accelerated	O
pathology	O
.	O
These	O
results	O
establish	O
an	O
independent	O
role	O
for	O
enhanced	O
p75TNF-R	protein
production	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
disease	O
and	O
implicate	O
the	O
direct	O
involvement	O
of	O
this	O
receptor	O
in	O
a	O
wide	O
range	O
of	O
human	O
inflammatory	O
pathologies	O
.	O

Expression	O
status	O
of	O
BCL-6	protein
and	O
syndecan-1	protein
identifies	O
distinct	O
histogenetic	O
subtypes	O
of	O
Hodgkin's	O
disease	O
.	O
The	O
tumor	cell_type
cells	cell_type
in	O
most	O
cases	O
of	O
Hodgkin's	O
disease	O
(	O
HD	O
)	O
have	O
been	O
recently	O
recognized	O
to	O
originate	O
from	O
the	O
B-cell	cell_type
lineage	cell_type
,	O
but	O
their	O
precise	O
differentiation	O
stage	O
is	O
not	O
fully	O
clarified.	O
Recently,	O
we	O
have	O
reported	O
that	O
the	O
histogenesis	O
of	O
B-cell	cell_type
lymphomas	cell_type
may	O
be	O
assessed	O
by	O
monitoring	O
the	O
expression	O
pattern	O
of	O
BCL-6	protein
,	O
a	O
transcription	protein
factor	protein
expressed	O
in	O
germinal	cell_type
center	cell_type
(GC)	cell_type
B	cell_type
cells	cell_type
,	O
and	O
CD138/	protein
syndecan-1	protein
(	O
syn-1	protein
),	O
a	O
proteoglycan	O
associated	O
with	O
post-GC,	O
terminal	O
B-cell	O
differentiation	O
.	O
In	O
this	O
study,	O
we	O
have	O
applied	O
these	O
two	O
markers	O
to	O
the	O
study	O
of	O
HD	O
histogenesis.	O
We	O
have	O
found	O
that	O
in	O
nodular	O
lymphocyte	O
predominance	O
HD	O
(	O
NLPHD	O
)	O
tumor	cell_type
cells	cell_type
consistently	O
display	O
the	O
BCL-6	protein
(+)/	O
syn-1	protein
(-)	O
phenotype	O
,	O
indicating	O
their	O
derivation	O
from	O
GC	cell_type
B	cell_type
cells	cell_type
.	O
Conversely,	O
classic	O
HD	O
(	O
CHD	O
)	O
is	O
heterogeneous	O
because	O
the	O
tumor	cell_type
cells	cell_type
of	O
a	O
fraction	O
of	O
CHD	O
display	O
the	O
BCL-6	protein
(-)/	O
syn-1	protein
(+)	O
phenotype	O
of	O
post-GC	O
B-cells,	O
whereas	O
another	O
fraction	O
of	O
CHD	O
is	O
constituted	O
by	O
a	O
mixture	O
of	O
tumor	cell_type
cells	cell_type
reflecting	O
the	O
GC	O
(	O
BCL-6	protein
(+)/	O
syn-1	protein
(-))	O
or	O
post-GC	O
(	O
BCL-6	protein
(-)/	O
syn-1	protein
(+))	O
phenotypes	O
.	O
BCL-6	cell_line
(-)/	cell_line
syn-1	cell_line
(+)	cell_line
tumor	cell_line
cells	cell_line
of	O
CHD	O
are	O
mostly	O
found	O
surrounded	O
by	O
T	cell_type
cells	cell_type
expressing	O
CD40L	protein
,	O
consistent	O
with	O
the	O
observation	O
that	O
CD40	protein
signaling	O
downregulates	O
BCL-6	protein
expression	O
.	O
These	O
data	O
indicate	O
that	O
tumor	cell_type
cells	cell_type
of	O
NLPHD	O
uniformly	O
display	O
a	O
GC	O
B-cell	O
phenotype	O
,	O
whereas	O
the	O
phenotype	O
of	O
tumor	cell_type
cells	cell_type
of	O
CHD	O
appears	O
to	O
be	O
modulated	O
by	O
the	O
surrounding	O
cellular	O
background,	O
particularly	O
CD40L	cell_type
+	cell_type
reactive	cell_type
T	cell_type
cells	cell_type
.	O

Molecular	O
and	O
cellular	O
analysis	O
of	O
human	O
immunodeficiency	O
virus	O
-induced	O
apoptosis	O
in	O
lymphoblastoid	O
T-cell-line-expressing	O
wild-type	O
and	O
mutated	O
CD4	O
receptors	protein
.	O
We	O
have	O
previously	O
shown	O
that	O
the	O
presence	O
of	O
the	O
CD4	protein
cytoplasmic	protein
tail	protein
is	O
critical	O
for	O
human	O
immunodeficiency	O
virus	O
(HIV)-induced	O
apoptosis	O
(J.Corbeil,	O
M.Tremblay,	O
and	O
D.D.Richman,	O
J.Exp.Med.183:39-48,	O
1996).	O
We	O
have	O
pursued	O
our	O
investigation	O
of	O
the	O
role	O
of	O
the	O
CD4	protein
transduction	O
pathway	O
in	O
HIV-induced	O
apoptosis	O
.	O
To	O
do	O
this,	O
wild-type	O
and	O
mutant	O
forms	O
of	O
the	O
CD4	protein
cytoplasmic	protein
tail	protein
were	O
stably	O
expressed	O
in	O
the	O
lymphoblastoid	cell_line
T-cell	cell_line
line	cell_line
A2.01	cell_line
.	O
Apoptosis	O
was	O
prevented	O
when	O
CD4	protein
truncated	O
at	O
residue	O
402	O
was	O
expressed;	O
however,	O
cells	O
expressing	O
mutated	O
receptors	O
that	O
do	O
not	O
associate	O
with	O
p56(lck)	protein
(mutated	O
at	O
the	O
dicysteine	protein
motif	protein
and	O
truncated	O
at	O
residue	O
418	O
)	O
but	O
which	O
conserved	O
proximal	O
domains	O
of	O
the	O
cytoplasmic	protein
tail	protein
underwent	O
apoptosis	O
like	O
wild-	protein
type	protein
CD4	protein
.	O
The	O
differences	O
between	O
wild-type	O
and	O
mutated	O
receptors	O
in	O
the	O
induction	O
of	O
apoptosis	O
were	O
not	O
related	O
to	O
levels	O
of	O
p56(lck)	protein
or	O
NF-	protein
kappaB	protein
activation	O
.	O
Initial	O
signaling	O
through	O
the	O
CD4	protein
receptor	protein
played	O
a	O
major	O
role	O
in	O
the	O
sensitization	O
of	O
HIV-infected	cell_type
T	cell_type
cells	cell_type
to	O
undergo	O
apoptosis	O
.	O
Incubation	O
of	O
HIV-infected	cell_type
cells	cell_type
with	O
monoclonal	protein
antibody	protein
(MAb)	protein
13B8-2	protein
,	O
which	O
binds	O
to	O
CD4	protein
in	O
a	O
region	O
critical	O
for	O
dimerization	O
of	O
the	O
receptor,	O
prevented	O
apoptosis	O
without	O
inhibiting	O
HIV	O
replication	O
.	O
Moreover,	O
the	O
apoptotic	O
process	O
was	O
not	O
related	O
to	O
Fas	protein
-Fas	protein
ligand	protein
interaction	O
;	O
however,	O
an	O
antagonistic	O
anti-Fas	O
MAb	O
(ZB-4)	O
enhanced	O
apoptosis	O
in	O
HIV-infected	cell_type
cells	cell_type
without	O
inducing	O
apoptosis	O
in	O
uninfected	cell_type
cells	cell_type
.	O
These	O
observations	O
demonstrate	O
that	O
CD4	protein
signaling	O
mediates	O
HIV-induced	O
apoptosis	O
by	O
a	O
mechanism	O
independent	O
of	O
Fas	protein
-Fas	protein
ligand	protein
interaction	O
,	O
does	O
not	O
require	O
p56(lck)	protein
signaling	O
,	O
and	O
may	O
involve	O
a	O
critical	O
region	O
for	O
CD4	protein
dimerization	O
.	O

p130	protein
,	O
p107	protein
,	O
and	O
pRb	protein
are	O
differentially	O
regulated	O
in	O
proliferating	cell_type
cells	cell_type
and	O
during	O
cell	O
cycle	O
arrest	O
by	O
alpha-interferon	protein
.	O
We	O
have	O
determined	O
how	O
the	O
phosphorylation	O
of	O
the	O
retinoblastoma	protein
family	protein
(	O
pRb	protein
,	O
p107	protein
,	O
and	O
p130	protein
)	O
is	O
governed	O
in	O
individual	O
cell	O
cycle	O
phases	O
of	O
Daudi	cell_line
B-cells	cell_line
during	O
cell	O
cycle	O
exit	O
triggered	O
by	O
alpha-interferon	protein
(	O
alpha-IFN	protein
).	O
alpha-IFN	protein
causes	O
dephosphorylation	O
of	O
pRb	protein
and	O
loss	O
of	O
p130	protein
phosphorylated	protein
Form	protein
3	protein
.	O
However,	O
the	O
change	O
in	O
p130	protein
phosphorylation	O
in	O
response	O
to	O
alpha-IFN	protein
occurs	O
before	O
dephosphorylation	O
of	O
pRb	protein
is	O
complete	O
because	O
loss	O
of	O
p130	protein
Form	protein
3	protein
occurs	O
throughout	O
the	O
cell	O
cycle	O
prior	O
to	O
complete	O
arrest	O
in	O
G1,	O
whereas	O
pRb	protein
is	O
dephosphorylated	O
only	O
in	O
G1	O
.	O
In	O
contrast,	O
p107	protein
is	O
dephosphorylated	O
and	O
is	O
then	O
depleted	O
from	O
cells	O
as	O
they	O
exit	O
the	O
cell	O
cycle.	O
p130	protein
,	O
predominantly	O
in	O
Form	O
1,	O
and	O
hypophosphorylated	protein
pRb	protein
bind	O
an	O
E2F	DNA
DNA	DNA
binding	DNA
site	DNA
;	O
p130	protein
complexes	O
E2F-4	protein
,	O
whereas	O
pRb	protein
binds	O
both	O
E2F-4	O
and	O
E2F-1	protein
.	O
The	O
phosphorylated	O
forms	O
of	O
E2F-4	protein
that	O
bind	O
to	O
the	O
E2F	DNA
DNA	DNA
site	DNA
are	O
different	O
from	O
hyperphosphorylated	O
E2F-4	protein
,	O
which	O
predominates	O
in	O
primary	cell_type
hemopoietic	cell_type
cells	cell_type
in	O
G0	O
.	O
We	O
conclude	O
that	O
although	O
cell	O
cycle	O
arrest	O
induced	O
by	O
alpha-IFN	protein
may	O
be	O
mediated	O
in	O
part	O
by	O
formation	O
of	O
a	O
complex	O
containing	O
p130	protein
and	O
E2F-4	protein
,	O
alpha-IFN	protein
does	O
not	O
induce	O
hyperphosphorylation	O
of	O
E2F-4	protein
,	O
which	O
characterizes	O
primary	cell_type
hemopoietic	cell_type
cells	cell_type
in	O
G0	O
.	O

The	O
transcription	protein
factors	protein
c-myb	protein
and	O
C/EBP	protein
alpha	protein
regulate	O
the	O
monocytic/myeloic	DNA
gene	DNA
MRP14	DNA
.	O
The	O
entry	O
of	O
microorganisms	O
into	O
the	O
body	O
induces	O
inflammatory	O
processes	O
.	O
During	O
this	O
process	O
a	O
sequence	O
of	O
cellular,	O
humoral,	O
non-specific	O
and	O
specific	O
actions	O
are	O
evoked	O
to	O
combat	O
the	O
infection.	O
Macrophages	cell_type
and	O
granulocytes	cell_type
,	O
which	O
are	O
developed	O
from	O
a	O
common	O
progenitor	O
cell,	O
are	O
the	O
cellular	O
components	O
of	O
the	O
specific	O
and	O
non-specific	O
immunoreaction	O
.	O
MRP14	DNA
(	O
Macrophage	protein
migration	protein
inhibitory	protein
related	protein
protein	protein
)	O
and	O
MRP8	protein
,	O
two	O
S-100	protein
proteins	protein
contained	O
in	O
high	O
concentrations	O
in	O
these	O
cells	O
are	O
obviously	O
essential	O
for	O
adhesion	O
and	O
migration	O
of	O
monocytes	cell_type
and	O
granulocytes	cell_type
.	O
To	O
investigate	O
the	O
transcriptional	O
regulation	O
of	O
these	O
genes	O
we	O
cotransfected	O
constructs	O
expressing	O
CAT	protein
under	O
control	O
of	O
the	O
MRP14	DNA
promoter	DNA
and	O
expression	O
constructs	O
of	O
C/EBP	protein
alpha	protein
and	O
v-myb	protein
,	O
two	O
transcription	protein
factors	protein
involved	O
in	O
myeloid/monocytic	O
differentiation	O
.	O
Transfection	O
with	O
C/EBP	protein
alpha	protein
revealed	O
a	O
massive	O
enhancement	O
of	O
the	O
MRP14	DNA
promoter	DNA
in	O
both,	O
HL	cell_type
60	cell_type
cells	cell_type
(granulocytic	O
differentiated)	O
and	O
L132	cell_type
fibroblasts	cell_type
.	O
In	O
contrast,	O
v-myb	protein
reduces	O
MRP14	DNA
promoter	DNA
activity	O
.	O
Northern	O
blot	O
analysis	O
of	O
L132	cell_type
cells	cell_type
transfected	O
with	O
the	O
C/EBP	protein
alpha	protein
expression	O
vector	O
demonstrate	O
that	O
C/EBP	protein
alpha	protein
is	O
sufficient	O
to	O
enhance	O
MRP14	protein
expression	O
in	O
the	O
context	O
of	O
the	O
whole	O
genome.	O

A	O
CD28	protein
-associated	O
signaling	O
pathway	O
leading	O
to	O
cytokine	DNA
gene	DNA
transcription	O
and	O
T	O
cell	O
proliferation	O
without	O
TCR	protein
engagement	O
.	O
Stimulation	O
of	O
resting	cell_type
human	cell_type
T	cell_type
cells	cell_type
with	O
the	O
CD28	protein
-specific	protein
mAb	protein
BW	protein
828	protein
induces	O
proliferation	O
and	O
cytokine	protein
synthesis	O
without	O
further	O
requirement	O
for	O
TCR	protein
coengagement	O
.	O
This	O
observation	O
prompted	O
us	O
to	O
postulate	O
that	O
signal	O
2	O
(	O
costimulatory	O
signal	O
)	O
alone	O
without	O
signal	O
1	O
(	O
TCR	protein
signal	O
)	O
can	O
activate	O
T	cell_type
cells	cell_type
.	O
To	O
test	O
whether	O
this	O
putative	O
function	O
of	O
CD28	protein
is	O
mediated	O
via	O
a	O
particular	O
signaling	O
pathway,	O
we	O
compared	O
early	O
signaling	O
events	O
initiated	O
in	O
resting	O
T	cell_type
cells	cell_type
by	O
the	O
stimulatory	protein
mAb	protein
BW	protein
828	protein
with	O
signals	O
triggered	O
by	O
the	O
nonstimulating	protein
CD28	protein
mAb	protein
9.3	protein
.	O
Stimulation	O
of	O
T	cell_type
cells	cell_type
with	O
BW	protein
828	protein
induced	O
an	O
increase	O
in	O
intracellular	O
Ca2+	O
,	O
but	O
did	O
not	O
lead	O
to	O
detectable	O
activation	O
of	O
the	O
protein	protein
kinases	protein
p56(lck)	protein
and	O
c-Raf-1	protein
.	O
This	O
pathway	O
resulted	O
in	O
the	O
induction	O
of	O
the	O
transcription	protein
factors	protein
NF-kappa	protein
B	protein
,	O
NF-AT	protein
,	O
and	O
proteins	O
binding	O
to	O
the	O
CD28	protein
response	O
element	O
of	O
the	O
IL-2	DNA
promoter	DNA
.	O
On	O
the	O
other	O
hand,	O
stimulation	O
of	O
T	cell_type
cells	cell_type
with	O
mAb	protein
9.3	protein
increased	O
the	O
level	O
of	O
intracellular	O
Ca2+	O
and	O
triggered	O
the	O
activation	O
of	O
p56(lck)	protein
and	O
c-Raf-1	protein
,	O
but	O
was	O
unable	O
to	O
induce	O
the	O
binding	O
of	O
transcription	protein
factors	protein
to	O
the	O
IL-2	DNA
promoter	DNA
.	O
In	O
contrast	O
to	O
the	O
differential	O
signaling	O
of	O
BW	protein
828	protein
and	O
9.3	protein
in	O
resting	O
T	O
cells,	O
the	O
two	O
mAbs	O
exhibited	O
a	O
similar	O
pattern	O
of	O
early	O
signaling	O
events	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
and	O
Jurkat	cell_type
cells	cell_type
(	O
p56(lck)	protein
activation	O
,	O
association	O
of	O
phosphatidylinositol	protein
3-kinase	protein
with	O
CD28	protein
),	O
indicating	O
that	O
the	O
signaling	O
capacity	O
of	O
CD28	protein
changes	O
with	O
activation.	O
These	O
data	O
support	O
the	O
view	O
that	O
stimulation	O
through	O
CD28	protein
can	O
induce	O
some	O
effector	O
functions	O
in	O
T	cell_type
cells	cell_type
and	O
suggest	O
that	O
this	O
capacity	O
is	O
associated	O
with	O
a	O
particular	O
pattern	O
of	O
early	O
signaling	O
events	O

Decreased	O
IL-12	protein
production	O
and	O
Th1	O
cell	O
development	O
by	O
acetyl	O
salicylic	O
acid	O
-mediated	O
inhibition	O
of	O
NF-kappaB	protein
.	O
IL-12	protein
is	O
a	O
75-kDa	protein
heterodimeric	protein
cytokine	protein
composed	O
of	O
two	O
covalently	O
linked	O
p35	O
and	O
p40	O
chains	O
.	O
This	O
pro-inflammatory	protein
cytokine	protein
plays	O
a	O
prominent	O
role	O
in	O
the	O
development	O
of	O
Th1	O
cell-mediated	O
immune	O
responses	O
.	O
Th1	O
cell-mediated	O
immune	O
responses	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
chronic	O
inflammatory	O
autoimmune	O
diseases	O
.	O
Thus,	O
IL-12	protein
appears	O
to	O
be	O
a	O
critical	O
factor	O
in	O
the	O
generation	O
and	O
maintenance	O
of	O
chronic	O
inflammatory	O
conditions	O
.	O
In	O
this	O
study,	O
we	O
investigated	O
the	O
effects	O
of	O
a	O
commonly	O
prescribed	O
anti-inflammatory	O
drug	O
,	O
acetyl	O
salicylic	O
acid	O
(	O
ASA	O
),	O
on	O
IL-12	protein
production	O
and	O
Th1	O
cell	O
development	O
.	O
ASA	O
was	O
found	O
to	O
inhibit	O
secretion	O
of	O
the	O
IL-12	protein
heterodimer	protein
as	O
well	O
as	O
p40	protein
monomer	protein
by	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
This	O
was	O
associated	O
with	O
the	O
down-regulation	O
of	O
IL-12p40	RNA
mRNA	RNA
expression	O
.	O
Analysis	O
of	O
the	O
regulation	O
of	O
the	O
p40	DNA
gene	DNA
promoter	DNA
revealed	O
that	O
ASA	O
inhibited	O
NF-kappaB	protein
activation	O
and	O
binding	O
to	O
the	O
p40-kappaB	DNA
site	DNA
in	O
the	O
p40	DNA
promoter	DNA
,	O
leading	O
to	O
transcriptional	O
repression	O
of	O
the	O
p40	DNA
gene	DNA
.	O
Addition	O
of	O
ASA	O
to	O
an	O
in	O
vitro	O
T	O
helper	O
cell	O
differentiation	O
system	O
,	O
at	O
concentrations	O
compatible	O
with	O
plasma	O
levels	O
reached	O
during	O
anti-inflammatory	O
therapy	O
,	O
resulted	O
in	O
reduced	O
development	O
of	O
Th1	cell_type
cells	cell_type
.	O
These	O
results	O
suggest	O
that	O
the	O
inhibition	O
of	O
NF-kappaB	protein
activation	O
by	O
ASA	O
leads	O
to	O
down-regulation	O
of	O
IL-12	protein
production	O
and	O
inhibition	O
of	O
Th1	O
cell	O
development	O
.	O

Attenuation	O
of	O
HLA-DR	protein
expression	O
by	O
mononuclear	cell_type
phagocytes	cell_type
infected	O
with	O
Mycobacterium	O
tuberculosis	O
is	O
related	O
to	O
intracellular	O
sequestration	O
of	O
immature	protein
class	protein
II	protein
heterodimers	protein
.	O
MHC	protein
class	protein
II	protein
expression	O
was	O
examined	O
in	O
macrophages	cell_type
infected	O
with	O
Mycobacterium	O
tuberculosis	O
.	O
IFN-gamma	protein
increased	O
the	O
surface	O
expression	O
of	O
class	protein
II	protein
molecules	protein
in	O
THP-1	cell_line
cells	cell_line
and	O
this	O
was	O
markedly	O
reduced	O
in	O
cells	O
infected	O
with	O
M.	O
tuberculosis	O
.	O
Despite	O
this	O
effect,	O
steady	O
state	O
levels	O
of	O
HLA-DRalpha	protein
,	O
HLA-DRbeta	protein
,	O
and	O
invariant	protein
(Ii)	protein
chains	protein
were	O
equivalent	O
in	O
control	O
and	O
infected	O
cells	O
.	O
Metabolic	O
labeling	O
combined	O
with	O
pulse-chase	O
experiments	O
and	O
biochemical	O
analysis	O
showed	O
that	O
the	O
majority	O
of	O
class	protein
II	protein
molecules	protein
in	O
infected	O
cells	O
became	O
resistant	O
to	O
endoglycosidase	protein
H	protein
,	O
consistent	O
with	O
normal	O
Golgi	O
processing	O
.	O
However,	O
results	O
of	O
intracellular	O
staining	O
and	O
dual	O
color	O
confocal	O
microscopy	O
revealed	O
a	O
significant	O
defect	O
in	O
transport	O
of	O
newly	O
synthesized	O
class	protein
II	protein
molecules	protein
through	O
the	O
endocytic	O
compartment	O
.	O
Thus,	O
compared	O
with	O
findings	O
in	O
control	O
cells,	O
class	protein
II	protein
molecules	protein
in	O
infected	cell_type
cells	cell_type
colocalized	O
to	O
a	O
minimal	O
extent	O
with	O
a	O
lysosomal-associated	protein
membrane	protein
protein-1	protein
+	O
endosomal	O
compartment	O
.	O
In	O
addition,	O
in	O
contrast	O
to	O
control	cell_type
cells	cell_type
,	O
class	protein
II	protein
molecules	protein
in	O
infected	cell_type
cells	cell_type
failed	O
to	O
colocalize	O
with	O
endocytosed	protein
BSA	protein
under	O
conditions	O
where	O
this	O
marker	O
is	O
known	O
to	O
label	O
late	O
endosomes	O
,	O
lysosomes	O
,	O
and	O
the	O
MHC	protein
class	protein
II	protein
compartment	O
.	O
Consistent	O
with	O
defective	O
transport	O
along	O
the	O
endocytic	O
pathway	O
,	O
the	O
maturation	O
of	O
SDS-stable	protein
class	protein
II	protein
alphabeta	protein
dimers	protein
--dependent	O
upon	O
removal	O
of	O
Ii	protein
chain	protein
and	O
peptide	O
loading	O
of	O
class	protein
II	protein
dimers	protein
in	O
the	O
MHC	protein
class	protein
II	protein
compartment	O
--was	O
markedly	O
impaired	O
in	O
M.	O
tuberculosis	O
-infected	cell_type
cells	cell_type
.	O
These	O
findings	O
indicate	O
that	O
defective	O
transport	O
and	O
processing	O
of	O
class	protein
II	protein
molecules	protein
through	O
the	O
endosomal/lysosomal	O
system	O
is	O
responsible	O
for	O
diminished	O
cell	O
surface	O
expression	O
of	O
MHC	protein
class	protein
II	protein
molecules	protein
in	O
cells	O
infected	O
with	O
M.	O
tuberculosis	O
.	O

Identification	O
of	O
upstream	DNA
regulatory	DNA
elements	DNA
that	O
repress	O
expression	O
of	O
adult	DNA
beta-like	DNA
globin	DNA
genes	DNA
in	O
a	O
primitive	O
erythroid	O
environment	O
.	O
Our	O
investigations	O
have	O
focused	O
on	O
localizing	O
cis-elements	DNA
responsible	O
for	O
the	O
down	O
regulation	O
of	O
the	O
adult	DNA
beta-like	DNA
globin	DNA
genes	DNA
(	O
delta	DNA
and	O
beta	DNA
)	O
in	O
immature	O
,	O
or	O
primitive	O
erythroid	O
tissues	O
.	O
We	O
studied	O
their	O
activity	O
after	O
transfection	O
into	O
K562	cell_line
cells	cell_line
,	O
an	O
erythroleukemia	cell_line
cell	cell_line
line	cell_line
with	O
an	O
embryonic-fetal	O
phenotype	O
.	O
Analyzed	O
DNA	DNA
sequences	DNA
included	O
delta	O
and	O
beta	O
5'	O
flanking	O
regions	O
extending	O
from	O
approximately	O
-500	DNA
to	DNA
+50bp	DNA
(	O
promoter	DNA
regions	DNA
),	O
truncated	O
delta	O
and	O
beta	DNA
5'	DNA
flanking	DNA
regions	DNA
extending	O
from	O
approximately	O
-250	DNA
to	DNA
+50	DNA
bp	DNA
,	O
and	O
chimeric	DNA
promoter	DNA
constructions	DNA
,	O
which	O
consisted	O
of	O
a	O
distal	O
delta	O
or	O
beta	O
fragment	O
fused	O
to	O
a	O
proximal	O
beta	O
or	O
delta	O
sequence	O
.	O
In	O
CAT	DNA
reporter	DNA
constructions	DNA
no	O
appreciable	O
level	O
of	O
CAT	protein
activity	O
was	O
supported	O
by	O
the	O
beta	DNA
globin	DNA
promoter	DNA
,	O
and	O
only	O
low	O
level	O
activity	O
by	O
the	O
delta	DNA
promoter	DNA
.	O
Truncation	O
of	O
the	O
beta	DNA
globin	DNA
promoter	DNA
led	O
to	O
a	O
2-3	O
fold	O
increase	O
in	O
promoter	O
activity	O
.	O
In	O
contrast,	O
deletion	O
of	O
the	O
upstream	DNA
portion	DNA
of	O
the	O
delta	DNA
promoter	DNA
led	O
to	O
a	O
10	O
fold	O
decrease	O
in	O
expression.	O
Coupling	O
of	O
the	O
upstream	DNA
beta	DNA
globin	DNA
sequence	DNA
from	O
approximately	O
-500	O
to	O
-250	O
bp	O
to	O
the	O
truncated	O
delta	DNA
promoter	DNA
fragment	O
led	O
to	O
complete	O
extinction	O
of	O
transcription	O
activity,	O
consistent	O
with	O
a	O
negative	O
regulatory	O
effect	O
of	O
the	O
beta	DNA
globin	DNA
gene	DNA
upstream	DNA
element	DNA
(s).	O
Fusion	O
of	O
the	O
upstream	DNA
portion	DNA
of	O
the	O
delta	DNA
promoter	DNA
to	O
the	O
truncated	O
beta	DNA
globin	DNA
promoter	DNA
yielded	O
a	O
modest	O
increase	O
in	O
promoter	O
strength	O
relative	O
to	O
the	O
truncated	DNA
beta	DNA
gene	DNA
promoter	DNA
,	O
indicating	O
the	O
presence	O
of	O
a	O
positive	DNA
transcriptional	DNA
element	DNA
(s)	O
in	O
the	O
upstream	DNA
delta	DNA
globin	DNA
regulatory	DNA
region	DNA
.	O
Site-directed	O
mutagenesis	O
of	O
binding	O
sites	O
for	O
the	O
repressor	O
proteins	O
BP1	O
and	O
BP2	O
in	O
the	O
upstream	DNA
portion	DNA
of	O
the	O
beta	DNA
globin	DNA
gene	DNA
flanking	DNA
region	DNA
led	O
to	O
a	O
4-6	O
fold	O
increase	O
in	O
promoter	O
activity	O
.	O
DNase	protein
I	protein
footprinting	O
of	O
the	O
upstream	DNA
delta-globin	DNA
region	DNA
revealed	O
protected	DNA
sequences	DNA
corresponding	O
to	O
consensus	DNA
binding	DNA
sites	DNA
for	O
GATA-1	protein
and	O
BP2	protein
.	O
These	O
results	O
confirm	O
that	O
sequences	O
in	O
the	O
upstream	DNA
promoter	DNA
region	DNA
of	O
the	O
adult	DNA
beta	DNA
globin	DNA
gene	DNA
contribute	O
to	O
its	O
factor-mediated	O
suppression	O
early	O
in	O
development	O
and	O
then	O
may	O
modulate	O
its	O
expression	O
at	O
a	O
later	O
stage.	O

Analysis	O
of	O
cytokine	protein
signaling	O
in	O
patients	O
with	O
extrinsic	O
asthma	O
and	O
hyperimmunoglobulin	O
E	O
.	O
BACKGROUND:	O
Recent	O
data	O
suggest	O
that	O
the	O
regulation	O
of	O
class	O
switching	O
to	O
IgE	protein
by	O
cytokines	protein
is	O
mediated	O
by	O
STAT	protein
transcription	protein
factors	protein
.	O
The	O
induction	O
of	O
IgE	protein
by	O
IL-4	protein
and	O
IL-13	protein
occurs	O
through	O
the	O
activation	O
of	O
the	O
intracellular	protein
signal-transducing	protein
protein	protein
Stat6	protein
,	O
whereas	O
the	O
inhibition	O
of	O
IgE	protein
class	O
switching	O
by	O
interferon-y	protein
(	O
IFN-gamma	protein
)	O
occurs	O
through	O
the	O
activation	O
of	O
Statl	protein
.	O
OBJECTIVE:	O
We	O
hypothesized	O
that	O
in	O
extrinsic	O
asthma	O
or	O
in	O
cases	O
of	O
markedly	O
elevated	O
IgE	protein
(ie,	O
hyperimmunoglobulin	O
E	O
[	O
HIE	O
])	O
increased	O
levels	O
of	O
IgE	protein
may	O
be	O
associated	O
with	O
alterations	O
in	O
the	O
cytokine	protein
levels	O
or	O
the	O
activation	O
of	O
Stat6	protein
.	O
METHODS:	O
PBMCs	cell_type
and	O
sera	O
from	O
8	O
patients	O
with	O
extrinsic	O
asthma	O
(mean	O
IgE	protein
,	O
285+/-100	O
IU/mL),	O
3	O
patients	O
with	O
HIE	O
(mean	O
IgE	protein
,	O
7050+/-1122	O
IU/mL),	O
and	O
14	O
nonatopic	O
control	O
subjects	O
(mean	O
IgE	protein
,	O
112+/-28	O
IU/mL)	O
were	O
analyzed.	O
RESULTS:	O
The	O
mean	O
IL-4	protein
level	O
detected	O
by	O
ELISA	O
was	O
much	O
greater	O
in	O
patients	O
with	O
HIE	O
than	O
control	O
subjects	O
(88.6+/-11.5	O
pg/mL	O
vs	O
11.5+/-7.1	O
pg/mL,	O
P	O
=	O
.005),	O
and	O
increased	O
IL-4	protein
levels	O
among	O
patients	O
with	O
both	O
asthma	O
and	O
HIE	O
correlated	O
with	O
the	O
increased	O
IgE	protein
levels	O
.	O
In	O
contrast,	O
IL-13	protein
levels	O
were	O
not	O
elevated.	O
Levels	O
of	O
Stat6	protein
protein	O
present	O
in	O
PBMCs	cell_type
did	O
not	O
differ	O
in	O
the	O
patients	O
and	O
control	O
subjects.	O
Examination	O
of	O
Stat6	protein
DNA-binding	O
activity	O
demonstrated	O
no	O
activation	O
of	O
IL-4	protein
signaling	O
in	O
patients	O
with	O
either	O
HIE	O
or	O
acute	O
asthma.	O
Interestingly,	O
evidence	O
for	O
the	O
presence	O
of	O
B	cell_type
cells	cell_type
that	O
have	O
already	O
switched	O
to	O
IgE	protein
was	O
seen	O
in	O
PBMCs	cell_type
of	O
several	O
patients	O
with	O
asthma	O
or	O
HIE	O
.	O
CONCLUSION:	O
These	O
results	O
indicate	O
that	O
(1)	O
IgE	protein
production	O
in	O
asthma	O
and	O
HIE	O
usually	O
is	O
associated	O
with	O
elevated	O
levels	O
of	O
IL-4	protein
,	O
but	O
not	O
IL-13	protein
,	O
in	O
the	O
peripheral	O
blood;	O
(2)	O
the	O
increased	O
sera	O
IL-4	protein
levels	O
in	O
asthma	O
and	O
HIE	O
are	O
not	O
sufficient	O
to	O
induce	O
Stat6	protein
activation	O
in	O
PBMCs	cell_type
;	O
and	O
(3)	O
evidence	O
of	O
switch	O
recombination	O
to	O
epsilon	O
may	O
be	O
detected	O
in	O
isolated	O
cases	O
of	O
elevated	O
IgE	protein
.	O
This	O
implies	O
that	O
high	O
levels	O
of	O
IgE	protein
in	O
these	O
patients	O
either	O
results	O
from	O
B	cell_type
cells	cell_type
that	O
have	O
already	O
undergone	O
class	O
switching	O
,	O
from	O
Ig	O
class	O
switching	O
that	O
is	O
localized	O
to	O
target	O
tissues	O
,	O
or	O
both.	O

Carboxyl-terminal	protein
15-amino	protein
acid	protein
sequence	protein
of	O
NFATx1	protein
is	O
possibly	O
created	O
by	O
tissue-specific	O
splicing	O
and	O
is	O
essential	O
for	O
transactivation	O
activity	O
in	O
T	cell_type
cells	cell_type
.	O
NFAT	protein
regulates	O
transcription	O
of	O
a	O
number	O
of	O
cytokine	O
and	O
other	O
immunoregulatory	DNA
genes	DNA
.	O
We	O
have	O
isolated	O
NFATx	protein
,	O
which	O
is	O
one	O
of	O
four	O
members	O
of	O
the	O
NFAT	protein
family	protein
of	O
transcription	protein
factors	protein
and	O
is	O
preferentially	O
expressed	O
in	O
the	O
thymus	O
and	O
peripheral	cell_type
blood	cell_type
leukocytes	cell_type
,	O
and	O
an	O
isoform	O
of	O
NFATx	protein
,	O
NFATx1	protein
.	O
Here	O
we	O
provide	O
evidence	O
showing	O
that	O
15	O
amino	O
acids	O
in	O
the	O
carboxyl-terminal	protein
end	protein
of	O
NFATx1	protein
are	O
required	O
for	O
its	O
maximum	O
transactivation	O
activity	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
A	O
fusion	O
between	O
these	O
15	O
amino	O
acids	O
and	O
the	O
GAL4	protein
DNA	protein
binding	protein
domain	protein
was	O
capable	O
of	O
transactivating	O
reporters	O
driven	O
by	O
the	O
GAL4	DNA
DNA	DNA
binding	DNA
site	DNA
.	O
Interestingly,	O
this	O
15-amino	protein
acid	protein
transactivation	protein
sequence	protein
is	O
well	O
conserved	O
in	O
NFAT	protein
family	protein
proteins	protein
,	O
although	O
the	O
sequences	O
contiguous	O
to	O
the	O
carboxyl-terminal	protein
regions	protein
of	O
the	O
NFAT	protein
family	protein
are	O
much	O
less	O
conserved.	O
We	O
also	O
report	O
three	O
additional	O
isoforms	O
of	O
NFATx	protein
,	O
designated	O
NFATx2	protein
,	O
NFATx3	protein
,	O
and	O
NFATx4	protein
.	O
This	O
transactivation	O
sequence	O
is	O
altered	O
by	O
tissue-specific	O
alternative	O
splicing	O
in	O
newly	O
isolated	O
NFATx	protein
isoforms	protein
,	O
resulting	O
in	O
lower	O
transactivation	O
activity	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
NFATx1	protein
is	O
expressed	O
predominantly	O
in	O
the	O
thymus	O
and	O
peripheral	cell_type
blood	cell_type
leukocyte	cell_type
,	O
while	O
the	O
skeletal	O
muscle	O
expressed	O
primarily	O
NFATx2	protein
.	O
In	O
Jurkat	cell_line
cells	cell_line
,	O
transcription	O
from	O
the	O
NFAT	DNA
site	DNA
of	O
the	O
IL-2	DNA
promoter	DNA
is	O
activated	O
strongly	O
by	O
NFATx1	protein
but	O
only	O
weakly	O
by	O
NFATx2	protein
.	O
These	O
data	O
demonstrate	O
that	O
the	O
15-amino	protein
acid	protein
sequence	protein
of	O
NFATx1	protein
is	O
a	O
major	protein
transactivation	protein
sequence	protein
required	O
for	O
induction	O
of	O
genes	O
by	O
NFATx1	protein
in	O
T	cell_type
cells	cell_type
and	O
possibly	O
regulates	O
NFAT	protein
activity	O
through	O
tissue-specific	O
alternative	O
splicing	O
.	O

Altered	protein
DNA-binding	protein
specificity	protein
mutants	protein
of	O
EKLF	protein
and	O
Sp1	O
show	O
that	O
EKLF	protein
is	O
an	O
activator	O
of	O
the	O
beta-globin	DNA
locus	DNA
control	DNA
region	DNA
in	O
vivo.	O
The	O
locus	DNA
control	DNA
region	DNA
of	O
the	O
beta-globin	DNA
cluster	DNA
contains	O
five	O
DNase	DNA
I	DNA
hypersensitive	DNA
sites	DNA
(	O
5'HS1-5	DNA
)	O
required	O
for	O
locus	O
activation	O
.	O
5'HS3	DNA
contains	O
six	O
G-rich	DNA
motifs	DNA
that	O
are	O
essential	O
for	O
its	O
activity.	O
Members	O
of	O
a	O
protein	O
family,	O
characterized	O
by	O
three	O
zinc	protein
fingers	protein
highly	O
homologous	O
to	O
those	O
found	O
in	O
transcription	protein
factor	protein
Sp1	protein
,	O
interact	O
with	O
these	O
motifs.	O
Because	O
point	O
mutagenesis	O
cannot	O
distinguish	O
between	O
family	O
members,	O
it	O
is	O
not	O
known	O
which	O
protein	O
activates	O
5'HS3	DNA
.	O
We	O
show	O
that	O
the	O
function	O
of	O
such	O
closely	O
related	O
proteins	O
can	O
be	O
distinguished	O
in	O
vivo	O
by	O
matching	O
point	O
mutations	O
in	O
5'HS3	DNA
with	O
amino	O
acid	O
changes	O
in	O
the	O
zinc	protein
fingers	protein
of	O
Sp1	protein
and	O
EKLF	protein
.	O
Testing	O
their	O
activity	O
in	O
transgenic	O
mice	O
shows	O
that	O
EKLF	protein
is	O
a	O
direct	O
activator	O
of	O
5'HS3	DNA
.	O

The	O
Epstein-Barr	protein
virus	protein
Rta	protein
protein	protein
activates	O
lytic	DNA
cycle	DNA
genes	DNA
and	O
can	O
disrupt	O
latency	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
The	O
transition	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
from	O
latency	O
into	O
the	O
lytic	O
cycle	O
is	O
associated	O
with	O
the	O
expression	O
of	O
two	O
immediate-early	DNA
viral	DNA
genes	DNA
,	O
BZLF1	DNA
and	O
BRLF1	DNA
.	O
Overexpression	O
of	O
ZEBRA,	O
the	O
product	O
of	O
BZLF1	DNA
,	O
is	O
sufficient	O
to	O
disrupt	O
latency	O
in	O
B	cell_type
lymphocytes	cell_type
and	O
epithelial	cell_type
cells	cell_type
by	O
stimulating	O
expression	O
of	O
lytic	DNA
cycle	DNA
genes	DNA
,	O
including	O
BRLF1	DNA
.	O
The	O
BRLF1	protein
product	protein
Rta	protein
functions	O
as	O
a	O
transcriptional	O
activator	O
in	O
both	O
B	cell_type
lymphocytes	cell_type
and	O
epithelial	cell_type
cells	cell_type
.	O
However,	O
Rta	protein
has	O
recently	O
been	O
reported	O
to	O
disrupt	O
latency	O
in	O
an	O
epithelial	O
specific	O
manner	O
(S.	O
Zalani,	O
E.	O
Holley-Guthrie,	O
and	O
S.	O
Kenney,	O
Proc.	O
Natl.	O
Acad.	O
Sci.	O
USA	O
93:9194-9199,	O
1996).	O
Here	O
we	O
demonstrate	O
that	O
expression	O
of	O
Rta	protein
is	O
also	O
sufficient	O
for	O
disruption	O
of	O
latency	O
in	O
a	O
permissive	cell_line
B-cell	cell_line
line	cell_line
.	O
In	O
HH514-16	cell_line
cells	cell_line
,	O
transfection	O
of	O
Rta	protein
leads	O
to	O
synthesis	O
of	O
ZEBRA	protein
,	O
viral	O
DNA	O
replication	O
,	O
and	O
late	O
gene	O
expression	O
.	O
However,	O
Rta	protein
by	O
itself	O
is	O
less	O
potent	O
than	O
ZEBRA	protein
in	O
the	O
ability	O
to	O
activate	O
most	O
early	O
and	O
late	O
lytic	DNA
cycle	DNA
genes	DNA
.	O
In	O
light	O
of	O
previous	O
work	O
implicating	O
ZEBRA	protein
in	O
the	O
activation	O
of	O
Rta	protein
,	O
we	O
suggest	O
a	O
cooperative	O
model	O
for	O
EBV	O
entry	O
into	O
the	O
lytic	O
cycle	O
.	O
Expression	O
of	O
either	O
BZLF1	DNA
or	O
BRLF1	DNA
triggers	O
expression	O
of	O
the	O
other	O
immediate-early	protein
factor	protein
,	O
and	O
together	O
these	O
activators	O
act	O
individually	O
or	O
in	O
synergy	O
on	O
downstream	DNA
targets	DNA
to	O
activate	O
the	O
viral	O
lytic	O
cycle	O
.	O

Transcription	O
of	O
a	O
minimal	DNA
promoter	DNA
from	O
the	O
NF-IL6	DNA
gene	DNA
is	O
regulated	O
by	O
CREB/ATF	protein
and	O
SP1	protein
proteins	protein
in	O
U937	cell_line
promonocytic	cell_line
cells	cell_line
.	O
NF-IL6	protein
is	O
an	O
important	O
transcriptional	O
regulator	O
of	O
genes	O
induced	O
in	O
activated	cell_type
monocytes/	cell_type
macrophages	cell_type
,	O
and	O
NF-IL6	protein
is	O
the	O
only	O
CCAAT/enhancer-binding	protein
protein	protein
(C/EBP)	protein
family	protein
member	O
whose	O
steady-state	O
mRNA	O
levels	O
increase	O
upon	O
activation	O
of	O
monocytes	cell_type
(1).	O
We	O
show	O
that	O
increased	O
transcription	O
of	O
the	O
NF-IL6	DNA
gene	DNA
is	O
responsible,	O
at	O
least	O
in	O
part,	O
for	O
induction	O
of	O
NF-IL6	RNA
mRNA	RNA
following	O
activation	O
of	O
U937	cell_line
promonocytic	cell_line
cells	cell_line
.	O
We	O
have	O
identified	O
a	O
104-bp	DNA
minimal	DNA
promoter	DNA
region	DNA
of	O
the	O
NF-IL6	DNA
gene	DNA
that	O
is	O
sufficient	O
for	O
basal	O
and	O
activation-dependent	O
induction	O
of	O
transcription	O
in	O
U937	cell_line
cells	cell_line
.	O
This	O
region	O
contains	O
binding	O
sites	O
for	O
the	O
cAMP	protein
response	protein
element-binding	protein
protein/activation	protein
transcription	protein
factor	protein
(	O
CREB/ATF	protein
)	O
and	O
Sp1	protein
families	O
of	O
transcription	protein
factors	protein
.	O
Each	O
site	O
is	O
functionally	O
important	O
and	O
contributes	O
independently	O
to	O
transcription	O
of	O
the	O
NF-IL6	DNA
gene	DNA
in	O
U937	cell_line
cells	cell_line
.	O

CIITA	protein
B-cell-specific	DNA
promoter	DNA
suppression	O
in	O
MHC	cell_line
class	cell_line
II	cell_line
-silenced	cell_line
cell	cell_line
hybrids	cell_line
.	O
In	O
this	O
study,	O
various	O
sets	O
of	O
somatic	cell_line
cell	cell_line
hybrids	cell_line
,	O
generated	O
by	O
the	O
fusion	O
of	O
epithelial	cell_line
cell	cell_line
lines	cell_line
with	O
B-lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
were	O
analyzed	O
for	O
the	O
expression	O
of	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
class	protein
II	protein
antigens	protein
.	O
We	O
first	O
demonstrate,	O
in	O
human	cell_line
and	cell_line
mouse	cell_line
intraspecies	cell_line
hybrids	cell_line
,	O
the	O
coordinate	O
suppression	O
of	O
MHC	protein
class	protein
II	protein
,	O
Ii	protein
(	O
invariant	protein
chain	protein
)	O
and	O
HLA-DM	DNA
gene	DNA
transcription	O
,	O
and	O
the	O
release	O
of	O
the	O
silencing	O
by	O
the	O
addition	O
of	O
interferon	protein
gamma	protein
.	O
Using	O
interspecies	O
hybrids,	O
the	O
segregation	O
of	O
human	DNA
chromosomes	DNA
allowed	O
us	O
to	O
establish	O
that	O
MHC	protein
class	protein
II	protein
extinction	O
is	O
linked	O
to	O
the	O
presence	O
in	O
the	O
hybrids	O
of	O
the	O
chromosomes	DNA
from	O
the	O
epithelial	cell_type
fusion	cell_type
partner	cell_type
.	O
Moreover,	O
our	O
data	O
provide	O
evidence	O
that	O
the	O
expression	O
pattern	O
of	O
MHC	RNA
class	RNA
II	RNA
mRNA	RNA
is	O
correlated	O
with	O
that	O
of	O
the	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
),	O
suggesting	O
that	O
CIITA	protein
is	O
the	O
actual	O
target	O
of	O
the	O
silencing.	O
To	O
gain	O
further	O
insight	O
into	O
the	O
suppression	O
phenomenon	O
we	O
performed	O
luciferase	O
assays	O
which	O
show	O
that	O
silencing	O
affects	O
the	O
activity	O
of	O
the	O
B-cell-specific	DNA
promoter	DNA
of	O
CIITA	protein
.	O
These	O
results	O
therefore	O
demonstrate	O
that	O
the	O
MHC	protein
class	protein
II	protein
gene	O
silencing	O
in	O
somatic	cell_line
cell	cell_line
hybrids	cell_line
is	O
due	O
to	O
an	O
active	O
suppression	O
of	O
one	O
of	O
the	O
promoters	DNA
of	O
the	O
CIITA	DNA
gene	DNA
,	O
mediated	O
by	O
the	O
epithelial	cell_type
cell	cell_type
fusion	cell_type
partner	cell_type
.	O

Class	O
II	O
transactivator-independent	O
endothelial	O
cell	O
MHC	protein
class	protein
II	protein
gene	O
activation	O
induced	O
by	O
lymphocyte	O
adhesion	O
.	O
NK	O
cells	O
induce	O
MHC	protein
class	protein
II	protein
molecules	O
on	O
the	O
surface	O
of	O
allogeneic	O
endothelial	O
cells	O
in	O
an	O
adhesion-dependent,	O
IFN-gamma	protein
-independent	O
manner	O
.	O
Here,	O
we	O
demonstrate	O
that	O
NK	cell_line
cells	cell_line
induce	O
HLA-DR	protein
on	O
the	O
surface	O
of	O
a	O
mutant	cell_line
cell	cell_line
line	cell_line
that	O
is	O
defective	O
in	O
IFN-gamma	protein
-induced	O
MHC	protein
class	protein
II	protein
expression	O
.	O
RNA	O
analysis	O
in	O
these	O
cells	O
and	O
in	O
a	O
cell	O
line	O
that	O
is	O
defective	O
in	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
demonstrates	O
that	O
NK	O
cell-induced	O
HLA-DR	RNA
alpha	RNA
mRNA	RNA
expression	O
is	O
also	O
CIITA	protein
-independent	O
.	O
The	O
Janus	cell_line
kinase-1-deficient	cell_line
cell	cell_line
line	cell_line
U4A	cell_line
expresses	O
HLA-DR	RNA
alpha	RNA
mRNA	RNA
in	O
response	O
to	O
NK	O
cell	O
activation	O
,	O
and	O
HLA-DR	DNA
alpha	DNA
promoter	DNA
constructs	DNA
transfected	O
into	O
these	O
cells	O
are	O
induced	O
by	O
NK	cell_line
cells	cell_line
but	O
not	O
IFN-gamma	protein
.	O
These	O
data	O
indicate	O
that	O
the	O
IFN-gamma	protein
-independent	O
component	O
of	O
the	O
target	O
cell	O
HLA-DR	protein
expression	O
induced	O
by	O
lymphocyte	O
adhesion	O
uses	O
a	O
signaling	O
pathway	O
that	O
is	O
distinct	O
from	O
the	O
IFN-gamma	protein
-dependent	O
mechanism	O
and	O
also	O
suggest	O
that	O
CIITA	protein
is	O
not	O
required.	O

Effects	O
of	O
overexpression	O
of	O
IL-1	protein
receptor-associated	protein
kinase	protein
on	O
NFkappaB	protein
activation	O
,	O
IL-2	protein
production	O
and	O
stress-activated	O
protein	O
kinases	O
in	O
the	O
murine	cell_line
T	cell_line
cell	cell_line
line	cell_line
EL4	cell_line
.	O
The	O
association	O
and	O
activation	O
of	O
the	O
IL-1	protein
receptor-associated	protein
protein	protein
kinase	protein
(	O
IRAK	protein
)	O
to	O
the	O
IL-1	protein
receptor	protein
complex	protein
is	O
one	O
of	O
the	O
earliest	O
events	O
detectable	O
in	O
IL-1	protein
signal	O
transduction	O
.	O
We	O
generated	O
permanent	O
clones	O
of	O
the	O
murine	cell_line
T	cell_line
cell	cell_line
line	cell_line
EL4	cell_line
6.1	cell_line
overexpressing	O
human	protein
(h)	protein
IRAK	protein
to	O
evaluate	O
the	O
role	O
of	O
this	O
kinase	O
in	O
IL-1	protein
signaling	O
.	O
Overexpression	O
of	O
hIRAK	protein
enhanced	O
IL-1	protein
-stimulated	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NFkappaB	protein
,	O
whereas	O
a	O
truncated	O
form	O
(	O
N-IRAK	protein
)	O
specifically	O
inhibited	O
IL-1	protein
-dependent	O
NFkappaB	protein
activity	O
.	O
In	O
clones	O
stably	O
overexpressing	O
hIRAK	protein
a	O
weak	O
constitutive	O
activation	O
of	O
NFkappaB	protein
correlated	O
with	O
a	O
low	O
basal	O
IL-2	protein
production	O
which	O
was	O
enhanced	O
in	O
an	O
IL-1	protein
-dependent	O
manner	O
.	O
Compared	O
to	O
the	O
parental	cell_line
cell	cell_line
line	cell_line
the	O
dose-response	O
curve	O
of	O
IL-1	protein
-induced	O
IL-2	protein
production	O
was	O
shifted	O
in	O
both	O
potency	O
and	O
efficacy.	O
These	O
results	O
demonstrate	O
that	O
IRAK	protein
directly	O
triggers	O
NFkappaB	protein
-mediated	O
gene	O
expression	O
in	O
EL4	cell_line
cells	cell_line
.	O
Qualitatively	O
different	O
effects	O
were	O
observed	O
for	O
the	O
IL-1	protein
-induced	O
activation	O
of	O
stress-activated	protein
protein	protein
(SAP)	protein
kinases	protein
:	O
permanent	O
overexpression	O
of	O
IRAK	protein
did	O
not	O
affect	O
the	O
dose	O
dependence	O
but	O
prolonged	O
the	O
kinetics	O
of	O
IL-1	protein
-induced	O
activation	O
of	O
SAP	protein
kinases	protein
,	O
suggesting	O
that	O
this	O
signaling	O
branch	O
may	O
be	O
regulated	O
by	O
distinct	O
mechanisms.	O

The	O
role	O
of	O
protein	protein
kinase	protein
C	protein
signaling	O
in	O
activated	O
DRA	DNA
transcription	O
.	O
Expression	O
of	O
human	DNA
MHC	DNA
HLA-DRA	DNA
class	DNA
II	DNA
gene	DNA
can	O
be	O
up-regulated	O
in	O
B	cell_type
cells	cell_type
by	O
Ig	O
cross-linking	O
as	O
well	O
as	O
by	O
phorbol	O
esters	O
such	O
as	O
12-O-tetradecanoyl	O
phorbol	O
13-acetate	O
(	O
TPA	O
).	O
Induced	O
DRA	DNA
expression	O
involves	O
activation	O
of	O
restricted	protein
protein	protein
kinase	protein
C	protein
(	protein
PKC	protein
)	protein
isoforms	protein
,	O
resulting	O
in	O
activated	O
activator	O
protein-1	protein
-dependent	O
transcription	O
.	O
In	O
this	O
report	O
expression	O
profiles	O
and	O
activation	O
of	O
PKC	protein
were	O
analyzed	O
in	O
human	cell_line
Raji	cell_line
B	cell_line
lymphoblastoid	cell_line
cells	cell_line
.	O
Transient	O
transfection	O
analysis	O
with	O
target	DNA
plasmids	DNA
containing	O
either	O
DRA	DNA
promoter	DNA
(wild-type	O
or	O
mutated)	O
or	O
TPA	DNA
response	DNA
elements	DNA
demonstrated	O
that	O
pretreatment	O
with	O
the	O
selective	O
PKC	protein
inhibitor	O
GF	O
109203X	O
repressed	O
TPA	O
-mediated	O
activation	O
.	O
Western	O
analysis	O
performed	O
on	O
cellular	O
fractions	O
of	O
resting	cell_type
cells	cell_type
and	O
of	O
TPA	cell_type
-activated	cell_type
cells	cell_type
revealed	O
abundant	O
expression	O
of	O
classical	protein
PKC-alpha	protein
(	O
cPKC-alpha	protein
),	O
cPKC-betaII	protein
,	O
and	O
atypical	protein
PKC-zeta	protein
isoforms	protein
and	O
identified	O
a	O
sustained	O
translocation	O
of	O
cPKC-alpha	protein
and	O
cPKC-betaII	protein
from	O
the	O
cytosolic	O
compartment	O
to	O
membranes	O
.	O
As	O
expected,	O
the	O
distribution	O
of	O
atypical	protein
PKC-zeta	protein
was	O
unaffected	O
by	O
TPA	O
treatment	O
and	O
displayed	O
an	O
even	O
distribution	O
between	O
cytosol	O
and	O
membranes	O
.	O
This	O
finding	O
was	O
confirmed	O
by	O
immunofluorescence	O
microscopy	O
.	O
The	O
TPA	O
-mediated	O
translocation	O
of	O
cPKC-alpha	protein
and	O
cPKC-betaII	protein
was	O
not	O
influenced	O
by	O
pretreatment	O
with	O
GF	O
109203X	O
.	O
Finally,	O
functional	O
activation	O
and	O
translocation	O
of	O
PKC	protein
were	O
investigated	O
with	O
a	O
selective	O
in	O
vitro	O
kinase	O
assay	O
.	O
Together,	O
these	O
results	O
show	O
that	O
activated	O
HLA-DRA	protein
expression	O
in	O
response	O
to	O
TPA	O
treatment	O
is	O
strictly	O
dependent	O
on	O
PKC	protein
activation	O
acting	O
on	O
the	O
X2	DNA
box	DNA
of	O
the	O
DRA	DNA
promoter	DNA
and	O
that	O
selective	O
inhibition	O
of	O
PKC	protein
enzymatic	O
activity	O
does	O
not	O
influence	O
subcellular	O
localization	O
of	O
expressed	O
PKC	protein
isoenzymes	protein
.	O
Thus,	O
the	O
translocation	O
event	O
per	O
se	O
occurs	O
independently	O
of	O
PKC	protein
activation	O
in	O
these	O
cells.	O

Inhibition	O
of	O
RNA	protein
polymerase	protein
II	protein
transcription	O
in	O
human	cell_type
cells	cell_type
by	O
synthetic	O
DNA-binding	O
ligands	O
[see	O
comments]	O
Sequence-specific	O
DNA-binding	O
small	O
molecules	O
that	O
can	O
permeate	O
human	cell_type
cells	cell_type
potentially	O
could	O
regulate	O
transcription	O
of	O
specific	O
genes.	O
Multiple	O
cellular	protein
DNA-binding	protein
transcription	protein
factors	protein
are	O
required	O
by	O
HIV	O
type	O
1	O
for	O
RNA	O
synthesis	O
.	O
Two	O
pyrrole-imidazole	O
polyamides	O
were	O
designed	O
to	O
bind	O
DNA	O
sequences	O
immediately	O
adjacent	O
to	O
binding	O
sites	O
for	O
the	O
transcription	protein
factors	protein
Ets-1	protein
,	O
lymphoid-enhancer	protein
binding	protein
factor	protein
1	protein
,	O
and	O
TATA-box	protein
binding	protein
protein	protein
.	O
These	O
synthetic	O
ligands	O
specifically	O
inhibit	O
DNA-binding	O
of	O
each	O
transcription	protein
factor	protein
and	O
HIV	O
type	O
1	O
transcription	O
in	O
cell-free	O
assays	O
.	O
When	O
used	O
in	O
combination,	O
the	O
polyamides	O
inhibit	O
virus	O
replication	O
by	O
&gt;99%	O
in	O
isolated	cell_type
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
,	O
with	O
no	O
detectable	O
cell	O
toxicity.	O
The	O
ability	O
of	O
small	O
molecules	O
to	O
target	O
predetermined	O
DNA	DNA
sequences	DNA
located	O
within	O
RNA	DNA
polymerase	DNA
II	DNA
promoters	DNA
suggests	O
a	O
general	O
approach	O
for	O
regulation	O
of	O
gene	O
expression,	O
as	O
well	O
as	O
a	O
mechanism	O
for	O
the	O
inhibition	O
of	O
viral	O
replication	O
.	O

musculin	DNA
:	O
a	O
murine	DNA
basic	DNA
helix-loop-helix	DNA
transcription	DNA
factor	DNA
gene	DNA
expressed	O
in	O
embryonic	O
skeletal	O
muscle	O
.	O
We	O
describe	O
the	O
embryonic	O
expression	O
of	O
musculin	protein
,	O
a	O
new	O
murine	O
member	O
of	O
the	O
bHLH	protein
family	protein
of	O
transcription	protein
factors	protein
.	O
Musculin	O
protein	O
is	O
closely	O
related	O
to	O
human	protein
ABF-1	protein
,	O
which	O
is	O
expressed	O
in	O
activated	O
B	cell_type
cells	cell_type
,	O
and	O
to	O
epicardin/capsulin/Pod-1	protein
,	O
which	O
is	O
expressed	O
in	O
branchial	cell_type
myoblasts	cell_type
,	O
visceral	O
and	O
urogenital	O
mesoderm	O
and	O
epicardium	O
.	O
In	O
situ	O
hybridisation	O
revealed	O
musculin	protein
expression	O
in	O
embryos	O
was	O
largely	O
restricted	O
to	O
the	O
embryonic	cell_type
skeletal	cell_type
muscle	cell_type
lineage	cell_type
.	O
While	O
all	O
skeletal	O
muscles	O
expressed	O
the	O
gene,	O
only	O
a	O
subset	O
of	O
myocytes	O
within	O
each	O
muscle	O
were	O
positive,	O
indicating	O
molecular	O
heterogeneity	O
within	O
fetal	O
muscle	O
.	O
Copyright	O
1998	O
Elsevier	O
Science	O
Ireland	O
Ltd.	O
All	O
Rights	O
Reserved.	O

Induction	O
of	O
T	O
cell	O
anergy	O
by	O
high	O
concentrations	O
of	O
immunodominant	O
native	O
peptide	O
is	O
accompanied	O
by	O
IL-10	protein
production	O
and	O
a	O
block	O
in	O
JNK	protein
activity	O
.	O
The	O
ability	O
to	O
induce	O
anergy	O
in	O
antigen-specific	cell_type
T	cell_type
cells	cell_type
has	O
potential	O
therapeutic	O
value	O
for	O
altering	O
pathologic	O
immune	O
responses	O
.	O
This	O
study	O
was	O
undertaken	O
to	O
further	O
analyze	O
changes	O
in	O
cytokine	protein
production	O
and	O
intracellular	O
signaling	O
during	O
anergy	O
induction	O
using	O
high	O
concentrations	O
of	O
native	O
peptide	O
ligand	O
of	O
tetanus	O
toxoid	O
(	O
TT	O
)-	O
and	O
myelin	O
basic	O
protein	O
(MBP)-	O
specific	O
human	O
T	O
cell	O
lines	O
.	O
The	O
TT	cell_line
-selected	cell_line
T	cell_line
cell	cell_line
line	cell_line
could	O
be	O
rendered	O
unresponsive	O
to	O
its	O
dominant	O
epitope	O
in	O
a	O
dose-dependent	O
manner	O
(IC50	O
=	O
0.03	O
microg/ml).	O
The	O
TT	cell_line
-selected	cell_line
line	cell_line
,	O
as	O
well	O
as	O
three	O
T	O
cell	O
clones	O
established	O
from	O
this	O
line,	O
continued	O
to	O
produce	O
IFN-gamma	protein
and	O
significantly	O
increased	O
IL-4	protein
and	O
IL-10	protein
production	O
when	O
anergy	O
was	O
induced	O
with	O
high	O
concentrations	O
of	O
the	O
immunodominant	O
epitope	O
.	O
JNK	protein
enzymatic	O
activity	O
was	O
blocked	O
in	O
anergized	cell_line
T	cell_line
cells	cell_line
.	O
The	O
MBP	protein
-selected	O
line	O
could	O
likewise	O
be	O
rendered	O
unresponsive	O
by	O
incubation	O
with	O
supraoptimal	O
concentrations	O
of	O
immunodominant	O
peptide	O
and	O
anergy	O
induction	O
was	O
accompanied	O
by	O
IL-10	protein
release	O
.	O
Both	O
T	cell_line
cell	cell_line
lines	cell_line
could	O
be	O
anergized	O
by	O
the	O
autopresentation	O
of	O
native	O
peptide	O
since	O
anergy	O
was	O
induced	O
in	O
cultures	O
lacking	O
fresh	O
antigen-presenting	cell_type
cells	cell_type
.	O
This	O
study	O
shows	O
that	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
cascade	O
is	O
blocked	O
when	O
anergy	O
is	O
induced	O
to	O
high	O
concentrations	O
of	O
soluble	O
peptide	O
.	O
Copyright	O
1998	O
Academic	O
Press.	O

Upregulation	O
of	O
interleukin	protein
6	protein
and	O
granulocyte	protein
colony-stimulating	protein
factor	protein
receptors	protein
by	O
transcription	protein
factor	protein
CCAAT	protein
enhancer	protein
binding	protein
protein	protein
alpha	protein
(	O
C/EBP	protein
alpha	protein
)	O
is	O
critical	O
for	O
granulopoiesis	O
.	O
Cytokines	O
stimulate	O
granulopoiesis	O
through	O
signaling	O
via	O
receptors	O
whose	O
expression	O
is	O
controlled	O
by	O
lineage-specific	O
transcription	protein
factors	protein
.	O
Previously,	O
we	O
demonstrated	O
that	O
granulocyte	RNA
colony-stimulating	RNA
factor	RNA
(	RNA
G-CSF	RNA
)	RNA
receptor	RNA
mRNA	RNA
was	O
undetectable	O
and	O
granulocyte	O
maturation	O
blocked	O
in	O
CCAAT	protein
enhancer	protein
binding	protein
protein	protein
alpha	protein
(	O
C/EBPalpha	protein
)-deficient	O
mice	O
.	O
This	O
phenotype	O
is	O
distinct	O
from	O
that	O
of	O
G-CSF	O
receptor-/-	O
mice	O
,	O
suggesting	O
that	O
other	O
genes	O
are	O
likely	O
to	O
be	O
adversely	O
affected	O
by	O
loss	O
of	O
C/EBPalpha	protein
.	O
Here	O
we	O
demonstrate	O
loss	O
of	O
interleukin	protein
6	protein
(IL-6)	protein
receptor	protein
and	O
IL-6-responsive	protein
colony-forming	protein
units	protein
(	O
CFU-IL6	protein
)	O
in	O
C/EBPalpha	protein
-/-	O
mice	O
.	O
The	O
observed	O
failure	O
of	O
granulopoiesis	O
could	O
be	O
rescued	O
by	O
the	O
addition	O
of	O
soluble	O
IL-6	protein
receptor	protein
and	O
IL-6	protein
or	O
by	O
retroviral	O
transduction	O
of	O
G-CSF	protein
receptors	protein
,	O
demonstrating	O
that	O
loss	O
of	O
both	O
of	O
these	O
receptors	O
contributes	O
to	O
the	O
absolute	O
block	O
in	O
granulocyte	O
maturation	O
observed	O
in	O
C/EBPalpha	cell_type
-deficient	cell_type
hematopoietic	cell_type
cells	cell_type
.	O
The	O
results	O
of	O
these	O
and	O
other	O
studies	O
suggest	O
that	O
additional	O
C/EBPalpha	DNA
target	DNA
genes	DNA
,	O
possibly	O
other	O
cytokine	O
receptors,	O
are	O
also	O
important	O
for	O
the	O
block	O
in	O
granulocyte	O
differentiation	O
observed	O
in	O
vivo	O
in	O
C/EBPalpha	protein
-deficient	O
mice	O
.	O

Phosphatidylinositides	O
bind	O
to	O
plasma	protein
membrane	protein
CD14	protein
and	O
can	O
prevent	O
monocyte	O
activation	O
by	O
bacterial	O
lipopolysaccharide	O
.	O
Although	O
bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
several	O
other	O
microbial	O
agonists	O
can	O
bind	O
to	O
mCD14	protein
(	O
membrane	protein
CD14	protein
),	O
a	O
cell-surface	O
receptor	O
found	O
principally	O
on	O
monocytes	cell_type
and	O
neutrophils	cell_type
,	O
host-derived	O
mCD14	protein
ligands	O
are	O
poorly	O
defined.	O
We	O
report	O
here	O
that	O
phosphatidylinositol	O
(	O
PtdIns	O
),	O
phosphatidylinositol	O
-4-phosphate	O
,	O
and	O
other	O
phosphatidylinositides	O
can	O
bind	O
to	O
mCD14	protein
.	O
Phosphatidylserine	O
(PS),	O
another	O
anionic	O
glycerophospholipid,	O
binds	O
to	O
mCD14	protein
with	O
lower	O
apparent	O
affinity	O
than	O
does	O
PtdIns	O
.	O
LPS	protein
-binding	protein
protein	protein
,	O
a	O
lipid	O
transfer	O
protein	O
found	O
in	O
serum,	O
facilitates	O
both	O
PS	O
-and	O
PtdIns	O
-	O
mCD14	protein
binding	O
.	O
PtdIns	O
binding	O
to	O
mCD14	protein
can	O
be	O
blocked	O
by	O
anti-CD14	protein
monoclonal	protein
antibodies	protein
that	O
inhibit	O
LPS	O
-mCD14	protein
binding	O
,	O
and	O
PtdIns	O
can	O
inhibit	O
both	O
LPS	O
-mCD14	protein
binding	O
and	O
LPS	O
-induced	O
responses	O
in	O
monocytes	cell_type
.	O
Serum-equilibrated	cell_type
PtdIns	cell_type
also	cell_type
binds	cell_type
to	cell_type
mCD14	cell_type
-expressing	cell_type
cells	cell_type
,	O
raising	O
the	O
possibility	O
that	O
endogenous	O
PtdIns	O
may	O
modulate	O
cellular	O
responses	O
to	O
LPS	O
and	O
other	O
mCD14	protein
ligands	O
in	O
vivo.	O

Protein	protein
kinase	protein
C	protein
regulates	O
Fas	protein
(	O
CD95/APO-1	protein
)	O
expression	O
.	O
Fas	protein
(	O
CD95/APO-1	protein
)	O
is	O
a	O
transmembrane	protein
protein	protein
of	O
the	O
TNF/neuron	protein
growth	protein
factor	protein
receptor	protein
family	protein
.	O
Ligation	O
of	O
Fas	protein
by	O
specific	protein
Abs	protein
or	O
Fas	protein
ligand	protein
(	O
FasL/CD95	protein
ligand	protein
)	O
induces	O
rapid	O
apoptotic	O
cell	O
death	O
in	O
a	O
variety	O
of	O
cell	O
types.	O
Despite	O
progress	O
in	O
understanding	O
the	O
death	O
signals	O
transduced	O
from	O
Fas	protein
,	O
very	O
little	O
is	O
known	O
with	O
regard	O
to	O
the	O
mechanisms	O
by	O
which	O
Fas	protein
expression	O
is	O
regulated.	O
Using	O
our	O
previously	O
established	O
murine	cell_line
T	cell_line
cell	cell_line
hybridoma	cell_line
model	cell_line
A1.1	cell_line
,	O
we	O
show	O
that	O
specific	O
protein	protein
kinase	protein
C	protein
(	O
PKC	protein
)	O
inhibitors	O
could	O
block	O
activation-induced	O
Fas	protein
expression	O
and	O
apoptosis.	O
The	O
activation	O
of	O
PKC	protein
with	O
PMA	O
or	O
1-oleoyl-2-acetyl-sn-glycerol	O
could	O
mimic	O
the	O
TCR	protein
signal	O
by	O
inducing	O
the	O
expression	O
of	O
Fas	protein
but	O
not	O
FasL.	O
PKC	protein
-dependent	O
Fas	protein
expression	O
was	O
also	O
observed	O
in	O
several	O
murine	O
and	O
human	O
tumor	O
cell	O
lines	O
.	O
Since	O
the	O
inhibition	O
of	O
Ca2+	O
redistribution	O
by	O
an	O
inhibitor	O
of	O
intracellular	O
Ca2+	O
mobilization	O
,	O
8-(diethylamino)-octyl-3,4,5-trimethoxybenzoate	O
hydrochloride	O
,	O
inhibited	O
TCR-induced	protein
FasL	protein
but	O
not	O
Fas	protein
,	O
the	O
expression	O
of	O
Fas	protein
appears	O
to	O
be	O
independent	O
of	O
Ca2+	O
mobilization	O
.	O
Significantly,	O
expression	O
of	O
the	O
newly	O
identified	O
Fas	DNA
-regulatory	DNA
gene	DNA
,	O
TDAG51	DNA
,	O
was	O
found	O
to	O
be	O
dependent	O
upon	O
the	O
activity	O
of	O
PKC	protein
.	O
PKC	protein
activation	O
only	O
induced	O
Fas	protein
expression	O
in	O
cells	O
expressing	O
wild-type	O
TDAG51	DNA
.	O
Thus,	O
Fas	protein
expression	O
is	O
likely	O
mediated	O
by	O
PKC	protein
through	O
TDAG51	DNA
.	O

Retinoic	O
acid	O
inhibits	O
CD40	protein
+	O
interleukin-4	protein
-mediated	O
IgE	protein
production	O
in	O
vitro.	O
To	O
elucidate	O
the	O
role	O
of	O
retinoic	O
acid	O
(RA)	O
in	O
anti-	protein
CD40	protein
+	O
interleukin-4	protein
(	O
IL-4	protein
)-mediated	O
B-cell	O
activation	O
,	O
the	O
effect	O
of	O
10(-12)	O
to	O
10(-6)	O
mol/L	O
RA	O
was	O
studied	O
in	O
anti-CD40	protein
(1	O
microgram/mL)	O
+	O
IL-4	protein
(5	O
ng/mL)-mediated	O
proliferation	O
and	O
Ig	O
synthesis	O
by	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
and	O
B	cell_type
cells	cell_type
in	O
healthy	O
donors	O
.	O
Anti-CD40	protein
+	O
IL-4	protein
-mediated	O
proliferation	O
of	O
PBMC	cell_type
and	O
B	cell_type
cells	cell_type
was	O
inhibited	O
by	O
RA	O
in	O
a	O
dose-dependent	O
manner	O
,	O
with	O
maximal	O
inhibition	O
of	O
62%	O
+/-	O
5%	O
in	O
PBMC	cell_type
and	O
55%	O
+/-	O
4.4%	O
in	O
B	cell_type
cells	cell_type
by	O
all-trans	O
RA	O
,	O
and	O
58%	O
+/-	O
6.7%	O
and	O
51%	O
+/-	O
4.7%,	O
respectively	O
by	O
13-cis	O
RA	O
.	O
IgE	protein
synthesis	O
was	O
even	O
more	O
markedly	O
inhibited	O
by	O
RA	O
starting	O
at	O
concentrations	O
of	O
&gt;10(-14)	O
mol/L	O
for	O
B	cell_type
cells	cell_type
and	O
&gt;10(-10)	O
mol/L	O
for	O
PBMC	cell_type
.	O
Maximal	O
inhibition	O
of	O
IgE	protein
production	O
for	O
B	cell_type
cells	cell_type
was	O
at	O
10(-8)	O
mol/L	O
for	O
all-trans	O
RA	O
(94%	O
+/-	O
1.8%)	O
and	O
96%	O
+/-	O
3.2%	O
for	O
13-cis	O
RA	O
.	O
Low	O
concentrations	O
of	O
RA	O
inhibiting	O
IgE	protein
synthesis	O
(10(-10)	O
mol/L)	O
affected	O
neither	O
B-cell	O
proliferation	O
nor	O
the	O
production	O
of	O
IgA	protein
,	O
IgG	protein
,	O
and	O
IgM	protein
.	O
Elucidation	O
of	O
the	O
mechanism	O
involved	O
in	O
this	O
inhibition	O
of	O
IgE	protein
production	O
shows	O
that	O
epsilon	O
germline	DNA
transcription	O
is	O
decreased	O
by	O
RA	O
,	O
whereas	O
production	O
of	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)	O
was	O
not	O
enhanced	O
in	O
the	O
presence	O
of	O
RA	O
.	O
To	O
differentiate	O
whether	O
the	O
RA	O
effect	O
was	O
mediated	O
by	O
RA	O
receptors	O
alpha	O
,	O
beta	O
,	O
and	O
gamma	O
,	O
the	O
expression	O
of	O
the	O
retinoic	protein
acid	protein
receptors	protein
(	O
RAR	protein
)	O
was	O
examined	O
by	O
reverse	protein
transcriptase	protein
-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
).	O
The	O
data	O
show	O
that	O
unstimulated	cell_type
human	cell_type
peripheral	cell_type
B	cell_type
cells	cell_type
express	O
mRNA	O
of	O
the	O
RA	O
receptor	O
alpha	O
,	O
beta	O
,	O
and	O
gamma	O
.	O
Using	O
retinoids	O
with	O
different	O
receptor	O
binding	O
specificity	O
(	O
CD336	O
,	O
CD437	O
,	O
CD2019	O
,	O
CD367	O
),	O
dose-dependent	O
inhibition	O
of	O
IgE	protein
synthesis	O
was	O
shown	O
by	O
all	O
four	O
derivates,	O
but	O
was	O
most	O
marked	O
by	O
an	O
RA	O
binding	O
the	O
alpha	protein
receptor	protein
with	O
high	O
specificity.	O
Taken	O
together,	O
this	O
study	O
shows	O
that	O
RA	O
inhibits	O
IgE	protein
production	O
of	O
anti-CD40	cell_line
+	cell_line
IL-4	cell_line
-stimulated	cell_line
B	cell_line
cells	cell_line
in	O
vitro.	O
Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	protein
induction	O
of	O
NF-kappaB	protein
involves	O
activation	O
of	O
the	O
IkappaB	protein
kinase	protein
alpha	protein
(	O
IKKalpha	protein
)	O
and	O
IKKbeta	protein
cellular	protein
kinases	protein
.	O
Tax	protein
corresponds	O
to	O
a	O
40-kDa	protein
transforming	protein
protein	protein
from	O
the	O
pathogenic	O
retrovirus	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
that	O
activates	O
nuclear	O
expression	O
of	O
the	O
NF-kappaB	protein
/Rel	protein
family	protein
of	O
transcription	protein
factors	protein
by	O
an	O
unknown	O
mechanism	O
.	O
Tax	protein
expression	O
promotes	O
N-terminal	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaB	protein
alpha	protein
,	O
a	O
principal	O
cytoplasmic	O
inhibitor	O
of	O
NF-kappaB	protein
.	O
Our	O
studies	O
now	O
demonstrate	O
that	O
HTLV-1	O
Tax	protein
activates	O
the	O
recently	O
identified	O
cellular	protein
kinases	protein
IkappaB	protein
kinase	protein
alpha	protein
(	O
IKKalpha	protein
)	O
and	O
IKKbeta	protein
,	O
which	O
normally	O
phosphorylate	O
IkappaB	protein
alpha	protein
on	O
both	O
of	O
its	O
N-terminal	O
regulatory	O
serines	O
in	O
response	O
to	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNF-alpha	protein
)	O
and	O
interleukin-1	protein
(	O
IL-1	protein
)	O
stimulation	O
.	O
In	O
contrast,	O
a	O
mutant	O
of	O
Tax	protein
termed	O
M22	protein
,	O
which	O
does	O
not	O
induce	O
NF-kappaB	protein
,	O
fails	O
to	O
activate	O
either	O
IKKalpha	protein
or	O
IKKbeta	protein
.	O
Furthermore,	O
endogenous	O
IKK	O
enzymatic	O
activity	O
was	O
significantly	O
elevated	O
in	O
HTLV-1-infected	O
and	O
Tax-expressing	O
T-cell	O
lines	O
.	O
Transfection	O
of	O
kinase-deficient	O
mutants	O
of	O
IKKalpha	protein
and	O
IKKbeta	protein
into	O
either	O
human	O
Jurkat	O
T	O
or	O
293	O
cells	O
also	O
inhibits	O
NF-kappaB	protein
-dependent	O
reporter	DNA
gene	DNA
expression	O
induced	O
by	O
Tax	protein
.	O
Similarly,	O
a	O
kinase-deficient	protein
mutant	protein
of	O
NIK	protein
(	O
NF-kappaB	protein
-inducing	protein
kinase	protein
),	O
which	O
represents	O
an	O
upstream	O
kinase	O
in	O
the	O
TNF-alpha	O
and	O
IL-1	O
signaling	O
pathways	O
leading	O
to	O
IKKalpha	protein
and	O
IKKbeta	protein
activation,	O
blocks	O
Tax	protein
induction	O
of	O
NF-kappaB	protein
.	O
However,	O
plasma	DNA
membrane-proximal	DNA
elements	DNA
in	O
these	O
proinflammatory	protein
cytokine	protein
pathways	O
are	O
apparently	O
not	O
involved	O
since	O
dominant	O
negative	O
mutants	O
of	O
the	O
TRAF2	O
and	O
TRAF6	O
adaptors	O
,	O
which	O
effectively	O
block	O
signaling	O
through	O
the	O
cytoplasmic	protein
tails	protein
of	O
the	O
TNF-alpha	protein
and	O
IL-1	protein
receptors,	O
respectively,	O
do	O
not	O
inhibit	O
Tax	protein
induction	O
of	O
NF-kappaB	protein
.	O
Together,	O
these	O
studies	O
demonstrate	O
that	O
HTLV-1	O
Tax	protein
exploits	O
a	O
distal	O
part	O
of	O
the	O
proinflammatory	protein
cytokine	protein
signaling	O
cascade	O
leading	O
to	O
induction	O
of	O
NF-kappaB	protein
.	O
The	O
pathological	O
alteration	O
of	O
this	O
cytokine	O
pathway	O
leading	O
to	O
NF-kappaB	protein
activation	O
by	O
Tax	protein
may	O
play	O
a	O
central	O
role	O
in	O
HTLV-1	O
-mediated	O
transformation	O
of	O
human	cell_type
T	cell_type
cells	cell_type
,	O
clinically	O
manifested	O
as	O
the	O
adult	O
T-cell	O
leukemia	O

Role	O
of	O
IKK1	protein
and	O
IKK2	protein
in	O
lipopolysaccharide	O
signaling	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Mononuclear	cell_type
phagocytes	cell_type
play	O
a	O
major	O
role	O
in	O
immune	O
and	O
inflammatory	O
responses	O
.	O
Bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
monocytes	cell_type
to	O
express	O
a	O
variety	O
of	O
genes	O
by	O
activating	O
the	O
NF-kappaB/Rel	protein
transcription	protein
factor	protein
family	protein
.	O
Recently,	O
we	O
have	O
reported	O
that	O
the	O
tumor	protein
necrosis	protein
factor	protein
and	O
interleukin	protein
1	protein
signaling	O
pathways	O
activate	O
two	O
kinases,	O
IKK1	protein
and	O
IKK2	protein
.	O
Phosphorylation	O
of	O
the	O
IkappaB	protein
cytoplasmic	protein
inhibitors	protein
,	O
IkappaBalpha	protein
,	O
IkappaBbeta	protein
,	O
and	O
IkappaBepsilon	protein
,	O
by	O
these	O
kinases	O
triggers	O
proteolytic	O
degradation	O
and	O
the	O
release	O
of	O
NF-kappaB/Rel	protein
proteins	protein
into	O
the	O
nucleus.	O
At	O
present,	O
the	O
role	O
of	O
the	O
IKKs	O
in	O
LPS	O
signaling	O
has	O
not	O
been	O
investigated.	O
Here,	O
we	O
report	O
that	O
LPS	O
induces	O
IKK	protein
activity	O
in	O
human	cell_type
monocytes	cell_type
and	O
THP-1	cell_line
monocytic	cell_line
cells	cell_line
.	O
The	O
kinetics	O
of	O
activation	O
of	O
kinase	O
activity	O
in	O
monocytic	cell_type
cells	cell_type
are	O
relatively	O
slow	O
with	O
maximal	O
activity	O
observed	O
at	O
60	O
min,	O
which	O
coincides	O
with	O
the	O
degradation	O
of	O
IkappaBs	protein
and	O
the	O
nuclear	O
translocation	O
of	O
NF-kappaB	protein
.	O
In	O
transfection	O
experiments,	O
overexpression	O
of	O
wild	O
type	O
IKK1	protein
,	O
a	O
dominant	protein
negative	protein
mutant	protein
IKK1	protein
(	O
K44M	protein
),	O
or	O
wild	protein
type	protein
IKK2	protein
did	O
not	O
affect	O
LPS	O
-induced	O
kappaB	protein
-dependent	O
transcription	O
in	O
monocytic	cell_type
cells	cell_type
.	O
In	O
contrast,	O
a	O
dominant	O
negative	O
mutant	O
of	O
IKK2	protein
inhibited	O
LPS	O
induction	O
of	O
kappaB	protein
-dependent	O
transcription	O
in	O
a	O
dose-dependent	O
manner	O
.	O
These	O
results	O
indicate	O
that	O
LPS	O
induction	O
of	O
kappaB-dependent	O
gene	O
expression	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
requires	O
activation	O
of	O
IKK2	protein
.	O

IL-7	protein
reconstitutes	O
multiple	O
aspects	O
of	O
v-Abl	protein
-mediated	O
signaling	O
.	O
The	O
mechanism	O
by	O
which	O
early	cell_type
lymphoid	cell_type
cells	cell_type
are	O
selectively	O
transformed	O
by	O
v-Abl	protein
is	O
currently	O
unknown.	O
Previous	O
studies	O
have	O
shown	O
constitutive	O
activation	O
of	O
IL-4	protein
and	O
IL-7	protein
signaling	O
pathways	O
,	O
as	O
measured	O
by	O
activation	O
of	O
Janus	protein
protein	protein
kinase	protein
(JAK)1	protein
,	O
JAK3	protein
,	O
STAT5	protein
,	O
and	O
STAT6	protein
,	O
in	O
pre-B	cell_type
cells	cell_type
transformed	O
by	O
v-Abl	protein
.	O
To	O
determine	O
whether	O
activation	O
of	O
these	O
cytokine	O
signaling	O
pathways	O
by	O
v-Abl	protein
is	O
important	O
in	O
the	O
cellular	O
events	O
induced	O
by	O
the	O
Abelson	O
murine	O
leukemia	O
virus	O
,	O
the	O
effects	O
of	O
IL-4	protein
and	O
IL-7	protein
on	O
pre-B	cell_type
cells	cell_type
transformed	O
with	O
a	O
temperature-sensitive	protein
v-Abl	protein
mutant	protein
were	O
examined.	O
Whereas	O
IL-4	protein
had	O
little	O
or	O
no	O
effect,	O
IL-7	protein
delayed	O
both	O
the	O
apoptosis	O
and	O
cell	O
cycle	O
arrest	O
that	O
occur	O
upon	O
v-Abl	protein
kinase	O
inactivation	O
.	O
IL-7	protein
also	O
delayed	O
the	O
decreases	O
in	O
the	O
levels	O
of	O
c-Myc	protein
,	O
Bcl-2	protein
,	O
and	O
Bcl-xL	protein
that	O
occur	O
upon	O
loss	O
of	O
v-Abl	protein
kinase	O
activity	O
.	O
IL-7	protein
did	O
not	O
maintain	O
v-Abl	protein
-mediated	O
differentiation	O
arrest	O
of	O
the	O
pre-B	cell_type
cells	cell_type
,	O
as	O
activation	O
of	O
NF-kappaB	protein
and	O
RAG	DNA
gene	DNA
transcription	O
was	O
unaffected	O
by	O
IL-7	protein
.	O
These	O
results	O
identify	O
a	O
potential	O
role	O
for	O
IL-7	protein
signaling	O
pathways	O
in	O
transformation	O
by	O
v-Abl	protein
while	O
demonstrating	O
that	O
a	O
combination	O
of	O
IL-4	protein
and	O
IL-7	protein
signaling	O
cannot	O
substitute	O
for	O
an	O
active	O
v-Abl	protein
kinase	O
in	O
transformed	cell_type
pre-B	cell_type
cells	cell_type
.	O

Differential	O
regulation	O
of	O
coproporphyrinogen	DNA
oxidase	DNA
gene	DNA
between	O
erythroid	O
and	O
nonerythroid	O
cells	O
.	O
Coproporphyrinogen	protein
oxidase	protein
(	O
CPO	protein
)	O
catalyzes	O
the	O
sixth	O
step	O
of	O
the	O
heme	protein
biosynthetic	O
pathway	O
.	O
To	O
assess	O
the	O
tissue-specific	O
regulation	O
of	O
the	O
CPO	DNA
gene	DNA
promoter	DNA
,	O
mouse	DNA
genomic	DNA
DNA	DNA
clones	DNA
for	O
CPO	protein
were	O
isolated.	O
Structural	O
analysis	O
demonstrated	O
that	O
the	O
mouse	DNA
CPO	DNA
gene	DNA
spans	O
approximately	O
11	O
kb	O
and	O
consists	O
of	O
seven	DNA
exons	DNA
,	O
just	O
like	O
its	O
human	O
counterpart.	O
Functional	O
analysis	O
of	O
the	O
promoter	O
by	O
transient	O
transfection	O
assays	O
indicated	O
that	O
synergistic	O
action	O
between	O
an	O
SP-1	DNA
-like	DNA
element	DNA
at	O
-21/-12,	O
a	O
GATA	DNA
site	DNA
at	O
-59/-54,	O
and	O
a	O
novel	DNA
regulatory	DNA
element	DNA
,	O
CPRE	DNA
(-	O
GGACTACAG	DNA
-)	O
at	O
-49/-41,	O
is	O
essential	O
for	O
the	O
promoter	O
activity	O
in	O
murine	cell_type
erythroleukemia	cell_type
(MEL)	cell_type
cells	cell_type
.	O
In	O
nonerythroid	cell_line
NIH3T3	cell_line
cells	cell_line
,	O
however,	O
the	O
GATA	DNA
site	DNA
is	O
not	O
required.	O
Gel	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
specific	O
DNA-protein	protein
complexes	protein
can	O
be	O
formed	O
with	O
each	O
element,	O
and	O
that	O
there	O
are	O
cell-specific	O
differences	O
in	O
factors,	O
which	O
bind	O
to	O
the	O
SP-1	DNA
-like	DNA
element	DNA
between	O
MEL	O
and	O
NIH3T3	O
cells	O
.	O
These	O
results	O
provide	O
evidence	O
for	O
differential	O
regulation	O
of	O
the	O
promoter	O
function	O
of	O
CPO	protein
gene	O
between	O
erythroid	O
and	O
nonerythroid	O
cells	O
.	O
Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O

Tumor	protein
suppressor	protein
proteins	protein
as	O
regulators	O
of	O
cell	O
differentiation	O
.	O
The	O
products	O
of	O
the	O
tumor	DNA
suppressor	DNA
genes	DNA
are	O
considered	O
to	O
function	O
as	O
specific	O
inhibitors	O
of	O
tumor	O
cell	O
growth.	O
In	O
this	O
communication,	O
we	O
present	O
evidence	O
to	O
show	O
that	O
these	O
proteins	O
inhibit	O
tumor	O
cell	O
proliferation	O
by	O
participating	O
in	O
the	O
activation	O
of	O
tumor	O
cell	O
differentiation	O
.	O
The	O
ML-1	cell_line
human	cell_line
myeloblastic	cell_line
leukemia	cell_line
cells	cell_line
used	O
in	O
this	O
study	O
proliferate	O
when	O
treated	O
with	O
insulin-like	protein
growth	protein
factor	protein
I	protein
and	O
transferrin	protein
but	O
differentiate	O
to	O
monocytes	cell_type
when	O
exposed	O
to	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
or	O
transforming	protein
growth	protein
factor	protein
beta1	protein
,	O
or	O
to	O
macrophage-like	cell_type
cells	cell_type
when	O
treated	O
with	O
both	O
these	O
cytokines	protein
.	O
Initiation	O
of	O
proliferation	O
but	O
not	O
of	O
differentiation	O
was	O
followed	O
by	O
a	O
20-	O
to	O
25-fold	O
increase	O
in	O
the	O
nuclear	O
level	O
of	O
the	O
DNA	protein
polymerase-associated	protein
processivity	protein
factor	protein
PCNA	protein
and	O
of	O
the	O
proliferation-specific	protein
transcription	protein
factor	protein
E2F1	protein
.	O
In	O
contrast,	O
induction	O
of	O
differentiation	O
but	O
not	O
of	O
proliferation	O
was	O
followed	O
by	O
a	O
25-	O
to	O
30-fold	O
increase	O
in	O
the	O
nuclear	O
level	O
of	O
the	O
tumor	protein
suppressor	protein
proteins	protein
p53	protein
(wild	O
type),	O
pRb	protein
,	O
and	O
p130/Rb2	protein
and	O
of	O
the	O
p53-dependent	protein
cyclin	protein
kinase	protein
inhibitor	protein
p21/Cip1	protein
.	O
p53	protein
and	O
p21/Cip1	protein
,	O
respectively,	O
inhibit	O
the	O
expression	O
and	O
activation	O
of	O
PCNA	protein
,	O
whereas	O
p130	protein
and	O
pRb	protein
,	O
respectively,	O
inhibit	O
the	O
expression	O
and	O
activation	O
of	O
E2F1	protein
.	O
As	O
a	O
result,	O
G1-S-associated	DNA
DNA	DNA
and	O
mRNA	O
synthesis	O
is	O
inhibited,	O
growth	O
uncoupled	O
from	O
differentiation,	O
and	O
maturation	O
enabled	O
to	O
proceed.	O
Where	O
this	O
function	O
of	O
the	O
tumor	protein
suppressor	protein
proteins	protein
is	O
impaired,	O
the	O
capacity	O
for	O
differentiation	O
is	O
lost,	O
which	O
leads	O
to	O
the	O
sustained	O
proliferation	O
that	O
is	O
characteristic	O
of	O
the	O
cancer	cell_type
cell	cell_type
.	O

Transcription	protein
factor	protein
activation	O
in	O
lymphokine	O
activated	O
killer	cell_type
cells	cell_type
and	O
lymphocytes	cell_type
from	O
patients	O
receiving	O
IL-2	protein
immunotherapy	O
.	O
Administration	O
of	O
the	O
cytokine	protein
interleukin-2	protein
(	O
IL-2	protein
)	O
can	O
result	O
in	O
therapeutic	O
benefits	O
for	O
individuals	O
with	O
renal	O
cell	O
carcinoma	O
and	O
melanoma	O
.	O
Here	O
we	O
report	O
an	O
analysis	O
of	O
the	O
transcription	O
factor	O
families	O
AP-1,	O
Sp1,	O
NF-kappaB	protein
,	O
and	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
STAT	protein
)	O
in	O
cancer	cell_type
patients'	cell_type
lymphocytes	cell_type
before	O
and	O
after	O
IL-2	protein
immunotherapy	O
,	O
as	O
assessed	O
by	O
a	O
gel-shift	O
assay	O
.	O
An	O
in	O
vitro	O
surrogate	O
of	O
IL-2	protein
immunotherapy	O
is	O
the	O
incubation	O
of	O
fresh	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
from	O
healthy	O
individuals	O
in	O
IL-2	protein
for	O
several	O
days,	O
resulting	O
in	O
the	O
production	O
of	O
lymphokine	protein
-activated	O
killer	O
(LAK)	O
activity	O
in	O
these	O
cultures.	O
One	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
profile	O
of	O
transcription	O
factor	O
activation	O
in	O
these	O
different	O
populations,	O
and	O
assess	O
whether	O
the	O
patterns	O
observed	O
correlated	O
with	O
functional	O
differences	O
in	O
these	O
cells.	O
Prior	O
to	O
in	O
vivo	O
IL-2	protein
administration,	O
the	O
typical	O
binding	O
pattern	O
of	O
transcription	protein
factors	protein
in	O
PBMC	cell_type
from	O
patients	O
resembled	O
that	O
seen	O
in	O
fresh	O
PBMC	cell_type
from	O
healthy	O
individuals	O
.	O
Over	O
a	O
3-week	O
course	O
of	O
IL-2	protein
therapy,	O
in	O
most	O
patients	O
the	O
binding	O
patterns	O
of	O
AP-1	protein
,	O
Sp1	protein
,	O
and	O
NF-kappaB	protein
proteins	O
changed	O
to	O
resemble	O
those	O
seen	O
in	O
PBMC	cell_type
activated	O
by	O
IL-2	protein
in	O
vitro.	O
However,	O
the	O
cells	O
obtained	O
from	O
IL-2	protein
-treated	O
patients	O
did	O
not	O
have	O
low-level	O
constitutive	O
expression	O
of	O
STAT	protein
binding	protein
factors	protein
as	O
did	O
LAK	protein
cells	protein
.	O
When	O
these	O
patient	O
cells	O
were	O
further	O
stimulated	O
by	O
IL-2	protein
in	O
vitro	O
,	O
additional	O
differences	O
in	O
STAT	protein
induction	O
patterns	O
were	O
noted.	O
These	O
data	O
provide	O
further	O
information	O
on	O
the	O
molecular	O
events	O
occurring	O
in	O
immune	cell_type
cells	cell_type
generated	O
through	O
in	O
vivo	O
and	O
in	O
vitro	O
administration	O
of	O
IL-2	protein
,	O
and	O
further	O
document	O
that	O
there	O
is	O
not	O
a	O
precise	O
congruence	O
between	O
PBMC	cell_type
activated	O
in	O
vivo	O
and	O
in	O
vitro	O
by	O
IL-2	protein
.	O

Activated	cell_type
platelets	cell_type
induce	O
monocyte	protein
chemotactic	protein
protein-1	protein
secretion	O
and	O
surface	O
expression	O
of	O
intercellular	cell_type
adhesion	cell_type
molecule-1	cell_type
on	O
endothelial	cell_type
cells	cell_type
[see	O
comments]	O
BACKGROUND:	O
Platelet/endothelium	O
interaction	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathophysiology	O
of	O
inflammation	O
and	O
atherosclerosis	O
.	O
The	O
role	O
of	O
platelets	O
for	O
monocyte	protein
chemotactic	protein
protein-1	protein
(	O
MCP-1	protein
)	O
secretion	O
and	O
surface	O
expression	O
of	O
intercellular	cell_type
adhesion	cell_type
molecule-1	cell_type
(	O
ICAM-1	protein
)	O
on	O
endothelial	cell_type
cells	cell_type
has	O
been	O
assessed.	O
METHODS	O
AND	O
RESULTS:	O
Monolayers	O
of	O
human	cell_type
umbilical	cell_type
vein	cell_type
endothelial	cell_type
cells	cell_type
were	O
incubated	O
with	O
nonstimulated	O
or	O
ADP-activated	cell_type
platelets	cell_type
for	O
6	O
hours,	O
and	O
secretion	O
of	O
MCP-1	protein
and	O
surface	O
expression	O
of	O
ICAM-1	protein
were	O
determined	O
by	O
ELISA	O
and	O
flow	O
cytometry	O
,	O
respectively.	O
In	O
the	O
presence	O
of	O
ADP-activated	cell_type
platelets	cell_type
,	O
both	O
MCP-1	protein
secretion	O
and	O
ICAM-1	protein
surface	O
expression	O
were	O
significantly	O
increased	O
compared	O
with	O
nonstimulated	cell_type
platelets	cell_type
(P&lt;0.02).	O
Activation	O
of	O
the	O
transcription	protein
factor	protein
nuclear	protein
factor-kappaB	protein
(	O
NF-kappaB	protein
)	O
determined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
and	O
kappaB	protein
-dependent	O
transcriptional	O
activity	O
was	O
enhanced	O
in	O
the	O
presence	O
of	O
activated	cell_type
platelets	cell_type
.	O
In	O
addition,	O
ADP-	cell_type
activated	cell_type
platelets	cell_type
induced	O
MCP-1	O
and	O
ICAM-1	O
promoter-dependent	O
transcription	O
.	O
Liposomal	O
transfection	O
of	O
a	O
double-stranded	O
kappaB	O
phosphorothioate	O
oligonucleotide	O
,	O
but	O
not	O
of	O
the	O
mutated	O
form,	O
inhibited	O
MCP-1	protein
secretion	O
and	O
surface	O
expression	O
of	O
ICAM-1	protein
on	O
activated	O
endothelium	O
(P&lt;0.05).	O
CONCLUSIONS:	O
The	O
present	O
study	O
indicates	O
that	O
activated	cell_type
platelets	cell_type
modulate	O
chemotactic	O
(	O
MCP-1	protein
)	O
and	O
adhesive	O
(	O
ICAM-1	protein
)	O
properties	O
of	O
endothelial	cell_type
cells	cell_type
via	O
an	O
NF-kappaB	protein
-dependent	O
mechanism	O
.	O
Platelet-induced	O
activation	O
of	O
the	O
NF-kappaB	protein
system	O
might	O
contribute	O
to	O
early	O
inflammatory	O
events	O
in	O
atherogenesis	O
.	O

Retinoid	protein
X	protein
receptor	protein
and	O
c-cerbA/thyroid	protein
hormone	protein
receptor	protein
regulate	O
erythroid	O
cell	O
growth	O
and	O
differentiation	O
.	O
Nuclear	protein
receptors	protein
are	O
important	O
regulators	O
of	O
erythroid	O
cell	O
development	O
.	O
Here	O
we	O
investigated	O
the	O
impact	O
of	O
retinoid	protein
X	protein
receptor	protein
(	O
RXR	protein
),	O
retinoic	protein
acid	protein
receptor	protein
(	O
RAR	protein
),	O
and	O
of	O
the	O
c-erbA/thyroid	protein
hormone	protein
(T3)	protein
receptor	protein
(	O
c-erbA/TR	protein
)	O
on	O
growth	O
and	O
differentiation	O
of	O
erythroid	cell_type
cells	cell_type
using	O
an	O
in	O
vitro	O
culture	O
system	O
of	O
stem	cell_type
cell	cell_type
factor-dependent	cell_type
erythroid	cell_type
progenitors	cell_type
.	O
RXR	protein
,	O
RAR	protein
,	O
and	O
c-erbA/TR	protein
-specific	O
ligands	O
were	O
found	O
to	O
induce	O
erythroid-specific	DNA
gene	DNA
expression	O
and	O
to	O
accelerate	O
erythroid	O
differentiation	O
in	O
culture,	O
with	O
T3	O
being	O
most	O
effective.	O
Furthermore,	O
while	O
ligand-activated	O
c-erbA/TR	protein
accelerated	O
differentiation	O
,	O
unliganded	O
c-erbA/TR	protein
effectively	O
blocked	O
differentiation	O
and	O
supported	O
sustained	O
progenitor	O
growth	O
in	O
culture.	O
Thus,	O
c-erbA/TR	protein
appears	O
to	O
act	O
as	O
a	O
binary	O
switch	O
affecting	O
erythroid	cell_type
cell	cell_type
fate	cell_type
:	O
unliganded	O
c-erbA/TR	protein
supports	O
growth	O
while	O
ligand-activated	O
c-erbA/TR	protein
induces	O
differentiation.	O
Additionally,	O
to	O
determine	O
the	O
impact	O
of	O
RXR	protein
for	O
erythroid	O
cell	O
development	O
,	O
dominant	O
interfering	O
mutant	protein
RXRs	protein
,	O
lacking	O
the	O
transcriptional	O
activator	O
functions	O
AF-1	protein
and	O
AF-2	protein
,	O
or	O
AF-2	protein
only,	O
or	O
the	O
entire	DNA
DNA-binding	DNA
domain	DNA
,	O
were	O
introduced	O
into	O
erythroid	cell_type
progenitor	cell_type
cells	cell_type
via	O
recombinant	O
retrovirus	O
vectors	O
and	O
analyzed	O
for	O
RXR	protein
-specific	O
effects.	O
It	O
was	O
found	O
that	O
expression	O
of	O
wild-type	protein
RXR	protein
and	O
of	O
the	O
RXR	protein
mutants	protein
devoid	O
of	O
AF-1	protein
and/or	O
AF-2	protein
supported	O
a	O
transient	O
outgrowth	O
of	O
erythroid	cell_type
cells	cell_type
.	O
In	O
marked	O
contrast,	O
expression	O
of	O
the	O
dominant	protein
interfering	protein
deltaDNA-binding	protein
domain	protein
RXR	protein
,	O
containing	O
a	O
deletion	O
of	O
the	O
entire	DNA
DNA-binding	DNA
domain	DNA
,	O
was	O
incompatible	O
with	O
erythroid	O
cell	O
growth	O
in	O
vitro,	O
suggesting	O
a	O
pivotal	O
role	O
of	O
RXR	protein
for	O
erythroid	O
cell	O
development	O
.	O

Peripheral	cell_type
T	cell_type
lymphocytes	cell_type
from	O
women	O
with	O
breast	O
cancer	O
exhibit	O
abnormal	O
protein	O
expression	O
of	O
several	protein
signaling	protein
molecules	protein
.	O
We	O
examined	O
signaling	O
molecules	O
of	O
peripheral	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
obtained	O
from	O
women	O
with	O
breast	O
cancer	O
.	O
In	O
6	O
of	O
14	O
patients	O
,	O
T	cell_type
lymphocytes	cell_type
displayed	O
an	O
impaired	O
ability	O
to	O
translocate	O
NFeB	protein
p65	protein
(	O
Rel-A	protein
)	O
following	O
activation	O
by	O
anti-CD3	O
and	O
IL-2	protein
.	O
This	O
observation	O
was	O
made	O
despite	O
normal	O
cytoplasmic	O
levels	O
of	O
the	O
Rel-A	protein
protein	protein
.	O
We	O
also	O
detected	O
abnormally	O
low	O
levels	O
of	O
the	O
signaling	protein
molecules	protein
T-cell	protein
receptor	protein
(TCR)-zeta	protein
,	O
ZAP-70	protein
and	O
p56lck	protein
in	O
4	O
of	O
14	O
breast	O
cancer	O
patients	O
,	O
i.e.,	O
defects	O
in	O
T-cell	protein
signaling	protein
molecules	protein
.	O
T	cell_type
lymphocytes	cell_type
from	O
6	O
of	O
the	O
14	O
patients	O
also	O
exhibited	O
an	O
increased	O
expression	O
of	O
the	O
dual	O
specificity	protein
phosphatase	protein
,	O
map	protein
kinase	protein
phosphatase-1	protein
(	O
MKP-1	protein
).	O
MKP-1	protein
inactivates	O
MAP	protein
kinase	protein
and	O
therefore	O
may	O
interfere	O
with	O
the	O
activation	O
of	O
c-jun	DNA
and	O
c-fos	DNA
.	O
Abnormalities	O
of	O
I	O
or	O
more	O
signaling	protein
molecules	protein
were	O
found	O
in	O
9	O
of	O
14	O
patients	O
;	O
however,	O
only	O
3	O
patients	O
had	O
T	cell_type
cells	cell_type
that	O
exhibited	O
all	O
5	O
defects.	O
Our	O
data	O
have	O
implications	O
for	O
the	O
detection	O
of	O
potentially	O
dysfunctional	O
T	cell_type
cells	cell_type
in	O
patients	O
with	O
cancer	O
.	O
For	O
example,	O
the	O
analysis	O
of	O
only	O
1	O
signaling	protein
molecule	protein
may	O
allow	O
patients	O
with	O
significant	O
defects	O
in	O
T-cell	O
signaling	O
to	O
go	O
unnoticed.	O
Finally,	O
despite	O
impaired	O
Rel-A	protein
translocation	O
,	O
T	cell_type
cells	cell_type
were	O
capable	O
of	O
transcribing	O
IL-2	protein
.	O
Impairments	O
in	O
the	O
translocation	O
of	O
Rel-B	protein
and	O
c-Rel	protein
further	O
suggest	O
that	O
the	O
NFKB	protein
family	protein
members	protein
Rel-A	protein
,	O
Rel-B	protein
and	O
c-Rel	protein
are	O
not	O
required	O
for	O
the	O
transcription	O
of	O
IL-2	protein
in	O
the	O
peripheral	cell_type
T	cell_type
lymphocytes	cell_type
of	O
patients	O
with	O
breast	O
cancer	O
.	O

Specific	O
glucocorticoid	O
binding	O
at	O
different	O
levels	O
of	O
human	O
motor	O
activity	O
.	O
We	O
studied	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
and	O
dissociation	O
constant	O
in	O
isolated	cell_type
human	cell_type
lymphocytes	cell_type
as	O
well	O
as	O
blood	O
concentrations	O
of	O
hormones	O
produced	O
by	O
the	O
hypothalamic-hypophyseal-adrenocortical	O
system	O
in	O
three	O
experimental	O
series:	O
at	O
normal	O
(17	O
subjects	O
),	O
decreased	O
(10	O
subjects	O
,	O
a	O
360-d	O
head-down	O
bed	O
rest)	O
and	O
increased	O
(8	O
subjects	O
,	O
physical	O
exercise	O
on	O
bicycle	O
ergometer)	O
levels	O
of	O
motor	O
activity.	O
In	O
the	O
first	O
series	O
we	O
found	O
that	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
and	O
dissociation	O
constant	O
did	O
not	O
depend	O
on	O
the	O
season,	O
on	O
the	O
age	O
of	O
subjects	O
nor	O
on	O
cortisol	O
concentrations	O
in	O
blood.	O
In	O
the	O
second	O
series	O
we	O
observed	O
the	O
following:	O
at	O
the	O
end	O
of	O
the	O
first	O
month	O
of	O
bed	O
rest	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
and	O
receptor	O
affinity	O
significantly	O
increased;	O
at	O
the	O
beginning	O
of	O
the	O
third	O
month	O
of	O
bed	O
rest	O
specific	O
glucocorticoid	O
binding	O
significantly	O
decreased	O
and	O
circadian	O
rhythms	O
of	O
adrenocorticotropin	O
and	O
cortisol	O
in	O
blood	O
varied	O
markedly;	O
at	O
the	O
end	O
of	O
the	O
sixth	O
month	O
of	O
bed	O
rest	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
returned	O
to	O
prebed	O
rest	O
levels	O
and	O
dissociation	O
constant	O
decreased.	O
In	O
the	O
third	O
series	O
physical	O
exercises	O
that	O
induced	O
an	O
activation	O
of	O
the	O
hypothalamic-hypophyseal-adrenocortical	O
system	O
(maximal	O
physical	O
exercises	O
and	O
prolonged	O
submaximal	O
exercises	O
at	O
70%	O
of	O
maximal	O
oxygen	O
uptake)	O
led	O
to	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
glucocorticoid	protein
receptors	protein
without	O
changes	O
of	O
dissociation	O
constant.	O
These	O
results	O
indicate	O
that	O
both	O
a	O
decrease	O
and	O
an	O
increase	O
of	O
human	O
motor	O
activity	O
resulted	O
in	O
significant	O
changes	O
of	O
specific	O
glucocorticoid	O
binding	O
which	O
were	O
not	O
influenced	O
by	O
changes	O
of	O
circulating	O
hormone	O
concentrations	O
in	O
blood	O
but	O
by	O
some	O
other	O
factors	O
affected	O
by	O
physical	O
activity	O
.	O

The	O
small	protein
GTP	protein
-binding	protein
protein	protein
Rho	protein
potentiates	O
AP-1	protein
transcription	O
in	O
T	cell_type
cells	cell_type
.	O
The	O
Rho	protein
family	O
of	O
small	protein
GTP	protein
-binding	protein
proteins	protein
is	O
involved	O
in	O
the	O
regulation	O
of	O
cytoskeletal	O
structure	O
,	O
gene	O
transcription	O
,	O
specific	O
cell	O
fate	O
development	O
,	O
and	O
transformation.	O
We	O
demonstrate	O
in	O
this	O
report	O
that	O
overexpression	O
of	O
an	O
activated	O
form	O
of	O
Rho	protein
enhances	O
AP-1	protein
activity	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
in	O
the	O
presence	O
of	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
),	O
but	O
activated	O
Rho	protein
(	O
V14Rho	protein
)	O
has	O
little	O
or	O
no	O
effect	O
on	O
NFAT	protein
,	O
Oct-1	protein
,	O
and	O
NF-kappaB	DNA
enhancer	DNA
element	DNA
activities	O
under	O
similar	O
conditions.	O
Overexpression	O
of	O
a	O
V14Rho	DNA
construct	DNA
incapable	O
of	O
membrane	O
localization	O
(	O
CAAX	DNA
deleted	DNA
)	O
abolishes	O
PMA	O
-induced	O
AP-1	protein
transcriptional	O
activation	O
.	O
The	O
effect	O
of	O
Rho	protein
on	O
AP-1	protein
is	O
independent	O
of	O
the	O
mitogen-activated	protein
protein	protein
kinase	protein
pathway	O
,	O
as	O
a	O
dominant-negative	protein
MEK	protein
and	O
a	O
MEK	protein
inhibitor	O
(	O
PD98059	O
)	O
did	O
not	O
affect	O
Rho	protein
-induced	O
AP-1	protein
activity	O
.	O
V14Rho	protein
binds	O
strongly	O
to	O
protein	protein
kinase	protein
Calpha	protein
(	O
PKCalpha	protein
)	O
in	O
vivo;	O
however,	O
deletion	O
of	O
the	O
CAAX	DNA
site	DNA
on	O
V14Rho	protein
severely	O
diminished	O
this	O
association.	O
Evidence	O
for	O
a	O
role	O
for	O
PKCalpha	protein
as	O
an	O
effector	O
of	O
Rho	protein
was	O
obtained	O
by	O
the	O
observation	O
that	O
coexpression	O
of	O
the	O
N-terminal	protein
domain	protein
of	O
PKCalpha	protein
blocked	O
the	O
effects	O
of	O
activated	O
Rho	protein
plus	O
PMA	O
on	O
AP-1	protein
transcriptional	O
activity	O
.	O
These	O
data	O
suggest	O
that	O
Rho	protein
potentiates	O
AP-1	protein
transcription	O
during	O
T-cell	O
activation	O

Changes	O
in	O
PKC	protein
isoforms	protein
in	O
human	cell_type
alveolar	cell_type
macrophages	cell_type
compared	O
with	O
blood	cell_type
monocytes	cell_type
.	O
Alveolar	O
macrophages	O
play	O
an	O
important	O
role	O
in	O
host	O
defense	O
and	O
in	O
other	O
types	O
of	O
inflammatory	O
processes	O
in	O
the	O
lung	O
.	O
These	O
cells	O
exhibit	O
many	O
alterations	O
in	O
function	O
compared	O
with	O
their	O
precursor	cell_type
cells	cell_type
,	O
blood	cell_type
monocytes	cell_type
.	O
To	O
evaluate	O
a	O
potential	O
mechanism	O
for	O
these	O
differences	O
in	O
function,	O
we	O
evaluated	O
expression	O
of	O
protein	protein
kinase	protein
C	protein
(	protein
PKC	protein
)	protein
isoforms	protein
.	O
We	O
found	O
an	O
increase	O
in	O
Ca2+	protein
-dependent	protein
PKC	protein
isoforms	protein
in	O
monocytes	O
compared	O
with	O
alveolar	O
macrophages.	O
We	O
also	O
found	O
differential	O
expression	O
of	O
the	O
Ca2+	protein
-independent	protein
isoforms	protein
in	O
alveolar	cell_type
macrophages	cell_type
compared	O
with	O
monocytes	cell_type
.	O
One	O
consequence	O
of	O
the	O
activation	O
of	O
PKC	protein
can	O
be	O
increased	O
expression	O
of	O
mitogen-activated	protein
protein	protein
(MAP)	protein
kinase	protein
pathways	O
.	O
Therefore,	O
we	O
also	O
evaluated	O
activation	O
of	O
the	O
MAP	protein
kinase	protein
extracellular	protein
signal-regulated	protein
kinase	protein
(	protein
ERK	protein
)	protein
2	protein
by	O
the	O
phorbol	O
ester	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
).	O
PMA	O
activated	O
ERK2	protein
kinase	protein
in	O
both	O
alveolar	cell_type
macrophages	cell_type
and	O
monocytes	cell_type
;	O
however,	O
monocytes	cell_type
consistently	O
showed	O
a	O
significantly	O
greater	O
activation	O
of	O
ERK2	protein
kinase	protein
by	O
PMA	O
compared	O
with	O
alveolar	cell_type
macrophages	cell_type
.	O
Another	O
known	O
consequence	O
of	O
the	O
activation	O
of	O
PKC	protein
and	O
subsequent	O
activation	O
of	O
ERK	protein
kinase	protein
is	O
activation	O
of	O
the	O
transcription	protein
factor	protein
activator	protein
protein-1	protein
(	O
AP-1	protein
).	O
We	O
evaluated	O
the	O
activation	O
of	O
AP-1	protein
by	O
PMA	O
in	O
both	O
monocytes	cell_type
and	O
macrophages.	O
We	O
found	O
very	O
little	O
detectable	O
activation	O
of	O
AP-1	protein
,	O
as	O
assessed	O
in	O
a	O
gel	O
shift	O
assay	O
,	O
in	O
alveolar	cell_type
macrophages	cell_type
,	O
whereas	O
monocytes	cell_type
showed	O
a	O
substantial	O
activation	O
of	O
AP-1	protein
by	O
PMA	O
.	O
These	O
studies	O
show	O
that	O
the	O
differential	O
expression	O
of	O
PKC	protein
isoforms	protein
in	O
alveolar	cell_type
macrophages	cell_type
and	O
blood	cell_type
monocytes	cell_type
is	O
associated	O
with	O
important	O
functional	O
alterations	O
in	O
the	O
cells.	O

Expression	O
of	O
gamma-IFN	DNA
responsive	DNA
genes	DNA
in	O
scavenger	O
receptor	O
over-expressing	cell_type
monocytes	cell_type
is	O
associated	O
with	O
xanthomatosis	O
.	O
We	O
have	O
recently	O
described	O
an	O
inherited	O
over-expression	O
of	O
the	O
macrophage	protein
scavenger	protein
receptor	protein
(	O
SR	protein
)	O
in	O
blood	cell_type
monocytes	cell_type
from	O
members	O
of	O
a	O
kindred,	O
only	O
two	O
of	O
whom	O
displayed	O
extensive	O
xanthomatosis	O
.	O
Using	O
mRNA	O
differential	O
display	O
we	O
demonstrated	O
abnormally	O
high	O
expression	O
of	O
the	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
(	O
STAT1alpha	protein
)	O
in	O
monocytes	cell_type
from	O
the	O
proband	cell_line
II-2	cell_line
.	O
Expression	O
of	O
gamma-interferon	protein
inducible	protein
protein	protein
10	protein
(	O
IP-10	protein
),	O
a	O
STAT1alpha	DNA
-responsive	DNA
gene	DNA
and	O
mediator	O
of	O
inflammatory	O
response,	O
was	O
also	O
abnormally	O
expressed	O
in	O
the	O
monocytes	cell_type
from	O
II-2	cell_line
.	O
Over-expression	O
of	O
both	O
genes	O
was	O
restricted	O
to	O
monocytes	cell_type
from	O
II-2	cell_line
and	O
was	O
not	O
observed	O
in	O
monocytes	cell_type
from	O
the	O
clinically	O
unaffected	O
family	O
members	O
,	O
unlike	O
that	O
of	O
SR	protein
.	O
Gel	O
retardation	O
assays	O
with	O
THP-1	cell_line
cell	cell_line
extracts	O
identified	O
gamma-IFN	protein
inducible	O
DNA	O
binding	O
activity	O
to	O
three	O
potential	O
STATI	DNA
DNA	DNA
binding	DNA
elements	DNA
in	O
the	O
human	DNA
IP-10	DNA
promoter	DNA
region	DNA
from	O
nucleotides	DNA
-	DNA
245	DNA
to	DNA
-	DNA
188	DNA
.	O
Taken	O
together	O
these	O
results	O
suggest	O
that	O
gamma-interferon	O
mediated	O
cell	O
activation	O
is	O
responsible	O
for	O
STAT1alpha	protein
-induced	O
transcription	O
of	O
the	O
IP-10	protein
gene	O
in	O
THP-1	cell_line
macrophages	cell_line
as	O
well	O
as	O
in	O
monocytes	cell_type
from	O
II-2	cell_line
.	O
Analysis	O
of	O
monocytes	cell_type
from	O
familial	O
hypercholesterolemic	O
(FH)	O
subjects	O
,	O
who	O
frequently	O
develop	O
xanthomatosis	O
,	O
revealed	O
a	O
significant	O
number	O
of	O
subjects	O
with	O
elevated	O
STAT1alpha	O
and	O
IP-10	O
expression	O
.	O
Our	O
data	O
suggest	O
that	O
the	O
inflammatory	O
effects	O
of	O
gamma-IFN	protein
signaling	O
could	O
play	O
a	O
role	O
in	O
foam	O
cell	O
formation	O
and	O
xanthomatosis	O
.	O

Redox	O
signals	O
and	O
NF-kappaB	protein
activation	O
in	O
T	cell_type
cells	cell_type
.	O
Accumulating	O
data	O
from	O
a	O
number	O
of	O
laboratories	O
have	O
recently	O
indicated	O
that	O
the	O
response	O
of	O
transcription	protein
factor	protein
NF-kappaB	protein
to	O
alterations	O
in	O
the	O
redox	O
homeostasis	O
of	O
cells	O
may	O
play	O
an	O
important	O
role	O
in	O
modulating	O
immune	O
function	O
.	O
The	O
activation	O
of	O
NF-kappaB	protein
has	O
been	O
recognized	O
to	O
regulate	O
a	O
number	O
of	O
genes	O
necessary	O
for	O
normal	O
T	O
cell	O
responses	O
including	O
IL-2	protein
,	O
IL-6	protein
,	O
IL-8	protein
,	O
and	O
several	O
T	protein
cell	protein
surface	protein
receptors	protein
.	O
Diminished	O
NF-kappaB	protein
activity	O
has	O
been	O
shown	O
to	O
occur	O
in	O
T	cell_type
cells	cell_type
with	O
aging,	O
suggesting	O
that	O
impaired	O
activation	O
of	O
NF-kappaB	protein
might	O
occur	O
during	O
cellular	O
senescence	O
.	O
In	O
addition,	O
aberrancies	O
in	O
NF-kappaB	protein
activity	O
have	O
been	O
implicated	O
in	O
the	O
immunopathogenesis	O
of	O
diseases	O
involving	O
immune	O
or	O
inflammatory	O
processes	O
such	O
as	O
atherosclerosis	O
and	O
HIV-1	O
infection	O
.	O
The	O
role	O
of	O
H2O2	O
and	O
other	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
as	O
an	O
integratory	O
secondary	O
messenger	O
for	O
divergent	O
T	O
cell	O
signals	O
has	O
been	O
complicated	O
by	O
the	O
fact	O
that	O
various	O
T	cell_line
cell	cell_line
lines	cell_line
and	O
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
differ	O
markedly	O
in	O
the	O
levels	O
of	O
NF-kappaB	protein
activation	O
induced	O
by	O
oxidant	O
stress.	O
Additionally,	O
proposed	O
pathways	O
of	O
NF-kappaB	protein
activation	O
have	O
been	O
based	O
on	O
indirect	O
evidence	O
provided	O
by	O
experiments	O
which	O
used	O
antioxidants	O
to	O
inhibit	O
active	O
NF-kappaB	protein
formation	O
.	O
Further,	O
complete	O
activation	O
of	O
T	cell_type
cells	cell_type
requires	O
at	O
least	O
two	O
signals,	O
one	O
that	O
stimulates	O
an	O
increase	O
in	O
intracellular	O
calcium	O
and	O
one	O
that	O
stimulates	O
enzymatic	O
processes	O
including	O
kinases.	O
Similarly,	O
substantial	O
evidence	O
indicates	O
that	O
full	O
activation	O
of	O
NF-kappaB	protein
requires	O
dual	O
signals.	O
The	O
ability	O
of	O
H2O2	O
or	O
other	O
ROS	O
to	O
induce	O
T	O
cell	O
signals	O
and	O
functional	O
responses	O
by	O
these	O
two	O
mechanisms	O
is	O
reviewed	O
and	O
the	O
specific	O
response	O
of	O
NF-kappaB	protein
to	O
redox	O
changes	O
in	O
T	cell_type
cells	cell_type
is	O
examined.	O
Data	O
are	O
also	O
presented	O
to	O
suggest	O
that	O
the	O
redox	O
regulation	O
in	O
NF-kappaB	protein
activation	O
may	O
be	O
relevant	O
to	O
immune-related	O
diseases	O
and	O
to	O
aging.	O

Uncoupling	O
of	O
nonreceptor	O
tyrosine	protein
kinases	protein
from	O
PLC-gamma1	protein
in	O
an	O
SLP-76-deficient	O
T	O
cell.	O
Activation	O
of	O
nonreceptor	protein
protein	protein
tyrosine	protein
kinases	protein
(	O
PTKs	protein
)	O
is	O
essential	O
for	O
T	protein
cell	protein
receptor	protein
(	O
TCR	protein
)	O
responsiveness	O
;	O
however,	O
the	O
function	O
of	O
individual	O
PTK	protein
substrates	protein
is	O
often	O
uncertain.	O
A	O
mutant	cell_line
T	cell_line
cell	cell_line
line	cell_line
was	O
isolated	O
that	O
lacked	O
expression	O
of	O
SLP-76	protein
(	O
SH2	protein
domain-containing	protein
leukocyte	protein
protein	protein
of	O
76	O
kilodaltons),	O
a	O
hematopoietically	protein
expressed	protein
adaptor	protein
protein	protein
and	O
PTK	protein
substrate	protein
.	O
SLP-76	protein
was	O
not	O
required	O
for	O
TCR	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
most	O
proteins,	O
but	O
was	O
required	O
for	O
optimal	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
phospholipase	protein
C-gamma1	protein
(	O
PLC-gamma1	protein
),	O
as	O
well	O
as	O
Ras	protein
pathway	O
activation	O
.	O
TCR	protein
-inducible	O
gene	O
expression	O
was	O
dependent	O
on	O
SLP-76	protein
.	O
Thus,	O
coupling	O
of	O
TCR-regulated	protein
PTKs	protein
to	O
downstream	O
signaling	O
pathways	O
requires	O
SLP-76	protein
.	O

A	O
novel	O
function	O
of	O
Stat1	protein
and	O
Stat3	protein
proteins	O
in	O
erythropoietin	protein
-induced	O
erythroid	O
differentiation	O
of	O
a	O
human	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
.	O
We	O
recently	O
determined	O
that	O
erythropoietin	protein
(	O
EPO	protein
)	O
activates	O
3	O
members	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(STAT)	O
family,	O
Stat1alpha	protein
,	O
Stat3	protein
,	O
and	O
Stat5	protein
,	O
in	O
the	O
human	cell_line
EPO	cell_line
-dependent	cell_line
cell	cell_line
lines	cell_line
,	O
UT-7	cell_line
and	O
UT-7/	cell_line
EPO	cell_line
(Kirito	O
et	O
al,	O
J	O
Biol	O
Chem	O
272:16507,	O
1997).	O
In	O
addition,	O
we	O
have	O
shown	O
that	O
Stat1alpha	protein
,	O
but	O
not	O
Stat3	protein
,	O
is	O
involved	O
in	O
EPO	protein
-induced	O
cellular	O
proliferation	O
.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
roles	O
of	O
Stat1alpha	protein
and	O
Stat3	protein
in	O
EPO	protein
-induced	O
erythroid	O
differentiation	O
.	O
UT-7/GM	cell_line
was	O
used	O
as	O
a	O
model	O
system,	O
because	O
this	O
cell	O
line	O
can	O
differentiate	O
into	O
erythroid-lineage	cell_type
cells	cell_type
with	O
EPO	protein
treatment	O
(Komatsu	O
et	O
al,	O
Blood	O
89:4021,	O
1997).	O
We	O
found	O
that	O
EPO	protein
did	O
not	O
activate	O
Stat1alpha	protein
or	O
Stat3	protein
in	O
UT-7/GM	cell_line
cells	cell_line
.	O
Transfection	O
experiments	O
showed	O
that	O
both	O
Stat1alpha	protein
and	O
Stat3	protein
inhibited	O
the	O
induction	O
by	O
EPO	protein
of	O
gamma-globin	O
and	O
erythroid-specific	O
5-aminolevulinate	O
synthetase	O
transcripts	O
,	O
resulting	O
in	O
a	O
reduction	O
of	O
the	O
percentage	O
of	O
hemoglobin-positive	cell_type
cells	cell_type
.	O
Dominant	O
negative	O
forms	O
of	O
Stat1alpha	protein
or	O
Stat3	protein
promoted	O
the	O
EPO	protein
-induced	O
erythroid	O
differentiation	O
of	O
UT-7/GM	cell_line
cells	cell_line
,	O
even	O
in	O
the	O
presence	O
of	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
,	O
although	O
this	O
cytokine	O
never	O
induced	O
erythroid	O
differentiation	O
of	O
the	O
parent	cell_line
UT-7/GM	cell_line
cells	cell_line
with	O
or	O
without	O
EPO	protein
.	O
A	O
cell	O
cycle	O
analysis	O
showed	O
that	O
the	O
constitutive	O
activation	O
of	O
Stat1alpha	protein
,	O
but	O
not	O
Stat3	protein
,	O
shortened	O
the	O
period	O
of	O
G0/G1	O
prolongation	O
caused	O
by	O
EPO	protein
stimulation	O
.	O
Taken	O
together,	O
our	O
data	O
suggest	O
that	O
Stat1alpha	protein
and	O
Stat3	protein
act	O
as	O
negative	O
regulators	O
in	O
EPO	protein
-induced	O
erythroid	O
differentiation	O
.	O
Specifically,	O
Stat1alpha	protein
may	O
activate	O
a	O
cell	DNA
cycle-associated	DNA
gene	DNA
(s),	O
leading	O
to	O
the	O
entry	O
of	O
cells	O
into	O
the	O
cell	O
cycle	O
.	O

Ro	O
09-2210	O
exhibits	O
potent	O
anti-proliferative	O
effects	O
on	O
activated	O
T	cell_type
cells	cell_type
by	O
selectively	O
blocking	O
MKK	protein
activity	O
.	O
By	O
using	O
high	O
throughput	O
screening	O
of	O
microbial	O
broths	O
,	O
we	O
have	O
identified	O
a	O
compound,	O
designated	O
Ro	O
09-2210	O
,	O
which	O
is	O
able	O
to	O
block	O
anti-CD3	protein
induced	O
peripheral	O
blood	O
T	O
cell	O
activation	O
with	O
an	O
IC50	O
=	O
40	O
nM.	O
Ro	O
09-2210	O
was	O
also	O
able	O
to	O
block	O
antigen-induced	O
IL-2	protein
secretion	O
with	O
an	O
IC50	O
=	O
30	O
nM,	O
but	O
was	O
considerably	O
less	O
potent	O
at	O
blocking	O
Ca2+	O
flux	O
stimulated	O
by	O
anti-CD3	protein
treatment	O
.	O
To	O
determine	O
the	O
mechanism	O
of	O
action	O
of	O
Ro	O
09-2210	O
,	O
we	O
set	O
up	O
a	O
transient	O
expression	O
system	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
using	O
a	O
variety	O
of	O
reporter	O
gene	O
constructs	O
and	O
showed	O
effective	O
inhibition	O
of	O
phorbol	O
ester	O
/	O
ionomycin	O
-induced	O
NF-AT	protein
activation	O
and	O
anti-CD3	O
induced	O
NF-AT	protein
with	O
IC50	O
=	O
7.7	O
and	O
10	O
nM,	O
respectively.	O
Ro	O
09-2210	O
was	O
also	O
able	O
to	O
inhibit	O
phorbol	O
ester	O
/	O
ionomycin	O
-induced	O
activation	O
of	O
AP1	protein
with	O
IC50	O
=	O
&lt;10	O
nM.	O
We	O
further	O
showed	O
that	O
Ro	O
09-2210	O
was	O
unable	O
to	O
inhibit	O
c-jun	DNA
induced	O
expression	O
of	O
AP1	DNA
-dependent	DNA
reporter	DNA
constructs	DNA
(IC50	O
&gt;	O
500	O
nM),	O
but	O
was	O
able	O
to	O
potently	O
inhibit	O
ras-induced	O
AP1	protein
activation	O
(IC50	O
=	O
20	O
nM).	O
This	O
suggested	O
that	O
Ro	O
09-2210	O
was	O
inhibiting	O
an	O
activator	O
of	O
AP-1	protein
which	O
was	O
upstream	O
of	O
c-jun	DNA
and	O
downstream	O
of	O
ras	protein
signaling	O
.	O
To	O
investigate	O
further,	O
we	O
then	O
purified	O
a	O
number	O
of	O
different	O
kinases,	O
including	O
PKC	protein
,	O
PhK	protein
,	O
ZAP-70	protein
,	O
ERK	protein
,	O
and	O
MEK	protein
1	protein
(a	O
MKK	protein
),	O
and	O
showed	O
that	O
Ro	O
09-2210	O
was	O
a	O
selective	O
inhibitor	O
of	O
MEK1	protein
in	O
vitro	O
(IC50	O
=	O
59	O
nM).	O

Coactivation	O
by	O
OCA-B	protein
:	O
definition	O
of	O
critical	O
regions	O
and	O
synergism	O
with	O
general	O
cofactors	O
.	O
Molecular	O
dissection	O
of	O
the	O
B-cell-specific	O
transcription	O
coactivator	O
OCA-B	protein
has	O
revealed	O
distinct	O
regions	O
important,	O
respectively,	O
for	O
recruitment	O
to	O
immunoglobulin	DNA
promoters	DNA
through	O
interaction	O
with	O
octamer-bound	protein
Oct-1	protein
and	O
for	O
subsequent	O
coactivator	O
function.	O
Further	O
analysis	O
of	O
general	O
coactivator	O
requirements	O
showed	O
that	O
selective	O
removal	O
of	O
PC4	protein
from	O
the	O
essential	O
USA	O
fraction	O
severely	O
impairs	O
Oct-1	O
and	O
OCA-B	O
function	O
in	O
a	O
cell-free	O
system	O
reconstituted	O
with	O
partially	O
purified	O
factors.	O
Full	O
activity	O
can	O
be	O
restored	O
by	O
the	O
combined	O
action	O
of	O
recombinant	O
PC4	protein
and	O
the	O
PC4	protein
-depleted	O
USA	O
fraction	O
,	O
thus	O
suggesting	O
a	O
joint	O
requirement	O
for	O
PC4	protein
and	O
another,	O
USA-derived	O
component	O
(s)	O
for	O
optimal	O
function	O
of	O
Oct-1	protein
/OCA-B	protein
in	O
the	O
reconstituted	O
system	O
.	O
Indeed,	O
USA-derived	protein
PC2	protein
was	O
found	O
to	O
act	O
synergistically	O
with	O
PC4	protein
in	O
reproducing	O
the	O
function	O
of	O
intact	O
USA	O
in	O
the	O
assay	O
system	O
.	O
Consistent	O
with	O
the	O
requirement	O
for	O
PC4	protein
in	O
the	O
reconstituted	O
system	O
,	O
OCA-B	protein
was	O
found	O
to	O
interact	O
directly	O
with	O
PC4	protein
.	O
Surprisingly,	O
however,	O
removal	O
of	O
PC4	protein
from	O
the	O
unfractionated	O
nuclear	O
extract	O
has	O
no	O
detrimental	O
effect	O
on	O
OCA-B	protein
/	O
Oct-1	protein
-dependent	O
transcription	O
.	O
These	O
results	O
lead	O
to	O
a	O
general	O
model	O
for	O
the	O
synergistic	O
function	O
of	O
activation	O
domains	O
in	O
Oct-1	protein
and	O
OCA-B	protein
(mediated	O
by	O
the	O
combined	O
action	O
of	O
the	O
multiple	O
USA	O
components	O
)	O
and,	O
further,	O
suggest	O
a	O
functional	O
redundancy	O
in	O
general	protein
coactivators	protein
.	O

Activation	O
of	O
Stat-3	protein
is	O
involved	O
in	O
the	O
induction	O
of	O
apoptosis	O
after	O
ligation	O
of	O
major	protein
histocompatibility	protein
complex	protein
class	protein
I	protein
molecules	protein
on	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Activation	O
of	O
Janus	protein
tyrosine	protein
kinases	protein
(	O
Jak	protein
)	O
and	O
Signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
Stat	protein
)	O
after	O
ligation	O
of	O
major	protein
histocompatibility	protein
complex	protein
class	protein
I	protein
(	O
MHC-I	protein
)	O
was	O
explored	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
Cross-linking	O
of	O
MHC-I	protein
mediated	O
tyrosine	O
phosphorylation	O
of	O
Tyk2	protein
,	O
but	O
not	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Jak3	protein
.	O
In	O
addition,	O
the	O
transcription	protein
factor	protein
Stat-3	protein
was	O
tyrosine	O
phosphorylated	O
in	O
the	O
cytoplasm	O
and	O
subsequently	O
translocated	O
to	O
the	O
cell	O
nucleus	O
.	O
Data	O
obtained	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
suggested	O
that	O
the	O
activated	protein
Stat-3	protein
protein	protein
associates	O
with	O
the	O
human	DNA
serum-inducible	DNA
element	DNA
(	DNA
hSIE	DNA
)	DNA
DNA-probe	DNA
derived	O
from	O
the	O
interferon-gamma	DNA
activated	DNA
site	DNA
(	O
GAS	DNA
)	O
in	O
the	O
c-fos	DNA
promoter	DNA
,	O
a	O
common	O
DNA	O
sequence	O
for	O
Stat	protein
protein	protein
binding	O
.	O
An	O
association	O
between	O
hSIE	DNA
and	O
Stat-3	protein
after	O
MHC-I	protein
ligation	O
was	O
directly	O
demonstrated	O
by	O
precipitating	O
Stat-3	protein
from	O
nuclear	O
extracts	O
with	O
biotinylated	O
hSIE	DNA
probe	DNA
and	O
avidin	protein
-coupled	O
agarose	O
.	O
To	O
investigate	O
the	O
function	O
of	O
the	O
activated	O
Stat-3	protein
,	O
Jurkat	cell_line
T	cell_line
cells	cell_line
were	O
transiently	O
transfected	O
with	O
a	O
Stat-3	protein
isoform	protein
lacking	O
the	O
transactivating	protein
domain	protein
.	O
This	O
dominant-negative	protein
acting	protein
Stat-3	protein
isoform	protein
significantly	O
inhibited	O
apoptosis	O
induced	O
by	O
ligation	O
of	O
MHC-I	protein
.	O
In	O
conclusion,	O
our	O
data	O
suggest	O
the	O
involvement	O
of	O
the	O
Jak/Stat	protein
signal	O
pathway	O
in	O
MHC-I	protein
-induced	O
signal	O
transduction	O
in	O
T	cell_type
cells	cell_type
.	O

IL-2	protein
-induced	O
growth	O
of	O
CD8+	cell_type
T	cell_type
cell	cell_type
prolymphocytic	cell_type
leukemia	cell_type
cells	cell_type
mediated	O
by	O
NF-kappaB	protein
induction	O
and	O
IL-2	protein
receptor	protein
alpha	protein
expression	O
.	O
The	O
binding	O
of	O
interleukin-2	protein
(	O
IL-2	protein
)	O
to	O
its	O
receptor	O
on	O
normal	O
T	cell_type
cells	cell_type
induces	O
nuclear	O
expression	O
of	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NF-kappaB	protein
),	O
activation	O
of	O
the	O
IL-2	DNA
receptor	DNA
(IL-2R)	DNA
alpha	DNA
chain	DNA
gene	DNA
,	O
and	O
cell	O
proliferation	O
.	O
In	O
the	O
present	O
study,	O
the	O
role	O
of	O
IL-2R	protein
signaling	O
in	O
the	O
growth	O
of	O
CD8+	cell_line
T	cell_line
cell	cell_line
prolymphocytic	cell_line
leukemia	cell_line
(T-PLL)	cell_line
cells	cell_line
has	O
been	O
investigated.	O
Flow	O
cytometry	O
revealed	O
that	O
primary	cell_type
leukemia	cell_type
cells	cell_type
from	O
a	O
patient	O
with	O
CD8+	O
T-PLL	O
expressed	O
IL-2R	O
alpha	O
and	O
beta	O
chains	O
,	O
and	O
the	O
cells	O
showed	O
a	O
proliferative	O
response	O
and	O
an	O
increase	O
in	O
IL-2Ralpha	protein
expression	O
on	O
culture	O
with	O
exogeneous	O
IL-2	protein
.	O
Northern	O
blot	O
analysis	O
failed	O
to	O
detect	O
IL-2	RNA
mRNA	RNA
,	O
suggesting	O
that	O
IL-2	protein
may	O
act	O
in	O
a	O
paracrine	O
manner	O
in	O
vivo.	O
Electrophoretic	O
mobility-shift	O
assays	O
revealed	O
that	O
recombinant	O
IL-2	protein
increased	O
NF-kappaB	protein
binding	O
activity	O
in	O
nuclear	O
extracts	O
of	O
the	O
leukemia	cell_type
cells	cell_type
,	O
and	O
Northern	O
blot	O
analysis	O
showed	O
that	O
IL-2	protein
increased	O
the	O
abundance	O
of	O
mRNAs	O
encoding	O
the	O
NF-kappaB	protein
components	O
c-Rel	protein
and	O
KBF1	protein
in	O
these	O
cells.	O
IL-2	protein
binding	O
analysis	O
demonstrated	O
that	O
IL-2	protein
markedly	O
increased	O
the	O
number	O
of	O
low	O
affinity	O
IL-2Rs	protein
on	O
the	O
leukemia	cell_type
cells	cell_type
,	O
without	O
an	O
effect	O
on	O
the	O
number	O
of	O
high-affinity	protein
IL-2Rs	protein
.	O
These	O
results	O
show	O
that	O
IL-2	protein
is	O
capable	O
of	O
inducing	O
the	O
nuclear	O
expression	O
of	O
NF-kappaB	protein
in	O
primary	cell_line
CD8+	cell_line
T-PLL	cell_line
cells	cell_line
,	O
and	O
that	O
this	O
effect	O
is	O
mediated,	O
at	O
least	O
in	O
part,	O
at	O
a	O
pretranslational	O
level	O

Dimethyldithiocarbamate	O
inhibits	O
in	O
vitro	O
activation	O
of	O
primary	cell_type
human	cell_type
CD4+	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Dithiocarbamates	O
(	O
DTC	O
),	O
a	O
diverse	O
group	O
of	O
industrial	O
and	O
therapeutic	O
chemicals	O
,	O
have	O
been	O
reported	O
to	O
inhibit,	O
enhance	O
or	O
have	O
no	O
effect	O
on	O
the	O
immune	O
system	O
.	O
These	O
apparent	O
inconsistencies	O
reflect	O
the	O
complexity	O
of	O
the	O
DTCs	O
biological	O
activities	O
and	O
are	O
probably	O
due	O
in	O
part	O
to	O
differences	O
in	O
dose,	O
route	O
of	O
exposure,	O
animal	O
species	O
used	O
and/or	O
specific	O
compound	O
tested.	O
The	O
studies	O
described	O
herein	O
were	O
undertaken	O
to	O
investigate	O
the	O
immunotoxicity	O
of	O
one	O
member	O
of	O
this	O
family,	O
dimethyldithiocarbamate	O
(	O
DMDTC	O
).	O
We	O
demonstrate	O
that	O
0.1-0.5	O
microM	O
DMDTC	O
inhibits	O
TNF-alpha	protein
-induced	O
activation	O
of	O
NF-kappaB	protein
in	O
primary	cell_type
human	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
This	O
inhibition	O
is	O
not	O
accompanied	O
by	O
a	O
loss	O
in	O
viability,	O
and	O
DMDTC	cell_type
-treated	cell_type
T	cell_type
cells	cell_type
retain	O
other	O
active	O
signaling	O
pathways	O
throughout	O
the	O
exposure	O
duration.	O
The	O
inhibition	O
of	O
NF-kappaB	protein
is	O
apparently	O
permanent	O
as	O
DMDTC	cell_type
-treated	cell_type
T	cell_type
cells	cell_type
did	O
not	O
regain	O
normal	O
TNF-alpha	protein
activation	O
,	O
even	O
after	O
72	O
h	O
in	O
culture.	O
DMDTC	O
does	O
not	O
appear	O
to	O
alter	O
NF-kappaB	protein
directly	O
as	O
pre-incubation	O
of	O
nuclear	O
extracts	O
with	O
DMDTC	O
does	O
not	O
diminish	O
binding	O
activity	O
of	O
this	O
protein.	O
We	O
further	O
demonstrate	O
that	O
0.1-0.5	O
microM	O
DMDTC	O
inhibits	O
intracellular	O
IL-2	protein
production	O
and	O
decreases	O
surface	O
expression	O
of	O
CD25	protein
(the	O
alpha	protein
subunit	protein
of	O
the	O
IL-2	protein
receptor	protein
)	O
in	O
T	cell_type
cells	cell_type
stimulated	O
with	O
phorbol	O
ester	O
.	O
These	O
data	O
demonstrate	O
that	O
DMDTC	O
is	O
a	O
potent	O
immunosuppressive	O
compound	O
in	O
vitro.	O

Human	DNA
15-lipoxygenase	DNA
gene	DNA
promoter	DNA
:	O
analysis	O
and	O
identification	O
of	O
DNA	DNA
binding	DNA
sites	DNA
for	O
IL-13-induced	protein
regulatory	protein
factors	protein
in	O
monocytes	cell_type
.	O
In	O
order	O
to	O
study	O
the	O
transcriptional	O
control	O
of	O
15-LO	protein
expression	O
,	O
we	O
have	O
cloned	O
and	O
sequenced	O
the	O
human	DNA
15-LO	DNA
promoter	DNA
region	DNA
.	O
The	O
15-LO	protein
promoter	O
is	O
associated	O
with	O
a	O
CpG	DNA
island	DNA
at	O
the	O
5'-end	DNA
of	O
the	O
gene,	O
and	O
sequence	O
analysis	O
reveals	O
putative	O
Sp1	O
and	O
Ap2	O
binding	O
site/s	O
and	O
absence	O
of	O
TATA	O
or	O
CAAT	O
motifs	O
.	O
Transcription	O
is	O
initiated	O
at	O
one	O
major	O
site.	O
Using	O
deletion	DNA
constructs	DNA
,	O
we	O
have	O
defined	O
an	O
active	DNA
promoter	DNA
region	DNA
of	O
1056	O
bp.	O
Gel-shift	O
assays	O
revealed	O
that	O
transcriptional	protein
factor	protein
(s)	O
induced	O
only	O
in	O
response	O
to	O
IL-13	protein
treatment	O
of	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
bind	O
to	O
the	O
15-LO	DNA
promoter	DNA
DNA	DNA
.	O
Two	O
regions,	O
DP1	DNA
(	O
-140	DNA
to	DNA
-92	DNA
bp	DNA
)	O
and	O
DP2	DNA
(	O
-353	DNA
to	DNA
-304	DNA
bp	DNA
)	O
of	O
the	O
promoter	O
were	O
essential	O
for	O
transcription	O
in	O
HeLa	cell_line
cells	cell_line
and	O
human	cell_type
peripheral	cell_type
monocytes	cell_type
.	O
Hela	O
nuclear	O
extracts	O
contained	O
a	O
specific	protein
nuclear	protein
factor(s)	protein
binding	O
to	O
15-LO	DNA
promoter	DNA
DNA	DNA
which	O
are	O
distinct	O
from	O
those	O
derived	O
from	O
IL-13	cell_line
-treated	cell_line
human	cell_line
peripheral	cell_line
monocyte	cell_line
nuclear	O
extracts	O
.	O
In	O
addition,	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
results	O
refined	O
the	O
previous	O
localization	O
of	O
15-LO	protein
to	O
human	DNA
chromosome	DNA
17p13.3	DNA
.	O

Ex	O
vivo	O
activation	O
of	O
tumor-draining	cell_type
lymph	cell_type
node	cell_type
T	cell_type
cells	cell_type
reverses	O
defects	O
in	O
signal	protein
transduction	protein
molecules	protein
.	O
The	O
adoptive	O
transfer	O
of	O
tumor-draining	O
lymph	O
node	O
(	O
LN	O
)	O
T	cell_type
cells	cell_type
activated	O
ex	O
vivo	O
with	O
anti-CD3	protein
and	O
interleukin	protein
2	protein
(	O
IL-2	protein
)	O
mediates	O
the	O
regression	O
of	O
the	O
poorly	O
immunogenic	O
murine	O
melanoma	O
D5	O
.	O
The	O
efficacy	O
of	O
the	O
activated	cell_type
LN	cell_type
cells	cell_type
is	O
augmented	O
when	O
the	O
sensitizing	O
tumor	O
is	O
a	O
genetically	cell_line
modified	cell_line
variant	cell_line
(designated	O
D5G6	cell_line
)	O
that	O
secretes	O
granulocyte/macrophage-colony-stimulating	protein
factor	protein
.	O
In	O
contrast	O
to	O
anti-CD3/	cell_line
IL-2	cell_line
-	cell_line
activated	cell_line
LN	cell_line
cells	cell_line
,	O
adoptive	O
transfer	O
of	O
freshly	O
isolated	O
tumor-draining	cell_type
LN	cell_type
T	cell_type
cells	cell_type
has	O
no	O
therapeutic	O
activity	O
.	O
To	O
determine	O
whether	O
the	O
acquisition	O
of	O
antitumor	O
function	O
during	O
ex	O
vivo	O
activation	O
is	O
associated	O
with	O
modifications	O
in	O
signal	O
transduction	O
capacity	O
,	O
the	O
protein	O
tyrosine	protein
kinases	protein
p56lck	protein
and	O
p59fyn	protein
and	O
proteins	O
of	O
the	O
NF-kappaB	protein
family	protein
were	O
analyzed	O
in	O
tumor-draining	cell_type
LN	cell_type
T	cell_type
cells	cell_type
.	O
The	O
levels	O
of	O
p56lck	protein
and	O
p59fyn	protein
were	O
lower	O
in	O
tumor-draining	O
than	O
in	O
normal	cell_type
LN	cell_type
T	cell_type
cells	cell_type
and	O
production	O
of	O
tyrosine	protein
-phosphorylated	protein
substrates	protein
was	O
markedly	O
depressed	O
following	O
anti-CD3	protein
stimulation	O
.	O
After	O
5-day	O
anti-CD3	protein
/IL-2	protein
activation,	O
levels	O
of	O
p56lck	protein
and	O
p59fyn	protein
and	O
protein	O
tyrosine	O
kinase	O
activity	O
increased.	O
Interestingly,	O
the	O
levels	O
of	O
p56lck	protein
,	O
p59fyn	protein
,	O
and	O
tyrosine	O
kinase	O
activity	O
were	O
higher	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
derived	O
from	O
LN	O
that	O
drained	O
D5G6	O
than	O
they	O
were	O
in	O
those	O
from	O
D5	O
tumors	O
.	O
In	O
contrast,	O
the	O
cytoplasmic	O
levels	O
of	O
c-Rel	protein
and	O
Rel	protein
A	protein
were	O
normal	O
in	O
freshly	O
isolated	O
tumor-draining	O
LN	O
,	O
as	O
was	O
nuclear	O
kappaB	protein
DNA-binding	O
activity	O
induced	O
by	O
anti-CD3	protein
mAb	protein
or	O
phorbol	O
myristate	O
acetate	O
.	O
Stimulation	O
of	O
activated	cell_type
LN	cell_type
cells	cell_type
with	O
D5	cell_type
tumor	cell_type
cells	cell_type
induced	O
the	O
nuclear	O
translocation	O
of	O
NF-kappaB	protein
.	O
These	O
findings	O
indicate	O
that	O
the	O
recovery	O
of	O
proteins	O
mediating	O
signal	O
transduction	O
through	O
the	O
T	protein
cell	protein
receptor/CD3	protein
complex	protein
in	O
LN	cell_type
T	cell_type
cells	cell_type
activated	O
ex	O
vivo	O
was	O
associated	O
with	O
the	O
acquisition	O
of	O
antitumor	O
function	O
.	O

Suppression	O
of	O
human	O
anti-porcine	O
T-cell	O
immune	O
responses	O
by	O
major	DNA
histocompatibility	DNA
complex	DNA
class	DNA
II	DNA
transactivator	DNA
constructs	DNA
lacking	O
the	O
amino	O
terminal	O
domain.	O
BACKGROUND:	O
The	O
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
is	O
a	O
bi-	protein
or	protein
multifunctional	protein
domain	protein
protein	protein
that	O
acts	O
as	O
a	O
transcriptional	protein
activator	protein
and	O
plays	O
a	O
critical	O
role	O
in	O
the	O
expression	O
of	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
.	O
We	O
have	O
previously	O
demonstrated	O
that	O
a	O
mutated	O
form	O
of	O
the	O
human	DNA
CIITA	DNA
gene	DNA
,	O
coding	O
for	O
a	O
protein	O
lacking	O
the	O
amino	protein
terminal	protein
151	protein
amino	protein
acids	protein
,	O
acts	O
as	O
a	O
potent	O
dominant-negative	O
suppressor	O
of	O
HLA	protein
class	protein
II	protein
expression	O
.	O
Porcine	protein
MHC	protein
class	protein
II	protein
antigens	protein
are	O
potent	O
stimulators	O
of	O
direct	O
T-cell	O
recognition	O
by	O
human	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
and	O
are,	O
therefore,	O
likely	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
rejection	O
responses	O
to	O
transgenic	O
pig	O
donors	O
in	O
clinical	O
xenotransplantation	O
.	O
We	O
were,	O
therefore,	O
interested	O
in	O
examining	O
mutated	O
CIITA	DNA
constructs	DNA
for	O
their	O
effect	O
on	O
porcine	O
MHC	protein
class	protein
II	protein
expression	O
.	O
METHODS:	O
Stable	O
transfectants	O
of	O
the	O
porcine	cell_line
vascular	cell_line
endothelial	cell_line
cell	cell_line
line	cell_line
PIEC	cell_line
with	O
mutated	O
CIITA	DNA
constructs	DNA
were	O
tested	O
for	O
SLA-DR	protein
and	O
SLA-DQ	protein
induction	O
by	O
recombinant	protein
porcine	protein
interferon-gamma	protein
.	O
Transient	O
transfectants	O
of	O
the	O
porcine	cell_line
B-cell	cell_line
line	cell_line
L23	cell_line
with	O
the	O
mutated	O
CIITA	DNA
constructs	DNA
were	O
tested	O
for	O
the	O
suppression	O
of	O
constitutive	O
SLA-DR	O
and	O
SLA-DQ	O
expression	O
.	O
T-cell	O
proliferation	O
studies	O
were	O
performed	O
using	O
highly	O
purified	O
human	cell_type
CD4+	cell_type
T	cell_type
cells	cell_type
.	O
RESULTS:	O
In	O
preliminary	O
studies,	O
we	O
demonstrated	O
that	O
transfection	O
of	O
the	O
PIEC	cell_line
line	cell_line
with	O
full-length	O
human	O
CIITA	DNA
constructs	DNA
resulted	O
in	O
strong	O
expression	O
of	O
SLA-DR	protein
and	O
SLA-DQ	protein
antigens,	O
thus	O
establishing	O
the	O
cross-species	O
effectiveness	O
of	O
human	protein
CIITA	protein
in	O
the	O
pig	O
.	O
The	O
mutated	DNA
human	DNA
CIITA	DNA
constructs	DNA
were,	O
therefore,	O
tested	O
in	O
the	O
pig	O
.	O
PIEC	cell_line
clones	cell_line
stably	O
transfected	O
with	O
one	O
of	O
these	O
constructs	O
showed	O
up	O
to	O
99%	O
suppression	O
of	O
SLA-DR	protein
and	O
SLA-DQ	protein
antigen	O
induction	O
and	O
marked	O
suppression	O
of	O
SLA-DRA	RNA
mRNA	RNA
induction	O
.	O
Moreover,	O
transient	O
transfection	O
of	O
the	O
porcine	cell_line
B-cell	cell_line
line	cell_line
L23	cell_line
showed	O
up	O
to	O
90%	O
suppression	O
of	O
constitutive	O
SLA-DR	O
and	O
SLA-DQ	O
antigen	O
expression	O
in	O
5-8	O
days.	O
In	O
functional	O
studies,	O
interferon-gamma	cell_line
-stimulated	cell_line
PIEC	cell_line
clones	cell_line
transfected	O
with	O
this	O
mutated	protein
CIITA	protein
construct	O
failed	O
to	O
stimulate	O
purified	O
human	cell_type
CD4+	cell_type
T	cell_type
lymphocytes	cell_type
.	O
CONCLUSION:	O
Mutated	DNA
human	DNA
CIITA	DNA
constructs	DNA
are	O
potent	O
suppressors	O
of	O
porcine	O
MHC	protein
class	protein
II	protein
expression	O
.	O

Macrophages	cell_type
in	O
human	O
atheroma	O
contain	O
PPARgamma	protein
:	O
differentiation-dependent	protein
peroxisomal	protein
proliferator-activated	protein
receptor	protein
gamma	protein
(	O
PPARgamma	protein
)	O
expression	O
and	O
reduction	O
of	O
MMP-9	protein
activity	O
through	O
PPARgamma	protein
activation	O
in	O
mononuclear	O
phagocytes	O
in	O
vitro.	O
Mononuclear	cell_type
phagocytes	cell_type
play	O
an	O
important	O
role	O
in	O
atherosclerosis	O
and	O
its	O
sequela	O
plaque	O
rupture	O
in	O
part	O
by	O
their	O
secretion	O
of	O
matrix	protein
metalloproteinases	protein
(	O
MMPs	protein
),	O
including	O
MMP-9	protein
.	O
Peroxisomal	protein
proliferator-activated	protein
receptor	protein
gamma	protein
(	O
PPARgamma	protein
),	O
a	O
transcription	protein
factor	protein
in	O
the	O
nuclear	O
receptor	O
superfamily,	O
regulates	O
gene	O
expression	O
in	O
response	O
to	O
various	O
activators,	O
including	O
15-deoxy-delta12,14-prostaglandin	O
J2	O
and	O
the	O
antidiabetic	O
agent	O
troglitazone	O
.	O
The	O
role	O
of	O
PPARgamma	protein
in	O
human	O
atherosclerosis	O
is	O
unexplored.	O
We	O
report	O
here	O
that	O
monocytes/macrophages	cell_type
in	O
human	O
atherosclerotic	O
lesions	O
(n	O
=	O
12)	O
express	O
immunostainable	protein
PPARgamma	protein
.	O
Normal	O
artery	O
specimens	O
(n	O
=	O
6)	O
reveal	O
minimal	protein
immunoreactive	protein
PPARgamma	protein
.	O
Human	cell_type
monocytes	cell_type
and	O
monocyte-derived	cell_type
macrophages	cell_type
cultured	O
for	O
6	O
days	O
in	O
5%	O
human	O
serum	O
expressed	O
PPARgamma	RNA
mRNA	RNA
and	O
protein	O
by	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
and	O
Western	O
blotting	O
,	O
respectively.	O
In	O
addition,	O
PPARgamma	RNA
mRNA	RNA
expression	O
in	O
U937	cell_line
cells	cell_line
increased	O
during	O
phorbol	O
12-myristate	O
13	O
acetate	O
-induced	O
differentiation	O
.	O
Stimulation	O
of	O
PPARgamma	protein
with	O
troglitazone	O
or	O
15-deoxy-delta12,14-prostaglandin	O
J2	O
in	O
human	O
monocyte-derived	cell_type
macrophages	cell_type
inhibited	O
MMP-9	protein
gelatinolytic	O
activity	O
in	O
a	O
concentration-dependent	O
fashion	O
as	O
revealed	O
by	O
zymography	O
.	O
This	O
inhibition	O
correlates	O
with	O
decreased	O
MMP-9	protein
secretion	O
as	O
determined	O
by	O
Western	O
blotting	O
.	O
Thus,	O
PPARgamma	protein
is	O
present	O
in	O
macrophages	cell_type
in	O
human	O
atherosclerotic	O
lesions	O
and	O
may	O
regulate	O
expression	O
and	O
activity	O
of	O
MMP-9	protein
,	O
an	O
enzyme	O
implicated	O
in	O
plaque	O
rupture	O
.	O
PPARgamma	protein
is	O
likely	O
to	O
be	O
an	O
important	O
regulator	O
of	O
monocyte/macrophage	O
function	O
with	O
relevance	O
for	O
human	O
atherosclerotic	O
disease	O
.	O

Erythropoietin	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Jak2	protein
,	O
STAT5A	protein
,	O
and	O
STAT5B	protein
in	O
primary	cell_type
cultured	cell_type
human	cell_type
erythroid	cell_type
precursors	cell_type
.	O
We	O
examined	O
signaling	O
by	O
erythropoietin	protein
in	O
highly	cell_type
purified	cell_type
human	cell_type
colony	cell_type
forming	cell_type
unit-erythroid	cell_type
cells	cell_type
,	O
generated	O
in	O
vitro	O
from	O
CD34(+)	cell_type
cells	cell_type
.	O
We	O
found	O
that	O
erythropoietin	protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Jak2	protein
,	O
STAT5A	protein
,	O
and	O
STAT5B	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
Jak2	protein
reaches	O
a	O
peak	O
around	O
10	O
minutes	O
after	O
stimulation	O
and	O
is	O
maximum	O
at	O
5	O
U/mL	O
of	O
erythropoietin	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
STAT5	protein
is	O
accompanied	O
by	O
the	O
translocation	O
of	O
activated	O
STAT5	protein
to	O
the	O
nucleus	O
as	O
shown	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
using	O
32Pi-labeled	O
STAT5	DNA
binding	DNA
site	DNA
in	O
the	O
beta-casein	DNA
promoter	DNA
.	O
Tyrosine	O
phosphorylation	O
STAT1	protein
or	O
STAT3	protein
was	O
not	O
detected	O
in	O
human	cell_type
erythroid	cell_type
precursors	cell_type
after	O
stimulation	O
with	O
erythropoietin	protein
.	O
Crkl	protein
,	O
an	O
SH2/SH3	protein
adapter	protein
protein	protein
,	O
becomes	O
coimmunoprecipitated	O
specifically	O
with	O
STAT5	protein
from	O
erythropoietin	cell_type
-stimulated	cell_type
erythroid	cell_type
cells	cell_type
;	O
although	O
it	O
was	O
shown	O
to	O
become	O
associated	O
with	O
c-Cbl	protein
in	O
the	O
studies	O
using	O
cell	cell_line
lines	cell_line
.	O
Thus,	O
human	cell_type
erythroid	cell_type
precursors	cell_type
can	O
be	O
expanded	O
in	O
vitro	O
in	O
sufficient	O
numbers	O
and	O
purity	O
to	O
allow	O
its	O
usage	O
in	O
signal	O
transduction	O
studies	O
.	O
This	O
report	O
sets	O
a	O
basis	O
for	O
further	O
studies	O
on	O
signaling	O
in	O
primary	cell_type
cultured	cell_type
human	cell_type
erythroid	cell_type
precursors	cell_type
,	O
which	O
in	O
turn	O
contribute	O
to	O
our	O
better	O
understanding	O
in	O
the	O
differentiation	O
processes	O
of	O
erythrocytes	cell_type
and	O
their	O
precursors.	O

Oxidative	O
stress	O
suppresses	O
transcription	protein
factor	protein
activities	O
in	O
stimulated	cell_type
lymphocytes	cell_type
.	O
Effects	O
of	O
oxidative	O
stress	O
on	O
stimulation-dependent	O
signal	O
transduction	O
,	O
leading	O
to	O
IL-2	protein
expression	O
,	O
were	O
studied.	O
Purified	cell_type
quiescent	cell_type
human	cell_type
blood	cell_type
T	cell_type
lymphocytes	cell_type
were	O
subjected	O
to:	O
(i)	O
acute	O
exposure	O
to	O
hydrogen	O
peroxide	O
;	O
(ii)	O
chronic	O
exposure	O
to	O
hydrogen	O
peroxide	O
;	O
and	O
(iii)	O
acute	O
exposure	O
to	O
ionizing	O
radiation	O
.	O
The	O
cells	O
were	O
then	O
stimulated	O
for	O
6	O
h.	O
DNA-binding	O
activities	O
(determined	O
by	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
)	O
of	O
three	O
transcription	protein
factors	protein
:	O
NFkappaB	protein
,	O
AP-1	protein
and	O
NFAT	protein
,	O
were	O
abolished	O
in	O
the	O
lymphocytes	cell_type
by	O
all	O
three	O
modes	O
of	O
oxidative	O
stress.	O
The	O
lymphocytes	cell_type
exhibited	O
lipid	O
peroxidation	O
only	O
upon	O
exposure	O
to	O
the	O
lowest	O
level	O
of	O
hydrogen	O
peroxide	O
used	O
(20	O
microM).	O
All	O
three	O
modes	O
of	O
oxidative	O
stress	O
induced	O
catalase	protein
activity	O
in	O
the	O
lymphocytes	cell_type
.	O
The	O
only	O
exception	O
was	O
hydrogen	O
peroxide	O
at	O
20	O
microM,	O
which	O
did	O
not	O
induce	O
catalase	protein
activity	O
.	O
We	O
conclude	O
that:	O
(i)	O
suppression	O
of	O
specific	O
transcription	protein
factor	protein
functions	O
can	O
potentially	O
serve	O
as	O
a	O
marker	O
of	O
exposure	O
to	O
oxidative	O
stress	O
and	O
its	O
effects	O
on	O
human	cell_type
lymphocytes	cell_type
;	O
(ii)	O
lipid	O
peroxidation	O
is	O
only	O
detectable	O
in	O
human	cell_type
lymphocytes	cell_type
upon	O
exposure	O
to	O
weak	O
oxidative	O
stress	O
which	O
does	O
not	O
induce	O
catalase	protein
activity	O
;	O
(iii)	O
therefore,	O
transcription	protein
factor	protein
DNA-binding	O
activities	O
are	O
more	O
sensitive	O
to	O
oxidative	O
stress	O
than	O
lipid	O
peroxidation	O
.	O

IL-4	protein
-dependent	O
regulation	O
of	O
TGF-alpha	O
and	O
TGF-beta1	O
expression	O
in	O
human	cell_type
eosinophils	cell_type
.	O
TGFs	protein
play	O
important	O
roles	O
in	O
wound	O
healing	O
and	O
carcinogenesis.	O
We	O
have	O
previously	O
demonstrated	O
that	O
eosinophils	cell_type
infiltrating	O
into	O
different	O
pathologic	O
processes	O
elaborate	O
TGF-alpha	protein
and	O
TGF-beta1	protein
.	O
Eosinophils	cell_type
infiltrating	O
hamster	O
cutaneous	O
wounds	O
were	O
found	O
to	O
express	O
TGFs	protein
sequentially.	O
In	O
this	O
study,	O
we	O
examined	O
the	O
biologic	O
mediators	O
that	O
may	O
regulate	O
the	O
expression	O
of	O
TGF	O
-alpha	O
and	O
-beta1	O
by	O
eosinophils	cell_type
.	O
Eosinophils	cell_type
were	O
isolated	O
from	O
the	O
peripheral	O
blood	O
of	O
healthy	O
donors	O
and	O
cultured	O
in	O
the	O
absence	O
or	O
presence	O
of	O
IL-3	protein
,	O
IL-4	protein
,	O
and	O
IL-5	protein
.	O
Cells	O
were	O
analyzed	O
by	O
in	O
situ	O
hybridization	O
and	O
immunohistochemistry.	O
Supernatants	O
from	O
these	O
cultures	O
were	O
assayed	O
for	O
secreted	O
TGF-alpha	protein
and	O
TGF-beta1	protein
using	O
TGF	protein
-specific	O
ELISAs	O
.	O
IL-3	protein
,	O
IL-4	protein
,	O
and	O
IL-5	protein
independently	O
up-regulated	O
TGF-beta1	RNA
mRNA	RNA
and	O
product	O
expression	O
by	O
eosinophils	cell_type
in	O
all	O
donors.	O
Interestingly,	O
TGF-alpha	protein
production	O
by	O
eosinophils	cell_type
was	O
up-regulated	O
by	O
IL-3	protein
and	O
IL-5	protein
but	O
was	O
down-regulated	O
by	O
IL-4	protein
.	O
Consistent	O
with	O
the	O
ability	O
of	O
IL-4	protein
to	O
regulate	O
eosinophil	O
responses	O
,	O
IL-4	protein
signaling	protein
molecules	protein
are	O
present	O
in	O
human	cell_type
eosinophils	cell_type
.	O
The	O
observation	O
that	O
IL-4	protein
can	O
differentially	O
regulate	O
the	O
expression	O
of	O
TGF-alpha	protein
and	O
TGF-beta1	protein
suggests	O
that	O
IL-4	protein
may	O
serve	O
as	O
a	O
physiologic	O
molecular	O
switch	O
of	O
TGF	protein
expression	O
by	O
the	O
infiltrating	O
eosinophils	cell_type
in	O
wound	O
healing	O
and	O
carcinogenesis	O
.	O

MLL	O
and	O
CALM	DNA
are	O
fused	O
to	O
AF10	DNA
in	O
morphologically	O
distinct	O
subsets	O
of	O
acute	O
leukemia	O
with	O
translocation	DNA
t(10;11)	DNA
:	O
both	O
rearrangements	O
are	O
associated	O
with	O
a	O
poor	O
prognosis.	O
The	O
translocation	DNA
t(10;11)	DNA
(p13;q14)	DNA
has	O
been	O
observed	O
in	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
as	O
well	O
as	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
).	O
A	O
recent	O
study	O
showed	O
a	O
MLL/	DNA
AF10	DNA
fusion	DNA
in	O
all	O
cases	O
of	O
AML	O
with	O
t(10;11)	DNA
and	O
various	O
breakpoints	O
on	O
chromosome	DNA
11	DNA
ranging	O
from	O
q13	DNA
to	O
q23	DNA
.	O
We	O
recently	O
cloned	O
CALM	DNA
(	O
Clathrin	DNA
Assembly	DNA
Lymphoid	DNA
Myeloid	DNA
leukemia	DNA
gene	DNA
),	O
the	O
fusion	O
partner	O
of	O
AF10	DNA
at	O
11q14	DNA
in	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
To	O
further	O
define	O
the	O
role	O
of	O
these	O
genes	O
in	O
acute	O
leukemias	O
,	O
10	O
cases	O
(9	O
AML	O
and	O
1	O
ALL	O
)	O
with	O
cytogenetically	O
proven	O
t(10;11)(p12-14;q13-21)	DNA
and	O
well-characterized	O
morphology,	O
immunophenotype,	O
and	O
clinical	O
course	O
were	O
analyzed.	O
Interphase	O
fluorescence	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
was	O
performed	O
with	O
2	O
YACs	DNA
flanking	O
the	O
CALM	DNA
region	DNA
,	O
a	O
YAC	DNA
contig	DNA
of	O
the	O
MLL	DNA
region	DNA
,	O
and	O
a	O
YAC	DNA
spanning	O
the	O
AF10	DNA
breakpoint.	O
Rearrangement	O
of	O
at	O
least	O
one	O
of	O
these	O
genes	O
was	O
detected	O
in	O
all	O
cases	O
with	O
balanced	O
t(10;11)	DNA
.	O
In	O
4	O
cases,	O
including	O
3	O
AML	O
with	O
immature	O
morphology	O
(1	O
AML	O
-M0	O
and	O
2	O
AML	O
-M1	O
)	O
and	O
1	O
ALL	O
,	O
the	O
signals	O
of	O
the	O
CALM	DNA
YACS	DNA
were	O
separated	O
in	O
interphase	O
cells,	O
indicating	O
a	O
translocation	O
breakpoint	O
within	O
the	O
CALM	DNA
region	DNA
.	O
MLL	O
was	O
rearranged	O
in	O
3	O
AML	O
with	O
myelomonocytic	O
differentiation	O
(2	O
AML-M2	O
and	O
1	O
AML-M5	O
),	O
including	O
1	O
secondary	O
AML	O
.	O
In	O
all	O
3	O
cases,	O
a	O
characteristic	O
immunophenotype	O
was	O
identified	O
(	O
CD4+	protein
,	O
CD13	protein
-,	O
CD33+,	O
CD65s+	O
).	O
AF-10	O
was	O
involved	O
in	O
5	O
of	O
6	O
evaluable	O
cases,	O
including	O
1	O
case	O
without	O
detectable	O
CALM	DNA
or	O
MLL	O
rearrangement	O
.	O
In	O
2	O
complex	O
translocations,	O
none	O
of	O
the	O
three	O
genes	O
was	O
rearranged.	O
All	O
cases	O
had	O
a	O
remarkably	O
poor	O
prognosis,	O
with	O
a	O
mean	O
survival	O
of	O
9.6	O
+/-	O
6.6	O
months.	O
For	O
the	O
7	O
AML	O
cases	O
that	O
were	O
uniformly	O
treated	O
according	O
to	O
the	O
AMLCG86/92	O
protocols	O
,	O
disease-free	O
and	O
overall	O
survival	O
was	O
significantly	O
worse	O
than	O
for	O
the	O
overall	O
study	O
group	O
(P	O
=	O
.03	O
and	O
P	O
=	O
.01,	O
respectively).	O
We	O
conclude	O
that	O
the	O
t(10;11)(p13;q14)	DNA
indicates	O
CALM	O
and	O
MLL	O
rearrangements	O
in	O
morphologically	O
distinct	O
subsets	O
of	O
acute	O
leukemia	O
and	O
may	O
be	O
associated	O
with	O
a	O
poor	O
prognosis	O
.	O

The	O
role	O
of	O
E-proteins	protein
in	O
B-	O
and	O
T-	O
lymphocyte	O
development	O
.	O
Department	O
of	O
lymphocytes	cell_type
from	O
hematopoietic	cell_type
stem	cell_type
cells	cell_type
is	O
controlled,	O
in	O
part,	O
by	O
the	O
activity	O
of	O
transcriptional	protein
regulatory	protein
proteins	protein
.	O
In	O
particular,	O
one	O
class	O
of	O
helix-loop-helix	protein
proteins	protein
,	O
termed	O
E-proteins	protein
,	O
have	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
during	O
B-cell	O
development	O
.	O
Recent	O
analysis	O
of	O
gene-targeted	O
mice	O
has	O
allowed	O
a	O
direct	O
assessment	O
of	O
the	O
functional	O
roles	O
of	O
several	protein
E-protein	protein
family	protein
members	protein
in	O
hematopoiesis.	O
In	O
this	O
review	O
we	O
describe	O
the	O
defects	O
in	O
B-	O
and	O
T-	O
lymphocyte	O
development	O
in	O
mice	O
carrying	O
targeted	O
mutations	O
in	O
the	O
E-protein	DNA
genes	DNA
and	O
discuss	O
our	O
current	O
understanding	O
of	O
the	O
role	O
of	O
these	O
proteins	O
in	O
lymphoid	O
development	O

Epstein-Barr	protein
virus-transforming	protein
protein	protein
latent	protein
infection	protein
membrane	protein
protein	protein
1	protein
activates	O
transcription	protein
factor	protein
NF-kappaB	protein
through	O
a	O
pathway	O
that	O
includes	O
the	O
NF-kappaB	protein
-inducing	protein
kinase	protein
and	O
the	O
IkappaB	protein
kinases	protein
IKKalpha	protein
and	O
IKKbeta	protein
.	O
The	O
Epstein-Barr	protein
virus	protein
oncoprotein	protein
latent	protein
infection	protein
membrane	protein
protein	protein
1	protein
(	O
LMP1	protein
)	O
is	O
a	O
constitutively	O
aggregated	O
pseudo-tumor	protein
necrosis	protein
factor	protein
receptor	protein
(	O
TNFR	protein
)	O
that	O
activates	O
transcription	protein
factor	protein
NF-kappaB	protein
through	O
two	O
sites	O
in	O
its	O
C-terminal	protein
cytoplasmic	protein
domain	protein
.	O
One	O
site	O
is	O
similar	O
to	O
activated	O
TNFRII	protein
in	O
associating	O
with	O
TNFR	protein
-associated	protein
factors	protein
TRAF1	protein
and	O
TRAF2	protein
,	O
and	O
the	O
second	O
site	O
is	O
similar	O
to	O
TNFRI	protein
in	O
associating	O
with	O
the	O
TNFRI	protein
death	protein
domain	protein
interacting	protein
protein	protein
TRADD	protein
.	O
TNFRI	protein
has	O
been	O
recently	O
shown	O
to	O
activate	O
NF-kappaB	protein
through	O
association	O
with	O
TRADD	protein
,	O
RIP	protein
,	O
and	O
TRAF2	protein
;	O
activation	O
of	O
the	O
NF-kappaB	protein
-inducing	protein
kinase	protein
(	O
NIK	protein
);	O
activation	O
of	O
the	O
IkappaB	protein
alpha	protein
kinases	protein
(	O
IKKalpha	protein
and	O
IKKbeta	protein
);	O
and	O
phosphorylation	O
of	O
IkappaB	protein
alpha	protein
.	O
IkappaB	protein
alpha	protein
phosphorylation	O
on	O
Ser-32	O
and	O
Ser-36	O
is	O
followed	O
by	O
its	O
degradation	O
and	O
NF-kappaB	protein
activation	O
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
NF-kappaB	protein
activation	O
by	O
LMP1	protein
or	O
by	O
each	O
of	O
its	O
effector	protein
sites	protein
is	O
mediated	O
by	O
a	O
pathway	O
that	O
includes	O
NIK	protein
,	O
IKKalpha	protein
,	O
and	O
IKKbeta	protein
.	O
Dominant	protein
negative	protein
mutants	protein
of	O
NIK	protein
,	O
IKKalpha	protein
,	O
or	O
IKKbeta	protein
substantially	O
inhibited	O
NF-kappaB	protein
activation	O
by	O
LMP1	protein
or	O
by	O
each	O
of	O
its	O
effector	protein
sites	protein
.	O

Targeted	O
disruption	O
of	O
the	O
MyD88	DNA
gene	DNA
results	O
in	O
loss	O
of	O
IL-1-	O
and	O
IL-18-	O
mediated	O
function	O
.	O
MyD88	protein
,	O
originally	O
isolated	O
as	O
a	O
myeloid	O
differentiation	O
primary	DNA
response	DNA
gene	DNA
,	O
is	O
shown	O
to	O
act	O
as	O
an	O
adaptor	O
in	O
interleukin-1	protein
(	O
IL-1	protein
)	O
signaling	O
by	O
interacting	O
with	O
both	O
the	O
IL-1	protein
receptor	protein
complex	protein
and	O
IL-1	protein
receptor-associated	protein
kinase	protein
(	O
IRAK	protein
).	O
Mice	O
generated	O
by	O
gene	O
targeting	O
to	O
lack	O
MyD88	protein
have	O
defects	O
in	O
T	O
cell	O
proliferation	O
as	O
well	O
as	O
induction	O
of	O
acute	O
phase	O
proteins	O
and	O
cytokines	protein
in	O
response	O
to	O
IL-1	protein
.	O
Increases	O
in	O
interferon-gamma	protein
production	O
and	O
natural	O
killer	O
cell	O
activity	O
in	O
response	O
to	O
IL-18	protein
are	O
abrogated.	O
In	O
vivo	O
Th1	O
response	O
is	O
also	O
impaired.	O
Furthermore,	O
IL-18	protein
-induced	O
activation	O
of	O
NF-kappaB	protein
and	O
c-Jun	protein
N-terminal	protein
kinase	protein
(	O
JNK	protein
)	O
is	O
blocked	O
in	O
MyD88	cell_line
-/-	cell_line
Th1-developing	cell_line
cells	cell_line
.	O
Taken	O
together,	O
these	O
results	O
demonstrate	O
that	O
MyD88	protein
is	O
a	O
critical	O
component	O
in	O
the	O
signaling	O
cascade	O
that	O
is	O
mediated	O
by	O
IL-1	protein
receptor	protein
as	O
well	O
as	O
IL-18	protein
receptor	protein
.	O

Ciprofloxacin	O
induces	O
an	O
immunomodulatory	O
stress	O
response	O
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Exposure	O
of	O
cells	O
to	O
adverse	O
environmental	O
conditions	O
invokes	O
a	O
genetically	O
programmed	O
series	O
of	O
events	O
resulting	O
in	O
the	O
induction	O
of	O
specific	DNA
genes	DNA
.	O
The	O
fluoroquinolone	O
antibiotic	O
ciprofloxacin	O
has	O
recently	O
been	O
reported	O
to	O
upregulate	O
interleukin-2	protein
(	O
IL-2	protein
)	O
gene	O
induction	O
.	O
In	O
the	O
present	O
investigation,	O
the	O
effect	O
of	O
ciprofloxacin	O
at	O
supratherapeutic	O
concentrations	O
on	O
immediate-early	O
(&lt;2	O
h)	O
gene	O
expression	O
in	O
primary	cell_type
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
was	O
studied	O
with	O
Northern	O
blots	O
.	O
In	O
addition,	O
transcriptional	O
activity	O
of	O
IL-2	protein
and	O
metallothionein	O
enhancer	O
and	O
promoter	O
regions	O
and	O
transcription	protein
factors	protein
AP-1	protein
,	O
NF-kappaB	protein
,	O
and	O
NF-AT	protein
were	O
analyzed	O
by	O
chloramphenicol	protein
acetyltransferase	protein
(	O
CAT	protein
)	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
respectively.	O
The	O
concentration	O
of	O
c-fos	O
,	O
c-jun	O
,	O
c-myc	O
,	O
junB	O
,	O
and	O
fra-1	O
mRNAs	O
was	O
increased	O
in	O
activated	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
incubated	O
with	O
ciprofloxacin	O
compared	O
to	O
that	O
in	O
untreated	O
controls.	O
Ciprofloxacin	O
increased	O
CAT	protein
activity	O
in	O
stimulated	O
lymphocytes	O
transfected	O
with	O
plasmids	cell_type
containing	O
either	O
the	O
IL-2	protein
or	O
metallothionein	DNA
enhancer	DNA
.	O
Furthermore,	O
among	O
the	O
transcription	protein
factors	protein
tested,	O
AP-1	protein
activity	O
was	O
increased	O
in	O
stimulated	cell_type
purified	cell_type
T	cell_type
helper	cell_type
lymphocytes	cell_type
incubated	O
with	O
ciprofloxacin	O
compared	O
to	O
drug-free	cell_type
controls	cell_type
.	O
Taken	O
together,	O
ciprofloxacin	O
increased	O
the	O
levels	O
of	O
immediate-early	RNA
transcripts	RNA
,	O
enhanced	O
IL-2	protein
and	O
metallothionein	protein
promoter	O
induction	O
,	O
and	O
upregulated	O
AP-1	protein
concentrations	O
in	O
primary	cell_type
lymphocytes	cell_type
,	O
reflecting	O
a	O
program	O
commonly	O
observed	O
in	O
mammalian	O
stress	O
responses	O
.	O

A	O
novel	O
retinoic	protein
acid	protein
receptor	protein
(	O
RAR	protein
)-selective	O
antagonist	O
inhibits	O
differentiation	O
and	O
apoptosis	O
of	O
HL-60	cell_line
cells	cell_line
:	O
implications	O
of	O
RARalpha	protein
-mediated	O
signals	O
in	O
myeloid	cell_type
leukemic	cell_type
cells	cell_type
.	O
Retinoic	O
acid	O
(	O
RA	O
)	O
induces	O
HL-60	cell_line
cells	cell_line
to	O
differentiate	O
terminally	O
into	O
mature	cell_type
granulocytes	cell_type
,	O
which	O
subsequently	O
die	O
by	O
apoptosis	O
.	O
The	O
biological	O
effects	O
of	O
RA	O
are	O
mediated	O
by	O
two	O
distinct	O
families	O
of	O
transcription	protein
factors	protein
:	O
retinoic	protein
acid	protein
receptors	protein
(	O
RARs	protein
)	O
and	O
retinoid	protein
X	protein
receptors	protein
(	O
RXRs	protein
).	O
RARs	protein
and	O
RXRs	protein
form	O
heterodimers	protein
and	O
regulate	O
retinoid-mediated	O
gene	O
expression	O
.	O
We	O
have	O
recently	O
developed	O
a	O
novel	O
RAR	protein
-selective	O
antagonist	O
(	O
ER27191	O
)	O
which	O
prevents	O
RAR	protein
activation	O
by	O
retinoids.	O
Using	O
this	O
RAR-selective	O
antagonist	O
,	O
and	O
RXR	protein
and	O
RAR	protein
agonist	O
,	O
we	O
demonstrate	O
the	O
RAR	protein
-mediated	O
signaling	O
pathway	O
is	O
important	O
for	O
differentiation	O
and	O
apoptosis	O
of	O
myeloid	cell_type
leukemic	cell_type
cells	cell_type
.	O
Simple	O
activation	O
of	O
RXRs	protein
is	O
not	O
sufficient	O
to	O
induce	O
apoptosis	O
of	O
the	O
cells.	O
Interestingly,	O
the	O
combination	O
of	O
the	O
RAR-selective	O
antagonist	O
and	O
9-cis	O
RA	O
resulted	O
in	O
partial	O
differentiation	O
and	O
apoptosis	O
of	O
HL-60	O
and	O
NB4	O
cells	O
,	O
whereas	O
the	O
RAR	protein
antagonist	O
completely	O
blocked	O
all-trans	O
RA	O
-induced	O
differentiation	O
and	O
apoptosis	O
of	O
the	O
cells.	O
Additional	O
experiments	O
showed	O
that	O
levels	O
of	O
BCL-2	protein
protein	protein
decreased	O
during	O
differentiation	O
of	O
myeloid	cell_type
leukemic	cell_type
cells	cell_type
.	O
Furthermore,	O
HL-60	cell_line
cells	cell_line
transduced	O
with	O
a	O
bcl-2	DNA
expression	DNA
vector	DNA
showed	O
the	O
same	O
differentiation	O
response	O
to	O
retinoids	O
as	O
did	O
parental	cell_line
HL-60	cell_line
cells	cell_line
even	O
though	O
apoptosis	O
was	O
inhibited	O
in	O
these	O
bcl-2-transduced	cell_line
cells	cell_line
,	O
suggesting	O
that	O
differentiation	O
and	O
apoptosis	O
are	O
regulated	O
independently	O
in	O
myeloid	cell_type
leukemic	cell_type
cells	cell_type
.	O

Thrombopoietin	protein
supports	O
in	O
vitro	O
erythroid	O
differentiation	O
via	O
its	O
specific	O
receptor	O
c-Mpl	protein
in	O
a	O
human	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
.	O
Thrombopoietin	protein
(	O
TPO	protein
)	O
acts	O
on	O
megakaryopoiesis	O
and	O
erythropoiesis	O
in	O
vitro	O
and	O
in	O
vivo.	O
We	O
isolated	O
a	O
novel	O
subline,	O
UT-7/GMT	cell_line
,	O
from	O
the	O
human	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
UT-7/GM	cell_line
(N.	O
Komatsu,	O
et	O
al.,	O
Blood,	O
89:	O
4021-4033,	O
1997).	O
A	O
small	O
population	O
of	O
UT-7/GM	cell_line
cells	cell_line
positively	O
stained	O
for	O
hemoglobin	protein
(	O
Hb	protein
)	O
after	O
a	O
7-day	O
exposure	O
to	O
TPO	protein
.	O
More	O
than	O
50%	O
of	O
TPO	cell_line
-treated	cell_line
UT-7/GMT	cell_line
cells	cell_line
positively	O
stained	O
for	O
Hb	protein
.	O
Using	O
UT-7/GMT	cell_line
cells	cell_line
,	O
we	O
examined	O
how	O
TPO	protein
promotes	O
hemoglobinization	O
.	O
TPO	protein
induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
TPO	protein
receptor	O
but	O
not	O
the	O
erythropoietin	protein
(	protein
EPO	protein
)	protein
receptor	protein
.	O
There	O
was	O
no	O
competition	O
between	O
TPO	protein
and	O
EPO	protein
for	O
binding	O
to	O
EPO	protein
receptor	protein
.	O
These	O
findings	O
suggest	O
that	O
TPO	protein
has	O
a	O
direct	O
effect	O
on	O
hemoglobinization	O
via	O
a	O
specific	O
receptor	O
on	O
UT-7/GMT	cell_line
cells	cell_line
.	O
Isoelectric	O
focusing	O
demonstrated	O
that	O
TPO	protein
induced	O
fetal	O
and	O
adult	O
Hb	O
synthesis	O
,	O
whereas	O
EPO	protein
induced	O
embryonic	O
,	O
fetal	O
,	O
and	O
adult	O
Hb	O
synthesis	O
.	O
Thus,	O
our	O
data	O
suggest	O
that	O
TPO	protein
has	O
a	O
distinct	O
action	O
on	O
erythropoiesis	O
.	O

Role	O
of	O
GATA-1	protein
in	O
proliferation	O
and	O
differentiation	O
of	O
definitive	O
erythroid	O
and	O
megakaryocytic	O
cells	O
in	O
vivo.	O
To	O
elucidate	O
the	O
contributions	O
of	O
GATA-1	protein
to	O
definitive	O
hematopoiesis	O
in	O
vivo,	O
we	O
have	O
examined	O
adult	O
mice	O
that	O
were	O
rendered	O
genetically	O
defective	O
in	O
GATA-1	protein
synthesis	O
(Takahashi	O
et	O
al,	O
J	O
Biol	O
Chem	O
272:12611,	O
1997).	O
Because	O
the	O
GATA-1	DNA
gene	DNA
is	O
located	O
on	O
the	O
X	DNA
chromosome	DNA
,	O
which	O
is	O
randomly	O
inactivated	O
in	O
every	O
cell,	O
heterozygous	O
females	O
can	O
bear	O
either	O
an	O
active	O
wild-type	O
or	O
mutant	O
(referred	O
to	O
as	O
GATA-1.05	DNA
)	O
GATA-1	protein
allele,	O
consequently	O
leading	O
to	O
variable	O
anemic	O
severity	O
.	O
These	O
heterozygous	O
mutant	O
mice	O
usually	O
developed	O
normally,	O
but	O
they	O
began	O
to	O
die	O
after	O
5	O
months.	O
These	O
affected	O
animals	O
displayed	O
marked	O
splenomegaly	O
,	O
anemia	O
,	O
and	O
thrombocytopenia	O
.	O
Proerythroblasts	cell_type
and	O
megakaryocytes	cell_type
massively	O
accumulated	O
in	O
the	O
spleens	O
of	O
the	O
heterozygotes	O
,	O
and	O
we	O
showed	O
that	O
the	O
neomycin	DNA
resistance	DNA
gene	DNA
(which	O
is	O
the	O
positive	O
selection	O
marker	O
in	O
ES	cell_type
cells	cell_type
)	O
was	O
expressed	O
profusely	O
in	O
the	O
abnormally	O
abundant	O
cells	O
generated	O
in	O
the	O
GATA-1.05	protein
mutant	O
females	O
.	O
We	O
also	O
observed	O
hematopoiesis	O
outside	O
of	O
the	O
bone	O
marrow	O
in	O
the	O
affected	O
mutant	O
mice	O
.	O
These	O
data	O
suggest	O
that	O
a	O
small	O
number	O
of	O
GATA-1.05	cell_line
mutant	cell_line
hematopoietic	cell_line
progenitor	cell_line
cells	cell_line
begin	O
to	O
proliferate	O
vigorously	O
during	O
early	O
adulthood,	O
but	O
because	O
the	O
cells	O
are	O
unable	O
to	O
terminally	O
differentiate,	O
this	O
leads	O
to	O
progenitor	O
proliferation	O
in	O
the	O
spleen	O
and	O
consequently	O
death.	O
Thus,	O
GATA-1	protein
plays	O
important	O
in	O
vivo	O
roles	O
for	O
directing	O
definitive	O
hematopoietic	cell_type
progenitors	cell_type
to	O
differentiate	O
along	O
both	O
the	O
erythroid	O
and	O
megakaryocytic	O
pathways	O
.	O
The	O
GATA-1	protein
heterozygous	O
mutant	O
mouse	O
shows	O
a	O
phenotype	O
that	O
is	O
analogous	O
to	O
human	O
myelodysplastic	O
syndrome	O
and	O
thus	O
may	O
serve	O
as	O
a	O
useful	O
model	O
for	O
this	O
disorder.	O

Differential	O
regulation	O
of	O
the	O
Janus	protein
kinase	protein
-STAT	protein
pathway	O
and	O
biologic	O
function	O
of	O
IL-13	protein
in	O
primary	O
human	O
NK	O
and	O
T	O
cells	O
:	O
a	O
comparative	O
study	O
with	O
IL-4	protein
.	O
IL-13	protein
,	O
a	O
cytokine	O
similar	O
to	O
IL-4	protein
,	O
is	O
a	O
regulator	O
of	O
human	O
B	O
cell	O
and	O
monocyte	O
functions	O
.	O
Biologic	O
effects	O
of	O
IL-13	protein
on	O
primary	O
human	O
NK	O
and	O
T	O
cells	O
have	O
not	O
been	O
well	O
defined.	O
We	O
demonstrate	O
that,	O
in	O
primary	cell_type
NK	cell_type
cells	cell_type
,	O
IL-13	protein
,	O
but	O
not	O
IL-4	protein
,	O
may	O
induce	O
low	O
levels	O
of	O
IFN-gamma	protein
secretion	O
.	O
When	O
NK	cell_type
cells	cell_type
were	O
costimulated	O
with	O
IL-13	protein
and	O
IL-2	protein
,	O
IL-13	protein
generally	O
resulted	O
in	O
two	O
types	O
of	O
reactivity:	O
IL-13	protein
synergized	O
with	O
IL-2	protein
to	O
stimulate	O
IFN-gamma	protein
production	O
or	O
it	O
modestly	O
inhibited	O
IL-2	protein
-mediated	O
IFN-gamma	protein
production	O
.	O
In	O
both	O
types	O
of	O
donors,	O
the	O
effect	O
of	O
IL-13	protein
on	O
IL-2	protein
-induced	O
IFN-gamma	protein
production	O
was	O
in	O
marked	O
contrast	O
to	O
the	O
strong	O
inhibition	O
seen	O
with	O
IL-4	protein
in	O
NK	cell_type
cells	cell_type
.	O
Additionally,	O
IL-13	protein
suppresses	O
IL-2-induced	O
NK	O
cytolytic	O
and	O
proliferative	O
activities	O
although	O
less	O
efficiently	O
than	O
IL-4	protein
.	O
In	O
T	cell_type
cells	cell_type
,	O
IL-13	protein
inhibits	O
anti-CD3	O
mAb/IL-2-	O
or	O
PHA-	O
mediated	O
IFN-gamma	O
production	O
and	O
enhances	O
cytolytic	O
potential.	O
Furthermore,	O
we	O
demonstrate	O
that	O
IL-13	protein
,	O
like	O
IL-4	protein
,	O
induces	O
distinct	O
STAT6-DNA	protein
binding	protein
complexes	protein
and	O
tyrosine	O
phosphorylation	O
of	O
STAT6	protein
and	O
Janus	protein
kinase	protein
3	protein
(	O
JAK3	protein
)	O
in	O
NK	O
and	O
T	cell_type
cells	cell_type
.	O
We	O
observed	O
that	O
Abs	O
directed	O
against	O
unique	O
domains	O
of	O
STAT6	protein
have	O
differential	O
effects	O
on	O
complexes	O
in	O
T	cell_type
cells	cell_type
but	O
not	O
in	O
NK	cell_type
cells	cell_type
,	O
suggesting	O
different	O
STAT6	protein
isoforms	protein
.	O
These	O
findings	O
show	O
that	O
IL-13	protein
and	O
IL-4	protein
have	O
the	O
ability	O
to	O
regulate	O
NK	O
and	O
T	O
cell	O
activation	O
and	O
that	O
IL-13	protein
is	O
a	O
potent	O
regulator	O
of	O
STAT6	protein
and	O
JAK3	protein
in	O
these	O
cell	O
types.	O

The	O
human	O
toll	O
signaling	O
pathway	O
:	O
divergence	O
of	O
nuclear	protein
factor	protein
kappaB	protein
and	O
JNK	protein
/SAPK	protein
activation	O
upstream	O
of	O
tumor	protein
necrosis	protein
factor	protein
receptor-associated	protein
factor	protein
6	protein
(	O
TRAF6	protein
).	O
The	O
human	O
homologue	O
of	O
Drosophila	protein
Toll	protein
(	O
hToll	protein
)	O
is	O
a	O
recently	O
cloned	O
receptor	O
of	O
the	O
interleukin	protein
1	protein
receptor	protein
(	protein
IL-1R	protein
)	protein
superfamily	protein
,	O
and	O
has	O
been	O
implicated	O
in	O
the	O
activation	O
of	O
adaptive	O
immunity	O
.	O
Signaling	O
by	O
hToll	protein
is	O
shown	O
to	O
occur	O
through	O
sequential	O
recruitment	O
of	O
the	O
adapter	protein
molecule	protein
MyD88	protein
and	O
the	O
IL-1R-associated	protein
kinase	protein
.	O
Tumor	protein
necrosis	protein
factor	protein
receptor-activated	protein
factor	protein
6	protein
(	O
TRAF6	protein
)	O
and	O
the	O
nuclear	protein
factor	protein
kappaB	protein
(	protein
NF-kappaB	protein
)-inducing	protein
kinase	protein
(	O
NIK	protein
)	O
are	O
both	O
involved	O
in	O
subsequent	O
steps	O
of	O
NF-kappaB	protein
activation	O
.	O
Conversely,	O
a	O
dominant	O
negative	O
version	O
of	O
TRAF6	protein
failed	O
to	O
block	O
hToll	protein
-induced	O
activation	O
of	O
stress-activated	protein
protein	protein
kinase/c-Jun	protein
NH2-terminal	protein
kinases	protein
,	O
thus	O
suggesting	O
an	O
early	O
divergence	O
of	O
the	O
two	O
pathways.	O

Inhibition	O
of	O
nuclear	protein
factor	protein
kappaB	protein
activation	O
attenuates	O
apoptosis	O
resistance	O
in	O
lymphoid	cell_type
cells	cell_type
.	O
Death-inducing	protein
ligands	protein
(	O
DILs	protein
)	O
such	O
as	O
tumor	protein
necrosis	protein
factor	protein
alpha	protein
(	O
TNFalpha	protein
)	O
or	O
the	O
cytotoxic	O
drug	O
doxorubicin	O
have	O
been	O
shown	O
to	O
activate	O
a	O
nuclear	protein
factor	protein
kappaB	protein
(	O
NFkappaB	protein
)-dependent	O
program	O
that	O
may	O
rescue	O
cells	O
from	O
apoptosis	O
induction.	O
We	O
demonstrate	O
here	O
that	O
TRAIL	protein
(	O
TNF-related	protein
apoptosis	protein
-inducing	protein
ligand	protein
),	O
a	O
recently	O
identified	O
DIL	protein
,	O
also	O
activates	O
NFkappaB	protein
in	O
lymphoid	O
cell	O
lines	O
in	O
a	O
kinetic	O
similar	O
to	O
TNFalpha	protein
.	O
NFkappaB	protein
activity	O
is	O
independent	O
from	O
FADD	protein
,	O
caspases	protein
,	O
and	O
apoptosis	O
induction	O
.	O
To	O
study	O
the	O
influence	O
of	O
NFkappaB	protein
activity	O
on	O
apoptosis	O
mediated	O
by	O
TRAIL	protein
,	O
CD95,	O
TNFalpha	protein
,	O
or	O
doxorubicin	O
,	O
NFkappaB	protein
activation	O
was	O
inhibited	O
using	O
the	O
proteasome	protein
inhibitor	O
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal	O
or	O
transient	O
overexpression	O
of	O
mutant	protein
IkappaBalpha	protein
.	O
Sensitivity	O
for	O
induction	O
of	O
apoptosis	O
was	O
markedly	O
increased	O
by	O
these	O
treatments	O
in	O
apoptosis	O
sensitive	O
cell	cell_line
lines	cell_line
.	O
Moreover,	O
both	O
in	O
cell	O
lines	O
and	O
in	O
primary	O
leukemia	O
cells	O
that	O
are	O
resistant	O
towards	O
induction	O
of	O
apoptosis	O
by	O
DILs	protein
and	O
doxorubicin	O
,	O
antagonization	O
of	O
NFkappaB	protein
activity	O
partially	O
restored	O
apoptosis	O
sensitivity	O
.	O
These	O
data	O
suggest	O
that	O
inhibition	O
of	O
NFkappaB	protein
activation	O
may	O
provide	O
a	O
molecular	O
approach	O
to	O
increase	O
apoptosis	O
sensitivity	O
in	O
anticancer	O
treatment	O
.	O

Loss-	O
and	O
gain-of-function	O
mutations	O
reveal	O
an	O
important	O
role	O
of	O
BSAP	protein
(	O
Pax-5	protein
)	O
at	O
the	O
start	O
and	O
end	O
of	O
B	O
cell	O
differentiation	O
.	O
Pax-5	protein
codes	O
for	O
the	O
transcription	protein
factor	protein
BSAP	protein
which	O
is	O
expressed	O
throughout	O
B	O
cell	O
development	O
except	O
in	O
terminally	cell_type
differentiated	cell_type
plasma	cell_type
cells	cell_type
.	O
Gene	O
targeting	O
experiments	O
in	O
the	O
mouse	O
revealed	O
a	O
differential	O
dependency	O
of	O
fetal	O
and	O
adult	O
B-lymphopoiesis	O
on	O
this	O
transcription	protein
factor	protein
.	O
BSAP	protein
is	O
required	O
for	O
B-lineage	O
commitment	O
in	O
the	O
fetal	O
liver	O
and	O
for	O
progression	O
beyond	O
an	O
early	O
pro-B	O
cell	O
stage	O
in	O
adult	O
bone	O
marrow	O
.	O
The	O
characterization	O
of	O
Pax-5	cell_type
-deficient	cell_type
pro-B	cell_type
cells	cell_type
demonstrated	O
an	O
important	O
role	O
of	O
BSAP	protein
in	O
the	O
regulation	O
of	O
the	O
CD19	protein
,	O
mb-1	protein
(	O
Ig	protein
alpha	protein
)	O
and	O
N-myc	DNA
genes	DNA
as	O
well	O
as	O
in	O
the	O
developmental	O
pathway	O
controlling	O
VH-to-DHJH	O
recombination	O
at	O
the	O
immunoglobulin	protein
heavy-chain	protein
(	protein
IgH	protein
)	protein
locus	protein
.	O
The	O
human	DNA
PAX-5	DNA
gene	DNA
was	O
recently	O
shown	O
to	O
participate	O
together	O
with	O
the	O
IgH	DNA
locus	DNA
in	O
the	O
chromosomal	O
translocation	O
t(9;14)(p13;q32)	DNA
.	O
This	O
translocation	O
is	O
characteristic	O
of	O
a	O
small	O
subset	O
of	O
non-Hodgkin	O
lymphomas	O
exhibiting	O
plasmacytoid	O
differentiation	O
.	O
The	O
translocated	DNA
PAX-5	DNA
gene	DNA
is	O
deregulated	O
by	O
the	O
insertion	O
of	O
IgH	DNA
regulatory	DNA
elements	DNA
into	O
its	O
5'	DNA
region	DNA
,	O
which	O
may	O
contribute	O
to	O
tumorigenesis	O
by	O
interfering	O
with	O
the	O
shut-down	O
of	O
PAX-5	protein
transcription	O
and	O
thus	O
with	O
the	O
completion	O
of	O
plasma	cell_type
cell	cell_type
differentiation	O

Acetylation	O
and	O
modulation	O
of	O
erythroid	protein
Kruppel-like	protein
factor	protein
(	O
EKLF	protein
)	O
activity	O
by	O
interaction	O
with	O
histone	protein
acetyltransferases	protein
.	O
Erythroid	protein
Kruppel-like	protein
factor	protein
(	O
EKLF	protein
)	O
is	O
a	O
red	protein
cell-specific	protein
transcriptional	protein
activator	protein
that	O
is	O
crucial	O
for	O
consolidating	O
the	O
switch	O
to	O
high	O
levels	O
of	O
adult	O
beta-globin	protein
expression	O
during	O
erythroid	O
ontogeny	O
.	O
EKLF	protein
is	O
required	O
for	O
integrity	O
of	O
the	O
chromatin	DNA
structure	DNA
at	O
the	O
beta-like	DNA
globin	DNA
locus	DNA
,	O
and	O
it	O
interacts	O
with	O
a	O
positive-acting	protein
factor	protein
in	O
vivo.	O
We	O
find	O
that	O
EKLF	protein
is	O
an	O
acetylated	protein
transcription	protein
factor	protein
,	O
and	O
that	O
it	O
interacts	O
in	O
vivo	O
with	O
CBP	protein
,	O
p300	protein
,	O
and	O
P/CAF	protein
.	O
However,	O
its	O
interactions	O
with	O
these	O
histone	protein
acetyltransferases	protein
are	O
not	O
equivalent,	O
as	O
CBP	protein
and	O
p300	protein
,	O
but	O
not	O
P/CAF	protein
,	O
utilize	O
EKLF	protein
as	O
a	O
substrate	O
for	O
in	O
vitro	O
acetylation	O
within	O
its	O
trans-	O
activation	protein
region	protein
.	O
The	O
functional	O
effects	O
of	O
these	O
interactions	O
are	O
that	O
CBP	protein
and	O
p300	protein
,	O
but	O
not	O
P/CAF	protein
,	O
enhance	O
EKLF	protein
's	O
transcriptional	O
activation	O
of	O
the	O
beta-globin	DNA
promoter	DNA
in	O
erythroid	cell_type
cells	cell_type
.	O
These	O
results	O
establish	O
EKLF	protein
as	O
a	O
tissue-specific	protein
transcription	protein
factor	protein
that	O
undergoes	O
post-translational	O
acetylation	O
and	O
suggest	O
a	O
mechanism	O
by	O
which	O
EKLF	protein
is	O
able	O
to	O
alter	O
chromatin	DNA
structure	O
and	O
induce	O
beta-globin	protein
expression	O
within	O
the	O
beta-like	DNA
globin	DNA
cluster	DNA
.	O

Recognition	O
of	O
herpes	protein
simplex	protein
virus	protein
type	protein
2	protein
tegument	protein
proteins	protein
by	O
CD4	cell_type
T	cell_type
cells	cell_type
infiltrating	O
human	O
genital	O
herpes	O
lesions	O
.	O
The	O
local	O
cellular	O
immune	O
response	O
to	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
)	O
is	O
important	O
in	O
the	O
control	O
of	O
recurrent	O
HSV	O
infection	O
.	O
The	O
antiviral	O
functions	O
of	O
infiltrating	cell_type
CD4-bearing	cell_type
T	cell_type
cells	cell_type
may	O
include	O
cytotoxicity	O
,	O
inhibition	O
of	O
viral	O
growth	O
,	O
lymphokine	protein
secretion	O
,	O
and	O
support	O
of	O
humoral	O
and	O
CD8	O
responses	O
.	O
The	O
antigens	O
recognized	O
by	O
many	O
HSV	cell_type
-specific	cell_type
CD4	cell_type
T	cell_type
cells	cell_type
localizing	O
to	O
genital	O
HSV	O
-2	O
lesions	O
are	O
unknown.	O
T	cell_type
cells	cell_type
recognizing	O
antigens	O
encoded	O
within	O
map	O
units	O
0.67	O
to	O
0.73	O
of	O
HSV	DNA
DNA	DNA
are	O
frequently	O
recovered	O
from	O
herpetic	O
lesions	O
.	O
Expression	O
cloning	O
with	O
this	O
region	O
of	O
DNA	O
now	O
shows	O
that	O
tegument	protein
protein	protein
VP22	protein
and	O
the	O
viral	protein
dUTPase	protein
,	O
encoded	O
by	O
genes	O
UL49	DNA
and	O
UL50	DNA
,	O
respectively,	O
are	O
T-cell	protein
antigens	protein
.	O
Separate	O
epitopes	protein
in	O
VP22	protein
were	O
defined	O
for	O
T-cell	cell_line
clones	cell_line
from	O
each	O
of	O
three	O
patients	O
.	O
Reactivity	O
with	O
the	O
tegument	protein
protein	protein
encoded	O
by	O
UL21	DNA
was	O
identified	O
for	O
an	O
additional	O
patient.	O
Three	O
new	O
epitopes	O
were	O
identified	O
in	O
VP16	protein
,	O
a	O
tegument	protein
protein	protein
associated	O
with	O
VP22	protein
.	O
Some	O
tegument-specific	cell_line
CD4	cell_line
T-cell	cell_line
clones	cell_line
exhibited	O
cytotoxic	O
activity	O
against	O
HSV	cell_type
-infected	cell_type
cells	cell_type
.	O
These	O
results	O
suggest	O
that	O
herpes	protein
simplex	protein
tegument	protein
proteins	protein
are	O
processed	O
for	O
antigen	O
presentation	O
in	O
vivo	O
and	O
are	O
possible	O
candidate	O
compounds	O
for	O
herpes	O
simplex	O
vaccines	O
.	O

Fibrinogen	protein
activates	O
NF-kappa	protein
B	protein
transcription	protein
factors	protein
in	O
mononuclear	cell_type
phagocytes	cell_type
.	O
Adhesion	O
to	O
extracellular	O
matrices	O
is	O
known	O
to	O
modulate	O
leukocyte	O
activation	O
,	O
although	O
the	O
mechanisms	O
are	O
not	O
fully	O
understood.	O
Mononuclear	cell_type
phagocytes	cell_type
are	O
exposed	O
to	O
fibrinous	O
provisional	O
matrix	O
throughout	O
migration	O
into	O
inflammatory	O
foci,	O
so	O
this	O
study	O
was	O
undertaken	O
to	O
determine	O
whether	O
fibrinogen	O
triggers	O
activation	O
of	O
NF-kappa	protein
B	protein
transcription	protein
factors	protein
.	O
U937	cell_line
cells	cell_line
differentiated	O
with	O
PMA	O
in	O
nonadherent	cell_line
culture	cell_line
were	O
shown	O
to	O
express	O
two	O
fibrinogen-binding	protein
integrins	protein
,	O
predominately	O
CD11b/CD18	protein
,	O
and	O
to	O
a	O
lesser	O
extent,	O
CD11c/CD18	protein
.	O
Cells	O
stimulated	O
with	O
fibrinogen	protein
(10-100	O
microg/ml)/Mn2+	O
(50	O
microM)	O
for	O
2	O
h	O
were	O
examined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
NF-kappa	protein
B	protein
activation	O
,	O
minimal	O
in	O
unstimulated	cell_type
cells	cell_type
,	O
was	O
substantially	O
up-regulated	O
by	O
fibrinogen	protein
.	O
Fibrinogen	protein
also	O
caused	O
activation	O
of	O
AP-1	protein
,	O
but	O
not	O
SP1	protein
or	O
cAMP	protein
response	protein
element-binding	protein
protein	protein
(CREB)	protein
factors	protein
.	O
Blocking	O
mAbs	protein
against	O
CD18	protein
and	O
CD11b	protein
abrogated	O
fibrinogen	protein
-induced	O
NF-kappa	protein
B	protein
activation	O
.	O
To	O
determine	O
the	O
effects	O
on	O
transcriptional	O
regulation	O
,	O
U937	cell_line
cells	cell_line
were	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
HIV-1	DNA
enhancer	DNA
(bearing	O
two	O
NF-kappa	DNA
B	DNA
sites	DNA
)	O
coupled	O
to	O
a	O
chloramphenicol	DNA
acetyltransferase	DNA
(	DNA
CAT	DNA
)	DNA
reporter	DNA
.	O
Cells	O
were	O
subsequently	O
stimulated	O
with	O
1)	O
PMA	O
for	O
24	O
h,	O
inducing	O
CAT	protein
activity	O
by	O
2.6-fold,	O
2)	O
fibrinogen	protein
/Mn2+	O
for	O
2	O
h,	O
inducing	O
CAT	protein
activity	O
by	O
3.2-fold,	O
or	O
3)	O
costimulation	O
with	O
fibrinogen	protein
and	O
PMA	O
,	O
inducing	O
5.7-fold	O
the	O
CAT	protein
activity	O
induced	O
by	O
PMA	O
alone.	O
We	O
conclude	O
that	O
contact	O
with	O
fibrinogen	protein
-derived	protein
proteins	protein
may	O
contribute	O
to	O
mononuclear	O
phagocyte	O
activation	O
by	O
signaling	O
through	O
CD11b/CD18	protein
,	O
resulting	O
in	O
selective	O
activation	O
of	O
transcriptional	protein
regulatory	protein
factors	protein
,	O
including	O
NF-kappa	protein
B	protein
.	O

Peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
and	O
monocytes	cell_type
and	O
B	cell_line
cell	cell_line
lines	cell_line
derived	O
from	O
patients	O
with	O
lupus	O
express	O
estrogen	O
receptor	O
transcripts	O
similar	O
to	O
those	O
of	O
normal	cell_type
cells	cell_type
.	O
OBJECTIVE:	O
To	O
identify	O
and	O
characterize	O
estrogen	RNA
receptor	RNA
(ER)	RNA
transcripts	RNA
expressed	O
in	O
immune	cell_type
cells	cell_type
of	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
and	O
healthy	O
donors	O
.	O
METHODS:	O
Peripheral	cell_type
blood	cell_type
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
were	O
prepared	O
from	O
patients	O
with	O
SLE	O
(n	O
=	O
6)	O
and	O
healthy	O
donors	O
(n	O
=	O
8).	O
T	cell_type
cells	cell_type
were	O
separated	O
into	O
CD4	cell_type
and	O
CD8	cell_type
.	O
Some	O
monocytes	cell_type
and	O
T	cell_type
cells	cell_type
were	O
stimulated	O
with	O
estradiol,	O
PMA	O
,	O
and	O
ionomycin	O
.	O
Epstein-Barr	O
virus-transformed	O
B	cell_line
cell	cell_line
lines	cell_line
(n	O
=	O
7)	O
and	O
B	cell_line
cell	cell_line
hybridomas	cell_line
(n	O
=	O
2)	O
established	O
from	O
patients	O
with	O
SLE	O
and	O
a	O
healthy	O
individual	O
were	O
used	O
as	O
a	O
B	O
cell	O
source	O
.	O
These	O
cells	O
were	O
examined	O
for	O
ER	RNA
mRNA	RNA
by	O
reverse	O
transcription	O
nested	O
polymerase	O
chain	O
reaction	O
.	O
Amplified	O
cDNA	DNA
were	O
sequenced	O
by	O
standard	O
methods.	O
RESULTS:	O
In	O
all	O
cells	O
tested,	O
ER	RNA
mRNA	RNA
was	O
expressed	O
without	O
prior	O
in	O
vitro	O
stimulation.	O
Partial	O
sequences	O
from	O
exons	DNA
1-8	DNA
were	O
nearly	O
identical	O
to	O
the	O
published	O
sequence	O
of	O
the	O
human	RNA
ER	RNA
mRNA	RNA
.	O
There	O
were	O
no	O
notable	O
differences	O
in	O
the	O
ER	RNA
transcripts	RNA
between	O
patients	O
and	O
healthy	O
controls	O
.	O
Variant	O
receptor	O
transcripts	O
lacking	O
exon	DNA
5	DNA
or	O
exon	DNA
7	DNA
,	O
which	O
encodes	O
the	O
hormone	O
binding	O
domain,	O
were	O
identified	O
in	O
the	O
majority	O
of	O
the	O
cells.	O
Precise	O
deletion	O
of	O
the	O
exons	O
suggests	O
that	O
they	O
are	O
alternatively	O
spliced	O
transcripts	O
.	O
Whether	O
the	O
detected	O
transcripts	O
are	O
translated	O
into	O
functional	O
receptor	O
proteins	O
remains	O
to	O
be	O
determined.	O
In	O
vitro	O
stimulation	O
did	O
not	O
affect	O
ER	RNA
mRNA	RNA
expression	O
.	O
The	O
presence	O
of	O
variants	O
did	O
not	O
correlate	O
with	O
disease	O
activity	O
or	O
medication.	O
CONCLUSION:	O
Monocytes	cell_type
,	O
T	cell_type
cells	cell_type
,	O
and	O
B	cell_type
cells	cell_type
in	O
patients	O
express	O
transcripts	O
of	O
the	O
normal	O
wild	protein
type	protein
ER	protein
and	O
the	O
hormone	protein
binding	protein
domain	protein
variants	protein
in	O
vivo.	O

DNA	O
damaging	O
agents	O
induce	O
expression	O
of	O
Fas	protein
ligand	protein
and	O
subsequent	O
apoptosis	O
in	O
T	cell_type
lymphocytes	cell_type
via	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
.	O
Apoptosis	O
induced	O
by	O
DNA	O
damage	O
and	O
other	O
stresses	O
can	O
proceed	O
via	O
expression	O
of	O
Fas	protein
ligand	protein
(	O
FasL	protein
)	O
and	O
ligation	O
of	O
its	O
receptor,	O
Fas	O
(CD95).	O
We	O
report	O
that	O
activation	O
of	O
the	O
two	O
transcription	O
factors	O
NF-kappa	O
B	O
and	O
AP-1	protein
is	O
crucially	O
involved	O
in	O
FasL	protein
expression	O
induced	O
by	O
etoposide	O
,	O
teniposide	O
,	O
and	O
UV	O
irradiation	O
.	O
A	O
nondegradable	O
mutant	O
of	O
I	protein
kappa	protein
B	protein
blocked	O
both	O
FasL	protein
expression	O
and	O
apoptosis	O
induced	O
by	O
DNA	O
damage	O
but	O
not	O
Fas	protein
ligation	O
.	O
These	O
stimuli	O
also	O
induced	O
the	O
stress-activated	O
kinase	O
pathway	O
(	O
SAPK	protein
/JNK	protein
),	O
which	O
was	O
required	O
for	O
the	O
maximal	O
induction	O
of	O
apoptosis	O
.	O
A	O
1.2	O
kb	O
FasL	DNA
promoter	DNA
responded	O
to	O
DNA	O
damage	O
,	O
as	O
well	O
as	O
coexpression	O
with	O
p65	protein
Rel	protein
or	O
Fos/Jun	protein
.	O
Mutations	O
in	O
the	O
relevant	O
NF-kappa	protein
B	protein
and	O
AP-1	DNA
binding	DNA
sites	DNA
eliminated	O
these	O
responses.	O
Thus,	O
activation	O
of	O
NF-kappa	protein
B	protein
and	O
AP-1	protein
contributes	O
to	O
stress-induced	O
apoptosis	O
via	O
the	O
expression	O
of	O
FasL	protein
.	O

A	O
small,	O
nonpeptidyl	O
mimic	O
of	O
granulocyte-colony-stimulating	protein
factor	protein
[see	O
commetns]	O
A	O
nonpeptidyl	O
small	O
molecule	O
SB	O
247464	O
,	O
capable	O
of	O
activating	O
granulocyte-colony-stimulating	protein
factor	protein
(	O
G-CSF	protein
)	O
signal	O
transduction	O
pathways	O
,	O
was	O
identified	O
in	O
a	O
high-throughput	O
assay	O
in	O
cultured	cell_type
cells	cell_type
.	O
Like	O
G-CSF	protein
,	O
SB	O
247464	O
induced	O
tyrosine	O
phosphorylation	O
of	O
multiple	protein
signaling	protein
proteins	protein
and	O
stimulated	O
primary	cell_type
murine	cell_type
bone	cell_type
marrow	cell_type
cells	cell_type
to	O
form	O
granulocytic	cell_type
colonies	cell_type
in	O
vitro.	O
It	O
also	O
elevated	O
peripheral	cell_type
blood	cell_type
neutrophil	cell_type
counts	O
in	O
mice.	O
The	O
extracellular	O
domain	O
of	O
the	O
murine	protein
G-CSF	protein
receptor	protein
was	O
required	O
for	O
the	O
activity	O
of	O
SB	O
247464	O
,	O
suggesting	O
that	O
the	O
compound	O
acts	O
by	O
oligomerizing	protein
receptor	protein
chains	protein
.	O
The	O
results	O
indicate	O
that	O
a	O
small	O
molecule	O
can	O
activate	O
a	O
receptor	O
that	O
normally	O
binds	O
a	O
relatively	O
large	O
protein	O
ligand.	O

Minimal	O
residual	O
disease	O
in	O
acute	O
myelogenous	O
leukemia	O
with	O
PML/RAR	protein
alpha	protein
or	O
AML1/ETO	protein
mRNA	O
and	O
phenotypic	O
analysis	O
of	O
possible	O
T	O
and	O
natural	O
killer	O
cells	O
in	O
bone	O
marrow	O
.	O
Here	O
we	O
studied	O
minimal	O
residual	O
disease	O
(	O
MRD	O
)	O
of	O
patients	O
with	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
who	O
have	O
PML/RAR	protein
alpha	protein
or	O
AML1/ETO	protein
as	O
well	O
as	O
the	O
phenotypic	O
analysis	O
of	O
lymphocyte	cell_type
subsets	cell_type
involved	O
in	O
antitumor	O
immunity	O
.	O
Eight	O
patients	O
in	O
long-term	O
(LT;	O
3	O
to	O
15	O
years)	O
and	O
15	O
patients	O
in	O
short-term	O
(ST;	O
up	O
to	O
3	O
years)	O
remission	O
were	O
studied.	O
Using	O
the	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
(RT)	O
assay	O
,	O
the	O
limit	O
of	O
detection	O
was	O
10(-5)	O
to	O
10(-6)	O
for	O
PML/RAR	RNA
alpha	RNA
transcript	RNA
and	O
10(-4)	O
to	O
10(-5)	O
for	O
the	O
AML1/ETO	RNA
transcript	RNA
.	O
Simultaneously,	O
T	cell_type
lymphocyte	cell_type
subsets	cell_type
and	O
NK	cell_type
cells	cell_type
from	O
the	O
peripheral	O
blood	O
(	O
PB	O
)	O
and	O
bone	O
marrow	O
(	O
BM	O
)	O
were	O
investigated	O
by	O
flow	O
cytometric	O
analysis	O
.	O
Four	O
of	O
the	O
eight	O
patients	O
in	O
LT	O
and	O
7	O
of	O
the	O
15	O
patients	O
in	O
ST	O
remission	O
were	O
MRD	O
-positive	O
.	O
Although	O
all	O
MRD	O
-positive	O
patients	O
in	O
LT	O
remission	O
are	O
still	O
until	O
now	O
event-free,	O
3	O
of	O
the	O
7	O
MRD	O
-positive	O
(	O
MRD	O
+)	O
patients	O
in	O
ST	O
remission	O
soon	O
relapsed.	O
The	O
total	O
populations	O
of	O
CD4	protein
+,	O
CD8	protein
+	O
and	O
CD56	protein
+	O
[	O
possible	O
T-cell	cell_type
and	O
natural	cell_type
killer	cell_type
(	O
T/NK	cell_type
)	O
populations	O
]	O
in	O
the	O
BM	O
of	O
ST	O
patients	O
and	O
MRD	O
+/LT	O
patients	O
were	O
significantly	O
(p	O
&lt;	O
.01)	O
low.	O
The	O
CD8	protein
+	O
CD28	protein
+	O
population	O
showed	O
the	O
same	O
tendency	O
(p	O
&lt;	O
.01-.02).	O
The	O
T/NK	cell_type
subsets	cell_type
in	O
the	O
BM	O
of	O
MRD	O
-negative	O
(	O
MRD	O
-)	O
LT	O
(	O
MRD	O
-/LT)	O
patients	O
showed	O
similar	O
numbers	O
of	O
cells	O
as	O
normal	O
volunteers.	O
Basically,	O
the	O
total	O
percentage	O
of	O
the	O
CD4	protein
+	O
,	O
CD8	protein
+	O
and	O
CD56	protein
+	O
cell	O
populations	O
in	O
the	O
BM	O
was	O
increased	O
and	O
in	O
the	O
following	O
order:	O
MRD	O
-/LT	O
patients	O
,	O
normal	O
volunteers,	O
MRD	O
+/LT	O
patients	O
and	O
MRD	O
+	O
or	O
-/ST	O
patients	O
.	O
The	O
percentages	O
of	O
the	O
T/NK-cell	cell_type
subsets	cell_type
in	O
the	O
PB	O
were	O
not	O
significantly	O
different	O
among	O
these	O
groups.	O
Thus,	O
the	O
difference	O
of	O
the	O
possible	O
T/NK-cell	cell_type
phenotype	O
in	O
the	O
BM	O
may	O
strongly	O
influence	O
clinical	O
and	O
molecular	O
remission	O
.	O
These	O
results	O
still	O
remain	O
to	O
be	O
confirmed	O
by	O
further	O
studies	O
of	O
the	O
functional	O
anti-tumor	O
immunity	O
of	O
T/NK	cell_type
cells	cell_type
of	O
AML	O
in	O
remission	O
.	O

Mycobacterium	O
tuberculosis	O
mannose-capped	O
lipoarabinomannan	O
can	O
induce	O
NF-kappaB	protein
-dependent	O
activation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
long	DNA
terminal	DNA
repeat	DNA
in	O
T	cell_type
cells	cell_type
.	O
Tuberculosis	O
has	O
emerged	O
as	O
an	O
epidemic,	O
extended	O
by	O
the	O
large	O
number	O
of	O
individuals	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
).	O
The	O
major	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	O
the	O
mycobacterial	cell_type
cell	cell_type
wall	O
component	O
mannose-capped	O
lipoarabinomannan	O
(	O
ManLAM	O
)	O
of	O
Mycobacterium	O
tuberculosis	O
(	O
M.	O
tuberculosis	O
)	O
could	O
activate	O
transcription	O
of	O
HIV-1	O
in	O
T	cell_type
cells	cell_type
with	O
the	O
use	O
of	O
an	O
in	O
vitro	O
cell	O
culture	O
system	O
.	O
These	O
experiments	O
are	O
of	O
prime	O
importance	O
considering	O
that	O
CD4	cell_type
-expressing	cell_type
T	cell_type
lymphocytes	cell_type
represent	O
the	O
major	O
virus	O
reservoir	O
in	O
the	O
peripheral	O
blood	O
of	O
infected	O
individuals	O
.	O
Using	O
the	O
1G5	cell_line
cell	cell_line
line	cell_line
harbouring	O
the	O
luciferase	DNA
reporter	DNA
gene	DNA
under	O
the	O
control	O
of	O
the	O
HIV-1	DNA
LTR	DNA
,	O
it	O
was	O
first	O
found	O
that	O
culture	O
protein	O
filtrates	O
(	O
CFP	O
)	O
from	O
M.	O
tuberculosis	O
or	O
purified	O
ManLAM	O
could	O
activate	O
HIV-1	DNA
LTR	DNA
-dependent	DNA
gene	DNA
expression	O
unlike	O
similarly	O
prepared	O
CFP	O
extracts	O
devoid	O
of	O
ManLAM	O
.	O
The	O
implication	O
of	O
protein	protein
tyrosine	protein
kinase(s)	protein
,	O
protein	protein
kinase	protein
A	protein
and/or	O
protein	protein
kinase	protein
C	protein
was	O
highlighted	O
by	O
the	O
abrogation	O
of	O
the	O
ManLAM	O
-mediated	O
activation	O
of	O
HIV-1	DNA
LTR	DNA
-driven	DNA
gene	DNA
expression	O
using	O
herbimycin	O
A	O
and	O
H7	O
.	O
It	O
was	O
also	O
determined,	O
using	O
electrophoresis	O
mobility	O
shift	O
assays	O
,	O
that	O
M.	O
tuberculosis	O
ManLAM	O
led	O
to	O
the	O
nuclear	O
translocation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappaB	protein
.	O
M.	O
tuberculosis	O
ManLAM	O
resulted	O
in	O
clear	O
induction	O
of	O
the	O
luciferase	DNA
gene	DNA
placed	O
under	O
the	O
control	O
of	O
the	O
wild-type,	DNA
but	DNA
not	DNA
the	DNA
kappaB	DNA
-mutated,	DNA
HIV-1	DNA
LTR	DNA
region	DNA
.	O
Finally,	O
the	O
ManLAM	O
-mediated	O
activation	O
of	O
HIV-1	DNA
LTR	DNA
transcription	O
was	O
found	O
to	O
be	O
independent	O
of	O
the	O
autocrine	O
or	O
paracrine	O
action	O
of	O
endogenous	protein
TNF-alpha	protein
.	O
The	O
results	O
suggest	O
that	O
M.	O
tuberculosis	O
can	O
upregulate	O
HIV-1	O
expression	O
in	O
T	cell_type
cells	cell_type
and	O
could	O
thus	O
have	O
the	O
potential	O
to	O
influence	O
the	O
pathogenesis	O
of	O
HIV-1	O
infection	O
.	O

Human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
long	DNA
terminal	DNA
repeat	DNA
quasispecies	DNA
differ	O
in	O
basal	O
transcription	O
and	O
nuclear	protein
factor	protein
recruitment	O
in	O
human	O
glial	O
cells	O
and	O
lymphocytes	O
.	O
The	O
generation	O
of	O
genomic	O
diversity	O
during	O
the	O
course	O
of	O
infection	O
has	O
the	O
potential	O
to	O
affect	O
all	O
aspects	O
of	O
HIV-1	O
replication	O
,	O
including	O
expression	O
of	O
the	O
proviral	DNA
genome	DNA
.	O
To	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
impact	O
of	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
sequence	O
diversity	O
on	O
LTR	DNA
-directed	DNA
gene	DNA
expression	O
in	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
and	O
immune	O
system	O
,	O
we	O
amplified	O
and	O
cloned	O
LTRs	DNA
from	O
proviral	DNA
DNA	DNA
in	O
HIV-1	cell_type
-infected	cell_type
peripheral	cell_type
blood	cell_type
.	O
Sequence	O
analysis	O
of	O
nineteen	O
LTRs	DNA
cloned	O
from	O
2	O
adult	O
and	O
3	O
pediatric	O
patients	O
revealed	O
an	O
average	O
of	O
33	O
nucleotide	O
changes	O
(with	O
respect	O
to	O
the	O
sequence	O
of	O
the	O
LAI	DNA
LTR	DNA
)	O
within	O
the	O
455-bp	DNA
U3	DNA
region	DNA
.	O
Transient	O
expression	O
analyses	O
in	O
cells	O
of	O
neuroglial	O
and	O
lymphocytic	O
origin	O
demonstrated	O
that	O
some	O
of	O
these	O
LTRs	DNA
had	O
activities	O
which	O
varied	O
significantly	O
from	O
the	O
LAI	DNA
LTR	DNA
in	O
U-373	cell_line
MG	cell_line
cells	cell_line
(an	O
astrocytoma	cell_line
cell	cell_line
line	cell_line
)	O
as	O
well	O
as	O
in	O
Jurkat	cell_line
cells	cell_line
(a	O
CD4-positive	cell_line
lymphocyte	cell_line
cell	cell_line
line	cell_line
).	O
While	O
LTRs	DNA
which	O
demonstrated	O
the	O
highest	O
activities	O
in	O
U-373	cell_line
MG	cell_line
cells	cell_line
also	O
yielded	O
high	O
activities	O
in	O
Jurkat	O
cells,	O
the	O
LTRs	DNA
were	O
generally	O
more	O
active	O
in	O
Jurkat	cell_line
cells	cell_line
when	O
compared	O
to	O
the	O
LAI	DNA
LTR	DNA
.	O
Differences	O
in	O
LTR	DNA
sequence	DNA
also	O
resulted	O
in	O
differences	O
in	O
transcription	O
factor	O
recruitment	O
to	O
cis-acting	DNA
sites	DNA
within	O
the	O
U3	DNA
region	DNA
of	O
the	O
LTR	DNA
,	O
as	O
demonstrated	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
In	O
particular,	O
naturally	O
occurring	O
sequence	O
variation	O
impacted	O
transcription	protein
factor	protein
binding	O
to	O
an	O
activating	DNA
transcription	DNA
factor/	DNA
cAMP	DNA
response	DNA
element	DNA
binding	DNA
(	DNA
ATF/CREB	DNA
)	DNA
binding	DNA
site	DNA
(located	O
between	O
the	O
LEF-1	protein
and	O
distal	O
NF-kappaB	protein
transcription	O
factor	O
binding	O
sites	O
)	O
that	O
we	O
identified	O
in	O
previous	O
studies	O
of	O
the	O
HIV-1	DNA
LTR	DNA
.	O
These	O
findings	O
suggest	O
that	O
LTR	DNA
sequence	DNA
changes	O
can	O
significantly	O
affect	O
basal	O
LTR	DNA
function	O
and	O
transcription	protein
factor	protein
recruitment	O
,	O
which	O
may,	O
in	O
turn,	O
alter	O
the	O
course	O
of	O
viral	O
replication	O
in	O
cells	O
of	O
CNS	O
and	O
immune	O
system	O
origin	O
.	O

HMG	protein
box	protein
containing	O
transcription	protein
factors	protein
in	O
lymphocyte	cell_type
differentiation	O
.	O
The	O
identification	O
of	O
the	O
mammalian	DNA
sex-determining	DNA
gene	DNA
Sry	DNA
has	O
led	O
to	O
the	O
discovery	O
of	O
a	O
large	O
family	O
of	O
related	O
('	O
HMG	protein
box	protein
')	O
transcription	protein
factors	protein
that	O
control	O
developmental	O
events	O
in	O
yeast	O
,	O
C.	O
elegans	O
,	O
Drosophila	O
and	O
vertebrates	O
.	O
In	O
lymphocyte	cell_type
differentiation	O
,	O
several	O
HMG	protein
box	protein
proteins	protein
play	O
a	O
decisive	O
role.	O
Sox-4	protein
is	O
important	O
for	O
very	O
early	O
B-cell	O
differentiation	O
,	O
while	O
TCF-1/LEF-1	protein
play	O
a	O
crucial	O
role	O
in	O
early	O
thymocyte	O
development	O
.	O
TCF/LEF	protein
proteins	protein
have	O
recently	O
been	O
found	O
to	O
constitute	O
a	O
downstream	O
component	O
of	O
the	O
Wingless/Wnt	O
signal	O
transduction	O
pathway	O
.	O
In	O
flies,	O
this	O
pathway	O
controls	O
segment	O
polarity;	O
in	O
Xenopus	O
it	O
controls	O
the	O
definition	O
of	O
the	O
body	O
axis	O
.	O
Deregulation	O
of	O
the	O
pathway	O
occurs	O
in	O
several	O
human	O
tumors	O
.	O
These	O
insights	O
in	O
the	O
molecular	O
events	O
that	O
are	O
involved	O
in	O
TCF/LEF	protein
function	O
in	O
these	O
organisms	O
may	O
eventually	O
lead	O
to	O
the	O
understanding	O
of	O
the	O
function	O
of	O
these	O
HMG	protein
box	protein
proteins	protein
in	O
lymphoid	O
development	O

Detection	O
of	O
adenovirus	DNA
DNA	DNA
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
by	O
polymerase	O
chain	O
reaction	O
assay	O
.	O
Adenovirus	O
can	O
establish	O
persistent	O
infections	O
which	O
may	O
reactivate	O
and	O
cause	O
disease	O
in	O
immunocompromised	O
hosts	O
.	O
Lymphocytes	cell_type
have	O
been	O
postulated	O
to	O
serve	O
as	O
a	O
site	O
of	O
adenoviral	O
persistence	O
based	O
upon	O
the	O
ability	O
to	O
isolate	O
adenovirus	O
from	O
tonsils	O
and	O
to	O
detect	O
adenovirus	DNA
DNA	DNA
by	O
Southern	O
blot	O
hybridization	O
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
To	O
test	O
this	O
hypothesis,	O
a	O
more	O
sensitive	O
and	O
specific	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
assay	O
was	O
developed	O
to	O
detect	O
adenovirus	DNA
DNA	DNA
.	O
Two	O
sets	O
of	O
nested	DNA
primers	DNA
were	O
designed	O
to	O
conserved	O
sequences	O
in	O
the	O
adenovirus	protein
E1A	protein
and	O
hexon	protein
genes	O
.	O
The	O
E1A	protein
and	O
hexon	protein
primers	O
amplified	O
DNA	O
from	O
representative	O
adenoviral	O
serotypes	O
in	O
all	O
six	O
adenoviral	O
groups	O
(A-F).	O
Both	O
primers	O
detected	O
a	O
single	O
copy	O
of	O
the	O
adenovirus	DNA
type	DNA
2	DNA
genome	DNA
but	O
were	O
less	O
sensitive	O
for	O
the	O
group	O
B	O
type	O
35.	O
None	O
of	O
33	O
PBMC	cell_type
specimens	O
from	O
healthy	O
adults	O
and	O
only	O
one	O
of	O
40	O
pediatric	O
samples	O
was	O
positive	O
(at	O
a	O
low	O
level)	O
for	O
adenovirus	DNA
DNA	DNA
by	O
nested	O
PCR	O
assay	O
.	O
In	O
comparison,	O
PBMC	cell_type
from	O
two	O
children	O
with	O
fatal	O
adenoviral	O
infection	O
were	O
both	O
strongly	O
positive	O
for	O
adenovirus	DNA
DNA	DNA
.	O
It	O
is	O
concluded	O
that,	O
in	O
contrast	O
to	O
a	O
previous	O
study,	O
PBMC	cell_type
are	O
not	O
a	O
common	O
site	O
of	O
persistent	O
group	O
C	O
adenoviral	O
infection	O
.	O
In	O
addition,	O
assay	O
of	O
PBMC	cell_type
by	O
the	O
adenovirus	O
-specific	O
PCR	O
may	O
help	O
detect	O
early	O
invasive	O
disease	O
and	O
warrants	O
further	O
evaluation.	O

Disruption	O
of	O
the	O
human	DNA
SCL	DNA
locus	DNA
by	O
"	O
illegitimate"	O
V-(D)-J	O
recombinase	O
activity	O
.	O
A	O
fusion	DNA
complementary	DNA
DNA	DNA
in	O
the	O
T	cell_line
cell	cell_line
line	cell_line
HSB-2	cell_line
elucidates	O
a	O
provocative	O
mechanism	O
for	O
the	O
disruption	O
of	O
the	O
putative	O
hematopoietic	protein
transcription	protein
factor	protein
SCL	protein
.	O
The	O
fusion	DNA
cDNA	DNA
results	O
from	O
an	O
interstitial	O
deletion	O
between	O
a	O
previously	O
unknown	DNA
locus	DNA
,	O
SIL	DNA
(	O
SCL	DNA
interrupting	DNA
locus	DNA
),	O
and	O
the	O
5'	DNA
untranslated	DNA
region	DNA
of	O
SCL	protein
.	O
Similar	O
to	O
1;14	O
translocations	O
,	O
this	O
deletion	O
disrupts	O
the	O
SCL	DNA
5'	DNA
regulatory	DNA
region	DNA
.	O
This	O
event	O
is	O
probably	O
mediated	O
by	O
V-(D)-J	O
recombinase	O
activity	O
,	O
although	O
neither	O
locus	O
is	O
an	O
immunoglobulin	protein
or	O
a	O
T	protein
cell	protein
receptor	protein
.	O
Two	O
other	O
T	cell_line
cell	cell_line
lines	cell_line
,	O
CEM	cell_line
and	O
RPMI	cell_line
8402	cell_line
,	O
have	O
essentially	O
identical	O
deletions.	O
Thus,	O
in	O
lymphocytes	cell_type
,	O
growth-affecting	DNA
genes	DNA
other	O
than	O
immune	protein
receptors	protein
risk	O
rearrangements	O
.	O

Thyroid	protein
hormone	protein
receptors	protein
form	O
distinct	O
nuclear	O
protein-	O
dependent	O
and	O
independent	O
complexes	O
with	O
a	O
thyroid	DNA
hormone	DNA
response	DNA
element	DNA
.	O
We	O
have	O
examined	O
the	O
binding	O
of	O
nuclear	protein
proteins	protein
and	O
recombinant	protein
thyroid	protein
hormone	protein
receptors	protein
(	O
TRs	protein
)	O
to	O
the	O
palindromic	DNA
thyroid	DNA
hormone	DNA
responsive	DNA
element	DNA
AGGTCATGACCT	O
(	O
TREp	DNA
)	O
using	O
a	O
gel	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
Four	O
specific	O
protein-DNA	protein
complexes	protein
were	O
detected	O
after	O
incubation	O
of	O
nuclear	O
extracts	O
(	O
NE	O
)	O
from	O
T3-responsive	cell_line
pituitary	cell_line
(GH3)	cell_line
cells	cell_line
with	O
a	O
TREp	DNA
-containing	DNA
DNA	DNA
fragment	DNA
.	O
This	O
was	O
compared	O
with	O
the	O
TREp	DNA
binding	O
of	O
reticulocyte	protein
lysate-synthesized	protein
TRs	protein
.	O
TR	protein
alpha	protein
1	protein
and	O
TR	protein
beta	protein
2	protein
each	O
formed	O
a	O
single	O
major	O
TR	protein
:	protein
TREp	protein
complex	protein
which	O
comigrated	O
with	O
the	O
least	O
retarded	O
complex	O
formed	O
by	O
GH3	O
NE	O
,	O
while	O
TR	protein
beta	protein
1	protein
formed	O
multiple	O
complexes	O
suggesting	O
that	O
it	O
can	O
bind	O
to	O
TREp	DNA
as	O
an	O
oligomer	protein
.	O
Interestingly,	O
coincubation	O
of	O
35S-	protein
TR	protein
alpha	protein
1	protein
,	O
GH3	O
NE	O
,	O
and	O
unlabeled	O
TREp	DNA
resulted	O
in	O
not	O
only	O
the	O
35S-TR:	protein
TREp	protein
complex	protein
,	O
but	O
in	O
two	O
additional	O
more	O
greatly	O
retarded	O
complexes	O
containing	O
35S-	protein
TR	protein
alpha	protein
1	protein
and	O
comigrating	O
with	O
those	O
formed	O
by	O
GH3	O
extract	O
alone.	O
Incubation	O
of	O
each	O
of	O
the	O
TRs	protein
with	O
NE	O
from	O
COS-7	cell_line
cells	cell_line
,	O
which	O
do	O
not	O
possess	O
sufficient	O
endogenous	O
TRs	protein
to	O
mediate	O
T3-responses	O
,	O
resulted	O
in	O
formation	O
of	O
a	O
new,	O
more	O
greatly	protein
shifted	protein
complex	protein
.	O
A	O
similar,	O
heat	O
labile	O
activity	O
which	O
altered	O
mobility	O
of	O
the	O
TR:TRE	protein
complex	protein
was	O
also	O
present	O
in	O
NE	O
from	O
T3-unresponsive	cell_line
JEG-3	cell_line
cells	cell_line
.	O
At	O
high	O
concentration	O
of	O
NE	O
,	O
all	O
of	O
the	O
TR	protein
bound	O
to	O
TREp	DNA
was	O
more	O
greatly	O
retarded	O
than	O
in	O
the	O
absence	O
of	O
NE	O
.	O
Truncation	O
of	O
TR	protein
alpha	protein
1	protein
at	O
amino	protein
acid	protein
210	protein
prevented	O
additional	O
complex	O
formation	O
in	O
the	O
presence	O
of	O
NE	O
without	O
affecting	O
DNA	O
binding	O
,	O
suggesting	O
that	O
the	O
carboxyl-terminus	protein
of	O
the	O
TRs	protein
is	O
essential	O
for	O
interaction	O
with	O
nuclear	protein
proteins	protein
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Cell-specific	O
differences	O
in	O
activation	O
of	O
NF-kappa	DNA
B	DNA
regulatory	DNA
elements	DNA
of	O
human	O
immunodeficiency	O
virus	O
and	O
beta	O
interferon	O
promoters	O
by	O
tumor	protein
necrosis	protein
factor	protein
.	O
Three	O
aspects	O
of	O
the	O
involvement	O
of	O
tumor	protein
necrosis	protein
factor	protein
in	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
pathogenesis	O
were	O
examined.	O
Tumor	RNA
necrosis	RNA
factor	RNA
alpha	RNA
(	RNA
TNF-alpha	RNA
)	RNA
mRNA	RNA
production	O
was	O
analyzed	O
by	O
polymerase	O
chain	O
reaction	O
amplification	O
in	O
monocytic	cell_line
U937	cell_line
cells	cell_line
and	O
in	O
a	O
chronically	cell_line
HIV	cell_line
infected	cell_line
U937	cell_line
cell	cell_line
line	cell_line
(	O
U9-IIIB	cell_line
).	O
TNF-alpha	RNA
RNA	RNA
was	O
undetectable	O
in	O
U937	cell_line
cells	cell_line
,	O
whereas	O
a	O
low	O
constitutive	O
level	O
was	O
detected	O
in	O
U9-IIIB	cell_line
cells	cell_line
.	O
Paramyxovirus	O
infection	O
induced	O
a	O
5-	O
to	O
10-fold	O
increase	O
in	O
the	O
steady-state	O
level	O
of	O
TNF-alpha	RNA
RNA	RNA
in	O
U9-IIIB	cell_line
cells	cell_line
compared	O
with	O
U937	cell_line
cells	cell_line
,	O
suggesting	O
that	O
HIV-infected	cell_line
monocytic	cell_line
cells	cell_line
produced	O
higher	O
levels	O
of	O
TNF-alpha	protein
than	O
did	O
normal	O
cells	O
after	O
a	O
secondary	O
virus	O
infection	O
.	O
The	O
effects	O
of	O
TNF-alpha	protein
on	O
gene	O
expression	O
were	O
examined	O
by	O
transient	O
expression	O
assays	O
using	O
reporter	DNA
chloramphenicol	DNA
acetyltransferase	DNA
plasmids	DNA
linked	O
to	O
regulatory	DNA
elements	DNA
from	O
the	O
HIV	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
and	O
the	O
beta	DNA
interferon	DNA
promoter	DNA
.	O
In	O
U937	O
and	O
Jurkat	O
T	O
lymphoid	O
cells	O
,	O
the	O
inducibility	O
of	O
the	O
different	O
hybrid	DNA
promoters	DNA
by	O
TNF-alpha	protein
or	O
phorbol	O
ester	O
varied	O
in	O
a	O
cell	O
type-	O
and	O
promoter	O
context-specific	O
manner;	O
the	O
levels	O
of	O
gene	O
activity	O
of	O
NF-kappa	DNA
B	DNA
-containing	DNA
plasmids	DNA
correlated	O
directly	O
with	O
induction	O
of	O
NF-kappa	protein
B	protein
DNA-binding	O
activity	O
.	O
Although	O
the	O
intact	O
beta	DNA
interferon	DNA
promoter	DNA
was	O
only	O
weakly	O
stimulated	O
by	O
phorbol	O
ester	O
or	O
TNF-alpha	protein
,	O
multimers	O
of	O
the	O
PRDII	DNA
NF-kappa	DNA
B	DNA
-binding	DNA
domain	DNA
were	O
inducible	O
by	O
both	O
agents.	O
TNF-alpha	protein
was	O
able	O
to	O
increase	O
expression	O
of	O
the	O
HIV	DNA
LTR	DNA
in	O
T	cell_type
cells	cell_type
,	O
but	O
in	O
monocytic	cell_type
cells	cell_type
,	O
TNF-alpha	protein
did	O
not	O
induce	O
the	O
HIV	DNA
LTR	DNA
above	O
a	O
constitutive	O
level	O
of	O
activity	O
.	O
This	O
level	O
of	O
NF-kappa	protein
B	protein
-independent	O
activity	O
appears	O
to	O
be	O
sufficient	O
for	O
virus	O
multiplication	O
,	O
since	O
TNF-alpha	protein
treatment	O
had	O
no	O
effect	O
on	O
the	O
kinetics	O
of	O
de	O
novo	O
HIV	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
and	O
viral	RNA
RNA	RNA
production	O
in	O
U937	cell_line
cells	cell_line
.	O
However,	O
in	O
Jurkat	cell_line
cells	cell_line
,	O
TNF-alpha	protein
dramatically	O
enhanced	O
the	O
spread	O
of	O
HIV-1	O
through	O
the	O
cell	O
population	O
and	O
increased	O
viral	RNA
RNA	RNA
synthesis	O
,	O
indicating	O
that	O
in	O
T	cell_type
cells	cell_type
HIV-1	O
multiplication	O
was	O
stimulated	O
by	O
TNF-alpha	protein
treatment	O
.	O

Functional	O
analysis	O
of	O
cis-linked	DNA
regulatory	DNA
sequences	DNA
in	O
the	O
HLA	DNA
DRA	DNA
promoter	DNA
by	O
transcription	O
in	O
vitro.	O
Two	O
consensus	O
sequences,	O
called	O
X	O
and	O
Y	O
boxes	O
,	O
capable	O
of	O
binding	O
nuclear	protein
proteins	protein
and	O
regulating	O
expression	O
in	O
B	cell_type
cells	cell_type
have	O
been	O
defined	O
within	O
the	O
immediate	O
upstream	O
region	O
of	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
promoters	DNA
.	O
Unlike	O
other	O
class	DNA
II	DNA
promoters	DNA
,	O
the	O
HLA-DR	DNA
alpha	DNA
(DRA)	DNA
promoter	DNA
also	O
contains	O
one	O
element	O
identical	O
to	O
the	O
"octamer"	DNA
motif	DNA
of	O
immunoglobulin	DNA
variable	DNA
region	DNA
promoters	DNA
that	O
is	O
responsible	O
for	O
B	O
cell-specific	O
transcription	O
.	O
This	O
"	O
octamer	DNA
"	O
in	O
the	O
context	O
of	O
DRA	protein
appears	O
capable	O
of	O
binding	O
both	O
the	O
ubiquitous	protein
(	O
OTF-1	protein
)	O
and	O
lymphoid-specific	protein
(	protein
OTF-2	protein
)	protein
"octamer"	protein
binding	protein
proteins	protein
,	O
but	O
at	O
least	O
one	O
other	O
distinct	O
"octamer"	protein
complex	protein
was	O
found.	O
In	O
order	O
to	O
characterize	O
the	O
function	O
of	O
cis-acting	DNA
elements	DNA
,	O
we	O
have	O
developed	O
an	O
in	O
vitro	O
system	O
in	O
which	O
a	O
DRA	DNA
promoter	DNA
construct	DNA
is	O
transcribed	O
more	O
efficiently	O
in	O
extracts	O
from	O
B	cell_type
cells	cell_type
than	O
in	O
extracts	O
from	O
class	cell_line
II-negative	cell_line
HeLa	cell_line
cells	cell_line
.	O
5'	O
deletion	O
constructs	O
which	O
lacked	O
the	O
Y	DNA
box	DNA
,	O
but	O
retained	O
the	O
"octamer"	DNA
motif	DNA
and	O
TATA	DNA
box	DNA
were	O
completely	O
inactive,	O
and	O
internal	O
deletion	O
of	O
the	O
Y	DNA
box	DNA
reduced	O
transcription	O
by	O
95%.	O
Using	O
supercoiled,	O
but	O
not	O
linear	O
templates,	O
we	O
observed	O
differences	O
in	O
transcription	O
efficiencies	O
from	O
templates	O
lacking	O
or	O
disrupting	O
the	O
X	DNA
consensus	DNA
element	DNA
that	O
reflect	O
effects	O
of	O
random	O
replacement	O
of	O
X	DNA
box	DNA
sequences	DNA
in	O
transient	O
expression	O
assays	O
.	O
Demonstration	O
of	O
the	O
complete	O
dependence	O
on	O
the	O
Y	DNA
box	DNA
in	O
this	O
system	O
suggests	O
that,	O
despite	O
its	O
demonstrated	O
importance	O
in	O
the	O
DRA	DNA
promoter	DNA
,	O
the	O
DRA	DNA
"octamer"	DNA
does	O
not	O
utilize	O
OTF-2	protein
in	O
a	O
manner	O
analogous	O
to	O
immunoglobulin	DNA
promoters	DNA
in	O
B	cell_type
cells	cell_type
.	O

Lipopolysaccharide	O
is	O
a	O
potent	O
monocyte/macrophage-specific	O
stimulator	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
.	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
potently	O
stimulates	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1-long	DNA
terminal	DNA
repeat	DNA
(	DNA
HIV-1-LTR	DNA
)	DNA
CAT	DNA
constructs	DNA
transfected	O
into	O
monocyte/macrophage-like	cell_line
cell	cell_line
lines	cell_line
but	O
not	O
a	O
T	cell_line
cell	cell_line
line	cell_line
.	O
This	O
effect	O
appears	O
to	O
be	O
mediated	O
through	O
the	O
induction	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
).	O
Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrate	O
that	O
LPS	O
induces	O
a	O
DNA	O
binding	O
activity	O
indistinguishable	O
from	O
NF-kappa	protein
B	protein
in	O
U937	cell_line
and	O
THP-1	cell_line
cells	cell_line
.	O
LPS	O
is	O
also	O
shown	O
to	O
dramatically	O
increase	O
HIV-1	O
production	O
from	O
a	O
chronically	cell_line
infected	cell_line
monocyte/macrophage-like	cell_line
cloned	cell_line
cell	cell_line
line	cell_line
,	O
U1	cell_line
,	O
which	O
produces	O
very	O
low	O
levels	O
of	O
HIV-1	O
at	O
baseline.	O
The	O
stimulation	O
of	O
viral	O
production	O
from	O
this	O
cell	O
line	O
occurs	O
only	O
if	O
these	O
cells	O
are	O
treated	O
with	O
granulocyte/macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
before	O
treatment	O
with	O
LPS	O
.	O
This	O
stimulation	O
of	O
HIV-1	O
production	O
is	O
correlated	O
with	O
an	O
increase	O
in	O
the	O
level	O
of	O
HIV-1	RNA
RNA	RNA
and	O
and	O
activation	O
of	O
NF-kappa	protein
B	protein
.	O
LPS	O
is	O
not	O
able	O
to	O
induce	O
HIV-1	O
production	O
in	O
a	O
cloned	O
T	cell_line
cell	cell_line
line	cell_line
.	O
The	O
effect	O
of	O
LPS	O
on	O
HIV-1	O
replication	O
occurs	O
at	O
picogram	O
per	O
milliliter	O
concentrations	O
and	O
may	O
be	O
clinically	O
significant	O
in	O
understanding	O
the	O
variability	O
of	O
the	O
natural	O
history	O
of	O
HIV-1	O
infection	O
.	O

Steroid	O
dose	O
sparing	O
:	O
pharmacodynamic	O
responses	O
to	O
single	O
versus	O
divided	O
doses	O
of	O
methylprednisolone	O
in	O
man.	O
Inhibitory	O
drug	O
interactions	O
affecting	O
the	O
metabolism	O
of	O
methylprednisolone	O
(	O
MP	O
)	O
may	O
produce	O
either	O
steroid	O
sparing	O
or	O
adverse	O
effects	O
partly	O
by	O
increasing	O
the	O
exposure	O
time	O
to	O
the	O
steroid	O
.	O
This	O
phenomenon	O
can	O
be	O
mimicked	O
by	O
administering	O
MP	O
in	O
divided	O
doses.	O
Two	O
types	O
of	O
responses	O
were	O
compared	O
after	O
a	O
single	O
MP	O
dose	O
(40	O
mg	O
bolus)	O
and	O
a	O
divided	O
regimen	O
(20	O
mg	O
bolus	O
and	O
a	O
5	O
mg	O
bolus	O
8	O
hours	O
later)	O
in	O
six	O
healthy	O
male	O
volunteers	O
.	O
The	O
suppression	O
of	O
basophils	cell_type
measured	O
as	O
whole	O
blood	O
histamine	O
and	O
plasma	O
cortisol	O
concentrations	O
was	O
assessed	O
during	O
32	O
hours.	O
The	O
37.5%	O
reduction	O
in	O
dose	O
produced	O
a	O
23%	O
overall	O
decreased	O
blood	O
histamine	O
response	O
.	O
A	O
pharmacodynamic	O
model	O
for	O
basophil	O
cell	O
distribution	O
to	O
and	O
from	O
an	O
extravascular	O
compartment	O
describes	O
the	O
effects	O
of	O
MP	O
after	O
both	O
regimens.	O
A	O
slower	O
initial	O
decline	O
in	O
blood	O
histamine	O
after	O
the	O
divided	O
regimen	O
may	O
be	O
related	O
to	O
incomplete	O
suppression	O
of	O
basophil	cell_type
cell	cell_type
return	O
to	O
blood	O
.	O
The	O
50%	O
inhibitory	O
concentrations	O
of	O
MP	O
of	O
about	O
5	O
ng/ml	O
were	O
similar	O
for	O
both	O
regimens.	O
The	O
decline	O
and	O
return	O
of	O
cortisol	O
concentrations	O
were	O
similar	O
between	O
MP	O
treatments	O
with	O
suppression	O
continuing	O
for	O
24	O
hours.	O
The	O
50%	O
inhibitory	O
concentrations	O
of	O
MP	O
values	O
for	O
adrenal	O
suppression	O
were	O
about	O
1	O
ng/ml.	O
Pharmacodynamic	O
modeling	O
is	O
useful	O
in	O
quantitating	O
corticosteroid	O
responses	O
and	O
generally	O
predicted	O
the	O
"dose-sparing"	O
effects	O
that	O
were	O
achieved	O
by	O
prolonging	O
MP	O
plasma	O
concentrations	O
.	O
This	O
study	O
supports	O
previous	O
clinical	O
observations	O
that	O
patients	O
may	O
require	O
morning	O
through	O
evening	O
exposure	O
to	O
MP	O
to	O
optimize	O
efficacy	O
while	O
adrenal	O
suppression	O
is	O
being	O
minimized.	O

1,25(OH)2D2	O
production	O
by	O
T	cell_type
lymphocytes	cell_type
and	O
alveolar	cell_type
macrophages	cell_type
recovered	O
by	O
lavage	O
from	O
normocalcemic	O
patients	O
with	O
tuberculosis.	O
To	O
compare	O
extra-renal	O
1,25(OH)2D3	O
production	O
in	O
different	O
types	O
of	O
granulomatous	O
disease	O
,	O
and	O
to	O
identify	O
the	O
cell	O
types	O
responsible,	O
we	O
have	O
evaluated	O
the	O
conversion	O
of	O
25(OH)D3	O
in	O
1,25(OH)2D3	O
by	O
uncultured	cell_type
cells	cell_type
recovered	O
by	O
bronchoalveolar	O
lavage	O
and	O
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
normocalcemic	O
patients	O
with	O
sarcoidosis	O
and	O
tuberculosis.	O
1,25(OH)2D3	O
was	O
produced	O
both	O
by	O
lavage	cell_type
cells	cell_type
(12/12	O
tuberculosis	O
patients	O
,	O
2/6	O
sarcoidosis	O
patients	O
)	O
and	O
blood	cell_type
mononuclear	cell_type
cells	cell_type
(3/5	O
tuberculosis	O
patients	O
,	O
0/3	O
sarcoidosis	O
patients	O
)	O
from	O
patients	O
but	O
not	O
controls,	O
but	O
significantly	O
greater	O
amounts	O
were	O
produced	O
by	O
lavage	O
cells	O
from	O
tuberculosis	O
patients	O
than	O
those	O
of	O
sarcoidosis	O
patients	O
(P	O
less	O
than	O
0.001).	O
1,25(OH)2D3	O
production	O
by	O
lavage	cell_type
cells	cell_type
from	O
tuberculosis	O
patients	O
correlated	O
with	O
the	O
number	O
of	O
CD8+	O
T	cell_type
lymphocytes	cell_type
present	O
but	O
not	O
other	O
cell	O
types.	O
T	cell_type
lymphocytes	cell_type
appeared	O
to	O
be	O
an	O
important	O
source	O
of	O
1,25(OH)2D3	O
production	O
,	O
since	O
purified	O
T	cell_type
lymphocytes	cell_type
from	O
all	O
patients	O
with	O
tuberculosis	O
produced	O
1,25(OH)2D3	O
,	O
and	O
1,25(OH)2D3	O
production	O
by	O
these	O
cells	O
correlated	O
closely	O
with	O
that	O
produced	O
by	O
unseparated	O
lavage	cell_type
cells	cell_type
.	O
Because	O
1,25(OH)2D3	O
can	O
improve	O
the	O
capacity	O
of	O
macrophages	cell_type
to	O
kill	O
mycobacteria	O
,	O
our	O
results	O
support	O
the	O
conclusion	O
that	O
macrophage-lymphocyte	O
interactions	O
,	O
mediated	O
at	O
least	O
in	O
part	O
by	O
1,25(OH)2D3	O
,	O
may	O
be	O
an	O
important	O
component	O
of	O
a	O
successful	O
antituberculous	O
immune	O
response	O
.	O

Megakaryocytic	O
and	O
erythrocytic	O
lineages	O
share	O
specific	O
transcription	protein
factors	protein
.	O
Erythroid-specific	DNA
genes	DNA
contain	O
binding	O
sites	O
for	O
NF-E1	protein
(also	O
called	O
GF-1	protein
and	O
Eryf-1	protein
;	O
refs	O
1-3	O
respectively),	O
the	O
principal	O
DNA-binding	protein
protein	protein
of	O
the	O
erythrocytic	cell_type
lineage	cell_type
.	O
NF-E1	protein
expression	O
seems	O
to	O
be	O
restricted	O
to	O
the	O
erythrocytic	cell_type
lineage	cell_type
.	O
A	O
closely	O
related	O
(if	O
not	O
identical)	O
protein	O
is	O
found	O
in	O
both	O
a	O
human	cell_line
megakaryocytic	cell_line
cell	cell_line
line	cell_line
and	O
purified	cell_line
human	cell_line
megakaryocytes	cell_line
;	O
it	O
binds	O
to	O
promoter	DNA
regions	DNA
of	O
two	O
megakaryocytic-specific	DNA
genes	DNA
.	O
The	O
binding	O
sites	O
and	O
partial	O
proteolysis	O
profile	O
of	O
this	O
protein	O
are	O
indistinguishable	O
from	O
those	O
of	O
the	O
erythroid	protein
protein	protein
;	O
also,	O
NF-E1	RNA
messenger	RNA
RNA	RNA
is	O
the	O
same	O
size	O
in	O
both	O
the	O
megakaryocytic	O
and	O
erythroid	O
cell	O
lines	O
.	O
Furthermore,	O
point	O
mutations	O
that	O
abolish	O
binding	O
of	O
NF-E1	protein
result	O
in	O
a	O
70%	O
decrease	O
in	O
the	O
transcriptional	O
activity	O
of	O
a	O
megakaryocytic-specific	DNA
promoter	DNA
.	O
We	O
also	O
find	O
that	O
NF-E2	protein
,	O
another	O
trans-acting	protein
factor	protein
of	O
the	O
erythrocytic	cell_type
lineage	cell_type
,	O
is	O
present	O
in	O
megakaryocytes	cell_line
.	O
Transcriptional	O
effects	O
in	O
both	O
lineages	O
might	O
then	O
be	O
mediated	O
in	O
part	O
by	O
the	O
same	O
specific	O
trans-acting	protein
factors	protein
.	O
Our	O
data	O
strengthen	O
the	O
idea	O
of	O
a	O
close	O
association	O
between	O
the	O
erythrocytic	O
and	O
the	O
megakaryocytic	O
lineages	O
and	O
could	O
also	O
explain	O
the	O
expression	O
of	O
markers	O
specific	O
to	O
the	O
erythrocytic	O
and	O
megakaryocytic	O
lineages	O
in	O
most	O
erythroblastic	O
and	O
megakaryoblastic	O
permanent	O
cell	O
lines	O
.	O

Transcriptional	O
down-regulation	O
of	O
c-myc	DNA
expression	O
by	O
protein	O
synthesis	O
-dependent	O
and	O
-independent	O
pathways	O
in	O
a	O
human	cell_line
T	cell_line
lymphoblastic	cell_line
tumor	cell_line
cell	cell_line
line	cell_line
.	O
We	O
show	O
that	O
in	O
the	O
human	cell_line
T	cell_line
lymphoblastic	cell_line
tumor	cell_line
cell	cell_line
line	cell_line
Molt4	RNA
c-myc	RNA
mRNA	RNA
and	O
protein	O
expression	O
is	O
down-regulated	O
after	O
exposure	O
to	O
dimethyl	O
sulfoxide	O
,	O
to	O
phorbol	O
myristate	O
acetate	O
,	O
or	O
to	O
the	O
calcium	O
ionophore	O
A23187	O
,	O
which	O
raises	O
the	O
intracellular	O
calcium	O
concentration	O
.	O
A	O
block	O
to	O
RNA	O
elongation	O
is	O
largely	O
responsible	O
for	O
decreased	O
c-myc	DNA
transcription	O
.	O
Although	O
negative	O
regulation	O
by	O
dimethyl	O
sulfoxide	O
takes	O
place	O
even	O
when	O
protein	O
synthesis	O
is	O
inhibited	O
by	O
cycloheximide	O
,	O
the	O
phorbol	O
myristate	O
acetate	O
effect	O
is	O
blocked	O
to	O
some	O
extent	O
only	O
by	O
cycloheximide	O
.	O
The	O
calcium	O
ionophore-induced	O
c-myc	DNA
suppression	O
,	O
however,	O
strictly	O
requires	O
de	O
novo	O
protein	O
synthesis	O
.	O
Therefore,	O
two	O
different	O
negative	O
regulatory	O
pathways	O
are	O
involved	O
in	O
c-myc	DNA
regulation	O
:	O
one	O
which	O
is	O
independent	O
and	O
one	O
which	O
depends	O
on	O
de	O
novo	O
protein	O
synthesis	O
.	O
The	O
latter	O
one	O
appears	O
to	O
be	O
mediated	O
by	O
a	O
rapidly	O
calcium	protein
-dependent	protein
induced	protein
gene	protein
product	protein
.	O

Oestrogen	protein
receptor	protein
(	O
ER	protein
)	O
analysis	O
in	O
B-cell	O
chronic	O
lymphocytic	O
leukemia	O
:	O
correlation	O
of	O
biochemical	O
and	O
immunocytochemical	O
methods	O
.	O
Oestrogen	protein
receptors	protein
(	O
ER	protein
)	O
are	O
present	O
in	O
neoplastic	cell_type
lymphoid	cell_type
cells	cell_type
and	O
have	O
been	O
considered	O
a	O
physiological	O
marker	O
of	O
growth	O
rate	O
or	O
differentiation.	O
Tamoxifen	O
,	O
an	O
oestrogen	O
antagonist	O
,	O
has	O
been	O
given	O
in	O
some	O
patients	O
with	O
CLL	O
and	O
Hodgkin's	O
disease	O
,	O
with	O
dramatic	O
response	O
in	O
single	O
cases.	O
Until	O
now,	O
ER	protein
status	O
has	O
been	O
assessed	O
using	O
a	O
steroid	O
binding	O
assay	O
(	O
SBA	O
)	O
which	O
has	O
many	O
inherent	O
problems.	O
Recently,	O
the	O
development	O
of	O
monoclonal	O
antibodies	O
directed	O
against	O
ER	protein
has	O
been	O
applied	O
to	O
the	O
study	O
of	O
breast	O
carcinomas	O
and	O
results	O
obtained	O
show	O
good	O
correlation	O
with	O
the	O
quantitative	O
SBA	O
.	O
We	O
studied	O
49	O
cases	O
of	O
B-cell	O
chronic	O
lymphocytic	O
leukemia	O
(	O
CLL	O
)	O
using	O
immunostaining	O
of	O
cytospin	O
preparations	O
.	O
In	O
30	O
of	O
these	O
cases	O
ER	protein
enzyme	O
immunoassay	O
(	O
ER	protein
-EIA	O
)	O
was	O
also	O
performed.	O
Cultured	cell_line
MCF-7	cell_line
cells	cell_line
,	O
derived	O
from	O
a	O
pleural	O
effusion	O
of	O
a	O
breast	O
cancer	O
patient	O
,	O
known	O
to	O
contain	O
high	O
levels	O
of	O
ER	protein
were	O
used	O
as	O
a	O
positive	O
control	O
(40-48%	O
ER	cell_type
positive	cell_type
cells	cell_type
by	O
immunocytochemistry;	O
200	O
fmol/mg	O
protein	O
by	O
EIA).	O
All	O
of	O
the	O
CLL	O
cases	O
except	O
two	O
(96%)	O
were	O
negative	O
for	O
ER	protein
(less	O
than	O
1%	O
staining;	O
less	O
than	O
4	O
fmol/mg	O
protein).	O
The	O
two	O
positive	O
cases	O
expressed	O
granular	O
ER	protein
staining	O
over	O
the	O
nucleus	O
(9.2	O
and	O
12.1%	O
positive	O
cells)	O
and	O
were	O
positive	O
by	O
EIA	O
and	O
SBA	O
.	O
It	O
is	O
concluded	O
that	O
(i)	O
patients	O
with	O
CLL	O
rarely	O
express	O
ER	protein
and	O
(ii)	O
immunocytochemical	O
staining	O
of	O
cytospin	O
preparations	O
is	O
a	O
valid	O
technique	O
for	O
the	O
measurement	O
of	O
ER	protein
.	O
It	O
is	O
of	O
interest	O
that	O
one	O
of	O
the	O
positive	O
cases	O
was	O
diagnosed	O
as	O
CLL	O
with	O
Richter's	O
transformation	O
confirming	O
earlier	O
findings.	O

Type-II	protein
estrogen	protein
binding	protein
sites	protein
in	O
a	O
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
and	O
growth-inhibitory	O
effect	O
of	O
estrogen	O
,	O
anti-estrogen	O
and	O
bioflavonoids	O
.	O
Type-II	protein
estrogen	protein
-binding	protein
sites	protein
(	O
type-II	protein
EBS	protein
)	O
have	O
been	O
demonstrated	O
in	O
the	O
human	cell_line
lymphoblastoid	cell_line
cell	cell_line
line	cell_line
IM-9	cell_line
using	O
a	O
whole-cell	O
assay	O
with	O
(6,7-3H)	O
estradiol	O
(	O
3H-E2	O
)	O
as	O
tracer.	O
Competition	O
analysis	O
showed	O
that	O
the	O
anti-estrogen	O
tamoxifen	O
and	O
the	O
flavonoids	O
quercetin	O
and	O
rutin	O
competed	O
for	O
(3H)-E2	O
binding	O
to	O
type-II	protein
EBS	protein
.	O
Growth	O
experiments	O
demonstrated	O
that	O
diethylstilbestrol	O
(	O
DES	O
)	O
tamoxifen	O
(	O
TAM	O
),	O
quercetin	O
and	O
rutin	O
exerted	O
a	O
reversible	O
dose-dependent	O
inhibition	O
of	O
cell	O
proliferation	O
in	O
the	O
range	O
of	O
concentrations	O
between	O
10	O
nM	O
and	O
10	O
microM.	O
The	O
relative	O
binding	O
affinity	O
of	O
quercetin	O
,	O
rutin	O
,	O
DES	O
and	O
TAM	O
for	O
type-II	protein
EBS	protein
correlated	O
well	O
with	O
their	O
potency	O
as	O
cell	O
growth	O
inhibitors	O
.	O
Moreover,	O
hesperidin,	O
a	O
flavonoid	O
which	O
does	O
not	O
bind	O
to	O
type-II	protein
EBS	protein
,	O
was	O
ineffective	O
in	O
inhibiting	O
cell	O
growth	O
.	O
Cell-cycle	O
analysis	O
showed	O
that	O
the	O
growth-inhibitory	O
effect	O
of	O
DES	O
,	O
TAM	O
or	O
quercetin	O
was	O
due	O
to	O
a	O
blocking	O
effect	O
in	O
the	O
G0-G1	O
phases.	O
Our	O
results	O
suggest	O
that	O
high	O
estrogen	O
and	O
anti-estrogen	O
concentrations	O
and	O
flavonoids	O
may	O
regulate	O
IM-9	cell_line
cell	O
growth	O
through	O
a	O
common	O
mechanism	O
involving	O
a	O
binding	O
interaction	O
with	O
type-II	protein
EBS	protein
.	O

[	O
Glucocorticoid	protein
receptors	protein
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
patients	O
with	O
bronchial	O
asthma	O
]	O
Quantitation	O
of	O
glucocorticoid	protein
receptors	protein
(	O
GCR	protein
)	O
and	O
the	O
study	O
of	O
their	O
affinity	O
for	O
glucocorticosteroids	O
(	O
GCS	O
)	O
were	O
made	O
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
of	O
bronchial	O
asthma	O
(	O
BA	O
)	O
patients	O
in	O
consideration	O
of	O
GCR	protein
treatment	O
and	O
serum	O
levels	O
of	O
endogenous	O
cortisol	O
.	O
It	O
is	O
stated	O
that	O
GCR	protein
of	O
healthy	O
controls	O
and	O
GCS	O
-untreated	O
patients	O
outnumbered	O
those	O
of	O
cortisol-dependent	O
BA	O
patients	O
on	O
hormone	O
therapy	O
.	O
Following	O
discontinuation	O
of	O
glucocorticoid	O
drugs	O
GCR	protein
count	O
in	O
cortisol	O
-dependent	O
BA	O
tends	O
to	O
rise.	O
Endogenous	O
cortisol	O
has	O
no	O
effect	O
on	O
GCR	protein
level	O
estimated	O
by	O
3H-triamcinolone	O
acetonide	O
.	O

Two	O
glucocorticoid	protein
binding	protein
sites	protein
on	O
the	O
human	protein
glucocorticoid	protein
receptor	protein
.	O
Glucocorticoids	O
are	O
known	O
to	O
have	O
a	O
lytic	O
effect	O
in	O
leukemic	cell_type
cells	cell_type
via	O
interactions	O
with	O
the	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
).	O
Cortisol	O
and	O
various	O
synthetic	O
glucocorticoids	O
bind	O
to	O
the	O
GR	protein
with	O
one-site	O
kinetics	O
.	O
Cortivazol	O
(	O
CVZ	O
)	O
is	O
a	O
unique,	O
high	O
potency	O
synthetic	O
glucocorticoid	O
,	O
which	O
has	O
a	O
phenylpyrazol	O
fused	O
to	O
the	O
A-ring	O
of	O
the	O
steroid	O
nucleus	O
and	O
displays	O
binding	O
consistent	O
with	O
two	O
or	O
more	O
sites	O
in	O
the	O
cytosol	O
from	O
CEM	cell_line
C7	cell_line
cells	cell_line
(a	O
human	cell_line
acute	cell_line
lymphoblastic	cell_line
T-cell	cell_line
line	cell_line
).	O
It	O
has	O
previously	O
been	O
shown	O
that	O
the	O
lower	O
affinity	O
class	O
of	O
sites	O
are	O
similar	O
in	O
affinity	O
and	O
site	O
molarity	O
to	O
those	O
recognized	O
by	O
dexamethasone	O
.	O
The	O
higher	O
affinity	O
sites	O
bind	O
CVZ	O
with	O
20-	O
to	O
50-fold	O
greater	O
affinity	O
,	O
consistent	O
with	O
CVZ	O
's	O
enhanced	O
biological	O
effects	O
.	O
In	O
mutant	O
leukemic	cell_type
cells	cell_type
resistant	O
to	O
the	O
lytic	O
effects	O
of	O
dexamethasone	O
,	O
CVZ	O
both	O
lyses	O
the	O
cells	O
and	O
recognizes	O
a	O
single	O
class	O
of	O
sites	O
similar	O
to	O
the	O
high	O
affinity	O
site	O
in	O
CEM	cell_line
C7	cell_line
cells	cell_line
.	O
We	O
have	O
carried	O
out	O
experiments	O
to	O
define	O
the	O
nature	O
of	O
the	O
higher	protein
affinity	protein
CVZ	protein
binding	protein
site	protein
.	O
We	O
now	O
show	O
that:	O
1)	O
CVZ	O
has	O
more	O
than	O
one	O
binding	O
site	O
in	O
a	O
second,	O
independent,	O
B-cell	cell_line
line	cell_line
,	O
IM-9	cell_line
;	O
2)	O
the	O
antiglucocorticoid	O
RU	O
38486	O
is	O
able	O
to	O
block	O
both	O
CVZ	O
's	O
higher	O
and	O
lower	O
affinity	O
sites;	O
3)	O
all	O
of	O
CVZ	protein
's	protein
binding	protein
sites	protein
are	O
on	O
a	O
protein	O
immunologically	O
indistinguishable	O
from	O
the	O
human	O
GR	protein
;	O
and	O
4)	O
freshly	O
isolated	O
clones	O
of	O
CVZ	O
-resistant	O
cells	O
have	O
lost	O
all	O
binding	O
sites	O
for	O
CVZ	O
.	O
These	O
data	O
indicate	O
that	O
CVZ	O
is	O
recognizing	O
two	O
glucocorticoid	protein
binding	protein
sites	protein
on	O
the	O
human	O
GR	protein
or	O
a	O
protein	O
very	O
similar	O
to	O
it.	O

Retroviral	O
mediated	O
transfer	O
and	O
expression	O
of	O
exogenous	DNA
genes	DNA
in	O
primary	cell_type
lymphoid	cell_type
cells	cell_type
:	O
assaying	O
for	O
a	O
viral	O
transactivator	protein
activity	O
in	O
normal	O
and	O
malignant	O
cells	O
.	O
In	O
this	O
report	O
we	O
describe	O
the	O
use	O
of	O
recombinant	O
retroviruses	O
to	O
characterize	O
the	O
activity	O
of	O
an	O
exogenous	DNA
promoter	DNA
in	O
primary	O
cells	O
obtained	O
from	O
patients	O
with	O
lymphoproliferative	O
disorders	O
.	O
The	O
infection	O
of	O
a	O
variety	O
of	O
cultured	O
and	O
primary	cell_type
lymphoid	cell_type
cells	cell_type
with	O
a	O
recombinant	O
retrovirus	O
containing	O
a	O
histone	DNA
promoter-driven	DNA
beta-galactosidase	DNA
gene	DNA
is	O
shown	O
to	O
result	O
in	O
the	O
expression	O
of	O
beta-galactosidase	protein
in	O
50%	O
to	O
100%	O
of	O
the	O
cells.	O
A	O
similar	O
infection	O
with	O
a	O
recombinant	O
retrovirus	O
containing	O
the	O
beta-galactosidase	DNA
gene	DNA
with	O
an	O
adenovirus	DNA
E2	DNA
promoter	DNA
,	O
results	O
in	O
beta-galactosidase	protein
activity	O
in	O
a	O
limited	O
number	O
of	O
cultured	cell_line
and	O
primary	cell_type
cells	cell_type
.	O
Since	O
the	O
adenovirus	DNA
E2	DNA
promoter	DNA
has	O
been	O
well	O
characterized	O
and	O
is	O
known	O
to	O
be	O
regulated	O
by	O
transactivators	protein
encoded	O
by	O
many	O
viruses	O
,	O
the	O
activity	O
of	O
this	O
promoter	O
in	O
specific	O
cell	O
types	O
is	O
discussed	O
in	O
reference	O
to	O
both	O
the	O
biology	O
of	O
the	O
cell	O
and	O
the	O
possible	O
presence	O
of	O
as	O
yet	O
undetected	O
viral	protein
gene	protein
products	protein
.	O

[The	O
effect	O
of	O
24,25-dihydroxyvitamin	O
D3	O
(	O
dioxyvit	O
)	O
on	O
Ca	O
metabolism	O
and	O
immune	O
status	O
during	O
chronic	O
kidney	O
failure	O
]	O
Active	O
metabolite	O
of	O
vitamin	O
D3	O
,	O
24R,25	O
(OH)2D3	O
(	O
dioxyvit	O
)	O
was	O
used	O
at	O
a	O
daily	O
dose	O
of	O
100	O
micrograms	O
in	O
treatment	O
of	O
children	O
affected	O
with	O
tubulointerstitial	O
disease	O
of	O
kidney	O
and	O
with	O
chronic	O
glomerulonephritis	O
under	O
conditions	O
of	O
kidney	O
insufficiency	O
.	O
The	O
drug	O
exhibited	O
distinct	O
normalizing	O
effect	O
on	O
patterns	O
of	O
calcium	O
metabolism	O
:	O
increase	O
of	O
total	O
and	O
ionized	O
Ca2+	O
and	O
of	O
25-OHD	O
,	O
decrease	O
in	O
concentration	O
of	O
parath	O
hormone	O
and	O
osteocalcine	O
in	O
blood	O
serum	O
as	O
well	O
as	O
on	O
immunological	O
parameters	O
:	O
restoration	O
of	O
decreased	O
content	O
of	O
T-	O
and	O
0-	O
lymphocytes	O
.	O
Concentration	O
of	O
receptors	O
of	O
hormonal	O
form	O
of	O
1,25(OH)2D3	O
was	O
found	O
to	O
be	O
minimal	O
in	O
lymphocytes	cell_type
under	O
conditions	O
of	O
chronic	O
kidney	O
insufficiency	O
,	O
while	O
their	O
expression,	O
after	O
the	O
dioxyvit	O
action,	O
was	O
detected	O
only	O
in	O
patients	O
with	O
glomerulonephritis	O
.	O
Specific	O
calcitropic	O
effect	O
of	O
dioxyvit	O
with	O
simultaneous	O
correction	O
of	O
vitamin	O
D	O
deficiency	O
were	O
apparently	O
responsible	O
for	O
high	O
efficacy	O
of	O
the	O
drug	O
in	O
treatment	O
of	O
calcium	O
metabolism	O
and	O
immunity	O
impairments	O
in	O
children	O
with	O
renal	O
deteriorations	O
at	O
the	O
step	O
of	O
chronic	O
kidney	O
insufficiency	O
.	O

[The	O
role	O
of	O
glucocorticoid	protein
receptors	protein
and	O
HLA	protein
antigens	protein
in	O
the	O
pathogenesis	O
of	O
Cushing's	protein
syndrome	protein
]	O
Lymphocytic	O
levels	O
of	O
glucocorticoid	protein
receptors	protein
were	O
evaluated	O
in	O
114	O
patients	O
suffering	O
from	O
Icenko-	O
Cushing's	protein
syndrome	protein
.	O
Incidence	O
of	O
HLA	protein
antigens	protein
was	O
determined	O
in	O
94	O
of	O
them.	O
A	O
significant	O
rise	O
of	O
A10	protein
and	O
B27	protein
antigen	protein
incidence	O
compared	O
to	O
that	O
in	O
normal	O
subjects	O
allows	O
these	O
antigens	O
to	O
be	O
considered	O
genetic	O
markers	O
of	O
Icenko-	O
Cushing's	protein
syndrome	protein
.	O
The	O
levels	O
of	O
glucocorticoid	protein
receptors	protein
in	O
lymphocytes	cell_type
of	O
the	O
patients	O
are	O
lower	O
than	O
in	O
normal	O
subjects	O
both	O
in	O
the	O
active	O
stage	O
of	O
the	O
disease	O
and	O
following	O
bilateral	O
total	O
adrenalectomy	O
.	O
The	O
patients	O
carrying	O
B27	protein
antigen	protein
had	O
lymphocytic	O
receptor	O
concentrations	O
under	O
the	O
levels	O
of	O
such	O
in	O
patients	O
free	O
of	O
the	O
antigen	O
carriage.	O
Antigen	protein
B27	protein
seems	O
to	O
be	O
a	O
cause	O
of	O
lower	O
levels	O
of	O
glucocorticoid	protein
receptors	protein
in	O
blood	cell_type
lymphocytes	cell_type
.	O

Effects	O
of	O
1	O
alpha,	O
25-dihydroxyvitamin	O
D3	O
on	O
the	O
human	cell_line
chronic	cell_line
myelogenous	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
RWLeu-4	cell_line
.	O
The	O
effects	O
of	O
1	O
alpha,	O
25-dihydroxyvitamin	O
D3	O
(	O
VD3	O
)	O
on	O
proliferation	O
,	O
differentiation	O
,	O
and	O
macromolecular	O
synthesis	O
in	O
the	O
new	O
Philadelphia	cell_line
chromosome-positive	cell_line
chronic	cell_line
myelogenous	cell_line
leukemia	cell_line
cell	cell_line
line	cell_line
,	O
RWLeu-4	cell_line
,	O
were	O
investigated.	O
Binding	O
of	O
[3H]VD3	O
was	O
saturable,	O
with	O
approximately	O
2000-3000	O
sites/cell,	O
and	O
half-maximal	O
binding	O
occurring	O
at	O
0.21-0.33	O
nM.	O
Treatment	O
of	O
RWLeu-4	cell_line
cells	cell_line
with	O
VD3	O
induced	O
24R-hydroxylase	protein
activity	O
,	O
a	O
marker	O
of	O
vitamin	O
D3	O
responsiveness	O
in	O
many	O
tissues.	O
Exposure	O
of	O
RWLeu-4	cell_line
cells	cell_line
to	O
VD3	O
also	O
inhibited	O
proliferation	O
and	O
DNA	O
synthesis	O
with	O
a	O
50%	O
effective	O
dose	O
of	O
3.5-10	O
nM	O
within	O
72	O
h;	O
in	O
addition,	O
protein	O
and	O
RNA	O
synthesis	O
were	O
inhibited	O
by	O
VD3	O
treatment	O
.	O
Exposure	O
of	O
RWLeu-4	cell_line
cells	cell_line
to	O
5	O
nM	O
VD3	O
for	O
72	O
h	O
caused	O
50%	O
of	O
the	O
cells	O
to	O
differentiate	O
into	O
macrophage/monocyte	cell_type
type	cell_type
cells	cell_type
as	O
judged	O
by	O
nitroblue	O
tetrazolium	O
staining	O
and	O
adherence	O
to	O
plastic.	O
Progressive	O
expression	O
of	O
cell	protein
surface	protein
maturation-specific	protein
antigens	protein
of	O
the	O
monocyte/macrophage	cell_type
lineage	cell_type
was	O
induced	O
by	O
treatment	O
of	O
RWLeu-4	cell_line
cells	cell_line
with	O
VD3	O
for	O
24	O
to	O
72	O
h	O
at	O
doses	O
that	O
inhibited	O
cellular	O
proliferation	O
.	O
c-myc	RNA
RNA	RNA
,	O
which	O
is	O
constitutively	O
expressed	O
in	O
RWLeu-4	cell_line
cells	cell_line
,	O
increased	O
after	O
0.5	O
h	O
of	O
treatment	O
with	O
50	O
nM	O
VD3	O
and	O
then	O
rapidly	O
decreased	O
to	O
barely	O
detectable	O
levels	O
after	O
4	O
h	O
of	O
treatment.	O
Finally,	O
the	O
in	O
vitro	O
tyrosine	O
kinase	O
activity	O
associated	O
with	O
the	O
p210bcr-abl	protein
oncogene	protein
product	protein
was	O
decreased	O
approximately	O
50%	O
by	O
VD3	O
treatment	O
.	O
Because	O
of	O
the	O
presence	O
of	O
a	O
functional	O
receptor-effector	O
system	O
for	O
VD3	O
and	O
multiple	O
biological	O
responses	O
to	O
the	O
hormone,	O
these	O
cells	O
provide	O
a	O
unique	O
model	O
system	O
with	O
which	O
to	O
probe	O
the	O
specific	O
effects	O
of	O
VD3	O
on	O
cell	O
growth	O
and	O
differentiation	O
in	O
chronic	O
myelogenous	O
leukemia	O
.	O

A	O
new	O
member	O
of	O
the	O
leucine	protein
zipper	protein
class	protein
of	O
proteins	O
that	O
binds	O
to	O
the	O
HLA	DNA
DR	DNA
alpha	DNA
promoter	DNA
.	O
Several	O
mutants	O
derived	O
from	O
transformed	cell_line
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
are	O
defective	O
in	O
expressing	O
major	DNA
histocompatibility	DNA
complex	DNA
(MHC)	DNA
class	DNA
II	DNA
genes	DNA
.	O
The	O
failure	O
to	O
express	O
a	O
class	DNA
II	DNA
gene	DNA
in	O
at	O
least	O
one	O
such	O
mutant	cell_line
line	cell_line
has	O
been	O
mapped	O
to	O
the	O
MHC	DNA
class	DNA
II	DNA
X	DNA
box	DNA
,	O
a	O
conserved	DNA
transcriptional	DNA
element	DNA
in	O
the	O
promoter	DNA
region	DNA
.	O
A	O
complementary	DNA
DNA	DNA
encoding	O
a	O
DNA-binding	protein
protein	protein
(	O
human	protein
X	protein
box	protein
binding	protein
protein	protein
,	O
hXBP-1	protein
)	O
whose	O
target	O
is	O
the	O
human	DNA
DR	DNA
alpha	DNA
X	DNA
box	DNA
and	O
the	O
3'	DNA
flanking	DNA
region	DNA
has	O
now	O
been	O
cloned.	O
This	O
complementary	DNA
DNA	DNA
encoded	O
a	O
protein	O
with	O
structural	O
similarities	O
to	O
the	O
c-jun	protein
proto-oncogene	protein
product	protein
,	O
and	O
its	O
target	O
sequence	O
was	O
closely	O
related	O
to	O
the	O
palindromic	DNA
target	DNA
sequence	DNA
of	O
c-jun	DNA
.	O
Mutation	O
of	O
the	O
hXBP-1	DNA
DNA	DNA
target	DNA
sequence	DNA
decreased	O
DR	DNA
alpha	DNA
promoter	DNA
activity	O
in	O
vivo.	O
These	O
studies	O
suggest	O
that	O
the	O
hXBP-1	protein
protein	protein
acts	O
as	O
a	O
transcription	protein
factor	protein
in	O
B	cell_type
cells	cell_type
.	O

Pseudohypoaldosteronism	O
in	O
eight	O
families:	O
different	O
forms	O
of	O
inheritance	O
are	O
evidence	O
for	O
various	O
genetic	O
defects	O
.	O
Pseudohypoaldosteronism	O
is	O
a	O
rare	O
hereditary	O
disorder	O
presenting	O
in	O
early	O
infancy	O
with	O
renal	O
salt	O
loss	O
leading	O
to	O
hyponatremia	O
and	O
hyperkalemia	O
despite	O
high	O
levels	O
of	O
plasma	O
aldosterone	O
.	O
The	O
patients	O
are	O
insensitive	O
to	O
mineralocorticoids	O
;	O
however,	O
sodium	O
supplementation	O
is	O
able	O
to	O
correct	O
electrolyte	O
abnormalities	O
.	O
Absent	O
or	O
greatly	O
diminished	O
type	O
I	protein
aldosterone	protein
receptors	protein
in	O
peripheral	cell_type
mononuclear	cell_type
leucocytes	cell_type
have	O
been	O
recently	O
demonstrated	O
and	O
explain	O
the	O
lack	O
of	O
response	O
to	O
mineralocorticoids	O
.	O
We	O
have	O
studied	O
the	O
mode	O
of	O
inheritance	O
in	O
eight	O
families	O
with	O
a	O
total	O
of	O
nine	O
patients	O
.	O
There	O
was	O
evidence	O
for	O
an	O
autosomal	O
recessive	O
form	O
of	O
inheritance	O
in	O
four	O
families,	O
while	O
the	O
other	O
four	O
families	O
appeared	O
to	O
have	O
an	O
autosomal	O
dominant	O
mode	O
of	O
transmission	O
.	O
In	O
three	O
families	O
the	O
autosomal	O
recessive	O
form	O
was	O
characterized	O
by	O
normal	protein
receptor	protein
as	O
well	O
as	O
hormone	O
data	O
in	O
both	O
parents,	O
while	O
in	O
one	O
family	O
receptor	O
levels	O
in	O
both	O
parents	O
were	O
greatly	O
reduced,	O
but	O
hormone	O
levels	O
were	O
normal.	O
In	O
the	O
four	O
families	O
with	O
an	O
autosomal	O
dominant	O
mode	O
of	O
transmission	O
there	O
was	O
always	O
one	O
parent	O
with	O
reduced	O
receptor	O
binding	O
in	O
peripheral	cell_type
mononuclear	cell_type
leucocytes	cell_type
and	O
elevated	O
serum	O
hormone	O
levels	O
.	O
These	O
parents	O
were	O
entirely	O
asymptomatic	O
.	O
In	O
an	O
extended	O
family	O
we	O
were	O
able	O
to	O
study	O
an	O
aunt	O
and	O
her	O
newborn	O
daughter,	O
who	O
were	O
both	O
also	O
biochemically	O
affected	O
but	O
clinically	O
asymptomatic	O
.	O
It,	O
therefore,	O
appears	O
that	O
this	O
dual	O
pattern	O
of	O
genetic	O
transmission	O
may	O
indicate	O
differing	O
genetic	O
defects	O
which	O
cause	O
the	O
same	O
clinical	O
picture	O
of	O
pseudohypoaldosteronism	O
.	O

Perceived	O
social	O
support	O
and	O
tumor	O
estrogen/progesterone	protein
receptor	protein
status	O
as	O
predictors	O
of	O
natural	protein
killer	protein
cell	protein
activity	protein
in	O
breast	O
cancer	O
patients	O
.	O
This	O
report	O
is	O
concerned	O
with	O
the	O
prediction	O
of	O
natural	O
killer	cell_type
(NK)	cell_type
cell	cell_type
activity	O
in	O
61	O
Stage	O
I	O
and	O
II	O
breast	O
cancer	O
patients	O
,	O
between	O
the	O
ages	O
of	O
25	O
and	O
70,	O
who	O
were	O
accrued	O
to	O
this	O
project.	O
All	O
baseline	O
interview	O
and	O
testing	O
data	O
were	O
obtained	O
either	O
just	O
before	O
patients	O
were	O
discharged	O
from	O
the	O
hospital,	O
or	O
at	O
their	O
first	O
outpatient	O
visit,	O
within	O
two	O
weeks	O
of	O
discharge.	O
A	O
major	O
interest	O
of	O
this	O
project	O
is	O
the	O
predictive	O
value	O
of	O
perceived	O
social	O
support,	O
as	O
a	O
potential	O
"stress"	O
buffer,	O
related	O
to	O
NK	O
activity	O
.	O
In	O
the	O
main	O
model	O
reported	O
here,	O
we	O
found	O
that	O
a	O
significant	O
amount	O
of	O
NK	O
activity	O
variance	O
could	O
be	O
explained	O
by	O
five	O
variables.	O
Higher	O
NK	O
activity	O
could	O
be	O
predicted	O
by	O
the	O
perception	O
of	O
high	O
quality	O
emotional	O
support	O
from	O
a	O
spouse	O
or	O
intimate	O
other	O
,	O
perceived	O
social	O
support	O
from	O
the	O
patient's	O
physician	O
,	O
estrogen	protein
receptor	protein
-negative	O
tumor	O
status	O
,	O
having	O
an	O
excisional	protein
biopsy	protein
as	O
surgical	protein
treatment	protein
,	O
and	O
actively	O
seeking	O
social	protein
support	protein
as	O
a	O
major	O
coping	O
strategy	O
(R2	O
=	O
0.33,	O
F(5,55)	O
=	O
5.5,	O
p	O
less	O
than	O
0.0004).	O
Findings	O
are	O
discussed	O
in	O
terms	O
of	O
host	O
interaction	O
with	O
tumor	protein
endocrine	protein
status	protein
,	O
and	O
the	O
role	O
that	O
social	protein
support	protein
might	O
play	O
in	O
modulating	O
such	O
activity.	O

[	O
Estrogen	protein
receptor	protein
content	O
of	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
in	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
]	O
ER	O
content	O
in	O
lymphocytes	cell_type
of	O
peripheral	O
blood	O
from	O
27	O
SLE	O
patients	O
and	O
20	O
healthy	O
controls	O
were	O
determined	O
by	O
dextran-coated	O
charcoal	O
assay	O
.	O
ER	protein
content	O
in	O
lymphocytes	cell_type
of	O
each	O
sample	O
was	O
expressed	O
by	O
both	O
fmol/mg	O
of	O
lymphocyte	protein
cytosolic	protein
protein	protein
and	O
fmol/micrograms	O
of	O
lymphocyte	DNA
DNA	DNA
.	O
The	O
results	O
showed	O
that	O
there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
ER	protein
content	O
of	O
lymphocytes	cell_type
from	O
the	O
controls	O
and	O
that	O
from	O
patients	O
with	O
SLE	O
.	O
But	O
the	O
logarithmic	O
mean	O
of	O
ER	protein
content	O
in	O
lymphocytes	cell_type
,	O
expressed	O
by	O
fmol/mg	O
of	O
cytosolic	protein
protein	protein
,	O
in	O
14	O
patients	O
with	O
active	O
SLE	O
(0.9356	O
+/-	O
0.31)	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
13	O
patients	O
with	O
inactive	O
SLE	O
(0.2979	O
+/-	O
0.23,	O
P	O
less	O
than	O
0.001)	O
and	O
in	O
the	O
controls	O
(0.6204	O
+/-	O
0.52,	O
P	O
less	O
than	O
0.001).	O
The	O
normal	O
upper	O
limit	O
of	O
ER	protein
content	O
in	O
lymphocytes	cell_type
,	O
expressed	O
by	O
fmol/micrograms	O
of	O
DNA,	O
was	O
0.136.	O
The	O
elevated	O
rate	O
of	O
ER	protein
content	O
in	O
lymphocytes	cell_type
in	O
14	O
active	O
SLE	O
(92.9%)	O
was	O
also	O
higher	O
than	O
that	O
in	O
quieiescent	O
patients	O
(23.1%,	O
P	O
less	O
than	O
0.001)	O
and	O
in	O
the	O
controls	O
(10%,	O
P	O
less	O
than	O
0.001).	O
Moreover,	O
the	O
elevated	O
level	O
of	O
ER	protein
content	O
was	O
found	O
to	O
be	O
related	O
to	O
the	O
positive	O
antidsDNA	protein
antibody	protein
and	O
hypocomplementemia	O
.	O

An	O
in	O
vitro	O
globin	DNA
gene	DNA
switching	O
model	O
based	O
on	O
differentiated	cell_type
embryonic	cell_type
stem	cell_type
cells	cell_type
.	O
We	O
used	O
mouse	cell_type
embryonic	cell_type
stem	cell_type
(ES)	cell_type
cells	cell_type
to	O
study	O
globin	DNA
gene	DNA
expression	O
and	O
switching	O
in	O
vitro.	O
We	O
show	O
that	O
ES-derived	cell_type
embryoid	cell_type
bodies	cell_type
express	O
the	O
full	O
complement	O
of	O
mouse	DNA
embryonic	DNA
globin	DNA
genes	DNA
in	O
the	O
correct	O
temporal	O
order	O
and	O
that	O
on	O
further	O
differentiation	O
,	O
a	O
switch	O
occurs	O
to	O
the	O
fetal/adult	DNA
genes	DNA
.	O
In	O
addition,	O
the	O
erythroid-specific	protein
transcription	protein
factor	protein
NF-E1	protein
was	O
shown	O
to	O
be	O
expressed	O
coordinately	O
with	O
that	O
of	O
globin	protein
in	O
embryoid	cell_type
bodies	cell_type
.	O
We	O
conclude	O
from	O
these	O
experiments	O
that	O
the	O
ES	O
cell	O
system	O
provides	O
a	O
good	O
model	O
to	O
study	O
hematopoietic	O
development	O
.	O
When	O
the	O
human	O
epsilon-	O
or	O
beta-	O
globin	O
genes	O
driven	O
by	O
the	O
dominant	DNA
control	DNA
region	DNA
(	O
DCR	DNA
)	O
are	O
introduced	O
into	O
this	O
system,	O
the	O
human	DNA
epsilon-	DNA
globin	DNA
gene	DNA
,	O
in	O
contrast	O
to	O
the	O
beta-	DNA
globin	DNA
gene	DNA
,	O
is	O
not	O
deregulated	O
by	O
the	O
presence	O
of	O
the	O
DCR	DNA
and	O
is	O
expressed	O
strictly	O
as	O
an	O
embryonic	DNA
gene	DNA
.	O
We	O
conclude	O
from	O
this	O
that	O
the	O
epsilon-	DNA
globin	DNA
gene	DNA
is	O
not	O
regulated	O
by	O
competition	O
with	O
other	O
genes	O
in	O
the	O
human	DNA
beta-globin	DNA
locus	DNA
.	O

Cloning	O
of	O
a	O
mitogen-inducible	DNA
gene	DNA
encoding	O
a	O
kappa	protein
B	protein
DNA-binding	protein
protein	protein
with	O
homology	O
to	O
the	O
rel	DNA
oncogene	DNA
and	O
to	O
cell-cycle	DNA
motifs	DNA
.	O
We	O
have	O
cloned	O
and	O
characterized	O
a	O
mitogen-inducible	DNA
gene	DNA
isolated	O
from	O
human	cell_type
T	cell_type
cells	cell_type
that	O
predicts	O
a	O
protein	O
of	O
968	protein
amino	protein
acids	protein
.	O
The	O
amino-terminal	protein
domain	protein
has	O
regions	O
homologous	O
to	O
the	O
oncogene	DNA
rel	DNA
and	O
to	O
the	O
developmentally	O
important	O
gene	O
dorsal	DNA
of	O
Drosophila	O
.	O
The	O
carboxy-terminal	protein
domain	protein
contains	O
repeat	O
structures	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
that	O
are	O
involved	O
in	O
cell-cycle	O
control	O
of	O
yeast	O
and	O
in	O
tissue	O
differentiation	O
in	O
Drosophila	O
and	O
Ceanorhabditis	O
elegans	O
,	O
as	O
well	O
as	O
in	O
the	O
putative	DNA
human	DNA
oncogene	DNA
bcl-3	DNA
and	O
in	O
the	O
ankyrin	protein
protein	protein
.	O
A	O
truncated	O
form	O
of	O
the	O
product	O
of	O
this	O
gene	O
translated	O
in	O
vitro	O
is	O
a	O
DNA-binding	protein
protein	protein
which	O
interacts	O
specifically	O
with	O
the	O
kappa	DNA
B	DNA
binding	DNA
site	DNA
found	O
in	O
many	O
inducible	DNA
genes	DNA
,	O
including	O
the	O
enhancer	O
in	O
human	O
immunodeficiency	O
virus	O
.	O
This	O
gene	O
is	O
yet	O
another	O
in	O
a	O
growing	O
list	O
of	O
important	O
regulatory	O
molecules	O
whose	O
expression	O
is	O
transcriptionally	O
induced	O
upon	O
cellular	O
activation	O
.	O

Extrarenal	O
receptor-effector-mechanisms	O
for	O
aldosterone	O
:	O
the	O
sequence	O
of	O
effects	O
on	O
the	O
cellular	O
electrolyte	O
transport	O
in	O
human	cell_type
lymphocytes	cell_type
and	O
their	O
implications	O
for	O
disorders	O
of	O
the	O
water	O
and	O
electrolyte	O
balances	O
.	O
High	O
affinity	O
aldosterone	O
binding	O
sites	O
have	O
not	O
only	O
been	O
described	O
in	O
the	O
classic	O
target	O
tissues	O
such	O
as	O
the	O
renal	O
tubules	O
,	O
but	O
also	O
in	O
non-classic	O
target	O
tissues	O
such	O
as	O
the	O
hippocampus	O
,	O
mammary	O
gland	O
,	O
endothelial	cell_type
cells	cell_type
and,	O
recently,	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
.	O
An	O
in	O
vitro	O
effect	O
of	O
aldosterone	O
on	O
intracellular	O
sodium	O
,	O
potassium	O
and	O
calcium	O
concentrations	O
and	O
cell	O
volume	O
was	O
shown	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
.	O
In	O
the	O
absence	O
of	O
aldosterone	O
,	O
the	O
intracellular	O
Na+	O
,	O
K+	O
and	O
Ca2+	O
concentrations	O
and	O
the	O
cell	O
volume	O
decreased	O
significantly,	O
but	O
remained	O
constant	O
when	O
aldosterone	O
(1.4	O
nmol/l)	O
was	O
added	O
to	O
the	O
incubation	O
medium	O
.	O
These	O
effects	O
of	O
aldosterone	O
were	O
blocked	O
by	O
the	O
aldosterone	O
antagonist	O
canrenone	O
(140	O
nmol/l).	O
The	O
sodium/proton	protein
exchanger	protein
of	O
the	O
cell	O
membrane	O
could	O
be	O
identified	O
as	O
the	O
primary	O
target	O
of	O
the	O
aldosterone	O
action,	O
possibly	O
non-genomically	O
mediated	O
through	O
membrane	protein
receptors	protein
.	O
The	O
clinical	O
significance	O
of	O
this	O
model	O
was	O
underlined	O
by	O
the	O
demonstration	O
of	O
absent	O
or	O
a	O
decreased	O
number	O
of	O
mineralocorticoid	protein
receptors	protein
and	O
the	O
lack	O
of	O
electrolyte	O
response	O
to	O
aldosterone	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
patients	O
with	O
pseudohypoaldosteronism	O
and	O
aldosteronism	O
.	O
Additionally,	O
an	O
abnormal	O
effector	O
mechanism	O
could	O
be	O
demonstrated	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
from	O
essential	O
hypertensives	O
.	O
These	O
studies	O
are	O
the	O
first	O
to	O
demonstrate	O
the	O
significance	O
of	O
extrarenal,	protein
nonepithelial	protein
mineralocorticoid	protein
receptors	protein
and	O
the	O
related	O
effector	O
mechanism	O
in	O
different	O
disorders	O
of	O
the	O
water	O
and	O
electrolyte	O
balance	O
in	O
man	O
.	O

Immunohistochemical	O
study	O
of	O
steroid	O
hormones	O
and	O
an	O
estrogen	O
binding	O
assay	O
in	O
malignant	cell_type
soft	cell_type
tissue	cell_type
tumors	cell_type
.	O
Immunohistochemically,	O
the	O
immunoreaction	O
against	O
5	O
steroid	O
hormone	O
anti-sera	O
(	O
estradiol	O
,	O
estriol	O
,	O
cortisol	O
,	O
progesterone	O
and	O
testosterone	O
)	O
was	O
examined	O
in	O
39	O
cases	O
with	O
the	O
malignant	cell_type
soft	cell_type
tissue	cell_type
tumors	cell_type
(	O
fibrosarcoma	O
:	O
8,	O
malignant	O
fibrous	O
histiocytoma	O
:	O
6,	O
rhabdomyosarcoma	O
:	O
10,	O
leiomyosarcoma	O
:	O
10,	O
liposarcoma	O
:	O
5).	O
Seventeen	O
cases	O
revealed	O
distinct	O
immunostaining	O
against	O
at	O
least	O
1	O
of	O
the	O
5	O
steroid	O
hormones	O
.	O
Immunostained	cell_type
tumor	cell_type
cells	cell_type
were	O
more	O
frequently	O
distributed	O
in	O
the	O
area	O
where	O
tumor	O
cell	O
infiltration	O
was	O
more	O
invasive.	O
The	O
majority	O
of	O
the	O
positive	O
cases	O
occurred	O
in	O
female	O
cases.	O
Furthermore,	O
the	O
existence	O
of	O
estrogen	protein
receptor	protein
(estrogen	O
binding	O
activity)	O
was	O
examined	O
histochemically	O
in	O
39	O
cases	O
and	O
it	O
was	O
detected	O
in	O
8.	O
We	O
concluded	O
that	O
steroid	O
hormones	O
might	O
be	O
closely	O
related	O
to	O
tumor	O
cell	O
infiltration	O
of	O
some	O
malignant	cell_type
soft	cell_type
tissue	cell_type
tumors	cell_type
.	O

Involvement	O
of	O
cyclic	protein
AMP-dependent	protein
protein	protein
kinases	protein
in	O
the	O
signal	O
transduction	O
pathway	O
for	O
interleukin-1	protein
.	O
Expression	O
of	O
a	O
highly	O
specific	O
protein	O
inhibitor	O
for	O
cyclic	protein
AMP-dependent	protein
protein	protein
kinases	protein
in	O
interleukin-1	cell_line
(IL-1)-responsive	cell_line
cells	cell_line
blocked	O
IL-1-induced	DNA
gene	DNA
transcription	O
that	O
was	O
driven	O
by	O
the	O
kappa	DNA
immunoglobulin	DNA
enhancer	DNA
or	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
.	O
This	O
inhibitor	O
did	O
not	O
affect	O
protein	protein
kinase	protein
C	protein
-mediated	O
gene	O
transcription	O
,	O
suggesting	O
that	O
cyclic	protein
AMP-dependent	protein
protein	protein
kinases	protein
are	O
involved	O
in	O
the	O
signal	O
transduction	O
pathway	O
for	O
IL-1	protein
in	O
a	O
number	O
of	O
responsive	cell_type
cell	cell_type
types	cell_type
.	O

The	O
Epstein-Barr	DNA
virus	DNA
(	DNA
EBV	DNA
)	DNA
ORI1yt	DNA
enhancer	DNA
is	O
not	O
B-cell	O
specific	O
and	O
does	O
not	O
respond	O
synergistically	O
to	O
the	O
EBV	O
transcription	O
factors	O
R	O
and	O
Z	O
.	O
The	O
Epstein-Barr	DNA
virus	DNA
DR	DNA
promoter	DNA
is	O
located	O
upstream	O
of	O
the	O
PstI	DNA
repeats	DNA
,	O
and	O
in	O
addition	O
to	O
the	O
TATA	DNA
box	DNA
,	O
it	O
contains	O
an	O
upstream	DNA
region	DNA
(positions	O
-69	O
to	O
-220)	O
responsive	O
to	O
EB1	protein
(Z)	protein
(the	O
BZLF1-encoded	protein
transcription	protein
factor	protein
)	O
and	O
an	O
enhancer	DNA
with	O
two	O
functionally	O
distinct	O
domains,	O
A	DNA
and	O
B	DNA
.	O
Domain	DNA
B	DNA
has	O
been	O
described	O
as	O
a	O
B-cell-specific	DNA
EB1	DNA
-responsive	DNA
element	DNA
(P.M.Lieberman,	O
J.M.Hardwick,	O
and	O
S.D.Hayward,	O
J.Virol.63:3040-3050,	O
1989)	O
activated	O
synergistically	O
by	O
EB1	protein
and	O
R	protein
,	O
an	O
EBV	protein
early	protein
product	protein
encoded	O
by	O
the	O
open	DNA
reading	DNA
frame	DNA
BRLF1	DNA
(M.A.	O
Cox,	O
J.Leahy,	O
and	O
J.M.Hardwick,	O
J.Virol.64:313-321,	O
1990).	O
We	O
show	O
here	O
that	O
domain	DNA
B	DNA
is	O
an	O
R-responsive	DNA
element	DNA
in	O
HeLa	cell_line
cells	cell_line
and	O
is	O
therefore	O
not	O
an	O
EB1	DNA
-responsive	DNA
B-cell-specific	DNA
element	DNA
.	O
However,	O
there	O
is	O
an	O
EB1	DNA
-binding	DNA
site	DNA
(	O
ZRE-B	DNA
)	O
located	O
within	O
the	O
R-responsive	DNA
enhancer	DNA
region	DNA
.	O
ZRE-B	DNA
can	O
be	O
deleted	O
without	O
affecting	O
the	O
R-dependent	O
enhancer	O
activity	O
.	O
Moreover,	O
there	O
is	O
no	O
cooperation	O
or	O
synergy	O
between	O
R	protein
and	O
EB1	protein
when	O
activating	O
the	O
B	DNA
domain	DNA
(	O
ZRE-B	DNA
plus	O
the	O
R-responsive	DNA
element	DNA
)	O
positioned	O
as	O
an	O
enhancer	DNA
.	O
ZRE-B	DNA
is	O
therefore	O
not	O
part	O
of	O
the	O
R-	DNA
inducible	DNA
enhancer	DNA
.	O
We	O
have	O
tested	O
several	O
subregions	O
of	O
the	O
DR	DNA
enhancer	DNA
B	DNA
domain	DNA
,	O
either	O
alone	O
or	O
in	O
combination,	O
for	O
their	O
capacity	O
to	O
transmit	O
the	O
R-activating	O
signal	O
to	O
the	O
rabbit	DNA
beta-globin	DNA
promoter	DNA
.	O
We	O
found	O
that	O
the	O
R-responsive	DNA
element	DNA
is	O
composed	O
of	O
four	O
protoenhancers	DNA
that	O
span	O
the	O
whole	O
B	DNA
domain	DNA
.	O
These	O
protoenhancers	DNA
alone	O
are	O
weakly	O
or	O
not	O
responsive	O
to	O
R	protein
.	O
One	O
of	O
the	O
protoenhancers	DNA
contains	O
the	O
overlapping	DNA
palindromes	DNA
5'-TTGTCCcgtGGACAAaTGTCC-3'	O
.	O
However,	O
one	O
palindrome	DNA
,	O
either	O
alone	O
or	O
duplicated,	O
or	O
the	O
overlapping	DNA
palindromes	DNA
did	O
not	O
respond	O
to	O
R.	O

Nuclear	O
3,5,3'-triiodothyronine	protein
receptors	protein
(	O
T3R	protein
)	O
of	O
circulating	cell_type
human	cell_type
lymphocytes	cell_type
in	O
hyper-	O
and	O
hypo	O
thyroidism	O
and	O
nonthyroidal	O
diseases	O
.	O
The	O
clinical	O
implications	O
of	O
nuclear	O
T3R	protein
alterations	O
of	O
circulating	cell_type
lymphocytes	cell_type
in	O
hyperthyroidism	O
,	O
hypothyroidism	O
and	O
nonthyroidal	O
diseases	O
were	O
investigated.	O
Nuclear	O
T3R	protein
in	O
lymphocytes	cell_type
was	O
determined	O
by	O
radio-ligand	O
binding	O
analysis	O
.	O
The	O
results	O
showed	O
that	O
in	O
hyper-	O
and	O
hypo	O
thyroid	O
patients	O
the	O
nuclear	O
affinity	O
(	O
Ka	O
)	O
for	O
T3	O
was	O
similar	O
to	O
that	O
of	O
normal	O
subjects	O
.	O
In	O
hyperthyroidism	O
nuclear	O
T3	O
maximal	O
binding	O
capacity	O
(	O
MBC	O
)	O
was	O
unaltered,	O
whereas	O
in	O
hypothyroidism	O
the	O
MBC	O
was	O
significantly	O
increased.	O
In	O
the	O
patients	O
with	O
diabetes	O
mellitus	O
,	O
chronic	O
renal	O
failure	O
and	O
hepatic	O
cirrhosis	O
,	O
the	O
nuclear	protein
T3R	protein
MBC	O
of	O
lymphocytes	cell_type
was	O
about	O
1.5-1.6	O
times	O
of	O
the	O
normal	O
controls	O
.	O
It	O
was	O
concluded	O
that	O
there	O
existed	O
hormonal	O
regulation	O
of	O
nuclear	protein
T3R	protein
,	O
and	O
up-regulation	O
was	O
seen	O
in	O
hypothyroidism	O
and	O
low	O
T3	O
syndrome	O
.	O

Lymphocyte	cell_line
cell	cell_line
lines	cell_line
from	O
vitamin	O
D-dependent	O
rickets	O
type	O
II	O
show	O
functional	O
defects	O
in	O
the	O
1	protein
alpha,25-dihydroxyvitamin	protein
D3	protein
receptor	protein
.	O
Lymphocyte	cell_line
cell	cell_line
lines	cell_line
were	O
established	O
from	O
five	O
patients	O
with	O
vitamin	O
D-dependent	O
rickets	O
,	O
type	O
II	O
(	O
VDDR-II	O
).	O
These	O
lines	O
were	O
established	O
by	O
infection	O
with	O
human	O
T-lymphotrophic	O
virus	O
type	O
I	O
(	O
HTLV-I	O
).	O
Binding	O
of	O
[3H]1	O
alpha,25-dihydroxyvitamin	O
D3	O
(	O
1,25(OH)2D3	O
)	O
to	O
its	O
receptor	O
in	O
these	O
cell	O
lines	O
was	O
compared	O
to	O
binding	O
studies	O
using	O
a	O
T-lymphocyte	cell_line
cell	cell_line
line	cell_line
(	O
S-LB1	cell_line
)	O
from	O
a	O
normal	O
individual.	O
The	O
1,25(OH)2D3	O
receptor	O
of	O
S-LB1	cell_line
was	O
comparable	O
to	O
the	O
well-characterized	O
chick	protein
intestinal	protein
1,25(OH)2D3	protein
receptor	protein
in	O
terms	O
of	O
its	O
ligand	O
binding	O
affinity	O
and	O
capacity,	O
its	O
mobility	O
on	O
5-20%	O
sucrose	O
gradients,	O
and	O
its	O
adsorption	O
to	O
and	O
elution	O
properties	O
from	O
DNA-cellulose	O
.	O
Three	O
cell	cell_line
lines	cell_line
established	O
from	O
patients	O
with	O
VDDR-II	O
(	O
Rh-	O
VDR	protein
,	O
Sh-	O
VDR	protein
,	O
and	O
Ab-	O
VDR	protein
)	O
showed	O
no	O
specific	O
binding	O
of	O
1,25(OH)2D3	O
to	O
a	O
receptor	protein
and	O
treatment	O
of	O
the	O
cultured	cell_line
cells	cell_line
with	O
1,25(OH)2D3	O
did	O
not	O
stimulate	O
production	O
of	O
24,25-dihydroxy-vitamin	O
D3	O
(	O
24,25(OH)2D3	O
),	O
a	O
response	O
which	O
is	O
diagnostic	O
of	O
the	O
presence	O
of	O
a	O
functional	protein
1,25(OH)2D3	protein
receptor	protein
.	O
In	O
a	O
fourth	O
cell	cell_line
line	cell_line
,	O
A1-VDR	cell_line
,	O
the	O
receptor	O
for	O
1,25(OH)2D3	O
had	O
a	O
low	O
binding	O
capacity	O
and	O
25(OH)D3-24-hydroxylase	protein
activity	O
was	O
not	O
detectable.	O
Induction	O
of	O
24,25-(OH)2D3	O
synthesis	O
by	O
1,25(OH)2D3	O
was	O
observed	O
in	O
the	O
fifth	O
cell	cell_line
line	cell_line
,	O
designated	O
Ro-VDR	cell_line
,	O
although	O
the	O
sensitivity	O
to	O
hormone	O
treatment	O
was	O
lower	O
than	O
in	O
the	O
control	cell_line
cell	cell_line
line	cell_line
from	O
a	O
normal	O
donor	O
.	O
The	O
capacity	O
of	O
the	O
receptor	protein
for	O
1,25(OH)2D3	O
was	O
low	O
in	O
Ro-VDR	cell_line
.	O
In	O
all	O
cell	cell_line
lines	cell_line
where	O
1,25(OH)2D3	O
binding	O
to	O
a	O
receptor	protein
was	O
detectable,	O
the	O
receptor	protein
had	O
the	O
typical	O
sedimentation	O
coefficient	O
of	O
3.7	O
S	O
on	O
sucrose	O
density	O
gradient	O
analysis	O
.	O
Binding	O
and	O
elution	O
properties	O
to	O
DNA-cellulose	O
,	O
however,	O
differed	O
from	O
normal	O
in	O
both	O
Ro-VDR	cell_line
and	O
A1-VDR	cell_line
cells	cell_line
where	O
elution	O
from	O
DNA-cellulose	O
occurred	O
at	O
a	O
lower	O
salt	O
concentration	O
than	O
is	O
typical	O
of	O
the	O
1,25(OH)2D3	protein
receptor	protein
.	O
While	O
Ro-VDR	cell_line
cells	cell_line
showed	O
typical	O
nuclear	O
localization	O
of	O
the	O
unoccupied	protein
1,25(OH)2D3	protein
receptor	protein
,	O
neither	O
the	O
unoccupied	O
nor	O
the	O
occupied	O
receptor	protein
from	O
A1-VDR	cell_line
cells	cell_line
was	O
completely	O
localized	O
in	O
the	O
nucleus	O
.	O
In	O
a	O
series	O
of	O
functional	O
studies	O
we	O
found	O
that	O
modulation	O
of	O
the	O
level	O
of	O
the	O
mRNAs	RNA
coding	O
for	O
both	O
the	O
c-myc	DNA
oncogene	DNA
and	O
the	O
growth	O
factor	O
known	O
as	O
granulocyte-monocyte	O
colony	O
stimulating	O
activity	O
by	O
1,25(OH)2D3	O
correlated	O
with	O
the	O
1,25(OH)2D3	protein
receptor	protein
status	O
of	O
these	O
cells.	O
Use	O
of	O
these	O
cell	cell_line
lines	cell_line
will	O
facilitate	O
further	O
study	O
of	O
the	O
molecular	O
defect(s)	O
in	O
the	O
receptor	protein
for	O
1,25(OH)2D3	O
in	O
vitamin	O
D-dependent	O
rickets	O
type	O
II	O
and	O
will	O
allow	O
a	O
correlation	O
with	O
impairment	O
of	O
cellular	O
functions	O
.	O

Transcriptional	O
and	O
post-transcriptional	O
regulation	O
of	O
c-jun	DNA
expression	O
during	O
monocytic	O
differentiation	O
of	O
human	cell_line
myeloid	cell_line
leukemic	cell_line
cells	cell_line
.	O
AP-1	protein
,	O
the	O
polypeptide	O
product	O
of	O
c-jun	DNA
,	O
recognizes	O
and	O
binds	O
to	O
specific	DNA
DNA	DNA
sequences	DNA
and	O
stimulates	O
transcription	O
of	O
genes	DNA
responsive	O
to	O
certain	O
growth	O
factors	O
and	O
phorbol	O
esters	O
such	O
as	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
).	O
We	O
studied	O
the	O
effects	O
of	O
TPA	O
on	O
the	O
regulation	O
of	O
c-jun	DNA
gene	O
expression	O
in	O
HL-60	cell_line
cells	cell_line
during	O
monocytic	O
differentiation	O
.	O
Low	O
levels	O
of	O
c-jun	RNA
transcripts	RNA
were	O
detectable	O
in	O
untreated	cell_line
HL-60	cell_line
leukemic	cell_line
cells	cell_line
,	O
increased	O
significantly	O
by	O
6	O
h,	O
and	O
reached	O
near	O
maximal	O
levels	O
by	O
24	O
h	O
of	O
exposure	O
to	O
32	O
nM	O
TPA	O
.	O
Similar	O
kinetics	O
of	O
c-jun	DNA
induction	O
by	O
TPA	O
were	O
observed	O
in	O
human	cell_line
U-937	cell_line
and	O
THP-1	cell_line
monocytic	cell_line
leukemia	cell_line
cells	cell_line
.	O
Similar	O
findings	O
were	O
obtained	O
with	O
bryostatin	O
1	O
(10	O
nM),	O
another	O
activator	O
of	O
protein	protein
kinase	protein
C	protein
and	O
inducer	O
of	O
monocytic	O
differentiation	O
.	O
Furthermore,	O
1,25-dihydroxyvitamin	O
D3	O
(0.5	O
microM),	O
a	O
structurally	O
distinct	O
agent	O
which	O
also	O
induces	O
HL-60	O
monocytic	O
differentiation	O
,	O
increased	O
c-jun	DNA
expression	O
.	O
TPA	O
treatment	O
of	O
HL-60	cell_line
cells	cell_line
in	O
the	O
presence	O
of	O
cycloheximide	O
was	O
associated	O
with	O
superinduction	O
of	O
c-jun	DNA
transcripts.	O
Run-on	O
analysis	O
demonstrated	O
detectable	O
levels	O
of	O
c-jun	DNA
gene	O
transcription	O
in	O
untreated	cell_line
HL-60	cell_line
cells	cell_line
,	O
and	O
that	O
exposure	O
to	O
TPA	O
increases	O
this	O
rate	O
3.3-fold.	O
Treatment	O
of	O
HL-60	cell_line
cells	cell_line
with	O
both	O
TPA	O
and	O
cycloheximide	O
had	O
no	O
effect	O
on	O
the	O
rates	O
of	O
c-jun	DNA
transcription	O
.	O
The	O
half-life	O
of	O
c-jun	RNA
RNA	RNA
as	O
determined	O
by	O
treating	O
HL-60	cell_line
cells	cell_line
with	O
TPA	O
and	O
actinomycin	O
D	O
was	O
30	O
min.	O
In	O
contrast,	O
the	O
half-life	O
of	O
c-jun	RNA
RNA	RNA
in	O
TPA	cell_line
-treated	cell_line
HL-60	cell_line
cells	cell_line
exposed	O
to	O
cycloheximide	O
and	O
actinomycin	O
D	O
was	O
greater	O
than	O
2	O
h.	O
These	O
findings	O
suggested	O
that	O
the	O
increase	O
in	O
c-jun	RNA
RNA	RNA
observed	O
during	O
TPA	O
-induced	O
monocytic	O
differentiation	O
is	O
mediated	O
by	O
both	O
transcriptional	O
and	O
post-transcriptional	O
mechanisms	O
.	O

[	O
Hormonal	O
interactions	O
and	O
glucocorticoid	protein
receptors	protein
in	O
patients	O
with	O
the	O
nephrotic	O
syndrome	O
]	O
As	O
many	O
as	O
27	O
children	O
aged	O
6	O
to	O
15	O
years	O
with	O
morphologically	O
verified	O
nephropathies	O
were	O
examined.	O
Four	O
variants	O
of	O
changes	O
in	O
the	O
thyroid	O
status	O
,	O
characteristic	O
of	O
children	O
with	O
different	O
variants	O
of	O
nephrotic	O
syndrome	O
were	O
distinguished:	O
1)	O
biochemical	O
signs	O
of	O
primary	O
hypothyroidism	O
,	O
2)	O
biochemical	O
signs	O
of	O
secondary	O
hypothyroidism	O
,	O
3)	O
low	O
content	O
of	O
T3,	O
4)	O
dysfunction	O
of	O
the	O
hypophyseal	O
and	O
thyroid	O
system	O
.	O
It	O
is	O
shown	O
that	O
the	O
low	O
level	O
of	O
steroid	protein
receptors	protein
,	O
thyroid	O
hormones	O
that	O
the	O
low	O
level	O
of	O
steroid	protein
receptors	protein
,	O
thyroid	O
hormones	O
(T3	O
and	O
T4)	O
and	O
cortisol	O
is	O
typical	O
of	O
children	O
with	O
the	O
signs	O
of	O
renal	O
dysplasia	O
.	O
It	O
is	O
assumed	O
that	O
superaddition	O
under	O
such	O
conditions	O
of	O
immune	O
glomerulopathy	O
(	O
glomerulonephritis	O
and	O
nephrotic	O
syndrome	O
)	O
gives	O
rise	O
to	O
the	O
resistance	O
to	O
the	O
treatment	O
with	O
glucocorticoids	O
.	O

Lymphoid	O
specific	O
gene	O
expression	O
of	O
the	O
adenovirus	DNA
early	DNA
region	DNA
3	DNA
promoter	DNA
is	O
mediated	O
by	O
NF-kappa	DNA
B	DNA
binding	DNA
motifs	DNA
.	O
A	O
primary	O
site	O
of	O
infection	O
by	O
human	O
adenoviruses	O
is	O
lymphoid	cell_type
cells	cell_type
.	O
However,	O
analysis	O
of	O
the	O
viral	DNA
control	DNA
elements	DNA
and	O
the	O
cellular	protein
factors	protein
that	O
regulate	O
adenoviral	O
gene	O
expression	O
in	O
lymphocytes	cell_type
has	O
not	O
been	O
reported.	O
The	O
adenovirus	protein
early	protein
region	protein
3	protein
(	protein
ES	protein
)	protein
gene	protein
products	protein
are	O
involved	O
in	O
the	O
maintenance	O
of	O
viral	O
persistence	O
by	O
complexing	O
with	O
the	O
class	protein
I	protein
MHC	protein
antigens	protein
,	O
thus	O
preventing	O
their	O
cell	O
surface	O
expression	O
with	O
a	O
resultant	O
decrease	O
in	O
host	O
immunologic	O
destruction	O
.	O
To	O
determine	O
whether	O
different	O
cellular	protein
factors	protein
were	O
involved	O
in	O
E3	O
regulation	O
in	O
lymphocytes	cell_type
as	O
compared	O
with	O
HeLa	cell_line
cells	cell_line
,	O
both	O
DNA	O
binding	O
and	O
transfection	O
analysis	O
with	O
the	O
E3	DNA
promoter	DNA
in	O
both	O
cell	O
types	O
were	O
performed.	O
These	O
studies	O
detected	O
two	O
novel	DNA
domains	DNA
referred	O
to	O
as	O
L1	DNA
and	O
L2	DNA
with	O
a	O
variety	O
of	O
lymphoid	O
but	O
not	O
HeLa	O
extracts	O
.	O
Each	O
of	O
these	O
domains	O
possessed	O
strong	O
homology	O
to	O
motifs	O
previously	O
found	O
to	O
bind	O
the	O
cellular	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Transfections	O
of	O
E3	DNA
constructs	DNA
linked	O
to	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
gene	DNA
revealed	O
that	O
mutagenesis	O
of	O
the	O
distal	DNA
NF-kappa	DNA
B	DNA
motif	DNA
(	O
L2	DNA
)	O
had	O
minimal	O
effects	O
on	O
promoter	O
expression	O
in	O
HeLa	cell_line
cells	cell_line
,	O
but	O
resulted	O
in	O
dramatic	O
decreases	O
in	O
expression	O
by	O
lymphoid	cell_type
cells	cell_type
.	O
In	O
contrast,	O
mutagenesis	O
of	O
proximal	DNA
NF-kappa	DNA
B	DNA
motif	DNA
(	O
L1	DNA
)	O
had	O
minimal	O
effects	O
on	O
gene	O
expression	O
in	O
both	O
HeLa	cell_line
cells	cell_line
and	O
lymphoid	cell_type
cells	cell_type
but	O
resulted	O
in	O
a	O
small,	O
but	O
reproducible,	O
increase	O
in	O
gene	O
expression	O
in	O
lymphoid	cell_type
cells	cell_type
when	O
coupled	O
to	O
the	O
L2	DNA
mutation	O
.	O
Reversing	O
the	O
position	O
and	O
subsequent	O
mutagenesis	O
of	O
the	O
L1	DNA
and	O
L2	DNA
domains	DNA
indicated	O
that	O
the	O
primary	DNA
sequence	DNA
of	O
these	O
motifs	O
rather	O
than	O
their	O
position	O
in	O
the	O
E3	DNA
promoter	DNA
was	O
critical	O
for	O
regulating	O
gene	O
expression	O
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Characterization	O
of	O
defensin	protein
resistance	O
phenotypes	O
associated	O
with	O
mutations	O
in	O
the	O
phoP	DNA
virulence	DNA
regulon	DNA
of	O
Salmonella	O
typhimurium	O
.	O
The	O
defensin	protein
sensitivities	O
of	O
Salmonella	O
typhimurium	O
strains	O
with	O
mutations	O
in	O
the	O
phoP/phoQ	DNA
two-component	DNA
virulence	DNA
regulon	DNA
were	O
tested	O
by	O
using	O
purified	protein
defensins	protein
NP-1	protein
and	O
NP-2	protein
.	O
Strains	O
with	O
mutations	O
in	O
either	O
gene	O
of	O
the	O
regulatory	DNA
pair	DNA
(	O
phoP	DNA
[	O
transcriptional	DNA
activator	DNA
]	O
or	O
phoQ	DNA
[	O
membrane	protein
sensor	protein
kinase	protein
])	O
had	O
increased	O
sensitivities	O
to	O
defensin	protein
.	O
The	O
predicted	O
periplasmic	protein
domain	protein
of	O
the	O
PhoQ	protein
protein	protein
contained	O
a	O
markedly	O
anionic	O
domain	O
that	O
could	O
interact	O
with	O
cationic	protein
proteins	protein
and	O
that	O
could	O
be	O
responsible	O
for	O
resistance	O
to	O
defensin	protein
.	O
Because	O
insertion	O
mutations	O
in	O
phoP	DNA
are	O
polar	O
on	O
phoQ	DNA
,	O
we	O
constructed	O
strains	O
that	O
expressed	O
the	O
PhoQ	protein
protein	protein
in	O
the	O
absence	O
of	O
PhoP	protein
to	O
test	O
whether	O
resistance	O
to	O
defensin	O
requires	O
only	O
the	O
phoQ	protein
gene	protein
product	protein
.	O
We	O
found	O
that	O
resistance	O
to	O
defensin	O
requires	O
the	O
function	O
of	O
both	O
components	O
of	O
this	O
regulatory	O
system	O
,	O
because	O
strains	O
expressing	O
PhoQ	protein
without	O
PhoP	protein
were	O
still	O
markedly	O
sensitive	O
to	O
defensins	protein
.	O
This	O
implied	O
that	O
a	O
pag	protein
(	protein
phoP	protein
-activated	protein
gene	protein
)	protein
product	protein
is	O
responsible	O
for	O
defensin	protein
resistance	O
.	O
We	O
also	O
tested	O
for	O
the	O
ability	O
of	O
defensins	protein
NP-1	protein
,	O
NP-5	protein
,	O
and	O
HNP-1	protein
to	O
activate	O
pag	DNA
expression	O
and	O
found	O
that	O
these	O
peptides	O
have	O
no	O
effect.	O
Defensin	O
resistance	O
is	O
not	O
the	O
only	O
virulence	O
characteristic	O
controlled	O
by	O
the	O
PhoP	protein
-PhoQ	protein
regulon	protein
because	O
mutations	O
in	O
pagC	DNA
,	O
as	O
well	O
as	O
ones	O
in	O
the	O
phoP	DNA
locus	DNA
that	O
resulted	O
in	O
constitutive	O
pag	DNA
activation	O
(phenotype	O
PhoPc	protein
),	O
had	O
no	O
effect	O
on	O
defensin	protein
resistance	O
,	O
even	O
though	O
they	O
rendered	O
the	O
organism	O
avirulent	O
and	O
deficient	O
in	O
survival	O
within	O
macrophages	cell_type
.	O
The	O
virulence	O
defect	O
conferred	O
by	O
mutations	O
in	O
the	O
phoP	DNA
-phoQ	DNA
two-component	O
regulatory	O
system	O
is	O
not	O
completely	O
explained	O
by	O
alterations	O
in	O
resistance	O
to	O
cationic	protein
proteins	protein
and	O
involves	O
the	O
control	O
of	O
other	O
proteins	O
necessary	O
for	O
S.	O
typhimurium	O
survival	O
within	O
macrophages	cell_type
.	O

Stimulation	O
of	O
a	O
human	cell_line
T-cell	cell_line
clone	cell_line
with	O
anti-CD3	protein
or	O
tumor	protein
necrosis	protein
factor	protein
induces	O
NF-kappa	protein
B	protein
translocation	O
but	O
not	O
human	O
immunodeficiency	O
virus	O
1	O
enhancer-dependent	O
transcription	O
.	O
The	O
expression	O
of	O
transiently	O
transfected	O
expression	O
vectors	O
under	O
the	O
control	O
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
or	O
its	O
enhancer	DNA
sequence	DNA
and	O
the	O
translocation	O
of	O
the	O
HIV	protein
enhancer-binding	protein
protein	protein
NF-kappa	protein
B	protein
were	O
analyzed	O
in	O
two	O
human	O
T-cell	cell_line
clones	cell_line
stimulated	O
through	O
their	O
T-cell	protein
receptor	protein
complex	protein
or	O
by	O
tumor	protein
necrosis	protein
factor	protein
or	O
phorbol	O
12-myristate	O
13-acetate	O
.	O
We	O
found	O
a	O
dissociation	O
of	O
NF-kappa	protein
B	protein
translocation	O
from	O
transactivation	O
of	O
either	O
the	O
HIV	DNA
LTR	DNA
or	O
the	O
HIV	DNA
enhancer	DNA
.	O
Interleukin	protein
2	protein
induced	O
proliferation	O
but	O
not	O
NF-kappa	protein
B	protein
translocation	O
or	O
LTR	DNA
transactivation	O
.	O
Phorbol	O
ester	O
or	O
specific	O
antigen	O
recognition	O
induced	O
HIV	DNA
LTR	DNA
transactivation	O
,	O
whereas	O
stimulation	O
with	O
tumor	protein
necrosis	protein
factor	protein
or	O
antibody	O
to	O
CD3	protein
did	O
not.	O
The	O
two	O
latter	O
signals	O
were	O
nevertheless	O
able	O
to	O
induce	O
NF-kappa	protein
B	protein
translocation	O
with	O
a	O
pattern	O
in	O
the	O
band-shift	O
assay	O
indistinguishable	O
from	O
that	O
observed	O
using	O
phorbol	O
ester	O
.	O
Our	O
finding	O
that	O
induction	O
of	O
NF-kappa	protein
B	protein
by	O
tumor	protein
necrosis	protein
factor	protein
or	O
antibody	protein
to	protein
CD3	protein
is	O
not	O
sufficient	O
to	O
induce	O
HIV	DNA
enhancer	DNA
-dependent	O
transcription	O
in	O
cloned	cell_line
T	cell_line
cells	cell_line
contrasts	O
with	O
results	O
obtained	O
in	O
most	O
lymphoblastoid	cell_line
T-cell	cell_line
lines	cell_line
and	O
indicates	O
that	O
normal	O
T	cell_type
lymphocytes	cell_type
differ	O
from	O
tumoral	cell_type
T	cell_type
cells	cell_type
in	O
terms	O
of	O
requirements	O
for	O
HIV	DNA
LTR	DNA
activation	O
.	O
Furthermore,	O
our	O
results	O
suggest	O
that	O
events	O
linked	O
to	O
T-cell	O
activation	O
,	O
in	O
addition	O
to	O
NF-kappa	protein
B	protein
translocation	O
per	O
se,	O
induce	O
functional	O
interactions	O
of	O
the	O
NF-kappa	protein
B	protein
complex	protein
with	O
the	O
HIV	DNA
enhancer	DNA
.	O

Decreased	O
concentration	O
of	O
1,25-dihydroxyvitamin	protein
D3	protein
receptors	protein
in	O
peripheral	cell_type
mononuclear	cell_type
cells	cell_type
of	O
patients	O
with	O
X-linked	O
hypophosphatemic	O
rickets	O
:	O
effect	O
of	O
phosphate	O
supplementation	O
.	O
Abnormal	O
renal	O
tubular	O
phosphate	O
transport	O
is	O
considered	O
to	O
be	O
the	O
primary	O
defect	O
in	O
X-linked	O
hypophosphatemic	O
rickets	O
(	O
XLH	O
).	O
However,	O
the	O
resistance	O
to	O
vitamin	O
D	O
treatment	O
in	O
XLH	O
cannot	O
be	O
explained	O
by	O
hypophosphatemia	O
alone.	O
Since	O
most	O
of	O
the	O
actions	O
of	O
vitamin	O
D	O
are	O
mediated	O
by	O
its	O
receptors	O
(	O
VDR	protein
),	O
abnormalities	O
of	O
VDR	protein
have	O
been	O
postulated	O
in	O
XLH	O
.	O
In	O
order	O
to	O
investigate	O
this	O
possibility,	O
we	O
measured	O
the	O
concentration	O
of	O
VDR	protein
in	O
PHA-activated	cell_line
peripheral	cell_line
mononuclear	cell_line
cells	cell_line
from	O
10	O
XLH	O
patients	O
.	O
Patients	O
without	O
phosphate	O
supplementation	O
showed	O
significantly	O
lower	O
concentration	O
(21.7	O
+/-	O
5.1	O
fmol/mg	O
protein,	O
mean	O
+/-	O
SEM)	O
compared	O
to	O
the	O
normal	O
controls	O
(60.7	O
+/-	O
4.0).	O
On	O
the	O
contrary,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
phosphate-supplemented	O
patients	O
(58.3	O
+/-	O
2.7)	O
and	O
controls	O
.	O
There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
VDR	protein
concentration	O
and	O
serum	O
phosphate	O
(P	O
less	O
than	O
0.05).	O
In	O
two	O
patients	O
,	O
VDR	protein
was	O
increased	O
after	O
daily	O
phosphate	O
supplementation	O
was	O
started.	O
These	O
results	O
indicate	O
that	O
a	O
decreased	O
concentration	O
of	O
VDR	protein
secondary	O
to	O
persistent	O
hypophosphatemia	O
is	O
one	O
of	O
the	O
causes	O
of	O
vitamin	O
D	O
resistance	O
in	O
XLH	O
.	O

Two	O
distinct	O
forms	O
of	O
active	protein
transcription	protein
factor	protein
CREB	protein
(	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
).	O
Mammalian	cell_type
cells	cell_type
express	O
two	O
distinct	O
forms	O
of	O
transcription	protein
factor	protein
CREB	protein
(	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
)	O
that	O
are	O
apparently	O
the	O
products	O
of	O
alternative	O
splicing	O
of	O
the	O
CREB	RNA
gene	RNA
transcript	RNA
.	O
The	O
two	O
proteins	O
differ	O
by	O
a	O
14-amino	protein
acid	protein
serine-rich	protein
insertion	protein
present	O
in	O
one	O
of	O
the	O
CREB	protein
isoforms	protein
.	O
We	O
show	O
that	O
both	O
CREB	protein
isoforms	protein
are	O
expressed	O
in	O
many	cell_type
cell	cell_type
types	cell_type
and	O
mammalian	O
species	O
.	O
Both	O
encode	O
proteins	O
that	O
bind	O
specifically	O
to	O
a	O
cAMP	DNA
response	DNA
element	DNA
in	DNA
vitro	DNA
.	O
As	O
expected	O
for	O
proteins	O
of	O
this	O
class,	O
the	O
CREB	protein
proteins	protein
bind	O
DNA	O
as	O
dimers.	O
Both	O
proteins	O
impart	O
cAMP	O
-regulated	O
transcriptional	O
activity	O
to	O
a	O
heterologous	DNA
DNA-binding	DNA
domain	DNA
,	O
showing	O
that	O
cAMP	O
directly	O
modulates	O
the	O
transcriptional	O
stimulatory	O
activity	O
of	O
CREB	protein
.	O
The	O
presence	O
of	O
multiple	O
CREB	protein
isoforms	protein
with	O
identical	O
DNA-binding	O
specificities	O
but	O
differences	O
in	O
the	O
presumed	O
regulatory	protein
domain	protein
raises	O
the	O
possibility	O
that	O
CREB	protein
proteins	protein
may	O
be	O
able	O
to	O
integrate	O
distinct	O
regulatory	O
signals	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
.	O

Human	protein
immunodeficiency	protein
virus	protein
vpr	protein
product	protein
is	O
a	O
virion-associated	protein
regulatory	protein
protein	protein
.	O
The	O
vpr	protein
product	protein
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
acts	O
in	O
trans	O
to	O
accelerate	O
virus	O
replication	O
and	O
cytopathic	O
effect	O
in	O
T	cell_type
cells	cell_type
.	O
Here	O
it	O
is	O
shown	O
that	O
the	O
HIV-1	O
viral	O
particle	O
contains	O
multiple	O
copies	O
of	O
the	O
vpr	protein
protein	protein
.	O
The	O
vpr	protein
product	protein
is	O
the	O
first	O
regulatory	O
protein	O
of	O
HIV-1	O
to	O
be	O
found	O
in	O
the	O
virus	O
particle	O
.	O
This	O
observation	O
raises	O
the	O
possibility	O
that	O
vpr	DNA
acts	O
to	O
facilitate	O
the	O
early	O
steps	O
of	O
infection	O
before	O
de	O
novo	O
viral	O
protein	O
synthesis	O
occurs.	O

A	O
novel	O
B-cell	protein
lineage-specific	protein
transcription	protein
factor	protein
present	O
at	O
early	O
but	O
not	O
late	O
stages	O
of	O
differentiation	protein
.	O
A	O
novel	O
B-cell-specific	protein
transcription	protein
factor	protein
,	O
BSAP	protein
,	O
was	O
identified	O
as	O
a	O
mammalian	protein
homolog	protein
of	O
the	O
sea	protein
urchin	protein
protein	protein
TSAP	protein
,	O
which	O
interacts	O
with	O
the	O
promoters	DNA
of	O
four	O
tissue-specific	O
late	O
histone	O
H2A-2	O
and	O
H2B-2	O
genes	O
.	O
As	O
shown	O
by	O
mobility-shift	O
,	O
methylation	O
interference	O
,	O
and	O
mutational	O
analyses	O
,	O
the	O
mammalian	protein
protein	protein
BSAP	protein
recognizes	O
all	O
four	O
sea	DNA
urchin	DNA
binding	DNA
sites	DNA
in	O
a	O
manner	O
indistinguishable	O
from	O
TSAP	protein
;	O
however,	O
the	O
two	O
proteins	O
differ	O
in	O
molecular	O
weight.	O
BSAP	protein
is	O
exclusively	O
restricted	O
to	O
the	O
B-cell	O
lineage	O
of	O
lymphoid	O
differentiation	O
.	O
Its	O
expression	O
appears	O
to	O
be	O
activated	O
during	O
pro-B-cell	O
development	O
,	O
is	O
abundant	O
at	O
the	O
pre-B-	O
and	O
mature	O
B-	O
cell	O
stages	O
,	O
but	O
is	O
absent	O
in	O
terminally	cell_type
differentiated	cell_type
plasma	cell_type
cells	cell_type
.	O
Moreover,	O
BSAP	protein
is	O
clearly	O
a	O
B-cell-specific	protein
transcription	protein
factor	protein
,	O
as	O
a	O
wild-type	DNA
but	O
not	O
a	O
mutant	DNA
TSAP	DNA
-binding	DNA
site	DNA
of	O
the	O
sea	O
urchin	O
functions	O
only	O
in	O
transfected	cell_line
B	cell_line
cells	cell_line
as	O
an	O
upstream	DNA
promoter	DNA
element	DNA
.	O
Competition	O
experiments	O
did	O
not	O
reveal	O
any	O
high-affinity	DNA
binding	DNA
site	DNA
for	O
BSAP	protein
in	O
known	O
regulatory	DNA
regions	DNA
of	O
immunoglobulin	O
and	O
class	O
II	O
major	O
histocompatibility	O
(MHC)	O
genes	O
,	O
suggesting	O
that	O
BSAP	protein
is	O
a	O
regulator	O
of	O
a	O
different	O
set	O
of	O
B-lymphoid-specific	DNA
genes	DNA
.	O

Octamer	protein
transcription	protein
factors	protein
and	O
the	O
cell	DNA
type-specificity	DNA
of	DNA
immunoglobulin	DNA
gene	DNA
expression	O
.	O
Antibodies	protein
are	O
produced	O
exclusively	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
The	O
expression	O
of	O
the	O
antibody-encoding	DNA
genes	DNA
,	O
the	O
immunoglobulin	DNA
(Ig)	DNA
genes	DNA
,	O
is	O
also	O
restricted	O
to	O
B	cell_type
cells	cell_type
.	O
The	O
octamer	DNA
sequence	DNA
ATGCAAAT	O
is	O
present	O
in	O
the	O
promoter	DNA
and	O
the	O
enhancer	DNA
of	O
Ig	DNA
genes	DNA
,	O
and	O
plays	O
an	O
important	O
role	O
in	O
its	O
tissue-specific	O
expression	O
.	O
This	O
sequence	DNA
motif	DNA
is	O
a	O
binding	O
site	O
for	O
nuclear	protein
proteins	protein
,	O
the	O
so-called	O
octamer	protein
transcription	protein
factors	protein
(	O
Oct	protein
or	O
OTF	protein
factors	protein
).	O
The	O
Oct-1	protein
protein	protein
is	O
present	O
in	O
all	O
cell	O
types	O
analyzed	O
so	O
far,	O
whereas	O
Oct-2A	protein
and	O
Oct-2B	protein
are	O
found	O
mainly	O
in	O
B	cell_type
lymphocytes	cell_type
.	O
All	O
three	O
proteins	O
show	O
the	O
same	O
sequence	O
specificity	O
and	O
binding	O
affinity	O
.	O
It	O
appears	O
that	O
the	O
B	O
cell-specific	O
expression	O
of	O
Ig	DNA
genes	DNA
is	O
mediated	O
at	O
least	O
in	O
part	O
by	O
cell	O
type-specific	protein
Oct	protein
factors	protein
,	O
and	O
that	O
there	O
are	O
both	O
quantitative	O
and	O
qualitative	O
differences	O
between	O
Oct-1	protein
and	O
Oct-2	protein
factors	protein
.	O
Recently,	O
a	O
number	O
of	O
other	O
octamer	protein
factor	protein
variants	protein
were	O
identified.	O
Many	O
of	O
these	O
may	O
be	O
created	O
by	O
alternative	O
splicing	O
of	O
a	O
primary	RNA
transcript	RNA
of	O
one	O
Oct	O
factor	O
gene	O
and	O
may	O
serve	O
a	O
specific	O
function	O
in	O
the	O
fine	O
tuning	O
of	O
gene	O
expression	O
.	O

A	O
factor	O
known	O
to	O
bind	O
to	O
endogenous	DNA
Ig	DNA
heavy	DNA
chain	DNA
enhancer	DNA
only	O
in	O
lymphocytes	cell_type
is	O
a	O
ubiquitously	protein
active	protein
transcription	protein
factor	protein
.	O
The	O
transcriptional	DNA
enhancer	DNA
located	O
in	O
the	O
first	O
intron	O
of	O
the	O
immunoglobulin	DNA
heavy	DNA
chain	DNA
constant	DNA
region	DNA
is	O
a	O
major	O
determinant	O
of	O
B-cell-specific	O
expression	O
of	O
immunoglobulin	DNA
genes	DNA
.	O
Like	O
other	O
enhancers	DNA
,	O
the	O
Ig	DNA
heavy	DNA
chain	DNA
enhancer	DNA
contains	O
several	O
short	O
sequence	DNA
motifs	DNA
that	O
bind	O
specific	protein
transcription	protein
factors	protein
.	O
Each	O
binding	DNA
site	DNA
contributes	O
to	O
the	O
overall	O
activity	O
of	O
the	O
enhancer	DNA
,	O
however	O
no	O
single	O
element	O
seems	O
absolutely	O
required	O
for	O
activity.	O
For	O
a	O
better	O
understanding	O
of	O
the	O
Ig	DNA
heavy	DNA
chain	DNA
enhancer	DNA
components	DNA
,	O
we	O
have	O
cloned	O
and	O
analyzed	O
individual	O
sequence	DNA
elements	DNA
.	O
We	O
find	O
that	O
the	O
factor	O
that	O
binds	O
to	O
the	O
E3	DNA
enhancer	DNA
motif	DNA
,	O
CATGTGGC	O
,	O
is	O
a	O
ubiquitous	protein
transcription	protein
factor	protein
.	O
It	O
is	O
present	O
in	O
an	O
active	O
form	O
in	O
both	O
B	cell_type
cells	cell_type
and	O
non-	cell_type
B	cell_type
cells	cell_type
,	O
where	O
it	O
can	O
mediate	O
transcriptional	O
activation	O
in	O
vitro	O
and	O
in	O
vivo.	O
However,	O
despite	O
its	O
ability	O
to	O
activate	O
transcription	O
of	O
a	O
transfected	DNA
reporter	DNA
gene	DNA
,	O
the	O
factor	O
is	O
apparently	O
unable	O
to	O
bind	O
to	O
the	O
endogenous	DNA
Ig	DNA
heavy	DNA
chain	DNA
enhancer	DNA
in	O
non-	cell_type
lymphoid	cell_type
cells	cell_type
:	O
In	O
previous	O
experiments	O
by	O
others,	O
the	O
characteristic	O
in	O
vivo	O
footprint	O
of	O
this	O
factor,	O
designated	O
NF-muE3	protein
,	O
was	O
detected	O
in	O
B	cell_type
cells	cell_type
but	O
not	O
in	O
non-B	cell_type
cells	cell_type
.	O
From	O
this	O
and	O
other	O
findings	O
the	O
picture	O
emerges	O
that	O
there	O
are	O
at	O
least	O
three	O
categories	O
of	O
factors	O
which	O
mediate	O
cell-type-specific	O
transcription	O
in	O
B	cell_type
lymphocytes	cell_type
:	O
(a)	O
cell-specific	protein
factors	protein
such	O
as	O
Oct-2A	protein
and	O
Oct-2B	protein
that	O
are	O
not	O
expressed	O
in	O
most	O
other	O
cell	O
types:	O
(b)	O
ubiquitous	protein
factors	protein
such	O
as	O
NF-kappa	protein
B	protein
that	O
are	O
constitutively	O
active	O
in	O
B	cell_type
cells	cell_type
but	O
are	O
sequestered	O
in	O
an	O
inactive	O
form	O
in	O
other	O
cells;	O
(c)	O
ubiquitously	protein
active	protein
factors	protein
,	O
exemplified	O
by	O
the	O
one	O
binding	O
to	O
the	O
E3	DNA
sequence	DNA
motif	DNA
.	O
This	O
factor	O
is	O
present	O
in	O
an	O
active	O
form	O
in	O
a	O
variety	O
of	O
cell	O
types	O
but	O
is	O
apparently	O
unable	O
to	O
bind	O
to	O
the	O
endogenous	DNA
Ig	DNA
heavy	DNA
chain	DNA
enhancer	DNA
in	O
non-B	cell_type
cells	cell_type
,	O
perhaps	O
due	O
to	O
a	O
non-permissive	O
chromatin	DNA
structure	O
of	O
the	O
Ig	DNA
heavy	DNA
chain	DNA
locus	DNA
.	O

[	O
Endocrine	O
status	O
changes	O
in	O
children	O
with	O
bronchial	O
asthma	O
]	O
A	O
study	O
was	O
made	O
of	O
adrenocortical	O
function	O
by	O
measuring	O
blood	O
plasma	O
cortisol	O
concentration	O
and	O
amount	O
of	O
glucocorticoid	protein
receptors	protein
in	O
lymphocytes	cell_type
as	O
well	O
as	O
thyroid	O
function	O
by	O
measuring	O
blood	O
plasma	O
triidothyronine	O
and	O
thyroxine	O
concentration	O
in	O
58	O
bronchial	O
asthma	O
children	O
aged	O
1	O
to	O
14	O
years.	O
The	O
authors	O
revealed	O
alterations	O
in	O
the	O
functional	O
activity	O
of	O
the	O
indicated	O
endocrine	O
glands	O
depending	O
on	O
the	O
intensity	O
of	O
bronchial	O
patency	O
disorders	O
and	O
the	O
nature	O
of	O
the	O
therapeutic	O
measures	O
carried	O
out.	O

TAR	DNA
independent	O
activation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
in	O
phorbol	O
ester	O
stimulated	O
T	cell_type
lymphocytes	cell_type
.	O
Multiple	DNA
regulatory	DNA
elements	DNA
in	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
HIV	DNA
LTR	DNA
)	O
are	O
required	O
for	O
activation	O
of	O
HIV	O
gene	O
expression	O
.	O
Previous	O
transfection	O
studies	O
of	O
HIV	DNA
LTR	DNA
constructs	DNA
linked	O
to	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
gene	DNA
indicated	O
that	O
multiple	O
regulatory	DNA
regions	DNA
including	O
the	O
enhancer	DNA
,	O
SP1	DNA
,	O
TATA	DNA
and	O
TAR	DNA
regions	DNA
were	O
important	O
for	O
HIV	O
gene	O
expression	O
.	O
To	O
characterize	O
these	O
regulatory	DNA
elements	DNA
further,	O
mutations	O
in	O
these	O
regions	O
were	O
inserted	O
into	O
both	O
the	O
5'	O
and	O
3'	O
HIV	DNA
LTRs	DNA
and	O
infectious	O
proviral	O
constructs	O
were	O
assembled.	O
These	O
constructs	O
were	O
transfected	O
into	O
either	O
HeLa	cell_line
cells	cell_line
,	O
Jurkat	cell_line
cells	cell_line
or	O
U937	cell_line
cells	cell_line
in	O
both	O
the	O
presence	O
and	O
absence	O
of	O
phorbol	O
esters	O
which	O
have	O
previously	O
been	O
demonstrated	O
to	O
activate	O
HIV	O
gene	O
expression	O
.	O
Viral	O
gene	O
expression	O
was	O
assayed	O
by	O
the	O
level	O
of	O
p24	protein
gag	protein
protein	protein
released	O
from	O
cultures	O
transfected	O
with	O
the	O
proviral	O
constructs	O
.	O
Results	O
in	O
all	O
cell	O
lines	O
indicated	O
that	O
mutations	O
of	O
the	O
SP1	DNA
,	O
TATA	DNA
and	O
the	O
TAR	DNA
loop	DNA
and	O
stem	DNA
secondary	DNA
structure	DNA
resulted	O
in	O
marked	O
decreases	O
in	O
gene	O
expression	O
while	O
mutations	O
of	O
the	O
enhancer	DNA
motif	DNA
or	O
TAR	DNA
primary	DNA
sequence	DNA
resulted	O
in	O
only	O
slight	O
decreases.	O
However,	O
viruses	O
containing	O
mutations	O
in	O
either	O
the	O
TAR	DNA
loop	DNA
sequences	DNA
or	O
stem	DNA
secondary	DNA
structure	DNA
which	O
were	O
very	O
defective	O
for	O
gene	O
expression	O
in	O
untreated	O
Jurkat	cell_line
cells	cell_line
,	O
gave	O
nearly	O
wild-type	O
levels	O
of	O
gene	O
expression	O
in	O
phorbol	cell_line
ester	cell_line
-treated	cell_line
Jurkat	cell_line
cells	cell_line
but	O
not	O
in	O
phorbol	cell_line
ester	cell_line
-treated	cell_line
HeLa	cell_line
or	O
U937	cell_line
cells	cell_line
.	O
High	O
level	O
gene	O
expression	O
of	O
these	O
TAR	DNA
mutant	DNA
constructs	DNA
in	O
phorbol	cell_line
ester	cell_line
-treated	cell_line
Jurkat	cell_line
cells	cell_line
was	O
eliminated	O
by	O
second	O
site	O
mutations	O
in	O
the	O
enhancer	DNA
region	DNA
or	O
by	O
disruption	O
of	O
the	O
tat	DNA
gene	DNA
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

A	O
case	O
of	O
hypersensitivity	O
to	O
thyroid	O
hormones	O
with	O
normally	O
functioning	O
thyroid	O
gland	O
and	O
increased	O
nuclear	O
triiodothyronine	protein
receptors	protein
.	O
A	O
52-year-old	O
male	O
presented	O
himself	O
with	O
tachycardia	O
crises	O
which	O
appeared	O
first	O
during	O
childhood,	O
increased	O
in	O
frequency	O
without	O
goiter	O
or	O
exophthalmos	O
.	O
Cardiac	O
and	O
adrenergic	O
diseases	O
were	O
excluded.	O
The	O
thyroid	O
function	O
was	O
normal	O
regarding	O
T4	O
,	O
free	O
T4	O
and	O
T3	O
,	O
TBG	O
,	O
radioiodine	O
uptake	O
,	O
TSH	O
and	O
T3	O
suppressibility	O
;	O
however	O
the	O
TSH	O
response	O
to	O
TRH	O
was	O
decreased.	O
The	O
lymphocyte	protein
nuclear	protein
T3	protein
receptor	protein
was	O
found	O
with	O
an	O
affinity	O
close	O
to	O
that	O
of	O
normal	O
volunteers	O
(Ka:	O
1.42	O
x	O
10(10)	O
M-1	O
vs	O
1.95	O
+/-	O
0.35	O
x	O
10(10)	O
M-1)	O
and	O
a	O
binding	O
capacity	O
markedly	O
increased	O
(9.9	O
vs	O
3.7	O
+/-	O
0.4	O
fmol	O
T3	O
/100	O
micrograms	O
DNA).	O
Pindolol	O
was	O
inefficient	O
on	O
the	O
dysrhythmia	O
which	O
disappeared	O
with	O
carbimazole	O
and	O
relapsed	O
after	O
withdrawal	O
of	O
the	O
antithyroid	O
drug.	O
Under	O
carbimazole	O
,	O
the	O
plasma	O
T4	O
markedly	O
decreased	O
(27.7	O
+/-	O
3.6	O
nmol/l)	O
but	O
the	O
patient	O
remained	O
euthyroid	O
.	O
The	O
clinical	O
course	O
and	O
the	O
laboratory	O
data	O
suggest	O
that	O
the	O
tachycardia	O
crises	O
are	O
the	O
consequence	O
of	O
a	O
hypersensitivity	O
of	O
the	O
heart	O
to	O
thyroid	O
hormones	O
,	O
associated	O
with	O
an	O
increased	O
number	O
of	O
T3	protein
nuclear	protein
receptor	protein
sites	O
in	O
lymphocytes	cell_type
.	O

Induction	O
of	O
immediate	DNA
early	DNA
response	DNA
genes	DNA
by	O
macrophage	protein
colony-stimulating	protein
factor	protein
in	O
normal	cell_type
human	cell_type
monocytes	cell_type
.	O
A	O
group	O
of	O
coordinately	O
induced	O
protooncogenes	DNA
,	O
cytoskeletal	O
,	O
and	O
extracellular	O
matrix	O
genes	O
have	O
been	O
termed	O
immediate	DNA
early	DNA
response	DNA
genes	DNA
,	O
and	O
their	O
induction	O
has	O
been	O
associated	O
with	O
growth	protein
factor	protein
-stimulated	O
cell	O
proliferation	O
.	O
We	O
have	O
investigated	O
the	O
induction	O
of	O
these	O
genes	O
by	O
macrophage-CSF	protein
(	O
M-CSF	protein
)	O
in	O
human	cell_type
monocytes	cell_type
that	O
do	O
not	O
proliferate	O
in	O
response	O
to	O
M-CSF	protein
but	O
require	O
the	O
factor	O
for	O
optimal	O
cell	O
differentiation	O
.	O
Normal	O
human	cell_type
monocytes	cell_type
were	O
isolated,	O
carefully	O
washed,	O
and	O
incubated	O
for	O
36	O
to	O
48	O
h	O
in	O
fetal	O
bovine	O
serum-containing	O
medium	O
.	O
At	O
the	O
end	O
of	O
this	O
incubation	O
the	O
resting	cell_type
cells	cell_type
were	O
stimulated	O
with	O
M-CSF	protein
,	O
and	O
RNA	RNA
was	O
isolated	O
for	O
analysis	O
by	O
Northern	O
blotting	O
.	O
RNA	RNA
from	O
control	O
resting	cell_type
cells	cell_type
contained	O
low	O
to	O
undetectable	O
levels	O
of	O
c-jun	RNA
,	O
fibronectin	RNA
receptor	RNA
,	O
and	O
actin	RNA
mRNA	RNA
.	O
Within	O
15	O
to	O
30	O
min	O
of	O
addition	O
of	O
M-CSF	protein
,	O
however,	O
there	O
was	O
a	O
dramatic	O
coordinate	O
induction	O
of	O
these	O
genes.	O
The	O
c-jun	DNA
gene	DNA
expression	O
was	O
very	O
transient	O
and	O
was	O
not	O
detectable	O
by	O
60	O
min	O
after	O
M-CSF	protein
addition	O
.	O
In	O
contrast,	O
the	O
expression	O
of	O
actin	O
and	O
fibronectin	O
receptor	O
mRNA	O
was	O
more	O
sustained,	O
and	O
the	O
expression	O
of	O
these	O
genes	O
remained	O
elevated	O
at	O
24	O
to	O
48	O
h	O
after	O
M-CSF	protein
addition	O
.	O
We	O
also	O
observed	O
the	O
induction	O
of	O
the	O
myelomonocytic	DNA
specific	DNA
tyrosine	DNA
kinase	DNA
hck	DNA
gene	DNA
simultaneously	O
with	O
the	O
other	O
immediate	DNA
early	DNA
response	DNA
genes	DNA
.	O
The	O
protein	O
synthesis	O
inhibitor	O
cycloheximide	O
did	O
not	O
block	O
the	O
induction	O
of	O
any	O
of	O
these	O
genes,	O
and	O
in	O
fact,	O
super-induced	O
the	O
expression	O
of	O
c-jun	DNA
and	O
hck	DNA
.	O
Nuclear	O
run	O
on	O
transcription	O
of	O
the	O
c-jun	DNA
,	O
hck	DNA
,	O
and	O
actin	DNA
genes	DNA
.	O
Therefore,	O
in	O
normal	cell_type
human	cell_type
monocytes	cell_type
M-CSF	protein
induces	O
immediate	DNA
early	DNA
response	DNA
genes	DNA
without	O
inducing	O
cell	O
proliferation.	O
These	O
genes	O
may	O
then	O
play	O
a	O
role	O
in	O
altering	O
the	O
physiologic	O
status	O
of	O
the	O
cells	O
in	O
response	O
to	O
CSF	protein
.	O

Inducible	O
nuclear	protein
factor	protein
binding	O
to	O
the	O
kappa	DNA
B	DNA
elements	DNA
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
enhancer	DNA
in	O
T	cell_type
cells	cell_type
can	O
be	O
blocked	O
by	O
cyclosporin	O
A	O
in	O
a	O
signal-dependent	O
manner	O
.	O
Cyclosporin	O
A	O
(	O
CsA	O
)	O
is	O
thought	O
to	O
exert	O
its	O
immunosuppressive	O
effects	O
by	O
inhibiting	O
the	O
expression	O
of	O
a	O
distinct	O
set	O
of	O
lymphokine	DNA
genes	DNA
which	O
are	O
induced	O
upon	O
T-cell	O
activation	O
,	O
among	O
them	O
the	O
gene	O
coding	O
for	O
interleukin-2	protein
.	O
In	O
addition,	O
the	O
activation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
is	O
partially	O
suppressed.	O
To	O
better	O
understand	O
the	O
molecular	O
mechanisms	O
underlying	O
suppression	O
by	O
CsA	O
,	O
we	O
have	O
investigated	O
the	O
effects	O
of	O
this	O
drug	O
on	O
transcription	protein
factors	protein
in	O
T	cell_type
cells	cell_type
.	O
Here	O
we	O
report	O
that	O
the	O
formation	O
of	O
two	O
distinct	O
mitogen-inducible	protein
DNA-binding	protein
complexes	protein
,	O
the	O
kappa	protein
B	protein
complex	protein
within	O
the	O
HIV	DNA
enhancer	DNA
and	O
the	O
NFAT-1	protein
complex	protein
within	O
the	O
interleukin-2	DNA
enhancer	DNA
,	O
is	O
inhibited	O
in	O
the	O
presence	O
of	O
CsA	O
.	O
The	O
kappa	O
B-binding	O
activity	O
with	O
the	O
HIV	DNA
enhancer	DNA
is	O
inhibited	O
only	O
if	O
it	O
is	O
activated	O
via	O
the	O
mitogen	protein
phytohemagglutinin	protein
whereas	O
phorbol	O
myristate	O
acetate	O
-mediated	O
activation	O
is	O
completely	O
insensitive	O
to	O
the	O
drug.	O
This	O
suggests	O
a	O
model	O
in	O
which	O
functionally	O
indistinguishable	O
kappa	protein
B	protein
complexes	protein
can	O
be	O
activated	O
via	O
two	O
separate	O
pathways	O
of	O
signal	O
transduction	O
distinguishable	O
by	O
CsA	O
.	O

Purification	O
of	O
TCF-1	protein
alpha	protein
,	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
that	O
activates	O
the	O
T-cell	DNA
receptor	DNA
C	DNA
alpha	DNA
gene	DNA
enhancer	DNA
in	O
a	O
context-dependent	O
manner.	O
The	O
differentiation	O
of	O
T	cell_type
cells	cell_type
into	O
functionally	O
diverse	O
subpopulations	O
is	O
controlled	O
in	O
part,	O
by	O
transcriptional	O
activation	O
and	O
silencing	O
;	O
however,	O
little	O
is	O
known	O
in	O
detail	O
about	O
the	O
proteins	O
that	O
influence	O
this	O
developmental	O
process	O
.	O
We	O
have	O
purified	O
a	O
new	O
T-cell-specific	protein
factor	protein
,	O
TCF-1	protein
alpha	protein
,	O
that	O
is	O
implicated	O
in	O
the	O
activation	O
of	O
genes	O
encoding	O
a	O
major	O
component	O
of	O
the	O
human	protein
T-cell	protein
receptor	protein
(	O
TCR	protein
).	O
TCF-1	protein
alpha	protein
,	O
originally	O
identified	O
and	O
purified	O
through	O
its	O
binding	O
sites	O
on	O
the	O
HIV-1	DNA
promoter	DNA
,	O
was	O
found	O
to	O
bind	O
to	O
the	O
TCR	DNA
alpha	DNA
enhancer	DNA
and	O
to	O
promoters	DNA
for	O
several	O
genes	DNA
expressed	O
at	O
significantly	O
earlier	O
stages	O
of	O
T-cell	O
development	O
than	O
the	O
TCR	DNA
alpha	DNA
gene	DNA
(e.g.,	O
p56lck	DNA
and	O
CD3	DNA
delta	DNA
).	O
Sequences	O
related	O
to	O
the	O
TCF-1	DNA
alpha	DNA
binding	DNA
motif	DNA
(	O
5'-GGCACCCTTTGA-3'	O
)	O
are	O
also	O
found	O
in	O
the	O
human	DNA
TCR	DNA
delta	DNA
(and	O
possibly	O
TCR	DNA
beta	DNA
)	O
enhancers	DNA
.	O
Southwestern	O
and	O
gel	O
renaturation	O
experiments	O
with	O
the	O
use	O
of	O
purified	O
protein	O
fractions	O
revealed	O
that	O
TCF-1	protein
alpha	protein
activity	O
is	O
derived	O
from	O
a	O
family	O
of	O
57-	protein
to	protein
53-kD	protein
proteins	protein
that	O
are	O
abundantly	O
expressed	O
in	O
mature	O
and	O
immature	O
T-cell	O
lines	O
(	O
Jurkat	cell_line
,	O
CCRF-CEM	cell_line
)	O
and	O
not	O
in	O
mature	cell_line
B	cell_line
cells	cell_line
(	O
JY	cell_line
,	O
Namalwa	cell_line
)	O
or	O
nonlymphoid	cell_line
(HeLa)	cell_line
cell	cell_line
lines	cell_line
.	O
A	O
small	O
95-bp	O
fragment	O
of	O
the	O
TCR	DNA
alpha	DNA
control	DNA
region	DNA
that	O
contains	O
the	O
TCF-1	DNA
alpha	DNA
binding	DNA
site	DNA
juxtaposed	O
between	O
a	O
cAMP-response	DNA
element	DNA
(the	O
CRE	DNA
or	O
T	DNA
alpha	DNA
1	DNA
motif	DNA
)	O
and	O
the	O
binding	DNA
site	DNA
for	O
a	O
distinct	O
lymphoid-specific	protein
protein	protein
(	O
TCF-2	protein
alpha	protein
)	O
behaved	O
as	O
a	O
potent	O
T-cell-specific	DNA
enhancer	DNA
in	O
vivo.	O
Tandem	O
copies	O
of	O
this	O
enhancer	O
functioned	O
synergistically	O
in	O
mature	cell_line
(Jurkat)	cell_line
T-cell	cell_line
lines	cell_line
as	O
well	O
as	O
resting	O
and	O
activated	O
immature	cell_line
(CCRF-CEM)	cell_line
T-cell	cell_line
lines	cell_line
.	O
Mutation	O
of	O
the	O
TCF-1	DNA
alpha	DNA
binding	DNA
site	DNA
diminished	O
enhancer	O
activity	O
and	O
disrupted	O
the	O
synergism	O
observed	O
in	O
vivo	O
between	O
tandem	DNA
enhancer	DNA
repeats	DNA
.	O
The	O
TCF-1	DNA
alpha	DNA
binding	DNA
site	DNA
was	O
also	O
required	O
for	O
TCR	protein
alpha	O
enhancer	O
activity	O
in	O
transcriptionally	O
active	O
extracts	O
from	O
Jurkat	cell_line
but	O
not	O
HeLa	cell_line
cells	cell_line
,	O
confirming	O
that	O
TCF-1	protein
alpha	protein
is	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
.	O
Curiously,	O
the	O
TCF-1	protein
alpha	protein
binding	O
element	O
was	O
inactive	O
in	O
vivo	O
when	O
removed	O
from	O
its	O
neighboring	O
elements	O
on	O
the	O
TCR	DNA
alpha	DNA
enhancer	DNA
and	O
positioned	O
in	O
one	O
or	O
more	O
copies	O
upstream	O
of	O
a	O
heterologous	DNA
promoter	DNA
.	O
Thus,	O
the	O
transcriptional	O
activity	O
of	O
TCF-1	protein
alpha	protein
appears	O
to	O
depend	O
on	O
the	O
TCF-2	protein
alpha	protein
and	O
T	protein
alpha	protein
1	protein
(	O
CREB	protein
)	O
transcription	protein
factors	protein
and	O
the	O
context	O
of	O
its	O
binding	O
site	O
within	O
the	O
TCR	DNA
alpha	DNA
enhancer	DNA
.	O

Tandem	DNA
AP-1-binding	DNA
sites	DNA
within	O
the	O
human	DNA
beta-globin	DNA
dominant	DNA
control	DNA
region	DNA
function	O
as	O
an	O
inducible	DNA
enhancer	DNA
in	O
erythroid	cell_type
cells	cell_type
.	O
A	O
powerful	O
enhancer	O
has	O
been	O
mapped	O
to	O
an	O
18-bp	DNA
DNA	DNA
segment	DNA
located	O
11	O
kb	O
5'	O
to	O
the	O
human	DNA
epsilon-globin	DNA
gene	DNA
within	O
the	O
dominant	DNA
control	DNA
or	O
locus-activating	DNA
region	DNA
.	O
This	O
enhancer	DNA
is	O
inducible	O
in	O
K562	cell_line
human	cell_line
erythroleukemia	cell_line
cells	cell_line
,	O
increasing	O
linked	O
gamma-globin	DNA
promoter	DNA
/luciferase	protein
gene	O
expression	O
to	O
170-fold	O
over	O
an	O
enhancerless	DNA
construct	DNA
.	O
The	O
enhancer	DNA
consists	O
of	O
tandem	DNA
AP-1-binding	DNA
sites	DNA
,	O
phased	O
10	O
bp	O
apart,	O
which	O
are	O
both	O
required	O
for	O
full	O
activity.	O
DNA-protein	O
binding	O
assays	O
with	O
nuclear	O
extracts	O
from	O
induced	O
cells	O
demonstrate	O
a	O
high	protein
molecular	protein
weight	protein
complex	protein
on	O
the	O
enhancer	DNA
.	O
The	O
formation	O
of	O
this	O
complex	O
also	O
requires	O
both	O
AP-1	DNA
sites	DNA
and	O
correlates	O
with	O
maximal	O
enhancer	DNA
activity	O
.	O
Induction	O
of	O
the	O
enhancer	DNA
may	O
have	O
a	O
role	O
in	O
the	O
increase	O
in	O
globin	DNA
gene	DNA
transcription	O
that	O
characterizes	O
erythroid	O
maturation	O
.	O
Enhancer	O
activity	O
appears	O
to	O
be	O
mediated	O
by	O
the	O
binding	O
of	O
a	O
complex	O
of	O
proteins	O
from	O
the	O
jun	DNA
and	DNA
fos	DNA
families	DNA
to	O
tandem	DNA
AP-1	DNA
consensus	DNA
sequences	DNA
.	O

Identification	O
of	O
a	O
novel	protein
factor	protein
that	O
interacts	O
with	O
an	O
immunoglobulin	DNA
heavy-chain	DNA
promoter	DNA
and	O
stimulates	O
transcription	O
in	O
conjunction	O
with	O
the	O
lymphoid	protein
cell-specific	protein
factor	protein
OTF2	protein
.	O
The	O
tissue-specific	O
expression	O
of	O
the	O
MOPC	DNA
141	DNA
immunoglobulin	DNA
heavy-chain	DNA
gene	DNA
was	O
studied	O
by	O
using	O
in	O
vitro	O
transcription	O
.	O
B-cell-specific	O
transcription	O
of	O
this	O
gene	O
was	O
dependent	O
on	O
the	O
octamer	DNA
element	DNA
5'-ATGCAAAG-3'	O
,	O
located	O
in	O
the	O
upstream	DNA
region	DNA
of	O
this	O
promoter	DNA
and	O
in	O
the	O
promoters	DNA
of	O
all	O
other	O
immunoglobulin	O
heavy-	O
and	O
light-	O
chain	O
genes	O
.	O
The	O
interaction	O
of	O
purified	O
octamer	protein
transcription	protein
factors	protein
1	O
and	O
2	O
(	O
OTF1	protein
and	O
OTF2	protein
)	O
with	O
the	O
MOPC	DNA
141	DNA
promoter	DNA
was	O
studied	O
by	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
DNase	protein
I	protein
footprinting	O
.	O
Purified	O
OTF1	protein
from	O
HeLa	cell_line
cells	cell_line
and	O
OTF1	protein
and	O
OTF2	protein
from	O
B	cell_type
cells	cell_type
bound	O
to	O
identical	O
sequences	O
within	O
the	O
heavy-chain	DNA
promoter	DNA
.	O
The	O
OTF	O
interactions	O
we	O
observed	O
extended	O
over	O
the	O
heptamer	DNA
element	DNA
5'-CTCAGGA-3'	O
,	O
and	O
it	O
seems	O
likely	O
that	O
the	O
binding	O
of	O
the	O
purified	protein
factors	protein
involves	O
cooperation	O
between	O
octamer	O
and	O
heptamer	O
sites	O
in	O
this	O
promoter	DNA
.	O
In	O
addition	O
to	O
these	O
elements,	O
we	O
identified	O
a	O
second	O
regulatory	DNA
element	DNA
,	O
the	O
N	DNA
element	DNA
with	O
the	O
sequence	O
5'-GGAACCTCCCCC-3'	O
.	O
The	O
N	DNA
element	DNA
could	O
independently	O
mediate	O
low	O
levels	O
of	O
transcription	O
in	O
both	O
B-cell	O
and	O
HeLa-cell	O
extracts	O
,	O
and,	O
in	O
conjunction	O
with	O
the	O
octamer	DNA
element	DNA
,	O
it	O
can	O
promote	O
high	O
levels	O
of	O
transcription	O
in	O
B-cell	O
extracts	O
.	O
The	O
N	DNA
element	DNA
bound	O
a	O
transcription	protein
factor	protein
,	O
NTF	protein
,	O
that	O
is	O
ubiquitous	O
in	O
cell-type	protein
distribution	protein
,	O
and	O
NTF	protein
was	O
distinct	O
from	O
any	O
of	O
the	O
previously	protein
described	protein
proteins	protein
that	O
bind	O
to	O
similar	O
sequences.	O
Based	O
on	O
these	O
results,	O
we	O
propose	O
that	O
NTF	protein
and	O
OTF2	protein
interactions	O
(both	O
with	O
their	O
cognate	DNA
DNA	DNA
elements	DNA
and	O
possibly	O
at	O
the	O
protein-protein	O
level	O
)	O
may	O
be	O
critical	O
to	O
B-cell-specific	O
expression	O
and	O
that	O
these	O
interactions	O
provide	O
additional	O
pathways	O
for	O
regulating	O
gene	O
expression	O
.	O

NF-kappa	protein
B	protein
as	O
inducible	O
transcriptional	protein
activator	protein
of	O
the	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
gene	DNA
.	O
The	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
granulocyte-	protein
macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
is	O
induced	O
upon	O
activation	O
of	O
T	cell_type
cells	cell_type
with	O
phytohemagglutinin	protein
and	O
active	O
phorbolester	O
and	O
upon	O
expression	O
of	O
tax1	protein
,	O
a	O
transactivating	protein
protein	protein
of	O
the	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
.	O
The	O
same	O
agents	O
induce	O
transcription	O
from	O
the	O
interleukin-2	O
receptor	O
alpha-chain	O
and	O
interleukin-2	O
genes	O
,	O
depending	O
on	O
promoter	DNA
elements	DNA
that	O
bind	O
the	O
inducible	protein
transcription	protein
factor	protein
NF-kappa	protein
B	protein
(or	O
an	O
NF-kappa	protein
B	protein
-like	protein
factor	protein
).	O
We	O
therefore	O
tested	O
the	O
possibility	O
that	O
the	O
GM-CSF	DNA
gene	DNA
is	O
also	O
regulated	O
by	O
a	O
cognate	O
motif	O
for	O
the	O
NF-kappa	protein
B	protein
transcription	protein
factor	protein
.	O
A	O
recent	O
functional	O
analysis	O
by	O
Miyatake	O
et	O
al.	O
(S.	O
Miyatake,	O
M.	O
Seiki,	O
M.	O
Yoshida,	O
and	O
K.	O
Arai,	O
Mol.	O
Cell.	O
Biol.	O
8:5581-5587,	O
1988)	O
described	O
a	O
short	DNA
promoter	DNA
region	DNA
in	O
the	O
GM-CSF	DNA
gene	DNA
that	O
conferred	O
strong	O
inducibility	O
by	O
T-cell-activating	O
signals	O
and	O
tax1	protein
,	O
but	O
no	O
NF-kappa	DNA
B	DNA
-binding	DNA
motifs	DNA
were	O
identified.	O
Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
showed	O
binding	O
of	O
purified	O
human	protein
NF-kappa	protein
B	protein
and	O
of	O
the	O
NF-kappa	protein
B	protein
activated	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
to	O
an	O
oligonucleotide	O
comprising	O
the	O
GM-CSF	DNA
promoter	DNA
element	DNA
responsible	O
for	O
mediating	O
responsiveness	O
to	O
T-cell-activating	O
signals	O
and	O
tax1	protein
.	O
As	O
shown	O
by	O
a	O
methylation	O
interference	O
analysis	O
and	O
oligonucleotide	O
competition	O
experiments,	O
purified	O
NF-kappa	protein
B	protein
binds	O
at	O
positions	DNA
-82	DNA
to	DNA
-91	DNA
(	O
GGGAACTACC	O
)	O
of	O
the	O
GM-CSF	DNA
promoter	DNA
sequence	O
with	O
an	O
affinity	O
similar	O
to	O
that	O
with	O
which	O
it	O
binds	O
to	O
the	O
biologically	DNA
functional	DNA
kappa	DNA
B	DNA
motif	DNA
in	O
the	O
beta	DNA
interferon	DNA
promoter	DNA
(	O
GGGAAATTCC	O
).	O
Two	O
kappa	DNA
B-like	DNA
motifs	DNA
at	O
positions	DNA
-98	DNA
to	DNA
-108	DNA
of	O
the	O
GM-CSF	DNA
promoter	DNA
were	O
also	O
recognized	O
but	O
with	O
much	O
lower	O
affinities.	O
Our	O
data	O
provide	O
strong	O
evidence	O
that	O
the	O
expression	O
of	O
the	O
GM-CSF	DNA
gene	DNA
following	O
T-cell	O
activation	O
is	O
controlled	O
by	O
binding	O
of	O
the	O
NF-kappa	protein
B	protein
transcription	protein
factor	protein
to	O
a	O
high-affinity	DNA
binding	DNA
site	DNA
in	O
the	O
GM-CSF	DNA
promoter	DNA
.	O

Effects	O
of	O
mitogenic	O
agents	O
upon	O
glucocorticoid	O
action	O
in	O
human	cell_type
tonsillar	cell_type
T-	cell_type
lymphocytes	cell_type
.	O
The	O
treatment	O
of	O
human	cell_type
tonsillar	cell_type
T-	cell_type
lymphocytes	cell_type
with	O
4-phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
),	O
resulted	O
in	O
about	O
two	O
fold	O
increase	O
in	O
glucocorticoid	protein
receptor	protein
(	O
GR	protein
)	O
number	O
,	O
without	O
any	O
significant	O
change	O
in	O
the	O
receptor	O
affinity	O
.	O
This	O
increase	O
disappeared	O
in	O
the	O
presence	O
of	O
cycloheximide	O
.	O
Alone,	O
PMA	O
and	O
calcium	O
ionophore	O
A23187	O
did	O
not	O
affect,	O
but	O
together	O
stimulated,	O
like	O
phytohaemagglutinin	protein
(	O
PHA	protein
),	O
leucine	O
and,	O
in	O
particular,	O
thymidine	O
incorporation	O
.	O
PMA	O
enhanced	O
slightly	O
the	O
stimulatory	O
effect	O
of	O
PHA	protein
.	O
Alone,	O
these	O
agents	O
failed	O
to	O
alter	O
the	O
suppressive	O
effect	O
of	O
dexamethasone	O
on	O
thymidine	O
and	O
leucine	O
incorporation	O
;	O
however,	O
PMA	O
-A23187	O
and	O
PMA	O
-PHA	protein
combinations	O
appeared	O
to	O
antagonize	O
the	O
suppression	O
by	O
dexamethasone	O
.	O

To	O
be	O
or	O
not	O
to	O
be	O
a	O
responder	O
in	O
T-cell	O
responses	O
:	O
ubiquitous	O
oligopeptides	O
in	O
all	O
proteins.	O
Amino	O
acid	O
sequences	O
of	O
all	O
proteins	O
are	O
essays	O
written	O
in	O
the	O
same	O
language.	O
Accordingly,	O
the	O
same	O
set	O
of	O
words	O
and	O
phrases	O
(	O
oligopeptides	O
)	O
appear	O
in	O
totally	O
unrelated	protein
proteins	protein
.	O
The	O
reason	O
that	O
only	O
certain	O
individuals	O
of	O
particular	O
major	protein
histocompatibility	protein
complex	protein
(MHC)	protein
haplotypes	protein
can	O
mount	O
T-cell	O
responses	O
against	O
a	O
given	O
antigen	O
of	O
pathogens	O
is	O
found	O
in	O
the	O
fact	O
that	O
T-cell	protein
receptors	protein
are	O
designed	O
to	O
recognize	O
18-20	O
residue-long	O
peptide	O
fragments	O
sandwiched	O
between	O
two	O
alpha-helices	protein
of	O
class	protein
I	protein
or	O
class	protein
II	protein
MHC	protein
molecules	protein
.	O
At	O
this	O
range	O
of	O
peptide	O
lengths	O
,	O
most	O
would	O
appear	O
as	O
self,	O
while	O
nonselfness	O
of	O
the	O
remainders	O
are	O
destined	O
to	O
be	O
quite	O
ambiguous,	O
hence	O
creating	O
responders	O
and	O
nonresponders.	O

Two	O
distinct	O
signal	O
transmission	O
pathways	O
in	O
T	cell_type
lymphocytes	cell_type
are	O
inhibited	O
by	O
complexes	O
formed	O
between	O
an	O
immunophilin	protein
and	O
either	O
FK506	O
or	O
rapamycin	O
.	O
Proliferation	O
and	O
immunologic	O
function	O
of	O
T	cell_type
lymphocytes	cell_type
are	O
initiated	O
by	O
signals	O
from	O
the	O
antigen	protein
receptor	protein
that	O
are	O
inhibited	O
by	O
the	O
immunosuppressant	O
FK506	O
but	O
not	O
by	O
its	O
structural	O
analog,	O
rapamycin	O
.	O
On	O
the	O
other	O
hand,	O
interleukin	protein
2	protein
(	O
IL-2	protein
)-induced	O
signals	O
are	O
blocked	O
by	O
rapamycin	O
but	O
not	O
by	O
FK506	O
.	O
Remarkably,	O
these	O
two	O
drugs	O
inhibit	O
each	O
other's	O
actions,	O
raising	O
the	O
possibility	O
that	O
both	O
act	O
by	O
means	O
of	O
a	O
common	O
immunophilin	protein
(	O
immunosuppressant	protein
binding	protein
protein	protein
).	O
We	O
find	O
that	O
the	O
dissociation	O
constant	O
of	O
rapamycin	O
to	O
the	O
FK506	protein
binding	protein
protein	protein
FKBP	protein
(Kd	O
=	O
0.2	O
nM)	O
is	O
close	O
to	O
the	O
dissociation	O
constant	O
of	O
FK506	O
to	O
FKBP	protein
(Kd	O
=	O
0.4	O
nM)	O
and	O
to	O
their	O
effective	O
biologic	O
inhibitory	O
concentrations	O
.	O
However,	O
an	O
excess	O
of	O
rapamycin	O
is	O
needed	O
to	O
revert	O
FK506	O
-mediated	O
inhibition	O
of	O
IL-2	protein
production	O
,	O
apoptosis	O
,	O
and	O
transcriptional	O
activation	O
of	O
NF-AT	protein
,	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
necessary	O
for	O
IL-2	DNA
gene	DNA
activation	O
.	O
Similarly,	O
an	O
excess	O
of	O
FK506	O
is	O
needed	O
to	O
revert	O
rapamycin	O
-mediated	O
inhibition	O
of	O
IL-2	protein
-induced	O
proliferation	O
.	O
The	O
drug	O
concentrations	O
required	O
for	O
antagonism	O
may	O
be	O
explained	O
by	O
the	O
relative	O
affinity	O
of	O
the	O
drugs	O
to,	O
and	O
by	O
the	O
abundance	O
of,	O
the	O
immunophilin	protein
FKBP	protein
.	O
FKBP	protein
has	O
been	O
shown	O
to	O
catalyze	O
the	O
interconversion	O
of	O
the	O
cis-	O
and	O
trans-	O
rotamers	O
of	O
the	O
peptidyl-prolyl	protein
amide	protein
bond	protein
of	O
peptide	O
substrates	O
;	O
here	O
we	O
show	O
that	O
rapamycin	O
,	O
like	O
FK506	O
,	O
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
rotamase	O
activity	O
of	O
FKBP	protein
(Ki	O
=	O
0.2	O
nM).	O
Neither	O
FKBP	protein
binding	O
nor	O
inhibition	O
of	O
rotamase	O
activity	O
of	O
FKBP	protein
alone	O
is	O
sufficient	O
to	O
explain	O
the	O
biologic	O
actions	O
of	O
these	O
drugs.	O
Rather,	O
these	O
findings	O
suggest	O
that	O
immunophilin	protein
bound	O
to	O
FK506	O
interferes	O
with	O
antigen	protein
receptor	protein
-induced	O
signals	O
,	O
while	O
rapamycin	O
bound	O
to	O
the	O
immunophilin	protein
interferes	O
with	O
IL-2	protein
-induced	O
signals	O
.	O

Adherence-dependent	O
increase	O
in	O
human	RNA
monocyte	RNA
PDGF(B)	RNA
mRNA	RNA
is	O
associated	O
with	O
increases	O
in	O
c-fos	O
,	O
c-jun	O
,	O
and	O
EGR2	O
mRNA	O
.	O
Adherence	O
is	O
an	O
important	O
initial	O
step	O
in	O
the	O
transition	O
of	O
a	O
circulating	cell_type
monocyte	cell_type
to	O
a	O
tissue	cell_type
macrophage	cell_type
.	O
This	O
differentiation	O
is	O
accompanied	O
by	O
an	O
augmented	O
capacity	O
to	O
generate	O
growth	protein
factors	protein
.	O
We	O
hypothesized	O
that	O
adherence	O
itself	O
might	O
be	O
an	O
important	O
trigger	O
for	O
a	O
sequence	O
of	O
gene	O
activation	O
culminating	O
in	O
cells	O
with	O
increased	O
mRNA	RNA
encoding	O
profibrotic	O
growth	protein
factors	protein
such	O
as	O
platelet-derived	protein
growth	protein
factor	protein
B	protein
subunit	protein
(	O
PDGF[B]	protein
)	O
and	O
transforming	protein
growth	protein
factor-beta	protein
(	O
TGF-beta	protein
).	O
After	O
in	O
vitro	O
adherence,	O
human	O
monocytes	O
had	O
a	O
biphasic	O
increase	O
in	O
PDGF(B)	RNA
mRNA	RNA
with	O
peaks	O
at	O
6	O
h	O
and	O
13	O
d.	O
No	O
increase	O
in	O
TGF-beta	RNA
mRNA	RNA
was	O
observed.	O
The	O
6-h	O
increase	O
in	O
PDGF(B)	RNA
mRNA	RNA
was	O
adherence	O
dependent,	O
and	O
in	O
addition,	O
was	O
abrogated	O
when	O
the	O
cytoskeletal	O
integrity	O
was	O
compromised	O
by	O
cytochalasin	O
D	O
.	O
The	O
6-h	O
increase	O
in	O
PDGF(B)	RNA
mRNA	RNA
was	O
unaltered	O
by	O
adherence	O
in	O
the	O
presence	O
of	O
the	O
monocyte	O
stimulus	O
lipopolysaccharide	O
.	O
Adherence	O
to	O
either	O
fibronectin	O
or	O
collagen-coated	O
plastic	O
had	O
little	O
consistent	O
effect	O
on	O
PDGF(B)	RNA
mRNA	RNA
accumulation	O
.	O
The	O
increased	O
PDGF(B)	RNA
mRNA	RNA
observed	O
in	O
adherent	cell_type
monocytes	cell_type
was	O
accompanied	O
by	O
increases	O
in	O
mRNAs	RNA
of	O
the	O
early	DNA
growth	DNA
response	DNA
genes	DNA
c-fos	DNA
(maximal	O
at	O
20	O
min),	O
c-jun,	O
and	O
EGR2	O
(maximal	O
at	O
6-24	O
h).	O
The	O
increase	O
in	O
c-jun	O
and	O
EGR2,	O
but	O
not	O
c-fos	DNA
,	O
mRNA	O
was	O
also	O
abrogated	O
by	O
cytochalasin	O
D	O
.	O
These	O
observations	O
suggest	O
that	O
adherence	O
results	O
in	O
increases	O
of	O
c-fos	O
,	O
c-jun	O
,	O
EGR2	O
,	O
and	O
PDGF(B)	O
mRNA	O
.	O
In	O
addition,	O
the	O
increases	O
in	O
c-jun	DNA
,	O
EGR2	DNA
,	O
and	O
PDGF(B)	protein
may	O
depend	O
on	O
cytoskeletal	O
rearrangement	O
.	O
Modulation	O
of	O
these	O
events	O
at	O
the	O
time	O
of	O
adherence	O
offers	O
a	O
mechanism	O
by	O
which	O
differential	O
priming	O
of	O
the	O
cells	O
may	O
be	O
accomplished.	O

Single	O
cell	O
assay	O
of	O
a	O
transcription	protein
factor	protein
reveals	O
a	O
threshold	O
in	O
transcription	O
activated	O
by	O
signals	O
emanating	O
from	O
the	O
T-cell	protein
antigen	protein
receptor	protein
.	O
Stimulation	O
of	O
T	cell_type
lymphocytes	cell_type
through	O
their	O
antigen	protein
receptor	protein
leads	O
to	O
the	O
appearance	O
of	O
several	O
transcription	protein
factors	protein
,	O
including	O
NF-AT	protein
and	O
NF-kappa	protein
B	protein
,	O
which	O
are	O
involved	O
in	O
regulating	O
genes	O
required	O
for	O
immunologic	O
activation.	O
To	O
investigate	O
the	O
activity	O
of	O
a	O
single	O
transcription	protein
factor	protein
in	O
individual	cell_type
viable	cell_type
cells	cell_type
,	O
we	O
have	O
applied	O
an	O
assay	O
that	O
uses	O
the	O
fluorescence-activated	O
cell	O
sorter	O
to	O
quantitate	O
beta-galactosidase	protein
(	O
beta-gal	protein
).	O
We	O
have	O
analyzed	O
the	O
distribution	O
of	O
NF-AT	protein
transcriptional	O
activity	O
among	O
T	cell_type
cells	cell_type
undergoing	O
activation	O
by	O
using	O
a	O
construct	O
in	O
which	O
three	O
tandem	O
copies	O
of	O
the	O
NF-AT	DNA
-binding	DNA
site	DNA
directs	O
transcription	O
of	O
the	O
lacZ	DNA
gene	DNA
.	O
Unexpectedly,	O
stimulation	O
of	O
cloned	cell_line
stably	cell_line
transfected	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
leads	O
to	O
a	O
bimodal	O
pattern	O
of	O
beta-gal	O
expression	O
in	O
which	O
some	O
cells	O
express	O
no	O
beta-gal	protein
and	O
others	O
express	O
high	O
levels.	O
This	O
expression	O
pattern	O
cannot	O
be	O
accounted	O
for	O
by	O
cell-cycle	O
position	O
or	O
heritable	O
variation.	O
Further	O
results,	O
in	O
which	O
beta-gal	protein
activity	O
is	O
correlated	O
with	O
NF-AT	protein
-binding	O
activity	O
,	O
indicate	O
that	O
the	O
concentration	O
of	O
NF-AT	protein
must	O
exceed	O
a	O
critical	O
threshold	O
before	O
transcription	O
initiates.	O
This	O
threshold	O
likely	O
reflects	O
the	O
NF-AT	protein
concentration-dependent	O
assembly	O
of	O
transcription	protein
complexes	protein
at	O
the	O
promoter	DNA
.	O
Similar	O
constructs	O
controlled	O
by	O
NF-kappa	protein
B	protein
or	O
the	O
entire	O
interleukin-2	DNA
enhancer	DNA
show	O
bimodal	O
expression	O
patterns	O
during	O
induction,	O
suggesting	O
that	O
thresholds	O
set	O
by	O
the	O
concentration	O
of	O
transcription	protein
factors	protein
may	O
be	O
a	O
common	O
property	O
of	O
inducible	DNA
genes	DNA
.	O

The	O
Epstein-Barr	DNA
virus	DNA
(	DNA
EBV	DNA
)	DNA
BMRF1	DNA
promoter	DNA
for	O
early	protein
antigen	protein
(	O
EA-D	protein
)	O
is	O
regulated	O
by	O
the	O
EBV	protein
transactivators	protein
,	O
BRLF1	protein
and	O
BZLF1	protein
,	O
in	O
a	O
cell-specific	O
manner	O
.	O
The	O
Epstein-Barr	protein
virus	protein
early	protein
antigen	protein
diffuse	protein
component	protein
(	O
EA-D	protein
)	O
is	O
essential	O
for	O
Epstein-Barr	O
virus	DNA
DNA	DNA
polymerase	O
activity	O
,	O
and	O
its	O
activity	O
is	O
suppressed	O
during	O
latent	O
infection.	O
We	O
investigated	O
the	O
regulation	O
of	O
the	O
promoter	DNA
(	O
BMRF1	DNA
)	O
for	O
this	O
early	O
gene	O
by	O
studying	O
its	O
responsiveness	O
in	O
vitro	O
to	O
two	O
immediate-early	protein
viral	protein
transactivators	protein
,	O
BZLF1	protein
(	O
Z	protein
)	O
and	O
BRLF1	protein
(	O
R	protein
),	O
focusing	O
on	O
the	O
differences	O
in	O
response	O
in	O
lymphoid	cell_type
cells	cell_type
and	O
epithelial	cell_type
cells	cell_type
.	O
In	O
lymphoid	cell_type
cells	cell_type
,	O
Z	protein
or	O
R	protein
alone	O
produced	O
only	O
small	O
increases	O
in	O
EA-D	DNA
promoter	DNA
activity	O
,	O
whereas	O
both	O
transactivators	protein
together	O
produced	O
a	O
large	O
stimulatory	O
effect.	O
In	O
epithelial	cell_type
cells	cell_type
,	O
the	O
Z	protein
transactivator	protein
alone	O
produced	O
maximal	O
stimulation	O
of	O
the	O
EA-D	DNA
promoter	DNA
;	O
the	O
effect	O
of	O
R	protein
and	O
Z	protein
together	O
was	O
no	O
greater	O
than	O
that	O
of	O
Z	protein
alone.	O
Deletional	O
analysis	O
and	O
site-directed	O
mutagenesis	O
of	O
the	O
EA-D	DNA
promoter	DNA
demonstrated	O
that	O
in	O
epithelial	cell_type
cells	cell_type
the	O
potential	O
AP-1	DNA
binding	DNA
site	DNA
plays	O
an	O
essential	O
role	O
in	O
Z	protein
responsiveness,	O
although	O
sequences	O
further	O
upstream	O
are	O
also	O
important.	O
In	O
lymphoid	cell_type
cells	cell_type
,	O
only	O
the	O
upstream	DNA
sequences	DNA
are	O
required	O
for	O
transactivation	O
by	O
the	O
Z/R	protein
combination,	O
and	O
the	O
AP-1	protein
site	protein
is	O
dispensable.	O
These	O
data	O
suggest	O
that	O
EA-D	DNA
(	DNA
BMRF1	DNA
)	DNA
promoter	DNA
regulation	O
by	O
Z	protein
and	O
R	protein
is	O
cell	O
type	O
specific	O
and	O
appears	O
to	O
involve	O
different	O
mechanisms	O
in	O
each	O
cell	O
type.	O

Complementary	DNA
DNA	DNA
encoding	O
the	O
human	protein
T-cell	protein
FK506	protein
-binding	protein
protein	protein
,	O
a	O
peptidylprolyl	protein
cis-trans	protein
isomerase	protein
distinct	O
from	O
cyclophilin	protein
.	O
The	O
recently	O
discovered	O
macrolide	O
FK506	O
has	O
been	O
demonstrated	O
to	O
have	O
potent	O
immunosuppressive	O
activity	O
at	O
concentrations	O
100-fold	O
lower	O
than	O
cyclosporin	O
A	O
,	O
a	O
cyclic	O
undecapeptide	O
that	O
is	O
used	O
to	O
prevent	O
rejection	O
after	O
transplantation	O
of	O
bone	O
marrow	O
and	O
organs	O
,	O
such	O
as	O
kidney	O
,	O
heart	O
,	O
and	O
liver	O
.	O
After	O
the	O
recent	O
discovery	O
that	O
the	O
cyclosporin	protein
A	protein
-binding	protein
protein	protein
cyclophilin	protein
is	O
identical	O
to	O
peptidylprolyl	protein
cis-trans	protein
isomerase	protein
,	O
a	O
cellular	protein
binding	protein
protein	protein
for	O
FK506	O
was	O
found	O
to	O
be	O
distinct	O
from	O
cyclophilin	protein
but	O
to	O
have	O
the	O
same	O
enzymatic	O
activity	O
.	O
In	O
this	O
study,	O
we	O
isolated	O
a	O
cDNA	DNA
coding	O
for	O
FK506	O
-binding	O
protein	O
(	O
FKBP	protein
)	O
from	O
human	O
peripheral	O
blood	O
T	cell_type
cells	cell_type
by	O
using	O
mixed	O
20-mer	O
oligonucleotide	O
probes	O
synthesized	O
on	O
the	O
basis	O
of	O
the	O
sequence,	O
Glu-Asp-Gly-Lys-Lys-Phe-Asp	O
,	O
reported	O
for	O
bovine	protein
FKBP	protein
.	O
The	O
DNA	O
isolated	O
contained	O
an	O
open	O
reading	O
frame	O
encoding	O
108	O
amino	O
acid	O
residues	O
.	O
The	O
first	O
40	O
residues	O
of	O
the	O
deduced	O
amino	protein
acid	protein
sequence	protein
were	O
identical	O
to	O
those	O
of	O
the	O
reported	O
amino-terminal	O
sequence	O
of	O
bovine	O
FKBP	protein
,	O
indicating	O
that	O
the	O
DNA	O
sequence	O
isolated	O
represents	O
the	O
gene	O
coding	O
for	O
FKBP	protein
.	O
Computer-assisted	O
analysis	O
of	O
the	O
deduced	O
amino	O
acid	O
sequence	O
indicates	O
that	O
FKBP	protein
exhibits	O
no	O
internal	O
homology	O
and	O
does	O
not	O
have	O
significant	O
sequence	O
similarity	O
to	O
any	O
other	O
amino	O
acid	O
sequences	O
of	O
known	O
proteins,	O
including	O
cyclophilin	protein
.	O
This	O
result	O
suggests	O
that	O
two	O
catalytically	O
similar	O
proteins,	O
cyclophilin	protein
and	O
FKBP	protein
,	O
evolved	O
independently.	O
In	O
Northern	O
blot	O
analysis	O
,	O
mRNA	RNA
species	RNA
of	O
approximately	O
1.8	O
kilobases	O
that	O
hybridized	O
with	O
human	DNA
FKBP	DNA
cDNA	DNA
were	O
detected	O
in	O
poly(A)+	RNA
RNAs	RNA
from	O
brain	O
,	O
lung	O
,	O
liver	O
,	O
and	O
placental	cell_type
cells	cell_type
and	O
leukocytes	cell_type
.	O
Induction	O
of	O
Jurkat	cell_line
leukemic	cell_line
T	cell_line
cells	cell_line
with	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
ionomycin	O
did	O
not	O
affect	O
the	O
level	O
of	O
FKBP	RNA
mRNA	RNA
.	O
Southern	O
blot	O
analysis	O
of	O
human	DNA
genomic	DNA
DNA	DNA
digested	O
with	O
different	O
restriction	protein
enzymes	protein
suggests	O
the	O
existence	O
of	O
only	O
a	O
few	O
copies	O
of	O
the	O
DNA	O
sequence	O
encoding	O
FKBP	protein
.	O
This	O
is	O
in	O
contrast	O
to	O
the	O
result	O
that	O
as	O
many	O
as	O
20	O
copies	O
of	O
the	O
cyclophilin	DNA
gene	DNA
and	O
possible	O
pseudogenes	O
may	O
be	O
present	O
in	O
the	O
mammalian	DNA
genome	DNA
.	O

Involvement	O
of	O
a	O
second	O
lymphoid-specific	DNA
enhancer	DNA
element	DNA
in	O
the	O
regulation	O
of	O
immunoglobulin	DNA
heavy-chain	DNA
gene	DNA
expression	O
.	O
To	O
determine	O
whether	O
enhancer	DNA
elements	DNA
in	O
addition	O
to	O
the	O
highly	O
conserved	O
octamer	DNA
(OCTA)-nucleotide	DNA
motif	DNA
are	O
important	O
for	O
lymphoid-specific	O
expression	O
of	O
the	O
immunoglobulin	DNA
heavy-chain	DNA
(IgH)	DNA
gene	DNA
,	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
mutating	O
the	O
binding	DNA
site	DNA
for	O
a	O
putative	protein
additional	protein
lymphoid-specific	protein
transcription	protein
factor	protein
,	O
designated	O
NF-microB	protein
,	O
in	O
the	O
murine	DNA
IgH	DNA
enhancer	DNA
.	O
We	O
demonstrate	O
that	O
the	O
NF-microB-binding	DNA
site	DNA
plays	O
a	O
critical	O
role	O
in	O
the	O
IgH	DNA
enhancer	DNA
,	O
because	O
mutation	O
of	O
the	O
microB	O
DNA	O
motif	O
decreased	O
transcriptional	O
activity	O
of	O
the	O
IgH	DNA
enhancer	DNA
in	O
cells	O
of	O
the	O
B-cell	cell_type
lineage	cell_type
but	O
not	O
in	O
nonlymphoid	cell_type
cells	cell_type
.	O
This	O
effect	O
was	O
comparable	O
to	O
or	O
even	O
stronger	O
than	O
the	O
effect	O
of	O
a	O
mutation	O
in	O
the	O
OCTA	DNA
site	DNA
.	O
Moreover,	O
combined	O
mutation	O
of	O
both	O
microB	DNA
and	O
OCTA	DNA
sites	DNA
further	O
reduced	O
enhancer	O
activity	O
in	O
lymphoid	cell_type
cells	cell_type
.	O
Interestingly,	O
alteration	O
of	O
either	O
the	O
microB	DNA
or	O
E3	DNA
site	DNA
in	O
a	O
70-base-pair	DNA
fragment	DNA
of	O
the	O
IgH	DNA
enhancer	DNA
that	O
lacks	O
the	O
binding	O
site	O
for	O
OCTA	O
abolished	O
enhancer	O
activity	O
in	O
lymphoid	cell_type
cells	cell_type
completely.	O
Nevertheless,	O
a	O
multimer	O
of	O
the	O
microB	DNA
motif	DNA
alone	O
showed	O
no	O
enhancer	O
activity	O
.	O
DNase	O
footprinting	O
analysis	O
corroborated	O
the	O
functional	O
data	O
showing	O
that	O
a	O
lymphoid-specific	protein
protein	protein
binds	O
to	O
the	O
microB	DNA
DNA	DNA
motif	DNA
.	O
Our	O
results	O
suggest	O
that	O
the	O
microB	DNA
element	DNA
is	O
a	O
new	O
crucial	O
element	O
important	O
for	O
lymphoid-specific	O
expression	O
of	O
the	O
IgH	O
gene	O
but	O
that	O
interaction	O
with	O
another	O
enhancer	DNA
element	DNA
is	O
essential	O
for	O
its	O
activity.	O

Stimulation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
2	O
(	O
HIV-2	O
)	O
gene	O
expression	O
by	O
the	O
cytomegalovirus	O
and	O
HIV-2	DNA
transactivator	DNA
gene	DNA
.	O
Human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
often	O
causes	O
latent	O
infection.	O
Transactivation	O
by	O
some	O
DNA	O
viruses	O
has	O
been	O
implicated	O
in	O
inducing	O
HIV-1	O
replication	O
and	O
pathogenesis.	O
The	O
transactivator	DNA
(IE-2)	DNA
gene	DNA
of	O
the	O
human	O
cytomegalovirus	O
(	O
CMV	O
)	O
can	O
enhance	O
HIV-2	O
as	O
well	O
as	O
HIV-1	O
gene	O
expression	O
in	O
vitro.	O
This	O
inducer	O
can	O
act	O
in	O
concert	O
with	O
the	O
HIV-2	DNA
tat	DNA
gene	DNA
and	O
T-cell	O
activation	O
in	O
enhancing	O
gene	O
expression	O
in	O
human	cell_type
CD4+	cell_type
lymphocytes	cell_type
.	O
While	O
the	O
HIV-2	O
and	O
HIV-1	DNA
tat	DNA
genes	DNA
and	O
T-cell	protein
activators	protein
apparently	O
employ	O
independent	O
modes	O
of	O
action,	O
the	O
CMV	DNA
transactivator	DNA
in	O
combination	O
with	O
the	O
HIV-2	DNA
tat	DNA
or	O
T-cell	protein
activators	protein
may	O
employ	O
a	O
gene	O
activation	O
pathway	O
with	O
some	O
common	O
and	O
some	O
distinct	O
components.	O
Both	O
HIV-2	O
and	O
CMV	DNA
transactivators	DNA
enhance	O
HIV-2	O
gene	O
expression	O
by	O
transcriptional	O
activation	O
involving	O
transcript	O
initiation	O
as	O
well	O
as	O
elongation	O
,	O
with	O
CMV	DNA
transactivator	DNA
affecting	O
elongation	O
more	O
than	O
the	O
initiation	O
.	O
A	O
significant	O
proportion	O
of	O
transcripts	RNA
appear	O
to	O
terminate	O
prematurely	O
in	O
the	O
absence	O
of	O
transactivators	protein
.	O
Deletion	O
mutation	O
analysis	O
of	O
the	O
HIV-2	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
suggests	O
that	O
the	O
element	O
that	O
responds	O
to	O
CMV	O
transactivation	O
in	O
human	cell_type
CD4+	cell_type
lymphocytes	cell_type
is	O
either	O
a	O
diffuse	O
one	O
or	O
located	O
downstream	O
of	O
the	O
HIV-2	DNA
enhancer	DNA
element	DNA
.	O

Quantitative	O
immunohistochemical	O
analysis	O
of	O
mononuclear	cell_type
infiltrates	cell_type
in	O
breast	O
carcinomas	O
--correlation	O
with	O
tumour	O
differentiation	O
.	O
Inflammatory	cell_type
infiltrates	cell_type
were	O
analysed	O
in	O
tissue	O
sections	O
of	O
76	O
breast	O
carcinomas	O
by	O
counting	O
the	O
percentage	O
of	O
macrophages	cell_type
,	O
IgA+	O
and	O
IgG+	O
plasma	O
cells	O
,	O
T	cell_type
cells	cell_type
with	O
their	O
subpopulations,	O
and	O
natural	cell_type
killer	cell_type
cells	cell_type
,	O
and	O
by	O
measuring	O
postcapillary	O
venules	O
(	O
PCVs	O
,	O
found	O
in	O
12	O
cases)	O
within	O
the	O
infiltrates.	O
These	O
parameters	O
were	O
correlated	O
with	O
nuclear	O
grade	O
and	O
biochemically	O
determined	O
hormone	O
receptor	O
status	O
,	O
known	O
markers	O
of	O
tumour	O
differentiation	O
.	O
A	O
direct	O
correlation	O
was	O
found	O
between	O
the	O
extent	O
of	O
inflammation	O
and	O
nuclear	O
grade	O
(P	O
less	O
than	O
0.0001),	O
and	O
an	O
inverse	O
correlation	O
between	O
inflammation	O
and	O
oestrogen	protein
receptor	protein
(	O
OR	protein
)	O
positivity	O
(P	O
less	O
than	O
0.05)	O
as	O
well	O
as	O
inflammation	O
and	O
progesterone	protein
receptor	protein
(	O
PR	protein
)	O
positivity	O
(P	O
less	O
than	O
0.05).	O
The	O
percentage	O
of	O
the	O
OKT8+	cell_line
suppressor/cytotoxic	cell_line
T	cell_line
cells	cell_line
increased	O
when	O
the	O
inflammation	O
expanded	O
from	O
scanty	O
to	O
moderate	O
(P	O
less	O
than	O
0.02).	O
The	O
diameter	O
of	O
the	O
PCVs	O
also	O
increased	O
with	O
increasing	O
inflammatory	O
infiltrate	O
(P	O
less	O
than	O
0.02).	O
In	O
addition,	O
a	O
direct	O
correlation	O
exists	O
between	O
the	O
diameter	O
of	O
the	O
PCVs	O
and	O
both	O
the	O
percentage	O
of	O
the	O
OKT8+	cell_line
T	cell_line
cells	cell_line
(P	O
less	O
than	O
0.04)	O
and	O
the	O
Leu-7+	O
natural	cell_type
killer	cell_type
cells	cell_type
(P	O
less	O
than	O
0.03).	O

Reactivity	O
of	O
lymphocytes	cell_line
to	O
a	O
progesterone	protein
receptor-specific	protein
monoclonal	protein
antibody	protein
.	O
In	O
this	O
study	O
we	O
present	O
evidence	O
for	O
reactivity	O
of	O
pregnancy	cell_type
lymphocytes	cell_type
,	O
but	O
not	O
nonpregnancy	cell_type
lymphocytes	cell_type
,	O
with	O
the	O
progesterone	protein
receptor-specific	protein
monoclonal	protein
antibody	protein
mPRI	protein
.	O
Using	O
an	O
avidin	protein
-biotin	protein
peroxidase	protein
detection	O
system	O
,	O
we	O
found	O
a	O
nuclear	O
staining	O
in	O
14.6	O
+/-	O
3.7%	O
(mean	O
+/-	O
SEM,	O
N	O
=	O
27)	O
of	O
pregnancy	cell_type
lymphocytes	cell_type
,	O
while	O
only	O
0.47	O
+/-	O
0.33%	O
(mean	O
+/-	O
SEM,	O
N	O
=	O
15)	O
of	O
nonpregnancy	cell_type
lymphocytes	cell_type
reacted	O
with	O
the	O
antibody.	O
To	O
characterize	O
the	O
receptor-bearing	O
subset,	O
CD8+	O
and	O
CD4+	O
cells	O
were	O
depleted	O
by	O
complement-dependent	O
lysis.	O
Depletion	O
of	O
CD8+	cell_line
cells	cell_line
was	O
accompanied	O
by	O
62	O
+/-	O
18%	O
loss	O
of	O
progesterone	cell_line
receptor	cell_line
-bearing	cell_line
cells	cell_line
,	O
while	O
depletion	O
of	O
CD4+	cell_line
cells	cell_line
resulted	O
in	O
a	O
twofold	O
increase	O
in	O
the	O
number	O
of	O
positively	O
staining	O
lymphocytes	cell_line
.	O
In	O
nonpregnancy	cell_line
lymphocytes	cell_line
a	O
3-day	O
PHA	protein
treatment	O
,	O
as	O
well	O
as	O
allogeneic	O
stimulation,	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
receptor-containing	cell_type
cells	cell_type
.	O
These	O
results	O
suggest	O
that	O
pregnancy	O
,	O
but	O
not	O
nonpregnancy	O
,	O
lymphocytes	cell_line
contain	O
progesterone	protein
binding	protein
structures	protein
,	O
and	O
that	O
these	O
are	O
inducible	O
by	O
mitogenic	O
or	O
alloantigenic	O
stimuli	O
.	O

Activation	O
of	O
human	cell_line
CD4	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Interaction	O
of	O
fibronectin	protein
with	O
VLA-5	protein
receptor	protein
on	O
CD4	cell_line
cells	cell_line
induces	O
the	O
AP-1	protein
transcription	protein
factor	protein
.	O
Fibronectin	protein
synergized	O
with	O
anti-CD3	protein
antibody	protein
to	O
promote	O
CD4	protein
cell	O
proliferation	O
in	O
a	O
serum-free	O
culture	O
system	O
whereas	O
no	O
proliferation	O
was	O
observed	O
when	O
CD4	cell_line
cells	cell_line
were	O
cultured	O
with	O
anti-CD3	protein
alone	O
or	O
fibronectin	protein
alone.	O
In	O
addition,	O
anti-CD29	protein
(	O
integrin	protein
beta	protein
1	protein
)	O
as	O
well	O
as	O
anti-VLA-5	protein
(	O
human	protein
fibronectin	protein
receptor	protein
)	O
antibodies	O
blocked	O
this	O
CD4	cell_line
cell	cell_line
activation	O
in	O
this	O
system.	O
Although	O
anti-CD3	protein
alone	O
or	O
fibronectin	protein
alone	O
cannot	O
induce	O
IL-2	protein
message	O
by	O
CD4	cell_line
cells	cell_line
,	O
the	O
combination	O
of	O
anti-CD3	protein
plus	O
fibronectin	protein
induced	O
IL-2	protein
message	O
by	O
CD4	cell_line
cells	cell_line
.	O
In	O
an	O
analysis	O
of	O
the	O
molecular	O
mechanism	O
by	O
which	O
IL-2	protein
message	O
was	O
generated,	O
we	O
showed	O
that	O
a	O
fibronectin	protein
-VLA-5	O
fibronectin	protein
receptor	protein
interaction	O
may	O
contribute	O
an	O
independent	O
signal	O
distinct	O
from	O
the	O
CD3	protein
pathway	O
of	O
activation	O
by	O
the	O
induction	O
of	O
an	O
AP-1	protein
transcriptional	protein
factor	protein
.	O
Thus	O
the	O
VLA-5	protein
fibronectin	protein
receptor	protein
on	O
CD4	cell_line
cells	cell_line
can	O
play	O
a	O
complementary	O
role	O
in	O
CD3	protein
-	O
TCR	protein
-mediated	O
signal	O
transduction	O
through	O
its	O
interaction	O
with	O
fibronectin	protein
.	O

Glucocorticoid	protein
receptors	protein
on	O
mononuclear	cell_type
leukocytes	cell_type
in	O
Alzheimer's	O
disease	O
.	O
Several	O
lines	O
of	O
evidence	O
suggest	O
disturbances	O
of	O
the	O
hypothalamic-pituitary-adrenal	O
(	O
HPA	O
)	O
system	O
in	O
Alzheimer's	O
disease	O
(	O
AD	O
).	O
In	O
an	O
exploration	O
of	O
the	O
potential	O
role	O
of	O
the	O
glucocorticoid	O
receptor	O
(GR)	O
in	O
AD	O
,	O
GR	O
density	O
and	O
affinity	O
were	O
assessed	O
on	O
mononuclear	cell_type
leukocytes	cell_type
of	O
12	O
AD	O
patients	O
and	O
12	O
healthy	O
controls	O
.	O
GR	O
binding	O
characteristics	O
did	O
not	O
differ	O
between	O
patients	O
and	O
controls	O
or	O
between	O
patients	O
subdivided	O
according	O
to	O
diagnosis	O
or	O
associated	O
clinical	O
features.	O
These	O
data	O
suggest	O
that	O
the	O
abnormalities	O
of	O
the	O
HPA	O
system	O
in	O
AD	O
are	O
not	O
related	O
to	O
a	O
GR	protein
deficiency	O
.	O

Oncogene	O
amplification	O
correlates	O
with	O
dense	O
lymphocyte	O
infiltration	O
in	O
human	O
breast	O
cancers	O
:	O
a	O
role	O
for	O
hematopoietic	protein
growth	protein
factor	protein
release	O
by	O
tumor	cell_type
cells	cell_type
?	O
One	O
hundred	O
six	O
primary	O
breast	O
cancer	O
samples	O
were	O
analysed	O
for	O
c-erbB2	O
,	O
int-2	O
,	O
and	O
c-myc	O
gene	O
amplification	O
.	O
Surgically	O
confirmed	O
nodal	O
involvement	O
was	O
observed	O
in	O
42%.	O
Level	O
of	O
gene	O
amplification	O
was	O
studied	O
by	O
Southern	O
and/or	O
slot	O
blot	O
techniques	O
.	O
Amplified	O
c-erbB2	DNA
gene	DNA
sequences	DNA
were	O
present	O
in	O
21.5%	O
of	O
all	O
samples.	O
Int-2	DNA
was	O
amplified	O
in	O
13.1%	O
and	O
c-myc	DNA
was	O
amplified	O
in	O
10.3%.	O
In	O
a	O
non-parametric	O
test	O
(Kruskal-Wallis)	O
a	O
strong	O
negative	O
association	O
was	O
found	O
between	O
high	O
levels	O
of	O
c-erbB2	DNA
amplification	O
and	O
absence	O
of	O
estrogen	O
receptor	O
(ER)	O
(P	O
=	O
.0009)	O
or	O
progesterone	protein
receptor	protein
(	O
PR	protein
)	O
(P	O
=	O
.011)	O
expression.	O
No	O
correlations	O
were	O
found	O
between	O
all	O
or	O
high	O
levels	O
of	O
amplification	O
of	O
each	O
oncogene	O
separately	O
or	O
combined	O
with	O
T,	O
N,	O
grade,	O
multifocality	O
of	O
tumor	O
,	O
or	O
associated	O
carcinoma	O
in	O
situ.	O
There	O
was	O
a	O
trend	O
approaching	O
statistical	O
significance	O
for	O
patients	O
with	O
c-erbB2	DNA
amplifications	O
to	O
have	O
positive	O
lymph	O
nodes	O
at	O
surgery	O
(P	O
=	O
0.09).	O
A	O
somewhat	O
surprising	O
finding	O
however	O
was	O
a	O
very	O
strong	O
association	O
between	O
oncogene	DNA
amplification	O
and	O
dense	O
lymphocyte	O
infiltration	O
of	O
the	O
tumor	O
(P	O
=	O
.05).	O
This	O
correlation	O
is	O
even	O
stronger	O
when	O
only	O
high	O
levels	O
of	O
amplification	O
are	O
considered,	O
either	O
for	O
each	O
oncogene	O
separately	O
(P	O
=	O
.0048)	O
or	O
in	O
combination	O
(P	O
=	O
.0007).	O
We	O
propose	O
that	O
malignant	O
cell	O
cytokine	protein
production	O
may	O
help	O
explain	O
this	O
observation.	O

Suppression	O
of	O
signals	O
required	O
for	O
activation	O
of	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
in	O
cells	O
constitutively	O
expressing	O
the	O
HTLV-I	protein
Tax	protein
protein	protein
.	O
Transient	O
short-term	O
expression	O
of	O
the	O
Tax	protein
protein	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type-I	O
(	O
HTLV-I	O
)	O
leads	O
to	O
activation	O
of	O
the	O
pleiotropic	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Consistent	O
with	O
findings	O
obtained	O
with	O
transient	O
expression	O
assays	O
,	O
we	O
observed	O
marked	O
accumulation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
in	O
the	O
nucleus	O
of	O
Namalwa	cell_line
B	cell_line
lymphoid	cell_line
cells	cell_line
,	O
which	O
constitutively	O
express	O
Tax	protein
.	O
In	O
contrast,	O
NF-kappa	protein
B	protein
activity	O
was	O
not	O
detected	O
in	O
the	O
nucleus	O
following	O
long-term	O
expression	O
of	O
Tax	protein
in	O
Jurkat	cell_line
T	cell_line
lymphocytes	cell_line
.	O
The	O
ability	O
of	O
both	O
mitogens	O
and	O
cytokines	protein
to	O
activate	O
NF-kappa	protein
B	protein
was	O
also	O
blocked	O
in	O
Jurkat	cell_line
cells	cell_line
constitutively	O
expressing	O
Tax	protein
.	O
However,	O
the	O
activation	O
of	O
other	O
mitogen-inducible	protein
transcription	protein
factors	protein
,	O
such	O
as	O
Fos	protein
and	O
Jun	protein
,	O
was	O
unaffected.	O
Thus,	O
depending	O
on	O
the	O
cellular	O
environment	O
,	O
the	O
short-	O
and	O
long-term	O
effects	O
of	O
Tax	protein
expression	O
can	O
be	O
quite	O
different.	O
Consequently,	O
one	O
function	O
of	O
Tax	protein
in	O
cells	O
infected	O
with	O
HTLV-I	O
might	O
involve	O
cell-type-specific	O
suppression	O
,	O
as	O
opposed	O
to	O
activation,	O
of	O
distinct	O
signal	O
pathways	O
.	O
The	O
cells	O
lines	O
described	O
here	O
should	O
be	O
useful	O
for	O
the	O
delineation	O
of	O
signaling	O
pathways	O
utilized	O
in	O
the	O
selective	O
regulation	O
of	O
gene	O
expression	O
.	O

Interferon-gamma	protein
and	O
the	O
sexual	O
dimorphism	O
of	O
autoimmunity	O
.	O
The	O
sexual	O
difference	O
in	O
the	O
incidence	O
of	O
autoimmune	O
diseases	O
has	O
remained	O
an	O
enigma	O
for	O
many	O
years.	O
In	O
the	O
examination	O
of	O
the	O
induction	O
of	O
autoimmunity	O
in	O
transgenic	O
mice	O
,	O
evidence	O
has	O
been	O
obtained	O
further	O
implicating	O
the	O
lymphokine	protein
interferon-gamma	protein
in	O
the	O
etiology	O
of	O
autoimmunity	O
.	O
Sex	O
steroid	O
regulation	O
of	O
the	O
production	O
of	O
this	O
molecule,	O
as	O
well	O
as	O
other	O
cytokines	protein
,	O
may	O
help	O
explain	O
the	O
gender-specific	O
differences	O
in	O
the	O
immune	O
system	O
,	O
including	O
autoimmunity	O
.	O

Cloning	O
of	O
a	O
transcriptionally	protein
active	protein
human	protein
TATA	protein
binding	protein
factor	protein
.	O
Transcription	protein
factor	protein
IID	protein
(	O
TFIID	protein
)	O
binds	O
to	O
the	O
TATA	DNA
box	DNA
promoter	DNA
element	DNA
and	O
regulates	O
the	O
expression	O
of	O
most	O
eukaryotic	DNA
genes	DNA
transcribed	O
by	O
RNA	protein
polymerase	protein
II	protein
.	O
Complementary	DNA
DNA	DNA
(	O
cDNA	DNA
)	O
encoding	O
a	O
human	protein
TFIID	protein
protein	protein
has	O
been	O
cloned.	O
The	O
human	protein
TFIID	protein
polypeptide	protein
has	O
339	O
amino	O
acids	O
and	O
a	O
molecular	O
size	O
of	O
37,745	O
daltons	O
.	O
The	O
carboxyl-terminal	protein
181	protein
amino	protein
acids	protein
of	O
the	O
human	protein
TFIID	protein
protein	protein
shares	O
80%	O
identity	O
with	O
the	O
TFIID	protein
protein	O
from	O
Saccharomyces	O
cerevisiae	O
.	O
The	O
amino	protein
terminus	protein
contains	O
an	O
unusual	O
repeat	O
of	O
38	O
consecutive	O
glutamine	O
residues	O
and	O
an	O
X-Thr-Pro	protein
repeat	protein
.	O
Expression	O
of	O
DNA	DNA
in	O
reticulocyte	O
lysates	O
or	O
in	O
Escherichia	O
coli	O
yielded	O
a	O
protein	O
that	O
was	O
competent	O
for	O
both	O
DNA	O
binding	O
and	O
transcription	O
activation	O
.	O

A	O
novel	O
T-cell	protein
trans-activator	protein
that	O
recognizes	O
a	O
phorbol	DNA
ester-inducible	DNA
element	DNA
of	O
the	O
interleukin-2	DNA
promoter	DNA
.	O
The	O
interleukin	DNA
2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
promoter	DNA
is	O
recognized	O
by	O
several	O
cell-type-specific	O
and	O
ubiquitous	O
transcriptional	O
regulators	O
that	O
integrate	O
information	O
transmitted	O
by	O
various	O
signaling	O
systems	O
leading	O
to	O
IL-2	protein
production	O
and	O
T-cell	cell_type
activation	O
.	O
Using	O
a	O
combination	O
of	O
transfection	O
,	O
protein-DNA	O
binding,	O
and	O
in	O
vitro	O
transcription	O
methods	O
,	O
we	O
have	O
discovered	O
the	O
novel	protein
T-cell-specific	protein
transcriptional	protein
activator	protein
TCF-1	protein
(for	O
T-Cell	protein
Factor-1	protein
),	O
which	O
recognizes	O
a	O
T-cell-specific	DNA
response	DNA
element	DNA
(	O
TCE	DNA
)	O
located	O
within	O
the	O
IL-2	DNA
promoter	DNA
.	O
Although	O
the	O
TCE	DNA
is	O
similar	O
in	O
sequence	O
to	O
a	O
consensus	DNA
NF	DNA
kappa	DNA
B	DNA
site	DNA
,	O
several	O
criteria	O
indicate	O
that	O
TCF-1	protein
is	O
distinct	O
from	O
NF	protein
kappa	protein
B	protein
.	O
However,	O
like	O
NF	protein
kappa	protein
B	protein
,	O
TCF-1	protein
activity	O
is	O
induced	O
by	O
phorbol	O
esters	O
and	O
other	O
T-cell	O
activators	O
.	O

Risk	O
factors	O
for	O
breast	O
recurrence	O
in	O
premenopausal	O
and	O
postmenopausal	O
patients	O
with	O
ductal	O
cancers	O
treated	O
by	O
conservation	O
therapy	O
.	O
Risk	O
factors	O
for	O
local	O
failure	O
were	O
evaluated	O
for	O
496	O
clinical	O
Stage	O
I-II	O
patients	O
with	O
infiltrating	O
ductal	O
carcinomas	O
(median	O
follow-up,	O
71	O
months)	O
treated	O
by	O
conservative	O
surgery	O
and	O
radiotherapy	O
.	O
Monofactorial	O
analysis	O
identified	O
the	O
following	O
factors	O
to	O
be	O
correlated	O
with	O
increased	O
risk:	O
moderate/marked	O
mononuclear	O
cell	O
reaction	O
(	O
MCR	O
),	O
high	O
histologic	O
grade	O
(G),	O
extensive	O
intraductal	O
component	O
(	O
EIC	O
),	O
tumor	O
necrosis	O
,	O
macroscopic	O
multiplicity	O
,	O
estrogen	protein
receptor	protein
negativity	O
,	O
anatomic	O
tumor	O
size	O
,	O
age	O
younger	O
than	O
40	O
years,	O
and	O
vascular	O
invasion	O
.	O
Only	O
MCR	O
,	O
G	O
,	O
and	O
EIC	O
proved	O
significant	O
in	O
Cox	O
multivariate	O
analysis	O
.	O
These	O
risk	O
factors	O
were	O
highly	O
age	O
dependent,	O
with	O
EIC	O
markedly	O
more	O
prevalent	O
in	O
women	O
younger	O
than	O
50,	O
MCR	O
and	O
G	O
in	O
women	O
younger	O
than	O
40.	O
Separate	O
Cox	O
analysis	O
for	O
premenopausal	O
patients	O
showed	O
that	O
MCR	O
/EIC	O
determined	O
risk	O
independent	O
of	O
resection	O
margins:	O
tumors	O
with	O
MCR	O
had	O
a	O
28%,	O
and	O
with	O
EIC	O
a	O
22%	O
probability	O
of	O
recurring	O
locally	O
by	O
5	O
years.	O
Premenopausal	O
patients	O
with	O
neither	O
risk	O
factor	O
had	O
a	O
very	O
low	O
failure	O
rate	O
(2.6%	O
at	O
5	O
years),	O
regardless	O
of	O
age.	O
For	O
postmenopausal	O
patients	O
risk	O
of	O
breast	O
recurrence	O
was	O
determined	O
both	O
by	O
adequacy	O
of	O
resection	O
margins	O
and	O
grade,	O
with	O
a	O
high	O
local	O
failure	O
rate	O
for	O
patients	O
having	O
G3	O
tumors	O
with	O
positive	O
or	O
indeterminate	O
margins	O
(31%	O
at	O
5	O
years).	O
The	O
authors	O
conclude	O
that	O
the	O
microscopic	O
examination	O
is	O
the	O
only	O
useful	O
tool	O
for	O
assessing	O
the	O
risk	O
of	O
local	O
failure,	O
which	O
is	O
quite	O
low	O
for	O
the	O
majority	O
of	O
patients	O
treated	O
with	O
breast	O
conservation	O
.	O
High-risk	O
patients	O
can	O
be	O
recognized	O
morphologically.	O
The	O
age	O
dependence	O
of	O
morphologic	O
risk	O
factors	O
appears	O
to	O
explain	O
the	O
high	O
local	O
failure	O
rate	O
seen	O
in	O
patients	O
younger	O
than	O
40.	O

Tax	protein
-independent	O
binding	O
of	O
multiple	O
cellular	protein
factors	protein
to	O
Tax	DNA
-response	DNA
element	DNA
DNA	DNA
of	O
HTLV-I	O
.	O
The	O
human	DNA
T-cell	DNA
leukemia	DNA
virus	DNA
type	DNA
I	DNA
(	DNA
HTLV-I	DNA
)	DNA
promoter	DNA
contains	O
three	O
copies	O
of	O
imperfect	O
repeats	O
of	O
a	O
21-base	O
pair	O
sequence	O
designated	O
here	O
as	O
TRE	DNA
(	O
Tax	DNA
-response	DNA
element	DNA
)	O
that	O
is	O
responsive	O
to	O
the	O
virally	protein
encoded	protein
transactivator	protein
protein	protein
Tax	protein
.	O
We	O
have	O
identified	O
and	O
separated	O
four	O
nuclear	protein
proteins	protein
from	O
C81-66-45	O
cells,	O
an	O
HTLV-I	cell_line
immortalized	cell_line
Tax	cell_line
-expressing	cell_line
human	cell_line
T-lymphocyte	cell_line
line	cell_line
(Salahuddin	O
et	O
al.,	O
1983),	O
that	O
interact	O
with	O
the	O
TRE	DNA
-DNA	DNA
,	O
none	O
of	O
which	O
are	O
identical	O
with	O
the	O
Tax	protein
-protein	protein
.	O
The	O
proteins	O
identified	O
have	O
molecular	O
weights	O
of	O
about	O
32,	O
36	O
to	O
42,	O
50	O
and	O
110	O
kD.	O
Four	O
different	O
methods	O
were	O
used	O
to	O
identify	O
the	O
proteins.	O
First,	O
from	O
different	O
cell	O
lines	O
three	O
or	O
all	O
four	O
of	O
the	O
nuclear	protein
proteins	protein
were	O
specifically	O
cross-linked	O
by	O
UV	O
irradiation	O
to	O
the	O
radioactively	O
labeled	O
TRE	DNA
-DNA	DNA
fragment	DNA
.	O
Second,	O
TRE	protein
-DNA	protein
binding	protein
proteins	protein
sedimented	O
through	O
a	O
glycerol	O
density	O
gradient	O
at	O
rates	O
corresponding	O
to	O
proteins	O
of	O
native	O
molecular	O
weights	O
of	O
35	O
to	O
50	O
kD	O
and	O
110	O
kD.	O
Third,	O
only	O
the	O
50	protein
kD	protein
protein	protein
was	O
retained	O
on	O
a	O
biotinylated	O
DNA-streptavidin	O
matrix	O
when	O
the	O
DNA	O
fragment	O
contained	O
the	O
TRE	DNA
-DNA	DNA
.	O
Fourth,	O
extensive	O
purification	O
by	O
several	O
cycles	O
of	O
TRE	DNA
-DNA	O
affinity	O
chromatography	O
resulted	O
in	O
the	O
32	O
,	O
36	O
to	O
42	O
and	O
110	O
kD	O
proteins	O
and	O
to	O
less	O
extent	O
the	O
50	protein
kD	protein
factor	protein
.	O
Two	O
abundant	O
proteins	O
of	O
75	O
and	O
80	O
kD	O
were	O
competed	O
out	O
by	O
poly[d(I-C)]	O
in	O
all	O
reactions.	O
The	O
cAMP-response	DNA
element	DNA
CRE	DNA
,	O
TGACGTCA	O
,	O
present	O
in	O
the	O
21	DNA
base-pair	DNA
sequence	DNA
,	O
appears	O
to	O
be	O
essential	O
for	O
specific	O
protein-	O
TRE	DNA
-DNA	O
interactions	O
because	O
mutation	O
of	O
the	O
two	O
G	O
's	O
destroys	O
this	O
complex.	O
This	O
result	O
suggests	O
that	O
the	O
cAMP	protein
response	protein
element	protein
binding	protein
protein	protein
,	O
CREB	protein
,	O
is	O
involved	O
in	O
the	O
protein-	protein
TRE	protein
-DNA	protein
complex	protein
and	O
in	O
mediating	O
the	O
Tax	protein
response	O
.	O

Two	O
distinct	O
transcription	protein
factors	protein
that	O
bind	O
the	O
immunoglobulin	DNA
enhancer	DNA
microE5/kappa	DNA
2	DNA
motif	DNA
.	O
Activity	O
of	O
the	O
immunoglobulin	O
heavy	O
and	O
kappa	O
light	O
chain	O
gene	O
enhancers	O
depends	O
on	O
a	O
complex	O
interplay	O
of	O
ubiquitous	protein
and	protein
developmentally	protein
regulated	protein
proteins	protein
.	O
Two	O
complementary	DNA
DNAs	DNA
were	O
isolated	O
that	O
encode	O
proteins,	O
denoted	O
ITF-1	protein
and	O
ITF-2	protein
,	O
that	O
are	O
expressed	O
in	O
a	O
variety	O
of	O
cell	O
types	O
and	O
bind	O
the	O
microE5/kappa	DNA
2	DNA
motif	DNA
found	O
in	O
both	O
heavy	O
and	O
kappa	O
light	O
chain	O
enhancers	O
.	O
The	O
complementary	DNA
DNAs	DNA
are	O
the	O
products	O
of	O
distinct	O
genes,	O
yet	O
both	O
ITF-1	protein
and	O
ITF-2	protein
are	O
structurally	O
and	O
functionally	O
similar.	O
The	O
two	O
proteins	O
interact	O
with	O
one	O
another	O
through	O
their	O
putative	O
helix-loop-helix	protein
motifs	protein
and	O
each	O
possesses	O
a	O
distinct	O
domain	O
that	O
dictates	O
transcription	O
activation	O
.	O

Elevated	O
glucocorticoid	protein
receptor	protein
concentrations	O
before	O
and	O
after	O
glucocorticoid	O
therapy	O
in	O
peripheral	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
patients	O
with	O
atopic	O
dermatitis	O
.	O
The	O
number	O
and	O
affinity	O
of	O
glucocorticoid	O
binding	O
sites	O
in	O
peripheral	cell_type
mononuclear	cell_type
leukocytes	cell_type
of	O
patients	O
with	O
atopic	O
dermatitis	O
(	O
AD	O
)	O
and	O
healthy	O
controls	O
were	O
determined	O
under	O
baseline	O
conditions	O
and	O
after	O
a	O
defined	O
oral	O
glucocorticoid	O
treatment	O
.	O
Patients	O
with	O
AD	O
(n	O
=	O
15)	O
exhibited	O
significantly	O
more	O
glucocorticoid	protein
receptors	protein
(	O
GR	protein
)	O
per	O
cell	O
than	O
the	O
control	O
group	O
(n	O
=	O
22),	O
while	O
the	O
GR	protein
affinity	O
did	O
not	O
differ.	O
Methylprednisolone	O
treatment	O
resulted	O
in	O
a	O
significant	O
reduction	O
of	O
the	O
GR	protein
sites	O
per	O
cell	O
in	O
the	O
steroid-treated	O
control	O
group	O
(n	O
=	O
10)	O
in	O
contrast	O
to	O
the	O
patients	O
.	O
The	O
dissociation	O
constant	O
was	O
not	O
affected	O
by	O
methylprednisolone	O
treatment	O
in	O
either	O
group.	O
In	O
view	O
of	O
the	O
therapeutic	O
efficiency	O
of	O
glucocorticoids	O
in	O
AD	O
and	O
findings	O
of	O
abnormal	O
cAMP	O
and	O
cAMP-phosphodiesterase	O
activity	O
,	O
the	O
elevated	O
GR	protein
concentrations	O
in	O
AD	O
lend	O
support	O
to	O
the	O
hypothesis	O
of	O
a	O
compensatory	O
GR	protein
upregulation	O
due	O
to	O
an	O
insufficient	O
action	O
of	O
endogenous	O
cortisol	O
or	O
to	O
altered	O
cAMP	O
-induced	O
GR	protein
expression	O
.	O

The	O
actions	O
of	O
cyclosporin	O
A	O
and	O
FK506	O
suggest	O
a	O
novel	O
step	O
in	O
the	O
activation	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
Cyclosporin	O
A	O
and	O
FK506	O
are	O
immunosuppressive	O
compounds	O
that	O
have	O
similar	O
inhibitory	O
effects	O
on	O
the	O
expression	O
of	O
several	O
lymphokines	protein
produced	O
by	O
T	cell_type
lymphocytes	cell_type
.	O
Despite	O
their	O
similar	O
effects	O
the	O
drugs	O
bind	O
to	O
two	O
different	O
cytosolic	protein
protein	protein
,	O
cyclophilin	protein
and	O
FKBP	protein
respectively,	O
which	O
raises	O
the	O
possibility	O
that	O
they	O
have	O
different	O
modes	O
of	O
action.	O
Using	O
constructs	O
in	O
which	O
mRNA	RNA
production	O
controlled	O
by	O
a	O
specific	O
transcription	protein
factor	protein
could	O
be	O
readily	O
measured	O
we	O
found	O
that	O
both	O
cyclosporin	O
A	O
and	O
FK506	O
completely	O
inhibited	O
transcription	O
activated	O
by	O
NF-AT	protein
,	O
NFIL2	protein
A	protein
,	O
NFIL2	protein
B	protein
and	O
partially	O
inhibited	O
transcription	O
activated	O
by	O
NF	protein
kappa	protein
B	protein
.	O
Cyclosporin	O
A	O
and	O
FK506	O
inhibited	O
only	O
transcriptional	O
activation	O
that	O
was	O
dependent	O
on	O
Ca2+	O
mobilization	O
.	O
However,	O
cyclosporin	O
A	O
and	O
FK506	O
did	O
not	O
inhibit	O
Ca2+	O
mobilization	O
dependent	O
expression	O
of	O
c-fos	RNA
mRNA	RNA
indicating	O
that	O
only	O
a	O
subset	O
of	O
signalling	O
pathways	O
regulated	O
by	O
Ca2+	O
is	O
sensitive	O
to	O
these	O
drugs.	O
Furthermore,	O
we	O
did	O
not	O
observe	O
any	O
qualitative	O
differences	O
between	O
the	O
effect	O
of	O
cyclosporin	O
A	O
and	O
FK506	O
on	O
six	O
different	O
transcription	protein
factors	protein
which	O
suggests	O
that	O
these	O
drugs	O
may	O
interfere	O
with	O
the	O
activity	O
of	O
a	O
novel	O
Ca2+	O
dependent	O
step	O
that	O
regulates	O
several	O
transcription	protein
factors	protein
.	O

The	O
internal	O
methionine	O
codons	O
of	O
human	DNA
T-cell	DNA
leukemia	DNA
virus	DNA
type	DNA
II	DNA
rex	DNA
gene	DNA
are	O
not	O
required	O
for	O
p24rex	protein
production	O
or	O
virus	O
replication	O
and	O
transformation	O
.	O
Human	O
T-cell	O
leukemia	O
virus	O
types	O
I	O
(	O
HTLV-I	O
)	O
and	O
II	O
(	O
HTLV-II	O
)	O
have	O
two	O
nonstructural	DNA
trans-acting	DNA
regulatory	DNA
genes	DNA
,	O
tax	DNA
and	O
rex	DNA
,	O
located	O
in	O
the	O
3'	DNA
region	DNA
of	O
the	O
viral	DNA
genome	DNA
.	O
The	O
tax	protein
gene	protein
product	protein
(	O
HTLV-I	protein
p40tax	protein
and	O
HTLV-II	protein
p37tax	protein
)	O
is	O
the	O
transcriptional	O
activator	O
of	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
.	O
The	O
rex	DNA
gene	DNA
encodes	O
two	O
protein	O
products,	O
p27rex	protein
/p21rex	protein
and	O
p26rex	protein
/p24rex	protein
in	O
HTLV-I	O
and	O
HTLV-II	O
,	O
respectively.	O
Rex	protein
acts	O
posttranscriptionally	O
to	O
facilitate	O
accumulation	O
of	O
full-length	O
gag/pol	protein
and	O
singly	O
spliced	O
env	RNA
mRNA	RNA
in	O
the	O
cytoplasm	O
of	O
HTLV-infected	cell_type
cells	cell_type
.	O
Previous	O
studies	O
showed	O
that	O
the	O
first	O
ATG	O
of	O
the	O
rex	DNA
gene	DNA
is	O
critical	O
for	O
Rex	protein
production	O
and	O
function.	O
The	O
importance	O
of	O
the	O
internal	O
ATGs	O
to	O
Rex	protein
function	O
is	O
not	O
known.	O
However,	O
in	O
vitro	O
mutagenesis	O
of	O
the	O
HTLV-I	O
rex	DNA
gene	DNA
has	O
provided	O
indirect	O
evidence	O
which	O
suggests	O
that	O
p21rex	protein
,	O
and	O
by	O
analogy	O
HTLV-II	O
p24rex	protein
,	O
results	O
from	O
initiation	O
at	O
an	O
internal	O
AUG	O
of	O
the	O
tax	RNA
/rex	RNA
mRNA	RNA
.	O
By	O
using	O
an	O
infectious	O
molecular	O
clone	O
of	O
HTLV-II	O
,	O
we	O
investigated	O
the	O
importance	O
of	O
the	O
internal	O
ATGs	O
of	O
the	O
rex	DNA
gene	DNA
on	O
Rex	protein
protein	O
production	O
and	O
function.	O
Our	O
results	O
indicate	O
that	O
p24rex	protein
of	O
HTLV-II	O
is	O
not	O
initiated	O
at	O
an	O
internal	O
AUG	O
and	O
that	O
the	O
internal	O
methionine	O
codons	O
are	O
not	O
crucial	O
to	O
the	O
function	O
of	O
the	O
rex	DNA
gene	DNA
and,	O
ultimately,	O
the	O
transforming	O
properties	O
of	O
the	O
virus	O
.	O

Astrocytes	cell_type
and	O
glioblastoma	cell_type
cells	cell_type
express	O
novel	O
octamer-DNA	protein
binding	protein
proteins	protein
distinct	O
from	O
the	O
ubiquitous	protein
Oct-1	protein
and	protein
B	protein
cell	protein
type	protein
Oct-2	protein
proteins	protein
.	O
The	O
'octamer'	DNA
sequence	DNA
,	O
ATGCAAAT	O
or	O
its	O
complement	O
ATTTGCAT	O
,	O
is	O
a	O
key	O
element	O
for	O
the	O
transcriptional	O
regulation	O
of	O
immunoglobulin	DNA
genes	DNA
in	O
B-lymphocytes	cell_type
as	O
well	O
as	O
a	O
number	O
of	O
housekeeping	DNA
genes	DNA
in	O
all	O
cell	O
types.	O
In	O
lymphocytes	cell_type
,	O
the	O
octamer-binding	protein
protein	protein
Oct-2A	protein
and	O
variants	O
thereof	O
are	O
thought	O
to	O
contribute	O
to	O
the	O
B-cell	DNA
specific	DNA
gene	DNA
expression	O
,	O
while	O
the	O
ubiquitous	O
protein	O
Oct-1	O
seems	O
to	O
control	O
general	O
octamer	DNA
site	DNA
-dependent	O
transcription	O
.	O
Various	O
other	O
genes,	O
for	O
example	O
interleukin-1	O
and	O
MHC	O
class	O
II	O
genes	O
,	O
contain	O
an	O
octamer	DNA
sequence	DNA
in	O
the	O
promoter	DNA
and	O
are	O
expressed	O
in	O
cells	O
of	O
both	O
the	O
immune	O
and	O
nervous	O
systems	O
.	O
This	O
prompted	O
us	O
to	O
analyze	O
the	O
octamer-binding	protein
proteins	protein
in	O
the	O
latter	O
cells.	O
Using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
at	O
least	O
six	O
novel	O
octamer	protein
binding	protein
proteins	protein
were	O
detected	O
in	O
nuclear	O
extracts	O
of	O
cultured	cell_type
mouse	cell_type
astrocytes	cell_type
.	O
These	O
proteins	O
are	O
differentially	O
expressed	O
in	O
human	O
glioblastoma	O
and	O
neuroblastoma	O
cell	O
lines	O
.	O
The	O
nervous	protein
system-derived	protein
(N-Oct)	protein
proteins	protein
bound	O
to	O
the	O
octamer	DNA
DNA	DNA
sequence	DNA
in	O
a	O
manner	O
which	O
is	O
indistinguishable	O
from	O
the	O
Oct-1	protein
and	O
Oct-2A	protein
proteins	protein
.	O
The	O
relationship	O
of	O
the	O
N-Oct	protein
proteins	protein
to	O
Oct-1	protein
and	O
Oct-2A	protein
was	O
analyzed	O
by	O
proteolytic	O
clipping	O
bandshift	O
assays	O
and	O
by	O
their	O
reactivity	O
towards	O
antisera	O
raised	O
against	O
recombinant	O
Oct-1	protein
and	O
Oct-2A	protein
proteins.	O
On	O
the	O
basis	O
of	O
these	O
assays,	O
all	O
N-Oct-factors	protein
were	O
found	O
to	O
be	O
distinct	O
from	O
the	O
ubiquitous	protein
Oct-1	protein
and	O
the	O
lymphoid-specific	protein
Oct-2A	protein
proteins.	O
In	O
melanoma	cell_type
cells	cell_type
that	O
contain	O
the	O
N-Oct-3	protein
factor	protein
,	O
a	O
transfected	O
lymphocyte-specific	O
promoter	O
was	O
neither	O
activated	O
nor	O
was	O
it	O
repressed	O
upon	O
contransfection	O
with	O
an	O
Oct-2A	DNA
expression	DNA
vector	DNA
.	O
We	O
therefore	O
speculate	O
that	O
N-Oct-3	protein
and	O
other	O
N-Oct	protein
factors	protein
have	O
a	O
specific	O
role	O
in	O
gene	O
expression	O
in	O
cells	O
of	O
the	O
nervous	O
system	O
.	O

Detection	O
in	O
non-erythroid	cell_type
cells	cell_type
of	O
a	O
factor	O
with	O
the	O
binding	O
characteristics	O
of	O
the	O
erythroid	protein
cell	protein
transcription	protein
factor	protein
EF1	protein
.	O
The	O
erythroid	protein
transcription	protein
factor	protein
erythroid	protein
factor-1	protein
(	O
EF1	protein
)	O
plays	O
a	O
critical	O
role	O
in	O
the	O
transcription	O
of	O
erythroid-specific	DNA
genes	DNA
.	O
Here	O
we	O
report	O
the	O
presence	O
of	O
a	O
factor	O
with	O
the	O
mobility	O
and	O
sequence-specific	O
DNA-binding	O
characteristics	O
of	O
EF1	protein
at	O
low	O
abundance	O
in	O
a	O
wide	O
variety	O
of	O
non-erythroid	cell_type
cell	cell_type
types	cell_type
.	O
This	O
is	O
the	O
first	O
report	O
of	O
an	O
EF1	protein
-like	O
activity	O
in	O
non-erythroid	cell_type
cells	cell_type
and	O
indicates	O
that	O
this	O
factor	O
may	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
genes	DNA
expressed	O
in	O
such	O
cells.	O

Protein	O
kinase	O
inhibitor	O
H-7	O
blocks	O
accumulation	O
of	O
unspliced	RNA
mRNA	RNA
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
).	O
Rex	protein
,	O
the	O
post-transcriptional	protein
regulator	protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
),	O
is	O
known	O
to	O
induce	O
accumulation	O
of	O
the	O
unspliced	RNA
viral	RNA
gag-pol	RNA
mRNA	RNA
.	O
Rex	protein
is	O
a	O
phosphoprotein	protein
found	O
in	O
the	O
cell	O
nucleolus	O
,	O
whose	O
function	O
may	O
be	O
regulated	O
by	O
its	O
localization	O
and	O
phosphorylation	O
.	O
We	O
have	O
examined	O
the	O
role	O
of	O
phosphorylation	O
on	O
Rex	protein
function	O
by	O
using	O
a	O
protein	O
kinase	O
inhibitor	O
,	O
H-7	O
[	O
1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine	O
].	O
Treatment	O
of	O
an	O
HTLV-I	cell_line
infected	cell_line
human	cell_line
T-cell	cell_line
line	cell_line
with	O
H-7	O
blocked	O
specifically	O
accumulation	O
of	O
the	O
unspliced	RNA
gag-pol	RNA
mRNA	RNA
,	O
resulting	O
in	O
the	O
decreased	O
Gag	protein
protein	protein
synthesis	O
that	O
corresponds	O
with	O
the	O
decreased	O
in	O
vivo	O
phosphorylation	O
of	O
Rex	protein
.	O
In	O
contrast,	O
other	O
viral	O
and	O
cellular	O
products	O
have	O
not	O
been	O
influenced	O
by	O
the	O
level	O
of	O
H-7	O
used.	O
Therefore,	O
the	O
phosphorylation	O
of	O
Rex	protein
is	O
required	O
for	O
the	O
viral	O
RNA	O
partition	O
of	O
HTLV-I	O
.	O

Increased	O
glucocorticoid	O
responsiveness	O
of	O
CD4+	cell_line
T-cell	cell_line
clonal	cell_line
lines	cell_line
grown	O
in	O
serum-free	O
media	O
.	O
CEM-C7	cell_line
,	O
a	O
human	cell_line
leukemic	cell_line
CD4+	cell_line
T-lymphocyte	cell_line
cell	cell_line
line	cell_line
and	O
three	O
of	O
its	O
subclones,	O
CEM-4R4	cell_line
,	O
CEM-3R43	cell_line
,	O
and	O
ICR-27	cell_line
,	O
previously	O
cultured	O
in	O
a	O
medium	O
supplemented	O
with	O
5	O
to	O
10%	O
fetal	O
bovine	O
serum	O
,	O
have	O
been	O
adapted	O
to	O
serum-free	O
media	O
.	O
The	O
best	O
medium	O
of	O
those	O
tested	O
was	O
RPMI	O
1640	O
supplemented	O
with	O
5	O
micrograms/ml	O
each	O
transferrin	protein
and	O
insulin	protein
+	O
5	O
ng/ml	O
sodium	O
selenite	O
+/-	O
0.1%	O
bovine	protein
serum	protein
albumin	protein
.	O
While	O
growing	O
either	O
with	O
or	O
without	O
albumin,	O
the	O
several	O
clonal	cell_line
lines	cell_line
of	O
CEM	cell_line
cells	O
displayed	O
growth	O
similar	O
to	O
serum-supplemented	O
cultures.	O
Cell	O
proliferation	O
of	O
CEM-C7	cell_line
cells	O
cultured	O
in	O
both	O
serum-free	O
media	O
has	O
been	O
sustained	O
for	O
3	O
mo.	O
with	O
culture	O
doubling	O
times	O
of	O
about	O
25	O
h	O
for	O
both	O
serum-supplemented	O
and	O
serum-free	O
cultures	O
(viability	O
greater	O
than	O
or	O
equal	O
to	O
90%).	O
Cell	O
morphology	O
remained	O
essentially	O
the	O
same	O
in	O
serum-free	O
or	O
serum	O
containing	O
media	O
.	O
The	O
expression	O
of	O
CD4	protein
,	O
a	O
marker	O
for	O
T-derived	cell_type
lymphoid	cell_type
cells	cell_type
,	O
was	O
not	O
significantly	O
different	O
in	O
serum-free	O
medium	O
.	O
When	O
grown	O
in	O
serum-free	O
medium,	O
CEM-C7	cell_line
cells	O
exhibited	O
increased	O
steroid	O
responsiveness	O
as	O
evidenced	O
by	O
increased	O
glucocorticoid	protein
receptor	protein
binding	O
sites	O
,	O
increased	O
induction	O
of	O
glutamine	protein
synthetase	protein
,	O
and	O
cell	O
lysis	O
at	O
lower	O
concentrations	O
of	O
steroid	O
.	O
Receptor	O
mutant	O
subclones	O
of	O
CEM-C7	cell_line
,	O
which	O
are	O
proven	O
to	O
be	O
completely	O
unresponsive	O
to	O
micromolar	O
concentrations	O
of	O
dexamethasone	O
when	O
grown	O
in	O
serum-supplemented	O
medium	O
,	O
become	O
partially	O
sensitive	O
to	O
the	O
hormone	O
after	O
growth	O
in	O
defined	O
medium.	O
The	O
increased	O
sensitivity	O
of	O
CEM-C7	cell_line
cells	cell_line
and	O
its	O
subclones	O
to	O
dexamethasone	O
in	O
serum-free	O
medium	O
returned	O
to	O
previous	O
levels	O
when	O
these	O
cells	O
were	O
recultured	O
in	O
serum-containing	O
medium	O
.	O
Our	O
results	O
suggest	O
that	O
substances	O
in	O
serum	O
influence	O
steroid	O
effects	O
on	O
these	O
cells	O
and	O
that	O
the	O
molecular	O
details	O
of	O
glucocorticoid	O
hormone	O
action	O
may	O
be	O
pursued	O
more	O
precisely	O
in	O
a	O
clearly	O
defined	O
culture	O
medium.	O

[	O
Glucocorticoid	protein
receptors	protein
on	O
human	O
peripheral	O
mononuclear	O
and	O
polymorphonuclear	O
leucocytes	O
:	O
changes	O
in	O
patients	O
with	O
yang-deficiency	O
]	O
It	O
was	O
found	O
that,	O
in	O
former	O
works,	O
the	O
glucocorticoid	protein
receptors	protein
(	O
GCR	protein
)	O
on	O
peripheral	cell_type
mixed	cell_type
leucocytes	cell_type
in	O
patients	O
with	O
Yang-deficiency	O
were	O
decreased.	O
In	O
this	O
work,	O
the	O
mixed	cell_type
leucocytes	cell_type
were	O
further	O
separated	O
into	O
mononuclear	O
(MNL)	O
and	O
polymorphonuclear	O
(PML)	O
leucocytes	O
,	O
and	O
GCR	protein
were	O
determined	O
in	O
each	O
part	O
of	O
leucocytes	cell_type
.	O
GCR	protein
on	O
MNL	cell_type
and	O
PML	cell_type
in	O
6	O
Yang	O
deficient	O
patients	O
were	O
3473	O
+/-	O
413	O
and	O
4433	O
+/-	O
651	O
sites/cell	O
respectively,	O
statistically	O
significant	O
from	O
the	O
normal	O
control	O
group	O
(4462	O
+/-	O
962	O
and	O
5622	O
+/-	O
782	O
sites/cell	O
respectively,	O
P	O
less	O
than	O
0.05).	O
GCR	protein
on	O
MNL	cell_type
,	O
PML	cell_type
and	O
mixed	cell_type
leucocytes	cell_type
in	O
5	O
patients	O
were	O
determined	O
simultaneously,	O
and	O
all	O
lowered	O
from	O
the	O
control	O
group	O
.	O
The	O
results	O
were	O
3369	O
+/-	O
370,	O
4986	O
+/-	O
419	O
and	O
4524	O
+/-	O
852	O
sites/cell	O
respectively,	O
with	O
the	O
lowest	O
GCR	protein
on	O
MNL	cell_type
and	O
highest	O
on	O
PML	cell_type
.	O

The	O
ubiquitous	protein
octamer-binding	protein
protein	protein
(s)	O
is	O
sufficient	O
for	O
transcription	O
of	O
immunoglobulin	DNA
genes	DNA
.	O
All	O
immunoglobulin	DNA
genes	DNA
contain	O
a	O
conserved	O
octanucleotide	DNA
promoter	DNA
element	DNA
,	O
ATGCAAAT	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
their	O
normal	O
B-cell-specific	O
transcription	O
.	O
Proteins	O
that	O
bind	O
this	O
octamer	O
have	O
been	O
purified,	O
and	O
cDNAs	DNA
encoding	O
octamer-binding	protein
proteins	protein
have	O
been	O
cloned.	O
Some	O
of	O
these	O
proteins	O
(referred	O
to	O
as	O
OTF-2	protein
)	O
are	O
lymphoid	O
specific,	O
whereas	O
at	O
least	O
one	O
other,	O
and	O
possibly	O
more	O
(referred	O
to	O
as	O
OTF-1	protein
),	O
is	O
found	O
ubiquitously	O
in	O
all	O
cell	O
types.	O
The	O
exact	O
role	O
of	O
these	O
different	O
proteins	O
in	O
directing	O
the	O
tissue-specific	O
expression	O
of	O
immunoglobulin	DNA
genes	DNA
is	O
unclear.	O
We	O
have	O
identified	O
two	O
human	cell_line
pre-B-cell	cell_line
lines	cell_line
that	O
contain	O
extremely	O
low	O
levels	O
of	O
OTF-2	protein
yet	O
still	O
express	O
high	O
levels	O
of	O
steady-state	RNA
immunoglobulin	RNA
heavy-chain	RNA
mRNA	RNA
in	O
vivo	O
and	O
efficiently	O
transcribe	O
an	O
immunoglobulin	DNA
gene	DNA
in	O
vitro.	O
Addition	O
of	O
a	O
highly	O
enriched	O
preparation	O
of	O
OTF-1	protein
made	O
from	O
one	O
of	O
these	O
pre-B	cell_line
cells	cell_line
or	O
from	O
HeLa	cell_line
cells	cell_line
specifically	O
stimulated	O
in	O
vitro	O
transcription	O
of	O
an	O
immunoglobulin	DNA
gene	DNA
.	O
Furthermore,	O
OFT-1	O
appeared	O
to	O
have	O
approximately	O
the	O
same	O
transactivation	O
ability	O
as	O
OTF-2	protein
when	O
normalized	O
for	O
binding	O
activity.	O
These	O
results	O
suggest	O
that	O
OTF-1	protein
,	O
without	O
OTF-2	protein
,	O
is	O
sufficient	O
for	O
transcription	O
of	O
immunoglobulin	DNA
genes	DNA
and	O
that	O
OTF-2	protein
alone	O
is	O
not	O
responsible	O
for	O
the	O
B-cell-specific	O
regulation	O
of	O
immunoglobulin	DNA
gene	DNA
expression	O
.	O

Effects	O
of	O
aldosterone	O
on	O
intralymphocytic	O
sodium	O
and	O
potassium	O
in	O
patients	O
with	O
essential	O
hypertension	O
.	O
In	O
vitro	O
binding	O
of	O
aldosterone	O
to	O
mineralocorticoid	protein
receptors	protein
on	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
(	O
HML	cell_type
)	O
and	O
its	O
effects	O
on	O
the	O
intracellular	O
sodium	O
and	O
potassium	O
concentrations	O
of	O
HML	cell_type
have	O
already	O
been	O
described.	O
In	O
the	O
present	O
paper	O
this	O
easily	O
accessible	O
human	O
cell	O
model	O
was	O
investigated	O
in	O
13	O
patients	O
with	O
essential	O
hypertension	O
.	O
In	O
only	O
four	O
patients	O
sodium	O
in	O
HML	cell_type
without	O
incubation	O
was	O
elevated	O
compared	O
with	O
the	O
range	O
for	O
normal	O
persons	O
.	O
A	O
decrease	O
of	O
intracellular	O
sodium	O
or	O
potassium	O
occurred	O
during	O
incubation	O
without	O
aldosterone	O
(P	O
less	O
than	O
0.02).	O
The	O
addition	O
of	O
1.4	O
nM	O
aldosterone	O
did	O
not	O
prevent	O
this	O
loss	O
of	O
electrolytes	O
as	O
observed	O
in	O
normal	O
persons	O
.	O
Plasma	protein
renin	protein
activity	O
and	O
aldosterone	O
were	O
not	O
correlated	O
with	O
the	O
electrolyte	O
response	O
and	O
were	O
within	O
the	O
normal	O
limits.	O
The	O
number	O
of	O
mineralocorticoid	protein
receptors	protein
/cell	O
were	O
within	O
or	O
close	O
to	O
the	O
normal	O
range	O
(n	O
=	O
9).	O
The	O
independence	O
of	O
intracellular	O
electrolytes	O
from	O
aldosterone	O
despite	O
a	O
normal	O
number	O
of	O
mineralocorticoid	protein
receptors	protein
may	O
reflect	O
an	O
impairment	O
of	O
the	O
mineralocorticoid	O
effector	O
mechanism	O
in	O
the	O
HML	cell_type
of	O
patients	O
with	O
essential	O
hypertension	O
.	O

[Differential	O
diagnostic	O
value	O
of	O
receptors	O
of	O
1,25-dihydroxyvitamin	O
D3	O
(	O
calcitriol	O
)	O
determination	O
in	O
lymphocytes	cell_type
of	O
children	O
with	O
rickets	O
and	O
rickets	O
-like	O
diseases	O
]	O
The	O
authors	O
provide	O
the	O
results	O
of	O
studying	O
1,25-dihydroxyvitamin	O
D3	O
(	O
calcitriol	O
)	O
in	O
lymphocytes	cell_type
of	O
children	O
with	O
rickets	O
and	O
rickets	O
-like	O
diseases	O
.	O
It	O
is	O
proposed	O
that	O
the	O
character	O
of	O
their	O
expression	O
under	O
the	O
influence	O
of	O
vitamin	O
D	O
may	O
be	O
used	O
with	O
differential	O
diagnostic	O
purposes	O
in	O
view.	O

Regulation	O
of	O
gene	O
expression	O
with	O
double-stranded	O
phosphorothioate	O
oligonucleotides	O
.	O
Alteration	O
of	O
gene	O
transcription	O
by	O
inhibition	O
of	O
specific	O
transcriptional	protein
regulatory	protein
proteins	protein
is	O
necessary	O
for	O
determining	O
how	O
these	O
factors	O
participate	O
in	O
cellular	O
differentiation	O
.	O
The	O
functions	O
of	O
these	O
proteins	O
can	O
be	O
antagonized	O
by	O
several	O
methods,	O
each	O
with	O
specific	O
limitations.	O
Inhibition	O
of	O
sequence-specific	protein
DNA-binding	protein
proteins	protein
was	O
achieved	O
with	O
double-stranded	O
(ds)	O
phosphorothioate	O
oligonucleotides	O
that	O
contained	O
octamer	O
or	O
kappa	O
B	O
consensus	O
sequences	O
.	O
The	O
phosphorothioate	O
oligonucleotides	O
specifically	O
bound	O
either	O
octamer	protein
transcription	protein
factor	protein
or	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
.	O
The	O
modified	O
oligonucleotides	O
accumulated	O
in	O
cells	O
more	O
effectively	O
than	O
standard	O
ds	O
oligonucleotides	O
and	O
modulated	O
gene	O
expression	O
in	O
a	O
specific	O
manner.	O
Octamer-dependent	O
activation	O
of	O
a	O
reporter	DNA
plasmid	DNA
or	O
NF-kappa	protein
B	protein
-dependent	O
activation	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
(	DNA
HIV	DNA
)	DNA
enhancer	DNA
was	O
inhibited	O
when	O
the	O
appropriate	O
phosphorothioate	O
oligonucleotide	O
was	O
added	O
to	O
a	O
transiently	cell_line
transfected	cell_line
B	cell_line
cell	cell_line
line	cell_line
.	O
Addition	O
of	O
phosphorothioate	O
oligonucleotides	O
that	O
contained	O
the	O
octamer	DNA
consensus	DNA
to	O
Jurkat	cell_line
T	cell_line
leukemia	cell_line
cells	cell_line
inhibited	O
interleukin-2	protein
(	O
IL-2	protein
)	O
secretion	O
to	O
a	O
degree	O
similar	O
to	O
that	O
observed	O
with	O
a	O
mutated	DNA
octamer	DNA
site	DNA
in	O
the	O
IL-2	DNA
enhancer	DNA
.	O
The	O
ds	O
phosphorothioate	O
oligonucleotides	O
probably	O
compete	O
for	O
binding	O
of	O
specific	O
transcription	O
factors	O
and	O
may	O
provide	O
anti-viral	O
,	O
immunosuppressive	O
,	O
or	O
other	O
therapeutic	O
effects	O
.	O

[Effect	O
of	O
the	O
regimen	O
of	O
kidney-tonifying	O
and	O
qi-invigorating	O
on	O
aging	O
changes	O
of	O
glucocorticoid	protein
receptor	protein
]	O
The	O
plasma	O
cortisol	O
concentration	O
and	O
the	O
sites	O
of	O
glucocorticoid	protein
receptor	protein
(	O
GCR	protein
)	O
in	O
the	O
peripheral	cell_type
lymphocytes	cell_type
were	O
measured	O
in	O
32	O
healthy	O
aged	O
persons	O
and	O
13	O
young	O
adults	O
.	O
In	O
animal	O
experiment	O
,	O
GCR	protein
of	O
spleen	cell_type
lymphocytic	cell_type
cell	cell_type
was	O
also	O
measured	O
in	O
18	O
aged	O
rats	O
and	O
9	O
young	O
rats	O
.	O
The	O
results	O
showed	O
that	O
GCR	protein
was	O
significantly	O
lower	O
in	O
the	O
aged	O
persons	O
or	O
rats	O
than	O
that	O
in	O
the	O
young	O
while	O
the	O
plasma	O
cortisol	O
level	O
didn't	O
change	O
with	O
aging.	O
So	O
we	O
think	O
that	O
GCR	protein
is	O
more	O
sensitive	O
than	O
the	O
plasma	O
cortisol	O
level	O
to	O
reflect	O
the	O
aging	O
change	O
of	O
the	O
adrenal	O
cortex	O
function	O
.	O
After	O
the	O
treatment	O
with	O
the	O
regimen	O
of	O
Kidney-tonifying	O
and	O
Qi-invigorating	O
,	O
the	O
GCR	protein
of	O
the	O
aged	O
persons	O
and	O
rats	O
was	O
enhanced,	O
and	O
in	O
this	O
way,	O
the	O
function	O
of	O
the	O
aged	O
adrenal	O
cortex	O
was	O
improved.	O

Interferon	O
affects	O
nuclear	protein
proteins	protein
in	O
cells	O
of	O
clinically	O
sensitive	O
chronic	O
myelogenous	O
leukemia	O
patients	O
.	O
Cytoplasmic	O
protein	O
extracts	O
from	O
chronic	cell_type
myelogenous	cell_type
leukemia	cell_type
(	cell_type
CML	cell_type
)	cell_type
cells	cell_type
contained	O
an	O
activity	O
that	O
altered	O
the	O
electrophoretic	O
mobility	O
of	O
complexes	O
formed	O
between	O
nuclear	protein
proteins	protein
and	O
the	O
transcriptional	O
enhancers	O
of	O
interferon	O
(IFN)-inducible	O
genes.	O
Exposure	O
of	O
CML	cell_type
cells	cell_type
to	O
IFN-alpha	protein
diminished	O
the	O
effect	O
of	O
the	O
CML	protein
cytoplasmic	protein
proteins	protein
on	O
these	O
nuclear	protein
protein-DNA	protein
complexes	protein
.	O
The	O
presence	O
of	O
clinical	O
responsiveness	O
to	O
IFN-alpha	protein
correlated	O
with	O
the	O
sensitivity	O
to	O
the	O
IFN	protein
-induced	O
change	O
in	O
the	O
electrophoretic	O
mobility	O
of	O
nuclear	protein
protein-DNA	protein
complexes	protein
.	O
These	O
data	O
suggest	O
that	O
the	O
action	O
of	O
IFN-alpha	protein
in	O
CML	O
may	O
be	O
linked	O
to	O
a	O
pathway	O
that	O
can	O
result	O
in	O
posttranslational	O
modification	O
of	O
nuclear	protein
proteins	protein
.	O

Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
transactivates	O
latent	protein
membrane	protein
protein	protein
LMP1	protein
.	O
Several	O
lines	O
of	O
evidence	O
are	O
compatible	O
with	O
the	O
hypothesis	O
that	O
Epstein-Barr	protein
virus	protein
(	protein
EBV	protein
)	protein
nuclear	protein
antigen	protein
2	protein
(	O
EBNA-2	protein
)	O
or	O
leader	protein
protein	protein
(	O
EBNA-LP	protein
)	O
affects	O
expression	O
of	O
the	O
EBV	protein
latent	protein
infection	protein
membrane	protein
protein	protein
LMP1	protein
.	O
We	O
now	O
demonstrate	O
the	O
following.	O
(i)	O
Acute	O
transfection	O
and	O
expression	O
of	O
EBNA-2	protein
under	O
control	O
of	O
simian	O
virus	O
40	O
or	O
Moloney	O
murine	O
leukemia	O
virus	O
promoters	O
resulted	O
in	O
increased	O
LMP1	protein
expression	O
in	O
P3HR-1-infected	cell_line
Burkitt's	cell_line
lymphoma	cell_line
cells	cell_line
and	O
the	O
P3HR-1	cell_line
or	O
Daudi	cell_line
cell	cell_line
line	cell_line
.	O
(ii)	O
Transfection	O
and	O
expression	O
of	O
EBNA-LP	protein
alone	O
had	O
no	O
effect	O
on	O
LMP1	protein
expression	O
and	O
did	O
not	O
act	O
synergistically	O
with	O
EBNA-2	protein
to	O
affect	O
LMP1	protein
expression	O
.	O
(iii)	O
LMP1	protein
expression	O
in	O
Daudi	cell_line
and	O
P3HR-1-infected	cell_line
cells	cell_line
was	O
controlled	O
at	O
the	O
mRNA	RNA
level	O
,	O
and	O
EBNA-2	protein
expression	O
in	O
Daudi	cell_line
cells	cell_line
increased	O
LMP1	RNA
mRNA	RNA
.	O
(iv)	O
No	O
other	O
EBV	DNA
genes	DNA
were	O
required	O
for	O
EBNA-2	protein
transactivation	O
of	O
LMP1	protein
since	O
cotransfection	O
of	O
recombinant	DNA
EBNA-2	DNA
expression	DNA
vectors	DNA
and	O
genomic	O
LMP1	DNA
DNA	DNA
fragments	DNA
enhanced	O
LMP1	protein
expression	O
in	O
the	O
EBV-negative	cell_line
B-lymphoma	cell_line
cell	cell_line
lines	cell_line
BJAB	cell_line
,	O
Louckes	cell_line
,	O
and	O
BL30	cell_line
.	O
(v)	O
An	O
EBNA-2	DNA
-responsive	DNA
element	DNA
was	O
found	O
within	O
the	O
-512	DNA
to	DNA
+40	DNA
LMP1	DNA
DNA	DNA
since	O
this	O
DNA	O
linked	O
to	O
a	O
chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
gene	DNA
was	O
transactivated	O
by	O
cotransfection	O
with	O
an	O
EBNA-2	DNA
expression	DNA
vector	DNA
.	O
(vi)	O
The	O
EBV	O
type	O
2	O
EBNA-2	protein
transactivated	O
LMP1	protein
as	O
well	O
as	O
the	O
EBV	protein
type	protein
1	protein
EBNA-2	protein
.	O
(vii)	O
Two	O
deletions	O
within	O
the	O
EBNA-2	protein
gene	O
which	O
rendered	O
EBV	O
transformation	O
incompetent	O
did	O
not	O
transactivate	O
LMP1	protein
,	O
whereas	O
a	O
transformation-competent	DNA
EBNA-2	DNA
deletion	DNA
mutant	DNA
did	O
transactivate	O
LMP1	protein
.	O
LMP1	protein
is	O
a	O
potent	O
effector	O
of	O
B-lymphocyte	O
activation	O
and	O
can	O
act	O
synergistically	O
with	O
EBNA-2	protein
to	O
induce	O
cellular	O
CD23	O
gene	O
expression	O
.	O
Thus,	O
EBNA-2	protein
transactivation	O
of	O
LMP1	protein
amplifies	O
the	O
biological	O
impact	O
of	O
EBNA-2	protein
and	O
underscores	O
its	O
central	O
role	O
in	O
EBV-induced	O
growth	O
transformation	O
.	O

The	O
expression	O
of	O
c-fos	DNA
,	O
c-jun	DNA
,	O
and	O
c-myc	DNA
genes	DNA
is	O
regulated	O
by	O
heat	O
shock	O
in	O
human	cell_type
lymphoid	cell_type
cells	cell_type
.	O
The	O
effect	O
of	O
heat	O
shock	O
on	O
the	O
expression	O
of	O
the	O
nuclear	DNA
protooncogenes	DNA
c-fos	DNA
,	O
c-jun	DNA
,	O
and	O
c-myc	DNA
was	O
studied	O
in	O
human	cell_type
lymphoid	cell_type
cells	cell_type
.	O
Heat	O
shock	O
caused	O
an	O
increase	O
in	O
c-fos	O
and	O
c-jun	O
mRNA	O
levels	O
and	O
a	O
decrease	O
in	O
c-myc	RNA
mRNA	RNA
levels	O
in	O
pre-B	O
(Hyon)	O
and	O
T	O
(DND-41)	O
cell	O
lines	O
as	O
well	O
as	O
in	O
freshly	O
isolated	O
normal	O
human	O
thymocytes.	O
The	O
changes	O
in	O
the	O
mRNA	O
levels	O
of	O
these	O
protooncogenes	DNA
in	O
Hyon	cell_line
cells	cell_line
were	O
most	O
pronounced	O
at	O
42	O
and	O
43	O
degrees	O
C;	O
kinetic	O
analysis	O
demonstrated	O
that	O
the	O
changes	O
could	O
be	O
detected	O
within	O
30	O
min	O
of	O
heat	O
shock	O
.	O
Altered	O
transcription	O
of	O
c-fos	DNA
and	O
c-myc	DNA
genes	DNA
was	O
the	O
primary	O
effect	O
of	O
heat	O
shock	O
.	O
Secondarily,	O
heat	O
shock	O
of	O
Hyon	cell_line
cells	cell_line
stabilized	O
the	O
c-myc	RNA
mRNA	RNA
level	O
by	O
increasing	O
its	O
half-life	O
from	O
24	O
to	O
45	O
min.	O
The	O
overall	O
effect	O
of	O
heat	O
shock	O
on	O
c-myc	RNA
mRNA	RNA
level	O
,	O
however,	O
was	O
a	O
marked	O
inhibition	O
of	O
its	O
transcription	O
.	O
These	O
results	O
demonstrate	O
that	O
the	O
transcription	O
of	O
nuclear	DNA
protooncogenes	DNA
is	O
regulated	O
by	O
heat	O
shock	O
indicating	O
a	O
role	O
for	O
nuclear	DNA
protooncogenes	DNA
in	O
the	O
stress	O
response	O
of	O
lymphoid	cell_type
cells	cell_type
.	O

Mapping	O
of	O
B-cell	protein
epitopes	protein
of	O
the	O
human	protein
hepatitis	protein
B	protein
virus	protein
X	protein
protein	protein
.	O
The	O
immune	O
response	O
to	O
the	O
X	protein
protein	protein
of	O
human	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
was	O
studied	O
by	O
epitope	O
mapping	O
by	O
using	O
a	O
set	O
of	O
MS2-HBx	protein
fusion	protein
proteins	protein
and	O
synthetic	O
peptides	O
.	O
Antibodies	O
in	O
sera	O
of	O
patients	O
with	O
acute	O
and	O
chronic	O
HBV	O
infection	O
showed	O
a	O
multispecific	O
immune	O
response	O
.	O
Each	O
serum	O
contained	O
antibodies	protein
to	O
a	O
different	O
set	O
of	O
epitopes	protein
,	O
which	O
taken	O
together	O
cover	O
most	O
of	O
the	O
HBx	protein
sequence	protein
.	O
Some	O
of	O
the	O
epitopes	O
were	O
detectable	O
only	O
by	O
immunoblotting	O
with	O
fusion	protein
proteins	protein
;	O
others	O
were	O
detectable	O
only	O
by	O
an	O
enzyme-linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
synthetic	O
peptides	O
.	O
The	O
carboxy-terminal	protein
half	protein
of	O
the	O
HBx	protein
protein	protein
was	O
preferentially	O
recognized	O
by	O
antibodies	protein
from	O
patients	O
with	O
chronic	O
hepatitis	O
and	O
contained	O
a	O
short	O
immunodominant	protein
antigenic	protein
region	protein
with	O
at	O
least	O
two	O
major	O
nonoverlapping	protein
epitopes	protein
.	O
Anti-	O
HBx	protein
antibody	O
titers	O
as	O
revealed	O
by	O
peptide	O
ELISAs	O
were	O
highest	O
and	O
most	O
frequent	O
in	O
patients	O
with	O
chronic	O
hepatitis	O
and	O
usually	O
low	O
in	O
acutely	O
infected	O
patients	O
and	O
asymptomatic	O
carriers	O
.	O
The	O
data	O
demonstrate	O
a	O
remarkable	O
qualitative	O
and	O
quantitative	O
heterogeneity	O
of	O
the	O
humoral	O
HBx	protein
immune	O
response	O
which	O
can	O
be	O
monitored	O
by	O
HBx	protein
-specific	O
peptide	O
ELISAs	O
.	O
Such	O
tests	O
may	O
become	O
useful	O
diagnostic	O
tools	O
.	O

[The	O
inhibitory	O
effect	O
of	O
hydrocortisone	O
on	O
the	O
chemotactic	O
migration	O
of	O
human	cell_type
leukocytes	cell_type
]	O
Random	O
migration	O
(	O
RM	O
)	O
and	O
chemotactic	O
migration	O
(	O
ChtM	O
)	O
of	O
human	cell_type
leukocytes	cell_type
to	O
yeast	O
activated	O
serum	O
were	O
studied	O
with	O
the	O
modified	O
Boyden	O
chamber	O
method	O
.	O
Both	O
RM	O
and	O
ChtM	O
showed	O
circadian	O
rhythm	O
.	O
Leukocytes	cell_type
migrated	O
most	O
rapidly	O
at	O
night.	O
The	O
difference	O
between	O
the	O
peak	O
(0:00)	O
and	O
trough	O
values	O
(8:00)	O
of	O
RM	O
and	O
ChtM	O
was	O
significant	O
statistically	O
(P	O
less	O
than	O
0.01).	O
ChtM	O
was	O
inhibited	O
by	O
hydrocortisone	O
(F)	O
of	O
physiological	O
concentration	O
(10(-9)-10(-7)	O
mol/L)	O
which	O
was	O
dose-dependent	O
and	O
completely	O
antagonized	O
by	O
the	O
competitive	O
antagonist	O
,	O
RU38486	O
.	O
The	O
inhibitory	O
effect	O
was	O
much	O
more	O
evident	O
with	O
higher	O
dose	O
(more	O
than	O
10(-5)	O
mol/L)	O
and	O
it	O
was	O
also	O
reversed	O
by	O
RU38486	O
,	O
but	O
only	O
partially.	O
It	O
is	O
suggested	O
that	O
glucocorticoids	O
(	O
GC	O
)	O
may	O
be	O
a	O
physiological	O
regulator	O
of	O
the	O
activity	O
of	O
leukocytes	cell_type
and	O
its	O
inhibitory	O
action	O
on	O
ChtM	O
may	O
be	O
involved	O
in	O
antiinflammatory	O
mechanisms	O
of	O
GC	O
of	O
pharmacological	O
doses	O
.	O
The	O
action	O
of	O
physiological	O
and	O
pharmacological	O
concentration	O
of	O
GC	O
may	O
be	O
mediated	O
by	O
low	protein
affinity	protein
specific	protein
binding	protein
sites	protein
of	O
glucocorticoid	protein
receptors	protein
.	O

Heterogeneity	O
of	O
antigen	protein
molecules	protein
recognized	O
by	O
anti-tax1	protein
monoclonal	protein
antibody	protein
Lt-4	protein
in	O
cell	O
lines	O
bearing	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
and	O
related	O
retroviruses	O
.	O
Using	O
a	O
monoclonal	protein
antibody	protein
,	O
Lt-4	protein
,	O
directed	O
against	O
human	protein
T	protein
cell	protein
leukemia	protein
virus	protein
type	protein
I	protein
(	protein
HTLV-I	protein
)	protein
trans-activator	protein
(	protein
tax1	protein
)	protein
antigen	protein
,	O
we	O
examined	O
the	O
expression	O
of	O
tax1	protein
and	O
related	O
antigens	protein
in	O
a	O
variety	O
of	O
T	cell_line
cell	cell_line
lines	cell_line
bearing	O
HTLV-I	O
and	O
related	O
retroviruses	O
,	O
simian	O
T	O
cell	O
leukemia	O
virus	O
type	O
I	O
(	O
STLV-I	O
)	O
and	O
HTLV-II	O
,	O
by	O
immunofluorescence	O
and	O
immunoblot	O
assays	O
.	O
Lt-4	protein
reacted	O
with	O
all	O
HTLV-I	cell_line
-bearing	cell_line
cell	cell_line
lines	cell_line
tested	O
and	O
five	O
out	O
of	O
eight	O
simian	cell_line
cell	cell_line
lines	cell_line
bearing	O
STLV-I	O
,	O
but	O
not	O
with	O
an	O
HTLV-II	cell_line
-bearing	cell_line
cell	cell_line
line	cell_line
.	O
Lt-4	protein
detected	O
40	O
kd	O
tax1	protein
antigen	protein
molecules	protein
in	O
most	O
HTLV-I	cell_line
-bearing	cell_line
cell	cell_line
lines	cell_line
except	O
one	O
cell	O
line	O
that	O
expressed	O
39	protein
kd	protein
tax1	protein
antigen	protein
.	O
In	O
the	O
STLV-I	cell_line
-bearing	cell_line
T	cell_line
cell	cell_line
lines	cell_line
,	O
tax1	protein
-related	protein
antigen	protein
molecules	protein
detected	O
by	O
Lt-4	protein
were	O
heterogeneous,	O
having	O
molecular	O
weights	O
in	O
the	O
range	O
of	O
36-41	O
kd.	O

Characterization	O
of	O
the	O
human	protein
immunodeficiency	protein
virus	protein
type	protein
1	protein
enhancer	protein
-binding	protein
proteins	protein
from	O
the	O
human	cell_line
T-cell	cell_line
line	cell_line
Jurkat	cell_line
.	O
The	O
transcription	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
is	O
under	O
the	O
control	O
of	O
cellular	protein
proteins	protein
that	O
bind	O
to	O
the	O
viral	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
Among	O
the	O
protein-binding	O
regions	O
of	O
the	O
HIV-1	DNA
LTR	DNA
is	O
the	O
transcription-enhancer	DNA
region	DNA
.	O
We	O
show	O
that	O
at	O
least	O
one	O
inducible	protein
,	O
C1	protein
,	O
and	O
one	O
constitutive,	protein
C2	protein
,	protein
protein	protein
can	O
bind	O
to	O
the	O
HIV	DNA
enhancer	DNA
in	O
Jurkat	cell_line
cells	cell_line
.	O
The	O
two	O
proteins	O
differ	O
in	O
their	O
surface	O
charge	O
,	O
since	O
they	O
are	O
separable	O
by	O
anion-exchange	O
chromatography	O
.	O
Bivalent	O
cations	O
such	O
as	O
Mg2+	O
and	O
Zn2+	O
differentially	O
affect	O
their	O
binding	O
to	O
oligonucleotides	O
which	O
contain	O
the	O
HIV-enhancer	DNA
domain	DNA
.	O
Both	O
C1	protein
and	O
C2	protein
proteins	protein
also	O
bind	O
to	O
a	O
similar	O
sequence	O
found	O
in	O
the	O
interleukin-2	DNA
-receptor	DNA
alpha-subunit	DNA
enhancer	DNA
.	O
The	O
inducible	protein
C1	protein
protein	protein
was	O
partially	O
purified	O
by	O
three	O
chromatographic	O
steps	O
and	O
characterized	O
by	O
u.v.	O
cross-linking	O
as	O
a	O
47	protein
kDa	protein
protein	protein
.	O

Differences	O
in	O
transcriptional	DNA
enhancers	DNA
of	O
HIV-1	O
and	O
HIV-2	O
.	O
Response	O
to	O
T	cell_type
cell	cell_type
activation	O
signals	O
.	O
T	cell_type
cell	cell_type
activation	O
results	O
in	O
high	O
levels	O
of	O
HIV	O
replication	O
and	O
is	O
thought	O
to	O
be	O
one	O
mechanism	O
leading	O
to	O
the	O
conversion	O
from	O
latent	O
to	O
active	O
viral	O
infection	O
.	O
In	O
HIV-1	O
,	O
the	O
sequences	O
that	O
respond	O
to	O
these	O
signaling	O
events	O
are	O
found	O
in	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
and	O
comprise	O
the	O
transcriptional	DNA
enhancer	DNA
,	O
which	O
contains	O
two	O
conserved	DNA
binding	DNA
sites	DNA
for	O
the	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF	protein
kappa	protein
B	protein
).	O
The	O
corresponding	O
region	O
in	O
the	O
second	O
AIDS	O
retrovirus	O
,	O
HIV-2	O
,	O
contains	O
a	O
conserved	O
and	O
a	O
divergent	O
NF	DNA
kappa	DNA
B	DNA
binding	DNA
site	DNA
.	O
We	O
demonstrate	O
that	O
the	O
HIV-1	DNA
LTR	DNA
responds	O
better	O
than	O
the	O
HIV-2	DNA
LTR	DNA
to	O
T	O
cell	O
activation	O
signals.	O
These	O
qualitative	O
differences	O
in	O
the	O
response	O
to	O
T	cell_type
cell	cell_type
activation	O
are	O
reproduced	O
not	O
only	O
when	O
HIV-1	O
or	O
HIV-2	O
enhancers	O
are	O
placed	O
upstream	O
of	O
a	O
heterologous	DNA
promoter	DNA
but	O
also	O
when	O
these	O
enhancers	DNA
are	O
switched	O
between	O
their	O
respective	O
LTR	DNA
.	O
In	O
electrophoretic	O
mobility	O
shift	O
assays,	O
NF	protein
kappa	protein
B	protein
binds	O
to	O
both	O
conserved	O
sites	O
in	O
the	O
HIV-1	DNA
transcriptional	DNA
enhancer	DNA
and	O
only	O
to	O
the	O
single	O
conserved	O
site	O
in	O
the	O
HIV-2	DNA
transcriptional	DNA
enhancer	DNA
.	O
Instead	O
of	O
NF	protein
kappa	protein
B	protein
,	O
the	O
activator	protein
protein	protein
3	protein
binds	O
to	O
the	O
divergent	O
site	O
in	O
HIV-2	O
.	O
In	O
conclusion,	O
HIV-1	O
and	O
HIV-2	O
are	O
differentially	O
regulated	O
by	O
T	O
cell	O
activation	O
signals,	O
and	O
this	O
difference	O
may	O
account	O
for	O
the	O
longer	O
period	O
of	O
viral	O
latency	O
observed	O
with	O
HIV-2	O
than	O
with	O
HIV-1	O
infection	O
.	O

NF-X2	protein
that	O
binds	O
to	O
the	O
DRA	DNA
X2-box	DNA
is	O
activator	protein
protein	protein
1	protein
.	O
Expression	O
cloning	O
of	O
c-Jun	protein
.	O
Human	protein
class	protein
II	protein
MHC	protein
Ag	protein
are	O
a	O
family	O
of	O
cell	protein
surface	protein
glycoproteins	protein
.	O
Their	O
constitutive	O
expression	O
is	O
limited	O
to	O
B	cell_type
lymphocytes	cell_type
and	O
thymic	cell_type
epithelial	cell_type
cells	cell_type
.	O
In	O
many	O
other	O
cells	O
their	O
expression	O
can	O
be	O
induced	O
by	O
IFN-gamma	protein
.	O
Conserved	O
upstream	O
promoter	O
sequences	O
regulate	O
this	O
tissue-specific	O
expression	O
of	O
class	DNA
II	DNA
genes	DNA
.	O
In	O
the	O
DRA	DNA
promoter	DNA
,	O
one	O
of	O
these	O
cis-acting	DNA
regulatory	DNA
motifs	DNA
is	O
the	O
X2-box	DNA
to	O
which	O
nuclear	protein
factor	protein
X2	protein
(	O
NF-X2	protein
)	O
binds.	O
Here,	O
we	O
present	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
full-length	DNA
cDNA	DNA
clone	DNA
encoding	O
NF-X2	protein
.	O
This	O
cDNA	DNA
clone	DNA
was	O
isolated	O
by	O
expression	O
cDNA	DNA
cloning	O
,	O
and	O
encodes	O
the	O
human	protein
c-Jun	protein
protein	protein
,	O
which	O
together	O
with	O
c-Fos	protein
forms	O
the	O
heterodimeric	protein
activator	protein
protein-1	protein
transcription	protein
complex	protein
.	O
Whereas	O
c-Fos	protein
/c-Jun	protein
heterodimers	protein
do	O
not	O
exist	O
in	O
B	cell_line
cells	cell_line
,	O
they	O
form	O
and	O
bind	O
to	O
the	O
X2-box	DNA
in	O
class	cell_line
II	cell_line
nonexpressing	cell_line
cells	cell_line
.	O
Thus,	O
c-Fos	protein
/c-Jun	protein
heterodimers	protein
might	O
contribute	O
to	O
the	O
repression	O
of	O
DRA	DNA
gene	DNA
expression	O
.	O

Synthesis	O
of	O
4,19-disubstituted	O
derivatives	O
of	O
DOC	O
.	O
Radioreceptor	O
assay	O
of	O
some	O
corticosteroid	O
derivatives	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
.	O
Several	O
new	O
4,19-substituted	O
steroids	O
and	O
previously	O
synthesized	O
corticosteroids	O
were	O
assayed	O
for	O
affinity	O
to	O
type	protein
1	protein
receptors	protein
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
.	O
11	O
beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione	O
(2)	O
was	O
hydrogenated	O
with	O
Pd-C	O
to	O
yield	O
a	O
mixture	O
of	O
all	O
four	O
dihydro	O
derivatives	O
5,	O
accompanied	O
by	O
4,21-diacetoxy-11	O
beta,19-epoxy-3-hydroxypregnan-20-one	O
(6)	O
and	O
21-acetoxy-11	O
beta,19-epoxy-4-hydroxypregnane-3,20-dione	O
(7).	O
With	O
hot	O
acetic	O
+	O
p-toluenesulfonic	O
acid	O
5	O
underwent	O
rearrangement	O
to	O
21-acetoxy-11	O
beta,19-epoxypregn-5-ene-4,20-dione	O
(8)	O
Pd-C	O
hydrogenation	O
of	O
3,21-diacetoxy-5	O
beta,19-cyclopregna-2,9(11)-diene-4,20-dione	O
(10)	O
gave	O
3,21-diacetoxy-5	O
beta,19-cyclopregn-5-ene-4,20-dione	O
(11)	O
and	O
the	O
9,11-dihydro	O
derivative	O
of	O
the	O
latter.	O
Treatment	O
of	O
10	O
with	O
warm	O
HCl	O
furnished	O
19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione	O
(13).	O
Pd-C	O
hydrogenation	O
of	O
its	O
diacetate	O
14	O
afforded	O
the	O
4,5-dihydro	O
derivative	O
18,	O
19-chloro-21-acetoxypregn-9(11)-en-20-one	O
(15),	O
its	O
4-acetoxy	O
derivative	O
16	O
and	O
the	O
3,4-diacetoxy	O
derivative	O
17.	O
When	O
tested	O
in	O
a	O
radioreceptor	O
assay	O
in	O
human	cell_type
mononuclear	cell_type
leukocytes	cell_type
the	O
synthesized	O
compounds	O
showed	O
only	O
low	O
relative	O
binding	O
affinities	O
(	O
RBA	O
)	O
to	O
type	protein
1	protein
receptor	protein
,	O
the	O
highest	O
being	O
0.72%	O
for	O
13	O
(	O
aldosterone	O
=	O
100%).	O
For	O
comparison,	O
other	O
RBA	O
in	O
this	O
system	O
were:	O
19-noraldosterone	O
,	O
20%;	O
18-deoxyaldosterone	O
,	O
5.8%;	O
18-deoxy-19-noraldosterone	O
,	O
4.7%;	O
18,21-anhydroaldosterone	O
,	O
0.37%;	O
17-isoaldosterone	O
,	O
7.6%	O
and	O
apoaldosterone	O
,	O
4.3%	O

Cell	O
type	O
specificity	O
and	O
activation	O
requirements	O
for	O
NFAT-1	protein
(	O
nuclear	protein
factor	protein
of	O
activated	cell_type
T-cells	cell_type
)	O
transcriptional	O
activity	O
determined	O
by	O
a	O
new	O
method	O
using	O
transgenic	O
mice	O
to	O
assay	O
transcriptional	O
activity	O
of	O
an	O
individual	O
nuclear	protein
factor	protein
.	O
Nuclear	protein
factor	protein
of	O
activated	cell_type
T-cells	cell_type
(	O
NFAT-1	protein
)	O
is	O
a	O
transcription	protein
factor	protein
which	O
is	O
considered	O
to	O
be	O
an	O
important	O
regulator	O
in	O
early	O
T-cell	O
activation	O
.	O
We	O
have	O
developed	O
a	O
system	O
to	O
monitor	O
the	O
transcriptional	O
activity	O
of	O
NFAT-1	protein
at	O
the	O
single	O
cell	O
level	O
in	O
whole	O
animals	O
.	O
The	O
system	O
is	O
based	O
on	O
the	O
use	O
of	O
an	O
oligomerized	O
NFAT-1	protein
binding	O
motif	O
that	O
directs	O
transcription	protein
of	protein
SV40	protein
T-antigen	protein
in	O
transgenic	O
mice	O
.	O
This	O
report	O
represents	O
the	O
first	O
demonstration	O
that	O
a	O
multimerized	O
short	O
binding	O
motif	O
can	O
function	O
appropriately	O
in	O
transgenic	O
mice	O
.	O
NFAT-1	protein
activity	O
had	O
previously	O
been	O
thought	O
to	O
be	O
confined	O
to	O
activated	cell_type
T-lymphocytes	cell_type
upon	O
release	O
of	O
intracellular	cell_type
calcium	cell_type
.	O
By	O
targeting	O
NFAT-1	protein
-dependent	O
gene	O
expression	O
in	O
transgenic	O
mice	O
we	O
discovered	O
new	O
sites	O
of	O
NFAT-1	protein
activity	O
.	O
Besides	O
in	O
T-lymphocytes	cell_type
NFAT-1	protein
activity	O
could	O
also	O
be	O
induced	O
in	O
T-lymphocyte-depleted	cell_type
spleen	cell_type
cells	cell_type
and	O
purified	cell_type
B-lymphocytes	cell_type
and	O
requires	O
agents	O
that	O
both	O
release	O
intracellular	O
calcium	O
and	O
activate	O
protein	protein
kinase	protein
C	protein
.	O
A	O
difference	O
in	O
the	O
time	O
course	O
of	O
appearance	O
of	O
NFAT-1	protein
activity	O
between	O
T-lymphocytes	cell_type
and	O
non-T-lymphocytes	cell_type
was	O
revealed.	O
Constitutive	O
expression	O
was	O
observed	O
in	O
a	O
small	O
population	O
of	O
cells	O
in	O
the	O
dermis	O
and	O
some	O
mice	O
have	O
developed	O
skin	O
lesions	O
.	O
Interestingly,	O
the	O
tissue	O
pattern	O
of	O
expression	O
of	O
the	O
NFAT-1	protein
activity	O
resembles	O
the	O
expression	O
pattern	O
described	O
for	O
HIV-LTR/tat	O
transgenic	O
mice	O
(Vogel,	O
J.,	O
Hinrichs,	O
S.	O
H.,	O
Reynolds,	O
R.	O
K.,	O
Luciw,	O
P.	O
A.,	O
and	O
Jay,	O
G.	O
(1988)	O
Nature	O
335,	O
606-611).	O
This	O
similarity	O
in	O
expression	O
and	O
the	O
fact	O
that	O
NFAT-1	protein
has	O
been	O
shown	O
to	O
bind	O
functional	DNA
sequences	DNA
in	O
HIV-LTR	DNA
suggest	O
a	O
role	O
for	O
NFAT-1	protein
in	O
dermal	O
activation	O
of	O
the	O
HIV-LTR	DNA
.	O

A	O
novel	O
T-cell	protein
protein	protein
which	O
recognizes	O
a	O
palindromic	DNA
sequence	DNA
in	O
the	O
negative	DNA
regulatory	DNA
element	DNA
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
long	DNA
terminal	DNA
repeat	DNA
.	O
Two	O
major	DNA
protein-binding	DNA
sites	DNA
within	O
the	O
negative	DNA
regulatory	DNA
element	DNA
of	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
long	DNA
terminal	DNA
repeat	DNA
have	O
been	O
identified.	O
One	O
(	O
site	DNA
B	DNA
)	O
contained	O
a	O
palindromic	DNA
sequence	DNA
with	O
homology	O
to	O
steroid/thyroid	DNA
hormone	DNA
response	DNA
elements	DNA
but	O
was	O
distinct	O
from	O
previously	O
described	O
binding	O
sites	O
of	O
this	O
class.	O
A	O
novel	O
T-cell	protein
protein	protein
recognized	O
the	O
palindromic	DNA
sequence	DNA
within	O
site	DNA
B	DNA
and	O
also	O
bound	O
estrogen-	O
or	O
thyroid	O
hormone-	O
response	O
elements	O
with	O
lower	O
affinity.	O
A	O
7-base-pair	O
mutation	O
in	O
the	O
site	DNA
B	DNA
palindrome	DNA
,	O
which	O
destroyed	O
protein	O
binding,	O
resulted	O
in	O
increased	O
expression	O
from	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
long	DNA
terminal	DNA
repeat	DNA
in	O
T	cell_type
cells	cell_type
.	O

Progesterone	O
suppression	O
of	O
pregnancy	cell_type
lymphocytes	cell_type
is	O
not	O
mediated	O
by	O
glucocorticoid	O
effect.	O
This	O
study	O
investigated	O
whether	O
the	O
suppressive	O
effect	O
of	O
progesterone	O
on	O
pregnancy	cell_type
lymphocytes	cell_type
is	O
mediated	O
by	O
specific	O
progesterone	protein
receptors	protein
.	O
The	O
effects	O
of	O
a	O
competitive	O
progesterone	O
antagonist	O
(	O
RU486	O
)	O
and	O
a	O
specific	O
glucocorticoid	protein
receptor	protein
blocker	O
(	O
RU43044	O
)	O
were	O
tested	O
on	O
the	O
release	O
of	O
a	O
blocking	protein
factor	protein
by	O
progesterone	cell_line
-treated	cell_line
pregnancy	cell_line
lymphocytes	cell_line
.	O
RU	O
486	O
tested	O
at	O
an	O
equal	O
concentration	O
as	O
progesterone	O
significantly	O
inhibited	O
the	O
production	O
of	O
the	O
blocking	protein
factor	protein
,	O
while	O
RU	O
43044	O
was	O
without	O
effect.	O
These	O
data	O
suggest	O
that	O
in	O
pregnancy,	O
lymphocyte	O
progesterone	O
acts	O
on	O
specific	O
progesterone	protein
receptors	protein
and	O
glucocorticoid	protein
binding	protein
sites	protein
are	O
not	O
involved.	O

The	O
56-59-kilodalton	protein
protein	protein
identified	O
in	O
untransformed	protein
steroid	protein
receptor	protein
complexes	protein
is	O
a	O
unique	protein
protein	protein
that	O
exists	O
in	O
cytosol	O
in	O
a	O
complex	O
with	O
both	O
the	O
70-	O
and	O
90-	O
kilodalton	O
heat	O
shock	O
proteins	O
.	O
It	O
has	O
previously	O
been	O
shown	O
that	O
9S	protein
,	O
untransformed	O
progestin	O
,	O
estrogen	O
,	O
androgen	O
,	O
and	O
glucocorticoid	O
receptor	O
complexes	O
in	O
rabbit	O
uterine	O
and	O
liver	O
cytosols	O
contain	O
a	O
59-kDa	protein
protein	protein
[Tai,	O
P.K.,	O
Maeda,	O
Y.,	O
Nakao,	O
K.,	O
Wakim,	O
N.G.,	O
Duhring,	O
J.L.,	O
&amp;	O
Faber,	O
L.E.(1986)	O
Biochemistry	O
25,	O
5269-5275].	O
In	O
this	O
work	O
we	O
show	O
that	O
the	O
monoclonal	protein
antibody	protein
KN	protein
382/EC1	protein
raised	O
against	O
the	O
rabbit	protein
59-kDa	protein
protein	protein
reacts	O
with	O
9S	protein
,	O
untransformed	protein
glucocorticoid	protein
receptor	protein
complexes	protein
in	O
cytosol	O
prepared	O
from	O
human	cell_line
IM-9	cell_line
lymphocytes	cell_line
but	O
not	O
with	O
4S	protein
salt-transformed	protein
receptors	protein
.	O
The	O
human	O
protein	O
recognized	O
by	O
the	O
EC1	protein
antibody	protein
is	O
a	O
56-kDa	protein
protein	protein
(	O
p56	protein
)	O
of	O
moderate	O
abundance	O
located	O
predominantly	O
in	O
the	O
cytoplasm	O
by	O
indirect	O
immunofluorescence	O
.	O
There	O
are	O
at	O
least	O
six	O
isomorphs	protein
of	O
p56	protein
by	O
two-dimensional	O
gel	O
analysis	O
.	O
N-Terminal	O
sequencing	O
(	O
20	O
amino	O
acids	O
)	O
shows	O
that	O
p56	protein
is	O
a	O
unique	protein
human	protein
protein	protein
.	O
When	O
p56	protein
is	O
immunoadsorbed	O
from	O
IM-9	cell_line
cell	cell_line
cytosol	O
,	O
both	O
the	O
70-	O
and	O
90-	O
kDa	O
heat	O
shock	O
proteins	O
are	O
coadsorbed	O
in	O
an	O
immune-specific	O
manner	O
.	O
Neither	O
heat	protein
shock	protein
protein	protein
reacts	O
directly	O
with	O
the	O
EC1	protein
antibody	protein
.	O
We	O
conclude	O
that	O
p56	protein
exists	O
in	O
cytosol	O
in	O
a	O
higher	O
order	O
complex	O
containing	O
hsp70	protein
and	O
hsp90	protein
,	O
both	O
of	O
which	O
in	O
turn	O
have	O
been	O
found	O
to	O
be	O
associated	O
with	O
untransformed	protein
steroid	protein
receptors	protein
.	O

Sequence-specific	O
DNA	O
binding	O
of	O
the	O
proto-oncoprotein	protein
ets-1	protein
defines	O
a	O
transcriptional	DNA
activator	DNA
sequence	DNA
within	O
the	O
long	DNA
terminal	DNA
repeat	DNA
of	O
the	O
Moloney	O
murine	O
sarcoma	O
virus	O
.	O
The	O
ets	DNA
proto-oncogene	DNA
family	DNA
is	O
a	O
group	O
of	O
sequence-related	DNA
genes	DNA
whose	O
normal	O
cellular	O
function	O
is	O
unknown.	O
In	O
a	O
study	O
of	O
cellular	protein
proteins	protein
involved	O
in	O
the	O
transcriptional	O
regulation	O
of	O
murine	O
retroviruses	O
in	O
T	cell_type
lymphocytes	cell_type
,	O
we	O
have	O
discovered	O
that	O
a	O
member	O
of	O
the	O
ets	DNA
gene	DNA
family	DNA
encodes	O
a	O
sequence-specific	protein
DNA-binding	protein
protein	protein
.	O
A	O
mouse	DNA
ets-1	DNA
cDNA	DNA
clone	DNA
was	O
obtained	O
by	O
screening	O
a	O
mouse	DNA
thymus	DNA
cDNA	DNA
expression	DNA
library	DNA
with	O
a	O
double-stranded	DNA
oligonucleotide	DNA
probe	DNA
representing	O
20	O
bp	O
of	O
the	O
Moloney	O
murine	O
sarcoma	O
virus	O
(	O
MSV	O
)	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
).	O
The	O
cDNA	DNA
sequence	DNA
has	O
an	O
813-bp	DNA
open	DNA
reading	DNA
frame	DNA
(	O
ORF	DNA
)	O
whose	O
predicted	O
amino	protein
acid	protein
sequence	protein
is	O
97.6%	O
identical	O
to	O
the	O
272	protein
carboxy-terminal	protein
amino	protein
acids	protein
of	O
the	O
human	protein
ets-1	protein
protein	protein
.	O
The	O
ORF	DNA
was	O
expressed	O
in	O
bacteria	O
,	O
and	O
the	O
30-kD	protein
protein	protein
product	protein
was	O
shown	O
to	O
bind	O
DNA	DNA
in	O
a	O
sequence-specific	O
manner	O
by	O
mobility-shift	O
assays	O
,	O
Southwestern	O
blot	O
analysis	O
,	O
and	O
methylation	O
interference	O
.	O
A	O
mutant	DNA
LTR	DNA
containing	O
four	O
base	O
pair	O
substitutions	O
in	O
the	O
ets-1	DNA
binding	DNA
site	DNA
was	O
constructed	O
and	O
was	O
shown	O
to	O
have	O
reduced	O
binding	O
in	O
vitro.	O
Transcriptional	O
efficiency	O
of	O
the	O
MSV	DNA
LTR	DNA
promoter	DNA
containing	O
this	O
disrupted	O
ets-1	DNA
binding	DNA
site	DNA
was	O
compared	O
to	O
the	O
activity	O
of	O
a	O
wild-type	DNA
promoter	DNA
in	O
mouse	cell_type
T	cell_type
lymphocytes	cell_type
in	O
culture,	O
and	O
15-	O
to	O
20-fold	O
reduction	O
in	O
expression	O
of	O
a	O
reporter	DNA
gene	DNA
was	O
observed.	O
We	O
propose	O
that	O
ets-1	protein
functions	O
as	O
a	O
transcriptional	O
activator	O
of	O
mammalian	O
type-C	O
retroviruses	O
and	O
speculate	O
that	O
ets-related	DNA
genes	DNA
constitute	O
a	O
new	O
group	O
of	O
eukaryotic	protein
DNA-binding	protein
proteins	protein
.	O

Type	protein
II	protein
estrogen	protein
binding	protein
sites	protein
in	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
:	O
variations	O
during	O
the	O
menstrual	O
cycle	O
.	O
We	O
have	O
previously	O
reported	O
that	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
contain	O
type	O
II	protein
estrogen	protein
binding	protein
sites	protein
(	O
type	protein
II	protein
EBS	protein
).	O
In	O
this	O
study,	O
the	O
fluctuations	O
of	O
type	protein
II	protein
EBS	protein
during	O
the	O
menstrual	O
cycle	O
were	O
analyzed	O
in	O
6	O
normally	O
menstruating	O
women	O
.	O
Approximately	O
3	O
times	O
higher	O
levels	O
of	O
type	protein
II	protein
EBS	protein
were	O
found	O
in	O
the	O
periovulatory	O
period	O
with	O
respect	O
to	O
both	O
follicular	O
and	O
luteal	O
phases	O
.	O
In	O
postmenopausal	O
women	O
the	O
mean	O
type	protein
II	protein
EBS	protein
levels	O
were	O
similar	O
to	O
those	O
observed	O
in	O
the	O
follicular	O
phase	O
of	O
the	O
cycle.	O
However,	O
in	O
3	O
postmenopausal	O
patients	O
a	O
short	O
course	O
of	O
estrogen	O
or	O
tamoxifen	O
resulted	O
in	O
a	O
marked	O
increase	O
of	O
type	protein
II	protein
EBS	protein
levels.	O
Tamoxifen	O
was	O
also	O
found	O
to	O
compete	O
with	O
17	O
beta-estradiol	O
for	O
type	protein
II	protein
EBS	protein
in	O
PBMC	cell_type
,	O
although	O
to	O
a	O
lesser	O
extent	O
than	O
diethylstilbestrol	O
.	O

Mononuclear	cell_type
leukocyte	cell_type
glucocorticoid	protein
receptor	protein
binding	O
characteristics	O
and	O
down-regulation	O
in	O
major	O
depression	O
.	O
Some	O
patients	O
with	O
major	O
depressive	O
disorder	O
(	O
MDD	O
)	O
have	O
elevated	O
plasma	O
cortisol	O
concentrations	O
and	O
show	O
failure	O
to	O
suppress	O
cortisol	O
secretion	O
upon	O
administration	O
of	O
dexamethasone	O
(	O
DEX	O
),	O
yet	O
they	O
do	O
not	O
have	O
Cushingoid	O
features	O
.	O
To	O
study	O
whether	O
this	O
represents	O
glucocorticoid	O
(	O
GC	O
)	O
resistance	O
,	O
[3H]-DEX-binding	O
assays	O
were	O
used	O
to	O
measure,	O
in	O
vitro,	O
the	O
GC	protein
receptor	protein
affinity	O
(1/Kd)	O
and	O
number	O
(	O
Bmax	O
)	O
in	O
mononuclear	cell_type
leukocytes	cell_type
of	O
11	O
MDD	O
patients	O
and	O
15	O
control	O
subjects	O
.	O
No	O
receptor	O
abnormalities	O
were	O
detected	O
in	O
the	O
MDD	O
group;	O
thus	O
any	O
cellular	O
defect	O
leading	O
to	O
a	O
lack	O
of	O
responsiveness	O
to	O
GC	O
in	O
the	O
MDD	O
patients	O
,	O
if	O
present,	O
probably	O
lies	O
beyond	O
the	O
initial	O
receptor	O
binding	O
.	O
DEX	O
(1.0	O
mg	O
orally)	O
was	O
administered	O
to	O
study	O
in	O
vivo	protein
GC	protein
receptor	protein
down-regulation	O
.	O
Compared	O
to	O
the	O
control	O
group	O
,	O
fewer	O
depressed	O
subjects	O
down-regulated	O
Bmax	O
after	O
DEX	O
.	O
By	O
paired	O
t-test	O
,	O
Bmax	O
decreased	O
significantly	O
in	O
the	O
control	O
group	O
but	O
not	O
in	O
the	O
depressed	O
group	O
.	O
Receptor	O
number	O
on	O
the	O
control	O
day	O
did	O
not	O
correlate	O
significantly	O
with	O
the	O
degree	O
of	O
receptor	O
down-regulation	O
,	O
severity	O
of	O
depression	O
or	O
cortisol	O
concentrations	O
across	O
all	O
the	O
subjects.	O
These	O
results	O
do	O
not	O
lend	O
support	O
to	O
previous	O
reports	O
suggesting	O
that	O
GC	O
resistance	O
in	O
MDD	O
results	O
from	O
a	O
GC	O
receptor-binding	O
abnormality	O
,	O
and	O
they	O
emphasize	O
the	O
importance	O
of	O
considering	O
receptor	O
studies	O
in	O
the	O
context	O
of	O
GC	O
-mediated	O
cell	O
processes	O
in	O
order	O
to	O
identify	O
the	O
exact	O
cellular	O
defect(s)	O
leading	O
to	O
GC	O
resistance	O
.	O

Ras-related	protein
GTP-binding	protein
proteins	protein
and	O
leukocyte	cell_type
signal	O
transduction	O
.	O
Many	O
aspects	O
of	O
leukocyte	cell_type
function	O
are	O
regulated	O
by	O
both	O
heterotrimeric	protein
and	O
Ras-related	protein
GTP-binding	protein
proteins	protein
,	O
but	O
there	O
is	O
little	O
definite	O
information	O
about	O
their	O
roles	O
in	O
the	O
specialized	O
processes	O
utilized	O
by	O
leukocytes	cell_type
for	O
cell	O
killing.	O
Recent	O
progress	O
in	O
understanding	O
the	O
regulation	O
of	O
the	O
phagocyte	protein
NADPH	protein
oxidase	protein
by	O
the	O
Rac	protein
GTP-binding	protein
proteins	protein
provides	O
a	O
basis	O
for	O
defining	O
the	O
operational	O
characteristics	O
of	O
one	O
such	O
phagocyte	O
system	O
.	O
It	O
is	O
clear	O
from	O
various	O
studies	O
that	O
the	O
activity	O
of	O
the	O
NADPH	protein
oxidase	protein
can	O
be	O
modulated	O
through	O
the	O
regulation	O
of	O
the	O
GTP-GDP	protein
state	protein
of	O
Rac	protein
.	O
Proteins	O
exist	O
in	O
leukocytes	cell_type
able	O
to	O
modify	O
GTP-binding	protein
protein	protein
function	O
in	O
this	O
manner,	O
and	O
their	O
activity	O
may	O
be	O
regulated	O
by	O
signals	O
generated	O
on	O
phagocyte	O
stimulation	O
.	O
Proteins	O
of	O
the	O
Ras	protein
superfamily	protein
are	O
likely	O
to	O
be	O
involved	O
in	O
a	O
variety	O
of	O
normal	O
phagocyte	O
functions	O
through	O
their	O
ability	O
to	O
modulate	O
the	O
assembly	O
of	O
actin	protein
filaments	protein
,	O
direct	O
vesicle	O
trafficking	O
and	O
fusion,	O
and	O
so	O
forth.	O

BSAP	protein
:	O
a	O
key	O
regulator	O
of	O
B-cell	cell_type
development	O
and	O
differentiation	O
.	O
B-cell-specific	protein
activator	protein
protein	protein
(	O
BSAP	protein
)	O
is	O
a	O
recently	O
identified	O
member	O
of	O
the	O
Pax-gene	DNA
family	DNA
of	O
transcription	protein
factors	protein
;	O
in	O
the	O
lymphoid	O
system	O
,	O
BSAP	protein
is	O
produced	O
only	O
in	O
B	cell_type
cells	cell_type
.	O
Here,	O
Markus	O
Neurath,	O
Eckhard	O
Stuber	O
and	O
Warren	O
Strober	O
describe	O
the	O
molecular	O
structure	O
of	O
BSAP	protein
and	O
focus	O
on	O
the	O
ability	O
of	O
this	O
protein	O
to	O
regulate	O
the	O
expression	O
of	O
B-cell-specific	DNA
genes	DNA
.	O
They	O
propose	O
that	O
BSAP	protein
is	O
a	O
key	protein
protein	protein
of	O
B	cell_type
cells	cell_type
and	O
that	O
it	O
not	O
only	O
influence	O
B-cell	O
development	O
but	O
also	O
influences	O
the	O
balance	O
between	O
B-cell	O
proliferation	O
and	O
immunoglobulin	protein
secretion	O
at	O
later	O
stages	O
of	O
B-cell	O
differentiation	O
.	O

Down-regulation	O
of	O
NF-kappa	protein
B	protein
protein	protein
levels	O
in	O
activated	O
human	O
lymphocytes	O
by	O
1,25-dihydroxyvitamin	O
D3	O
[published	O
erratum	O
appears	O
in	O
Proc	O
Natl	O
Acad	O
Sci	O
U	O
S	O
A	O
1996	O
Jan	O
9;93(1):524]	O
The	O
effect	O
of	O
1,25-dihydroxyvitamin	O
D3	O
[	O
1,25(OH)2)D3	O
],	O
a	O
steroid	O
hormone	O
with	O
immunomodulating	O
properties,	O
on	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
proteins	O
was	O
examined	O
in	O
in	cell_line
vitro	cell_line
activated	cell_line
normal	cell_line
human	cell_line
lymphocytes	cell_line
by	O
Western	O
blot	O
analysis	O
.	O
Over	O
a	O
72-hr	O
period	O
of	O
activation,	O
the	O
expression	O
of	O
the	O
50-kDa	protein
NF-kappa	protein
B	protein
,	O
p50	protein
,	O
and	O
its	O
precursor,	O
p105	protein
,	O
was	O
increased	O
progressively.	O
When	O
cells	O
were	O
activated	O
in	O
the	O
presence	O
of	O
1,25(OH)2D3	O
,	O
the	O
levels	O
of	O
the	O
mature	O
protein	O
as	O
well	O
as	O
its	O
precursor	O
were	O
decreased.	O
The	O
effect	O
of	O
the	O
hormone	O
on	O
the	O
levels	O
of	O
p50	protein
was	O
demonstrable	O
in	O
the	O
cytosolic	O
and	O
nuclear	O
compartments	O
;	O
it	O
required	O
between	O
4	O
and	O
8	O
hr	O
and	O
was	O
specific,	O
as	O
25-hydroxyvitamin	O
D3	O
and	O
24,25-dihydroxyvitamin	O
D3	O
were	O
ineffective.	O
Besides	O
p50	protein
,	O
1,25(OH)2D3	O
decreased	O
the	O
levels	O
of	O
another	O
NF-kappa	protein
B	protein
protein	protein
,	O
namely	O
c-rel	protein
.	O
In	O
addition,	O
1,25(OH)2D3	O
decreased	O
the	O
abundance	O
of	O
a	O
specific	protein
DNA-protein	protein
complex	protein
formed	O
upon	O
incubation	O
of	O
nuclear	O
extracts	O
from	O
activated	O
lymphocytes	O
with	O
a	O
labeled	O
NF-kappa	protein
B	protein
DNA	protein
binding	protein
motif	protein
.	O
Further,	O
1,25(OH)2D3	O
inhibited	O
the	O
transcriptional	O
activity	O
of	O
NF-kappa	protein
B	protein
in	O
Jurkat	cell_line
cells	cell_line
transiently	O
transfected	O
with	O
a	O
construct	DNA
containing	O
four	O
tandem	DNA
repeats	DNA
of	O
the	O
NF-kappa	DNA
B	DNA
binding	DNA
sequence	DNA
of	O
the	O
immunoglobulin	DNA
kappa	DNA
light	DNA
chain	DNA
gene	DNA
linked	O
to	O
the	O
chloramphenicol	DNA
acetyltransferase	DNA
reporter	DNA
gene	DNA
.	O
These	O
observations	O
demonstrate	O
directly	O
that	O
there	O
is	O
de	O
novo	O
synthesis	O
of	O
NF-kappa	protein
B	protein
during	O
human	O
lymphocyte	O
activation	O
and	O
suggest	O
that	O
this	O
process	O
is	O
hormonally	O
regulated.	O

The	O
myeloid	DNA
zinc	DNA
finger	DNA
gene	DNA
,	O
MZF-1	DNA
,	O
regulates	O
the	O
CD34	DNA
promoter	DNA
in	O
vitro.	O
MZF-1	DNA
is	O
a	O
C2H2	DNA
zinc	DNA
finger	DNA
gene	DNA
encoding	O
a	O
putative	protein
transcriptional	protein
regulator	protein
of	O
myeloid	O
differentiation	O
.	O
The	O
MZF-1	DNA
protein	O
contains	O
13	O
C2H2	protein
zinc	protein
fingers	protein
arranged	O
in	O
bipartite	O
DNA	protein
binding	protein
domains	protein
containing	O
zinc	protein
fingers	protein
through	O
4	O
and,	O
in	O
the	O
carboxy-terminus	protein
,	O
5	O
through	O
13.	O
We	O
previously	O
identified	O
the	O
DNA	DNA
consensus	DNA
binding	DNA
site	DNA
recognized	O
by	O
the	O
two	O
DNA	protein
binding	protein
domains	protein
.	O
To	O
assess	O
the	O
transcription	O
regulatory	O
function	O
of	O
MZF-1	DNA
,	O
the	O
full-length	O
MZF-1	DNA
coding	O
region	O
was	O
fused	O
to	O
the	O
DNA	protein
binding	protein
domain	protein
of	O
the	O
yeast	protein
transactivator	protein
GAL4	protein
.	O
The	O
expression	O
vector	O
was	O
cotransfected	O
with	O
the	O
chloramphenicol	DNA
acetyl	DNA
transferase	DNA
(CAT)	DNA
reporter	DNA
gene	DNA
regulated	O
by	O
the	O
thymidine	DNA
kinase	DNA
promoter	DNA
containing	O
GAL4	DNA
DNA	DNA
binding	DNA
sites	DNA
into	O
NIH	cell_line
3T3	cell_line
,	O
293	cell_line
,	O
K562	cell_line
,	O
and	O
Jurkat	cell_line
cell	cell_line
lines	cell_line
.	O
MZF-1	DNA
represses	O
CAT	DNA
reporter	DNA
gene	DNA
expression	O
via	O
GAL4	protein
binding	O
sites	O
in	O
the	O
nonhematopoietic	cell_line
cell	cell_line
lines	cell_line
NIH	cell_line
3T3	cell_line
and	O
293	cell_line
.	O
In	O
contrast,	O
MZF-1	DNA
activates	O
CAT	DNA
reporter	DNA
gene	DNA
expression	O
in	O
the	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
K562	cell_line
and	O
Jurkat	cell_line
.	O
The	O
MZF-1	DNA
binding	DNA
sites	DNA
are	O
present	O
in	O
the	O
promoters	DNA
of	O
several	O
genes	DNA
expressed	O
during	O
myeloid	O
differentiation	O
,	O
including	O
the	O
CD34	DNA
promoter	DNA
.	O
MZF-1	DNA
transcriptional	O
regulation	O
of	O
this	O
physiologically	DNA
relevant	DNA
promoter	DNA
was	O
assessed	O
in	O
both	O
hematopoietic	cell_line
and	O
nonhematopoietic	cell_line
cell	cell_line
lines	cell_line
.	O
Recombinant	protein
MZF-1	protein
protein	protein
specifically	O
binds	O
to	O
the	O
consensus	DNA
binding	DNA
sites	DNA
in	O
the	O
CD34	DNA
promoter	DNA
in	O
mobility	O
shift	O
assays	O
.	O
MZF-1	DNA
expression	O
vectors	O
were	O
cotransfected	O
with	O
the	O
luciferase	DNA
reporter	DNA
plasmids	DNA
regulated	O
by	O
the	O
CD34	DNA
promoter	DNA
into	O
both	O
nonhematopoietic	O
and	O
hematopoietic	O
cell	O
lines	O
.	O
As	O
with	O
the	O
heterologous	O
DNA	protein
binding	protein
domain	protein
,	O
MZF-1	DNA
represses	O
reporter	DNA
gene	DNA
expression	O
in	O
nonhematopoietic	cell_line
cell	cell_line
lines	cell_line
and	O
activates	O
expression	O
in	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
.	O
Activation	O
of	O
CD34	protein
expression	O
in	O
hematopoietic	cell_line
cell	cell_line
lines	cell_line
is	O
dependent	O
on	O
the	O
presence	O
of	O
intact	O
MZF-1	DNA
binding	DNA
sites	DNA
.	O
The	O
cell	O
type-specific	O
regulation	O
of	O
the	O
CD34	DNA
promoter	DNA
by	O
MZF-1	DNA
suggests	O
the	O
presence	O
of	O
tissue-specific	O
regulators/adapters	O
or	O
differential	O
MZF-1	DNA
modifications	O
that	O
determine	O
MZF-1	DNA
transcriptional	O
regulatory	O
function	O
.	O

The	O
murine	O
BCL6	DNA
gene	DNA
is	O
induced	O
in	O
activated	cell_type
lymphocytes	cell_type
as	O
an	O
immediate	DNA
early	DNA
gene	DNA
.	O
The	O
chromosomal	O
translocation	O
involving	O
3q27	DNA
is	O
often	O
detected	O
in	O
human	cell_type
B-cell	cell_type
lymphomas	cell_type
,	O
especially	O
diffuse	O
lymphomas	O
with	O
a	O
large-cell	O
component	O
.	O
The	O
BCL6	DNA
gene	DNA
has	O
been	O
isolated	O
from	O
the	O
chromosomal	O
breakpoint	O
in	O
these	O
lymphomas	O
.	O
Here	O
we	O
cloned	O
the	O
murine	DNA
BCL6	DNA
(mBCL6)	DNA
cDNA	DNA
from	O
the	O
muscle	DNA
cDNA	DNA
library	DNA
using	O
the	O
human	DNA
BCL6	DNA
(hBCL6)	DNA
cDNA	DNA
as	O
a	O
probe.	O
The	O
predicted	O
amino	O
acid	O
sequence	O
was	O
95%	O
identical	O
to	O
that	O
of	O
hBCL6	protein
.	O
It	O
contains	O
six	O
repeats	O
of	O
the	O
Kruppel-like	protein
zinc-finger	protein
motif	protein
that	O
are	O
completely	O
identical	O
to	O
those	O
of	O
hBCL6	protein
,	O
indicating	O
that	O
the	O
BCL6	DNA
gene	DNA
is	O
well	O
conserved	O
between	O
humans	O
and	O
mice	O
.	O
Expression	O
of	O
the	O
mBCL6	DNA
gene	DNA
was	O
ubiquitously	O
detected	O
in	O
adult	O
mouse	O
tissues	O
including	O
lymphatic	O
organs	O
.	O
Furthermore,	O
it	O
was	O
induced	O
in	O
lymphocytes	cell_type
activated	O
with	O
phorbol	O
ester	O
and	O
Ca2+	O
ionophore	O
within	O
30	O
min	O
after	O
stimulation.	O
This	O
induction	O
was	O
not	O
inhibited	O
by	O
treatment	O
of	O
the	O
cells	O
with	O
a	O
protein	O
synthesis	O
inhibitor	O
,	O
cycloheximide	O
.	O
These	O
results	O
suggest	O
that	O
BCL6	protein
plays	O
a	O
role	O
in	O
activated	cell_type
lymphocytes	cell_type
as	O
an	O
immediate	O
early	O
gene.	O

The	O
role	O
of	O
BSAP	protein
(	O
Pax-5	protein
)	O
in	O
B-cell	O
development	O
.	O
The	O
hierarchy	O
of	O
transcriptional	O
control	O
in	O
B-cell	O
development	O
has	O
recently	O
been	O
analyzed	O
by	O
targeted	O
gene	O
inactivation	O
in	O
the	O
mouse	O
.	O
In	O
this	O
manner,	O
the	O
paired	DNA
box	DNA
containing	DNA
gene	DNA
Pax-5	DNA
,	O
encoding	O
the	O
B	protein
cell	protein
specific	protein
transcription	protein
factor	protein
BSAP	protein
,	O
has	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
early	O
B	O
lymphopoiesis	O
.	O
Other	O
experimental	O
strategies	O
have	O
implicated	O
BSAP	protein
in	O
the	O
control	O
of	O
cell	O
proliferation	O
,	O
isotype	O
switching	O
and	O
transcription	O
of	O
the	O
immunoglobulin	DNA
heavy-chain	DNA
gene	DNA
at	O
late	O
stages	O
of	O
B-cell	O
differentiation	O
.	O

The	O
DNA-binding	O
properties	O
of	O
two	protein
heat	protein
shock	protein
factors	protein
,	O
HSF1	protein
and	O
HSF3	protein
,	O
are	O
induced	O
in	O
the	O
avian	cell_line
erythroblast	cell_line
cell	cell_line
line	cell_line
HD6	cell_line
.	O
Avian	O
cells	O
express	O
three	O
heat	DNA
shock	DNA
transcription	DNA
factor	DNA
(	DNA
HSF	DNA
)	DNA
genes	DNA
corresponding	O
to	O
a	O
novel	protein
factor	protein
,	O
HSF3	protein
,	O
and	O
homologs	O
of	O
mouse	O
and	O
human	O
HSF1	protein
and	O
HSF2	protein
.	O
Analysis	O
of	O
the	O
biochemical	O
and	O
cell	O
biological	O
properties	O
of	O
these	O
HSFs	protein
reveals	O
that	O
HSF3	protein
has	O
properties	O
in	O
common	O
with	O
both	O
HSF1	protein
and	O
HSF2	protein
and	O
yet	O
has	O
features	O
which	O
are	O
distinct	O
from	O
both.	O
HSF3	protein
is	O
constitutively	O
expressed	O
in	O
the	O
erythroblast	cell_line
cell	cell_line
line	cell_line
HD6	cell_line
,	O
the	O
lymphoblast	cell_line
cell	cell_line
line	cell_line
MSB	cell_line
,	O
and	O
embryo	cell_line
fibroblasts	cell_line
,	O
and	O
yet	O
its	O
DNA-binding	O
activity	O
is	O
induced	O
only	O
upon	O
exposure	O
of	O
HD6	O
cells	O
to	O
heat	O
shock.	O
Acquisition	O
of	O
HSF3	protein
DNA-binding	O
activity	O
in	O
HD6	cell_line
cells	cell_line
is	O
accompanied	O
by	O
oligomerization	O
from	O
a	O
non-DNA-binding	protein
dimer	protein
to	O
a	O
DNA-binding	protein
trimer	protein
,	O
whereas	O
the	O
effect	O
of	O
heat	O
shock	O
on	O
HSF1	protein
is	O
oligomerization	O
of	O
an	O
inert	protein
monomer	protein
to	O
a	O
DNA-binding	protein
trimer	protein
.	O
Induction	O
of	O
HSF3	protein
DNA-binding	O
activity	O
is	O
delayed	O
compared	O
with	O
that	O
of	O
HSF1	protein
.	O
As	O
occurs	O
for	O
HSF1	protein
,	O
heat	O
shock	O
leads	O
to	O
the	O
translocation	O
of	O
HSF3	protein
to	O
the	O
nucleus.	O
HSF	O
exhibits	O
the	O
properties	O
of	O
a	O
transcriptional	protein
activator	protein
,	O
as	O
judged	O
from	O
the	O
stimulatory	O
activity	O
of	O
transiently	protein
overexpressed	protein
HSF3	protein
measured	O
by	O
using	O
a	O
heat	DNA
shock	DNA
element-containing	DNA
reporter	DNA
construct	DNA
and	O
as	O
independently	O
assayed	O
by	O
the	O
activity	O
of	O
a	O
chimeric	protein
GAL4	protein
-HSF3	protein
protein	protein
on	O
a	O
GAL4	DNA
reporter	DNA
construct	DNA
.	O
These	O
results	O
reveal	O
that	O
HSF3	protein
is	O
negatively	O
regulated	O
in	O
avian	cell_type
cells	cell_type
and	O
acquires	O
DNA-binding	O
activity	O
in	O
certain	O
cells	O
upon	O
heat	O
shock	O
.	O

Direct	O
demonstration	O
of	O
NFATp	protein
dephosphorylation	O
and	O
nuclear	O
localization	O
in	O
activated	cell_line
HT-2	cell_line
cells	cell_line
using	O
a	O
specific	O
NFATp	protein
polyclonal	protein
antibody	protein
.	O
Nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
regulates	O
transcription	O
of	O
a	O
number	O
of	O
cytokine	protein
genes	protein
,	O
and	O
NFAT	protein
DNA	O
binding	O
activity	O
is	O
stimulated	O
following	O
T	O
cell	O
activation	O
.	O
Several	O
lines	O
of	O
evidence	O
have	O
suggested	O
that	O
NFAT	protein
is	O
a	O
substrate	O
for	O
calcineurin	protein
,	O
a	O
serine/threonine	protein
phosphatase	protein
.	O
Using	O
a	O
polyclonal	O
antibody	O
to	O
murine	protein
NFATp	protein
,	O
Western	O
blot	O
analysis	O
of	O
various	O
mouse	O
tissues	O
demonstrated	O
that	O
the	O
110-130-kDa	O
NFATp	protein
protein	protein
was	O
highly	O
expressed	O
in	O
thymus	O
and	O
spleen	O
.	O
Treatment	O
of	O
immunoprecipitated	O
NFATp	protein
from	O
untreated	O
HT-2	cell_line
cells	cell_line
with	O
calcineurin	protein
resulted	O
in	O
the	O
dephosphorylation	O
of	O
NFATp	protein
,	O
demonstrating	O
that	O
NFATp	protein
is	O
an	O
in	O
vitro	O
substrate	O
for	O
calcineurin	protein
.	O
NFATp	protein
immunoprecipitated	O
from	O
32P-labeled	cell_line
HT-2	cell_line
cells	cell_line
migrated	O
as	O
an	O
approximately	O
120-kDa	O
protein	O
that	O
was	O
localized	O
to	O
the	O
cytosol	O
of	O
the	O
cells.	O
Treatment	O
of	O
the	O
cells	O
with	O
ionomycin	O
resulted	O
in	O
a	O
decrease	O
in	O
the	O
molecular	O
weight	O
of	O
NFATp	protein
and	O
a	O
loss	O
of	O
32P	O
,	O
consistent	O
with	O
NFATp	protein
dephosphorylation	O
.	O
The	O
dephosphorylation	O
of	O
NFATp	protein
was	O
accompanied	O
by	O
localization	O
of	O
the	O
protein	O
to	O
the	O
nuclear	O
fraction	O
.	O
Both	O
of	O
these	O
events	O
were	O
blocked	O
by	O
preincubation	O
of	O
the	O
cells	O
with	O
FK506	O
,	O
a	O
calcineurin	protein
inhibitor	O
,	O
consistent	O
with	O
the	O
hypothesis	O
that	O
NFATp	protein
is	O
a	O
calcineurin	protein
substrate	O
in	O
cells.	O

Activation	O
and	O
expression	O
of	O
the	O
nuclear	protein
factors	protein
of	O
activated	cell_type
T	cell_type
cells	cell_type
,	O
NFATp	protein
and	O
NFATc	protein
,	O
in	O
human	cell_type
natural	cell_type
killer	cell_type
cells	cell_type
:	O
regulation	O
upon	O
CD16	protein
ligand	O
binding	O
.	O
The	O
putative	O
factors	O
that	O
couple	O
the	O
signal	O
transduction	O
from	O
surface	O
receptors	O
to	O
the	O
activation	O
of	O
cytokine	protein
synthesis	O
in	O
natural	cell_type
killer	cell_type
(NK)	cell_type
cells	cell_type
have	O
not	O
been	O
elucidated.	O
We	O
report	O
here	O
that	O
the	O
nuclear	protein
factor	protein
of	O
activated	cell_type
T	cell_type
cells	cell_type
(	O
NFATp	protein
),	O
a	O
cyclosporin	protein
A	protein
(	protein
CsA	protein
)-sensitive	protein
factor	protein
that	O
regulates	O
the	O
transcription	O
of	O
several	O
cytokines	protein
,	O
mediates	O
CD16	protein
-induced	O
activation	O
of	O
cytokine	protein
genes	protein
in	O
human	cell_type
NK	cell_type
cells	cell_type
.	O
CD16	protein
(	O
Fc	protein
gamma	protein
RIIIA	protein
)-induced	O
expression	O
of	O
cytokine	RNA
mRNA	RNA
in	O
NK	cell_type
cells	cell_type
occurs	O
via	O
a	O
CsA	O
-sensitive	O
and	O
Ca(2+)-dependent	O
mechanism	O
.	O
Stimulation	O
of	O
NK	cell_type
cells	cell_type
with	O
CD16	protein
ligands	O
induces	O
NFAT	protein
-like	O
DNA	O
binding	O
activity	O
in	O
the	O
nuclear	O
extracts	O
from	O
these	O
cells,	O
as	O
detected	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O
This	O
occurs	O
with	O
fast	O
kinetics	O
after	O
stimulation,	O
via	O
a	O
CsA	O
-sensitive	O
and	O
Ca(2+)-dependent	O
mechanism	O
that	O
does	O
not	O
require	O
de	O
novo	O
protein	O
synthesis.	O
NK	protein
cell	protein
NFAT	protein
is	O
present	O
in	O
the	O
cytosol	O
of	O
nonstimulated	cell_type
cells	cell_type
,	O
migrates	O
to	O
the	O
nucleus	O
upon	O
stimulation,	O
and	O
can	O
associate	O
with	O
AP-1	protein
.	O
Two	O
distinct	O
molecules,	O
NFATp	protein
and	O
NFATc	protein
,	O
have	O
been	O
reported	O
to	O
mediate	O
NFAT	protein
activity	O
.	O
The	O
results	O
of	O
supershift	O
assays	O
using	O
NFATp-	O
and	O
NFATc-	O
specific	O
antibodies	O
indicate	O
that	O
NK	O
cell	O
activation	O
early	O
after	O
CD16	protein
ligand	O
binding	O
involves	O
primarily,	O
if	O
not	O
exclusively,	O
NFATp	protein
,	O
and	O
Western	O
blot	O
analysis	O
shows	O
that	O
this	O
has	O
the	O
same	O
electrophoretic	O
mobility	O
(approximately	O
120	O
kD)	O
as	O
that	O
of	O
T	cell_type
lymphocytes	cell_type
.	O
NK	cell_type
cells	cell_type
do	O
not	O
express	O
NFATc	protein
constitutively,	O
but	O
NFATc	RNA
mRNA	RNA
accumulation	O
is	O
induced	O
in	O
these	O
cells	O
within	O
2	O
h	O
of	O
stimulation	O
with	O
CD16	O
ligands	O
.	O
However,	O
supershift	O
assays	O
using	O
the	O
available	O
mAb	protein
recognizing	O
the	O
T	protein
cell	protein
NFATc	protein
revealed	O
no	O
detectable	O
NFATc	protein
protein	O
in	O
nuclear	O
and	O
cytoplasmic	O
extracts	O
from	O
CD16-	O
or	O
phorbol	cell_line
ester	cell_line
-stimulated	cell_line
cells	cell_line
at	O
any	O
time	O
tested,	O
up	O
to	O
4	O
h.	O
These	O
results	O
provide	O
the	O
first	O
direct	O
evidence	O
that	O
both	O
CsA	protein
-sensitive	protein
transcription	protein
factors	protein
,	O
NFATp	protein
and	O
NFATc	protein
,	O
are	O
expressed	O
in	O
human	O
NK	cell_type
cells	cell_type
,	O
and	O
that	O
their	O
activation	O
and/or	O
expression	O
can	O
be	O
regulated	O
in	O
primary	O
cells	O
by	O
a	O
single	O
stimulus,	O
that,	O
in	O
the	O
case	O
of	O
CD16	O
in	O
NK	cell_type
cells	cell_type
,	O
results	O
in	O
early	O
activation	O
of	O
NFATp	protein
and	O
subsequently	O
induced	O
expression	O
of	O
NFATc	RNA
mRNA	RNA
.	O

Interleukin	O
2	O
signaling	O
involves	O
the	O
phosphorylation	O
of	O
Stat	protein
proteins	protein
.	O
One	O
of	O
the	O
most	O
important	O
cytokines	protein
involved	O
in	O
immune	O
response	O
regulation	O
is	O
interleukin	O
2	O
(IL-2),	O
a	O
potent	O
activator	O
of	O
the	O
proliferation	O
and	O
function	O
of	O
T	cell_type
lymphocytes	cell_type
and	O
natural	cell_type
killer	cell_type
cells	cell_type
.	O
The	O
mechanisms	O
by	O
which	O
the	O
effects	O
of	O
IL-2	protein
are	O
propagated	O
within	O
cells	O
are	O
not	O
understood.	O
While	O
the	O
binding	O
of	O
IL-2	protein
to	O
its	O
receptor	O
was	O
recently	O
shown	O
to	O
lead	O
to	O
the	O
activation	O
of	O
two	O
kinases	protein
,	O
Jak-1	protein
and	O
Jak-3	protein
,	O
subsequent	O
steps	O
in	O
the	O
signaling	O
pathway	O
to	O
the	O
nucleus	O
that	O
lead	O
to	O
the	O
activation	O
of	O
specific	O
genes	O
had	O
not	O
been	O
characterized.	O
Since	O
many	O
cytokines	protein
that	O
activate	O
Jak	protein
kinases	protein
also	O
lead	O
to	O
the	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
members	O
of	O
the	O
Stat	protein
family	protein
of	O
transcription	protein
factors	protein
,	O
the	O
ability	O
of	O
IL-2	protein
to	O
trigger	O
Stat	O
phosphorylation	O
was	O
examined.	O
Exposure	O
of	O
activated	O
human	cell_type
T	cell_type
lymphocytes	cell_type
or	O
of	O
a	O
natural	cell_line
killer	cell_line
cell	cell_line
line	cell_line
(	O
NKL	cell_line
)	O
to	O
IL-2	protein
leads	O
to	O
the	O
phosphorylation	O
of	O
Stat1	protein
alpha	protein
,	O
Stat1	protein
beta	protein
,	O
and	O
Stat3	protein
,	O
as	O
well	O
as	O
of	O
two	O
Stat-related	protein
proteins	protein
,	O
p94	protein
and	O
p95	protein
.	O
p94	protein
and	O
p95	protein
share	O
homology	O
with	O
Stat1	protein
at	O
the	O
phosphorylation	protein
site	protein
and	O
in	O
the	O
Src	protein
homology	protein
2	protein
(SH2)	protein
domain	protein
,	O
but	O
otherwise	O
are	O
immunologically	O
distinct	O
from	O
Stat1	protein
.	O
These	O
Stat	protein
proteins	protein
were	O
found	O
to	O
translocate	O
to	O
the	O
nucleus	O
and	O
to	O
bind	O
to	O
a	O
specific	DNA
DNA	DNA
sequence	DNA
.	O
These	O
findings	O
suggest	O
a	O
mechanism	O
by	O
which	O
IL-2	protein
binding	O
to	O
its	O
receptor	O
may	O
activate	O
specific	DNA
genes	DNA
involved	O
in	O
immune	O
cell	O
function	O
.	O

Expression	O
of	O
c-fos	DNA
correlates	O
with	O
IFN-alpha	protein
responsiveness	O
in	O
Philadelphia	O
chromosome	O
positive	O
chronic	O
myelogenous	O
leukemia	O
.	O
This	O
study	O
evaluates	O
(i)	O
constitutive	O
levels	O
of	O
oncogene	DNA
and	O
p53	RNA
transcripts	RNA
in	O
chronic	O
phase	O
CML	O
patients	O
and	O
(ii)	O
their	O
modulations	O
subsequent	O
to	O
in	O
vivo	O
therapy	O
with	O
rIFN-alpha	protein
2c	protein
.	O
Peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
pbmc	cell_type
)	O
and	O
bone	cell_type
marrow	cell_type
cells	cell_type
of	O
26	O
patients	O
were	O
examined	O
for	O
c-fos	O
,	O
c-myc	O
,	O
p53	O
and	O
the	O
hybrid	O
bcr/abl	O
mRNA	O
levels	O
.	O
Results	O
indicated	O
that	O
(i)	O
constitutive	O
c-fos	RNA
transcript	RNA
levels	O
are	O
significantly	O
higher	O
in	O
patients	O
subsequently	O
responding	O
to	O
IFN-alpha	protein
therapy	O
(p	O
&lt;	O
0.01)	O
and	O
positively	O
correlated	O
with	O
the	O
proportion	O
of	O
lymphocytes	cell_type
(r	O
=	O
0.6895,	O
p	O
&lt;	O
0.01)	O
and	O
negatively	O
with	O
the	O
proportion	O
of	O
immature	cell_type
cells	cell_type
(r	O
=	O
-0.568,	O
p	O
&lt;	O
0.01)	O
contained	O
in	O
the	O
pbmc	cell_type
preparations	O
tested,	O
(ii)	O
constitutive	RNA
mRNA	RNA
levels	O
of	O
the	O
hybrid	DNA
bcr/abl	DNA
,	O
c-myc	DNA
and	O
p53	DNA
are	O
positively	O
correlated	O
with	O
each	O
other,	O
but	O
failed	O
to	O
relate	O
to	O
disease	O
parameters,	O
and	O
(iii)	O
acute	O
and	O
chronic	O
in	O
vivo	O
exposure	O
to	O
IFN-alpha	protein
is	O
accompanied	O
by	O
upregulation	O
of	O
c-fos	DNA
and	O
downregulation	O
of	O
c-myc	RNA
mRNA	RNA
levels	O
in	O
responder	O
patients	O
.	O

Menopause	O
is	O
associated	O
with	O
a	O
significant	O
increase	O
in	O
blood	O
monocyte	O
number	O
and	O
a	O
relative	O
decrease	O
in	O
the	O
expression	O
of	O
estrogen	protein
receptors	protein
in	O
human	cell_type
peripheral	cell_type
monocytes	cell_type
.	O
PROBLEM:	O
The	O
clinical	O
significance	O
of	O
the	O
differential	O
expression	O
of	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
in	O
human	cell_type
monocytes	cell_type
was	O
evaluated.	O
METHOD:	O
Two	O
color	O
flow	O
cytometry	O
analysis	O
was	O
used	O
on	O
peripheral	O
blood	O
samples	O
of	O
young	O
and	O
postmenopausal	O
females	O
and	O
postmenopausal	O
females	O
treated	O
with	O
estrogen	O
replacement	O
therapy	O
.	O
In	O
addition,	O
the	O
monocyte	O
and	O
lymphocyte	O
counts	O
and	O
the	O
blood	O
estrogen	O
levels	O
of	O
each	O
patient	O
were	O
determine.	O
RESULTS:	O
During	O
menopause	O
there	O
is	O
a	O
significant	O
decrease	O
in	O
the	O
percentage	O
of	O
ER	cell_type
positive	cell_type
monocytes	cell_type
,	O
and	O
an	O
increase	O
in	O
blood	cell_type
monocyte	cell_type
number	O
,	O
which	O
declines	O
following	O
estrogen	O
replacement	O
therapy	O
to	O
values	O
of	O
the	O
young.	O
CONCLUSIONS:	O
These	O
findings	O
suggest	O
that	O
estrogen	O
modulates	O
the	O
monocyte	cell_type
numbers	O
and	O
its	O
effects	O
may	O
be	O
mediated	O
through	O
the	O
ER	protein
in	O
the	O
monocytes	cell_type
.	O

Staphylococcal	protein
enterotoxins	protein
modulate	O
interleukin	protein
2	protein
receptor	protein
expression	O
and	O
ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
Janus	protein
protein-	protein
tyrosine	protein
kinase	protein
3	protein
(	O
Jak3	protein
)	O
and	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
(	O
Stat	protein
proteins	protein
).	O
Staphylococcal	protein
enterotoxins	protein
(	O
SE	protein
)	O
stimulate	O
T	cell_type
cells	cell_type
expressing	O
the	O
appropriate	O
variable	protein
region	protein
beta	protein
chain	protein
of	protein
(	protein
V	protein
beta	protein
)	protein
T-cell	protein
receptors	protein
and	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
several	O
autoimmune	O
diseases	O
.	O
Depending	O
on	O
costimulatory	O
signals	O
,	O
SE	protein
induce	O
either	O
proliferation	O
or	O
anergy	O
in	O
T	cell_type
cells	cell_type
.	O
In	O
addition,	O
SE	protein
can	O
induce	O
an	O
interleukin-2	protein
(	O
IL-2	protein
)	O
nonresponsive	O
state	O
and	O
apoptosis	O
.	O
Here,	O
we	O
show	O
that	O
SE	protein
induce	O
dynamic	O
changes	O
in	O
the	O
expression	O
of	O
and	O
signal	O
transduction	O
through	O
the	O
IL-2	O
receptor	O
(IL-2R)	O
beta	O
and	O
gamma	O
chains	O
(	O
IL-2R	protein
beta	protein
and	O
IL-2R	protein
gamma	protein
)	O
in	O
human	cell_line
antigen-specific	cell_line
CD4+	cell_line
T-cell	cell_line
lines	cell_line
.	O
Thus,	O
after	O
4	O
hr	O
of	O
exposure	O
to	O
SEA	protein
and	O
SEB	protein
,	O
the	O
expression	O
of	O
IL-2R	protein
beta	protein
was	O
down-regulated,	O
IL-2R	protein
gamma	protein
was	O
slightly	O
up-regulated,	O
while	O
IL-2R	protein
alpha	protein
remained	O
largely	O
unaffected.	O
The	O
changes	O
in	O
the	O
composition	O
of	O
IL-2Rs	protein
were	O
accompanied	O
by	O
inhibition	O
of	O
IL-2	protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
Janus	protein
protein-	protein
tyrosine	protein
kinase	protein
3	protein
(	O
Jak3	protein
)	O
and	O
signal	protein
transducers	protein
and	protein
activators	protein
of	protein
transcription	protein
called	O
Stat3	protein
and	O
Stat5	protein
.	O
In	O
parallel	O
experiments,	O
IL-2	protein
-driven	O
proliferation	O
was	O
inhibited	O
significantly.	O
After	O
16	O
hr	O
of	O
exposure	O
to	O
SE	protein
,	O
the	O
expression	O
of	O
IL-2R	protein
beta	protein
remained	O
low,	O
while	O
that	O
of	O
IL2R	protein
alpha	protein
and	O
IL2R	protein
gamma	protein
was	O
further	O
up-regulated,	O
and	O
ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
Jak3	protein
and	O
Stat	protein
proteins	protein
was	O
partly	O
normalized.	O
Yet,	O
IL-2	protein
-driven	O
proliferation	O
remained	O
profoundly	O
inhibited,	O
suggesting	O
that	O
signaling	O
events	O
other	O
than	O
Jak3	protein
/Stat	protein
activation	O
had	O
also	O
been	O
changed	O
following	O
SE	protein
stimulation	O
.	O
In	O
conclusion,	O
our	O
data	O
suggest	O
that	O
SE	protein
can	O
modulate	O
IL-2R	protein
expression	O
and	O
signal	O
transduction	O
involving	O
the	O
Jak/Stat	protein
pathway	O
in	O
CD4+	cell_line
T-cell	cell_line
lines	cell_line
.	O

Constitutive	O
NF-kappa	protein
B	protein
activation	O
,	O
enhanced	O
granulopoiesis	O
,	O
and	O
neonatal	O
lethality	O
in	O
I	protein
kappa	protein
B	protein
alpha	protein
-deficient	O
mice	O
.	O
Transcription	protein
factors	protein
belonging	O
to	O
the	O
NF-kappa	protein
B	protein
family	protein
are	O
controlled	O
by	O
inhibitory	protein
I	protein
kappa	protein
B	protein
proteins	protein
,	O
mainly	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
I	protein
kappa	protein
B	protein
beta	protein
.	O
Apparently	O
normal	O
at	O
birth,	O
I	protein
kappa	protein
B	protein
alpha	protein
-/-	O
mice	O
exhibit	O
severe	O
runting,	O
skin	O
defects	O
,	O
and	O
extensive	O
granulopoiesis	O
postnatally,	O
typically	O
dying	O
by	O
8	O
days.	O
Hematopoietic	O
tissues	O
from	O
these	O
mice	O
display	O
elevated	O
levels	O
of	O
both	O
nuclear	protein
NF-kappa	protein
B	protein
and	O
mRNAs	RNA
of	O
some,	O
but	O
not	O
all,	O
genes	O
thought	O
to	O
be	O
regulated	O
by	O
NF-kappa	protein
B	protein
.	O
NF-kappa	protein
B	protein
elevation	O
results	O
in	O
these	O
phenotypic	O
abnormalities	O
because	O
mice	O
lacking	O
both	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
the	O
p50	protein
subunit	protein
of	O
NF-kappa	protein
B	protein
show	O
a	O
dramatically	O
delayed	O
onset	O
of	O
abnormalities	O
.	O
In	O
contrast	O
to	O
hematopoietic	cell_type
cells	cell_type
,	O
I	cell_line
kappa	cell_line
B	cell_line
alpha	cell_line
-/-	cell_line
embryonic	cell_line
fibroblasts	cell_line
show	O
minimal	O
constitutive	protein
NF-kappa	protein
B	protein
,	O
as	O
well	O
as	O
normal	O
signal-dependent	O
NF-kappa	protein
B	protein
activation	O
that	O
is	O
concomitant	O
with	O
I	protein
kappa	protein
B	protein
beta	protein
degradation	O
.	O
Our	O
results	O
indicate	O
that	O
I	O
kappa	O
b	O
beta,	O
but	O
not	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
is	O
required	O
for	O
the	O
signal-dependent	O
activation	O
of	O
NF-kappa	protein
B	protein
in	O
fibroblasts	cell_type
.	O
However,	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
required	O
for	O
the	O
postinduction	O
repression	O
of	O
NF-kappa	protein
B	protein
in	O
fibroblasts	cell_type
.	O
These	O
results	O
define	O
distinct	O
roles	O
for	O
the	O
two	O
forms	O
of	O
I	protein
kappa	protein
B	protein
and	O
demonstrate	O
the	O
necessity	O
for	O
stringent	O
control	O
of	O
NF-kappa	protein
B	protein
.	O

Interleukin-7	protein
can	O
induce	O
the	O
activation	O
of	O
Jak	protein
1	protein
,	O
Jak	protein
3	protein
and	O
STAT	protein
5	protein
proteins	protein
in	O
murine	O
T	cell_type
cells	cell_type
.	O
The	O
activation	O
of	O
Janus	protein
protein	protein
tyrosine	protein
kinases	protein
(	O
Jak	protein
)	O
and	O
STAT	protein
(	protein
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
)	protein
proteins	protein
has	O
recently	O
been	O
linked	O
to	O
the	O
signal	O
transduction	O
mechanism	O
of	O
several	O
cytokines	protein
.	O
IL-7	protein
was	O
observed	O
to	O
induce	O
a	O
rapid	O
and	O
dose-dependent	O
tyrosine	O
phosphorylation	O
of	O
Jak	protein
1	protein
and	O
Jak	protein
3	protein
and	O
concomitantly,	O
the	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
of	O
multiple	O
STAT	protein
proteins	protein
.	O
The	O
STAT	protein
proteins	protein
utilized	O
by	O
IL-7	protein
were	O
identical	O
to	O
those	O
induced	O
by	O
IL-2	protein
and	O
could	O
be	O
identified	O
as	O
various	O
STAT	protein
5	protein
isoforms	protein
.	O
Moreover,	O
the	O
induction	O
of	O
both	O
Jak	O
1	O
and	O
3	O
,	O
and	O
STAT	protein
5	protein
activity	O
strongly	O
correlated	O
with	O
the	O
growth-promoting	O
effects	O
of	O
IL-7	protein
,	O
suggesting	O
that	O
this	O
signal	O
transduction	O
mechanism	O
may	O
play	O
a	O
key	O
role	O
in	O
IL-7	protein
-induced	O
proliferation	O
.	O

Cytokine	protein
-modulating	O
activity	O
of	O
tepoxalin	O
,	O
a	O
new	O
potential	O
antirheumatic	O
.	O
Tepoxalin	O
is	O
a	O
new	O
dual	O
cyclooxygenase/5-lipoxygenase	O
anti-inflammatory	O
compound	O
currently	O
under	O
clinical	O
investigation.	O
It	O
has	O
been	O
shown	O
to	O
possess	O
anti-inflammatory	O
activity	O
in	O
a	O
variety	O
of	O
animal	O
models	O
and	O
more	O
recently	O
to	O
inhibit	O
IL-2	protein
induced	O
signal	O
transduction	O
.	O
The	O
current	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
cytokine	protein
modulating	O
activity	O
of	O
tepoxalin	O
and	O
the	O
role	O
of	O
iron	O
in	O
these	O
effects.	O
In	O
human	cell_type
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
)	O
stimulated	O
with	O
OKT3/PMA	O
,	O
tepoxalin	O
inhibited	O
lymphocyte	cell_type
proliferation	O
with	O
an	O
IC50	O
of	O
6	O
microM.	O
Additionally,	O
it	O
inhibited	O
the	O
production	O
of	O
LTB4	protein
(IC50	O
=	O
0.5	O
microM)	O
and	O
the	O
cytokines	protein
IL-2	protein
,	O
IL-6	protein
and	O
TNF	protein
alpha	protein
(IC50	O
=	O
10-12	O
microM).	O
Cytotoxicity	O
was	O
not	O
demonstrated	O
at	O
these	O
concentrations.	O
Add-back	O
experiments	O
with	O
either	O
cytokines	protein
(	O
IL-2	protein
or	O
IL-6	protein
),	O
LTB4	protein
or	O
conditioned	O
media	O
failed	O
to	O
restore	O
the	O
proliferative	O
response	O
in	O
the	O
presence	O
of	O
tepoxalin	O
.	O
However,	O
the	O
concurrent	O
addition	O
of	O
iron	O
(in	O
the	O
form	O
of	O
ferrous	O
or	O
ferric	O
chloride	O
and	O
other	O
iron	O
salts	O
)	O
reversed	O
the	O
inhibition	O
of	O
proliferation	O
caused	O
by	O
tepoxalin	O
.	O
Tepoxalin	O
also	O
inhibits	O
the	O
activation	O
of	O
NF	protein
kappa	protein
B	protein
,	O
a	O
transcription	protein
factor	protein
which	O
acts	O
on	O
several	O
cytokine	DNA
genes	DNA
.	O
Tepoxalin	O
's	O
effect	O
on	O
NF	protein
kappa	protein
B	protein
is	O
also	O
reversed	O
by	O
the	O
addition	O
of	O
iron	O
salts	O
.	O
These	O
data	O
suggest	O
that	O
the	O
action	O
of	O
tepoxalin	O
to	O
inhibit	O
proliferation	O
in	O
PBMC	cell_type
may	O
be	O
at	O
least	O
in	O
part	O
due	O
to	O
its	O
ability	O
to	O
reduce	O
the	O
amount	O
of	O
available	O
iron	O
resulting	O
in	O
decreased	O
activation	O
of	O
NF	protein
kappa	protein
B	protein
and	O
subsequent	O
inhibition	O
of	O
cytokine	protein
production	O
.	O

N-	protein
and	protein
C-terminal	protein
sequences	protein
control	O
degradation	O
of	O
MAD3/	protein
I	protein
kappa	protein
B	protein
alpha	protein
in	O
response	O
to	O
inducers	O
of	O
NF-kappa	protein
B	protein
activity	O
.	O
The	O
proteolytic	O
degradation	O
of	O
the	O
inhibitory	protein
protein	protein
MAD3/	protein
I	protein
kappa	protein
B	protein
alpha	protein
in	O
response	O
to	O
extracellular	O
stimulation	O
is	O
a	O
prerequisite	O
step	O
in	O
the	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
.	O
Analysis	O
of	O
the	O
expression	O
of	O
human	protein
I	protein
kappa	protein
B	protein
alpha	protein
protein	protein
in	O
stable	O
transfectants	O
of	O
mouse	cell_line
70Z/3	cell_line
cells	cell_line
shows	O
that,	O
as	O
for	O
the	O
endogenous	O
murine	O
protein,	O
exogenous	O
I	protein
kappa	protein
B	protein
alpha	protein
is	O
degraded	O
in	O
response	O
to	O
inducers	O
of	O
NF-kappa	protein
B	protein
activity	O
,	O
such	O
as	O
phorbol	O
myristate	O
acetate	O
or	O
lipopolysaccharide	O
.	O
In	O
addition,	O
pretreatment	O
of	O
the	O
cells	O
with	O
the	O
proteasome	protein
inhibitor	O
N-Ac-Leu-Leu-norleucinal	O
inhibits	O
this	O
ligand-induced	O
degradation	O
and,	O
in	O
agreement	O
with	O
previous	O
studies,	O
stabilizes	O
a	O
hyperphosphorylated	O
form	O
of	O
the	O
human	protein
I	protein
kappa	protein
B	protein
alpha	protein
protein	protein
.	O
By	O
expressing	O
mutant	O
forms	O
of	O
the	O
human	O
protein	O
in	O
this	O
cell	cell_line
line	cell_line
,	O
we	O
have	O
been	O
able	O
to	O
delineate	O
the	O
sequences	O
responsible	O
for	O
both	O
the	O
ligand-induced	O
phosphorylation	O
and	O
the	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Our	O
results	O
show	O
that	O
deletion	O
of	O
the	O
C	protein
terminus	protein
of	O
the	O
I	protein
kappa	protein
B	protein
alpha	protein
molecule	O
up	O
to	O
amino	protein
acid	protein
279	protein
abolishes	O
constitutive	O
but	O
not	O
ligand-inducible	O
phosphorylation	O
and	O
inhibits	O
ligand-inducible	O
degradation	O
.	O
Further	O
analysis	O
reveals	O
that	O
the	O
inducible	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
maps	O
to	O
two	O
serines	O
in	O
the	O
N	protein
terminus	protein
of	O
the	O
protein	O
(residues	O
32	O
and	O
36)	O
and	O
that	O
the	O
mutation	O
of	O
either	O
residue	O
is	O
sufficient	O
to	O
abolish	O
ligand-induced	O
degradation,	O
whereas	O
both	O
residues	O
must	O
be	O
mutated	O
to	O
abolish	O
inducible	O
phosphorylation	O
of	O
the	O
protein.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Microtubules	protein
mediate	O
cellular	O
25-hydroxyvitamin	O
D3	O
trafficking	O
and	O
the	O
genomic	O
response	O
to	O
1,25-dihydroxyvitamin	O
D3	O
in	O
normal	O
human	cell_type
monocytes	cell_type
.	O
The	O
genomic	O
actions	O
of	O
1,25-dihydroxyvitamin	O
D3	O
(1,25(OH)2D3)	O
are	O
mediated	O
by	O
the	O
intracellular	O
vitamin	protein
D	protein
receptor	protein
(	O
VDR	protein
).	O
Although	O
immunocytochemistry	O
has	O
shown	O
that	O
disruption	O
of	O
microtubular	O
assembly	O
prevents	O
nuclear	O
access	O
of	O
the	O
sterol-	protein
VDR	protein
complex	protein
,	O
the	O
role	O
of	O
microtubules	protein
in	O
the	O
response	O
to	O
1,25(OH)2D3	O
has	O
not	O
been	O
studied	O
in	O
viable	cell_type
cells	cell_type
.	O
Our	O
studies	O
examined	O
this	O
interaction	O
in	O
normal	O
human	cell_type
monocytes	cell_type
.	O
Monocytes	O
convert	O
25(OH)D3	O
to	O
1,25(OH)2D3	O
and	O
to	O
24-hydroxylated	O
metabolites	O
more	O
polar	O
than	O
1,25(OH)2D3	O
.	O
Microtubule	O
disruption	O
totally	O
abolished	O
the	O
ability	O
of	O
exogenous	O
1,25(OH)2D3	O
to	O
suppress	O
its	O
own	O
synthesis	O
and	O
to	O
induce	O
24-hydroxylase	RNA
mRNA	RNA
and	O
activity,	O
without	O
affecting	O
either	O
total	O
1,25(OH)2D3	O
uptake	O
or	O
maximal	O
1,25(OH)2D3	O
-VDR	protein
binding	O
.	O
Thus,	O
intact	O
microtubules	protein
are	O
essential	O
for	O
1,25(OH)2D3	O
-dependent	O
modulation	O
of	O
gene	O
transcription	O
.	O
Interestingly,	O
microtubule	protein
disruption	O
also	O
decreased	O
monocyte	cell_type
1,25(OH)2D3	O
synthesis	O
,	O
not	O
by	O
decreasing	O
the	O
Vmax	O
of	O
monocyte	protein
mitochondrial	protein
1	protein
alpha-hydroxylase	protein
but	O
through	O
an	O
increase	O
in	O
the	O
Km	O
for	O
25(OH)2D3	O
.	O
We	O
examined	O
25(OH)D3	O
transport	O
.	O
Microtubule	O
disruption	O
did	O
not	O
affect	O
total	O
cellular	O
25(OH)D3	O
uptake	O
but	O
reduced	O
its	O
intracellular	O
trafficking	O
to	O
the	O
mitochondria	O
.	O
Thus,	O
microtubules	protein
participate	O
in	O
intracellular	O
25(OH)D3	O
transport	O
,	O
and	O
their	O
integrity	O
determines	O
normal	O
1,25(OH)2D3	O
synthesis	O
.	O

Relationship	O
between	O
Rap1	protein
protein	protein
phosphorylation	O
and	O
regulation	O
of	O
Ca2+	O
transport	O
in	O
platelets	cell_type
:	O
a	O
new	O
approach.	O
Although	O
the	O
interrelationship	O
between	O
the	O
two	O
messengers	O
Ca2+	O
and	O
cyclic	O
AMP	O
in	O
platelet	O
function	O
is	O
well	O
documented,	O
its	O
mechanism	O
of	O
action	O
still	O
remains	O
to	O
be	O
established.	O
We	O
investigated	O
here	O
the	O
question	O
of	O
the	O
regulation	O
of	O
platelet	protein
Ca(2+)-ATPases	protein
by	O
cyclic	O
AMP	O
through	O
the	O
phosphorylation	O
of	O
the	O
Rap1	protein
protein	protein
using	O
a	O
pathological	O
model	O
.	O
We	O
first	O
found	O
experimental	O
conditions	O
where	O
Ca(2+)-transport	O
by	O
platelet	O
membrane	O
vesicles	O
appeared	O
to	O
be	O
dependent	O
on	O
the	O
phosphorylation	O
of	O
the	O
Rap1	protein
protein	protein
.	O
Then,	O
we	O
studied	O
platelets	cell_type
of	O
patients	O
with	O
congestive	O
heart	O
failure	O
for	O
their	O
expression	O
of	O
the	O
potential	O
97	protein
kDa	protein
Ca(2+)-ATPase	protein
target	protein
of	O
regulation	O
through	O
the	O
Rap1	protein
protein	protein
as	O
well	O
as	O
the	O
phosphorylation	O
of	O
the	O
Rap1	protein
protein	protein
using	O
the	O
catalytic	protein
subunit	protein
of	O
the	O
cyclic	protein
AMP	protein
-dependent	protein
protein	protein
kinase	protein
(	O
C.	protein
Sub.	protein
).	O
In	O
the	O
first	O
patients	O
studied,	O
we	O
found	O
no	O
significant	O
modification	O
in	O
the	O
expression	O
of	O
the	O
97	protein
kDa	protein
Ca(2+)-ATPase	protein
by	O
Western	O
blotting	O
using	O
the	O
PL/IM	protein
430	protein
monoclonal	protein
antibody	protein
which	O
specifically	O
recognized	O
this	O
isoform.	O
In	O
contrast,	O
the	O
Rap1	protein
protein	protein
was	O
differentially	O
phosphorylated	O
when	O
using	O
15	O
micrograms/ml	O
of	O
the	O
C.	protein
Sub.	protein
These	O
results	O
allowed	O
us	O
to	O
use	O
these	O
pathological	O
platelets	cell_type
to	O
study	O
the	O
relationship	O
between	O
the	O
expression	O
of	O
Rap1	protein
protein	protein
and	O
the	O
regulation	O
of	O
Ca2+	O
transport	O
by	O
selecting	O
a	O
patient	O
with	O
severe	O
heart	O
failure	O
.	O
We	O
could	O
show	O
a	O
decrease	O
in	O
the	O
expression	O
as	O
well	O
as	O
in	O
the	O
phosphorylation	O
of	O
Rap1	protein
protein	protein
and	O
demonstrate	O
a	O
lower	O
effect	O
of	O
C.	protein
Sub.	protein
on	O
Ca2+	O
transport	O
.	O
Finally,	O
by	O
studying	O
a	O
further	O
series	O
of	O
patients	O
,	O
we	O
could	O
confirm	O
that	O
the	O
decrease	O
in	O
Rap1	protein
protein	protein
expression	O
in	O
heart	O
failure,	O
whatever	O
its	O
extent,	O
was	O
variable,	O
and	O
could	O
strictly	O
correlate	O
the	O
expression	O
of	O
Rap1	protein
protein	protein
with	O
the	O
stimulatory	O
effect	O
of	O
C.	protein
Sub.	protein
on	O
Ca2+	O
transport	O
.	O
Besides	O
the	O
evidence	O
for	O
regulation	O
of	O
the	O
expression	O
of	O
the	O
Rap1	protein
protein	protein
in	O
platelets	cell_type
from	O
patients	O
with	O
heart	O
failure	O
,	O
these	O
findings	O
constitute	O
a	O
new	O
approach	O
in	O
favour	O
of	O
the	O
regulation	O
of	O
platelet	O
Ca2+	O
transport	O
through	O
the	O
phosphorylation	O
of	O
the	O
Rap1	protein
protein	protein
.	O

An	O
IRF-1	protein
-dependent	O
pathway	O
of	O
DNA	O
damage-induced	O
apoptosis	O
in	O
mitogen-activated	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Lymphocytes	cell_line
are	O
particularly	O
susceptible	O
to	O
DNA	O
damage-induced	O
apoptosis	O
,	O
a	O
response	O
which	O
may	O
serve	O
as	O
a	O
form	O
of	O
'	O
altruistic	O
suicide	O
'	O
to	O
counter	O
their	O
intrinsic	O
high	O
potential	O
for	O
mutation	O
and	O
clonal	O
expansion	O
.	O
The	O
tumour	protein
suppressor	protein
p53	protein
has	O
been	O
shown	O
to	O
regulate	O
this	O
type	O
of	O
apoptosis	O
in	O
thymocytes	cell_type
,	O
but	O
an	O
as	O
yet	O
unknown,	O
p53	protein
-independent	O
pathway	O
(s)	O
appears	O
to	O
mediate	O
the	O
same	O
event	O
in	O
mitogen-activated	cell_line
mature	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Here	O
we	O
show	O
DNA	O
damage-induced	O
apoptosis	O
in	O
these	O
T	cell_type
lymphocytes	cell_type
is	O
dependent	O
on	O
the	O
antioncogenic	protein
transcription	protein
factor	protein
interferon	protein
regulatory	protein
factor	protein
(IRF)-1	protein
.	O
Thus	O
two	O
different	O
anti-onco-genic	protein
transcription	protein
factors	protein
,	O
p53	protein
and	O
IRF-1	protein
,	O
are	O
required	O
for	O
distinct	O
apoptotic	O
pathways	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
We	O
also	O
show	O
that	O
mitogen	O
induction	O
of	O
the	O
interleukin-1	DNA
beta	DNA
converting	DNA
enzyme	DNA
(	DNA
ICE	DNA
)	DNA
gene	DNA
,	O
a	O
mammalian	protein
homologue	protein
of	O
the	O
Caenorhabditis	DNA
elegans	DNA
cell	DNA
death	DNA
gene	DNA
ced-3	DNA
,	O
is	O
IRF-1	protein
-dependent	O
.	O
Ectopic	O
overexpression	O
of	O
IRF-1	protein
results	O
in	O
the	O
activation	O
of	O
the	O
endogenous	DNA
gene	DNA
for	O
ICE	protein
and	O
enhances	O
the	O
sensitivity	O
of	O
cells	O
to	O
radiation-induced	O
apoptosis	O
.	O

Circadian	O
rhythm	O
of	O
glucocorticoid	protein
receptors	protein
in	O
human	cell_type
peripheral	cell_type
leukocytes	cell_type
and	O
their	O
reactivity	O
to	O
glucocorticoids	O
.	O
1)	O
There	O
exists	O
a	O
CR	O
of	O
GR	protein
in	O
human	cell_type
leukocytes	cell_type
,	O
PMN	cell_type
,	O
and	O
monocytes	cell_type
with	O
the	O
peak	O
values	O
from	O
0400	O
to	O
0800	O
hr	O
and	O
the	O
trough	O
values	O
between	O
2300	O
and	O
0000	O
hr.	O
The	O
difference	O
between	O
them	O
was	O
significant	O
statistically.	O
2)	O
The	O
FI	O
of	O
the	O
chemotactic	O
migration	O
rate	O
of	O
PMN	cell_type
by	O
cortisol	O
also	O
showed	O
diurnal	O
changes	O
which	O
were	O
synchronous	O
with	O
that	O
of	O
GR	protein
.	O
This	O
indicates	O
that	O
the	O
CR	O
of	O
GR	protein
may	O
be	O
of	O
functional	O
significance.	O
3)	O
In	O
Cushing's	O
syndrome	O
,	O
the	O
CR	O
of	O
GR	protein
was	O
normal	O
in	O
spite	O
of	O
the	O
fact	O
that	O
the	O
CR	O
of	O
plasma	O
cortisol	O
was	O
disturbed.	O
This	O
indicates	O
the	O
independency	O
of	O
the	O
CR	O
of	O
GR	protein
from	O
that	O
of	O
cortisol	O
.	O
4)	O
In	O
apoplexy	O
caused	O
by	O
brain	O
ischemia	O
,	O
the	O
CR	O
of	O
GR	protein
was	O
abolished	O
in	O
patients	O
with	O
basal	O
lesions	O
but	O
preserved	O
when	O
the	O
lesions	O
were	O
located	O
in	O
the	O
cerebral	O
cortex	O
.	O
These	O
results	O
strongly	O
suggest	O
that	O
the	O
main	O
"	O
circadian	O
pacemaker	O
"	O
of	O
GR	protein
is	O
located	O
in	O
the	O
basal	O
brain	O
,	O
most	O
probably	O
in	O
the	O
suprachiasmatic	O
nuclei	O
as	O
has	O
been	O
suggested	O
for	O
rodents	O
.	O

B-lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
from	O
multiple	O
sclerosis	O
patients	O
and	O
a	O
healthy	O
control	O
producing	O
a	O
putative	O
new	O
human	O
retrovirus	O
and	O
Epstein-Barr	O
virus	O
.	O
On	O
several	O
occasions	O
we	O
have	O
observed	O
retrovirus-like	O
particles	O
(	O
RVLPs	O
)	O
by	O
transmission	O
electron	O
microscopy	O
(	O
EM	O
)	O
of	O
cultured	cell_line
T	cell_line
cells	cell_line
from	O
a	O
patient	O
with	O
MS	O
.	O
Later	O
we	O
established	O
spontaneously	O
formed	O
B-lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
(	O
LCLs	cell_line
)	O
from	O
a	O
patient	O
with	O
an	O
MS	O
-like	O
disease	O
and	O
from	O
another	O
patient	O
with	O
MS	O
who	O
had	O
a	O
reactivated	O
Epstein-Barr	O
virus	O
(EBV)	O
infection	O
.	O
Both	O
LCLs	cell_line
were	O
found	O
by	O
EM	O
to	O
produce	O
RVLP	O
and	O
EBV	O
particles	O
.	O
Reverse	O
transcriptase	O
(RT)	O
assays	O
were	O
positive	O
in	O
purified	O
viral	O
material	O
from	O
both	O
LCLs	cell_line
.	O
To	O
substantiate	O
these	O
findings	O
we	O
initiated	O
an	O
intensified	O
culturing	O
procedure	O
and	O
were	O
able	O
to	O
establish	O
LCLs	cell_line
from	O
5	O
out	O
of	O
21	O
consecutive	O
MS	O
patients	O
and	O
1	O
out	O
of	O
13	O
consecutive	O
healthy	O
controls	O
.	O
All	O
LCLs	cell_line
were	O
found	O
to	O
produce	O
both	O
RVLP	O
and	O
EBV	O
particles	O
by	O
EM	O
.	O
Whether	O
the	O
putative	O
new	O
retrovirus	O
(es)	O
and	O
EBV	O
have	O
any	O
causal	O
relationship	O
to	O
MS	O
is	O
still	O
not	O
known,	O
but	O
the	O
findings	O
support	O
this	O
possibility.	O

Identification	O
of	O
an	O
ionomycin	DNA
/cyclosporin	DNA
A	DNA
-responsive	DNA
element	DNA
within	O
the	O
human	DNA
T	DNA
cell	DNA
receptor	DNA
gamma	DNA
enhancer	DNA
.	O
Activation	O
through	O
the	O
Ca2+	O
/	O
calcineurin	protein
pathway	O
is	O
essential	O
to	O
the	O
transcription	O
of	O
many	O
cytokine	DNA
genes	DNA
.	O
The	O
conserved	DNA
cis-acting	DNA
sequence	DNA
,	O
GGAAAA	O
,	O
and	O
transcription	protein
factors	protein
binding	O
to	O
this	O
sequence	O
are	O
involved	O
in	O
the	O
response	O
to	O
increased	O
intracellular	O
Ca2+	O
concentrations	O
.	O
Here	O
we	O
report	O
the	O
identification	O
and	O
importance	O
of	O
the	O
same	O
sequence	O
in	O
a	O
non-cytokine	DNA
gene	DNA
,	O
the	O
human	DNA
T	DNA
cell	DNA
receptor	DNA
gamma	DNA
(	DNA
TCRG	DNA
)	DNA
enhancer	DNA
.	O
Results	O
from	O
site-directed	O
mutations	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
strongly	O
suggest	O
that	O
this	O
sequence	O
mediates	O
the	O
ionomycin	O
-induced	O
activation	O
of	O
the	O
TCRG	DNA
enhancer	DNA
.	O
Our	O
studies	O
provide	O
an	O
explanation	O
for	O
a	O
previous	O
observation	O
that	O
TCRG	RNA
mRNA	RNA
levels	O
,	O
but	O
not	O
mRNA	O
levels	O
for	O
T	O
cell	O
receptor	O
alpha	O
and	O
-beta	O
,	O
are	O
increased	O
by	O
ionomycin	O
treatment	O
.	O

Coexpression	O
of	O
NF-kappa	protein
B	protein
/Rel	protein
and	O
Sp1	protein
transcription	protein
factors	protein
in	O
human	O
immunodeficiency	O
virus	O
1	O
-induced,	O
dendritic	O
cell-T-cell	O
syncytia	O
.	O
Productive	O
infection	O
of	O
T	cell_type
cells	cell_type
with	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV-1	O
)	O
typically	O
requires	O
that	O
the	O
T	cell_type
cells	cell_type
be	O
stimulated	O
with	O
antigens	O
or	O
mitogens	O
.	O
This	O
requirement	O
has	O
been	O
attributed	O
to	O
the	O
activation	O
of	O
the	O
transcription	protein
factor	protein
NF-kappa	protein
B	protein
,	O
which	O
synergizes	O
with	O
the	O
constitutive	protein
transcription	protein
factor	protein
Sp1	protein
to	O
drive	O
the	O
HIV-1	DNA
promoter	DNA
.	O
Recently,	O
we	O
have	O
found	O
that	O
vigorous	O
replication	O
of	O
HIV-1	O
takes	O
place	O
in	O
nonactivated	O
memory	cell_type
T	cell_type
cells	cell_type
after	O
syncytium	O
formation	O
with	O
dendritic	cell_type
cells	cell_type
(	O
DCs	cell_type
).	O
These	O
syncytia	O
lack	O
activated	cell_type
cells	cell_type
as	O
determined	O
by	O
an	O
absence	O
of	O
staining	O
for	O
Ki-67	O
cell	O
cycle	O
antigen.	O
The	O
expression	O
and	O
activity	O
of	O
NF-kappa	protein
B	protein
and	O
Sp1	protein
were,	O
therefore,	O
analyzed	O
in	O
isolated	O
T	cell_type
cells	cell_type
and	O
DCs	cell_type
from	O
humans	O
and	O
mice	O
.	O
We	O
have	O
used	O
immunolabeling	O
,	O
Western	O
blot	O
analysis	O
,	O
and	O
electrophoretic	O
mobility	O
shift	O
and	O
supershift	O
assays	O
.	O
T	cell_type
cells	cell_type
lack	O
active	O
NF-kappa	protein
B	protein
but	O
express	O
Sp1	protein
as	O
expected.	O
DCs	cell_type
express	O
high	O
levels	O
of	O
all	O
known	O
NF-kappa	protein
B	protein
and	O
Rel	protein
proteins	protein
,	O
with	O
activity	O
residing	O
primarily	O
within	O
RelB	protein
,	O
p50	protein
,	O
and	O
p65	protein
.	O
However,	O
DCs	cell_type
lack	O
Sp1	protein
,	O
which	O
may	O
explain	O
the	O
failure	O
of	O
HIV-1	O
to	O
replicate	O
in	O
purified	O
DCs	cell_type
.	O
Coexpression	O
of	O
NF-kappa	protein
B	protein
and	O
Sp1	protein
occurs	O
in	O
the	O
heterologous	cell_type
DC-T-cell	cell_type
syncytia	cell_type
that	O
are	O
induced	O
by	O
HIV-1	O
.	O
Therefore,	O
HIV-1	O
-induced	O
cell	O
fusion	O
brings	O
together	O
factors	O
that	O
upregulate	O
virus	O
transcription	O
.	O
Since	O
DCs	cell_type
and	O
memory	O
T	cell_type
cells	cell_type
frequently	O
traffic	O
together	O
in	O
situ,	O
these	O
unusual	O
heterologous	cell_type
syncytia	cell_type
could	O
develop	O
in	O
infected	O
individuals	O
and	O
lead	O
to	O
chronic	O
HIV-1	O
replication	O
without	O
ostensible	O
immune	O
stimulation	O
.	O

Cupric	O
ion	O
blocks	O
NF	protein
kappa	protein
B	protein
activation	O
through	O
inhibiting	O
the	O
signal-induced	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
A	O
transcription	protein
factor	protein
NF	protein
kappa	protein
B	protein
,	O
which	O
regulates	O
expression	O
of	O
various	O
cellular	O
genes	O
involved	O
in	O
immune	O
responses	O
and	O
viral	DNA
genes	DNA
including	O
HIV	O
,	O
is	O
sequestered	O
in	O
the	O
cytoplasm	O
as	O
a	O
complex	O
with	O
an	O
inhibitory	protein
protein	protein
I	protein
kappa	protein
B	protein
.	O
Various	O
extracellular	O
signals	O
induce	O
phosphorylation	O
and	O
rapid	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
to	O
release	O
NF	protein
kappa	protein
B	protein
.	O
Cu2+	O
was	O
found	O
to	O
inhibit	O
the	O
activation	O
of	O
NF	protein
kappa	protein
B	protein
induced	O
by	O
TNF-alpha	protein
,	O
TPA	O
,	O
or	O
H2O2	O
.	O
Deoxycholate	O
treatment	O
of	O
the	O
cytoplasmic	O
extract	O
prepared	O
from	O
cells	O
stimulated	O
by	O
TNF-alpha	protein
in	O
the	O
presence	O
of	O
Cu2+	O
resulted	O
in	O
the	O
release	O
of	O
NF	protein
kappa	protein
B	protein
from	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
indicating	O
that	O
Cu2+	O
interferes	O
with	O
the	O
dissociation	O
of	O
the	O
NF	protein
kappa	protein
B	protein
-I	protein
kappa	protein
B	protein
complex	protein
.	O
Neither	O
phosphorylation	O
nor	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
was	O
observed	O
upon	O
TNF-alpha	protein
stimulation	O
in	O
the	O
presence	O
of	O
Cu2+	O
.	O
These	O
results	O
indicate	O
that	O
Cu2+	O
inhibits	O
the	O
release	O
of	O
NF	protein
kappa	protein
B	protein
by	O
blockade	O
of	O
a	O
signal	O
leading	O
to	O
the	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O

Cloning	O
a	O
cDNA	DNA
from	O
human	O
NK/	cell_type
T	cell_type
cells	cell_type
which	O
codes	O
for	O
a	O
protein	O
with	O
high	O
proline	O
content	O
.	O
A	O
cDNA	DNA
clone	DNA
,	O
B4-2	DNA
,	O
was	O
isolated	O
from	O
a	O
natural	DNA
killer	DNA
(NK)	DNA
minus	DNA
T	DNA
cell	DNA
subtractive	DNA
library	DNA
.	O
The	O
B4-2	DNA
clone	O
coded	O
for	O
an	O
mRNA	RNA
of	O
2061	O
bp	O
in	O
length.	O
It	O
encodes	O
a	O
deduced	O
327	protein
aa	protein
protein	protein
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
35.2	O
kDa.	O
Searching	O
of	O
B4-2	DNA
DNA	DNA
and	O
protein	O
sequences	O
against	O
various	O
databases	O
revealed	O
no	O
high	O
homology	O
to	O
other	O
sequences.	O
However,	O
B4-2	DNA
has	O
an	O
unusually	O
high	O
proline	O
content	O
(13%),	O
contains	O
a	O
putative	O
nuclear	protein
targeting	protein
sequence	protein
,	O
and	O
has	O
several	O
SPXX	protein
motifs	protein
which	O
are	O
frequently	O
found	O
in	O
gene	protein
regulatory	protein
proteins	protein
.	O
One	O
of	O
the	O
stretches	O
of	O
prolines	O
in	O
B4-2	DNA
closely	O
resembles	O
the	O
ligand	O
for	O
proteins	O
with	O
SH3	protein
domains	protein
.	O
Northern	O
hybridization	O
data	O
showed	O
that	O
B4-2	DNA
is	O
not	O
a	O
lymphoid	DNA
specific	DNA
gene	DNA
and	O
is	O
expressed	O
in	O
a	O
hepatoma	cell_line
cell	cell_line
line	cell_line
and	O
also	O
weakly	O
transcribed	O
or	O
absent	O
in	O
a	O
variety	O
of	O
other	O
cells.	O
A	O
polyclonal	O
antiserum	O
raised	O
against	O
recombinant	protein
B4-2	protein
recognizes	O
a	O
32-34	protein
kDa	protein
protein	protein
in	O
lymphocytes	cell_type
.	O

Activation	O
of	O
JAK3	protein
,	O
but	O
not	O
JAK1	protein
,	O
is	O
critical	O
for	O
IL-2	protein
-induced	O
proliferation	O
and	O
STAT5	protein
recruitment	O
by	O
a	O
COOH-terminal	protein
region	protein
of	O
the	O
IL-2	protein
receptor	protein
beta-chain	protein
.	O
A	O
number	O
of	O
cytokines	protein
and	O
growth	protein
factors	protein
use	O
the	O
JAK	protein
-STAT	protein
pathway	O
to	O
signal	O
from	O
the	O
cell	O
membrane	O
to	O
the	O
nucleus	O
.	O
While	O
homodimerizing	protein
cytokine	protein
receptors	protein
may	O
transmit	O
signal	O
via	O
a	O
single	O
form	O
of	O
JAK	protein
(i.e.	O
growth	protein
hormone	protein
receptors	protein
),	O
several	O
multicomponent	protein
cytokine	protein
receptors	protein
have	O
been	O
shown	O
to	O
require	O
simultaneous	O
activation	O
of	O
pairs	O
of	O
different	O
JAK	protein
kinases	protein
(i.e.	O
interferon	protein
receptors	protein
).	O
Recent	O
evidence	O
for	O
a	O
preferential	O
coupling	O
of	O
JAK3	protein
to	O
interleukin-2	protein
receptor-gamma	protein
(	O
IL-2R	protein
gamma	protein
)	O
and	O
JAK1	protein
to	O
IL-2R	protein
beta	protein
supports	O
the	O
concept	O
of	O
heterotrans-activation	O
of	O
JAK1	protein
and	O
JAK3	protein
caused	O
by	O
IL-2	protein
-induced	O
heterodimerization	O
of	O
their	O
receptor	O
partners	O
.	O
The	O
present	O
study	O
verified	O
the	O
ability	O
of	O
IL-2	protein
to	O
cause	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
JAK1	protein
and	O
JAK3	protein
,	O
but	O
demonstrated	O
that	O
IL-2	protein
stimulated	O
JAK3	protein
to	O
a	O
significantly	O
larger	O
extent	O
than	O
JAK1	protein
in	O
human	cell_type
T	cell_type
lymphocytes	cell_type
and	O
the	O
YT	cell_line
cell	cell_line
line	cell_line
.	O
This	O
conclusion	O
was	O
based	O
upon	O
several	O
independent	O
criteria,	O
including	O
more	O
vigorous	O
tyrosine	O
phosphorylation	O
of	O
JAK3	protein
,	O
more	O
marked	O
enzymatic	O
activation	O
of	O
JAK3	protein
as	O
well	O
as	O
higher	O
abundance	O
of	O
JAK3	protein
in	O
activated	O
IL-2	protein
receptor	protein
complexes	protein
.	O
Furthermore,	O
when	O
human	protein
IL-2R	protein
beta	protein
was	O
stably	O
expressed	O
in	O
murine	cell_line
BA/F3	cell_line
cells	cell_line
,	O
robust	O
IL-2	protein
-induced	O
proliferation	O
and	O
JAK3	protein
activation	O
occurred	O
without	O
detectable	O
involvement	O
of	O
either	O
JAK1	protein
,	O
JAK2	protein
or	O
TYK2	protein
.	O
We	O
therefore	O
propose	O
that	O
IL-2	protein
receptor	protein
signal	O
transduction	O
does	O
not	O
depend	O
on	O
equimolar	O
heterodimerization	O
of	O
JAK1	protein
and	O
JAK3	protein
following	O
IL-2	protein
-induced	O
heterodimerization	O
of	O
IL-2R	protein
beta	protein
and	O
IL-2R	protein
gamma	protein
.	O
Nonetheless,	O
a	O
membrane-proximal	protein
region	protein
of	O
human	O
IL-2R	protein
beta	protein
(	O
Asn240-Leu335	protein
)	O
was	O
critical	O
for	O
JAK3	protein
activation,	O
and	O
the	O
amount	O
of	O
JAK3	protein
present	O
in	O
activated	O
IL-2	protein
receptor	protein
complexes	protein
increased	O
with	O
time,	O
suggesting	O
that	O
stabilization	O
of	O
JAK3	protein
binding	O
to	O
the	O
receptor	protein
complex	protein
relies	O
on	O
both	O
IL-2R	protein
beta	protein
and	O
IL-2R	protein
gamma	protein
.	O
Moreover,	O
STAT5	protein
was	O
found	O
to	O
be	O
the	O
predominant	O
STAT	protein
transcription	protein
factor	protein
used	O
by	O
IL-2	protein
in	O
human	cell_type
T	cell_type
cells	cell_type
,	O
and	O
specifically	O
required	O
a	O
COOH-terminal	protein
region	protein
of	O
IL-2R	protein
beta	protein
(	O
Ser386-Val525	protein
),	O
while	O
STAT5	protein
recruitment	O
was	O
not	O
correlated	O
to	O
activation	O
of	O
IL-2R	protein
gamma	protein
or	O
JAK3	protein
.	O

Up-regulation	O
of	O
high-affinity	O
dehydroepiandrosterone	O
binding	O
activity	O
by	O
dehydroepiandrosterone	O
in	O
activated	O
human	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Although	O
evidence	O
indicates	O
that	O
dehydroepiandrosterone	O
(	O
DHEA	O
)	O
exerts	O
direct	O
physiological	O
effects	O
,	O
its	O
mechanism	O
of	O
action	O
remains	O
unknown.	O
DHEA	O
binding	O
sites	O
were	O
examined	O
using	O
a	O
whole-cell	O
binding	O
assay	O
in	O
a	O
human	cell_line
T	cell_line
lymphoid	cell_line
cell	cell_line
line	cell_line
,	O
PEER	cell_line
,	O
revealing	O
that	O
a	O
single	O
class	O
of	O
high-affinity	O
binding	O
sites	O
for	O
DHEA	O
(dissociation	O
constant	O
=	O
7.4	O
+/-	O
0.53	O
nmol/L,	O
mean	O
+/-	O
SE,	O
n	O
=	O
4)	O
was	O
greatly	O
increased	O
when	O
treated	O
with	O
DHEA	O
,	O
phorbol-12-myristate-13-acetate	O
,	O
and	O
the	O
Ca2+	O
ionophore	O
A23187.	O
Bound	O
[3H]	O
DHEA	O
was	O
displaced	O
sensitively	O
by	O
DHEA	O
and	O
secondarily	O
by	O
dihydrotestosterone	O
,	O
but	O
not	O
effectively	O
by	O
other	O
steroids	O
,	O
including	O
DHEA	O
sulfate	O
.	O
These	O
results	O
not	O
only	O
indicate	O
the	O
existence	O
of	O
a	O
DHEA	protein
receptor	protein
,	O
but	O
also	O
suggest	O
that	O
T	cell_type
cells	cell_type
become	O
susceptible	O
to	O
regulation	O
by	O
DHEA	O
during	O
the	O
process	O
of	O
signal-induced	O
activation	O
.	O

Ubiquitin-mediated	O
processing	O
of	O
NF-kappa	protein
B	protein
transcriptional	protein
activator	protein
precursor	protein
p105	protein
.	O
Reconstitution	O
of	O
a	O
cell-free	O
system	O
and	O
identification	O
of	O
the	O
ubiquitin-carrier	protein
protein	protein
,	O
E2	protein
,	O
and	O
a	O
novel	O
ubiquitin-protein	protein
ligase	protein
,	O
E3	protein
,	O
involved	O
in	O
conjugation.	O
In	O
most	O
cases,	O
the	O
transcriptional	protein
factor	protein
NF-kappa	protein
B	protein
is	O
a	O
heterodimer	protein
consisting	O
of	O
two	O
subunits,	O
p50	protein
and	O
p65	protein
,	O
which	O
are	O
encoded	O
by	O
two	O
distinct	O
genes	O
of	O
the	O
Rel	DNA
family	DNA
.	O
p50	protein
is	O
translated	O
as	O
a	O
precursor	O
of	O
105	protein
kDa	protein
.	O
The	O
C-terminal	protein
domain	protein
of	O
the	O
precursor	O
is	O
rapidly	O
degraded,	O
forming	O
the	O
mature	protein
p50	protein
subunit	protein
consisted	O
of	O
the	O
N-terminal	protein
region	protein
of	O
the	O
molecule.	O
The	O
mechanism	O
of	O
generation	O
of	O
p50	protein
is	O
not	O
known.	O
It	O
has	O
been	O
suggested	O
that	O
the	O
ubiquitin	protein
-proteasome	protein
system	O
is	O
involved	O
in	O
the	O
process;	O
however,	O
the	O
specific	O
enzymes	protein
involved	O
and	O
the	O
mechanism	O
of	O
limited	O
proteolysis	O
,	O
in	O
which	O
half	O
of	O
the	O
molecule	O
is	O
spared,	O
have	O
been	O
obscure.	O
Palombella	O
and	O
colleagues	O
(Palombella,	O
V.J.,	O
Rando,	O
O.J.,	O
Goldberg,	O
A.L.,	O
and	O
Maniatis,	O
T.(1994)	O
Cell	O
78,	O
773-785)	O
have	O
shown	O
that	O
ubiquitin	protein
is	O
required	O
for	O
the	O
processing	O
in	O
a	O
cell-free	O
system	O
of	O
a	O
truncated,	O
artificially	O
constructed,	O
60-kDa	protein
precursor	protein
.	O
They	O
have	O
also	O
shown	O
that	O
proteasome	protein
inhibitors	O
block	O
the	O
processing	O
both	O
in	O
vitro	O
and	O
in	O
vivo.	O
In	O
this	O
study,	O
we	O
demonstrate	O
reconstitution	O
of	O
a	O
cell-free	O
processing	O
system	O
and	O
demonstrate	O
directly	O
that:	O
(a)	O
the	O
ubiquitin	protein
-proteasome	protein
system	O
is	O
involved	O
in	O
processing	O
of	O
the	O
intact	O
p105	protein
precursor,	O
(b)	O
conjugation	O
of	O
ubiquitin	protein
to	O
the	O
precursor	O
is	O
an	O
essential	O
intermediate	O
step	O
in	O
the	O
processing,	O
(c)	O
the	O
recently	O
discovered	O
novel	O
species	O
of	O
the	O
ubiquitin	protein
-carrier	protein
protein	protein
,	O
E2-F1	protein
,	O
that	O
is	O
involved	O
in	O
the	O
conjugation	O
and	O
degradation	O
of	O
p53	protein
,	O
is	O
also	O
required	O
for	O
the	O
limited	O
processing	O
of	O
the	O
p105	protein
precursor	protein
,	O
and	O
(d)	O
a	O
novel,	O
approximately	O
320-kDa	protein
species	protein
of	O
ubiquitin	protein
-protein	protein
ligase	protein
,	O
is	O
involved	O
in	O
the	O
process.	O
This	O
novel	O
enzyme	O
is	O
distinct	O
from	O
E6-AP	protein
,	O
the	O
p53	protein
-conjugating	protein
ligase	protein
,	O
and	O
from	O
E3	protein
alpha	protein
,	O
the	O
"N-end	protein
rule"	protein
ligase	protein
.	O

Flutamide	O
in	O
the	O
treatment	O
of	O
hirsutism	O
:	O
long-term	O
clinical	O
effects	O
,	O
endocrine	O
changes	O
,	O
and	O
androgen	protein
receptor	protein
behavior	O
.	O
OBJECTIVE:	O
To	O
investigate	O
the	O
long-term	O
effects	O
of	O
treatment	O
with	O
low	O
doses	O
of	O
flutamide	O
on	O
clinical	O
and	O
hormonal	O
parameters	O
,	O
as	O
well	O
as	O
on	O
the	O
androgen	protein
receptor	protein
status,	O
in	O
hirsute	O
women	O
.	O
DESIGN:	O
Eighteen	O
hirsute	O
patients	O
with	O
regular	O
menses	O
were	O
studied	O
basally	O
and	O
during	O
treatment	O
with	O
125	O
mg	O
flutamide	O
,	O
three	O
times	O
per	O
day	O
for	O
12	O
months.	O
Barrier	O
or	O
intrauterine	O
contraception	O
was	O
used	O
during	O
the	O
study	O
in	O
sexually	O
active	O
women	O
.	O
Safety	O
parameters	O
were	O
assessed	O
throughout	O
the	O
study.	O
Hirsutism	O
,	O
graded	O
by	O
the	O
modified	O
Ferriman-Gallwey	O
score	O
,	O
and	O
hormonal	O
parameters	O
were	O
evaluated	O
basally	O
and	O
at	O
4-month	O
intervals	O
during	O
treatment.	O
Gonadotropin-releasing	O
hormone	O
and	O
ACTH	O
stimulation	O
tests	O
were	O
performed	O
before	O
and	O
after	O
3	O
to	O
4	O
months	O
of	O
therapy	O
.	O
In	O
addition,	O
the	O
concentration	O
of	O
androgen	protein
receptors	protein
in	O
mononuclear	cell_type
leukocytes	cell_type
was	O
measured,	O
in	O
both	O
the	O
follicular	O
and	O
luteal	O
phases	O
of	O
the	O
menstrual	O
cycle	O
,	O
basally	O
and	O
after	O
4	O
months	O
of	O
flutamide	O
treatment.	O
RESULTS:	O
Flutamide	O
was	O
well	O
tolerated	O
in	O
all	O
women	O
,	O
with	O
the	O
noticeable	O
exception	O
of	O
one	O
patient	O
who	O
presented	O
increased	O
serum	protein
transaminase	protein
after	O
8	O
months	O
of	O
therapy	protein
.	O
Hirsutism	O
markedly	O
improved	O
in	O
all	O
women	O
during	O
the	O
treatment	O
(	O
Ferriman-Gallwey	O
score	O
after	O
1	O
year:	O
4.1	O
+/-	O
0.5	O
versus	O
14.1	O
+/-	O
0.9).	O
A	O
reduction	O
of	O
serum	O
androgens	O
was	O
found,	O
whereas	O
no	O
change	O
was	O
observed	O
in	O
either	O
basal	O
or	O
GnRH-stimulated	O
gonadotropins	O
or	O
in	O
the	O
cortisol	O
and	O
17	O
alpha-hydroxyprogesterone	O
response	O
to	O
ACTH	O
.	O
Cycles	O
remained	O
ovulatory.	O
Before	O
treatment,	O
the	O
number	O
of	O
androgen	protein
receptors	protein
was	O
higher	O
in	O
the	O
luteal	O
than	O
in	O
the	O
follicular	O
phase	O
.	O
This	O
rhythmic	O
differentiation	O
disappeared	O
after	O
the	O
patients	O
had	O
been	O
given	O
the	O
antiandrogen	O
drug	O
.	O
CONCLUSIONS:	O
Flutamide	O
is	O
effective	O
in	O
the	O
treatment	O
of	O
hirsutism	O
but	O
requires	O
constant	O
surveillance	O
of	O
liver	O
function	O
.	O
Androgen	O
receptor	O
blockade	O
might	O
be	O
potentiated	O
by	O
a	O
reduction	O
of	O
serum	O
androgens	O
.	O
Flutamide	O
affects	O
androgen	protein
receptor	protein
behavior	O
during	O
the	O
menstrual	O
cycle	O
.	O
The	O
meaning	O
of	O
this	O
finding	O
remains	O
to	O
be	O
elucidated	O
.	O

Constitutive	O
expression	O
of	O
HIV-1	protein
tat	protein
protein	protein
in	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
using	O
a	O
BK	O
virus	O
vector	O
.	O
The	O
production	O
and	O
characterization	O
of	O
Jurkat	cell_line
cell	cell_line
lines	cell_line
that	O
constitutively	O
express	O
functional	O
human	protein
immune	protein
deficiency	protein
virus	protein
type	protein
1	protein
(	protein
HIV-1	protein
)	protein
tat	protein
protein	protein
,	O
using	O
a	O
BK	O
virus	O
plasmid	O
expression	O
vector	O
and	O
HIV-1	DNA
tat	DNA
cDNA	DNA
,	O
is	O
described.	O
An	O
increased	O
growth	O
rate	O
of	O
these	O
Jurkat-tat	cell_line
cell	cell_line
lines	cell_line
as	O
compared	O
with	O
control	cell_line
cell	cell_line
lines	cell_line
was	O
observed.	O

A	O
PEBP2	protein
alpha/AML-1-related	protein
factor	protein
increases	O
osteocalcin	DNA
promoter	DNA
activity	O
through	O
its	O
binding	O
to	O
an	O
osteoblast-specific	DNA
cis-acting	DNA
element	DNA
.	O
To	O
identify	O
osteoblast-specific	DNA
cis-acting	DNA
elements	DNA
and	O
trans-acting	protein
factors	protein
,	O
we	O
initiated	O
an	O
analysis	O
of	O
the	O
promoter	DNA
of	O
a	O
mouse	DNA
osteocalcin	DNA
gene	DNA
,	O
an	O
osteoblast-specific	DNA
gene	DNA
.	O
In	O
this	O
promoter,	O
we	O
identified	O
two	O
osteoblast-specific	DNA
cis-acting	DNA
elements	DNA
(Ducy,	O
P.and	O
Karsenty,	O
G.(1995)	O
Mol.Cell.Biol.15,	O
1858-1869).	O
The	O
sequence	O
of	O
one	O
of	O
these	O
elements	DNA
,	O
OSE2	DNA
,	O
is	O
identical	O
to	O
the	O
DNA-binding	DNA
site	DNA
of	O
the	O
PEBP2	protein
alpha/AML-1	protein
transcription	protein
factors	protein
,	O
the	O
mammalian	protein
homologues	protein
of	O
the	O
Drosophila	protein
Runt	protein
protein	protein
.	O
Here	O
we	O
show,	O
using	O
nuclear	O
extracts	O
,	O
recombinant	protein
protein	protein
,	O
and	O
a	O
specific	O
antiserum	O
against	O
AML-1	protein
proteins	protein
in	O
DNA-binding	O
assays	O
,	O
that	O
one	O
member	O
of	O
this	O
family,	O
AML-1B	protein
,	O
binds	O
specifically	O
to	O
OSE2	DNA
and	O
is	O
immunologically	O
related	O
to	O
OSF2	protein
,	O
the	O
factor	O
present	O
in	O
osteoblast	O
nuclear	O
extracts	O
that	O
binds	O
to	O
OSE2	DNA
.	O
By	O
DNA	O
cotransfection	O
experiments	O
,	O
we	O
also	O
demonstrate	O
that	O
AML-1B	protein
can	O
increase	O
the	O
activity	O
of	O
a	O
short	O
osteocalcin	DNA
promoter	DNA
through	O
its	O
binding	O
to	O
OSE2	DNA
.	O
Lastly,	O
the	O
different	O
mobilities	O
of	O
osteoblast	protein
nuclear	protein
extract-DNA	protein
complexes	protein
compared	O
with	O
T-cell	protein
nuclear	protein
extract-DNA	protein
complexes	protein
,	O
along	O
with	O
the	O
inability	O
of	O
OSF2	protein
to	O
be	O
upregulated	O
by	O
retinoic	O
acid	O
,	O
unlike	O
the	O
other	O
PEBP2	protein
alpha	protein
factors	protein
,	O
suggest	O
that	O
OSF2	protein
is	O
a	O
new	O
member	O
of	O
this	O
family	O
of	O
transcription	protein
factors	protein
.	O
Thus,	O
this	O
study	O
demonstrates	O
that	O
AML-1B	protein
can	O
increase	O
gene	O
expression	O
of	O
an	O
osteoblast-specific	DNA
gene	DNA
through	O
its	O
binding	O
to	O
an	O
osteoblast-specific	DNA
cis-acting	DNA
element	DNA
and	O
presents	O
evidence	O
that	O
OSF2	protein
is	O
a	O
member	O
of	O
the	O
PEBP2	protein
alpha/AML-1	protein
family	protein
of	O
transcription	protein
factors	protein
.	O

Initiation	protein
binding	protein
repressor	protein
,	O
a	O
factor	O
that	O
binds	O
to	O
the	O
transcription	DNA
initiation	DNA
site	DNA
of	O
the	O
histone	DNA
h5	DNA
gene	DNA
,	O
is	O
a	O
glycosylated	protein
member	protein
of	O
a	O
family	O
of	O
cell	protein
growth	protein
regulators	protein
[corrected]	O
[published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1996	O
Feb;16(2):735]	O
Initiation	protein
binding	protein
repressor	protein
[corrected]	O
(	O
IBR	protein
)	O
is	O
a	O
chicken	protein
erythrocyte	protein
factor	protein
(apparent	O
molecular	O
mass,	O
70	O
to	O
73	O
kDa)	O
that	O
binds	O
to	O
the	O
sequences	O
spanning	O
the	O
transcription	DNA
initiation	DNA
site	DNA
of	O
the	O
histone	DNA
h5	DNA
gene	DNA
,	O
repressing	O
its	O
transcription	O
.	O
A	O
variety	O
of	O
other	O
cells,	O
including	O
transformed	cell_type
erythroid	cell_type
precursors	cell_type
,	O
do	O
not	O
have	O
IBR	protein
but	O
a	O
factor	O
referred	O
to	O
as	O
IBF	protein
(68	O
to	O
70	O
kDa)	O
that	O
recognizes	O
the	O
same	O
IBR	protein
sites.	O
We	O
have	O
cloned	O
the	O
IBR	DNA
cDNA	DNA
and	O
studied	O
the	O
relationship	O
of	O
IBR	protein
and	O
IBF	protein
.	O
IBR	protein
is	O
a	O
503-amino-acid-long	protein
acidic	protein
protein	protein
which	O
is	O
99.0%	O
identical	O
to	O
the	O
recently	O
reported	O
human	protein
NRF-1/alpha-Pal	protein
factor	protein
and	O
highly	O
related	O
to	O
the	O
invertebrate	O
transcription	protein
factors	protein
P3A2	protein
and	O
erected	protein
wing	protein
gene	protein
product	protein
(	O
EWG	protein
).	O
We	O
present	O
evidence	O
that	O
IBR	protein
and	O
IBF	protein
are	O
most	O
likely	O
identical	O
proteins,	O
differing	O
in	O
their	O
degree	O
of	O
glycosylation	O
.	O
We	O
have	O
analyzed	O
several	O
molecular	O
aspects	O
of	O
IBR/F	protein
and	O
shown	O
that	O
the	O
factor	O
associates	O
as	O
stable	O
homodimers	protein
and	O
that	O
the	O
dimer	protein
is	O
the	O
relevant	protein
DNA-binding	protein
species	protein
.	O
The	O
evolutionarily	O
conserved	O
N-terminal	protein
half	protein
of	O
IBR/F	protein
harbors	O
the	O
DNA-binding/dimerization	protein
domain	protein
(outer	O
limits,	O
127	O
to	O
283),	O
one	O
or	O
several	O
casein	protein
kinase	protein
II	protein
sites	protein
(37	O
to	O
67),	O
and	O
a	O
bipartite	protein
nuclear	protein
localization	protein
signal	protein
(89	O
to	O
106)	O
which	O
appears	O
to	O
be	O
necessary	O
for	O
nuclear	O
targeting	O
.	O
Binding	O
site	O
selection	O
revealed	O
that	O
the	O
alternating	protein
RCGCRYGCGY	protein
consensus	protein
constitutes	O
high-affinity	O
IBR/F	DNA
binding	DNA
sites	DNA
and	O
that	O
the	O
direct-repeat	DNA
palindrome	DNA
TGCGCATGCGCA	O
is	O
the	O
optimal	DNA
site	DNA
.	O
A	O
survey	O
of	O
genes	DNA
potentially	O
regulated	O
by	O
this	O
family	O
of	O
factors	protein
primarily	O
revealed	O
genes	DNA
involved	O
in	O
growth-related	O
metabolism	O
.	O

Triggering	O
of	O
the	O
human	O
interleukin-6	O
gene	O
by	O
interferon-gamma	O
and	O
tumor	O
necrosis	O
factor-alpha	O
in	O
monocytic	O
cells	O
involves	O
cooperation	O
between	O
interferon	protein
regulatory	protein
factor-1	protein
,	O
NF	protein
kappa	protein
B	protein
,	O
and	O
Sp1	protein
transcription	protein
factors	protein
.	O
We	O
investigated	O
the	O
molecular	O
basis	O
of	O
the	O
synergistic	O
induction	O
by	O
interferon-gamma	protein
(	O
IFN-gamma	protein
)/	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
of	O
human	DNA
interleukin-6	DNA
(IL-6)	DNA
gene	DNA
in	O
THP-1	cell_type
monocytic	cell_type
cells	cell_type
,	O
and	O
compared	O
it	O
with	O
the	O
basis	O
of	O
this	O
induction	O
by	O
lipopolysaccharide	O
(	O
LPS	O
).	O
Functional	O
studies	O
with	O
IL-6	DNA
promoter	DNA
demonstrated	O
that	O
three	O
regions	O
are	O
the	O
targets	O
of	O
the	O
IFN-gamma	protein
and/or	O
TNF-alpha	protein
action,	O
whereas	O
only	O
one	O
of	O
these	O
regions	O
seemed	O
to	O
be	O
implicated	O
in	O
LPS	O
activation	O
.	O
The	O
three	O
regions	O
concerned	O
are:	O
1)	O
a	O
region	O
between	O
-73	O
and	O
-36,	O
which	O
is	O
the	O
minimal	DNA
element	DNA
inducible	O
by	O
LPS	O
or	O
TNF-alpha	protein
;	O
2)	O
an	O
element	O
located	O
between	O
-181	O
and	O
-73,	O
which	O
appeared	O
to	O
regulate	O
the	O
response	O
to	O
IFN-gamma	protein
and	O
TNF-alpha	protein
negatively;	O
and	O
3)	O
a	O
distal	DNA
element	DNA
upstream	DNA
of	O
-224,	O
which	O
was	O
inducible	O
by	O
IFN-gamma	protein
alone.	O
LPS	O
signaling	O
was	O
found	O
to	O
involve	O
NF	protein
kappa	protein
B	protein
activation	O
by	O
the	O
p50/p65	protein
heterodimers	protein
.	O
Synergistic	O
induction	O
of	O
the	O
IL-6	DNA
gene	DNA
by	O
IFN-gamma	protein
and	O
TNF-alpha	protein
,	O
in	O
monocytic	cell_type
cells	cell_type
,	O
involved	O
cooperation	O
between	O
the	O
IRF-1	protein
and	O
NF	protein
kappa	protein
B	protein
p65	protein
homodimers	protein
with	O
concomitant	O
removal	O
of	O
the	O
negative	O
effect	O
of	O
the	O
retinoblastoma	DNA
control	DNA
element	DNA
present	O
in	O
the	O
IL-6	DNA
promoter	DNA
.	O
This	O
removal	O
occurred	O
by	O
activation	O
of	O
the	O
constitutive	protein
Sp1	protein
factor	protein
,	O
whose	O
increased	O
binding	O
activity	O
and	O
phosphorylation	O
were	O
mediated	O
by	O
IFN-gamma	protein
.	O

Mutation	O
of	O
Jak3	protein
in	O
a	O
patient	O
with	O
SCID	O
:	O
essential	O
role	O
of	O
Jak3	protein
in	O
lymphoid	O
development	O
.	O
Males	O
with	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
XSCID	O
)	O
have	O
defects	O
in	O
the	O
common	O
cytokine	DNA
receptor	DNA
gamma	DNA
chain	DNA
(	DNA
gamma	DNA
c	DNA
)	DNA
gene	DNA
that	O
encodes	O
a	O
shared,	O
essential	O
component	O
of	O
the	O
receptors	O
of	O
interleukin-2	protein
(	O
IL-2	protein
),	O
IL-4	protein
,	O
IL-7	protein
,	O
IL-9	protein
,	O
and	O
IL-15	protein
.	O
The	O
Janus	protein
family	protein
tyrosine	protein
kinase	protein
Jak3	protein
is	O
the	O
only	O
signaling	O
molecule	O
known	O
to	O
be	O
associated	O
with	O
gamma	protein
c	protein
,	O
so	O
it	O
was	O
hypothesized	O
that	O
defects	O
in	O
Jak3	protein
might	O
cause	O
an	O
XSCID	O
-like	O
phenotype	O
.	O
A	O
girl	O
with	O
immunological	O
features	O
indistinguishable	O
from	O
those	O
of	O
XSCID	O
was	O
therefore	O
selected	O
for	O
analysis.	O
An	O
Epstein-Barr	cell_line
virus	cell_line
(	cell_line
EBV	cell_line
)-transformed	cell_line
cell	cell_line
line	cell_line
derived	O
from	O
her	O
lymphocytes	cell_type
had	O
normal	O
gamma	protein
c	protein
expression	O
but	O
lacked	O
Jak3	protein
protein	protein
and	O
had	O
greatly	O
diminished	O
Jak3	RNA
messenger	RNA
RNA	RNA
.	O
Sequencing	O
revealed	O
a	O
different	O
mutation	O
on	O
each	O
allele:	O
a	O
single	O
nucleotide	O
insertion	O
resulting	O
in	O
a	O
frame	O
shift	O
and	O
premature	O
termination	O
in	O
the	O
Jak3	protein
JH4	protein
domain	protein
and	O
a	O
nonsense	O
mutation	O
in	O
the	O
Jak3	protein
JH2	O
domain	O
.	O
The	O
lack	O
of	O
Jak3	protein
expression	O
correlated	O
with	O
impaired	O
B	O
cell	O
signaling	O
,	O
as	O
demonstrated	O
by	O
the	O
inability	O
of	O
IL-4	protein
to	O
activate	O
Stat6	protein
in	O
the	O
EBV	cell_line
-transformed	cell_line
cell	cell_line
line	cell_line
from	O
the	O
patient.	O
These	O
observations	O
indicate	O
that	O
the	O
functions	O
of	O
gamma	protein
c	protein
are	O
dependent	O
on	O
Jak3	protein
and	O
that	O
Jak3	protein
is	O
essential	O
for	O
lymphoid	O
development	O
and	O
signaling.	O

Constitutive	O
overexpression	O
of	O
the	O
L-selectin	DNA
gene	DNA
in	O
fresh	O
leukemic	cell_type
cells	cell_type
of	O
adult	O
T-cell	O
leukemia	O
that	O
can	O
be	O
transactivated	O
by	O
human	protein
T-cell	protein
lymphotropic	protein
virus	protein
type	protein
1	protein
Tax	protein
.	O
L-selectin	protein
is	O
an	O
adhesion	O
molecule	O
of	O
the	O
selectin	O
family	O
that	O
mediates	O
the	O
initial	O
step	O
of	O
leukocyte	O
adhesion	O
to	O
vascular	O
endothelium	O
.	O
Upon	O
cellular	O
activation	O
,	O
expression	O
of	O
the	O
L-selectin	DNA
gene	DNA
is	O
downregulated	O
at	O
both	O
the	O
protein	O
and	O
mRNA	O
levels	O
.	O
To	O
understand	O
the	O
mechanism	O
of	O
leukemic	cell_type
cell	cell_type
infiltration	O
into	O
organs	O
,	O
we	O
studied	O
the	O
expression	O
and	O
regulation	O
of	O
L-selectin	RNA
mRNA	RNA
in	O
fresh	O
leukemic	cell_type
cells	cell_type
of	O
adult	O
T-cell	O
leukemia	O
(	O
ATL	O
)	O
patients	O
and	O
investigated	O
the	O
response	O
of	O
the	O
L-selectin	DNA
promoter	DNA
to	O
human	protein
T-cell	protein
lymphotropic	protein
virus	protein
type	protein
1	protein
(	protein
HTLV-1	protein
)	protein
Tax	protein
,	O
which	O
is	O
a	O
viral	protein
transcriptional	protein
transactivator	protein
.	O
Flow	O
cytometry	O
showed	O
that	O
L-selectin	protein
was	O
expressed	O
on	O
fresh	O
ATL	cell_line
cells	cell_line
along	O
with	O
other	O
activation	protein
antigens	protein
.	O
Northern	O
blot	O
analysis	O
showed	O
that	O
ATL	cell_line
cells	cell_line
overexpressed	O
that	O
L-selectin	RNA
mRNA	RNA
and	O
that	O
the	O
level	O
was	O
aberrantly	O
upregulated	O
after	O
PMA	O
stimulation	O
.	O
Studies	O
using	O
in	O
situ	O
hybridization	O
showed	O
expression	O
of	O
the	O
L-selectin	RNA
mRNA	RNA
in	O
the	O
infiltrating	O
leukemic	cell_type
cells	cell_type
in	O
the	O
liver	O
of	O
two	O
ATL	O
patients	O
.	O
Intravenous	O
injection	O
of	O
a	O
rat	cell_line
T-cell	cell_line
line	cell_line
that	O
overexpresses	O
L-selectin	protein
showed	O
increased	O
organ	O
infiltration	O
.	O
The	O
induction	O
of	O
Tax	protein
expression	O
in	O
JPX9	cell_line
cells	cell_line
resulted	O
in	O
about	O
a	O
twofold	O
increase	O
in	O
the	O
mRNA	RNA
expression	O
levels	O
compared	O
with	O
the	O
basal	O
level	O
.	O
Chloramphenicol	protein
acetyltransferase	protein
(	O
CAT	protein
)	O
assay	O
after	O
transient	O
cotransfection	O
showed	O
about	O
a	O
fivefold	O
transactivation	O
of	O
the	O
L-selectin	DNA
promoter	DNA
by	O
Tax	protein
.	O
The	O
serum	O
level	O
of	O
the	O
shed	O
form	O
of	O
L-selectin	protein
was	O
significantly	O
increased	O
in	O
ATL	O
patients	O
(mean	O
+/-	O
SD,	O
4,215.4	O
+/-	O
4,111	O
ng/mL)	O
compared	O
with	O
those	O
of	O
asymptomatic	O
carriers	O
and	O
healthy	O
blood	O
donors	O
(mean	O
+/-	O
SD,	O
1,148.0	O
+/-	O
269.0	O
ng/mL	O
and	O
991.9	O
+/-	O
224	O
ng/mL,	O
respectively).	O
These	O
results	O
indicated	O
that	O
ATL	cell_line
cells	cell_line
constitutively	O
overexpress	O
the	O
L-selectin	DNA
gene	DNA
that	O
can	O
be	O
transactivated	O
by	O
HTLV-1	O
Tax	protein
.	O
The	O
overexpression	O
of	O
L-selectin	protein
,	O
as	O
well	O
as	O
of	O
inflammatory	protein
cytokines	protein
,	O
by	O
ATL	cell_line
cells	cell_line
may	O
provide	O
a	O
basis	O
for	O
ATL	cell_line
cells	cell_line
to	O
attach	O
the	O
vascular	O
endothelium	O
,	O
leading	O
to	O
transmigration	O
and	O
organ	O
infitration	O
.	O

Human	O
herpesvirus	O
6	O
variant	O
A	O
,	O
but	O
not	O
variant	O
B	O
,	O
infects	O
EBV	cell_line
-positive	cell_line
B	cell_line
lymphoid	cell_line
cells	cell_line
,	O
activating	O
the	O
latent	DNA
EBV	DNA
genome	DNA
through	O
a	O
BZLF-1	protein
-dependent	O
mechanism	O
.	O
Human	O
herpesvirus	O
6	O
,	O
a	O
predominantly	O
T	O
lymphotropic	O
virus	O
,	O
has	O
been	O
recently	O
shown	O
to	O
infect	O
some	O
EBV	cell_line
-positive	cell_line
B	cell_line
cell	cell_line
lines	cell_line
,	O
and	O
to	O
induce	O
in	O
them	O
the	O
activation	O
of	O
the	O
EBV	O
lytic	O
cycle	O
.	O
Here	O
we	O
have	O
confirmed	O
and	O
extended	O
such	O
observations,	O
showing	O
that	O
(1)	O
this	O
phenomenon	O
is	O
restricted	O
to	O
the	O
variant	O
A	O
of	O
HHV-6	O
:	O
in	O
fact	O
two	O
isolates	O
belonging	O
to	O
the	O
HHV-6	O
variant	O
B	O
(	O
BA92	O
and	O
Z29	O
)	O
were	O
neither	O
able	O
to	O
infect	O
any	O
B	cell_line
cell	cell_line
line	cell_line
,	O
independently	O
of	O
the	O
EBV	O
status	O
,	O
nor	O
to	O
induce	O
the	O
EBV	O
genome	O
expression	O
.	O
The	O
only	O
exception	O
is	O
represented	O
by	O
the	O
P3HR1	cell_line
cells	cell_line
,	O
in	O
which,	O
however,	O
the	O
infection	O
by	O
the	O
variant	O
B	O
does	O
not	O
determine	O
induction	O
of	O
EBV	protein
antigens	protein
;	O
(2)	O
the	O
presence	O
of	O
the	O
EBV	DNA
genome	DNA
contributes	O
to	O
the	O
susceptibility	O
of	O
the	O
B	cell_line
cell	cell_line
lines	cell_line
to	O
HHV-6	O
infection	O
,	O
increasing	O
the	O
binding	O
sites	O
and	O
the	O
percentage	O
of	O
infectable	cell_type
cells	cell_type
,	O
as	O
detected	O
by	O
immunoelectron	O
microscopy	O
;	O
and	O
(3)	O
HHV-6	cell_line
infected	cell_line
T	cell_line
cells	cell_line
,	O
transfected	O
with	O
plasmids	DNA
bearing	O
the	O
promoter	DNA
regions	DNA
of	O
the	O
EBV	O
early	O
genes	O
BZLF1	DNA
and	O
BMRF1	DNA
,	O
show	O
a	O
strong	O
transactivation	O
of	O
these	O
promoters	DNA
.	O

Evidence	O
for	O
normal	O
vitamin	RNA
D	RNA
receptor	RNA
messenger	RNA
ribonucleic	RNA
acid	RNA
and	O
genotype	O
in	O
absorptive	O
hypercalciuria	O
.	O
Absorptive	O
hypercalciuria	O
(a	O
stone-forming	O
condition	O
)	O
is	O
characterized	O
by	O
gut	O
hyperabsorption	O
of	O
calcium	O
,	O
hypercalciuria	O
,	O
and	O
reduced	O
bone	O
density	O
.	O
Inasmuch	O
as	O
these	O
features	O
implicate	O
enhanced	O
calcitriol	O
action	O
in	O
gut	O
and	O
bone	O
,	O
we	O
analyzed	O
the	O
vitamin	DNA
D	DNA
receptor	DNA
(	DNA
VDR	DNA
)	DNA
gene	DNA
to	O
ascertain	O
whether	O
an	O
abnormality	O
of	O
this	O
gene	O
marks	O
patients	O
with	O
intestinal	O
hyperabsorption	O
of	O
calcium	O
.	O
We	O
have	O
compared	O
the	O
frequency	O
of	O
a	O
restriction	DNA
fragment	DNA
length	DNA
polymorphism	DNA
(	O
Bsm	DNA
I	DNA
)	O
associated	O
with	O
different	O
alleles	O
of	O
the	O
VDR	DNA
gene	DNA
in	O
a	O
group	O
of	O
33	O
well	O
characterized	O
absorptive	O
hypercalciuric	O
patients	O
and	O
a	O
group	O
of	O
36	O
normal	O
race-	O
and	O
age-matched	O
control	O
subjects	O
.	O
There	O
was	O
no	O
difference	O
between	O
the	O
distribution	O
of	O
the	O
VDR	protein
alleles	O
in	O
the	O
patient	O
population	O
when	O
compared	O
with	O
the	O
normal	O
population	O
.	O
The	O
coding	O
region	O
of	O
VDR	RNA
messenger	RNA
RNA	RNA
was	O
also	O
normal,	O
as	O
determined	O
by	O
both	O
DNA	DNA
sequence	DNA
analysis	O
and	O
chemical	O
mismatch	O
cleavage	O
analysis	O
of	O
copy	O
DNA	O
from	O
11	O
index	O
absorptive	O
hypercalciuric	O
patients	O
.	O
On	O
the	O
basis	O
of	O
these	O
results,	O
we	O
propose	O
that	O
the	O
enhanced	O
intestinal	O
calcium	O
absorption	O
invariably	O
seen	O
in	O
absorptive	O
hypercalciuria	O
and	O
attendant	O
symptoms	O
of	O
this	O
disorder	O
are	O
not	O
attributable	O
to	O
mutations	O
of	O
the	O
VDR	protein
and	O
are	O
not	O
linked	O
to	O
a	O
common	O
VDR	DNA
genotype	DNA
.	O

Transcriptional	O
regulation	O
of	O
the	O
gene	O
encoding	O
the	O
human	protein
C-type	protein
lectin	protein
leukocyte	protein
receptor	protein
AIM/CD69	protein
and	O
functional	O
characterization	O
of	O
its	O
tumor	DNA
necrosis	DNA
factor-alpha	DNA
-responsive	DNA
elements	DNA
.	O
The	O
human	protein
activation	protein
antigen	protein
CD69	protein
is	O
a	O
member	O
of	O
the	O
C-type	protein
animal	protein
lectin	protein
superfamily	protein
that	O
functions	O
as	O
a	O
signal-transmitting	protein
receptor	protein
.	O
Although	O
the	O
expression	O
of	O
CD69	protein
can	O
be	O
induced	O
in	O
vitro	O
on	O
cells	O
of	O
most	O
hematopoietic	O
lineages	O
with	O
a	O
wide	O
variety	O
of	O
stimuli,	O
in	O
vivo	O
it	O
is	O
mainly	O
expressed	O
by	O
T-	cell_type
lymphocytes	cell_type
located	O
in	O
the	O
inflammatory	O
infiltrates	O
of	O
several	O
human	O
diseases	O
.	O
To	O
elucidate	O
the	O
mechanisms	O
that	O
regulate	O
the	O
constitutive	O
and	O
inducible	O
expression	O
of	O
CD69	protein
by	O
leukocytes	cell_type
,	O
we	O
isolated	O
the	O
promoter	DNA
region	DNA
of	O
the	O
CD69	protein
gene	O
and	O
carried	O
out	O
its	O
functional	O
characterization	O
.	O
Sequence	O
analysis	O
of	O
the	O
5'-flanking	DNA
region	DNA
of	O
the	O
CD69	DNA
gene	DNA
revealed	O
the	O
presence	O
of	O
a	O
potential	O
TATA	DNA
element	DNA
30	DNA
base	DNA
pairs	DNA
upstream	DNA
of	O
the	O
major	O
transcription	DNA
initiation	DNA
site	DNA
and	O
several	O
putative	O
binding	O
sequences	O
for	O
inducible	O
transcription	protein
factors	protein
(	O
NF-kappa	protein
B	protein
,	O
Egr-1	protein
,	O
AP-1	protein
),	O
which	O
might	O
mediate	O
the	O
inducible	O
expression	O
of	O
this	O
gene.	O
Transient	O
expression	O
of	O
CD69	DNA
promoter-based	DNA
reporter	DNA
gene	DNA
constructs	DNA
in	O
K562	cell_line
cells	cell_line
indicated	O
that	O
the	O
proximal	DNA
promoter	DNA
region	DNA
spanning	O
positions	O
-78	O
to	O
+16	O
contained	O
the	O
cis-acting	DNA
sequences	DNA
necessary	O
for	O
basal	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
-inducible	O
transcription	O
of	O
the	O
CD69	DNA
gene	DNA
.	O
Removal	O
of	O
the	O
upstream	O
sequences	O
located	O
between	O
positions	O
-78	O
and	O
-38	O
resulted	O
in	O
decreased	O
promoter	O
strength	O
and	O
abolished	O
the	O
response	O
to	O
phorbol	O
12-myristate	O
13-acetate.	O
We	O
also	O
found	O
that	O
tumor	protein
necrosis	protein
factor-alpha	protein
(	O
TNF-alpha	protein
)	O
is	O
capable	O
of	O
inducing	O
the	O
surface	O
expression	O
of	O
the	O
CD69	protein
molecule	O
as	O
well	O
as	O
the	O
promoter	O
activity	O
of	O
fusion	O
plasmids	O
that	O
contain	O
5'-flanking	O
sequences	O
of	O
the	O
CD69	protein
gene,	O
suggesting	O
that	O
this	O
cytokine	O
may	O
regulate	O
in	O
vivo	O
the	O
expression	O
of	O
CD69	protein
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS)	O

Characterization	O
of	O
5'	DNA
end	DNA
of	DNA
human	DNA
thromboxane	DNA
receptor	DNA
gene	DNA
.	O
Organizational	O
analysis	O
and	O
mapping	O
of	O
protein	DNA
kinase	DNA
C--responsive	DNA
elements	DNA
regulating	O
expression	O
in	O
platelets	cell_type
.	O
Platelet	protein
thromboxane	protein
receptors	protein
are	O
acutely	O
and	O
reversibly	O
upregulated	O
after	O
acute	O
myocardial	O
infarction	O
.	O
To	O
determine	O
if	O
platelet	O
thromboxane	protein
receptors	protein
are	O
under	O
transcriptional	O
control	O
,	O
we	O
isolated	O
and	O
characterized	O
human	DNA
genomic	DNA
DNA	DNA
clones	DNA
containing	O
the	O
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
thromboxane	DNA
receptor	DNA
gene	DNA
.	O
The	O
exon-intron	DNA
structure	DNA
of	O
the	O
5'	DNA
portion	DNA
of	O
the	O
thromboxane	DNA
receptor	DNA
gene	DNA
was	O
determined	O
initially	O
by	O
comparing	O
the	O
nucleotide	DNA
sequence	DNA
of	O
the	O
5'	DNA
flanking	DNA
genomic	DNA
clone	DNA
with	O
that	O
of	O
a	O
novel	DNA
human	DNA
uterine	DNA
thromboxane	DNA
receptor	DNA
cDNA	DNA
that	O
extended	O
the	O
mRNA	RNA
141	DNA
bp	DNA
further	DNA
upstream	DNA
than	O
the	O
previously	DNA
identified	DNA
human	DNA
placental	DNA
cDNA	DNA
.	O
A	O
major	O
transcription	DNA
initiation	DNA
site	DNA
was	O
located	O
in	O
three	O
human	O
tissues	O
approximately	O
560	DNA
bp	DNA
upstream	DNA
from	O
the	O
translation	DNA
initiation	DNA
codon	DNA
and	O
380	DNA
bp	DNA
upstream	DNA
from	O
any	O
previously	O
identified	O
transcription	DNA
initiation	DNA
site	DNA
.	O
The	O
thromboxane	DNA
receptor	DNA
gene	DNA
has	O
neither	O
a	O
TATA	DNA
nor	O
a	O
CAAT	DNA
consensus	DNA
site	DNA
.	O
Promoter	O
function	O
of	O
the	O
5'	DNA
flanking	DNA
region	DNA
of	O
the	O
thromboxane	DNA
receptor	DNA
gene	DNA
was	O
evaluated	O
by	O
transfection	O
of	O
thromboxane	DNA
receptor	DNA
gene	DNA
promoter/	DNA
chloramphenicol	DNA
acetyltransferase	DNA
(	DNA
CAT	DNA
)	DNA
chimera	DNA
plasmids	DNA
into	O
platelet-like	O
K562	cell_line
cells	cell_line
.	O
Thromboxane	O
receptor	DNA
promoter	DNA
activity	O
,	O
as	O
assessed	O
by	O
CAT	protein
expression	O
,	O
was	O
relatively	O
weak	O
but	O
was	O
significantly	O
enhanced	O
by	O
phorbol	O
ester	O
treatment	O
.	O
Functional	O
analysis	O
of	O
5'	DNA
deletion	DNA
constructs	DNA
in	O
transfected	O
K562	cell_line
cells	cell_line
and	O
gel	O
mobility	O
shift	O
localized	O
the	O
major	O
phorbol	O
ester	O
-responsive	O
motifs	O
in	O
the	O
thromboxane	DNA
receptor	DNA
gene	DNA
promoter	O
to	O
a	O
cluster	O
of	O
activator	DNA
protein-2	DNA
(	DNA
AP-2	DNA
)	DNA
binding	DNA
consensus	DNA
sites	DNA
located	O
approximately	O
1.8	O
kb	O
5'	O
from	O
the	O
transcription	DNA
initiation	DNA
site	DNA
.	O
These	O
studies	O
are	O
the	O
first	O
to	O
determine	O
the	O
structure	O
and	O
organization	O
of	O
the	O
5'	O
end	O
of	O
the	O
thromboxane	DNA
receptor	DNA
gene	DNA
and	O
demonstrate	O
that	O
thromboxane	DNA
receptor	DNA
gene	DNA
expression	O
can	O
be	O
regulated	O
by	O
activation	O
of	O
protein	protein
kinase	protein
C	protein
via	O
induction	O
of	O
an	O
AP-2	protein
-like	protein
nuclear	protein
factor	protein
binding	O
to	O
upstream	DNA
promoter	DNA
elements	DNA
.	O
These	O
findings	O
strongly	O
suggest	O
that	O
the	O
mechanism	O
for	O
previously	O
described	O
upregulation	O
of	O
platelet	protein
thromboxane	protein
receptors	protein
after	O
acute	O
myocardial	O
infarction	O
is	O
increased	O
thromboxane	DNA
receptor	DNA
gene	DNA
transcription	O
in	O
platelet-progenitor	cell_type
cells	cell_type
.	O

Estrogen	protein
receptor	protein
concentration	O
and	O
social	O
factors	O
as	O
predictors	O
of	O
natural	O
killer	O
cell	O
activity	O
in	O
early-stage	O
breast	O
cancer	O
patients	O
.	O
Confirmation	O
of	O
a	O
model.	O
Previous	O
work	O
of	O
ours	O
has	O
demonstrated	O
that	O
a	O
significant	O
amount	O
of	O
natural	O
killer	O
(NK)	O
activity	O
variance	O
after	O
surgery	O
in	O
stage	O
I	O
and	O
II	O
breast	O
cancer	O
patients	O
could	O
be	O
accounted	O
for	O
by	O
both	O
the	O
estrogen	protein
receptor	protein
(	O
ER	protein
)	O
status	O
of	O
the	O
tumor	O
and	O
by	O
social	O
factors	O
,	O
namely,	O
perceived	O
social	O
support	O
and	O
seeking	O
social	O
support	O
as	O
a	O
general	O
coping	O
strategy	O
.	O
As	O
considerable	O
evidence	O
has	O
accumulated	O
that	O
social	O
support	O
in	O
both	O
animal	O
and	O
human	O
populations	O
may	O
have	O
survival	O
value,	O
we	O
sought	O
to	O
test	O
the	O
reliability	O
of	O
this	O
regression	O
model	O
,	O
using	O
coping	O
and	O
perceived	O
support	O
factor	O
values	O
obtained	O
at	O
3	O
months	O
after	O
surgery	O
to	O
account	O
for	O
concurrent	O
follow-up	O
NK	O
activity	O
in	O
this	O
serially	O
assessed	O
group	O
of	O
patients	O
.	O
It	O
was	O
found	O
that	O
the	O
most	O
significant	O
variable	O
predicting	O
NK	O
activity	O
at	O
follow-up	O
was	O
tumor	O
ER	protein
concentration	O
,	O
with	O
higher	O
NK	O
activity	O
associated	O
with	O
ER	protein
-status	O
.	O
In	O
addition,	O
seeking	O
social	O
support	O
as	O
a	O
coping	O
strategy,	O
as	O
well	O
as	O
the	O
perceived	O
quality	O
of	O
support,	O
also	O
entered	O
the	O
model	O
to	O
account	O
for	O
a	O
significant	O
amount	O
of	O
NK	O
activity	O
variance	O
(multivariate	O
F	O
=	O
5.25,	O
p	O
less	O
than	O
0.001).	O
If,	O
as	O
the	O
literature	O
suggests,	O
NK	O
activity	O
is	O
relevant	O
to	O
breast	O
cancer	O
control	O
,	O
and	O
since	O
ER	protein
-tumors	O
have	O
a	O
worse	O
prognosis,	O
we	O
suggest	O
here	O
that	O
perhaps	O
such	O
tumors	O
are	O
resistant	O
to	O
control	O
by	O
NK	cell_type
cells	cell_type
because	O
they	O
lack	O
the	O
ability	O
to	O
attract	O
an	O
accumulation	O
of	O
effector	cell_type
cells	cell_type
to	O
the	O
tumor	O
site	O
,	O
or	O
because	O
blocking	O
factors	O
at	O
the	O
site	O
of	O
the	O
tumor	O
prevent	O
local	O
tumor	O
control	O
at	O
the	O
site	O
of	O
action.	O
The	O
finding	O
related	O
to	O
social	O
support	O
also	O
replicates	O
results	O
from	O
an	O
independent	O
sample	O
of	O
breast	O
cancer	O
patients	O
.	O
This	O
finding,	O
taken	O
together	O
with	O
other	O
evidence	O
that	O
this	O
social	O
variable	O
is	O
associated	O
with	O
longer	O
survival	O
in	O
breast	O
cancer	O
populations	O
,	O
underscores	O
the	O
potential	O
importance	O
of	O
this	O
social	O
support	O
variable	O
.	O
Our	O
findings	O
also	O
suggest	O
one	O
possible	O
immunological	O
variable	O
involved	O
,	O
with	O
potential	O
clinical	O
significance	O
,	O
for	O
this	O
patient	O
population	O
.	O

Solution	O
structure	O
of	O
the	O
sequence-specific	DNA
HMG	DNA
box	DNA
of	O
the	O
lymphocyte	protein
transcriptional	protein
activator	protein
Sox-4	protein
.	O
Two	O
groups	O
of	O
HMG	protein
box	protein
proteins	protein
are	O
distinguished.	O
Proteins	O
in	O
the	O
first	O
group	O
contain	O
multiple	O
HMG	protein
boxes	protein
,	O
are	O
non-sequence-specific	O
,	O
and	O
recognize	O
structural	O
features	O
as	O
found	O
in	O
cruciform	DNA
DNA	DNA
and	O
cross-over	DNA
DNA	DNA
.	O
The	O
abundant	O
chromosomal	protein
protein	protein
HMG-1	protein
belongs	O
to	O
this	O
subgroup.	O
Proteins	O
in	O
the	O
second	O
group	O
carry	O
a	O
single	protein
HMG	protein
box	protein
with	O
affinity	O
for	O
the	O
minor	DNA
groove	DNA
of	O
the	O
heptamer	DNA
motif	DNA
AACAAAG	O
or	O
variations	O
thereof.	O
A	O
solution	O
structure	O
for	O
the	O
non-sequence-specific	O
C-terminal	protein
HMG	protein
box	protein
of	O
HMG-1	protein
has	O
recently	O
been	O
proposed.	O
Now,	O
we	O
report	O
the	O
solution	O
structure	O
of	O
the	O
sequence-specific	protein
HMG-box	protein
of	O
the	O
SRY-related	protein
protein	protein
Sox-4	protein
.	O
NMR	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
three	O
alpha-helices	protein
(	O
Val10-Gln22	protein
,	O
Glu30-Leu41	protein
and	O
Phe50-Tyr65	protein
)	O
connected	O
by	O
loop	protein
regions	protein
(	O
Ser23-Ala49	protein
and	O
Leu42-Pro49	protein
).	O
Helices	O
I	O
and	O
II	O
are	O
positioned	O
in	O
an	O
antiparallel	protein
mode	protein
and	O
form	O
one	O
arm	O
of	O
the	O
HMG	protein
box	protein
.	O
Helix	protein
III	protein
is	O
less	O
rigid,	O
makes	O
an	O
average	O
angle	O
of	O
about	O
90	O
degrees	O
with	O
helices	O
I	O
and	O
II	O
,	O
and	O
constitutes	O
the	O
other	O
arm	O
of	O
the	O
molecule.	O
As	O
in	O
HMG1B	protein
,	O
the	O
overall	O
structure	O
of	O
the	O
Sox-4	protein
HMG	protein
box	protein
is	O
L-shaped	O
and	O
is	O
maintained	O
by	O
a	O
cluster	O
of	O
conserved,	O
mainly	O
aromatic	O
residues	O
.	O

Nuclear	protein
factor-IL6	protein
activates	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O
Positive	DNA
regulatory	DNA
element	DNA
I	DNA
(	O
PRE-I	DNA
)	O
is	O
a	O
strong	O
enhancer	DNA
element	DNA
essential	O
for	O
expression	O
of	O
the	O
human	DNA
IL-4	DNA
gene	DNA
.	O
To	O
identify	O
transcription	protein
factors	protein
binding	O
to	O
PRE-I	DNA
,	O
we	O
screened	O
a	O
cDNA	DNA
expression	DNA
library	DNA
from	O
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
isolated	O
a	O
cDNA	DNA
encoding	O
nuclear	protein
factor	protein
(NF)-IL6	protein
(also	O
known	O
as	O
C/EBP	protein
beta	protein
).	O
NF-IL6	RNA
mRNA	RNA
was	O
found	O
in	O
human	cell_line
Jurkat	cell_line
T	cell_line
cells	cell_line
and	O
in	O
the	O
mouse	cell_line
Th2	cell_line
clone	cell_line
D10	cell_line
,	O
but	O
not	O
in	O
Th1	cell_line
clone	cell_line
29	cell_line
.	O
rNF-IL6	protein
expressed	O
in	O
bacteria	O
was	O
shown	O
to	O
specifically	O
bind	O
to	O
PRE-I	DNA
.	O
PRE-I	DNA
forms	O
multiple	protein
DNA-protein	protein
complexes	protein
with	O
nuclear	O
extracts	O
from	O
Jurkat	cell_line
cells	cell_line
.	O
Some	O
of	O
these	O
complexes	O
were	O
demonstrated	O
to	O
contain	O
NF-IL6	protein
by	O
using	O
anti-	protein
C/EBP	protein
beta	protein
Abs	protein
.	O
Overexpression	O
of	O
NF-IL6	protein
enhanced	O
expression	O
of	O
the	O
chloramphenicol	DNA
acetyl	DNA
transferase	DNA
reporter	DNA
gene	DNA
linked	O
to	O
the	O
PRE-I	protein
-thymidine	protein
kinase	protein
or	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
more	O
than	O
10-fold	O
in	O
Jurkat	cell_line
cells	cell_line
.	O
Promoter	O
deletion	O
studies	O
revealed	O
two	O
additional	O
NF-IL6	DNA
binding	DNA
sites	DNA
located	O
at	O
positions	O
-44	O
to	O
-36	O
(	O
C/EBP	protein
proximal	protein
)	O
and	O
-87	O
to	O
-79	O
(	O
C/EBP	protein
medial	protein
),	O
respectively.	O
Our	O
results	O
demonstrate	O
that	O
NF-IL6	protein
is	O
involved	O
in	O
transcriptional	O
activation	O
of	O
the	O
human	DNA
IL-4	DNA
promoter	DNA
in	O
T	cell_type
cells	cell_type
.	O

Identification	O
of	O
an	O
I	protein
kappa	protein
B	protein
alpha-associated	protein
protein	protein
kinase	protein
in	O
a	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
and	O
determination	O
of	O
its	O
phosphorylation	protein
sites	protein
on	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
is	O
stored	O
in	O
the	O
cytoplasm	O
as	O
an	O
inactive	O
form	O
through	O
interaction	O
with	O
I	protein
kappa	protein
B	protein
.	O
Stimulation	O
of	O
cells	O
leads	O
to	O
a	O
rapid	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
which	O
is	O
presumed	O
to	O
be	O
important	O
for	O
the	O
subsequent	O
degradation	O
.	O
We	O
have	O
recently	O
reported	O
the	O
establishment	O
of	O
a	O
lipopolysaccharide	O
(	O
LPS	O
)-dependent	O
cell-free	O
activation	O
system	O
of	O
NF-kappa	protein
B	protein
in	O
association	O
with	O
the	O
induction	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
phosphorylation	O
.	O
In	O
this	O
study,	O
we	O
have	O
identified	O
a	O
kinase	protein
in	O
cell	O
extracts	O
from	O
the	O
LPS	cell_line
-stimulated	cell_line
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
,	O
THP-1	cell_line
,	O
that	O
specifically	O
binds	O
and	O
phosphorylates	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
LPS	O
stimulation	O
transiently	O
enhanced	O
the	O
I	protein
kappa	protein
B	protein
alpha	protein
-bound	protein
kinase	protein
activity	O
in	O
THP-1	cell_line
cells	cell_line
.	O
Mutational	O
analyses	O
of	O
I	protein
kappa	protein
B	protein
alpha	O
and	O
competition	O
experiments	O
with	O
the	O
synthetic	O
peptides	O
identified	O
major	O
phosphorylation	protein
sites	protein
by	O
the	O
bound	O
kinase	protein
as	O
Ser	O
and	O
Thr	O
residues	O
in	O
the	O
C-terminal	protein
acidic	protein
domain	protein
of	O
I	protein
kappa	protein
B	protein
alpha	protein
.	O
Moreover,	O
we	O
show	O
that	O
the	O
peptide	O
,	O
corresponding	O
to	O
the	O
C-terminal	protein
acidic	protein
domain	protein
of	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
blocked	O
the	O
LPS	O
-induced	O
NF-kappa	protein
B	protein
activation	O
as	O
well	O
as	O
inducible	O
phosphorylation	O
of	O
endogenous	O
I	protein
kappa	protein
B	protein
alpha	protein
in	O
a	O
cell-free	O
system	O
using	O
THP-1	cell_line
cells	cell_line
.	O
These	O
results	O
suggested	O
that	O
the	O
bound	protein
kinase	protein
is	O
involved	O
in	O
the	O
signaling	O
pathway	O
of	O
LPS	O
by	O
inducing	O
the	O
phosphorylation	O
of	O
the	O
C-terminal	protein
region	protein
of	O
I	protein
kappa	protein
B	protein
alpha	protein
and	O
subsequent	O
dissociation	O
of	O
the	O
NF-kappa	protein
B	protein
.	O
I	protein
kappa	protein
B	protein
alpha	protein
complex	protein
.	O

Bik	protein
,	O
a	O
novel	O
death-inducing	protein
protein	protein
shares	O
a	O
distinct	O
sequence	O
motif	O
with	O
Bcl-2	protein
family	protein
proteins	protein
and	O
interacts	O
with	O
viral	O
and	O
cellular	protein
survival-promoting	protein
proteins	protein
.	O
The	O
survival-promoting	O
activity	O
of	O
the	O
Bcl-2	protein
family	protein
of	O
proteins	O
appears	O
to	O
be	O
modulated	O
by	O
interactions	O
between	O
various	O
cellular	protein
proteins	protein
.	O
We	O
have	O
identified	O
a	O
novel	O
cellular	protein
protein	protein
,	O
Bik	protein
,	O
that	O
interacts	O
with	O
the	O
cellular	protein
survival-promoting	protein
proteins	protein
,	O
Bcl-2	protein
and	O
Bcl-xL	protein
,	O
as	O
well	O
as	O
the	O
viral	protein
survival-promoting	protein
proteins	protein
,	O
Epstein	protein
Barr	protein
virus	protein
-BHRF1	protein
and	O
adenovirus	protein
E1B-19	protein
kDa	protein
.	O
In	O
transient	O
transfection	O
assays	O
,	O
Bik	protein
promotes	O
cell	O
death	O
in	O
a	O
manner	O
similar	O
to	O
the	O
death-promoting	protein
members	protein
of	O
the	O
Bcl-2	protein
family	protein
,	O
Bax	protein
and	O
Bak	protein
.	O
This	O
death-promoting	O
activity	O
of	O
Bik	protein
can	O
be	O
suppressed	O
by	O
coexpression	O
of	O
Bcl-2	protein
,	O
Bcl-XL	protein
,	O
EBV-BHRF1	protein
and	O
E1B-19	protein
kDa	protein
proteins	O
suggesting	O
that	O
Bik	protein
may	O
be	O
a	O
common	O
target	O
for	O
both	O
cellular	O
and	O
viral	O
anti-apoptotic	O
proteins	O
.	O
While	O
Bik	protein
does	O
not	O
show	O
overt	O
homology	O
to	O
the	O
BH1	protein
and	O
BH2	protein
conserved	O
domains	O
characteristic	O
of	O
the	O
Bcl-2	protein
family	protein
,	O
it	O
does	O
share	O
a	O
9	O
amino	protein
acid	protein
domain	protein
(	O
BH3	protein
)	O
with	O
Bax	protein
and	O
Bak	protein
which	O
may	O
be	O
a	O
critical	O
determinant	O
for	O
the	O
death-promoting	O
activity	O
of	O
these	O
proteins.	O

The	O
human	DNA
TCF-1	DNA
gene	DNA
encodes	O
a	O
nuclear	protein
DNA-binding	protein
protein	protein
uniquely	O
expressed	O
in	O
normal	O
and	O
neoplastic	O
T-lineage	O
lymphocytes	O
.	O
The	O
TCF-1	DNA
gene	DNA
encodes	O
a	O
putative	protein
transcription	protein
factor	protein
with	O
affinity	O
for	O
a	O
sequence	DNA
motif	DNA
occurring	O
in	O
a	O
number	O
of	O
T-cell	DNA
enhancers	DNA
.	O
TCF-1	RNA
mRNA	RNA
was	O
originally	O
found	O
to	O
be	O
expressed	O
in	O
a	O
T	O
cell-specific	O
fashion	O
within	O
a	O
set	O
of	O
human	cell_line
and	cell_line
mouse	cell_line
cell	cell_line
lines	cell_line
.	O
In	O
contrast,	O
expression	O
reportedly	O
occurs	O
in	O
multiple	O
nonlymphoid	O
tissues	O
during	O
murine	O
embryogenesis	O
.	O
We	O
have	O
now	O
raised	O
a	O
monoclonal	protein
antibody	protein
to	O
document	O
expression	O
and	O
biochemistry	O
of	O
the	O
human	protein
TCF-1	protein
protein	protein
.	O
As	O
expected,	O
the	O
TCF-1	protein
protein	protein
was	O
detectable	O
only	O
in	O
cell	cell_line
lines	cell_line
of	cell_line
T	cell_line
lineage	cell_line
.	O
Its	O
expression	O
was	O
always	O
restricted	O
to	O
the	O
nucleus	O
.	O
Immunohistochemistry	O
on	O
a	O
panel	O
of	O
human	O
tissues	O
revealed	O
that	O
the	O
TCF-1	protein
protein	protein
was	O
found	O
exclusively	O
in	O
thymocytes	O
and	O
in	O
CD3+	cell_line
T	cell_line
cells	cell_line
in	O
peripheral	O
lymphoid	O
tissues	O
.	O
Western	O
blotting	O
yielded	O
a	O
set	O
of	O
bands	O
ranging	O
from	O
25	O
kD	O
to	O
55	O
kD,	O
resulting	O
from	O
extensive	O
alternative	O
splicing	O
.	O
The	O
TCF-1	protein
protein	O
was	O
detectable	O
in	O
all	O
samples	O
of	O
a	O
set	O
of	O
22	O
T-cell	cell_type
malignancies	cell_type
of	O
various	O
stages	O
of	O
maturation,	O
but	O
was	O
absent	O
from	O
a	O
large	O
number	O
of	O
other	O
hematologic	cell_type
neoplasms	cell_type
.	O
These	O
observations	O
imply	O
a	O
T	O
cell-specific	O
function	O
for	O
TCF-1	protein
,	O
a	O
notion	O
corroborated	O
by	O
recent	O
observations	O
on	O
Tcf-1	O
knock-out	O
mice	O
.	O
In	O
addition,	O
these	O
results	O
indicate	O
that	O
nuclear	O
TCF-1	protein
expression	O
can	O
serve	O
as	O
a	O
pan-T-lineage	O
marker	O
in	O
the	O
diagnosis	O
of	O
lymphoid	O
malignancies	O
.	O

Cross-linking	O
of	O
Fc	protein
gamma	protein
receptors	protein
activates	O
HIV-1	DNA
long	DNA
terminal	DNA
repeat	DNA
-driven	O
transcription	O
in	O
human	cell_type
monocytes	cell_type
.	O
Elevation	O
of	O
the	O
levels	O
of	O
circulating	protein
immune	protein
complexes	protein
frequently	O
accompanies	O
HIV-1	O
infection	O
and	O
is	O
a	O
prognostic	O
indicator	O
of	O
clinical	O
progression	O
from	O
asymptomatic	O
infection	O
to	O
AIDS	O
.	O
Here	O
we	O
report	O
that	O
cross-linking	O
of	O
Fc	protein
gamma	protein
RI	protein
or	O
Fc	protein
gamma	protein
RII	protein
by	O
adherent	protein
human	protein
IgG	protein
or	O
by	O
specific	O
anti-Fc	protein
gamma	protein
R	protein
mAb	protein
activates	O
HIV-1	O
gene	O
expression	O
in	O
the	O
human	cell_line
monocytic	cell_line
cell	cell_line
line	cell_line
BF24	cell_line
and	O
increased	O
HIV	RNA
RNA	RNA
expression	O
in	O
monocytes	cell_type
from	O
HIV	O
infected	O
patients	O
as	O
assayed	O
by	O
reverse	O
transcription-PCR	O
.	O
In	O
THP-1	cell_line
cells	cell_line
,	O
Fc	protein
gamma	protein
R	protein
cross-linking	O
induced	O
NF-kappa	protein
B	protein
,	O
which	O
is	O
known	O
to	O
bind	O
to	O
the	O
regulatory	DNA
region	DNA
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
of	O
HIV-1	O
and	O
to	O
activate	O
HIV-1	O
transcription	O
.	O
Anti-TNF-alpha	protein
antibody	protein
but	O
not	O
anti-IL-1	protein
beta	protein
antibody	protein
strongly	O
inhibited	O
both	O
the	O
induction	O
of	O
HIV-1	O
-	O
LTR	DNA
-driven	O
transcription	O
and	O
the	O
induction	O
of	O
NF-kappa	protein
B	protein
by	O
Fc	protein
gamma	protein
R	protein
cross-linking	O
.	O
These	O
results	O
indicate	O
that	O
Fc	protein
gamma	protein
R	protein
can	O
mediate	O
a	O
TNF-alpha	protein
-dependent	O
induction	O
of	O
HIV-1	DNA
gene	DNA
transcription	O
and	O
suggest	O
that	O
immune	protein
complexes	protein
may	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
HIV-1	O
infection	O
by	O
augmenting	O
viral	O
replication	O
in	O
monocytes	cell_type
.	O

Signalling	O
via	O
CD28	protein
of	O
human	cell_line
naive	cell_line
neonatal	cell_line
T	cell_line
lymphocytes	cell_line
.	O
Accessory	O
molecules	O
play	O
a	O
crucial	O
role	O
in	O
the	O
development	O
of	O
the	O
T	O
cell	O
response	O
to	O
antigenic	O
challenge.	O
We	O
have	O
examined	O
the	O
role	O
of	O
CD28	protein
in	O
modulating	O
the	O
'	O
naive'	O
neonatal	O
T	O
cell	O
response	O
to	O
anti-CD2	protein
-mediated	O
activation	O
.	O
To	O
compare	O
the	O
role	O
of	O
CD28	protein
,	O
neonatal	cell_type
and	O
adult	cell_type
T	cell_type
cells	cell_type
were	O
stimulated	O
with	O
a	O
pair	O
of	O
mitogenic	protein
anti-CD2	protein
antibodies	protein
in	O
the	O
presence	O
or	O
absence	O
of	O
anti-	protein
CD28	protein
MoAb	protein
.	O
With	O
anti-CD2	protein
alone,	O
neonatal	cell_type
T	cell_type
cells	cell_type
proliferated	O
slightly	O
but	O
produced	O
no	O
detectable	O
IL-2	protein
,	O
whereas	O
adult	O
T	cell_type
cells	cell_type
proliferated	O
vigorously,	O
with	O
significant	O
IL-2	protein
production	O
.	O
Costimulation	O
with	O
anti-	protein
CD28	protein
MoAb	protein
greatly	O
enhanced	O
the	O
proliferative	O
response	O
of	O
neonatal	cell_type
T	cell_type
cells	cell_type
to	O
levels	O
equivalent	O
to	O
those	O
of	O
adult	cell_type
T	cell_type
cells	cell_type
,	O
whereas	O
adult	cell_type
T	cell_type
cells	cell_type
showed	O
only	O
slight	O
increases.	O
Although	O
IL-2	protein
secretion	O
was	O
increased	O
in	O
the	O
presence	O
of	O
anti-	protein
CD28	protein
MoAb	protein
,	O
neonatal	cell_type
T	cell_type
cell	cell_type
IL-2	protein
production	O
remained	O
lower	O
than	O
in	O
adults	O
.	O
In	O
contrast,	O
enhancement	O
of	O
IL-2	RNA
mRNA	RNA
expression	O
in	O
neonates	O
was	O
similar	O
to	O
adult	O
levels	O
.	O
Anti-	O
CD28	protein
MoAb	protein
costimulation	O
increased	O
NF	protein
kappa	protein
B	protein
levels	O
in	O
neonates	O
,	O
albeit	O
to	O
levels	O
lower	O
than	O
that	O
of	O
adults	O
.	O
The	O
cellular	O
mechanism	O
governing	O
the	O
diminished	O
proliferative	O
response	O
of	O
neonatal	cell_type
T	cell_type
lymphocytes	cell_type
to	O
anti-CD2	protein
may	O
therefore	O
be	O
due	O
to	O
decreased	O
NF	protein
kappa	protein
B	protein
induction	O
,	O
reduced	O
IL-2	RNA
mRNA	RNA
expression	O
and	O
deficient	O
IL-2	protein
production	O
.	O
Although	O
anti-	protein
CD28	protein
MoAb	protein
costimulation	O
enhances	O
all	O
of	O
the	O
above	O
signals,	O
NF	O
kappa	O
B	O
and	O
IL-2	O
levels	O
remain	O
lower	O
than	O
in	O
adults	O
,	O
suggesting	O
the	O
need	O
for	O
further	O
activation	O
requirements	O
in	O
the	O
neonate	O
.	O

TCL1	O
oncogene	O
activation	O
in	O
preleukemic	cell_type
T	cell_type
cells	cell_type
from	O
a	O
case	O
of	O
ataxia-telangiectasia	O
.	O
The	O
TCL1	DNA
oncogene	DNA
on	O
human	DNA
chromosome	DNA
14q32.1	DNA
is	O
involved	O
in	O
chromosome	O
translocations	O
[	O
t(14;14)(q11;q32.1)	DNA
and	O
t(7;14)(q35;q32.1)	DNA
]	O
and	O
inversions	O
[	O
inv14(q11;q32.1)	DNA
]	O
with	O
TCR	DNA
alpha/beta	DNA
loci	DNA
in	O
T-cell	O
leukemias	O
,	O
such	O
as	O
T-prolymphocytic	O
(	O
T-PLL	O
).	O
It	O
is	O
also	O
involved	O
in	O
T-	O
acute	O
and-	O
chronic	O
leukemias	O
arising	O
in	O
cases	O
of	O
ataxia-telangiectasia	O
(	O
AT	O
),	O
an	O
immunodeficiency	O
syndrome	O
.	O
Similar	O
chromosomal	O
rearrangements	O
occur	O
also	O
in	O
the	O
clonally	O
expanded	O
T	cell_type
cells	cell_type
in	O
AT	O
patients	O
before	O
the	O
appearance	O
of	O
the	O
overt	O
leukemia	O
.	O
We	O
have	O
analyzed	O
the	O
expression	O
of	O
TCL1	RNA
mRNA	RNA
and	O
protein	protein
in	O
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
(	O
PBLs	cell_type
)	O
from	O
four	O
AT	O
cases	O
and	O
from	O
healthy	O
controls	O
.	O
We	O
found	O
that	O
the	O
TCL1	DNA
gene	DNA
was	O
overexpressed	O
in	O
the	O
PBLs	cell_type
of	O
an	O
AT	O
patient	O
with	O
a	O
large	cell_line
clonal	cell_line
T-cell	cell_line
population	cell_line
exhibiting	O
the	O
t(14;14)	O
translocation	O
but	O
not	O
in	O
the	O
lymphocytes	cell_type
of	O
the	O
other	O
cases.	O
Fluorescence	O
in	O
situ	O
hybridization	O
of	O
the	O
TCL1	DNA
genomic	DNA
locus	DNA
to	O
lymphocyte	O
metaphases	O
from	O
the	O
AT	O
patient	O
with	O
the	O
T-cell	O
clonal	O
expansion	O
showed	O
that	O
the	O
breakpoint	O
of	O
the	O
t(14;14)	O
translocation	O
lies	O
within	O
the	O
TCL1	DNA
locus	DNA
and	O
is	O
accompanied	O
by	O
an	O
inverted	DNA
duplication	DNA
of	O
the	O
distal	DNA
part	DNA
of	O
chromosome	DNA
14	DNA
.	O
These	O
data	O
indicate	O
that	O
TCL1	DNA
is	O
activated	O
in	O
preleukemic	cell_line
clonal	cell_line
cells	cell_line
as	O
a	O
consequence	O
of	O
chromosome	O
translocation	O
involving	O
sequences	O
from	O
the	O
TCR	DNA
locus	DNA
at	O
14q11	DNA
.	O
Deregulation	O
of	O
TCL1	DNA
is	O
the	O
first	O
event	O
in	O
the	O
initiation	O
of	O
malignancy	O
in	O
these	O
types	O
of	O
leukemias	O
and	O
represents	O
a	O
potential	O
tool	O
for	O
clinical	O
evaluation	O
.	O

C/EBP	protein
proteins	protein
activate	O
transcription	O
from	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
long	DNA
terminal	DNA
repeat	DNA
in	O
macrophages/	O
monocytes	cell_type
.	O
Three	O
binding	O
sites	O
for	O
C/EBP	protein
proteins	protein
are	O
found	O
in	O
the	O
human	DNA
immunodeficiency	DNA
virus	DNA
type	DNA
1	DNA
(	DNA
HIV-1	DNA
)	DNA
long	DNA
terminal	DNA
repeat	DNA
(	O
LTR	DNA
)	O
(V.M.	O
Tesmer,	O
A.Rajadhyaksha,	O
J.Babin,	O
and	O
M.Bina,	O
Proc.Natl.Acad.Sci.	O
USA	O
90:7298-7302,	O
1993).	O
We	O
have	O
determined	O
the	O
functional	O
role	O
of	O
C/EBP	protein
proteins	protein
and	O
C/EBP	DNA
sites	DNA
in	O
regulating	O
transcription	O
from	O
the	O
HIV-	DNA
1	DNA
LTR	DNA
in	O
monocytes	cell_type
/macrophages	cell_type
.	O
Inhibition	O
of	O
endogenous	protein
C/EBP	protein
proteins	protein
,	O
using	O
either	O
an	O
excess	O
of	O
C/EBP	DNA
binding	DNA
sites	DNA
or	O
a	O
trans-	DNA
dominant	DNA
negative	DNA
inhibitor	DNA
,	O
demonstrated	O
that	O
C/EBP	protein
proteins	protein
are	O
required	O
for	O
basal	O
and	O
activated	O
levels	O
of	O
HIV-1	DNA
LTR	DNA
transcription	O
in	O
the	O
promonocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
.	O
Northern	O
(RNA)	O
blots	O
and	O
binding	O
assays	O
showed	O
that	O
NF-IL6	protein
is	O
the	O
only	O
known	O
C/EBP	protein
family	protein
member	protein
which	O
is	O
increased	O
when	O
U937	cell_line
cells	cell_line
are	O
activated.	O
Mutational	O
analyses	O
of	O
the	O
HIV-1	DNA
LTR	DNA
showed	O
that	O
one	O
C/EBP	DNA
site	DNA
is	O
required	O
for	O
normal	O
LTR	DNA
transcription	O
both	O
before	O
and	O
after	O
cellular	O
activation	O
and	O
that	O
the	O
two	O
3'	O
C/EBP	DNA
sites	DNA
are	O
functionally	O
equivalent.	O
However,	O
transcription	O
from	O
crippled	DNA
HIV-1	DNA
LTRs	DNA
lacking	O
C/EBP	DNA
sites	DNA
can	O
still	O
be	O
induced	O
following	O
activation	O
of	O
U937	cell_line
cells	cell_line
.	O
Several	O
models	O
are	O
suggested	O
for	O
how	O
elevated	O
NF-IL6	protein
may	O
participate	O
in	O
an	O
autostimulatory	O
loop	O
involving	O
HIV	O
infection	O
,	O
macrophage	O
activation	O
,	O
cytokine	protein
expression	O
,	O
and	O
HIV	O
replication	O
.	O

Human	O
immunodeficiency	O
virus	O
type-2	O
gene	O
expression	O
:	O
two	O
enhancers	DNA
and	O
their	O
activation	O
by	O
T-cell	cell_type
activators	O
.	O
The	O
human	O
immunodeficiency	O
viruses	O
(	O
HIVs	O
)	O
may	O
include	O
a	O
spectrum	O
of	O
retroviruses	O
with	O
varying	O
potential	O
to	O
infect	O
their	O
host,	O
undergo	O
long	O
periods	O
of	O
latent	O
infection	O
,	O
and	O
induce	O
pathology	O
.	O
Since	O
expression	O
of	O
the	O
viruses	O
is	O
in	O
large	O
part	O
regulated	O
by	O
the	O
sequence	DNA
elements	DNA
in	O
their	O
long	DNA
terminal	DNA
repeats	DNA
(	O
LTRs	DNA
),	O
this	O
study	O
was	O
directed	O
to	O
an	O
analysis	O
of	O
the	O
regulatory	DNA
elements	DNA
in	O
the	O
HIV-2	DNA
LTR	DNA
.	O
The	O
HIV-2	DNA
LTR	DNA
was	O
found	O
to	O
contain	O
two	O
enhancers	DNA
.	O
One	O
of	O
these	O
enhancers	DNA
is,	O
in	O
part,	O
identical	O
to	O
the	O
HIV-1	DNA
enhancer	DNA
.	O
This	O
enhancer	DNA
in	O
HIV-1	O
is	O
the	O
T-cell	DNA
activation	DNA
response	DNA
element	DNA
;	O
in	O
HIV-2	O
,	O
however,	O
it	O
is	O
the	O
second	DNA
enhancer	DNA
that	O
is	O
mainly	O
responsible	O
for	O
activation	O
in	O
response	O
to	O
T-cell	O
activators	O
.	O
The	O
second	O
enhancer	DNA
interacts	O
with	O
two	O
nuclear	protein
binding	protein
proteins	protein
(85	O
kD	O
and	O
27	O
kD	O
mobility)	O
that	O
appear	O
to	O
be	O
required	O
for	O
optimal	O
enhancer	O
function	O
and	O
activation.	O
Observations	O
such	O
as	O
these	O
encourage	O
the	O
speculation	O
that	O
there	O
may	O
be	O
subtle	O
differences	O
in	O
the	O
regulation	O
of	O
HIV-1	O
and	O
HIV-2	O
expression	O
that	O
may	O
be	O
relevant	O
to	O
the	O
possible	O
longer	O
latency	O
and	O
reduced	O
pathogenicity	O
of	O
HIV-2	O
.	O

NF-M	protein
(	O
chicken	protein
C/EBP	protein
beta	protein
)	O
induces	O
eosinophilic	O
differentiation	O
and	O
apoptosis	O
in	O
a	O
hematopoietic	cell_line
progenitor	cell_line
cell	cell_line
line	cell_line
.	O
CAAT/enhancer	protein
binding	protein
proteins	protein
(	O
C/EBPs	protein
)	O
are	O
transcriptional	O
activators	O
implicated	O
in	O
the	O
differentiation	O
processes	O
of	O
various	O
cell	O
lineages.	O
We	O
have	O
shown	O
earlier	O
that	O
NF-M	protein
,	O
the	O
chicken	protein
homolog	protein
of	O
C/EBP	protein
beta	protein
,	O
is	O
specifically	O
expressed	O
in	O
myelomonocytic	O
and	O
eosinophilic	O
cells	O
of	O
the	O
hematopoietic	O
system.	O
To	O
investigate	O
the	O
role	O
of	O
NF-M	protein
in	O
hematopoietic	cell_line
cell	cell_line
lineage	cell_line
commitment,	O
we	O
constructed	O
a	O
conditional	O
form	O
of	O
the	O
protein	O
by	O
fusing	O
it	O
to	O
the	O
hormone	protein
binding	protein
domain	protein
of	O
the	O
human	protein
estrogen	protein
receptor	protein
.	O
This	O
construct	O
was	O
stably	O
expressed	O
in	O
a	O
multipotent	cell_line
progenitor	cell_line
cell	cell_line
line	cell_line
transformed	O
by	O
the	O
Myb-Ets	protein
oncoprotein	protein
.	O
We	O
report	O
here	O
that	O
both	O
NF-M	DNA
-dependent	DNA
promoter	DNA
constructs	DNA
and	O
resident	O
genes	O
could	O
be	O
activated	O
by	O
addition	O
of	O
beta-estradiol	O
to	O
the	O
NF-M	cell_line
-estrogen	cell_line
receptor	cell_line
expressing	cell_line
progenitors	cell_line
.	O
At	O
the	O
same	O
time,	O
we	O
observed	O
a	O
down-regulation	O
of	O
progenitor-specific	protein
surface	protein
markers	protein
and	O
the	O
up-regulation	O
of	O
differentiation	protein
markers	protein
restricted	O
to	O
the	O
eosinophil	cell_type
and	O
myeloid	cell_type
lineages	cell_type
.	O
In	O
addition	O
to	O
the	O
onset	O
of	O
differentiation	O
,	O
cell	O
death	O
was	O
induced	O
with	O
typical	O
apoptotic	O
features.	O
Our	O
results	O
suggest	O
that	O
NF-M	protein
plays	O
an	O
important	O
role	O
in	O
commitment	O
along	O
the	O
eosinophil	cell_type
lineage	cell_type
and	O
in	O
the	O
induction	O
of	O
apoptosis	O
.	O

Prolactin	protein
and	O
interleukin-2	protein
receptors	protein
in	O
T	cell_type
lymphocytes	cell_type
signal	O
through	O
a	O
MGF-STAT5-like	protein
transcription	protein
factor	protein
.	O
The	O
cell	O
surface	O
receptors	O
for	O
PRL	protein
and	O
interleukin-2	protein
(	O
IL-2	protein
)	O
are	O
structurally	O
distinct,	O
but	O
share	O
regulatory	O
tasks	O
in	O
T	cell_type
lymphocytes	cell_type
.	O
They	O
can	O
stimulate	O
proliferation	O
and	O
activate	O
transcription	O
of	O
over-lapping	O
sets	O
of	O
genes	O
of	O
T	cell_type
cells	cell_type
.	O
PRL	protein
and	O
IL-2	protein
receptor	O
activation	O
are	O
both	O
linked	O
to	O
the	O
Jak/Stat	protein
(	O
signal	protein
transducer	protein
and	protein
activator	protein
of	protein
transcription	protein
)	O
pathway	O
.	O
We	O
investigated	O
the	O
ability	O
of	O
PRL	protein
and	O
IL-2	protein
to	O
activate	O
Stat	protein
proteins	protein
in	O
different	O
T	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
DNA	O
binding	O
specificities,	O
the	O
reactivities	O
toward	O
Stat-specific	O
antisera	O
,	O
and	O
the	O
mol	O
wt	O
of	O
IL-2	protein
-and	O
PRL	protein
-induced	protein
DNA-binding	protein
proteins	protein
in	O
Nb2	O
and	O
C196	O
T	O
cell	O
lines	O
were	O
investigated.	O
A	O
comparison	O
with	O
the	O
Stat	protein
proteins	protein
induced	O
by	O
interferon-gamma	protein
,	O
PRL	protein
,	O
and	O
IL-6	protein
in	O
T47D	cell_line
mammary	cell_line
tumor	cell_line
cells	cell_line
was	O
made.	O
We	O
found	O
that	O
these	O
parameters	O
were	O
indistinguishable	O
for	O
one	O
of	O
the	O
PRL-	O
and	O
IL-2-	O
induced	O
factors	O
.	O
A	O
transcription	O
factor	O
closely	O
related	O
to	O
mammary	protein
gland	protein
factor-Stat5	protein
is	O
rapidly	O
activated	O
upon	O
interaction	O
of	O
IL-2	protein
and	O
PRL	protein
with	O
their	O
respective	O
receptors.	O
Activation	O
of	O
a	O
second	O
protein	O
related	O
to	O
Stat1	protein
was	O
also	O
observed.	O
Our	O
results	O
emphasize	O
the	O
role	O
of	O
PRL	protein
as	O
a	O
regulator	O
of	O
the	O
immune	O
response	O
and	O
indicate	O
that	O
the	O
Stat	protein
factors	protein
mammary	protein
gland	protein
factor-Stat5	protein
and	O
Stat1	protein
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
during	O
T	O
cell	O
development	O
.	O

ETS1	protein
transactivates	O
the	O
human	DNA
GM-CSF	DNA
promoter	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
stimulated	O
with	O
PMA	O
and	O
ionomycin	O
.	O
Activation	O
of	O
T	cell_type
helper	cell_type
cells	cell_type
results	O
in	O
coordinate	O
expression	O
of	O
a	O
number	O
of	O
cytokines	protein
involved	O
in	O
differentiation	O
,	O
proliferation	O
and	O
activation	O
of	O
the	O
haematopoietic	O
system	O
.	O
Granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
(	O
GM-CSF	protein
)	O
is	O
one	O
such	O
cytokine	protein
whose	O
increased	O
expression	O
results	O
partly	O
from	O
increases	O
in	O
transcription	O
.	O
Cis-acting	DNA
elements	DNA
with	O
NF	protein
kappa	protein
B	protein
,	O
AP-1	protein
and	O
ETS-like	DNA
motifs	DNA
have	O
been	O
identified	O
in	O
the	O
promoter	O
region	O
of	O
the	O
GM-CSF	DNA
gene	DNA
,	O
which	O
are	O
important	O
for	O
transcriptional	O
activity	O
following	O
PMA	O
and	O
ionomycin	O
stimulation.	O
A	O
number	O
of	O
the	O
ETS	protein
family	protein
of	O
transcription	protein
factors	protein
are	O
expressed	O
in	O
T	cell_type
cells	cell_type
,	O
including	O
ETS1	protein
and	O
ELF1	protein
.	O
Here	O
we	O
describe	O
the	O
ability	O
of	O
these	O
factors	O
to	O
interact	O
with	O
a	O
site	O
(	O
GM5	DNA
),	O
located	O
within	O
the	O
CLE0	DNA
element	DNA
,	O
-47	DNA
to	DNA
-40	DNA
upstream	DNA
of	O
the	O
GM-CSF	DNA
transcription	DNA
initiation	DNA
site	DNA
.	O
Exogenous	O
ETS1	protein
,	O
but	O
not	O
ELF1	protein
,	O
can	O
transactivate	O
GM-CSF	protein
,	O
through	O
the	O
GM5	DNA
site,	O
in	O
a	O
PMA	O
/	O
ionomycin	O
dependent	O
manner	O
.	O
Other	O
unidentified	O
ETS-like	protein
factors	protein
present	O
in	O
Jurkat	cell_line
cells	cell_line
are	O
also	O
capable	O
of	O
binding	O
GM5	DNA
.	O
Mutation	O
of	O
the	O
core	O
ETS	DNA
binding	DNA
site	DNA
from	O
-GGAA-	DNA
to	DNA
-GGAT-	DNA
prevents	O
the	O
binding	O
of	O
ETS-like	protein
factors	protein
with	O
the	O
exception	O
of	O
ETS1	protein
.	O
The	O
GM-CSF	DNA
promoter	DNA
,	O
modified	O
in	O
this	O
way	O
to	O
be	O
ETS1	protein
specific	O
,	O
is	O
fully	O
responsive	O
to	O
PMA	O
/	O
ionomycin	O
induction,	O
in	O
addition	O
to	O
ETS1	protein
transactivation	O
in	O
the	O
presence	O
of	O
PMA	O
and	O
ionomycin	O
.	O
Together	O
these	O
data	O
suggest	O
that	O
ETS1	protein
may	O
be	O
involved	O
in	O
mediating	O
the	O
increased	O
GM-CSF	protein
production	O
associated	O
with	O
T	cell_type
cell	cell_type
activation	O
.	O

Quantitation	O
of	O
beta	RNA
1	RNA
triiodothyronine	RNA
receptor	RNA
mRNA	RNA
in	O
human	O
tissues	O
by	O
competitive	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O
Thyroid	O
hormones	O
act	O
by	O
binding	O
to	O
nuclear	protein
receptor	protein
proteins	protein
,	O
the	O
thyroid	protein
hormone	protein
receptors	protein
(	O
TR	protein
)	O
alpha	O
and	O
beta	O
.	O
Data	O
from	O
cell	O
culture	O
and	O
animal	O
studies	O
indicate	O
that	O
TR	protein
expression	O
may	O
be	O
regulated	O
to	O
modulate	O
target	O
organ	O
responsiveness	O
to	O
thyroid	O
hormone	O
.	O
To	O
investigate	O
whether	O
such	O
adaptive	O
changes	O
in	O
TR	protein
expression	O
occur	O
in	O
humans,	O
we	O
determined	O
the	O
mRNA	O
levels	O
of	O
the	O
hTR	protein
beta	protein
1	protein
in	O
various	O
thyroid	O
states	O
.	O
Patients	O
with	O
overt	O
hypo	O
-or	O
hyper	O
thyroidism	O
were	O
enrolled	O
in	O
the	O
study.	O
Total	RNA
RNA	RNA
was	O
isolated	O
from	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
and	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
determined	O
by	O
quantitative	O
competitive	O
reverse	O
transcription	O
PCR	O
.	O
For	O
comparison,	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
were	O
determined	O
in	O
lymphocytes	cell_type
and	O
normal	O
thyroid	O
tissue	O
of	O
euthyroid	O
patients	O
.	O
Human	RNA
TR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
in	O
lymphocytes	cell_type
were	O
1.8	O
+/-	O
0.4,	O
1.9	O
+/-	O
0.5,	O
1.1	O
+/-	O
0.4	O
10(-18)	O
mol/microgram	O
RNA	O
in	O
hypo	O
-,	O
eu	O
-and	O
hyper	O
thyroid	O
patients	O
,	O
respectively,	O
corresponding	O
to	O
an	O
estimated	O
0.5	O
-2	O
molecules	O
per	O
cell.	O
Although	O
the	O
mean	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
were	O
40%	O
lower	O
in	O
hyperthyroid	O
than	O
in	O
euthyroid	O
subjects,	O
this	O
difference	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O
Similar	O
levels	O
of	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
were	O
detected	O
in	O
thyroid	O
gland	O
from	O
euthyroid	O
patients	O
.	O
In	O
summary,	O
we	O
developed	O
an	O
assay	O
for	O
the	O
quantitative	O
determination	O
of	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
in	O
small	O
human	O
tissue	O
samples	O
,	O
containing	O
as	O
little	O
as	O
50	O
ng	O
of	O
total	O
RNA.	O
Absolute	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
are	O
very	O
low	O
with	O
an	O
estimated	O
one	O
molecule	O
of	O
mRNA	RNA
being	O
present	O
in	O
a	O
mononuclear	cell_type
blood	cell_type
cell	cell_type
or	O
thyrocyte	cell_type
.	O
No	O
up-regulation	O
of	O
hTR	protein
beta	protein
1	protein
was	O
seen	O
in	O
hypothyroid	O
relative	O
to	O
euthyroid	O
patients	O
.	O
However,	O
there	O
is	O
a	O
non-significant	O
trend	O
towards	O
a	O
down-regulation	O
of	O
hTR	RNA
beta	RNA
1	RNA
mRNA	RNA
levels	O
in	O
hyperthyroid	O
patients	O
.	O

Multiple	O
proteins	protein
interact	O
with	O
the	O
nuclear	DNA
inhibitory	DNA
protein	DNA
repressor	DNA
element	DNA
in	O
the	O
human	DNA
interleukin-3	DNA
promoter	DNA
.	O
T	O
cell	O
expression	O
of	O
interleukin	protein
3	protein
(	O
IL-3	protein
)	O
is	O
directed	O
by	O
positive	O
and	O
negative	O
cis-acting	O
DNA	O
elements	O
clustered	O
within	O
300	O
base	O
pairs	O
of	O
the	O
transcriptional	DNA
start	DNA
site	DNA
.	O
A	O
strong	O
repressor	protein
element	protein
,	O
termed	O
nuclear	protein
inhibitory	protein
protein	protein
(	O
NIP	protein
),	O
was	O
previously	O
mapped	O
to	O
a	O
segment	O
of	O
the	O
IL-3	DNA
promoter	DNA
between	O
nucleotides	DNA
-271	DNA
and	DNA
-250	DNA
.	O
Functional	O
characterization	O
of	O
this	O
element	O
demonstrates	O
that	O
it	O
can	O
mediate	O
repression	O
when	O
linked	O
in	O
cis	O
to	O
a	O
heterologous	DNA
promoter	DNA
.	O
DNA	O
binding	O
experiments	O
were	O
carried	O
out	O
to	O
characterize	O
the	O
repressor	O
activity	O
.	O
Using	O
varying	O
conditions,	O
three	O
distinct	O
complexes	O
were	O
shown	O
to	O
interact	O
specifically	O
with	O
the	O
NIP	DNA
region	DNA
,	O
although	O
only	O
one	O
correlates	O
with	O
repressor	O
activity	O
.	O
Complex	protein
1	protein
results	O
from	O
binding	O
of	O
a	O
ubiquitous	O
polypeptide	O
that	O
recognizes	O
the	O
3'	DNA
portion	DNA
of	O
this	O
sequence	O
and	O
is	O
not	O
required	O
for	O
repression	O
.	O
Complex	protein
2	protein
corresponds	O
to	O
binding	O
of	O
transcription	protein
factor	protein
(	O
upstream	protein
stimulatory	protein
factor	protein
)	O
to	O
an	O
E-box	DNA
motif	DNA
in	O
the	O
5'	DNA
portion	DNA
of	O
the	O
NIP	DNA
region	DNA
.	O
DNA	O
binding	O
specificity	O
of	O
complex	O
3	O
overlaps	O
with	O
that	O
of	O
upstream	protein
stimulatory	protein
factor	protein
but	O
is	O
clearly	O
distinct.	O
To	O
determine	O
which	O
of	O
the	O
latter	O
two	O
complexes	O
represents	O
NIP	protein
activity	O
,	O
we	O
incorporated	O
small	O
alterations	O
into	O
the	O
NIP	DNA
site	DNA
of	O
an	O
IL-3	DNA
promoter	DNA
-linked	DNA
reporter	DNA
construct	DNA
and	O
examined	O
their	O
effects	O
on	O
NIP	protein
-mediated	O
repression	O
.	O
Functional	O
specificity	O
for	O
repression	O
matches	O
the	O
DNA	O
binding	O
specificity	O
of	O
complex	protein
3	protein
;	O
both	O
repressor	O
activity	O
and	O
complex	protein
3	protein
binding	O
require	O
the	O
consensus	DNA
sequence	DNA
CTCACNTNC	O
.	O

The	O
hematopoietic	protein
transcription	protein
factor	protein
PU.1	protein
is	O
downregulated	O
in	O
human	cell_line
multiple	cell_line
myeloma	cell_line
cell	cell_line
lines	cell_line
.	O
PU.1	protein
is	O
a	O
hematopoietic	protein
transcription	protein
factor	protein
belonging	O
to	O
the	O
Ets-family	protein
.	O
It	O
is	O
identical	O
to	O
the	O
Spi-1	DNA
oncogene	DNA
,	O
which	O
is	O
implicated	O
in	O
spleen	O
focus-forming	O
virus-induced	O
murine	O
erythroleukemias	O
.	O
PU.1	protein
seems	O
to	O
be	O
required	O
for	O
early	O
development	O
of	O
multiple	cell_type
hematopoietic	cell_type
lineages	cell_type
,	O
but	O
its	O
expression	O
in	O
mature	cell_type
cells	cell_type
is	O
preferentially	O
observed	O
in	O
cells	O
of	O
the	O
B-cell-and	cell_type
monocyte/macrophage-	cell_type
differentiation	cell_type
lineage	cell_type
.	O
It	O
binds	O
the	O
so-called	O
Pu	DNA
box	DNA
,	O
an	O
important	O
tissue-specific	DNA
regulatory	DNA
DNA	DNA
element	DNA
present	O
in	O
a	O
number	O
of	O
genes	O
expressed	O
in	O
these	O
cell	cell_type
lineages	cell_type
.	O
We	O
have	O
analyzed	O
the	O
expression	O
and	O
activity	O
of	O
PU.1	protein
during	O
human	O
B-cell	O
development	O
using	O
a	O
panel	O
of	O
B-cell	cell_line
lines	cell_line
representing	O
different	O
stages	O
of	O
maturation,	O
from	O
early	cell_line
precursors	cell_line
to	O
differentiated	cell_line
plasma	cell_line
cells	cell_line
.	O
PU.1	RNA
mRNA	RNA
expression	O
and	O
PU.1	protein
DNA	O
binding	O
activity	O
,	O
as	O
measured	O
by	O
Northern	O
blot	O
analysis	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
respectively,	O
were	O
evident	O
in	O
cell	cell_line
lines	cell_line
representing	O
pro-B	O
,	O
pre-B	O
,	O
and	O
mature	O
B	O
cells	O
.	O
We	O
could	O
also	O
show	O
Pu	DNA
box	DNA
-dependent	O
transactivation	O
of	O
a	O
reporter	O
gene	O
in	O
transient	O
transfections	O
in	O
these	O
cell	cell_line
lines	cell_line
.	O
In	O
contrast,	O
in	O
a	O
number	O
of	O
multiple	cell_line
myeloma	cell_line
cell	cell_line
lines	cell_line
,	O
representing	O
differentiated,	cell_type
plasma	cell_type
cell-like	cell_type
B	cell_type
cells	cell_type
,	O
PU.1	protein
DNA	O
binding	O
activity	O
,	O
mRNA	O
expression	O
,	O
and	O
Pu	DNA
box	DNA
-dependent	O
transactivation	O
were	O
absent	O
or	O
detectable	O
at	O
a	O
very	O
low	O
level.	O
In	O
lymphoblastoid	cell_line
cell	cell_line
lines	cell_line
,	O
which	O
exemplify	O
an	O
intermediate	O
stage	O
of	O
B-cell	O
differentiation	O
,	O
a	O
reduced	O
expression	O
and	O
activity	O
were	O
observed.	O
The	O
findings	O
in	O
the	O
human	cell_line
multiple	cell_line
myeloma	cell_line
cell	cell_line
lines	cell_line
represent	O
the	O
first	O
examples	O
of	O
B	cell_type
cells	cell_type
with	O
downregulated	O
PU.1	protein
expression	O
and	O
apparently	O
contradict	O
observations	O
in	O
the	O
murine	O
system	O
in	O
which	O
PU.1	protein
is	O
expressed	O
and	O
active	O
in	O
plasmacytoma	cell_line
cell	cell_line
lines	cell_line
.	O
At	O
present,	O
it	O
is	O
unclear	O
whether	O
the	O
lack	O
of	O
PU.1	protein
expression	O
and	O
activity	O
in	O
human	cell_line
multiple	cell_line
myeloma	cell_line
cell	cell_line
lines	cell_line
represents	O
a	O
malignancy-associated	O
defect	O
in	O
these	O
cells	O
or	O
exemplifies	O
a	O
normal	O
developmental	O
regulation	O
in	O
terminally	cell_type
differentiated	cell_type
B	cell_type
cells	cell_type
.	O

Regulation	O
of	O
granulocyte-macrophage	protein
colony-stimulating	protein
factor	protein
and	O
E-selectin	protein
expression	O
in	O
endothelial	cell_type
cells	cell_type
by	O
cyclosporin	O
A	O
and	O
the	O
T-cell	protein
transcription	protein
factor	protein
NFAT	protein
.	O
Nuclear	protein
factor	protein
of	protein
activated	protein
T	protein
cells	protein
(	O
NFAT	protein
)	O
was	O
originally	O
described	O
as	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
athat	O
supported	O
the	O
activation	O
of	O
cytokine	protein
gene	O
expression	O
and	O
mediated	O
the	O
immunoregulatory	protein
effects	O
of	O
cyclosporin	O
A	O
(	O
CsA	O
).	O
As	O
we	O
observed	O
that	O
activated	cell_type
endothelial	cell_type
cells	cell_type
also	O
expressed	O
NFAT	protein
,	O
we	O
tested	O
the	O
antiinflammatory	O
properties	O
of	O
CsA	O
in	O
endothelial	cell_type
cells	cell_type
.	O
Significantly,	O
CsA	O
completely	O
suppressed	O
the	O
induction	O
of	O
NFAT	protein
in	O
endothelial	cell_type
cells	cell_type
and	O
inhibited	O
the	O
activity	O
of	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
(	DNA
GM-CSF	DNA
)	DNA
gene	DNA
regulatory	DNA
elements	DNA
that	O
use	O
NFAT	protein
by	O
60%.	O
CsA	O
similarly	O
mediated	O
a	O
reduction	O
of	O
up	O
to	O
65%	O
in	O
GM-CSF	RNA
mRNA	RNA
and	O
protein	O
expression	O
in	O
activated	cell_type
endothelial	cell_type
cells	cell_type
.	O
CsA	O
also	O
suppressed	O
E-selectin	protein
,	O
but	O
not	O
vascular	protein
cell	protein
adhesion	protein
molecule-1	protein
(	O
VCAM-1	protein
)	O
expression	O
in	O
endothelial	O
cells,	O
even	O
though	O
the	O
E-selectin	DNA
promoter	DNA
is	O
activated	O
by	O
NF-kappa	protein
B	protein
rather	O
than	O
NFAT	protein
.	O
Hence,	O
induction	O
of	O
cell	O
surface	O
expression	O
of	O
this	O
leukocyte	protein
adhesion	protein
molecule	protein
by	O
tumor	protein
necrosis	protein
factor	protein
(TNF)-alpha	protein
was	O
reduced	O
by	O
40%	O
in	O
the	O
presence	O
of	O
CsA	O
,	O
and	O
this	O
was	O
reflected	O
by	O
a	O
29%	O
decrease	O
in	O
neutrophil	cell_type
adhesion	O
.	O
The	O
effects	O
of	O
CsA	O
on	O
endothelial	cell_type
cells	cell_type
were	O
also	O
detected	O
at	O
the	O
chromatin	DNA
structure	O
level	O
,	O
as	O
DNasel	DNA
hypersensitive	DNA
sites	DNA
within	O
both	O
the	O
GM-CSF	protein
enhancer	O
and	O
the	O
E-selectin	DNA
promoter	DNA
were	O
suppressed	O
by	O
CsA	O
.	O
This	O
represents	O
the	O
first	O
report	O
of	O
NFAT	protein
in	O
endothelial	cell_type
cells	cell_type
and	O
suggests	O
mechanisms	O
by	O
which	O
CsA	O
could	O
function	O
as	O
an	O
antiinflammatory	O
agent	O
.	O

Costimulation	O
requirement	O
for	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
transcription	O
factor	O
activation	O
in	O
T	cell_type
cells	cell_type
.	O
The	O
transcriptional	O
activity	O
of	O
the	O
IL-2	DNA
promoter	DNA
requires	O
T-cell	cell_type
costimulation	O
delivered	O
by	O
the	O
TCR	protein
and	O
the	O
auxiliary	protein
receptor	protein
CD28	protein
.	O
Several	O
transcription	protein
factors	protein
participate	O
in	O
IL-2	protein
promoter	O
activation	O
,	O
among	O
which	O
are	O
AP-1	protein
-like	protein
factors	protein
and	O
NF-kappa	protein
B	protein
.	O
Protein	O
phosphorylation	O
has	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
these	O
two	O
factors:	O
(1)	O
it	O
induces	O
the	O
transactivating	O
capacity	O
of	O
the	O
AP-1	protein
protein	protein
c-Jun	protein
;	O
and	O
(2)	O
it	O
is	O
involved	O
in	O
the	O
release	O
of	O
the	O
cytoplasmic	protein
inhibitor	protein
,	O
I	protein
kappa	protein
B	protein
,	O
from	O
NF-kappa	protein
B	protein
,	O
allowing	O
translocation	O
of	O
the	O
latter	O
into	O
the	O
nucleus	O
.	O
We	O
have	O
recently	O
shown	O
that	O
both	O
phosphorylation	O
processes	O
require	O
T-cell	O
costimulation	O
.	O
Furthermore,	O
in	O
activated	cell_type
T	cell_type
cells	cell_type
,	O
the	O
kinetics	O
of	O
the	O
two	O
phosphorylation	O
events	O
are	O
essentially	O
similar.	O
According	O
to	O
our	O
results,	O
however,	O
the	O
kinases	O
responsible	O
for	O
the	O
two	O
processes	O
are	O
distinct	O
entities.	O
Whereas	O
TPCK	protein
inhibits	O
phosphorylation	O
of	O
I	protein
kappa	protein
B	protein
and,	O
consequently,	O
activation	O
of	O
NF-kappa	protein
B	protein
,	O
it	O
markedly	O
enhances	O
the	O
activity	O
of	O
JNK	protein
,	O
the	O
MAP	protein
kinase-related	protein
kinase	protein
that	O
phosphorylates	O
the	O
transactivation	protein
domain	protein
of	O
c-Jun	protein
.	O
We,	O
therefore,	O
propose	O
the	O
activation	O
scheme	O
presented	O
in	O
FIGURE	O
3	O
for	O
T-cell	O
costimulation	O
.	O
Costimulation	O
results	O
in	O
the	O
activation	O
of	O
a	O
signaling	O
pathway	O
that	O
leads	O
to	O
the	O
simultaneous	O
induction	O
of	O
the	O
two	O
transcription	protein
factors	protein
,	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
.	O
Integration	O
of	O
the	O
signals	O
generated	O
by	O
TCR	protein
and	O
CD28	protein
engagement	O
occurs	O
along	O
this	O
pathway,	O
which	O
then	O
bifurcates	O
to	O
induce	O
I	protein
kappa	protein
B	protein
phosphorylation	O
and	O
NF-kappa	protein
B	protein
activation	O
on	O
the	O
one	O
hand,	O
and	O
JNK	protein
activation	O
and	O
c-Jun	protein
phosphorylation	O
on	O
the	O
other.	O
We	O
are	O
currently	O
engaged	O
in	O
defining	O
where	O
the	O
two	O
signals	O
integrate	O
along	O
the	O
AP-1	protein
/	O
NF-kappa	protein
B	protein
pathway	O
.	O

Regulation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
and	O
cytokine	O
gene	O
expression	O
in	O
myeloid	cell_type
cells	cell_type
by	O
NF-kappa	protein
B	protein
/Rel	protein
transcription	protein
factors	protein
.	O
CD4+	cell_line
macrophages	cell_line
in	O
tissues	O
such	O
as	O
lung	O
,	O
skin	O
,	O
and	O
lymph	O
nodes	O
,	O
promyelocytic	cell_type
cells	cell_type
in	O
bone	O
marrow	O
,	O
and	O
peripheral	cell_type
blood	cell_type
monocytes	cell_type
serve	O
as	O
important	O
targets	O
and	O
reservoirs	O
for	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
.	O
HIV-1	O
-infected	O
myeloid	cell_type
cells	cell_type
are	O
often	O
diminished	O
in	O
their	O
ability	O
to	O
participate	O
in	O
chemotaxis	O
,	O
phagocytosis	O
,	O
and	O
intracellular	O
killing	O
.	O
HIV-1	O
infection	O
of	O
myeloid	cell_type
cells	cell_type
can	O
lead	O
to	O
the	O
expression	O
of	O
surface	protein
receptors	protein
associated	O
with	O
cellular	O
activation	O
and/or	O
differentiation	O
that	O
increase	O
the	O
responsiveness	O
of	O
these	O
cells	O
to	O
cytokines	protein
secreted	O
by	O
neighboring	O
cells	O
as	O
well	O
as	O
to	O
bacteria	O
or	O
other	O
pathogens.	O
Enhancement	O
of	O
HIV-1	O
replication	O
is	O
related	O
in	O
part	O
to	O
increased	O
DNA-binding	O
activity	O
of	O
cellular	protein
transcription	protein
factors	protein
such	O
as	O
NF-kappa	protein
B	protein
.	O
NF-kappa	protein
B	protein
binds	O
to	O
the	O
HIV-1	DNA
enhancer	DNA
region	O
of	O
the	O
long	DNA
terminal	DNA
repeat	DNA
and	O
contributes	O
to	O
the	O
inducibility	O
of	O
HIV-1	O
gene	O
expression	O
in	O
response	O
to	O
multiple	O
activating	O
agents.	O
Phosphorylation	O
and	O
degradation	O
of	O
the	O
cytoplasmic	protein
inhibitor	protein
I	protein
kappa	protein
B	protein
alpha	O
are	O
crucial	O
regulatory	O
events	O
in	O
the	O
activation	O
of	O
NF-kappa	protein
B	protein
DNA-binding	O
activity	O
.	O
Both	O
N-	O
and	O
C-	O
terminal	O
residues	O
of	O
I	protein
kappa	protein
B	protein
alpha	O
are	O
required	O
for	O
inducer-mediated	O
degradation	O
.	O
Chronic	O
HIV-1	O
infection	O
of	O
myeloid	cell_type
cells	cell_type
leads	O
to	O
constitutive	O
NF-kappa	protein
B	protein
DNA-binding	O
activity	O
and	O
provides	O
an	O
intranuclear	O
environment	O
capable	O
of	O
perpetuating	O
HIV-1	O
replication	O
.	O
Increased	O
intracellular	O
stores	O
of	O
latent	protein
NF-kappa	protein
B	protein
may	O
also	O
result	O
in	O
rapid	O
inducibility	O
of	O
NF-kappa	protein
B	protein
-dependent	O
cytokine	protein
gene	O
expression	O
.	O
In	O
response	O
to	O
secondary	O
pathogenic	O
infections	O
or	O
antigenic	O
challenge,	O
cytokine	protein
gene	O
expression	O
is	O
rapidly	O
induced,	O
enhanced,	O
and	O
sustained	O
over	O
prolonged	O
periods	O
in	O
HIV-1	cell_line
-infected	cell_line
myeloid	cell_line
cells	cell_line
compared	O
with	O
uninfected	cell_type
cells	cell_type
.	O
Elevated	O
levels	O
of	O
several	O
inflammatory	protein
cytokines	protein
have	O
been	O
detected	O
in	O
the	O
sera	O
of	O
HIV-1	O
-infected	O
individuals	O
.	O
Secretion	O
of	O
myeloid	protein
cell-derived	protein
cytokines	protein
may	O
both	O
increase	O
virus	O
production	O
and	O
contribute	O
to	O
AIDS-associated	O
disorders	O
.	O

Steroid	O
mediated	O
lysis	O
of	O
lymphoblasts	cell_type
requires	O
the	O
DNA	O
binding	O
region	O
of	O
the	O
steroid	O
hormone	O
receptor.	O
Glucocorticoids	O
kill	O
certain	O
types	O
of	O
lymphoblasts	cell_type
,	O
but	O
the	O
mechanisms	O
are	O
unknown.	O
It	O
is	O
clear	O
that	O
sufficient	O
numbers	O
of	O
functional	O
glucocorticoid	protein
receptors	protein
are	O
required	O
to	O
mediate	O
lysis,	O
but	O
whether	O
they	O
do	O
so	O
through	O
the	O
classical	O
model	O
of	O
steroid	O
hormone	O
activation	O
and	O
modulation	O
of	O
gene	O
expression	O
has	O
not	O
been	O
established.	O
In	O
this	O
report	O
we	O
have	O
asked	O
which	O
region(s)	O
of	O
the	O
steroid	protein
receptor	protein
are	O
important	O
for	O
mediating	O
lysis	O
in	O
leukemic	cell_type
T	cell_type
lymphoblasts	cell_type
.	O
CEM-ICR	cell_line
27	cell_line
leukemic	cell_line
lymphoblasts	cell_line
,	O
a	O
clone	O
of	O
CEM	cell_line
cells	cell_line
which	O
lack	O
functional	O
glucocorticoid	protein
receptors	protein
and	O
therefore	O
are	O
neither	O
lysed	O
by	O
dexamethasone	O
nor	O
capable	O
of	O
showing	O
glutamine	protein
synthetase	protein
induction	O
,	O
were	O
provided	O
with	O
steroid	protein
receptors	protein
by	O
DNA	O
transfections	O
of	O
various	O
receptor	O
gene	O
constructs.	O
We	O
measured	O
steroid	O
mediated	O
lysis	O
,	O
receptor	O
number	O
and	O
induction	O
of	O
glutamine	protein
synthetase	protein
in	O
the	O
transfected	cell_line
cells	cell_line
.	O
Our	O
results	O
provide	O
evidence	O
that	O
the	O
lysis	O
mechanism	O
in	O
the	O
ICR27	cell_line
lymphoblasts	cell_line
is	O
restored	O
when	O
functional	O
receptor	O
number	O
is	O
restored.	O
The	O
DNA	protein
binding	protein
region	protein
specifying	O
high	O
affinity	O
for	O
GRE	DNA
sites	DNA
is	O
required.	O
Lysis	O
is	O
mediated	O
by	O
any	O
steroid	O
that	O
allows	O
for	O
activation	O
of	O
the	O
receptor	O
containing	O
such	O
a	O
region.	O
Our	O
data	O
support	O
the	O
view	O
that	O
steroid	O
-mediated	O
cell	O
death	O
occurs	O
by	O
a	O
process	O
requiring	O
direct	O
interaction	O
of	O
steroid	protein
-receptor	protein
complexes	protein
with	O
the	O
genome.	O

Functional	O
characterization	O
of	O
the	O
murine	protein
homolog	protein
of	O
the	O
B	protein
cell-specific	protein
coactivator	protein
BOB.1/OBF.1	protein
.	O
B	O
cell-specific	O
transcriptional	O
promoter	O
activity	O
mediated	O
by	O
the	O
octamer	DNA
motif	DNA
requires	O
the	O
Oct1	protein
or	O
Oct2	protein
protein	protein
and	O
additional	O
B	protein
cell-restricted	protein
cofactors	protein
.	O
One	O
such	O
cofactor	protein
,	O
BOB.1/OBF.1	protein
,	O
was	O
recently	O
isolated	O
from	O
human	cell_type
B	cell_type
cells	cell_type
.	O
Here,	O
we	O
describe	O
the	O
isolation	O
and	O
detailed	O
characterization	O
of	O
the	O
murine	protein
homolog	protein
.	O
Full-length	O
cDNAs	DNA
and	O
genomic	DNA
clones	DNA
were	O
isolated,	O
and	O
the	O
gene	O
structure	O
was	O
determined.	O
Comparison	O
of	O
the	O
deduced	O
amino	O
acids	O
shows	O
88%	O
sequence	O
identity	O
between	O
mouse	O
and	O
human	O
BOB.1/OBF.1	O
.	O
The	O
NH2-terminal	protein
126	protein
amino	protein
acids	protein
of	O
BOB.1/OBF.1	protein
are	O
both	O
essential	O
and	O
sufficient	O
for	O
interaction	O
with	O
the	O
POU	protein
domains	protein
of	O
either	O
Oct1	protein
or	O
Oct2	protein
.	O
This	O
protein-protein	O
interaction	O
does	O
not	O
require	O
the	O
simultaneous	O
binding	O
of	O
Oct	protein
proteins	protein
to	O
DNA,	O
and	O
high	O
resolution	O
footprinting	O
of	O
the	O
Oct	DNA
-DNA	O
interaction	O
reveals	O
that	O
binding	O
of	O
BOB.1/OBF.1	protein
to	O
Oct1	protein
or	O
Oct2	protein
does	O
not	O
alter	O
the	O
interaction	O
with	O
DNA.	O
BOB.1/OBF.1	protein
can	O
efficiently	O
activate	O
octamer-dependent	O
promoters	O
in	O
fibroblasts	cell_type
;	O
however,	O
it	O
fails	O
to	O
stimulate	O
octamer-dependent	DNA
enhancer	DNA
activity	O
.	O
Fusion	O
of	O
subdomains	O
of	O
BOB.1/OBF.1	protein
with	O
the	O
GAL4	protein
DNA	protein
binding	protein
domain	protein
reveals	O
that	O
both	O
NH2-	O
and	O
COOH-	O
terminal	O
domains	O
of	O
BOB.1/OBF.1	protein
contribute	O
to	O
full	O
transactivation	O
function,	O
the	O
COOH-terminal	protein
domain	protein
is	O
more	O
efficient	O
in	O
this	O
transactivation	O
assay	O
.	O
Consistent	O
with	O
the	O
failure	O
of	O
full-length	protein
BOB.1/OBF.1	protein
to	O
stimulate	O
octamer-dependent	DNA
enhancer	DNA
elements	DNA
in	O
non	cell_type
B	cell_type
cells	cell_type
,	O
the	O
GAL4	protein
fusions	protein
likewise	O
only	O
stimulate	O
from	O
a	O
promoter-proximal	O
position	O
.	O

Anti-immunoglobulin	protein
M	protein
activates	O
nuclear	protein
calcium/calmodulin-dependent	protein
protein	protein
kinase	protein
II	protein
in	O
human	cell_type
B	cell_type
lymphocytes	cell_type
.	O
We	O
and	O
others	O
have	O
previously	O
shown	O
that	O
the	O
nuclear	protein
protein	protein
,	O
Ets-1	protein
,	O
is	O
phosphorylated	O
in	O
a	O
calcium-dependent	O
manner	O
after	O
ligation	O
of	O
immunoglobulin	protein
(Ig)	protein
M	protein
on	O
B	cell_type
lymphocytes	cell_type
.	O
As	O
this	O
phosphorylation	O
was	O
independent	O
of	O
protein	protein
kinase	protein
C	protein
activity	O
,	O
we	O
tested	O
whether	O
a	O
calcium/calmodulin-dependent	protein
protein	protein
kinase	protein
(	O
CaM	protein
kinase	protein
)	O
might	O
phosphorylate	O
the	O
Ets-1	protein
protein	protein
after	O
elevation	O
of	O
intracellular	O
free	O
calcium	O
concentrations	O
.	O
The	O
dephosphorylated	O
form	O
of	O
Ets-1	protein
has	O
been	O
shown	O
to	O
bind	O
to	O
chromatin	DNA
,	O
suggesting	O
that	O
the	O
operative	protein
kinase	protein
should	O
be	O
detectable	O
in	O
the	O
nucleus	O
.	O
We	O
prepared	O
nuclear	O
extracts	O
from	O
two	O
human	cell_line
B	cell_line
cell	cell_line
lines	cell_line
in	O
which	O
increased	O
intracellular	O
free	O
calcium	O
levels	O
correlated	O
with	O
increased	O
phosphorylation	O
of	O
the	O
Ets-1	protein
protein.	O
Activity	O
of	O
the	O
CaM	protein
kinases	protein
was	O
determined	O
using	O
a	O
synthetic	O
peptide	O
substrate	O
both	O
in	O
the	O
absence	O
and	O
presence	O
of	O
an	O
inhibitor	O
specific	O
for	O
the	O
CaM	protein
kinase	protein
family	protein
,	O
KN-62	O
.	O
Stimulation	O
of	O
cells	O
with	O
anti-IgM	protein
led	O
to	O
increased	O
activity	O
of	O
a	O
nuclear	protein
kinase	protein
that	O
could	O
phosphorylate	O
the	O
peptide,	O
and	O
this	O
activity	O
was	O
reduced	O
by	O
10	O
microM	O
KN-62	O
.	O
Kinase	O
activity	O
was	O
reduced	O
in	O
lysates	O
preadsorbed	O
using	O
an	O
antibody	protein
specific	O
for	O
CaM	protein
kinase	protein
II	protein
.	O
Two-dimensional	O
phosphopeptide	O
maps	O
of	O
the	O
Ets-1	protein
protein	O
from	O
cells	O
incubated	O
with	O
ionomycin	O
or	O
anti-IgM	protein
contained	O
two	O
unique	O
phosphopeptides	O
that	O
were	O
absent	O
in	O
untreated	O
cells.	O
Incubation	O
of	O
isolated	protein
Ets-1	protein
protein	protein
with	O
purified	O
CaM	protein
kinase	protein
II	protein
produced	O
phosphorylation	O
of	O
peptides	O
that	O
migrated	O
identically	O
to	O
those	O
found	O
in	O
cells	O
incubated	O
with	O
either	O
anti-IgM	protein
or	O
ionomycin	O
.	O
These	O
data	O
suggest	O
a	O
model	O
of	O
signal	O
transduction	O
by	O
the	O
antigen	protein
receptor	protein
on	O
B	cell_type
lymphocytes	cell_type
in	O
which	O
increased	O
intracellular	O
free	O
calcium	O
can	O
rapidly	O
activate	O
nuclear	protein
CaM	protein
kinase	protein
II	protein
,	O
potentially	O
resulting	O
in	O
phosphorylation	O
and	O
regulation	O
of	O
DNA-binding	protein
proteins	protein
.	O

Transcriptional	O
activation	O
and	O
repression	O
,	O
two	O
properties	O
of	O
the	O
lymphoid-specific	protein
transcription	protein
factor	protein
Oct-2a	protein
.	O
The	O
lymphoid-specific	protein
transcription	protein
factor	protein
Oct-2a	protein
contains	O
two	O
transcriptional	protein
activation	protein
domains	protein
which	O
are	O
located	O
within	O
the	O
N-terminal	protein
and	O
C-terminal	protein
regions	protein
.	O
To	O
study	O
their	O
differential	protein
activation	protein
properties	protein
,	O
we	O
linked	O
the	O
isolated	O
effector	protein
domains	protein
to	O
the	O
GAL4	protein
DNA-binding	protein
domain	protein
.	O
We	O
have	O
shown	O
that	O
both	O
activating	O
regions	O
of	O
Oct-2a	protein
,	O
isolated	O
from	O
their	O
natural	O
context,	O
can	O
activate	O
transcription	O
as	O
promoter	protein
factors	protein
.	O
In	O
contrast	O
to	O
the	O
C-terminus	protein
,	O
activation	O
by	O
the	O
N-terminal	protein
domain	protein
is	O
dependent	O
on	O
a	O
yet	O
unidentified	O
factor(s)	O
binding	O
to	O
the	O
simian	DNA
virus	DNA
40	DNA
enhancer	DNA
.	O
The	O
results	O
obtained	O
by	O
duplication	O
of	O
activation	protein
domains	protein
or	O
their	O
mixed	O
combination	O
suggest	O
that	O
the	O
domains	O
are	O
functionally	O
independent.	O
However,	O
activation	O
from	O
a	O
remote	O
position	O
could	O
only	O
be	O
achieved	O
with	O
the	O
C-terminus	protein
of	O
Oct-2a	protein
in	O
B	cell_type
cells	cell_type
.	O
In	O
lymphoid	cell_type
cells	cell_type
,	O
higher	O
activation	O
levels	O
were	O
observed,	O
suggesting	O
that	O
distinct	O
B-cell-specific	protein
cofactors	protein
in	O
concert	O
with	O
the	O
effector	protein
domains	protein
of	O
Oct-2a	protein
might	O
be	O
involved	O
in	O
mediating	O
transcription	O
from	O
proximal	O
and	O
remote	O
positions	O
.	O
Furthermore,	O
we	O
identified	O
a	O
repression	O
domain	O
at	O
the	O
N-terminus	O
of	O
Oct-2a	protein
.	O
When	O
transferred	O
to	O
a	O
potent	O
activator	O
,	O
transcriptional	O
stimulation	O
was	O
inhibited	O
efficiently.	O
These	O
results	O
underscore	O
the	O
modular	O
structure	O
of	O
Oct-2a	protein
with	O
separable	O
domains	O
for	O
activation	O
and	O
repression	O
and	O
suggest	O
that	O
Oct-2a	protein
might	O
have	O
complex	O
regulatory	O
functions	O
in	O
vivo.	O

Nonopsonic	O
phagocytosis	O
of	O
Pseudomonas	O
aeruginosa	O
by	O
macrophages	cell_type
and	O
polymorphonuclear	cell_type
leukocytes	cell_type
requires	O
the	O
presence	O
of	O
the	O
bacterial	O
flagellum	O
.	O
Whereas	O
the	O
mechanism	O
of	O
nonopsonic	O
phagocytosis	O
of	O
Pseudomonas	O
aeruginosa	O
has	O
been	O
described,	O
the	O
bacterial	O
ligands	O
required	O
are	O
poorly	O
understood.	O
To	O
identify	O
the	O
requisite	O
bacterial	O
ligands	O
,	O
studies	O
with	O
isogenic	O
mutants	O
of	O
P.	O
aeruginosa	O
PAK	O
lacking	O
pili	O
,	O
flagella	O
,	O
and	O
the	O
RpoN	protein
sigma	protein
factor	protein
were	O
undertaken.	O
The	O
RpoN	O
mutant	O
,	O
lacking	O
pili	O
,	O
flagella	O
,	O
and	O
nonpilus	protein
adhesins	protein
,	O
bound	O
poorly	O
and	O
was	O
resistant	O
to	O
ingestion	O
by	O
both	O
macrophages	cell_type
and	O
neutrophils	cell_type
.	O
Pili	O
were	O
not	O
absolutely	O
required	O
for	O
binding	O
or	O
phagocytosis	O
of	O
P.	O
aeruginosa	O
.	O
The	O
presence	O
of	O
a	O
flagellum	O
was	O
not	O
required	O
for	O
binding	O
of	O
P.	O
aeruginosa	O
to	O
macrophages	cell_type
but	O
was	O
critical	O
for	O
the	O
subsequent	O
internalization	O
of	O
the	O
bacterium	O
,	O
suggesting	O
that	O
this	O
factor	O
or	O
a	O
surface	O
ligand	O
associated	O
with	O
its	O
assembly	O
was	O
responsible	O
for	O
stimulation	O
of	O
nonopsonic	O
phagocytosis	O
.	O

Identification	O
of	O
essential	O
GATA	DNA
and	O
Ets	DNA
binding	DNA
motifs	DNA
within	O
the	O
promoter	O
of	O
the	O
platelet	DNA
glycoprotein	DNA
Ib	DNA
alpha	DNA
gene	DNA
.	O
Platelet	protein
glycoprotein	protein
(	O
GP	protein
)	O
Ib-IX-V	protein
is	O
a	O
multisubunit	protein
adhesion	protein
receptor	protein
that	O
supports	O
platelet	O
attachment	O
to	O
thrombogenic	O
surfaces	O
at	O
sites	O
of	O
vascular	O
injury	O
.	O
The	O
congenital	O
absence	O
of	O
the	O
receptor	O
results	O
in	O
a	O
bleeding	O
disorder	O
associated	O
with	O
"giant"	cell_type
platelets	cell_type
,	O
a	O
condition	O
linking	O
the	O
expression	O
of	O
the	O
complex	O
to	O
platelet	O
morphogenesis	O
.	O
To	O
understand	O
better	O
the	O
expression	O
of	O
the	O
GP	protein
Ib-IX-V	protein
complex	protein
,	O
studies	O
were	O
undertaken	O
to	O
define	O
the	O
essential	O
genetic	DNA
elements	DNA
supporting	O
the	O
expression	O
of	O
the	O
alpha-subunit	protein
of	O
the	O
complex	O
(	O
GP	protein
Ib	protein
alpha	protein
).	O
GP	DNA
Ib	DNA
alpha	DNA
promoter	DNA
activity	O
was	O
evaluated	O
by	O
transfection	O
of	O
human	cell_type
erythroleukemia	cell_type
cells	cell_type
with	O
reporter	O
plasmids	O
coding	O
for	O
the	O
enzyme	protein
,	O
luciferase	protein
.	O
Studies	O
were	O
initiated	O
with	O
a	O
fragment	O
extending	O
2,738	O
nucleotides	O
5'	O
to	O
the	O
transcription	DNA
start	DNA
site	DNA
and	O
lead	O
to	O
the	O
identification	O
of	O
253	O
nucleotides	O
retaining	O
full	O
promoter	O
activity	O
in	O
human	cell_type
erythroleukemia	cell_type
cells	cell_type
.	O
In	O
cells	O
of	O
nonhematopoietic	cell_type
lineage	cell_type
,	O
human	cell_type
endothelial	cell_type
and	O
HeLa	cell_type
cells	cell_type
,	O
the	O
GP	DNA
Ib	DNA
alpha	DNA
promoter	DNA
activity	O
was	O
no	O
greater	O
than	O
background	O
levels	O
obtained	O
with	O
promoterless	DNA
constructs	DNA
.	O
Gel	O
shift	O
assays	O
and	O
site-directed	O
mutagenesis	O
studies	O
defined	O
essential	O
GATA	DNA
and	O
Ets	DNA
binding	DNA
motifs	DNA
93	DNA
and	DNA
150	DNA
nucleotides	DNA
upstream	DNA
of	O
the	O
transcription	DNA
start	DNA
site	DNA
,	O
a	O
finding	O
which	O
further	O
substantiates	O
these	O
elements	O
as	O
important	O
determinants	O
of	O
megakaryocytic	O
gene	O
expression	O
.	O
The	O
results	O
define	O
essential	O
cis-acting	DNA
elements	DNA
responsible	O
for	O
the	O
expression	O
of	O
GP	protein
Ib	protein
alpha	protein
and	O
provide	O
insights	O
into	O
molecular	O
events	O
coinciding	O
with	O
the	O
release	O
of	O
normal	cell_type
platelets	cell_type
into	O
the	O
bloodstream	O
.	O

CD30	protein
ligation	O
induces	O
nuclear	protein
factor-kappa	protein
B	protein
activation	O
in	O
human	cell_line
T	cell_line
cell	cell_line
lines	cell_line
.	O
CD30	protein
is	O
a	O
recently	O
described	O
member	O
of	O
the	O
tumor	protein
necrosis	protein
factor	protein
/nerve	protein
growth	protein
factor	protein
receptor	protein
superfamily	protein
.	O
In	O
this	O
report,	O
we	O
show	O
that	O
following	O
incubation	O
of	O
L540	cell_line
cells	cell_line
(	O
Hodgkin's	cell_line
disease	cell_line
-derived,	cell_line
T	cell_line
cell-like,	cell_line
CD30	cell_line
+	cell_line
cells	cell_line
)	O
with	O
the	O
agonistic	protein
anti-	protein
CD30	protein
monoclonal	protein
antibodies	protein
(	O
mAb	protein
)	O
M44	protein
and	O
M67	protein
,	O
two	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
DNA	O
binding	O
activities	O
were	O
induced	O
in	O
nuclear	O
extracts	O
,	O
as	O
determined	O
in	O
gel	O
retardation	O
assays	O
.	O
The	O
effect	O
of	O
the	O
mAb	protein
towards	O
NF-kappa	protein
B	protein
activation	O
was	O
rapid,	O
as	O
it	O
occurred	O
within	O
20	O
min,	O
and	O
was	O
sustained	O
for	O
up	O
to	O
6	O
h.	O
By	O
comparison,	O
an	O
isotype-matched	protein
antibody	protein
had	O
no	O
effect	O
on	O
NF-kappa	protein
B	protein
activation	O
.	O
Moreover,	O
in	O
human	cell_line
T	cell_line
helper	cell_line
(Th)	cell_line
clones	cell_line
functionally	O
characterized	O
as	O
being	O
of	O
the	O
type	O
0,	O
type	O
1	O
and	O
type	O
2	O
(28%,	O
&lt;	O
1%	O
und	O
93%	O
CD30+,	O
respectively),	O
the	O
extent	O
of	O
CD30	protein
-mediated	O
NF-kappa	protein
B	protein
activation	O
correlated	O
with	O
the	O
proportion	O
of	O
CD30+	cell_line
cells	cell_line
.	O
In	O
all	O
cell	O
lines	O
investigated,	O
the	O
NF-kappa	protein
B	protein
complexes	protein
induced	O
following	O
CD30	protein
engagement	O
were	O
shown	O
to	O
contain	O
p50	protein
NF-kappa	protein
B1	protein
,	O
p65	protein
RelA	protein
,	O
and	O
possibly	O
other	O
transcription	protein
factors	protein
.	O
Collectively,	O
our	O
results	O
demonstrate	O
that	O
nuclear	O
translocation	O
and	O
activation	O
of	O
NF-kappa	protein
B	protein
rank	O
among	O
the	O
short-term	O
cellular	O
responses	O
elicited	O
following	O
CD30	protein
ligation	O
.	O

Pathogenesis	O
of	O
atherosclerosis	O
.	O
The	O
earliest	O
lesion	O
in	O
the	O
development	O
of	O
an	O
atherosclerotic	O
plaque	O
is	O
the	O
fatty	O
streak	O
.	O
This	O
chronic	O
inflammatory	O
reaction	O
results	O
from	O
a	O
sequence	O
of	O
events	O
that	O
begins	O
with	O
the	O
trapping	O
of	O
low	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
in	O
the	O
subendothelial	O
space	O
of	O
the	O
artery	O
wall	O
.	O
The	O
trapped	O
LDL	O
is	O
seeded	O
with	O
oxidative	O
species	O
released	O
by	O
the	O
overlying	O
endothelium	O
,	O
and	O
lipid	O
oxidation	O
is	O
initiated	O
within	O
the	O
LDL	O
particle.	O
Some	O
of	O
the	O
lipids	O
that	O
result	O
lead	O
to	O
the	O
activation	O
of	O
NFkB-like	protein
transcription	protein
factors	protein
that	O
cause	O
the	O
expression	O
of	O
genes	O
whose	O
protein	protein
products	protein
mediate	O
monocyte	O
binding	O
,	O
monocyte	cell_type
chemotaxis	O
into	O
the	O
subendothelial	O
space	O
,	O
and	O
conversion	O
into	O
macrophages	cell_type
.	O
At	O
least	O
1	O
major	DNA
gene	DNA
modulates	O
the	O
oxidation	O
of	O
LDL	O
lipids	O
and/or	O
the	O
biologic	O
response	O
to	O
these	O
lipids.	O
The	O
inverse	O
relation	O
between	O
high	O
density	O
lipoprotein	O
(	O
HDL	O
)	O
and	O
atherosclerotic	O
events	O
may	O
in	O
part	O
be	O
due	O
to	O
enzymes	protein
associated	O
with	O
HDL	O
that	O
destroy	O
the	O
biologically	O
active	O
lipids	O
generated	O
in	O
LDL	O
.	O

Estrogen	protein
and	O
progesterone	protein
receptors	protein
in	O
vernal	O
keratoconjunctivitis	O
.	O
PURPOSE:	O
Sex-related	O
influences	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
vernal	O
keratoconjunctivitis	O
(	O
VKC	O
),	O
an	O
allergic	O
eosinophilic	O
disease.	O
METHODS:	O
The	O
authors	O
evaluated	O
tarsal	O
and	O
bulbar	O
conjunctival	O
biopsies	O
from	O
seven	O
patients	O
with	O
severe	O
and	O
symptomatic	O
VKC	O
for	O
the	O
presence	O
of	O
estrogen	protein
and	O
progesterone	protein
receptors	protein
by	O
using	O
monoclonal	protein
antibodies	protein
with	O
a	O
peroxidase-antiperoxidase	O
technique	O
.	O
RESULTS:	O
Both	O
the	O
epithelium	O
and	O
subepithelium	O
of	O
the	O
tarsal	O
and	O
bulbar	O
conjunctiva	O
of	O
patients	O
with	O
VKC	O
,	O
but	O
not	O
those	O
of	O
four	O
nonatopic	O
control	O
subjects	O
,	O
showed	O
intense	O
positive	O
staining	O
for	O
estrogen	O
and	O
progesterone	protein
receptors	protein
.	O
Immunofluorescence	O
colocalization	O
of	O
both	O
estrogen	protein
and	O
progesterone	protein
receptors	protein
with	O
eosinophil	protein
cationic	protein
protein	protein
showed	O
that	O
approximately	O
70%	O
of	O
positive	cell_type
cells	cell_type
were	O
eosinophils	cell_type
.	O
CONCLUSIONS:	O
Sexual	O
hormones	O
,	O
through	O
their	O
receptors	protein
,	O
may	O
influence	O
the	O
activity	O
of	O
eosinophils	cell_type
in	O
patients	O
with	O
VKC	O
.	O

CIITA	protein
activates	O
the	O
expression	O
of	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
in	O
mouse	O
T	O
cells.	O
It	O
has	O
long	O
been	O
a	O
puzzle	O
that	O
MHC	protein
class	protein
II	protein
molecules	protein
are	O
expressed	O
in	O
human	cell_type
T	cell_type
cells	cell_type
after	O
activation	O
but	O
not	O
in	O
mouse	cell_type
T	cell_type
cells	cell_type
;	O
this	O
expression	O
is	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
cell	O
mediated	O
immune	O
response	O
.	O
Recently	O
the	O
MHC	protein
class	protein
II	protein
transactivator	protein
(	O
CIITA	protein
)	O
has	O
been	O
reported	O
to	O
be	O
a	O
major	protein
regulatory	protein
factor	protein
for	O
both	O
the	O
constitutive	O
and	O
IFN	O
inducible	O
expression	O
of	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
.	O
Here	O
we	O
show	O
that	O
human	cell_type
T	cell_type
cells	cell_type
expressing	O
MHC	O
class	O
II	O
have	O
CIITA	protein
transcripts	O
while	O
MHC	O
class	O
II-negative	O
human	cell_type
T	cell_type
cells	cell_type
and	O
mouse	cell_type
T	cell_type
cells	cell_type
do	O
not.	O
The	O
expression	O
of	O
MHC	DNA
class	DNA
II	DNA
genes	DNA
in	O
mouse	cell_type
T	cell_type
cells	cell_type
can	O
be	O
reconstituted	O
upon	O
transfection	O
with	O
the	O
human	DNA
CIITA	DNA
cDNA	DNA
.	O
These	O
data	O
indicate	O
that	O
the	O
expression	O
of	O
CIITA	protein
explains	O
the	O
expression	O
or	O
lack	O
of	O
expression	O
of	O
MHC	protein
class	protein
II	protein
in	O
human	cell_type
and	O
mouse	cell_type
T	cell_type
cells	cell_type
respectively.	O

Anti-Ro(SSA)	protein
autoantibodies	protein
are	O
associated	O
with	O
T	DNA
cell	DNA
receptor	DNA
beta	DNA
genes	DNA
in	O
systemic	O
lupus	O
erythematosus	O
patients	O
.	O
Several	O
of	O
the	O
heterogeneous	O
clinical	O
manifestations	O
of	O
systemic	O
lupus	O
erythematosus	O
have	O
been	O
associated	O
with	O
specific	O
autoantibodies	protein
.	O
Associations	O
between	O
HLA	protein
class	protein
II	protein
antigens	protein
and	O
autoantibodies	protein
to	O
the	O
ribonucleoproteins	protein
Ro(SSA)	protein
and	O
La(SSB)	protein
have	O
been	O
reported	O
in	O
these	O
patients.	O
Because	O
HLA	protein
class	protein
II	protein
molecules	protein
present	O
antigen	O
to	O
T	protein
cell	protein
receptors	protein
(	O
TCRs	protein
),	O
we	O
have	O
searched	O
for	O
a	O
TCR	DNA
gene	DNA
associated	O
with	O
the	O
production	O
of	O
anti-	protein
Ro(SSA)	protein
antibodies	protein
.	O
A	O
pair	O
of	O
restriction	DNA
fragment	DNA
length	DNA
polymorphisms	DNA
(	O
RFLPs	DNA
),	O
one	O
of	O
which	O
hybridizes	O
to	O
the	O
TCR	DNA
constant	DNA
region	DNA
C	DNA
beta	DNA
1	DNA
and	O
the	O
other	O
to	O
the	O
C	DNA
beta	DNA
2	DNA
gene	DNA
,	O
has	O
been	O
identified,	O
suggesting	O
these	O
may	O
be	O
genotypic	O
markers	O
for	O
an	O
extended	O
region	O
of	O
the	O
TCR	DNA
beta	DNA
locus	DNA
.	O
This	O
RFLP	DNA
pair	DNA
occurs	O
in	O
76%	O
of	O
patients	O
with	O
Ro(SSA)	protein
precipitins,	O
84%	O
of	O
anti-	O
Ro(SSA)	protein
-positive	O
patients	O
lacking	O
La(SSB)	protein
precipitins	protein
,	O
but	O
only	O
41%	O
of	O
the	O
patients	O
lacking	O
both	O
precipitins	protein
(P	O
=	O
0.0004).	O
This	O
disproportionate	O
occurrence	O
in	O
a	O
subset	O
of	O
lupus	O
patients	O
indicates	O
that	O
these	O
RFLPs	DNA
are	O
not	O
disease	O
susceptibility	O
markers,	O
but	O
rather	O
are	O
important	O
markers	O
for	O
TCR	DNA
genes	DNA
whose	O
products	O
are	O
involved	O
in	O
the	O
production	O
of	O
anti-	protein
Ro(SSA)	protein
antibodies	protein
.	O
The	O
majority	O
of	O
patients	O
who	O
have	O
these	O
RFLPs	DNA
and	O
HLA	protein
class	protein
II	protein
antigens	protein
previously	O
associated	O
with	O
the	O
anti-	O
Ro(SSA)	protein
response	O
make	O
this	O
antibody,	O
suggesting	O
that	O
interactions	O
between	O
products	O
of	O
these	O
loci	DNA
occur	DNA
in	O
response	O
to	O
Ro(SSA)	protein
.	O

Inhibition	O
of	O
NF-AT	protein
-dependent	O
transcription	O
by	O
NF-kappa	protein
B	protein
:	O
implications	O
for	O
differential	O
gene	O
expression	O
in	O
T	cell_type
helper	cell_type
cell	cell_type
subsets	cell_type
.	O
Activation	O
of	O
individual	O
CD4+	cell_line
T	cell_line
cells	cell_line
results	O
in	O
differential	O
lymphokine	protein
expression	O
:	O
interleukin	protein
2	protein
(	O
IL-2	protein
)	O
is	O
preferentially	O
produced	O
by	O
T	cell_line
helper	cell_line
type	cell_line
1	cell_line
(TH1)	cell_line
cells	cell_line
,	O
which	O
are	O
involved	O
in	O
cell-mediated	O
immune	O
responses,	O
whereas	O
IL-4	protein
is	O
synthesized	O
by	O
TH2	cell_line
cells	cell_line
,	O
which	O
are	O
essential	O
for	O
humoral	O
immunity	O
.	O
The	O
Ca(2+)	protein
-dependent	protein
factor	protein
NF-ATp	protein
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
transcription	O
of	O
both	O
these	O
lymphokine	DNA
genes	DNA
.	O
However,	O
while	O
IL2	protein
expression	O
requires	O
the	O
contribution	O
of	O
Ca(2+)-	O
and	O
protein	protein
kinase	protein
C	protein
-dependent	O
signals	O
,	O
we	O
report	O
that	O
activation	O
of	O
human	protein
IL4	protein
transcription	O
through	O
the	O
Ca(2+)-dependent	O
pathway	O
is	O
diminished	O
by	O
protein	protein
kinase	protein
C	protein
stimulation	O
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
.	O
This	O
phenomenon	O
is	O
due	O
to	O
mutually	O
exclusive	O
binding	O
of	O
NF-ATp	protein
and	O
NF-kappa	protein
B	protein
to	O
the	O
P	DNA
sequence	DNA
,	O
an	O
element	O
located	O
69	DNA
bp	DNA
upstream	DNA
of	O
the	O
IL4	DNA
transcription	DNA
initiation	DNA
site	DNA
.	O
Human	DNA
IL4	DNA
promoter	DNA
-mediated	O
transcription	O
is	O
downregulated	O
in	O
Jurkat	cell_line
cells	cell_line
stimulated	O
with	O
the	O
NF-kappa	protein
B	protein
-activating	protein
cytokine	protein
tumor	protein
necrosis	protein
factor	protein
alpha	protein
and	O
suppressed	O
in	O
RelA	cell_line
-overexpressing	cell_line
cells	cell_line
.	O
In	O
contrast,	O
protein	protein
kinase	protein
C	protein
stimulation	O
or	O
RelA	protein
overexpression	O
does	O
not	O
affect	O
the	O
activity	O
of	O
a	O
human	DNA
IL4	DNA
promoter	DNA
containing	O
a	O
mouse	DNA
P	DNA
sequence	DNA
,	O
which	O
is	O
a	O
higher-affinity	DNA
site	DNA
for	O
NF-ATp	protein
and	O
a	O
lower-affinity	DNA
site	DNA
for	O
RelA	protein
.	O
Thus,	O
competition	O
between	O
two	O
general	O
transcriptional	protein
activators	protein
,	O
RelA	protein
and	O
NF-ATp	protein
,	O
mediates	O
the	O
inhibitory	O
effect	O
of	O
protein	protein
kinase	protein
C	protein
stimulation	O
on	O
IL4	protein
expression	O
and	O
may	O
contribute	O
to	O
differential	O
gene	O
expression	O
in	O
TH	cell_line
cells	cell_line
.	O

Regulation	O
of	O
the	O
balance	O
of	O
cytokine	protein
production	O
and	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	protein
)	O
transcription	O
factor	O
activity	O
by	O
cytokines	protein
and	O
inflammatory	O
synovial	O
fluids.	O
The	O
balance	O
between	O
type	O
1	O
and	O
2	O
T	O
helper	O
cell	O
cytokine	O
production	O
plays	O
an	O
important	O
role	O
in	O
several	O
animal	O
models	O
of	O
autoimmunity,	O
and	O
skewed	O
patterns	O
of	O
cytokine	protein
expression	O
have	O
been	O
described	O
in	O
human	O
inflammatory	O
diseases	O
.	O
Many	O
cytokines	protein
activate	O
signal	protein
transducer	protein
and	protein
activation	protein
of	protein
transcription	protein
(	protein
STAT	protein
)	protein
transcription	protein
factors	protein
,	O
which,	O
in	O
turn,	O
activate	O
transcription	O
of	O
inflammatory	O
effector	O
genes.	O
We	O
used	O
mononuclear	cell_line
cell	cell_line
priming	cell_line
cultures	cell_line
and	O
inflammatory	cell_type
synovial	cell_type
fluids	cell_type
(	O
SFs	cell_type
)	O
derived	O
from	O
arthritis	O
patients	O
to	O
examine	O
the	O
regulation	O
of	O
cytokine	protein
production	O
and	O
STAT	protein
activity	O
by	O
an	O
inflammatory	O
synovial	O
microenvironment	O
.	O
Exposure	O
to	O
SFs	cell_type
during	O
priming	O
resulted	O
in	O
an	O
81%	O
inhibition	O
of	O
interferon	protein
(IFN)-gamma	protein
,	O
but	O
not	O
interleukin	protein
(IL)	protein
4	protein
,	O
production	O
by	O
effector	cell_type
cells	cell_type
generated	O
in	O
priming	O
cultures.	O
SF	O
suppression	O
was	O
mediated	O
by	O
IL-4	protein
and	O
IL-10	protein
and	O
inhibition	O
of	O
IL-12	protein
expression	O
,	O
and	O
it	O
was	O
reversed	O
in	O
a	O
dominant	O
fashion	O
by	O
exogenous	O
IL-12.	O
SFs	cell_type
blocked	O
the	O
sustained	O
activity	O
of	O
transcription	protein
factor	protein
Stat1	protein
,	O
but	O
not	O
Stat3	protein
,	O
during	O
the	O
priming	O
period,	O
and	O
Stat1	protein
activity	O
was	O
differentially	O
regulated	O
by	O
cytokines	protein
in	O
parallel	O
with	O
their	O
positive	O
or	O
negative	O
regulation	O
of	O
IFN-gamma	protein
production	O
.	O
Active	O
Stat3	protein
,	O
but	O
not	O
Stat1	protein
,	O
was	O
detected	O
in	O
cells	O
from	O
inflamed	O
joints	O
.	O
These	O
results	O
suggest	O
a	O
role	O
for	O
altered	O
balance	O
of	O
Stat1	O
and	O
Stat3	O
transcriptional	O
activity	O
in	O
the	O
regulation	O
of	O
T	cell_type
cell	cell_type
differentiation	O
and	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
synovitis	O
.	O

Triggering	O
of	O
complement	protein
receptors	protein
CR1	protein
(	O
CD35	protein
)	O
and	O
CR3	protein
(	O
CD11b/CD18	protein
)	O
induces	O
nuclear	O
translocation	O
of	O
NF-kappa	protein
B	protein
(	O
p50/p65	protein
)	O
in	O
human	cell_type
monocytes	cell_type
and	O
enhances	O
viral	O
replication	O
in	O
HIV-infected	cell_type
monocytic	cell_type
cells	cell_type
.	O
Monocyte/macrophages	cell_type
may	O
harbor	O
HIV	O
in	O
a	O
nonproductive	O
fashion	O
for	O
prolonged	O
periods	O
of	O
time.	O
Viral	O
gene	O
expression	O
may	O
be	O
reactivated	O
by	O
stimulation	O
of	O
the	O
cells	O
with	O
LPS	O
or	O
cytokines	protein
such	O
as	O
TNF-alpha	protein
in	O
vitro.	O
The	O
effect	O
of	O
LPS	O
and	O
TNF-alpha	protein
is	O
mediated	O
by	O
their	O
ability	O
to	O
induce	O
nuclear	O
translocation	O
of	O
the	O
DNA-binding	protein
heterodimer	protein
NF-kappa	protein
B	protein
(	O
p50/p65	protein
),	O
which	O
binds	O
to	O
a	O
specific	O
sequence	O
in	O
the	O
HIV-long	DNA
terminal	DNA
repeat	DNA
.	O
The	O
present	O
study	O
demonstrates	O
that	O
triggering	O
of	O
complement	protein
receptors	protein
CR1	protein
(	O
CD35	protein
)	O
and	O
CR3	protein
(	O
CD11b/CD18	protein
)	O
enhances	O
viral	O
replication	O
in	O
HIV-infected	cell_line
human	cell_line
monocytic	cell_line
cells	cell_line
.	O
Monocytic	cell_line
cell	cell_line
lines	cell_line
and	O
normal	O
peripheral	O
blood	O
monocytes	O
were	O
infected	O
with	O
HIV-1	O
in	O
vitro	O
and	O
cultured	O
in	O
the	O
presence	O
or	O
absence	O
of	O
F(ab')2	protein
fragments	protein
of	O
monoclonal	protein
anti-	protein
CR1	protein
or	O
anti-	protein
CR3	protein
Abs	protein
or	O
with	O
C3	protein
fragments	protein
.	O
Stimulation	O
of	O
CR1	protein
or	O
CR3	protein
induces	O
a	O
two-	O
to	O
fourfold	O
increase	O
in	O
the	O
amount	O
of	O
cell-associated	O
and	O
released	O
p24	protein
Ag	protein
in	O
cell	cell_line
cultures	cell_line
that	O
was	O
equivalent	O
to	O
that	O
observed	O
in	O
control	cell_line
cultures	cell_line
triggered	O
with	O
LPS	O
.	O
We	O
further	O
observed	O
that	O
stimulation	O
of	O
CR1	protein
or	O
CR3	protein
induces	O
the	O
nuclear	O
translocation	O
of	O
NF-kappa	protein
B	protein
p50/p65	protein
in	O
infected	cell_type
cells	cell_type
.	O
Translocation	O
of	O
NF-kappa	protein
B	protein
p50/p65	protein
was	O
also	O
observed	O
following	O
stimulation	O
of	O
CR1	protein
or	O
CR3	protein
of	O
uninfected	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
from	O
HIV-seronegative	O
donors	O
.	O
The	O
amount	O
of	O
protein	O
translocated	O
was	O
similar	O
to	O
that	O
observed	O
when	O
cells	O
were	O
stimulated	O
with	O
rhTNF-alpha	protein
.	O
TNF-alpha	protein
did	O
not	O
mediate	O
the	O
translocation	O
of	O
NF-kappa	protein
B	protein
p50/p65	protein
induced	O
by	O
triggering	O
of	O
complement	protein
receptors	protein
.	O
Taken	O
together,	O
these	O
observations	O
suggest	O
that	O
HIV	O
gene	O
expression	O
may	O
be	O
activated	O
in	O
infected	cell_type
monocytes	cell_type
through	O
interaction	O
of	O
the	O
cells	O
with	O
complement-opsonized	protein
particles	protein
and	O
that	O
enhanced	O
viral	O
replication	O
is	O
associated	O
with	O
C3	protein
receptor	protein
-mediated	O
nuclear	O
translocation	O
of	O
the	O
NF-kappa	protein
B	protein
complex	protein
.	O

Attenuation	O
of	O
gamma	protein
interferon	protein
-induced	O
tyrosine	O
phosphorylation	O
in	O
mononuclear	cell_type
phagocytes	cell_type
infected	O
with	O
Leishmania	O
donovani	O
:	O
selective	O
inhibition	O
of	O
signaling	O
through	O
Janus	protein
kinases	protein
and	O
Stat1	protein
.	O
The	O
induction	O
of	O
gene	O
transcription	O
in	O
response	O
to	O
gamma	protein
interferon	protein
is	O
impaired	O
in	O
mononuclear	cell_type
phagocytes	cell_type
infected	O
with	O
Leishmania	O
donovani	O
,	O
and	O
the	O
mechanisms	O
involved	O
are	O
not	O
fully	O
understood.	O
The	O
changes	O
in	O
gene	O
expression	O
brought	O
about	O
by	O
gamma	protein
interferon	protein
are	O
thought	O
to	O
involve	O
transient	O
increases	O
in	O
the	O
activities	O
of	O
cellular	protein
protein	protein
tyrosine	protein
kinases	protein
,	O
including	O
the	O
Janus	protein
kinases	protein
Jak1	protein
and	O
Jak2	protein
,	O
leading	O
to	O
tyrosine	O
phosphorylation	O
of	O
the	O
transcription	protein
factor	protein
Stat1	protein
.	O
To	O
investigate	O
the	O
mechanisms	O
accounting	O
for	O
the	O
impaired	O
responses	O
to	O
gamma	protein
interferon	protein
,	O
a	O
model	O
system	O
for	O
examining	O
overall	O
changes	O
in	O
protein	O
tyrosine	O
phosphorylation	O
,	O
activation	O
of	O
Jak1	protein
and	O
Jak2	protein
and	O
phosphorylation	O
of	O
Stat1	protein
was	O
developed	O
in	O
phorbol	cell_line
12-myristate	cell_line
13-acetate	cell_line
-differentiated	cell_line
U-937	cell_line
cells	cell_line
.	O
Analysis	O
of	O
whole-cell	O
lysates	O
by	O
antiphosphotyrosine	O
immunoblotting	O
showed	O
that	O
incubation	O
with	O
gamma	protein
interferon	protein
brought	O
about	O
specific	O
increases	O
in	O
phosphotyrosine	O
labeling	O
of	O
several	O
proteins.	O
Increased	O
labeling	O
of	O
these	O
proteins	O
occurred	O
to	O
similar	O
extents	O
in	O
control	cell_type
cells	cell_type
and	O
in	O
cells	O
that	O
had	O
been	O
infected	O
with	O
L.	O
donovani	O
for	O
16	O
h.	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Stat1	protein
were	O
immunoprecipitated	O
from	O
control	O
and	O
interferon-treated	cell_line
cells	cell_line
,	O
and	O
tyrosine	O
phosphorylation	O
of	O
these	O
proteins,	O
detected	O
by	O
antiphosphotyrosine	O
immunoblotting	O
was	O
used	O
to	O
measured	O
their	O
activation.	O
Tyrosine	O
phosphorylation	O
of	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Stat1	protein
increased	O
markedly,	O
in	O
a	O
dose-dependent	O
manner,	O
in	O
U-937	cell_line
cells	cell_line
incubated	O
with	O
gamma	protein
interferon	protein
.	O
In	O
contrast,	O
in	O
cells	O
infected	O
with	O
L.	O
donovani	O
,	O
tyrosine	O
phosphorylation	O
of	O
Jak1	protein
,	O
Jak2	protein
,	O
and	O
Stat1	protein
was	O
markedly	O
impaired.	O
This	O
effect	O
was	O
dependent	O
upon	O
the	O
duration	O
of	O
exposure	O
to	O
L.	O
donovani	O
and	O
was	O
maximal	O
and	O
complete	O
at	O
16	O
h.	O
Results	O
similar	O
to	O
those	O
observed	O
with	O
U-937	cell_line
cells	cell_line
were	O
also	O
obtained	O
with	O
human	cell_type
peripheral	cell_type
blood	cell_type
monocytes	cell_type
.	O
These	O
findings	O
indicate	O
that	O
infection	O
of	O
human	cell_type
mononuclear	cell_type
phagocytes	cell_type
with	O
L.	O
donovani	O
leads	O
to	O
impaired	O
gamma	protein
interferon	protein
-mediated	O
tyrosine	O
phosphorylation	O
and	O
selective	O
effects	O
on	O
the	O
Jak-	O
Stat1	protein
pathway	O
.	O
Unresponsiveness	O
to	O
gamma	protein
interferon	protein
for	O
activation	O
of	O
this	O
pathway	O
may	O
explain	O
impaired	O
transcriptional	O
responses	O
in	O
leishmania-infected	cell_type
cells	cell_type
.	O

Mutually	O
exclusive	O
interaction	O
of	O
a	O
novel	O
matrix	protein
attachment	protein
region	protein
binding	protein
protein	protein
and	O
the	O
NF-muNR	protein
enhancer	protein
repressor	protein
.	O
Implications	O
for	O
regulation	O
of	O
immunoglobulin	protein
heavy	protein
chain	protein
expression	O
.	O
The	O
immunoglobulin	protein
heavy	protein
chain	protein
(	O
IgH	protein
)	O
intronic	O
enhancer	O
stimulates	O
transcription	O
from	O
functional	O
promoters	O
in	O
B	O
lymphocytes	O
but	O
not	O
other	O
cell	O
types.	O
The	O
observation	O
that	O
binding	O
sites	O
for	O
the	O
nuclear	protein
factor-mu	protein
negative	protein
regulator	protein
(	protein
NF-muNR	protein
)	protein
enhancer	protein
repressor	protein
overlap	protein
nuclear	protein
matrix	protein
attachment	protein
regions	protein
(	O
MARs	protein
)	O
in	O
this	O
enhancer	DNA
has	O
lead	O
to	O
the	O
hypothesis	O
that	O
the	O
cell	O
type	O
specificity	O
of	O
the	O
enhancer	DNA
might	O
be	O
controlled	O
by	O
regulating	O
nuclear	O
matrix	O
attachment	O
(Scheuermann,	O
R.	O
H.,	O
and	O
Chen,	O
U.	O
(1989)	O
Genes	O
&amp;	O
Dev.	O
3,	O
1255-1266).	O
To	O
understand	O
the	O
role	O
of	O
MARs	protein
in	O
IgH	DNA
enhancer	DNA
regulation	O
,	O
we	O
have	O
identified	O
a	O
novel	O
MAR-binding	protein
protein	protein
,	O
MAR-BP1	protein
,	O
from	O
soluble	O
nuclear	O
matrix	O
preparations	O
based	O
on	O
its	O
ability	O
to	O
bind	O
to	O
the	O
MARs	protein
associated	O
with	O
the	O
IgH	DNA
enhancer	DNA
.	O
Purified	O
MAR-BP1	protein
migrates	O
as	O
a	O
33-kDa	protein
protein	protein
,	O
and	O
it	O
can	O
be	O
found	O
in	O
nuclear	O
matrix	O
preparations	O
from	O
a	O
number	O
of	O
different	O
types	O
of	O
lymphoid	cell_line
cell	cell_line
lines	cell_line
.	O
Although	O
specific	O
binding	O
sites	O
have	O
been	O
difficult	O
to	O
localize	O
by	O
chemical	O
or	O
enzymatic	O
footprinting	O
procedures	O
,	O
NF-muNR	protein
binding	O
sites	O
are	O
critical	O
for	O
efficient	O
MAR-BP1	protein
binding	O
.	O
Indeed,	O
binding	O
of	O
the	O
IgH	DNA
enhancer	DNA
to	O
either	O
intact	O
nuclear	O
matrix	O
preparations	O
or	O
to	O
MAR-BP1	protein
is	O
mutually	O
exclusive	O
to	O
NF-muNR	protein
binding	O
.	O
These	O
results	O
are	O
consistent	O
with	O
a	O
model	O
for	O
cell-type	O
specific	O
regulation	O
in	O
which	O
binding	O
of	O
the	O
NF-muNR	protein
repressor	protein
to	O
the	O
IgH	DNA
enhancer	DNA
prevents	O
nuclear	O
matrix	O
attachment	O
in	O
inappropriate	O
cells	O
by	O
interfering	O
with	O
MAR-BP1	protein
/enhancer	DNA
interaction	O
.	O

PU.1	protein
(	O
Spi-1	protein
)	O
and	O
C/EBP	protein
alpha	protein
regulate	O
expression	O
of	O
the	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
receptor	DNA
alpha	DNA
gene	DNA
.	O
Growth	protein
factor	protein
receptors	protein
play	O
an	O
important	O
role	O
in	O
hematopoiesis	O
.	O
In	O
order	O
to	O
further	O
understand	O
the	O
mechanisms	O
directing	O
the	O
expression	O
of	O
these	O
key	O
regulators	O
of	O
hematopoiesis	O
,	O
we	O
initiated	O
a	O
study	O
investigating	O
the	O
transcription	protein
factors	protein
activating	O
the	O
expression	O
of	O
the	O
granulocyte-macrophage	DNA
colony-stimulating	DNA
factor	DNA
(	DNA
GM-CSF	DNA
)	DNA
receptor	DNA
alpha	DNA
gene	DNA
.	O
Here,	O
we	O
demonstrate	O
that	O
the	O
human	DNA
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
directs	O
reporter	DNA
gene	DNA
activity	O
in	O
a	O
tissue-specific	O
fashion	O
in	O
myelomonocytic	cell_type
cells	cell_type
,	O
which	O
correlates	O
with	O
its	O
expression	O
pattern	O
as	O
analyzed	O
by	O
reverse	O
transcription	O
PCR	O
.	O
The	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
contains	O
an	O
important	O
functional	O
site	O
between	O
positions	O
-53	O
and	O
-41	O
as	O
identified	O
by	O
deletion	O
analysis	O
of	O
reporter	DNA
constructs	DNA
.	O
We	O
show	O
that	O
the	O
myeloid	O
and	O
B	protein
cell	protein
transcription	protein
factor	protein
PU.1	protein
binds	O
specifically	O
to	O
this	O
site.	O
Furthermore,	O
we	O
demonstrate	O
that	O
a	O
CCAAT	DNA
site	DNA
located	O
upstream	O
of	O
the	O
PU.1	DNA
site	DNA
between	O
positions	O
-70	O
and	O
-54	O
is	O
involved	O
in	O
positive-negative	O
regulation	O
of	O
the	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
activity	O
.	O
C/EBP	protein
alpha	protein
is	O
the	O
major	O
CCAAT/enhancer	protein
-binding	protein
protein	protein
(	O
C/EBP	protein
)	O
form	O
binding	O
to	O
this	O
site	O
in	O
nuclear	O
extracts	O
of	O
U937	cell_line
cells	cell_line
.	O
Point	O
mutations	O
of	O
either	O
the	O
PU.1	DNA
site	DNA
or	O
the	O
C/EBP	DNA
site	DNA
that	O
abolish	O
the	O
binding	O
of	O
the	O
respective	O
factors	O
result	O
in	O
a	O
significant	O
decrease	O
of	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
activity	O
in	O
myelomonocytic	cell_type
cells	cell_type
only.	O
Furthermore,	O
we	O
demonstrate	O
that	O
in	O
myeloid	O
and	O
B	O
cell	O
extracts	O
,	O
PU.1	protein
forms	O
a	O
novel,	O
specific,	O
more	O
slowly	O
migrating	O
complex	O
(	O
PU-SF	protein
)	O
when	O
binding	O
the	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
PU.1	DNA
site	DNA
.	O
This	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
specific	O
interaction	O
with	O
PU.1	protein
on	O
a	O
myeloid	DNA
PU.1	DNA
binding	DNA
site	DNA
.	O
The	O
novel	O
complex	O
is	O
distinct	O
from	O
that	O
described	O
previously	O
as	O
binding	O
to	O
B	DNA
cell	DNA
enhancer	DNA
sites	DNA
and	O
can	O
be	O
formed	O
by	O
addition	O
of	O
PU.1	protein
to	O
extracts	O
from	O
certain	O
nonmyeloid	cell_type
cell	cell_type
types	cell_type
which	O
do	O
not	O
express	O
PU.1	protein
,	O
including	O
T	cell_type
cells	cell_type
and	O
epithelial	cell_type
cells	cell_type
,	O
but	O
not	O
from	O
erythroid	cell_type
cells	cell_type
.	O
Furthermore,	O
we	O
demonstrate	O
that	O
the	O
PU-SF	protein
complex	protein
binds	O
to	O
PU.1	protein
sites	O
found	O
on	O
a	O
number	O
of	O
myeloid	DNA
promoters	DNA
,	O
and	O
its	O
formation	O
requires	O
an	O
intact	O
PU.1	DNA
site	DNA
adjacent	O
to	O
a	O
single-stranded	O
region.	O
Expression	O
of	O
PU.1	protein
in	O
nonmyeloid	cell_type
cells	cell_type
can	O
activate	O
the	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
.	O
Deletion	O
of	O
the	O
amino-terminal	protein
region	protein
of	O
PU.1	protein
results	O
in	O
a	O
failure	O
to	O
form	O
the	O
PU-SF	protein
complex	O
and	O
in	O
a	O
concomitant	O
loss	O
of	O
transactivation,	O
suggesting	O
that	O
formation	O
of	O
the	O
PU-SF	protein
complex	protein
is	O
of	O
functional	O
importance	O
for	O
the	O
activity	O
of	O
the	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
.	O
Finally,	O
we	O
demonstrate	O
that	O
C/EBP	protein
alpha	protein
can	O
also	O
active	O
the	O
GM-CSF	DNA
receptor	DNA
alpha	DNA
promoter	DNA
in	O
nonmyeloid	cell_type
cells	cell_type
.	O
(ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS)	O

HMG-I	protein
binds	O
to	O
GATA	DNA
motifs	DNA
:	O
implications	O
for	O
an	O
HPFH	O
syndrome	O
.	O
We	O
have	O
examined	O
binding	O
of	O
the	O
nuclear	protein
protein	protein
HMG-I	protein
to	O
the	O
human	DNA
gamma-globin	DNA
promoter	DNA
.	O
We	O
find	O
that	O
HMG-I	protein
binds	O
preferentially	O
to	O
the	O
more	O
3'	O
of	O
a	O
pair	O
of	O
GATA	DNA
motifs	DNA
in	O
the	O
gamma-globin	DNA
promoter	DNA
;	O
this	O
paired	O
motif	O
is	O
bound	O
by	O
the	O
erythroid	protein
factor	protein
GATA-1	protein
.	O
A	O
naturally	O
occurring	O
mutation	O
(-175	O
T-C)	O
in	O
the	O
area	O
bound	O
by	O
HMG-I	protein
results	O
in	O
overexpression	O
of	O
gamma-globin	protein
in	O
adult	cell_type
red	cell_type
blood	cell_type
cells	cell_type
(	O
HPFH	cell_type
)	O
and	O
up-regulation	O
of	O
the	O
gamma-globin	DNA
promoter	DNA
in	O
in	O
vitro	O
expression	O
assays	O
;	O
HMG-I	protein
does	O
not	O
bind	O
to	O
this	O
mutant	DNA
sequence	DNA
.	O
A	O
survey	O
of	O
GATA	DNA
motifs	DNA
from	O
other	O
globin	DNA
cis-elements	DNA
demonstrates	O
HMG-I	protein
binding	O
to	O
most	O
of	O
them.	O
These	O
findings	O
implicate	O
HMG-I	protein
in	O
the	O
HPFH	cell_type
phenotype	O
;	O
we	O
speculate	O
that	O
it	O
may	O
participate	O
in	O
the	O
formation	O
of	O
multiprotein	protein
complexes	protein
that	O
regulate	O
globin	O
gene	O
expression	O
.	O

Constitutive	O
activation	O
of	O
different	O
Jak	protein
tyrosine	protein
kinases	protein
in	O
human	protein
T	protein
cell	protein
leukemia	protein
virus	protein
type	protein
1	protein
(	protein
HTLV-1	protein
)	protein
tax	protein
protein	protein
or	O
virus-transformed	cell_line
cells	cell_line
.	O
HTLV-1	O
infection	O
causes	O
an	O
adult	O
T	O
cell	O
leukemia	O
in	O
humans	O
.	O
The	O
viral	protein
encoded	protein
protein	protein
tax	protein
,	O
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
oncogenesis	O
.	O
Our	O
previous	O
data	O
obtained	O
from	O
a	O
tax	protein
transgenic	O
mouse	O
model	O
revealed	O
that	O
tax	protein
transforms	O
mouse	cell_type
fibroblasts	cell_type
but	O
not	O
thymocytes	cell_type
,	O
despite	O
comparable	O
levels	O
of	O
tax	protein
expression	O
in	O
both	O
tissues.	O
Constitutive	O
tyrosine	O
phosphorylation	O
of	O
a	O
130-kD	protein
protein	protein
(s)	O
was	O
observed	O
in	O
the	O
tax	protein
transformed	cell_line
fibroblast	cell_line
B	cell_line
line	cell_line
and	O
in	O
HTLV-1	cell_line
transformed	cell_line
human	cell_line
lymphoid	cell_line
lines	cell_line
,	O
but	O
not	O
in	O
thymocytes	cell_type
from	O
Thy-tax	O
transgenic	O
mice	O
.	O
Phosphotyrosine	O
immunoprecipitation	O
followed	O
by	O
Western	O
blot	O
analysis	O
with	O
a	O
set	O
of	O
Jak	protein
kinase	protein
specific	protein
antibodies	protein
,	O
identified	O
p130	O
as	O
Jak2	protein
in	O
the	O
tax	protein
transformed	O
mouse	cell_line
fibroblastic	cell_line
cell	cell_line
line	cell_line
and	O
Jak3	protein
in	O
HTLV-1	cell_line
transformed	cell_line
human	cell_line
T	cell_line
cell	cell_line
lines	cell_line
.	O
Phosphorylation	O
of	O
Jak2	protein
in	O
tax	cell_line
transformed	cell_line
cells	cell_line
resulted	O
from	O
high	O
expression	O
of	O
IL-6	protein
.	O
Tyrosine	O
phosphorylation	O
of	O
this	O
protein	O
could	O
also	O
be	O
induced	O
in	O
Balb/c3T3	cell_line
cells	cell_line
using	O
a	O
supernatant	O
from	O
the	O
B	cell_line
line	cell_line
,	O
which	O
was	O
associated	O
with	O
induction	O
of	O
cell	O
proliferation	O
.	O
Both	O
phosphorylation	O
and	O
proliferation	O
were	O
inhibited	O
by	O
IL-6	protein
neutralizing	protein
antibodies	protein
.	O
Constitutive	O
phosphorylation	O
of	O
Jak	protein
kinases	protein
may	O
facilitate	O
tumor	O
growth	O
in	O
both	O
HTLV-1	cell_type
infected	cell_type
human	cell_type
T	cell_type
cells	cell_type
and	O
the	O
transgenic	O
mouse	O
model	O
.	O

Regulation	O
of	O
c-jun	RNA
mRNA	RNA
expression	O
by	O
hydroxyurea	O
in	O
human	cell_line
K562	cell_line
cells	cell_line
during	O
erythroid	O
differentiation	O
[published	O
erratum	O
appears	O
in	O
Biochim	O
Biophys	O
Acta	O
1995	O
Dec	O
27;1264(3):409]	O
Hydroxyurea	O
(	O
HU	O
)	O
is	O
an	O
antitumor	O
agent	O
which	O
also	O
induces	O
hemoglobinization	O
during	O
erythroid	O
differentiation	O
.	O
In	O
addition,	O
HU	O
stimulates	O
the	O
synthesis	O
of	O
fetal	protein
hemoglobin	protein
in	O
sickle	O
cell	O
anemia	O
patients	O
.	O
To	O
further	O
understand	O
its	O
mechanism	O
of	O
action,	O
we	O
investigated	O
the	O
effects	O
of	O
HU	O
on	O
regulation	O
of	O
c-jun	DNA
expression	O
prior	O
to	O
the	O
onset	O
of	O
erythroid	O
differentiation	O
of	O
K562	cell_line
cells	cell_line
.	O
HU	O
induced	O
a	O
dose-dependent	O
stimulation	O
of	O
c-jun	DNA
synthesis.	O
The	O
levels	O
of	O
c-jun	RNA
mRNA	RNA
was	O
elevated	O
4	O
to	O
7.5-fold	O
by	O
HU	O
within	O
2	O
h.	O
This	O
was	O
followed	O
by	O
a	O
gradual	O
decline	O
to	O
the	O
basal	O
level	O
by	O
24	O
h.	O
Both	O
nuclear	O
run-on	O
and	O
actinomycin	O
D	O
pulse	O
experiments	O
strongly	O
indicate	O
that	O
HU	O
regulates	O
c-jun	RNA
mRNA	RNA
expression	O
by	O
increasing	O
the	O
rate	O
of	O
synthesis	O
as	O
well	O
as	O
stabilizing	O
the	O
c-jun	RNA
mRNA	RNA
.	O
In	O
addition,	O
the	O
level	O
of	O
jun	protein
protein	protein
was	O
elevated	O
by	O
2	O
to	O
5-fold	O
within	O
4	O
h	O
in	O
HU	cell_line
treated	cell_line
cells	cell_line
.	O
Furthermore,	O
concentrations	O
of	O
HU	O
below	O
250	O
microM	O
slightly	O
increased	O
the	O
5X	O
AP-1	protein
/CAT	protein
activity	O
.	O
These	O
results	O
strongly	O
suggest	O
that	O
HU	O
induces	O
both	O
transcriptional	O
and	O
post-transcription	O
regulation	O
of	O
c-jun	DNA
during	O
erythroid	O
differentiation	O
.	O

In	O
vivo	O
and	O
in	O
vitro	O
effects	O
of	O
glucocorticoids	O
on	O
lymphocyte	O
proliferation	O
in	O
man	O
:	O
relationship	O
to	O
glucocorticoid	protein
receptors	protein
.	O
Interrelations	O
between	O
the	O
hypothalamic-pituitary-adrenal	O
system	O
(	O
HPA	O
)	O
and	O
the	O
immune	O
system	O
represent	O
a	O
well-documented	O
biological	O
phenomenon	O
.	O
While	O
in	O
vitro	O
administration	O
of	O
glucocorticoids	O
may	O
inhibit	O
concanavalin	O
A	O
(Con	O
A)-	O
and	O
phytohemagglutinin	O
(PHA)-	O
induced	O
T-cell	O
proliferation	O
,	O
pokeweed	protein
mitogen	protein
(	O
PWM	protein
)-driven	O
B-cell	O
mitogenesis	O
is	O
relatively	O
resistant	O
to	O
glucocorticoids	O
.	O
To	O
further	O
explore	O
the	O
link	O
between	O
the	O
HPA	O
and	O
the	O
immune	O
system	O
in	O
relation	O
to	O
glucocorticoid	protein
receptor	protein
function	O
,	O
dose-response	O
curves	O
were	O
obtained	O
for	O
Con	O
A	O
-and	O
PHA	protein
-induced	O
T-cell	O
mitogenesis	O
,	O
PWM	protein
-generated	O
B-cell	O
mitogenesis	O
and	O
spontaneous	O
lymphocyte	O
proliferation	O
in	O
13	O
healthy	O
controls	O
.	O
Glucocorticoid	O
effects	O
were	O
assessed	O
in	O
vivo	O
by	O
depletion	O
of	O
endogenous	O
glucocorticoids	O
after	O
oral	O
administration	O
of	O
1.5	O
g	O
metyrapone	O
(	O
MET	O
)	O
and	O
subsequent	O
glucocorticoid	O
replacement	O
,	O
and	O
in	O
vitro	O
by	O
incubation	O
of	O
the	O
cells	O
with	O
different	O
doses	O
of	O
dexamethasone	O
(	O
DEX	O
).	O
There	O
was	O
a	O
significant	O
decrease	O
in	O
PWM	protein
-induced	O
B-cell	O
mitogenesis	O
and	O
a	O
more	O
pronounced	O
effect	O
of	O
DEX	O
administered	O
in	O
vitro	O
on	O
spontaneous	O
lymphocyte	O
proliferation	O
after	O
MET	O
treatment	O
when	O
compared	O
with	O
the	O
DEX	O
plus	O
MET	O
pretreated	O
condition	O
in	O
vivo.	O
These	O
data	O
suggest	O
that	O
the	O
inhibition	O
of	O
spontaneous	O
lymphocyte	O
proliferation	O
by	O
glucocorticoids	O
in	O
vitro	O
is	O
related	O
to	O
glucocorticoid	protein
receptor	protein
function	O
.	O
The	O
decrease	O
in	O
PWM	protein
-generated	O
B-cell	O
proliferation	O
following	O
cortisol	O
depletion	O
by	O
MET	O
may	O
be	O
seen	O
in	O
connection	O
with	O
impaired	O
glucocorticoid	O
-mediated	O
induction	O
of	O
interleukin-1	protein
receptor	protein
synthesis	O
.	O

Transcription	O
specific	O
differences	O
visualized	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
pattern	O
on	O
interphase	O
nuclei	O
of	O
different	O
cell	O
types.	O
Application	O
of	O
a	O
"formamide	O
free"	O
and	O
thus	O
"material	O
preserving"	O
in	O
situ	O
hybridization	O
technique	O
using	O
the	O
cDNA	DNA
of	O
the	O
myf3	DNA
gene	DNA
revealed	O
the	O
following	O
results:	O
Human	cell_type
rhabdomyosarcoma	cell_type
cells	cell_type
,	O
characterized	O
by	O
a	O
high	O
expression	O
of	O
myf3	DNA
show	O
intensive	O
hybridization	O
signals	O
in	O
their	O
interphase	O
.	O
RNase	protein
treatment	O
prior	O
to	O
hybridization	O
considerably	O
reduces	O
the	O
size	O
of	O
this	O
signals.	O
In	O
comparison,	O
isolated	O
nuclei	O
of	O
human	cell_type
lymphocytes	cell_type
in	O
which	O
no	O
need	O
for	O
the	O
expression	O
of	O
this	O
gene	O
exists,	O
show	O
barely	O
hybridization	O
signals	O
.	O
Correspondingly,	O
RNase	protein
treatment	O
had	O
no	O
effect	O
on	O
hybridization	O
pattern	O
at	O
all.	O
In	O
conclusion	O
an	O
increased	O
transcription	O
efficiency	O
of	O
a	O
cell	O
type	O
specific	O
gene	O
is	O
accompanied	O
by	O
a	O
higher	O
hybridization	O
accessibility	O
in	O
the	O
corresponding	O
cell	O
nuclei	O
.	O

Oncogenicity	O
of	O
human	O
papillomavirus-	O
or	O
adenovirus-	O
transformed	O
cells	O
correlates	O
with	O
resistance	O
to	O
lysis	O
by	O
natural	cell_type
killer	cell_type
cells	cell_type
.	O
The	O
reasons	O
for	O
the	O
dissimilar	O
oncogenicities	O
of	O
human	O
adenoviruses	O
and	O
human	O
papillomaviruses	O
(	O
HPV	O
)	O
in	O
humans	O
are	O
unknown	O
but	O
may	O
relate	O
to	O
differences	O
in	O
the	O
capacities	O
of	O
the	O
E1A	protein
and	O
E7	protein
proteins	protein
to	O
target	cell_type
cells	cell_type
for	O
rejection	O
by	O
the	O
host	cell_type
natural	cell_type
killer	cell_type
(NK)	cell_type
cell	cell_type
response	O
.	O
As	O
one	O
test	O
of	O
this	O
hypothesis,	O
we	O
compared	O
the	O
abilities	O
of	O
E1A	protein
-and	O
E7	protein
-expressing	O
human	O
fibroblastic	O
or	O
keratinocyte-derived	O
human	O
cells	O
to	O
be	O
selectively	O
killed	O
by	O
either	O
unstimulated	cell_type
or	O
interferon	cell_line
(IFN)-activated	cell_line
NK	cell_line
cells	cell_line
.	O
Cells	O
expressing	O
the	O
E1A	protein
oncoprotein	protein
were	O
selectively	O
killed	O
by	O
unstimulated	cell_line
NK	cell_line
cells	cell_line
,	O
while	O
the	O
same	O
parental	cell_type
cells	cell_type
but	O
expressing	O
the	O
HPV	O
type	O
16	O
(	O
HPV-16	O
)	O
or	O
HPV-18	O
E7	protein
oncoprotein	protein
were	O
resistant	O
to	O
NK	O
cell	O
lysis	O
.	O
The	O
ability	O
of	O
IFN-activated	cell_line
NK	cell_line
cells	cell_line
to	O
selectively	O
kill	O
virally	O
transformed	O
cells	O
depends	O
on	O
IFN	protein
's	O
ability	O
to	O
induce	O
resistance	O
to	O
NK	O
cell	O
lysis	O
in	O
normal	O
(i.e.,	O
non-viral	cell_line
oncogene-expressing	cell_line
)	O
but	O
not	O
virally	cell_line
transformed	cell_line
cells	cell_line
.	O
E1A	protein
blocked	O
IFN	protein
's	O
induction	O
of	O
cytolytic	O
resistance	O
,	O
resulting	O
in	O
the	O
selective	O
lysis	O
of	O
adenovirus-transformed	cell_line
cells	cell_line
by	O
IFN	cell_line
-activated	cell_line
NK	cell_line
cells	cell_line
.	O
The	O
extent	O
of	O
IFN	protein
-induced	O
NK	O
cell	O
killing	O
of	O
E1A	cell_line
-expressing	cell_line
cells	cell_line
was	O
proportional	O
to	O
the	O
level	O
of	O
E1A	protein
expression	O
and	O
correlated	O
with	O
the	O
ability	O
of	O
E1A	protein
to	O
block	O
IFN	protein
-stimulated	O
gene	O
expression	O
in	O
target	cell_type
cells	cell_type
.	O
In	O
contrast,	O
E7	protein
blocked	O
neither	O
IFN	protein
-stimulated	O
gene	O
expression	O
nor	O
IFN	protein
's	O
induction	O
of	O
cytolytic	O
resistance	O
,	O
thereby	O
precluding	O
the	O
selective	O
lysis	O
of	O
HPV	cell_line
-transformed	cell_line
cells	cell_line
by	O
IFN	cell_line
-activated	cell_line
NK	cell_line
cells	cell_line
.	O
In	O
conclusion,	O
E1A	protein
expression	O
marks	O
cells	O
for	O
destruction	O
by	O
the	O
host	O
NK	cell_type
cell	cell_type
response	O
,	O
whereas	O
the	O
E7	protein
oncoprotein	protein
lacks	O
this	O
activity.	O

Regulation	O
of	O
IkB	protein
alpha	protein
phosphorylation	O
by	O
PKC-	O
and	O
Ca(2+)-	O
dependent	O
signal	O
transduction	O
pathways	O
.	O
The	O
Ca(2+)	protein
-dependent	protein
phosphatase	protein
calcineurin	protein
,	O
a	O
target	O
of	O
FK506	O
and	O
CsA	O
,	O
synergizes	O
with	O
PKC	protein
-induced	O
activation	O
of	O
nuclear	protein
factor	protein
(NF)-kappa	protein
B	protein
in	O
T	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
have	O
investigated	O
whether	O
this	O
synergy	O
is	O
present	O
in	O
other	O
cell	O
types	O
and	O
the	O
mechanism(s)	O
by	O
which	O
these	O
two	O
pathways	O
lead	O
to	O
NF-kappa	protein
B	protein
activation	O
.	O
While	O
this	O
synergy	O
is	O
present	O
in	O
other	O
cell	O
types,	O
in	O
the	O
monocytic	cell_line
cell	cell_line
line	cell_line
U937	cell_line
calcineurin	protein
is	O
also	O
sufficient	O
to	O
activate	O
NF-kappa	protein
B	protein
.	O
Having	O
previously	O
shown	O
that	O
Ca(2+)-	O
and	O
PKC-	O
dependent	O
pathways	O
synergize	O
by	O
accelerating	O
the	O
degradation	O
of	O
IkB	protein
alpha	protein
,	O
we	O
focused	O
on	O
the	O
regulation	O
of	O
IkB	protein
alpha	protein
phosphorylation	O
.	O
While	O
PKC	protein
-dependent	O
pathways	O
sequentially	O
result	O
in	O
the	O
phosphorylation	O
and	O
in	O
an	O
incomplete	O
degradation	O
of	O
IkB	protein
alpha	protein
in	O
T	cell_line
cell	cell_line
lines	cell_line
,	O
co-activation	O
of	O
Ca(2+)	O
-dependent	O
pathways	O
accelerates	O
the	O
rate	O
of	O
IkB	protein
alpha	protein
phosphorylation	O
and	O
results	O
in	O
its	O
complete	O
degradation.	O
Activation	O
of	O
Ca(2+)	O
-dependent	O
pathways	O
alone	O
do	O
not	O
result	O
in	O
the	O
phosphorylation	O
and/or	O
degradation	O
of	O
IkB	protein
alpha	protein
in	O
Jurkat	cell_line
T	cell_line
or	O
in	O
U937	cell_line
cells	cell_line
.	O
Treatment	O
of	O
T	cell_type
cells	cell_type
with	O
the	O
selective	O
PKC	protein
inhibitor	O
GF109203X	O
abrogates	O
the	O
PMA	O
-induced	O
IkB	protein
alpha	protein
phosphorylation	O
/degradation	O
irrespective	O
of	O
activation	O
of	O
Ca(2+)	O
-dependent	O
pathways	O
,	O
but	O
not	O
the	O
phosphorylation	O
and	O
degradation	O
of	O
IkB	protein
alpha	protein
induced	O
by	O
TNF-alpha	protein
,	O
a	O
PKC	protein
-independent	O
stimulus	O
.	O
Contrary	O
to	O
the	O
interaction	O
with	O
PKC	protein
,	O
Ca(2+)	O
-dependent	O
pathways	O
synergize	O
with	O
TNF-alpha	protein
not	O
at	O
the	O
level	O
of	O
IkB	protein
alpha	protein
phosphorylation	O
,	O
but	O
at	O
the	O
level	O
of	O
its	O
degradation.	O
These	O
results	O
indicate	O
that	O
Ca(2+)	O
-dependent	O
pathways	O
,	O
including	O
the	O
phosphatase	protein
calcineurin	protein
,	O
participate	O
in	O
the	O
regulation	O
of	O
NF-kappa	protein
B	protein
in	O
a	O
cell	O
specific	O
fashion	O
and	O
synergize	O
with	O
PKC	protein
-dependent	O
and	O
-independent	O
pathways	O
at	O
the	O
level	O
of	O
IkB	protein
alpha	protein
phosphorylation	O
and	O
degradation	O
.	O

Vitamin	O
E	O
therapy	O
of	O
acute	O
CCl4	O
-induced	O
hepatic	O
injury	O
in	O
mice	O
is	O
associated	O
with	O
inhibition	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
binding	O
.	O
Oxidative	O
stress	O
,	O
with	O
reactive	O
oxygen	O
intermediate	O
formation	O
,	O
may	O
represent	O
a	O
common	O
mechanism	O
by	O
which	O
liver	O
injury	O
is	O
induced	O
by	O
diverse	O
etiologies.	O
Oxidative	O
stress	O
enhances	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activity	O
,	O
and	O
NF-kappa	protein
B	protein
activity	O
has	O
been	O
shown	O
to	O
enhance	O
the	O
expression	O
of	O
cytotoxic	protein
cytokines	protein
.	O
Acute	O
hepatic	O
injury	O
caused	O
by	O
reactive	O
oxygen	O
intermediate	O
production	O
was	O
induced	O
by	O
an	O
intraperitoneal	O
injection	O
of	O
CCl4	O
in	O
mice	O
.	O
This	O
injury	O
was	O
significantly	O
inhibited	O
by	O
intravenous	O
pretreatment	O
of	O
the	O
mice	O
with	O
a	O
water-soluble	O
emulsion	O
of	O
alpha-tocopherol	O
.	O
Alpha-tocopherol	O
treatment	O
of	O
the	O
mice	O
given	O
the	O
CCl4	O
also	O
reduced	O
the	O
NF-kappa	protein
B	protein
binding	O
to	O
levels	O
approaching	O
those	O
found	O
in	O
normal	O
mice	O
.	O
In	O
vitro	O
treatment	O
of	O
a	O
monocyte/macrophage	O
cell	O
line	O
with	O
CCl4	O
led	O
to	O
enhanced	O
NF-kappa	protein
B	protein
binding	O
and	O
an	O
increase	O
in	O
tumor	RNA
necrosis	RNA
factor-alpha	RNA
(	RNA
TNF-alpha	RNA
)	RNA
messenger	RNA
RNA	RNA
levels	O
.	O
Liver	O
specimens	O
taken	O
from	O
patients	O
with	O
acute	O
fulminant	O
hepatitis	O
had	O
markedly	O
increased	O
NF-kappa	protein
B	protein
binding	O
activity	O
in	O
comparison	O
with	O
the	O
binding	O
of	O
normal	O
livers	O
.	O
These	O
data	O
demonstrate	O
that	O
abolishing	O
acute	O
hepatic	O
injury	O
with	O
alpha-tocopherol	O
,	O
a	O
free	O
radical	O
scavenger	O
,	O
also	O
eliminated	O
increased	O
NF-kappa	protein
B	protein
binding	O
.	O
It	O
is	O
tempting	O
to	O
speculate	O
that	O
enhanced	O
NF-kappa	protein
B	protein
expression	O
caused	O
by	O
free	O
radical	O
production/oxidative	O
stress	O
may	O
modulate	O
liver	O
injury	O
,	O
perhaps	O
through	O
an	O
effect	O
on	O
cytotoxic	protein
cytokine	protein
synthesis	O
.	O

Immunosuppression	O
by	O
glucocorticoids	O
:	O
inhibition	O
of	O
NF-kappa	protein
B	protein
activity	O
through	O
induction	O
of	O
I	protein
kappa	protein
B	protein
synthesis	O
[see	O
comments]	O
Glucocorticoids	O
are	O
among	O
the	O
most	O
potent	O
anti-inflammatory	O
and	O
immunosuppressive	O
agents	O
.	O
They	O
inhibit	O
synthesis	O
of	O
almost	O
all	O
known	O
cytokines	protein
and	O
of	O
several	O
cell	protein
surface	protein
molecules	protein
required	O
for	O
immune	O
function	O
,	O
but	O
the	O
mechanism	O
underlying	O
this	O
activity	O
has	O
been	O
unclear.	O
Here	O
it	O
is	O
shown	O
that	O
glucocorticoids	O
are	O
potent	O
inhibitors	O
of	O
nuclear	protein
factor	protein
kappa	protein
B	protein
(	O
NF-kappa	protein
B	protein
)	O
activation	O
in	O
mice	O
and	O
cultured	cell_line
cells	cell_line
.	O
This	O
inhibition	O
is	O
mediated	O
by	O
induction	O
of	O
the	O
I	protein
kappa	protein
B	protein
alpha	O
inhibitory	O
protein,	O
which	O
traps	O
activated	O
NF-kappa	protein
B	protein
in	O
inactive	protein
cytoplasmic	protein
complexes	protein
.	O
Because	O
NF-kappa	protein
B	protein
activates	O
many	O
immunoregulatory	DNA
genes	DNA
in	O
response	O
to	O
pro-inflammatory	O
stimuli,	O
the	O
inhibition	O
of	O
its	O
activity	O
can	O
be	O
a	O
major	O
component	O
of	O
the	O
anti-inflammatory	O
activity	O
of	O
glucocorticoids	O
.	O

Transcriptional	O
repression	O
of	O
the	O
interleukin-2	DNA
gene	DNA
by	O
vitamin	O
D3	O
:	O
direct	O
inhibition	O
of	O
NFATp/AP-1	protein
complex	protein
formation	O
by	O
a	O
nuclear	protein
hormone	protein
receptor	protein
.	O
T-	O
lymphocyte	O
proliferation	O
is	O
suppressed	O
by	O
1,25-dihydroxyvitamin	O
D3	O
[	O
1,25(OH)2D3	O
],	O
the	O
active	O
metabolite	O
of	O
vitamin	O
D3	O
,	O
and	O
is	O
associated	O
with	O
a	O
decrease	O
in	O
interleukin	O
2	O
(IL-2)	O
,	O
gamma	O
interferon	O
,	O
and	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
mRNA	O
levels	O
.	O
We	O
report	O
here	O
that	O
1,25(OH)2D3	O
-mediated	O
repression	O
in	O
Jurkat	cell_line
cells	cell_line
is	O
cycloheximide	O
resistant	O
,	O
suggesting	O
that	O
it	O
is	O
a	O
direct	O
transcriptional	O
repressive	O
effect	O
on	O
IL-2	protein
expression	O
by	O
the	O
vitamin	protein
D3	protein
receptor	protein
(	O
VDR	protein
).	O
We	O
therefore	O
examined	O
vitamin	O
D3	O
-mediated	O
repression	O
of	O
activated	O
IL-2	protein
expression	O
by	O
cotransfecting	O
Jurkat	cell_line
cells	cell_line
with	O
IL-2	DNA
promoter/reporter	DNA
constructs	DNA
and	O
a	O
VDR	DNA
overexpression	DNA
vector	DNA
and	O
by	O
DNA	O
binding	O
.	O
We	O
delineated	O
an	O
element	O
conferring	O
both	O
DNA	O
binding	O
by	O
the	O
receptor	O
in	O
vitro	O
and	O
1,25(OH)2D3	O
-mediated	O
repression	O
in	O
vivo	O
to	O
a	O
short	O
40-bp	DNA
region	DNA
encompassing	O
an	O
important	O
positive	DNA
regulatory	DNA
element	DNA
,	O
NF-AT-1	DNA
,	O
which	O
is	O
bound	O
by	O
a	O
T-cell-specific	protein
transcription	protein
factor	protein
,	O
NFATp	protein
,	O
as	O
well	O
as	O
by	O
AP-1	protein
.	O
VDR	protein
DNA-binding	protein
mutants	protein
were	O
unable	O
to	O
either	O
bind	O
to	O
this	O
element	O
in	O
vitro	O
or	O
repress	O
in	O
vivo;	O
the	O
VDR	protein
DNA-binding	protein
domain	protein
alone,	O
however,	O
bound	O
the	O
element	O
but	O
also	O
could	O
not	O
repress	O
IL-2	protein
expression	O
.	O
These	O
results	O
indicate	O
that	O
DNA	O
binding	O
by	O
VDR	protein
is	O
necessary	O
but	O
not	O
sufficient	O
to	O
mediate	O
IL-2	protein
repression	O
.	O
By	O
combining	O
partially	protein
purified	protein
proteins	protein
in	O
vitro,	O
we	O
observed	O
the	O
loss	O
of	O
the	O
bound	O
NFATp	protein
/AP-1-DNA	protein
complex	protein
upon	O
inclusion	O
of	O
VDR	protein
or	O
VDR	protein
-retinoid	protein
X	protein
receptor	protein
.	O
Order	O
of	O
addition	O
and	O
off-rate	O
experiments	O
indicate	O
that	O
the	O
VDR	protein
-retinoid	protein
X	protein
receptor	protein
heterodimer	protein
blocks	O
NFATp	protein
/	protein
AP-1	protein
complex	protein
formation	O
and	O
then	O
stably	O
associates	O
with	O
the	O
NF-AT-1	DNA
element	DNA
.	O
This	O
direct	O
inhibition	O
by	O
a	O
nuclear	O
hormone	O
receptor	O
of	O
transcriptional	protein
activators	protein
of	O
the	O
IL-2	DNA
gene	DNA
may	O
provide	O
a	O
mechanistic	O
explanation	O
of	O
how	O
vitamin	O
derivatives	O
can	O
act	O
as	O
potent	O
immunosuppressive	O
agents	O
.	O

Tissue-specific	O
regulation	O
of	O
the	O
rabbit	DNA
15-lipoxygenase	DNA
gene	DNA
in	O
erythroid	cell_type
cells	cell_type
by	O
a	O
transcriptional	DNA
silencer	DNA
.	O
The	O
15-lipoxygenase	DNA
(lox)	DNA
gene	DNA
is	O
expressed	O
in	O
a	O
tissue-specific	O
manner	O
,	O
predominantly	O
in	O
erythroid	cell_type
cells	cell_type
but	O
also	O
in	O
airway	cell_type
epithelial	cell_type
cells	cell_type
and	O
eosinophils	cell_type
.	O
We	O
demonstrate	O
in	O
this	O
report	O
that	O
the	O
5'	DNA
flanking	DNA
DNA	DNA
of	O
the	O
15-lox	DNA
gene	DNA
contains	O
sequences	O
which	O
down-regulate	O
its	O
activity	O
in	O
a	O
variety	O
of	O
non-erythroid	cell_line
cell	cell_line
lines	cell_line
but	O
not	O
in	O
two	O
erythroid	cell_line
cell	cell_line
lines	cell_line
.	O
The	O
element	O
has	O
characteristics	O
of	O
a	O
transcriptional	DNA
'silencer'	DNA
since	O
it	O
functions	O
in	O
both	O
orientations.	O
The	O
main	O
activity	O
of	O
the	O
silencer	DNA
has	O
been	O
mapped	O
to	O
the	O
first	O
900	O
bp	O
of	O
5'	DNA
flanking	DNA
DNA	DNA
,	O
which	O
contains	O
nine	O
binding	O
sites	O
for	O
a	O
nuclear	protein
factor	protein
present	O
in	O
non-	O
erythroid	cell_type
cells	cell_type
but	O
not	O
in	O
erythroid	cell_type
cells	cell_type
.	O
These	O
binding	O
sites	O
have	O
similar	O
sequences	O
and	O
multiple	O
copies	O
of	O
the	O
binding	DNA
sites	DNA
confer	O
tissue-specific	O
down-regulation	O
when	O
attached	O
to	O
a	O
minimal	DNA
lox	DNA
promoter	DNA
fragment	DNA
.	O
The	O
5'	DNA
flanking	DNA
DNA	DNA
also	O
contains	O
a	O
cluster	O
of	O
three	O
binding	DNA
sites	DNA
for	O
the	O
GATA	protein
family	protein
of	O
transcription	protein
factors	protein
.	O

Phosphorylation	O
of	O
the	O
transcription	protein
factor	protein
NFATp	protein
inhibits	O
its	O
DNA	O
binding	O
activity	O
in	O
cyclosporin	cell_line
A-treated	cell_line
human	cell_line
B	cell_line
and	O
T	cell_type
cells	cell_type
.	O
Cyclosporin	O
A	O
(	O
CsA	O
)	O
exerts	O
its	O
immunosuppressive	O
effect	O
by	O
inhibiting	O
the	O
activity	O
of	O
nuclear	protein
factor	protein
of	O
activated	O
T	cell_type
cells	cell_type
(	O
NFAT	protein
),	O
thus	O
preventing	O
transcriptional	O
induction	O
of	O
several	O
cytokine	O
genes.	O
This	O
effect	O
is	O
thought	O
to	O
be	O
largely	O
mediated	O
through	O
inactivation	O
of	O
the	O
phosphatase	O
calcineurin	protein
,	O
which	O
in	O
turn	O
inhibits	O
translocation	O
of	O
an	O
NFAT	protein
component	O
to	O
the	O
nucleus.	O
Here	O
we	O
report	O
that	O
CsA	O
treatment	O
of	O
Raji	cell_line
B	cell_line
and	O
Jurkat	cell_line
T	cell_line
cell	cell_line
lines	cell_line
yields	O
a	O
phosphorylated	O
form	O
of	O
NFATp	protein
that	O
is	O
inhibited	O
in	O
DNA-binding	O
and	O
in	O
its	O
ability	O
to	O
form	O
an	O
NFAT	protein
complex	protein
with	O
Fos	protein
and	O
Jun	protein
.	O
Immunoblot	O
analyses	O
and	O
metabolic	O
labeling	O
with	O
[32P]orthophosphate	O
show	O
that	O
CsA	O
alters	O
NFATp	protein
migration	O
on	O
SDS-polyacrylamide	O
gel	O
electrophoresis	O
by	O
increasing	O
its	O
phosphorylation	O
level	O
without	O
affecting	O
subcellular	O
distribution.	O
Dephosphorylation	O
by	O
in	O
vitro	O
treatment	O
with	O
calcineurin	protein
or	O
alkaline	protein
phosphatase	protein
restores	O
NFATp	protein
DNA	O
binding	O
activity	O
and	O
its	O
ability	O
to	O
reconstitute	O
an	O
NFAT	protein
complex	protein
with	O
Fos	protein
and	O
Jun	protein
proteins.	O
These	O
data	O
point	O
to	O
a	O
new	O
mechanism	O
for	O
CsA	O
-sensitive	O
regulation	O
of	O
NFATp	protein
in	O
which	O
dephosphorylation	O
is	O
critical	O
for	O
DNA	O
binding.	O

Transcription	protein
factors	protein
as	O
targets	O
for	O
oxidative	O
signalling	O
during	O
lymphocyte	O
activation	O
.	O
We	O
previously	O
have	O
demonstrated	O
a	O
requirement	O
for	O
oxidative	O
events	O
during	O
cell	O
cycle	O
entry	O
in	O
T	cell_type
lymphocytes	cell_type
and	O
have	O
hypothesised	O
that	O
reactive	O
oxygen	O
species	O
may	O
act	O
as	O
intracellular	O
signalling	O
agents	O
during	O
lymphocyte	O
activation	O
.	O
In	O
the	O
current	O
study,	O
cysteamine	O
,	O
an	O
aminothiol	O
compound	O
with	O
antioxidant	O
activity	O
,	O
has	O
been	O
used	O
to	O
further	O
investigate	O
the	O
role	O
of	O
oxidative	O
signalling	O
during	O
lymphocyte	O
activation	O
.	O
Treatment	O
of	O
normal	O
human	cell_type
peripheral	cell_type
blood	cell_type
lymphocytes	cell_type
with	O
cysteamine	O
in	O
vitro	O
was	O
found	O
to	O
inhibit	O
proliferation	O
in	O
a	O
dose-dependent	O
manner	O
,	O
with	O
essentially	O
complete	O
inhibition	O
occurring	O
at	O
a	O
dose	O
of	O
400	O
microM.	O
This	O
inhibitory	O
effect	O
was	O
limited	O
to	O
the	O
first	O
2	O
h	O
after	O
mitogenic	O
activation	O
,	O
localizing	O
the	O
time-frame	O
of	O
action	O
of	O
cysteamine	O
to	O
within	O
the	O
commitment	O
period	O
.	O
It	O
therefore	O
was	O
of	O
interest	O
to	O
establish	O
which,	O
if	O
any,	O
commitment	O
events	O
were	O
affected	O
by	O
oxidative	O
signalling	O
during	O
cell	O
cycle	O
entry	O
.	O
Taking	O
the	O
IL-2	DNA
gene	DNA
as	O
a	O
candidate,	O
we	O
examined	O
the	O
effect	O
of	O
cysteamine	O
treatment	O
on	O
early	DNA
gene	DNA
expression	O
during	O
lymphocyte	O
activation	O
,	O
and	O
on	O
the	O
activity	O
of	O
transcription	protein
factors	protein
AP-1	protein
,	O
NF-kappa	protein
B	protein
,	O
NF-AT	protein
and	O
Oct1	protein
,	O
whose	O
functions	O
are	O
required	O
for	O
expression	O
of	O
the	O
IL-2	protein
mRNA.	O
Cysteamine	O
treatment	O
inhibited	O
both	O
expression	O
of	O
the	O
IL-2	RNA
mRNA	RNA
and	O
secretion	O
of	O
IL-2	protein
into	O
the	O
culture	O
medium	O
.	O
The	O
inhibitory	O
effect	O
of	O
cysteamine	O
may	O
be	O
mediated	O
at	O
least	O
in	O
part	O
by	O
an	O
effect	O
on	O
transcription	protein
factor	protein
function	O
,	O
as	O
the	O
DNA	O
binding	O
activities	O
of	O
AP-1	protein
and	O
NF-kappa	protein
B	protein
extracted	O
from	O
mitogen-stimulated	cell_type
cells	cell_type
were	O
significantly	O
inhibited	O
by	O
cysteamine	O
treatment	O
.	O
Interestingly,	O
Oct1	O
and	O
NF-AT	O
DNA	O
binding	O
activity	O
were	O
not	O
affected	O
by	O
cysteamine	O
treatment,	O
suggesting	O
that	O
oxidative	O
signalling	O
processes	O
operate	O
in	O
a	O
selective	O
manner.	O
The	O
identification	O
of	O
regulatory	protein
proteins	protein
,	O
such	O
as	O
transcription	protein
factors	protein
,	O
as	O
molecular	O
targets	O
for	O
oxidative	O
signalling	O
provides	O
further	O
evidence	O
to	O
implicate	O
oxidative	O
signalling	O
as	O
being	O
intimately	O
involved	O
in	O
the	O
G0	O
to	O
G1	O
phase	O
transition	O
in	O
T	cell_type
lymphocytes	cell_type
.	O

Sex	O
and	O
age	O
distribution	O
of	O
1,25(OH)2D3	protein
receptors	protein
in	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
from	O
normal	O
human	O
subjects	O
.	O
Specific	O
receptors	O
for	O
1,25	O
Dihydroxyvitamin	O
D3	O
have	O
been	O
described	O
in	O
human	O
peripheral	cell_type
blood	cell_type
mononuclear	cell_type
cells	cell_type
(	O
PBMC	cell_type
).	O
We	O
have	O
tried	O
to	O
find	O
out	O
whether	O
these	O
receptors	O
could	O
show	O
any	O
difference	O
in	O
sex	O
or	O
age	O
distribution.	O
Twenty	O
two	O
healthy	O
men	O
aged	O
21-66	O
yr	O
(mean	O
+/-	O
SD	O
41.0	O
+/-	O
13.6)	O
and	O
nineteen	O
healthy	O
women	O
aged	O
22-60	O
yr	O
(38.9	O
+/-	O
13.9)	O
have	O
been	O
studied.	O
The	O
mean	O
dissociation	O
constant	O
(	O
Kd	O
)	O
was	O
similar	O
in	O
both	O
sexes	O
(1.35	O
+/-	O
0.70	O
x	O
10(-10)	O
M	O
in	O
males,	O
1.13	O
+/-	O
0.66	O
x	O
10(-10)	O
M	O
in	O
females),	O
but	O
the	O
concentration	O
of	O
binding	O
sites	O
(Nmax)	O
was	O
significantly	O
lower	O
in	O
females	O
(2.32	O
+/-	O
0.92	O
fmol/10(7)	O
PBMC	cell_type
vs	O
4.43	O
+/-	O
1.38	O
fmol/10(7)	O
PBMC	cell_type
in	O
males	O
;	O
p	O
=	O
0.0001).	O
Neither	O
Kd	O
nor	O
Nmax	O
were	O
significantly	O
correlated	O
with	O
age.	O
No	O
difference	O
was	O
found	O
between	O
pre	O
and	O
post	O
menopausal	O
women	O
.	O
Further	O
studies	O
are	O
needed	O
to	O
elucidate	O
if	O
this	O
sex	O
difference	O
in	O
PBMC	protein
receptors	protein
for	O
1.25	O
Dihydroxyvitamin	O
D3	O
is	O
of	O
any	O
pathophysiological	O
relevance	O
.	O

Expression	O
of	O
Id2	O
and	O
Id3	O
mRNA	O
in	O
human	cell_type
lymphocytes	cell_type
.	O
Helix-loop-helix	protein
(	protein
HLH	protein
)	protein
transcription	protein
factors	protein
are	O
involved	O
in	O
cellular	O
growth	O
and	O
differentiation	O
.	O
The	O
Id	protein
(	O
inhibitor	O
of	O
DNA	O
binding	O
and	O
differentiation	O
)	O
HLH	protein
proteins	protein
,	O
in	O
a	O
dominantly	O
negative	O
fashion,	O
regulate	O
transcriptional	O
activities	O
of	O
basic	protein
HLH	protein
proteins	protein
.	O
We	O
examined	O
by	O
northern	O
hybridization	O
the	O
expression	O
of	O
Id2	O
and	O
Id3	O
mRNA	O
in	O
human	cell_line
leukemia/lymphoma	cell_line
lines	cell_line
and	O
patient	O
samples	O
,	O
as	O
well	O
as	O
resting	O
and	O
activated	cell_line
normal	cell_line
human	cell_line
lymphocytes	cell_line
from	O
peripheral	O
blood	O
(	O
PBL	cell_type
).	O
The	O
Id2	RNA
mRNA	RNA
was	O
abundantly	O
expressed	O
in	O
5/12	cell_line
T-cell	cell_line
and	O
3/4	cell_line
B-cell	cell_line
lines	cell_line
,	O
and	O
Id3	RNA
mRNA	RNA
was	O
detected	O
in	O
4/12	cell_line
T-cell	cell_line
and	O
3/4	cell_line
B-cell	cell_line
lines	cell_line
.	O
Interestingly,	O
Id2	RNA
,	O
but	O
not	O
Id3	RNA
,	O
mRNA	O
was	O
strongly	O
expressed	O
in	O
4/5	cell_line
T-cell	cell_line
lines	cell_line
infected	O
with	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
(	O
ATL-1k	cell_line
,	O
MT-2	cell_line
,	O
S-LB1	cell_line
)	O
and	O
type	O
II	O
(	O
Mo	cell_line
)	O
.	O
Another	O
unexpected	O
finding	O
was	O
that	O
T-cell	O
leukemias	O
and	O
T-cell	cell_line
lines	cell_line
often	O
expressed	O
either	O
Id2	RNA
or	O
Id3	RNA
mRNA	RNA
.	O
In	O
addition,	O
resting	cell_type
PBL	cell_type
constitutively	O
expressed	O
prominent	O
levels	O
of	O
Id2	RNA
mRNA	RNA
,	O
but	O
not	O
Id3	RNA
mRNA	RNA
.	O
Upon	O
PHA	protein
-stimulation	O
,	O
Id2	protein
expression	O
decreased	O
and	O
Id3	protein
levels	O
increased	O
with	O
biphasic	O
kinetics.	O
Taken	O
together,	O
our	O
studies	O
revealed	O
three	O
unexpected	O
findings	O
which	O
require	O
further	O
analysis:	O
(1)	O
expression	O
of	O
Id2	RNA
mRNA	RNA
is	O
often	O
associated	O
with	O
lymphocytic	O
transformation	O
by	O
HTLV-I	O
or	O
-II;	O
(2)	O
T-cells	O
usually	O
express	O
either	O
Id2	protein
or	O
Id3	RNA
mRNA	RNA
,	O
but	O
B-cells	O
often	O
express	O
both	O
simultaneously;	O
(3)	O
non-dividing,	O
normal	O
PBL	cell_type
express	O
high	O
levels	O
of	O
Id2	protein
and	O
no	O
Id3	RNA
mRNA	RNA
;	O
and	O
with	O
the	O
onset	O
of	O
cellular	O
proliferation,	O
levels	O
of	O
Id2	RNA
mRNA	RNA
decrease	O
while	O
levels	O
of	O
Id3	RNA
mRNA	RNA
increase,	O
suggesting	O
that	O
regulation	O
of	O
expression	O
of	O
these	O
closely	O
related	O
genes	DNA
is	O
disparate.	O

Salicylates	O
inhibit	O
lipopolysaccharide	O
-induced	O
transcriptional	O
activation	O
of	O
the	O
tissue	O
factor	O
gene	O
in	O
human	cell_type
monocytic	cell_type
cells	cell_type
.	O
Binding	O
of	O
plasma	protein
Factor	protein
VII/VIIa	protein
to	O
the	O
tissue	protein
factor	protein
(TF)	protein
receptor	protein
initiates	O
the	O
coagulation	protein
protease	protein
cascades	O
.	O
TF	O
expression	O
by	O
circulating	cell_type
monocytes	cell_type
is	O
associated	O
with	O
thrombotic	O
and	O
inflammatory	O
complications	O
in	O
a	O
variety	O
of	O
diseases.	O
Transcriptional	O
activation	O
of	O
the	O
human	DNA
TF	DNA
gene	DNA
in	O
monocytic	cell_type
cells	cell_type
exposed	O
to	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
mediated	O
by	O
binding	O
of	O
c-Rel/p65	protein
heterodimers	protein
to	O
a	O
kappa	DNA
B	DNA
site	DNA
in	O
the	O
TF	DNA
promoter	DNA
.	O
Here,	O
we	O
report	O
that	O
a	O
family	O
of	O
anti-inflammatory	O
agents	O
,	O
known	O
as	O
the	O
salicylates,	O
inhibited	O
LPS	O
induction	O
of	O
TF	O
activity	O
and	O
TF	DNA
gene	DNA
transcription	O
in	O
human	cell_type
monocytes	cell_type
and	O
monocytic	cell_line
THP-1	cell_line
cells	cell_line
at	O
clinically	O
relevant	O
doses.	O
Furthermore,	O
sodium	O
salicylate	O
blocked	O
the	O
LPS	O
-induced	O
proteolytic	O
degradation	O
of	O
I	protein
kappa	protein
B	protein
alpha	protein
,	O
which	O
prevented	O
the	O
nuclear	O
translocation	O
of	O
c-Rel/p65	protein
heterodimers	protein
.	O
In	O
contrast,	O
two	O
other	O
nonsteroidal	O
anti-inflammatory	O
drugs	O
,	O
ibuprofen	O
and	O
indomethacin	O
,	O
did	O
not	O
inhibit	O
LPS	O
induction	O
of	O
the	O
TF	DNA
gene	DNA
.	O
These	O
results	O
indicated	O
that	O
salicylates	O
inhibited	O
LPS	O
induction	O
of	O
TF	DNA
gene	DNA
transcription	O
in	O
monocytic	cell_type
cells	cell_type
by	O
preventing	O
nuclear	O
translocation	O
of	O
c-Rel/p65	protein
heterodimers	protein
.	O
The	O
clinical	O
benefits	O
of	O
salicylates	O
in	O
the	O
treatment	O
of	O
several	O
diseases,	O
including	O
atherosclerosis	O
and	O
rheumatoid	O
arthritis	O
,	O
may	O
be	O
related	O
to	O
their	O
ability	O
to	O
reduce	O
monocyte	O
gene	O
expression	O
.	O

Activation	O
of	O
the	O
signal	O
transducer	O
and	O
transcription	O
(	O
STAT	protein
)	O
signaling	O
pathway	O
in	O
a	O
primary	O
T	O
cell	O
response	O
.	O
Critical	O
role	O
for	O
IL-6	protein
.	O
The	O
T	O
cell	O
activation	O
is	O
initiated	O
by	O
interaction	O
of	O
specific	O
Ags	protein
with	O
TCR	protein
,	O
followed	O
by	O
activation	O
of	O
intracellular	O
biochemical	O
events	O
leading	O
to	O
activation	O
of	O
several	O
genes.	O
The	O
activation	O
of	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	protein
(STAT)	protein
proteins	protein
in	O
a	O
primary	O
TCR	protein
-mediated	O
activation	O
of	O
T	cell_type
cells	cell_type
have	O
been	O
explored.	O
In	O
purified	cell_type
human	cell_type
peripheral	cell_type
blood	cell_type
T	cell_type
cells	cell_type
,	O
nuclear	protein
STAT	protein
proteins	protein
were	O
activated	O
approximately	O
3	O
h	O
after	O
activation	O
by	O
cross-linked	O
anti-CD3	protein
Abs	protein
.	O
These	O
STAT	protein
proteins	protein
were	O
detected	O
by	O
using	O
the	O
IFN-gamma-activated	DNA
sequence	DNA
(	O
GAS	DNA
)	O
and	O
related	O
oligonucleotides	O
as	O
probes	O
in	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
Analysis	O
of	O
the	O
nuclear	O
extracts	O
with	O
anti-STAT	protein
Abs	protein
indicated	O
that	O
they	O
contained	O
STAT-3	protein
and	O
additional	O
proteins	O
crossreactive	O
with	O
the	O
STAT	protein
family	protein
.	O
The	O
induction	O
of	O
STAT	protein
activity	O
was	O
inhibited	O
completely	O
by	O
pretreatment	O
with	O
either	O
cycloheximide	O
or	O
cyclosporin	O
A	O
,	O
thus	O
indicating	O
that	O
the	O
induction	O
was	O
due	O
to	O
a	O
secondary	protein
factor	protein
produced	O
by	O
the	O
activated	O
T	cell_type
cells	cell_type
.	O
As	O
neutralizing	protein
anti-	protein
IL-6	protein
Abs	protein
effectively	O
down-regulated	O
the	O
early	O
induction	O
of	O
STAT	protein
proteins	protein
and	O
as	O
exogenously	O
added	O
IL-6	protein
rapidly	O
activated	O
DNA	O
binding	O
similar	O
to	O
TCR	protein
-mediated	O
bindings	O
,	O
it	O
can	O
be	O
concluded	O
that	O
IL-6	protein
is	O
the	O
factor	O
responsible	O
for	O
the	O
activation	O
of	O
STAT	protein
proteins	protein
in	O
a	O
primary	O
T	O
cell	O
response	O
.	O

The	O
normal	O
cell	O
cycle	O
activation	O
program	O
is	O
exploited	O
during	O
the	O
infection	O
of	O
quiescent	cell_type
B	cell_type
lymphocytes	cell_type
by	O
Epstein-Barr	O
virus	O
.	O
B	cell_type
lymphocytes	cell_type
in	O
the	O
peripheral	O
circulation	O
are	O
maintained	O
in	O
a	O
non-proliferative	O
state	O
.	O
Antigen	O
recognition	O
stimulates	O
limited	O
proliferation,	O
whereas	O
infection	O
with	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
results	O
in	O
continual	O
proliferation	O
and	O
the	O
outgrowth	O
of	O
immortal	cell_line
cell	cell_line
lines	cell_line
.	O
Because	O
it	O
is	O
not	O
clear	O
at	O
which	O
point	O
in	O
cell	O
cycle	O
the	O
peripheral	cell_type
B	cell_type
lymphocytes	cell_type
are	O
arrested,	O
we	O
characterized	O
the	O
expression	O
of	O
several	O
cell	DNA
cycle-associated	DNA
genes	DNA
in	O
quiescent	O
and	O
stimulated	O
cells	O
.	O
We	O
show	O
that	O
the	O
expression	O
of	O
four	O
cell	DNA
genes	DNA
,	O
cdc-2	DNA
,	O
cyclin	DNA
E	DNA
,	O
CD23	DNA
,	O
and	O
cyclin	DNA
D2	DNA
,	O
are	O
up-regulated	O
approximately	O
100-fold	O
as	O
a	O
result	O
of	O
EBV	O
-mediated	O
immortalization	O
.	O
Because	O
these	O
genes	O
play	O
a	O
positive	O
role	O
in	O
cell	O
proliferation,	O
we	O
suggest	O
that	O
this	O
regulatory	O
switch	O
contributes	O
to	O
controlling	O
entry	O
into	O
the	O
cell	O
cycle	O
.	O
Transient	O
stimulation	O
of	O
quiescent	cell_type
B	cell_type
lymphocytes	cell_type
with	O
either	O
a	O
cocktail	O
of	O
anti-CD40	protein
,	O
anti-IgM	protein
,	O
and	O
IL4	protein
,	O
or	O
EBV	O
results	O
in	O
the	O
rapid	O
expression	O
of	O
the	O
same	O
four	O
genes,	O
suggesting	O
that,	O
after	O
infection,	O
EBV	O
exploits	O
the	O
normal	O
program	O
of	O
B-lymphocyte	cell_type
cell	O
cycle	O
activation	O
.	O

Expression	O
of	O
the	O
chemokine	protein
receptor	protein
BLR2/EBI1	protein
is	O
specifically	O
transactivated	O
by	O
Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
.	O
In	O
our	O
attempt	O
to	O
identify	O
chemokine	protein
receptors	protein
that	O
are	O
related	O
to	O
Burkitt's	protein
lymphoma	protein
receptor	protein
1	protein
(	O
BLR1	protein
)	O
and	O
are	O
expressed	O
in	O
activated	cell_type
lymphocytes	cell_type
we	O
used	O
RT-PCR	O
resulting	O
in	O
the	O
isolation	O
of	O
a	O
cDNA	O
encoding	O
a	O
seven	protein
transmembrane	protein
receptor	protein
termed	O
BLR2	protein
.	O
The	O
protein	O
shows	O
significant	O
sequence	O
similarities	O
to	O
the	O
family	O
of	O
G-protein	protein
coupled	protein
chemokine	protein
receptors	protein
and	O
turned	O
out	O
to	O
be	O
identical	O
to	O
the	O
recently	O
described	O
receptor	protein
EBI1	protein
.	O
Northern	O
blot	O
analysis	O
revealed	O
that	O
BLR2	RNA
mRNA	RNA
could	O
be	O
highly	O
stimulated	O
in	O
mitogen-	O
and	O
anti-CD3-	O
treated	O
peripheral	O
blood	O
lymphocytes	O
.	O
BLR2	RNA
-specific	RNA
mRNA	RNA
could	O
be	O
detected	O
in	O
all	O
Epstein-Barr	cell_line
virus	cell_line
positive	cell_line
B	cell_line
cell	cell_line
lines	cell_line
.	O
We	O
show	O
that	O
transcription	O
of	O
the	O
BLR2	DNA
gene	DNA
could	O
be	O
specifically	O
induced	O
in	O
Epstein-Barr	cell_line
virus	cell_line
negative	cell_line
BL	cell_line
41	cell_line
cells	cell_line
via	O
estrogen-mediated	O
activation	O
of	O
Epstein-Barr	protein
virus	protein
nuclear	protein
antigen	protein
2	protein
,	O
a	O
key	O
regulator	O
of	O
viral	DNA
and	DNA
cellular	DNA
genes	DNA
in	O
immortalized	cell_line
B	cell_line
cells	cell_line
.	O
Our	O
data	O
suggest	O
an	O
involvement	O
of	O
BLR2	protein
in	O
the	O
regulation	O
of	O
migration	O
in	O
activated	cell_type
lymphocytes	cell_type
and	O
in	O
viral	O
pathogenesis	O
.	O

A	O
central	O
role	O
for	O
a	O
single	DNA
c-Myb	DNA
binding	DNA
site	DNA
in	O
a	O
thymic	DNA
locus	DNA
control	DNA
region	DNA
.	O
Locus	DNA
control	DNA
regions	DNA
(	O
LCRs	DNA
)	O
are	O
powerful	O
assemblies	O
of	O
cis	DNA
elements	DNA
that	O
organize	O
the	O
actions	O
of	O
cell-type-specific	protein
trans-acting	protein
factors	protein
.	O
A	O
2.3-kb	protein
LCR	protein
in	O
the	O
human	DNA
adenosine	DNA
deaminase	DNA
(ADA)	DNA
gene	DNA
first	DNA
intron	DNA
,	O
which	O
controls	O
expression	O
in	O
thymocytes	cell_type
,	O
is	O
composed	O
of	O
a	O
200-bp	DNA
enhancer	DNA
domain	DNA
and	O
extended	O
flanking	O
sequences	O
that	O
facilitate	O
activation	O
from	O
within	O
chromatin	DNA
.	O
Prior	O
analyses	O
have	O
demonstrated	O
that	O
the	O
enhancer	DNA
contains	O
a	O
28-bp	DNA
core	DNA
region	DNA
and	O
local	O
adjacent	O
augmentative	O
cis	DNA
elements	DNA
.	O
We	O
now	O
show	O
that	O
the	O
core	O
contains	O
a	O
single	O
critical	O
c-Myb	DNA
binding	DNA
site	DNA
.	O
In	O
both	O
transiently	cell_line
cotransfected	cell_line
human	cell_line
cells	cell_line
and	O
stable	O
chromatin-integrated	cell_line
yeast	cell_line
cells	cell_line
,	O
c-Myb	protein
strongly	O
transactivated	DNA
reporter	DNA
constructs	DNA
that	O
contained	O
polymerized	DNA
core	DNA
sequences	DNA
.	O
c-Myb	protein
protein	protein
was	O
strongly	O
evident	O
in	O
T	cell_type
lymphoblasts	cell_type
in	O
which	O
the	O
enhancer	DNA
was	O
active	O
and	O
was	O
localized	O
within	O
discrete	O
nuclear	O
structures	O
.	O
Fetal	O
murine	O
thymus	O
exhibited	O
a	O
striking	O
concordance	O
of	O
endogenous	O
c-myb	DNA
expression	O
with	O
that	O
of	O
mouse	DNA
ADA	DNA
and	O
human	DNA
ADA	DNA
LCR	DNA
-directed	O
transgene	O
expression	O
.	O
Point	O
mutation	O
of	O
the	O
c-Myb	DNA
site	DNA
within	O
the	O
intact	O
2.3-kb	protein
LCR	protein
severely	O
attenuated	O
enhancer	O
activity	O
in	O
transfections	O
and	O
LCR	DNA
activity	O
in	O
transgenic	cell_line
thymocytes	cell_line
.	O
Within	O
the	O
context	O
of	O
a	O
complex	DNA
enhancer	DNA
and	O
LCR	DNA
,	O
c-Myb	protein
can	O
act	O
as	O
an	O
organizer	O
of	O
thymocyte-specific	DNA
gene	DNA
expression	O
via	O
a	O
single	O
binding	O
site.	O

A	O
regulatory	DNA
element	DNA
in	O
the	O
human	DNA
interleukin	DNA
2	DNA
gene	DNA
promoter	DNA
is	O
a	O
binding	DNA
site	DNA
for	O
the	O
zinc	protein
finger	protein
proteins	protein
Sp1	protein
and	O
EGR-1	protein
.	O
Activation	O
of	O
the	O
interleukin	DNA
2	DNA
(	DNA
IL-2	DNA
)	DNA
gene	DNA
after	O
antigen	O
recognition	O
is	O
a	O
critical	O
event	O
for	O
T	O
cell	O
proliferation	O
and	O
effector	O
function.	O
Prior	O
studies	O
have	O
identified	O
several	O
transcription	protein
factors	protein
that	O
contribute	O
to	O
the	O
activity	O
of	O
the	O
IL-2	DNA
promoter	DNA
in	O
stimulated	cell_type
T	cell_type
lymphocytes	cell_type
.	O
Here	O
we	O
describe	O
a	O
novel	O
regulatory	DNA
element	DNA
within	O
the	O
IL-2	DNA
promoter	DNA
located	O
immediately	O
upstream	O
of	O
the	O
nuclear	DNA
factor	DNA
of	DNA
activated	DNA
T	DNA
cell	DNA
(	DNA
NFAT	DNA
)	DNA
domain	DNA
.	O
This	O
region	O
(termed	O
the	O
zinc	DNA
finger	DNA
protein	DNA
binding	DNA
region	DNA
(	O
ZIP	DNA
))	O
serves	O
as	O
binding	O
site	O
for	O
two	O
differently	O
regulated	O
zinc	protein
finger	protein
proteins	protein
:	O
the	O
constitutively	protein
expressed	protein
transcription	protein
factor	protein
Sp1	protein
and	O
the	O
inducible	protein
early	protein
growth	protein
response	protein
protein	protein
EGR-1	protein
.	O
In	O
unstimulated	cell_type
cells	cell_type
which	O
do	O
not	O
secrete	O
IL-2	protein
,	O
only	O
Sp1	protein
binds	O
to	O
this	O
region,	O
while	O
in	O
stimulated	cell_line
IL-2	cell_line
secreting	cell_line
cells	cell_line
the	O
inducible	protein
EGR-1	protein
protein	protein
recognizes	O
this	O
element.	O
In	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
the	O
ZIP	DNA
site	DNA
serves	O
as	O
an	O
activator	O
for	O
IL-2	protein
gene	O
expression	O
,	O
and	O
a	O
combination	O
of	O
ZIP	DNA
and	O
NFAT	DNA
binding	DNA
sites	DNA
is	O
required	O
for	O
maximal	O
IL-2	DNA
promoter	DNA
activity	O
.	O
These	O
results	O
suggest	O
a	O
critical	O
role	O
of	O
the	O
ZIP	DNA
site	DNA
for	O
IL-2	DNA
promoter	DNA
activity	O
.	O

Activation	O
of	O
the	O
HIV-1	DNA
enhancer	DNA
by	O
the	O
LEF-1	protein
HMG	protein
protein	protein
on	O
nucleosome-assembled	DNA
DNA	DNA
in	O
vitro.	O
Lymphoid	protein
enhancer-binding	protein
factor	protein
1	protein
(	O
LEF-1	protein
)	O
is	O
a	O
regulatory	protein
high	protein
mobility	protein
group	protein
(HMG)	protein
protein	protein
that	O
activates	O
the	O
T	DNA
cell	DNA
receptor	DNA
alpha	DNA
(	DNA
TCR	DNA
alpha	DNA
)	DNA
enhancer	DNA
in	O
a	O
context-restricted	O
manner	O
in	O
T	cell_type
cells	cell_type
.	O
In	O
this	O
paper	O
we	O
demonstrate	O
that	O
the	O
distal	O
region	O
of	O
the	O
human	DNA
immunodeficiency	DNA
virus-1	DNA
(	DNA
HIV-1	DNA
)	DNA
enhancer	DNA
,	O
which	O
contains	O
DNA-binding	DNA
sites	DNA
for	O
LEF-1	protein
and	O
Ets-1,	O
also	O
provides	O
a	O
functional	O
context	O
for	O
activation	O
by	O
LEF-1	protein
.	O
First,	O
we	O
show	O
that	O
mutations	O
in	O
the	O
LEF-1	DNA
-binding	DNA
site	DNA
inhibit	O
the	O
activity	O
of	O
multimerized	DNA
copies	DNA
of	O
the	O
HIV-1	DNA
enhancer	DNA
in	O
Jurkat	cell_line
T	cell_line
cells	cell_line
,	O
and	O
that	O
LEF-1	protein
/GAL4	protein
can	O
activate	O
a	O
GAL4-substituted	DNA
HIV-1	DNA
enhancer	DNA
80-	O
to	O
100-fold	O
in	O
vivo.	O
Second,	O
recombinant	protein
LEF-1	protein
is	O
shown	O
to	O
activate	O
HIV-1	O
transcription	O
on	O
chromatin-assembled	DNA
DNA	DNA
in	O
vitro.	O
By	O
using	O
a	O
nucleosome	protein
-assembly	O
system	O
derived	O
from	O
Drosophila	O
embryos	O
,	O
we	O
find	O
that	O
the	O
packaging	O
of	O
DNA	O
into	O
chromatin	DNA
in	O
vitro	O
strongly	O
represses	O
HIV-1	O
transcription	O
and	O
that	O
repression	O
can	O
be	O
counteracted	O
efficiently	O
by	O
preincubation	O
of	O
the	O
DNA	O
with	O
LEF-1	protein
(or	O
LEF-1	protein
and	O
Ets-1	protein
)	O
supplemented	O
with	O
fractions	O
containing	O
the	O
promoter-binding	protein
protein	protein
,	O
Sp1	protein
.	O
Addition	O
of	O
TFE-3	protein
,	O
which	O
binds	O
to	O
an	O
E-box	DNA
motif	DNA
upstream	O
of	O
the	O
LEF-1	O
and	O
Ets-1	O
sites	O
,	O
further	O
augments	O
transcription	O
in	O
this	O
system.	O
Individually	O
or	O
collectively,	O
none	O
of	O
the	O
three	O
enhancer-binding	protein
proteins	protein
(	O
LEF-1	protein
,	O
Ets-1	protein
,	O
and	O
TFE-3	protein
)	O
could	O
activate	O
transcription	O
in	O
the	O
absence	O
of	O
Sp1	protein
.	O
A	O
truncation	protein
mutant	protein
of	O
LEF-1	protein
(	O
HMG-88	protein
),	O
which	O
contains	O
the	O
HMG	protein
box	protein
but	O
lacks	O
the	O
trans-activation	protein
domain	protein
,	O
did	O
not	O
activate	O
transcription	O
from	O
nucleosomal	DNA
DNA	DNA
,	O
indicating	O
that	O
bending	O
of	O
DNA	O
by	O
the	O
HMG	protein
domain	protein
is	O
not	O
sufficient	O
to	O
activate	O
transcription	O
in	O
vitro.	O
We	O
conclude	O
that	O
transcription	O
activation	O
by	O
LEF-1	protein
in	O
vitro	O
is	O
a	O
chromatin	DNA
-dependent	O
process	O
that	O
requires	O
a	O
functional	O
trans-activation	protein
domain	protein
in	O
addition	O
to	O
the	O
HMG	protein
domain	protein
.	O

HIV-1	protein
envelope	protein
glycoproteins	protein
induce	O
activation	O
of	O
activated	O
protein-1	protein
in	O
CD4+	cell_type
T	cell_type
cells	cell_type
[published	O
erratum	O
appears	O
in	O
J	O
Biol	O
Chem	O
1995	O
Dec	O
1;270(48):29038]	O
Activation	O
of	O
CD4	cell_type
positive	cell_type
T	cell_type
cells	cell_type
is	O
a	O
primary	O
requirement	O
for	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
entry	O
,	O
efficient	O
HIV	O
replication	O
,	O
and	O
progression	O
to	O
AIDS	O
,	O
Utilizing	O
CD4	cell_line
positive	cell_line
T	cell_line
cell	cell_line
lines	cell_line
and	O
purified	cell_type
T	cell_type
cells	cell_type
from	O
normal	O
individuals	O
,	O
we	O
have	O
demonstrated	O
that	O
native	protein
envelope	protein
glycoproteins	protein
of	O
HIV	O
,	O
gp	protein
160	protein
,	O
can	O
induce	O
activation	O
of	O
transcription	protein
factor,	protein
activated	protein
protein-1	protein
(	O
AP-1	protein
).	O
The	O
stimulatory	O
effects	O
of	O
gp160	protein
are	O
mediated	O
through	O
the	O
CD4	protein
molecule	protein
,	O
since	O
treatment	O
of	O
gp160	protein
with	O
soluble	O
CD4-IgG	protein
abrogates	O
its	O
activity,	O
and	O
CD4	cell_line
negative	cell_line
T	cell_line
cell	cell_line
lines	cell_line
fail	O
to	O
be	O
stimulated	O
with	O
gp160	protein
.	O
Immunoprecipitation	O
of	O
the	O
gp	protein
160	protein
-induced	O
nuclear	O
extracts	O
with	O
polyclonal	protein
antibodies	protein
to	O
Fos	protein
and	O
Jun	protein
proteins	protein
indicates	O
that	O
AP-1	protein
complex	protein
is	O
comprised	O
of	O
members	O
of	O
these	O
family	O
of	O
proteins.	O
The	O
gp160	protein
-induced	protein
AP-1	protein
complex	protein
is	O
dependent	O
upon	O
protein	O
tyrosine	O
phosphorylation	O
and	O
is	O
protein	O
synthesis-independent	O
.	O
This	O
stimulation	O
can	O
also	O
be	O
abolished	O
by	O
inhibitors	O
of	O
protein	protein
kinase	protein
C	protein
,	O
but	O
it	O
is	O
unaffected	O
by	O
calcium	O
channel	O
blocker	O
or	O
cyclosporine	O
A	O
.	O
This	O
gp160	protein
treatment	O
adversely	O
affects	O
the	O
functional	O
capabilities	O
of	O
T	cell_type
cells	cell_type
:	O
pre-treatment	O
of	O
CD4+	cell_type
T	cell_type
cells	cell_type
with	O
gp160	protein
for	O
4	O
h	O
at	O
37	O
degrees	O
C	O
inhibited	O
anti-CD3	protein
-induced	O
interleukin-2	protein
secretion	O
.	O
Effects	O
similar	O
to	O
gp160	protein
were	O
seen	O
with	O
anti-CD4	protein
mAb	protein
.	O
The	O
aberrant	O
activation	O
of	O
AP-1	protein
by	O
gp160	protein
in	O
CD4	cell_type
positive	cell_type
T	cell_type
cells	cell_type
could	O
result	O
in	O
up-regulation	O
of	O
cytokines	protein
containing	O
AP-1	DNA
sites	DNA
,	O
e.g.	O
interleukin-3	protein
and	O
granulocyte	protein
macrophage	protein
colony-stimulating	protein
factor	protein
,	O
and	O
concurrently	O
lead	O
to	O
T	cell_type
cell	cell_type
unresponsiveness	O
by	O
inhibiting	O
interleukin-2	protein
secretion	O
.	O

